[{"lang": "ja", "path": "dac", "title": "ヒトデータ審査委員会", "fulltext": "", "modified": "2025-05-07", "introtext": "<p style=\"font-size: 22px; line-height: 20px;\">ヒトデータ審査委員会</p>\r\n<p style=\"font-size: 22px; line-height: 20px;\">&nbsp;</p>\r\n<p style=\"font-size: 18px; line-height: 20px;\">&nbsp; &nbsp; &nbsp; &nbsp;<a href=\"/files/DAC/HumanDataReviewBoard2025.pdf\" target=\"_blank\">ヒトデータ審査委員会名簿</a></p>\r\n<p style=\"font-size: 14px; line-height: 20px;\">&nbsp;</p>\r\n<p style=\"font-size: 14px; line-height: 20px;\">&nbsp;</p>\r\n<p style=\"font-size: 16px; line-height: 20px;\">第一回（２０２４年９月２５日）<a href=\"index.php?Itemid=358&amp;lang=ja\" target=\"_blank\">議事次第</a>　　<a href=\"files/DAC/DAC_summary-1.pdf\" target=\"_blank\">議事要旨</a></p>\r\n<p style=\"font-size: 14px; line-height: 20px;\">&nbsp;</p>\r\n<p style=\"font-size: 14px; line-height: 20px;\">&nbsp;</p>\r\n<p style=\"font-size: 18px; line-height: 20px;\">&nbsp; &nbsp; &nbsp; &nbsp;<a href=\"https://biosciencedbc.jp/research-development/nbdc-services/discontinued/#humandbs-dac\" target=\"_blank\" rel=\"noopener\">過去のNBDCヒトデータ審査委員会</a></p>\r\n<p style=\"font-size: 14px; line-height: 20px;\">&nbsp;</p>\r\n<p style=\"font-size: 14px; line-height: 20px;\">&nbsp;</p>", "publish_up": "2013-01-05"}, {"lang": "en", "path": "dac", "title": "Data Access Committee", "fulltext": "", "modified": "2025-05-07", "introtext": "<p style=\"font-size: 14px; line-height: 20px;\"><a href=\"files/DAC/HumanDataReviewBoard2025en.pdf\" target=\"_blank\">Human Data Review Board Members</a></p>", "publish_up": "2013-01-05"}, {"lang": "ja", "path": "dac/committee-1", "title": "第一回ヒトデータ審査委員会　議事次第", "fulltext": "", "modified": "2024-11-07", "introtext": "<p><strong><span style=\"font-family: helvetica; font-size: 15pt; color: #3366ff;\">第 1 回　ヒトデータ審査委員会</span></strong></p>\r\n<p><span style=\"font-family: helvetica; font-size: 10pt;\">日　時　：2024年9月25日(水)　11:00〜12:00</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 10pt;\">場　所　：京都大学 東京オフィス　大会議室Ａ（オンライン ZOOM併用）</span></p>\r\n<p>&nbsp;</p>\r\n<p><strong><span style=\"font-family: helvetica; font-size: 12pt;\">【議事次第】</span></strong></p>\r\n<ul style=\"list-style-type: none;\">\r\n<li><span style=\"font-family: helvetica; font-size: 11pt;\">1.　利用状況報告（報告）</span></li>\r\n<li><span style=\"font-family: helvetica; font-size: 11pt;\">2.　審査システムの仕様変更について（報告）</span></li>\r\n<li><span style=\"font-family: helvetica; font-size: 11pt;\">3.　利用申請時の研究者要件確認について（議論）</span></li>\r\n<li><span style=\"font-family: helvetica; font-size: 11pt;\">4.　フリーディスカッション</span></li>\r\n</ul>\r\n<p>&nbsp;</p>\r\n<p><strong><span style=\"font-family: helvetica; font-size: 12pt;\">【配布資料】</span></strong></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">資料１：<a href=\"files/DAC/1st_meeting/DAC-1_document-1.pdf\" target=\"_blank\">第 1 回ヒトデータ審査委員会説明資料</a></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">参考資料１：第 1 回ヒトデータ審査委員会　出席者名簿</span></p>", "publish_up": "2024-11-07"}, {"lang": "ja", "path": "data-processing", "title": "加工データ", "fulltext": "", "modified": "2024-03-31", "introtext": "<p><span style=\"font-family: helvetica; font-size: 15pt;\"><strong>データ加工について</strong></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　データ利用者の利便性向上のため、NBDCヒトデータベースに制限公開データとして登録されたデータ（元データ）に対して一定のワークフローにより加工した、アライメントデータ・バリアントコールデータ・統計データを、ヒトデータ審査委員会によって元データの利用を許可されたデータ利用者が希望する場合、加工データも併せて閲覧・利用することを可能にしています。加工データは、元のデータに紐づく形で配置され、Analysis と Datasetのtitleに 「Processed by JGA」と記載されています。 なお、加工データを含む解析結果を論文等で公表する際は、<span style=\"text-decoration: underline;\"><strong>元データのアクセッション番号を記載して下さい</strong></span>。</span></p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 15pt;\"><strong>加工方法</strong></span></p>\r\n<p><strong><span style=\"font-family: helvetica; font-size: 11pt;\">・生殖系列の全ゲノムシークエンスデータの加工</span></strong></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　　 GATK best practice - Germline short variant discovery（SNPs + Indels）に則り加工しております。詳細は<a href=\"index.php?option=com_content&amp;view=article&amp;id=2277&amp;Itemid=2286&amp;lang=ja\" target=\"_blank\">こちら</a></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　　ワークフローのソースコード（jga-analysis）：<a href=\"https://github.com/ddbj/jga-analysis\" target=\"_blank\" rel=\"noopener\">https://github.com/ddbj/jga-analysis</a></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　　<a href=\"index.php?option=com_content&amp;view=article&amp;id=2278&amp;Itemid=2287&amp;lang=ja\" target=\"_blank\">加工済みデータ一覧</a></span></p>\r\n<p>&nbsp;</p>\r\n<p><strong><span style=\"font-family: helvetica; font-size: 11pt;\">・インピュテーション用の参照パネルデータの加工</span></strong></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　　bcftools（バージョン1.9）ならびに、beagle-bref3（バージョン28Jun21.220）を用いて参照パネルを作成しております。詳細は<a href=\"index.php?option=com_content&amp;view=article&amp;id=2279&amp;Itemid=2288&amp;lang=ja\" target=\"_blank\">こちら</a></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　　ワークフローのソースコード（imputation-server-wf）：</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　　　　　・bcftools-index-t.cwl：<a href=\"https://github.com/ddbj/imputation-server-wf/blob/main/Tools/bcftools-index-t.cwl\" target=\"_blank\" rel=\"noopener\">https://github.com/ddbj/imputation-server-wf/blob/main/Tools/bcftools-index-t.cwl</a></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　　　　　・beagle-bref3.cwl：<a href=\"https://github.com/ddbj/imputation-server-wf/blob/main/Tools/beagle-bref3.cwl\" target=\"_blank\" rel=\"noopener\">https://github.com/ddbj/imputation-server-wf/blob/main/Tools/beagle-bref3.cwl</a></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　　<a href=\"index.php?option=com_content&amp;view=article&amp;id=2280&amp;Itemid=2289&amp;lang=ja\" target=\"_blank\">加工済みデータ一覧</a></span></p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">なお、DBCLSおよび生命情報・DDBJ センターが実施する当該データ加工において、NBDCヒトデータベースの利用促進活動の目的以外に利用することはありません。</span></p>", "publish_up": "2022-12-22"}, {"lang": "en", "path": "data-processing", "title": "Data Processing", "fulltext": "", "modified": "2024-03-31", "introtext": "<h3><strong><span style=\"color: #000000;\">About Data Processing</span></strong></h3>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">&nbsp; For the convenience of data users, alignment data, variant call data, and statistical data, which are processed by a certain workflow on data deposited to the NBDC Human Database as controlled-access data (original data), can be used together with the original data if the user who is permitted to use the original data by the Human Data Review Board and wishes to use the processed data as well. The processed data are placed in a way that they are connected to the original data, and are indicated as \"Processed by JGA\" in the title of the Analysis and Dataset. When publishing analysis results including processed data, please <span style=\"text-decoration: underline;\"><strong>include the accession number of the original data in the article</strong></span>.</span></p>\r\n<p>&nbsp;</p>\r\n<h3><strong><span style=\"color: #000000;\">How to process the data:</span></strong></h3>\r\n<p><strong><span style=\"font-family: helvetica; font-size: 11pt;\">- Whole genome sequencing analysis data (germline)</span></strong></p>\r\n<ul style=\"list-style: circle; font-family: helvetica; font-size: 11pt;\">\r\n<li><span style=\"font-family: helvetica; font-size: 11pt;\">Data were processed by using of <a href=\"en/whole-genome-sequencing\" target=\"_blank\" rel=\"noopener\">GATK Best Practice - Germline short variant discovery (SNPs and Indels)</a></span></li>\r\n<li><span style=\"font-family: helvetica; font-size: 11pt;\">Workflow Source Code (jga-analysis): <a href=\"https://github.com/ddbj/jga-analysis\" target=\"_blank\" rel=\"noopener\">https://github.com/ddbj/jga-analysis</a></span></li>\r\n<li><a href=\"index.php?option=com_content&amp;view=article&amp;id=2283&amp;Itemid=2292&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 11pt;\">List of processed data</span></a></li>\r\n</ul>\r\n<p>&nbsp;</p>\r\n<p><strong><span style=\"font-family: helvetica; font-size: 11pt;\">- Imputation reference panel</span></strong></p>\r\n<ul style=\"list-style: circle; font-family: helvetica; font-size: 11pt;\">\r\n<li><span style=\"font-family: helvetica; font-size: 11pt;\">Reference panels were created by using of <a href=\"en/imputation-reference\" target=\"_blank\" rel=\"noopener\">bcftools (version 1.9) and beagle-bref3 (version 28Jun21.220)</a></span></li>\r\n<li><span style=\"font-family: helvetica; font-size: 11pt;\">Workflow Source Code (imputation-server-wf): </span>\r\n<ul style=\"list-style: square; font-family: helvetica; font-size: 11pt;\">\r\n<li><span style=\"font-family: helvetica; font-size: 11pt;\">bcftools-index-t.cwl: <a href=\"https://github.com/ddbj/imputation-server-wf/blob/main/Tools/bcftools-index-t.cwl\" target=\"_blank\" rel=\"noopener\">https://github.com/ddbj/imputation-server-wf/blob/main/Tools/bcftools-index-t.cwl</a></span></li>\r\n<li><span style=\"font-family: helvetica; font-size: 11pt;\">beagle-bref3.cwl: <a href=\"https://github.com/ddbj/imputation-server-wf/blob/main/Tools/beagle-bref3.cwl\" target=\"_blank\" rel=\"noopener\">https://github.com/ddbj/imputation-server-wf/blob/main/Tools/beagle-bref3.cwl</a></span></li>\r\n</ul>\r\n</li>\r\n<li><a href=\"index.php?option=com_content&amp;view=article&amp;id=2285&amp;Itemid=2294&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 11pt;\">List of processed data</span></a></li>\r\n</ul>\r\n<p>&nbsp;</p>\r\n<p>* In such data processing conducted by the DBCLS and the Bioinformation and DDBJ Center, the data will not be used for any purposes other than those of activities to promote the use of the NBDC human database.</p>", "publish_up": "2022-12-22"}, {"lang": "ja", "path": "data-submission", "title": "データの提供", "fulltext": "", "modified": "2025-04-24", "introtext": "<p class=\"text-info\"><span style=\"color: #000000;\">2017年5月30日より改正個人情報保護法および改正倫理指針が施行されます。データ提供を行う際には、新指針に沿った手続きを実施する必要がありますのでご留意ください。詳細は</span><a href=\"/faq\" target=\"_blank\" rel=\"noopener noreferrer\">FAQ</a><span style=\"color: #000000;\">をご参照ください。</span></p>\r\n<p><strong><span style=\"font-size: 14pt; color: #ff0000;\">＝＝2020年9月30日より、メールでの申請書類受付は終了し、申請システムによる手続きへ移行しました＝＝</span></strong></p>\r\n<p>　※　過去のデータ提供申請の際に添付いただいた倫理関係書類の取り込み中です。</p>\r\n<p>&nbsp;</p>\r\n<p>NBDCヒトデータベースへのヒトに関するデータ（遺伝情報、臨床情報、画像情報など）の提供手続きは以下の通りです。</p>\r\n<ol>\r\n<li><a href=\"/guidelines/data-sharing-guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">NBDCヒトデータ共有ガイドライン</a>、<a href=\"/guidelines/security-guidelines-for-submitters\" target=\"_blank\" rel=\"noopener noreferrer\">NBDCヒトデータベースセキュリティガイドライン（データ提供者向け）</a>の最新版を熟読し、権利や責務について確認してください。</li>\r\n<li>データ提供申請に必要な以下の情報を準備してください。\r\n<ul style=\"list-style-type: circle;\">\r\n<li>提供するデータに関する情報：研究内容の概要（目的、方法、対象、発表論文など）、データの種類（名称・量、アクセス制限レベルの分類に関する情報、公開可能日など）</li>\r\n<li>研究代表者の氏名、所属情報（所属機関名、職名、所在地）、連絡先（電話番号、メールアドレス）</li>\r\n<li>所属機関の長の氏名、職名、連絡先　※所属機関の長とは、倫理審査委員会によって承認された研究計画の実施を許可する者を指します。</li>\r\n<li>提供するデータを産出した際の研究計画書（倫理審査申請書）</li>\r\n<li>インフォームドコンセントの際の説明文書および同意文書のフォーム　※実際に署名されたものではなくフォーム（書式）をご提出ください。</li>\r\n<li>所属機関等の倫理審査委員会の審査・承認を受けた上で、所属機関の長が研究実施について許可したことが分かる書面（承認通知書など）の写し</li>\r\n</ul>\r\n<p>※倫理関係書類は、ヒトデータ審査委員会による申請審査の目的でのみ使用いたします。</p>\r\n</li>\r\n<li>データ提供申請には、研究代表者、ならびに、研究代表者によって指名された申請者（研究代表者に代わってデータ提供申請手続きを実施する者）やデータアップロード担当者のDDBJアカウントが必要ですので、<a href=\"https://www.ddbj.nig.ac.jp/ddbj-account.html\" target=\"_blank\" rel=\"noopener noreferrer\">アカウント登録</a>を行ってください。所属機関の長のアカウントは不要です。</li>\r\n<li>JavaScriptを有効にした上で<a href=\"https://humandbs.ddbj.nig.ac.jp/nbdc/application/\" target=\"_blank\" rel=\"noopener noreferrer\">申請システム</a>（推奨ブラウザ：Chrome、Firefox）へDDBJアカウント・パスワードを使用してログインしてください。<strong>※DDBJアカウントの登録内容の反映に15分程度要しますのでご留意ください。</strong>\r\n<div style=\"border-style: solid; border-width: 1px; margin-top: 11px; padding-left: 5px; padding-right: 5px;\">\r\n<ul style=\"list-style-type: square;\">\r\n<li>既に提供しているデータと<strong><span style=\"color: #ff0000;\">同じポリシーのデータ</span>（同じインフォームドコンセント説明文書や同意文書、研究計画書由来のデータ）<span style=\"color: #ff0000;\">の差し替えや追加を行なう場合</span></strong>は、<span style=\"text-decoration: underline;\"><strong>提供データ更新申請</strong></span>になります（7.をご参照ください）。ポリシーが異なる場合や新規申請は、データ提供申請になります。</li>\r\n<li>明らかに『人を対象とする生命科学・医学系研究に関する倫理指針』の対象にならないヒト由来試料からのデータ（既に学術的な価値が定まり、研究用として広く利用され、かつ、一般に入手可能な試料・情報）を提供する場合、研究代表者の署名済み『データ提供申請簡易審査希望届』（自由書式）を提出することで、所属機関の長による研究実施許可書（承認通知書等）の代わりとすることができます（<a href=\"files/deposit_exemption.docx\">例参照</a>）。</li>\r\n<li>異なるアクセスレベル（非制限公開、制限公開）のデータを一度に申請することが可能です。</li>\r\n</ul>\r\n</div>\r\n<ul style=\"list-style-type: lower-roman;\">\r\n<li>データ提供申請グループを作成します。画面左側にあるメニューの [グループ作成] を選択し、グループ名、グループの説明、グループ種別『データ提供申請グループ』を入力し、保存ボタンを押すことでグループが作成されます。[メンバタブ] の [メンバを招待する] ボタンをクリックし、研究代表者、申請者、データアップロード担当者の所属機関が発行したメールアドレスもしくはDDBJアカウントを入力し、招待します。招待されたメンバへメールが送付され、メンバにより招待が許可されると、グループにメンバとして登録されます。</li>\r\n<li>メンバ登録後、データ提供申請の代表者をグループのPIに変更した上で、申請フォームの入力に進んでください。代表者がグループを作成した場合は、既にPI/Ownerになっているため、変更の必要はありません。なお、申請には日本語表記の氏名、電話番号、職名等の情報が必要になります。申請システムログイン後の画面右上にありますDDBJアカウントをクリックし、表示される『ユーザ情報の更新』から情報を更新して下さい。</li>\r\n<li>[データ提供申請を行う] ボタンをクリックします。遷移先のページの提供申請一覧の上にある言語を選択し（日本で研究活動を実施する研究者は、原則、日本語を選択してください）、[新規申請を開始する] ボタンをクリックします。正常に作成されると申請の入力フォームに遷移します。</li>\r\n<li>データ提供申請グループを選択します。当該グループに登録されている研究代表者、申請者の情報は自動的に入力されます。修正が必要な場合は、データ提供申請グループの登録情報を修正してください。</li>\r\n<li>申請フォームに沿って必要事項を入力・必要書類の添付をしてください。最後に申請ボタンを押してください。\r\n<ul style=\"list-style-type: circle;\">\r\n<li>所属機関の長：倫理審査委員会によって承認された研究計画の実施を許可する者が該当するので、審査結果通知書等に記載された所属機関の長の情報を入力してください。</li>\r\n<li>データを提供する研究題目：倫理審査委員会による承認＋所属機関の長による許可を受けた研究計画書に記載された題目名を記載してください。</li>\r\n<li>研究計画書（倫理審査申請書）、インフォームドコンセントの説明文書・同意文書、承認通知書、等の書類を添付する際には、file typeを指定してください。1つのファイルに対し、複数個のfile typeを指定することが可能です。</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>データ提供申請の審査結果はデータ提供申請グループ宛のメールにて通知致します。通常、必要な書面が整ってから2週間程度で通知されますが、繁忙期や祝日等の状況により遅くなることがありますのでご了承ください。</li>\r\n<li>承認された場合は、データのアップロード方法や専用サイト（案）の確認依頼について、ヒトデータ審査委員会事務局から別途ご連絡いたします<a href=\"#info1\">*<sup>1</sup></a>。</li>\r\n<li>既に提供しているデータと同じポリシーのデータの差し替えや追加を行なう場合は、<strong>提供データ更新申請</strong>を選択してください。申請システムのデータ提供申請一覧から当初のデータ提供申請の際に発番された [J-DS番号] を押下することで詳細画面に遷移し、セレクトボックスから [提供データ更新申請] を選択することで、申請書の作成及び申請が可能です。提供データ更新申請の際には、更新・追加いただくファイルに関する詳細一覧を作成いただく必要があります。<a href=\"files/replace_filelist.xls\">ファイルをダウンロード</a>いただき、必要事項（1ファイルにつき1行で記載してください。データ追加の場合は、B・E・F・H～K列は必須です。差し替えの場合はB・E・F・H～K列に加え、G・L列も必須です。）を記載の上、添付してください。研究計画書など倫理関係書類が更新されているようでしたら、併せて添付して下さい。</li>\r\n</ol>\r\n<p>&nbsp;</p>\r\n<p style=\"margin-left: 30px;\"><a name=\"info1\">*1</a>：データのアクセスレベルと種類によって、所定のデータベースへ登録していただきます。データ登録方法については各サイトを、また、登録先データベースに迷った際には、<a href=\"https://www.ddbj.nig.ac.jp/data-categories.html\" target=\"_blank\" rel=\"noopener noreferrer\">こちらのサイト</a>をご参照ください。</p>\r\n<p style=\"margin-left: 30px;\">　　・非制限公開データ（NGS配列データ）：<a href=\"https://www.ddbj.nig.ac.jp/dra/index.html\" target=\"_blank\" rel=\"noopener noreferrer\">DDBJ Sequence Read Archive（DRA）</a></p>\r\n<p style=\"margin-left: 30px;\">　　・非制限公開データ（発現データ）：<a href=\"https://www.ddbj.nig.ac.jp/gea/index.html\" target=\"_blank\" rel=\"noopener noreferrer\">Genomic Expression Archive（GEA）</a></p>\r\n<p style=\"margin-left: 30px;\">　　・非制限公開データ（参照配列データなど）：<a href=\"https://www.ddbj.nig.ac.jp/ddbj/mss.html\" target=\"_blank\" rel=\"noopener noreferrer\">DDBJ</a></p>\r\n<p style=\"margin-left: 30px;\">　　・制限公開データ全般：<a href=\"https://www.ddbj.nig.ac.jp/jga/index.html\" target=\"_blank\" rel=\"noopener noreferrer\">Japanese Genotype-phenotype Archive（JGA）</a></p>\r\n<p>&nbsp;</p>\r\n<p style=\"margin-left: 30px;\">　<span style=\"color: #ff0000;\">※　登録したデータを投稿論文等に引用する場合は、各データベースへデータが格納された際に発行されるアクセッション番号（DRR、E-GEAD、AP、JGAS/JGAD 番号）をご記載ください。</span></p>\r\n<p style=\"margin-left: 30px;\">　<span style=\"color: #ff0000;\">※　提供申請内容の一部（データ概要）は、NBDCヒトデータベースWebサイトの各研究ページより公開されます。</span></p>\r\n<p style=\"margin-left: 30px;\">　　　掲載内容につきましては、研究データ一覧および各研究ページをご参照ください。公開時期につきましては、別途ご相談ください。</p>\r\n<p style=\"margin-left: 30px;\">　※　今後、国内外のデータベース間においてデータ共有を進めていく可能性があります。その場合、以下の方針で行なう予定です。</p>\r\n<p style=\"margin-left: 30px;\">　　・非制限公開データ：ミラー、データの交換等による共有。</p>\r\n<p style=\"margin-left: 30px;\">　　・制限公開データ：メタデータ（データについての説明項目）のみを交換し、データ利用の審査および配布はDBCLS/生命情報・DDBJセンターが担当。</p>\r\n<p style=\"margin-left: 30px;\">なお、生命情報・DDBJセンターのDDBJ/DRAは、<a href=\"http://www.ncbi.nlm.nih.gov/\" target=\"_blank\" rel=\"noopener noreferrer\">National Center for Biotechnology Information (NCBI)</a>および<a href=\"http://www.ebi.ac.uk/ena/\" target=\"_blank\" rel=\"noopener noreferrer\">European Nucleotide Archive / The European Bioinformatics Institute (ENA / EBI)</a>と共に構成される<a href=\"https://www.ddbj.nig.ac.jp/insdc.html\" target=\"_blank\" rel=\"noopener noreferrer\">International Nucleotide Sequence Database Collaboration (INSDC)</a>事業として運用されています。そのため、DDBJ/DRAから公開されたデータは、INSDCメンバー間で共有されます。JGAにつきましても、今後&nbsp;<a href=\"http://www.ncbi.nlm.nih.gov/gap\" target=\"_blank\" rel=\"noopener noreferrer\">database of Genotypes and Phenotypes (dbGaP)</a>および<a href=\"https://www.ebi.ac.uk/ega/\" target=\"_blank\" rel=\"noopener noreferrer\">European Genome-phenome Archive (EGA)</a>と共に一部のメタデータ（データ提供時にいただくデータを説明する付帯情報）の共有を行なっていく予定です。ご了承ください。</p>", "publish_up": "2013-01-02"}, {"lang": "en", "path": "data-submission", "title": "Data Submission", "fulltext": "", "modified": "2025-04-24", "introtext": "<p>The following describes the procedures for submission of human data (genomic and genetic information, clinical information, photographic information, etc.) to the NBDC Human Database.</p>\r\n<ol><ol>\r\n<li>Carefully read <a href=\"/en/guidelines/data-sharing-guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">the latest NBDC Guidelines for Human Data Sharing</a>&nbsp;and <a href=\"/en/guidelines/security-guidelines-for-submitters\" target=\"_blank\" rel=\"noopener noreferrer\">NBDC Security Guidelines for Human Data (for Data Submitters)</a></li>\r\n<li>Collect the following information and documents.\r\n<ul style=\"list-style-type: circle;\">\r\n<li>Information on the data to be submitted: a summary of the study (its purpose, method, subject, published papers, etc.) and the kind of data (the name, size, access restriction category, potential release date, etc.).</li>\r\n<li>The name of the principal investigator (PI), his/her affiliated institution, and contact information.</li>\r\n<li>The name, title, and e-mail address of the head of the PI's affiliated institution. *The head of the institution refers to the person who endorses the institutional review board (IRB)'s approval or the decision that IRB is unnecessary.</li>\r\n<li>The research plan (application form for IRB) that you obtained the data to be provided.</li>\r\n<li>The consent form used to give an informed consent to research subjects. *Provide the \"FORM\", not the signed documents.</li>\r\n<li>Notification from IRB approval, and permission to conduct the research given by the head of the PI's affiliated organization.</li>\r\n</ul>\r\n<p>* Documents concerning ethics review will be used only for the purpose of reviewing applications for data use / submission by the Human Data Review Board</p>\r\n</li>\r\n<li>To apply an application for data submission, a DDBJ account for each researcher (PI, applicant, and data uploader) is required. If you do not have the account, <a href=\"https://www.ddbj.nig.ac.jp/ddbj-account-e.html\" target=\"_blank\" rel=\"noopener noreferrer\">please create it</a> before the application. The account for the head of PI's affiliated organization is NOT required.</li>\r\n<li>Please log-in to <a href=\"https://humandbs.ddbj.nig.ac.jp/nbdc/application/\" target=\"_blank\" rel=\"noopener noreferrer\">the NBDC application system</a> with your DDBJ account and password (recommended browsers: Chrome, Firefox). You need JavaScript enabled to use it.　<strong>**Please note that it takes about 15 minutes to reflect the creations/alterations of your DDBJ account&nbsp;information.**</strong>\r\n<div style=\"border-style: solid; border-width: 1px; margin-top: 11px; padding-left: 5px; padding-right: 5px;\">\r\n<ul style=\"list-style-type: square;\">\r\n<li>If you are adding or replacing data with the data that were obtained <strong><span style=\"color: #ff0000;\">under the same policy</span></strong> as the data you have already provided<strong> (i.e., data that were obtained with the same consent form and that were subjected to the same research proposal)</strong>, please submit <span style=\"text-decoration: underline;\"><strong>the application for Updating Submitted Data</strong></span> (see 7.). Submit a new application for data submission if the data policy is different.</li>\r\n<li>When the data submitter provides data that is clearly not the subject of “Ethical Guidelines for Human Genome/Genetic Analysis Research” or “Ethical Guidelines for Medical and Health Research Involving Human Subjects” to the NBDC Human Database, the data submitter must submit a “statement requesting a simplified review of application for data submission” (in an arbitrary format) signed by the PI (<a href=\"files/deposit_exemption_e.docx\">see example</a>). Submission of this statement can be a substitute for submission of documents concerning ethics review (e.g., research protocol, informed consent form, and notice of approval).</li>\r\n<li>It is possible to apply for data with different access levels (unrestricted-access and controlled access) at once.</li>\r\n</ul>\r\n</div>\r\n<ul style=\"list-style-type: lower-roman;\">\r\n<li>Please create a group. Select [Create Group] in the menu box and enter group information: Group Name, Description, Type (Data Submitter Group). Please save the information. Then, select [Member tab] and press [Invite] button. Please invite your collaborators to the Data Submitter Group. Data Submitter Groups are needed to be included following investigators: PI, applicant, and data uploaders. The member who has no DDBJ account at this point, please enter his/her e-mail address issued by his/her affiliated organization. An e-mail is sent to the invited members, and they accept the invitation, they will be registered as a member of the group. PI of the data submission application must be set as \"PI\" in the group. It can be change with radio button in the Member tab.</li>\r\n<li>After the member registration, please start data submission application (press [Application for data submission]).</li>\r\n<li>Please select \"Language\" and press [Create new application] button. Researchers conducting research activities in Japan, in principle, should select Japanese language.</li>\r\n<li>Please select your Data Submitter Group. Information of PI and collaborators registered to the group are entered automatically. If any information needs to be revised, please revise the registered information of the Data Submitter Group.</li>\r\n<li>Please fill out the application form and attach the required documents. Finally, press [Apply] button.\r\n<ul style=\"list-style-type: circle;\">\r\n<li>A head of the organization: The person who permits the implementation of the research plan approved by an Ethical Review Board (ERB) is applicable, so please enter the information of the head of the organization to which the researcher belongs to as indicated on the notification from the ethical review results.</li>\r\n<li>Title of the Study: Please write the same study title which was shown in the research proposal approved by ERB.</li>\r\n<li>When you attach documents, please specify the file type; multiple file types can be specified for one file.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>The Data Submitter Group Member will be notified the decision of the review by e-mail (normally, within a couple of weeks after complete the information and documents needed for the review).</li>\r\n<li>If the application is approved, the secretariat of NBDC Human Data Review Board will contact you separately about how to upload the data and request confirmation of the dedicated website (draft)<sup>*1</sup>.</li>\r\n<li>If you are adding or replacing data with the data that were obtained under the same policy as the data you have already provided, please submit the application for <span style=\"text-decoration: underline;\"><strong>Updating Submitted Data</strong></span> linked to the previous application for data submission. Please apply \"The application for Updating Submitted Data\" via the NBDC application system. [Menu] &gt; [Application for data submission] &gt; press the appropriate J-DS number in the List &gt; select [The application for Updating Submitted Data] then press [Start] button. When you submit the&nbsp;application for updating submitted data, you need to prepare a list of files to be updated or added. Please download <a href=\"files/replace_filelist_e.xls\">this form</a> and fill it out. When adding data, columns B, E, F, H to K are required. When replacing data, columns G and L are also required in addition to columns B, E, F, H to K. If the research plan and other related documents have been updated, please attach them as well.</li>\r\n</ol></ol>\r\n<p>&nbsp;</p>\r\n<p style=\"margin-left: 30px;\">*1 Depending on the access level and type of data, you will be asked to upload your data in a designated database. Please refer to the respective websites for information on how to upload your data, and if you are unsure of which database to register to, please check <a href=\"https://www.ddbj.nig.ac.jp/documents/data-categories-e.html\" target=\"_blank\" rel=\"noopener noreferrer\">this website</a>.</p>\r\n<p style=\"margin-left: 70px;\">- Unrestricted-access data (sequence reads derived from Next Generation Sequencers): <a href=\"https://www.ddbj.nig.ac.jp/dra/index-e.html\" target=\"_blank\" rel=\"noopener noreferrer\">DDBJ Sequence Read Archive (DRA)</a></p>\r\n<p style=\"margin-left: 70px;\">- Unrestricted-access data (Expression data): <a href=\"https://www.ddbj.nig.ac.jp/gea/index-e.html\" target=\"_blank\" rel=\"noopener noreferrer\">Genomic Expression Archive (GEA)</a></p>\r\n<p style=\"margin-left: 70px;\">- Unrestricted-access data (Annotated/Assembled Sequences): <a href=\"https://www.ddbj.nig.ac.jp/ddbj/mss-e.html\" target=\"_blank\" rel=\"noopener noreferrer\">DDBJ</a></p>\r\n<p style=\"margin-left: 70px;\">- Controlled-Access data: <a href=\"https://www.ddbj.nig.ac.jp/jga/index-e.html\" target=\"_blank\" rel=\"noopener noreferrer\">Japanese Genotype-phenotype Archive (JGA)</a></p>\r\n<p>&nbsp;</p>\r\n<p style=\"margin-left: 30px;\"># In referring to data sets in your paper, use the data set IDs that were issued (which can also be used as DRA, E-GEAD, AP, JGAS/JGAD).</p>\r\n<p style=\"margin-left: 30px;\"><span style=\"color: #ff0000;\"># Some of the information provided in the application for data submission (the summary of data) and researcher information (the name of the PI, the name of his/her affiliated institution, relevant funding/grant, and related publications) will be made public on the web page for the study found in the NBDC Human Database website. </span></p>\r\n<p style=\"margin-left: 30px;\">For an example of published information, please see the list of research data and the web page for each study. Please contact us to discuss the information content and the timing of publication.</p>\r\n<p style=\"margin-left: 30px;\"><span style=\"color: #ff0000;\"># It is possible that data will be shared in the future with domestic and overseas databases. The following policy will apply to such data sharing.</span></p>\r\n<p style=\"margin-left: 70px;\">- Unrestricted-access data: sharing will be conducted through mirror sites, data exchange, etc.</p>\r\n<p style=\"margin-left: 70px;\">- Controlled-access data: only metadata (descriptions of the main data) will be exchanged; the DBCLS will continue to review data use and to distribute data to only approved data users.</p>\r\n<p style=\"margin-left: 30px;\">There is a trilateral cooperative relationship among the DDBJ, <a href=\"http://www.ncbi.nlm.nih.gov/\" target=\"_blank\" rel=\"noopener noreferrer\">the National Center for Biotechnology Information (NCBI) </a>, and <a href=\"http://www.ebi.ac.uk/ena/\" target=\"_blank\" rel=\"noopener noreferrer\">the European Nucleotide Archive of the European Bioinformatics Institute (ENA/EBI) </a>. For this reason, the data stored in the DRA are shared with <a href=\"http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi\" target=\"_blank\" rel=\"noopener noreferrer\">the Sequence Read Archive (SRA) </a> and <a href=\"http://www.ebi.ac.uk/ena/\" target=\"_blank\" rel=\"noopener noreferrer\">the EBI Sequence Read Archive (ERA) </a>. Some of the metadata (the supplementary data submitted at the time of data submission that explain the main data) is planned to be shared in the future with <a href=\"http://www.ncbi.nlm.nih.gov/gap\" target=\"_blank\" rel=\"noopener noreferrer\">the database of Genotypes and Phenotypes (dbGap) </a> and <a href=\"https://www.ebi.ac.uk/ega/\" target=\"_blank\" rel=\"noopener noreferrer\">the European Genome-phenotype Archive (EGA) </a>. We appreciate your understanding.</p>\r\n<p>&nbsp;</p>", "publish_up": "2013-01-02"}, {"lang": "ja", "path": "data-use", "title": "データの利用", "fulltext": "", "modified": "2025-04-24", "introtext": "<p><span style=\"font-family: helvetica; font-size: 10pt;\">NBDCヒトデータベースにおいて提供しているヒトに関するデータの利用手続きは以下の通りです。</span></p>\r\n<div style=\"border-style: solid; border-width: 1px; padding-left: 5px; display: inline-block;\">\r\n<p><span style=\"font-family: helvetica; font-size: 10pt;\">データ利用期間中における1年毎のデータ利用報告申請、ならびに、データ利用終了時のデータ利用終了申請を未提出のガイドライン違反者は<a href=\"index.php?option=com_content&amp;view=article&amp;id=2631&amp;Itemid=2573&amp;lang=ja\" target=\"_blank\">こちら</a>に公表されます。</span></p>\r\n</div>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 15pt;\"><strong>&nbsp;<span style=\"text-decoration: underline;\">非制限公開データ</span></strong></span><span style=\"text-decoration: underline;\"><span style=\"font-family: helvetica; font-size: 11pt;\"> （利用可能な研究データ一覧のアクセス制限欄に”非制限公開”と表記。）</span></span></p>\r\n<p style=\"margin-left: 30px;\">1.&nbsp;<a href=\"/guidelines/data-sharing-guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">NBDCヒトデータ共有ガイドライン</a>の最新版を熟読してください。</p>\r\n<p style=\"margin-left: 30px;\">2. <a href=\"index.php?option=com_content&amp;view=article&amp;id=58&amp;Itemid=308\" target=\"_blank\" rel=\"noopener noreferrer\">利用可能な研究データ一覧</a>から各研究内容を確認（Research IDをクリック）のうえ、自由にデータをダウンロードしてください。</p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 15pt;\"><strong>&nbsp;<span style=\"text-decoration: underline;\">制限公開データ</span></strong></span><span style=\"text-decoration: underline;\"><span style=\"font-family: helvetica; font-size: 11pt;\"> （利用可能な研究データ一覧のアクセス制限欄に”制限”と表記。データの利用には利用申請が必要。）</span></span></p>\r\n<p><span style=\"text-decoration: underline;\"><span style=\"font-family: helvetica; font-size: 11pt;\"></span></span><strong><span style=\"color: #ff0000; font-size: 14pt;\">＝＝2020年9月30日より、メールでの申請書類受付は終了し、申請システムによる手続きへ移行しました＝＝</span></strong></p>\r\n<p><span style=\"color: #ff0000; font-size: 11pt;\"></span>　※　過去のデータ利用申請の際に添付いただいた倫理関係書類の取り込み中です。</p>\r\n<p>&nbsp;</p>\r\n<p>利用申請方法は以下の通りです。</p>\r\n<ol><ol>\r\n<li><a href=\"/guidelines/data-sharing-guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">NBDCヒトデータ共有ガイドライン</a>の最新版を熟読し、権利や責務、利用者要件について確認してください。</li>\r\n<li><a href=\"index.php?option=com_content&amp;view=article&amp;id=58&amp;Itemid=308\" target=\"_blank\" rel=\"noopener noreferrer\">利用可能な研究データ一覧</a>から各研究内容を確認（Research IDをクリック）のうえ、利用したいデータセットのDataset IDを控えてください。データ利用申請時に必要になります。その際、データセット毎に付与されている利用者要件（利用にあたっての制限事項に記載されているPolicyの内容）に合致するか確認してください。1回の申請で、複数のDatasetを申請することが可能です。</li>\r\n<li>データ利用申請のために必要な以下の情報を準備してください。\r\n<ul style=\"list-style-type: circle;\">\r\n<li>研究代表者およびデータ利用を希望する研究分担者の情報（氏名、職名、メールアドレス、研究者ID、倫理講習受講の有無）、ならびに解析等受託先がある場合は受託者の情報（所属機関、決まっている場合は担当者名・職名・メールアドレス・研究者ID・倫理講習受講の有無）　※同一機関に所属する研究分担者、ならびに受託者を1回の申請で登録することが可能です。</li>\r\n<li>研究代表者によって利用申請される研究内容に関連した研究に従事したことがわかるエビデンス（論文や学会発表等の情報）</li>\r\n<li>所属機関の長の氏名、職名、メールアドレス　※所属機関の長とは、倫理審査委員会によって承認された研究計画の実施を許可する者を指します。</li>\r\n<li>取得したデータを使用する研究の研究計画書（倫理審査申請書など）</li>\r\n<li>所属機関等の倫理審査委員会の審査・承認を受けた上で、所属機関の長が研究実施について許可したことが分かる書面（承認通知書など）の写し</li>\r\n</ul>\r\n<p>※倫理関係書類は、ヒトデータ審査委員会による申請審査の目的でのみ使用いたします。</p>\r\n</li>\r\n<li><a href=\"/guidelines/security-guidelines-for-users\" target=\"_blank\" rel=\"noopener noreferrer\">NBDCヒトデータ取扱いセキュリティガイドライン（データ利用者向け）</a>の内容を確認し、使用したいデータのアクセス制限レベル（Type IまたはType II）に応じて必要な対策を実施してください。<a href=\"files/security_checklist_for_users.xlsx\" style=\"text-decoration-line: underline;\">NBDCヒトデータ取り扱いセキュリティガイドラインチェックリスト</a>をダウンロードし、実施状況を記載してください。データの保管・解析に機関外サーバ<a href=\"#info1\"><sup style=\"background-color: initial;\">*1</sup></a>の利用を予定されている場合は、各機関外サーバ運用機関のサイトから公開されているセキュリティチェックリスト（機関外サーバ運用責任者向け）を入手した上で、当該機関外サーバがNBDCヒトデータ取扱いセキュリティガイドラインを満たしていることを確認してください。</li>\r\n<li>データ利用申請には、研究代表者、ならびに、研究分担者の内、研究代表者によって指名された申請者（研究代表者に代わってデータ利用申請手続きを実施する者）やデータダウンロード担当者のDDBJアカウントが必要ですので、<a href=\"https://www.ddbj.nig.ac.jp/ddbj-account.html\" target=\"_blank\" rel=\"noopener noreferrer\">アカウント登録</a>を行ってください。所属機関の長のアカウントは不要です。</li>\r\n<li>利用を許可されたデータセット転送時に必要となる<a href=\"https://www.ddbj.nig.ac.jp/jga/download.html#key-for-decryption\" target=\"_blank\" rel=\"noopener noreferrer\">『データセット復号用公開鍵・秘密鍵ペア』を作成</a>してください。データ利用申請の際に『公開鍵』を登録していただきます。</li>\r\n<li>JavaScriptを有効にした上で<a href=\"https://humandbs.ddbj.nig.ac.jp/nbdc/application/\" target=\"_blank\" rel=\"noopener noreferrer\">申請システム</a>（推奨ブラウザ：Chrome、Firefox）へDDBJアカウント・パスワードを使用してログインしてください。<strong>※DDBJアカウントの登録内容の反映に15分程度要しますのでご留意ください。</strong>\r\n<ul style=\"list-style-type: lower-roman;\">\r\n<li>データ利用申請グループを作成します。画面左側にあるメニューの [グループ作成] を選択し、グループ名、グループの説明、グループ種別『データ利用申請グループ』を入力し、保存ボタンを押すことでグループが作成されます。[メンバタブ] の [メンバを招待する] ボタンをクリックし、同一機関に所属する研究者（グループには、『データ利用申請の際の代表者』『申請作業代表者』『データダウンロード担当者』を必ず含めてください）の情報を入力し、招待します。 この時点でDDBJアカウントを保有していないメンバを招待する場合は、所属機関が発行したメールアドレスを記載してください。招待されたメンバへメールが送付され、メンバにより招待が許可されると、グループにメンバとして登録されます。</li>\r\n<li>メンバ登録後、データ利用申請の代表者をグループのPIに変更した上で、申請フォームの入力に進んでください。代表者がグループを作成した場合は、既にPI/Ownerになっているため、変更の必要はありません。なお、申請には日本語表記の氏名、電話番号、職名等の情報が必要になります。申請システムログイン後の画面右上にありますDDBJアカウントをクリックし、表示される『ユーザ情報の更新』から情報を更新して下さい。</li>\r\n<li>[データ利用申請を行う] ボタンをクリックします。遷移先のページの利用申請一覧の上にある言語を選択し（日本で研究活動を実施する研究者は、原則、日本語を選択してください）、[新規申請を開始する] ボタンをクリックします。正常に作成されると申請の入力フォームに遷移します。</li>\r\n<li>データ利用申請グループを選択します。当該グループに登録されている研究代表者、分担者情報は自動的に入力されます。修正が必要な場合は、データ利用申請グループの登録情報を修正してください。『データ利用申請の際の代表者』『申請作業代表者』『データダウンロード担当者』に該当しない分担者情報は『その他の研究分担者』に記載してください。</li>\r\n<li>申請フォームに沿って必要事項を入力・必要書類の添付をしてください。最後に申請ボタンを押してください。\r\n<ul style=\"list-style-type: circle;\">\r\n<li>所属機関の長：倫理審査委員会によって承認された研究計画の実施を許可する者が該当するので、審査結果通知書等に記載された所属機関の長の情報を入力してください。</li>\r\n<li>データを利用する研究題目：倫理審査委員会による承認＋所属機関の長による許可を受けた研究計画書に記載された題目名を記載してください。</li>\r\n<li>研究計画書（倫理審査申請書）、承認通知書、NBDCヒトデータ取扱いセキュリティガイドラインチェックリスト、等の書類を添付する際には、file typeを指定してください。1つのファイルに対し、複数個のfile typeを指定することが可能です。</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>データ利用申請の審査結果はデータ利用申請グループ宛のメールにて通知致します。通常、審査に必要な書面が整ってから2週間程度で通知されますが、繁忙期や祝日等の状況により遅くなることがありますのでご了承ください。承認後、データのアクセス権限が付与されますので、<a href=\"https://www.ddbj.nig.ac.jp/jga/download.html\" target=\"_blank\" rel=\"noopener noreferrer\">JGA利用手順</a>に従ってデータへアクセスしてください。</li>\r\n<li><span style=\"text-decoration: underline;\"><strong>データ利用期間が複数年にまたがる場合</strong></span>、1年毎にデータの利用状況およびセキュリティ環境の報告が必要です。申請システムのデータ利用申請一覧から該当する [J-DU番号] を押下することで詳細画面に遷移し、[申請開始] ボタンの左側にあるセレクトボックスから [データ利用報告申請] を選択することで、申請書の作成及び申請が可能です。 ※報告が遅れた場合、データを利用できなくなることがありますのでご留意ください。</li>\r\n<li><span style=\"text-decoration: underline;\"><strong>データ利用期間の延長を希望する場合</strong></span>は、データ利用期間満了の一か月前までに申請してください。申請システムのデータ利用申請一覧から、該当する [J-DU番号] を押下することで詳細画面に遷移し、[申請開始] ボタンの左側にあるセレクトボックスから [データ利用期間延長申請] を選択することで、申請書の作成および申請が可能です。その際、機関の長より許可されている研究期間がわかる書類を添付する必要があります<a href=\"#info2\"><sup>*2</sup></a>。</li>\r\n<li><span style=\"text-decoration: underline;\"><strong>利用するデータセットを追加したい場合</strong></span>は、利用データセット追加申請をしてください。申請システムのデータ利用申請一覧から、該当する [J-DU番号] を押下することで詳細画面に遷移し、[申請開始] ボタンの左側にあるセレクトボックスから [利用データセット追加申請] を選択することで、申請書の作成および申請が可能です。</li>\r\n<li><span style=\"text-decoration: underline;\"><strong>データ利用を終了する際</strong></span>は、データの利用状況ならびにデータの破棄状況の報告が必要です。申請システムのデータ利用申請一覧から、該当する [J-DU番号] を押下することで詳細画面に遷移し、[申請開始] ボタンの左側にあるセレクトボックスから [データ利用終了申請] を選択することで、申請書の作成および申請が可能です。データを利用することによって生じた集計・統計解析結果等の二次データの保管を希望する場合は、データ保管申請を行なってください。なお、<strong><span style=\"text-decoration: underline;\">何らかの理由でデータを利用しなかった場合も、データの利用状況ならびにデータの破棄状況の報告は必要です。</span></strong></li>\r\n</ol></ol>\r\n<p>&nbsp;</p>\r\n<p style=\"margin-left: 30px;\"><a name=\"info1\">*1</a>：機関外サーバの詳細は<a href=\"/guidelines/data-sharing-guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">NBDCヒトデータ共有ガイドライン</a>および<a href=\"off-premise-server\" target=\"_blank\" rel=\"noopener noreferrer\">こちらのサイト</a>をご参照ください。</p>\r\n<p style=\"margin-left: 30px;\"><a name=\"info2\">*2</a>：所属機関の変更は随時ご連絡ください。<span style=\"color: #ff0000;\"><strong><span style=\"text-decoration: underline;\">所属機関が変更された場合、研究を遂行するためには、新しい所属機関の長による研究実施許可、および、新しい所属機関からのデータ利用申請が必要となります</span></strong></span>ので、早めにご連絡・ご対応くださいますよう、宜しくお願い申し上げます。</p>\r\n<p>&nbsp;</p>\r\n<p style=\"margin-left: 30px;\">&nbsp; ※　データ提供者や試料・情報提供者からの申し出等により、データ利用に関する承認が取消される場合がありますので、予めご了承願います。</p>\r\n<p style=\"margin-left: 30px;\">&nbsp; ※　制限公開データの利用者情報（研究代表者氏名、所属機関、国・州名、研究題目、利用データのID、利用期間）が各研究内容のページに掲載されます。</p>\r\n<p style=\"margin-left: 30px;\"><span style=\"color: #ff0000;\">&nbsp; ※　既に利用しているデータを、明白に異なる別の研究に利用する場合は、再度データ利用申請が必要です。</span></p>", "publish_up": "2013-01-02"}, {"lang": "en", "path": "data-use", "title": "Data Use", "fulltext": "", "modified": "2025-04-24", "introtext": "<p><span style=\"font-family: helvetica; font-size: 10pt;\">The following describes the procedures to be followed for use of human data available from the NBDC Human Database.</span></p>\r\n<div style=\"border-style: solid; border-width: 1px; padding-left: 5px; padding-right: 5px; display: inline-block;\">\r\n<p><span style=\"font-family: helvetica; font-size: 10pt;\">Violators of the Guidelines who have not submitted an annual data use report during the data use period and a report on the completion of data use shall be disclosed <a href=\"index.php?option=com_content&amp;view=article&amp;id=2632&amp;Itemid=2574&amp;lang=en\" target=\"_blank\">here</a>.</span></p>\r\n</div>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 15pt;\"><strong>&nbsp;<span style=\"text-decoration: underline;\">Unrestricted-access Data&nbsp;</span></strong></span><span style=\"text-decoration: underline;\"><span style=\"font-family: helvetica; font-size: 11pt;\">(marked as \"Unrestricted-access\" under the column with the heading \"Type of Data\" in the list of available research data)</span></span></p>\r\n<p style=\"margin-left: 30px;\">1.&nbsp;Carefully read <a href=\"en/guidelines/data-sharing-guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">the latest NBDC Guidelines for Human Data Sharing</a>.</p>\r\n<p style=\"margin-left: 30px;\">2. Read the description of the study of interest (the description can be accessed by clicking on the corresponding research ID in <a href=\"en/data-use/all-researches\" target=\"_blank\" rel=\"noopener noreferrer\">the list of available research data</a>) and download the data.</p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 15pt;\"><strong>&nbsp;<span style=\"text-decoration: underline;\">Controlled-Access Data&nbsp;</span></strong></span><span style=\"text-decoration: underline;\"><span style=\"font-family: helvetica; font-size: 11pt;\">(marked as \"Controlled-Access\" under the column with the heading \"Type of Data\" in the list of available research data)</span></span></p>\r\n<p><strong><span style=\"font-family: helvetica; font-size: 14pt; color: #ff0000;\">== The NBDC application system was available from Sep. 30, 2020 (application via e-mail attachment was closed) ==</span></strong></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">&nbsp; Past applications and reports for data use will be incorporated as they become available into the application system.</span></p>\r\n<p>&nbsp;</p>\r\n<p>The procedure to apply for data use is as follows</p>\r\n<ol><ol>\r\n<li>Carefully read&nbsp;<a href=\"en/guidelines/data-sharing-guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">the latest NBDC Guidelines for Human Data Sharing</a></li>\r\n<li>Read the description of the study of interest (the description can be accessed by clicking on the corresponding research ID <a href=\"en/data-use/all-researches\" target=\"_blank\" rel=\"noopener noreferrer\">in the list of available research data</a>) and note the dataset ID of the desired data set. You will need the dataset ID when applying for data use. At that time, please make sure that the user requirements (shown at the comments in the molecular data section) for each dataset are met. It is possible to include multiple access-level datasets in a single application.</li>\r\n<li>Collect the following information and documents that are required in the application for data use.\r\n<ul style=\"list-style-type: circle;\">\r\n<li>The information (name, title, e-mail address, researcher ID, ethics training) on the principal investigator (PI) and all research collaborators who wish to use data. Research collaborators working at the same affiliated organization can be registered in one application.</li>\r\n<li>Information on publications related to the study for which the PI is applying for data use.</li>\r\n<li>The name, title, and e-mail address of the head of the PI’s affiliated organization or signing official. *The head of the organization refers to the person who endorses the institutional review board (IRB) approval or the decision that IRB is unnecessary.</li>\r\n<li>The research proposal (application form for IRB) for the study in which the data will be used.</li>\r\n<li>Notification from IRB approval, and permission to conduct the research given by the head of the PI's affiliated organization.</li>\r\n</ul>\r\n<p>* Documents concerning ethics review will be used only for the purpose of reviewing applications for data use / submission by the Human Data Review Board</p>\r\n</li>\r\n<li>Read and understand <a href=\"en/guidelines/security-guidelines-for-users\" target=\"_blank\" rel=\"noopener noreferrer\">the latest NBDC Security Guidelines for Human Data (for Data Users) </a>and take necessary measures according to the level of access restriction (Type I or Type II) for the desired data set. Download<a href=\"files/security_checklist_for_users_e.xlsx\"> the checklist for the NBDC Security Guidelines for Human Data</a> and complete it. If you plan to use an \"<a href=\"en/off-premise-server\" target=\"_blank\" rel=\"noopener noreferrer\">Off-Premise-Server</a>\", please ask Off-premise-server Providers<a href=\"#info1\"><sup>*1</sup></a> to have their checklist and confirm it if the server fulfilled the NBDC Security Guidelines for Human Data.</li>\r\n<li>To apply a data use application, a DDBJ account for each researcher (PI, applicant, and data downloaders) is required. If you do not have the account, <a href=\"https://www.ddbj.nig.ac.jp/ddbj-account-e.html\" target=\"_blank\" rel=\"noopener noreferrer\">please create it</a> before application. The account for the head of PI's affiliated organization is NOT required.</li>\r\n<li>Register the public key for dataset encryption in the NBDC data use application. <a href=\"https://www.ddbj.nig.ac.jp/jga/download-e.html#key-for-decryption\" target=\"_blank\" rel=\"noopener noreferrer\">Generate a public/private key pair</a> for each data use application. Please see \"<a href=\"https://www.ddbj.nig.ac.jp/account-e.html#generate-key-pair\" target=\"_blank\" rel=\"noopener noreferrer\">Generate public and private key pair</a>\" for details.</li>\r\n<li>Please log-in to <a href=\"https://humandbs.ddbj.nig.ac.jp/nbdc/application/\" target=\"_blank\" rel=\"noopener noreferrer\">the NBDC application system</a> with your DDBJ account and password (recommended browsers: Chrome, Firefox). You need JavaScript enabled to use it.&nbsp; &nbsp;<strong>**Please note that it takes about 15 minutes to reflect the creations/alterations of your DDBJ account information.**</strong>\r\n<ul style=\"list-style-type: lower-roman;\">\r\n<li>Please create a group. Select [Create Group] in the menu box and enter group information: Group Name, Description, Type (Data User Group). Please save the information. Then, select [Member tab] and press [Invite] button. Please invite your collaborators in the same affiliated organization with the PI in the Data User Group. A Data User Group need to include following investigators: PI, applicant, and data downloaders. The member who has no DDBJ account at this point, please enter his/her e-mail address issued by his/her affiliated organization. An e-mail is sent to the invited members, and they accept the invitation, they will be registered as a member of the group. PI of the data use application must be set as \"PI\" in the group. It can be change with radio button in the Member tab.</li>\r\n<li>After the member registration, please start data use application (press [Application for data use]).</li>\r\n<li>Please select \"Language” and press [Create new application] button. Researchers conducting research activities in Japan, in principle, should select Japanese language.</li>\r\n<li>Please select your Data User Group. Information of PI and collaborators registered to the group are entered automatically. If any information needs to be revised, please revise the registered information of the Data User Group. \"Other research collaborators\" is the researcher who is a collaborator but not necessary to access the data.</li>\r\n<li>Please fill out the application form and attach the required documents. Finally, press [Apply] button.\r\n<ul style=\"list-style-type: circle;\">\r\n<li>A head of the organization: The person who permits the implementation of the research plan approved by an Ethical Review Board (ERB) is applicable, so please enter the information of the head of the organization to which the researcher belongs to as indicated on the notification from the ethical review results.</li>\r\n<li>Title of the Study: Please write the same study title which was shown in the research proposal approved by ERB.</li>\r\n<li>When you attach documents, please specify the file type; multiple file types can be specified for one file.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>The Data User Group Member will be notified the decision of the review by e-mail (normally, within a couple of weeks after complete the information and documents needed for the review). After the application for data use is approved by NBDC Human Data Review Board, metadata, encrypted data files and decryption tools is created in the download directory in the JGA server. Please follow <a href=\"https://www.ddbj.nig.ac.jp/jga/download-e.html#data-use-approval-download\" target=\"_blank\" rel=\"noopener noreferrer\">the instruction</a> to access the approved data.</li>\r\n<li><strong>When you use the data for multiple years:</strong> You need to report on data use and security status every year. Please apply \"The application for reporting on the use of Controlled-Access Data\" via&nbsp;<a href=\"https://humandbs.ddbj.nig.ac.jp/nbdc/application/\" target=\"_blank\" rel=\"noopener noreferrer\">the NBDC application system</a>. [Menu] &gt; [Application for data use] &gt; press the appropriate DU number&nbsp;in the List &gt; select [The application for reporting on the use of Controlled-Access Data] then press [Start] button. <span style=\"text-decoration: underline;\"><strong>*Please note that failure to report on time may result in your data being unavailable for a breach of the guidelines.</strong></span></li>\r\n<li><strong>When you need to use the dataset beyond the term originally stated in the application for data use:</strong> One month prior to the original expiration of the data use period, a request for the desired data use period may be applied together with a document such as the approval notification by an Ethical Review Committee (by which document the term approved can be confirmed) via&nbsp;<a href=\"https://humandbs.ddbj.nig.ac.jp/nbdc/application/\" target=\"_blank\" rel=\"noopener noreferrer\">the NBDC application system</a>. [Menu] &gt; [Application for data use] &gt; press the appropriate DU number&nbsp;in the List &gt; select [The application for extending the period of data use] then press [Start] button.</li>\r\n<li><strong>When you find additional attractive datasets:</strong> Please apply via&nbsp;<a href=\"https://humandbs.ddbj.nig.ac.jp/nbdc/application/\" target=\"_blank\" rel=\"noopener noreferrer\">the NBDC application system</a>. [Menu] &gt; [Application for data use] &gt; press the appropriate DU number&nbsp;in the List &gt; select [The application for adding dataset that you plan to use] then press [Start] button.</li>\r\n<li><strong>When you finish to use the data:</strong> You must promptly delete all data (all data downloaded from the NBDC Human Database or all of the data if part of the data is stored) and all data that can restore the data according to the NBDC Human Data Security Guidelines and report his/her data use and deletion via&nbsp;<a href=\"https://humandbs.ddbj.nig.ac.jp/nbdc/application/\" target=\"_blank\" rel=\"noopener noreferrer\">the NBDC application system</a>. At the same time, you may apply for retention of secondary data (e.g., results of calculations based on controlled-access data) and may retain the secondary data. Depending on the degree of data processing and the storage period, however, the application may be rejected. [Menu] &gt; [Application for data use] &gt; press the appropriate DU number&nbsp;in the List &gt; select [The application for reporting on the deletion of Controlled-access data] then press [Start] button. <span style=\"text-decoration: underline;\">*<strong>Even if you do not use the data for some reason, you are required to report on the use and deletion of the data.</strong></span></li>\r\n</ol></ol>\r\n<p>&nbsp;</p>\r\n<!--\r\n<p style=\"margin-left: 30px;\">*1 If you are not able to use the online application form due to system-related problems, you may download the necessary forms from <a href=\"index.php?option=com_content&amp;view=article&amp;id=133&amp;Itemid=244&amp;lang=en\" target=\"_blank\">the list of application forms</a>.</p>\r\n-->\r\n<p style=\"margin-left: 30px;\"><a name=\"info1\">*1</a>: Learn more about the \"Off-premise-server\", please check <a href=\"en/guidelines/data-sharing-guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">the NBDC Guidelines for Human Data Sharing</a> and <a href=\"en/off-premise-server\" target=\"_blank\" rel=\"noopener noreferrer\">the site</a>.</p>\r\n<p style=\"margin-left: 30px;\"><span style=\"color: #ff0000;\"><a name=\"info2\">*2</a>: Should your affiliated organization change, contact us at your earliest convenience and complete the necessary procedures in a timely manner because continuation of the study requires ethics review for the study at the new organization and submission of an application for data use (for the new organization). We appreciate your cooperation.</span></p>\r\n<p>&nbsp;</p>\r\n<p style=\"margin-left: 30px;\"># Note in advance that the approval for data use may be rescinded due to a request from the data providers or study participants.</p>\r\n<p style=\"margin-left: 30px;\"># Information on the users of controlled-access data (the name of the PI, his/her affiliated institution, country and state, the research title, the data set ID, and the period of data use) will be showed on the web page of each study.</p>\r\n<p style=\"margin-left: 30px;\"><span style=\"color: #ff0000;\">&nbsp;# If, due to incidental findings, you would like to utilize the currently used data for a separate study that is clearly different from the study approved for data use, you must submit a new application for data use.</span></p>", "publish_up": "2013-01-02"}, {"lang": "ja", "path": "data-use/all-researches", "title": "利用可能な研究データ一覧", "fulltext": "", "modified": "2025-09-24", "introtext": "<p>データ利用方法は<a href=\"data-use\">こちら</a>をご覧下さい。</p>\r\n<!--\r\n<table class=\"table-style style-greystripes\" style=\"width: 1500px; height: 333px;\">\r\n-->\r\n<table id=\"list-of-all-researches\" class=\"table-style style-greystripes\">\r\n<thead>\r\n<tr><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">Research ID</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">研究題目</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">公開日</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">データの種類</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">研究方法</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">手法</span></th><th class=\"”highlight”\" align=\"center\">\r\n<p><span style=\"font-size: small;\">参加者</span></p>\r\n<p><span style=\"font-size: small;\">（対象集団）</span></p>\r\n</th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">提供者</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">アクセス制限</span></th></tr>\r\n</thead>\r\n<tbody>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=41&amp;Itemid=262\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0001.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000002</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SCA31罹患患者のゲノム解析データ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2013/12/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SCA31：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">森下 真一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=53&amp;Itemid=264\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0003.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">DRA000908</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関節リウマチ患者及び健常人における</span></p>\r\n<p><span style=\"font-size: small;\">HLA領域の塩基配列比較解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2013/07/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HLA領域</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">33検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">井ノ上 逸朗</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=55&amp;Itemid=294\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0004.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000001</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">上皮成長因子受容体遺伝子異変を有する</span></p>\r\n<p><span style=\"font-size: small;\">肺腺癌の体細胞性遺伝子変異プロファイル</span></p>\r\n<p><span style=\"font-size: small;\">解明のための分子疫学的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/07/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Genome Analyzer IIx）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺腺癌：97症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">後藤 功一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2608&amp;Itemid=2557&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0005.v8</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA001273</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000032</span></p>\r\n<p><span style=\"font-size: small;\">DRA003791</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000093</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000123</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000166</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000191</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000192</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000200</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000201</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000323</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000490</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">難聴の遺伝子解析と臨床応用に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/01/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/02/24</span></p>\r\n<p><span style=\"font-size: small;\">v3:2017/06/19</span></p>\r\n<p><span style=\"font-size: small;\">v4:2018/02/13</span></p>\r\n<p><span style=\"font-size: small;\">v5:2019/04/18</span></p>\r\n<p><span style=\"font-size: small;\">v6:2021/07/30</span></p>\r\n<p><span style=\"font-size: small;\">v7:2021/11/19</span></p>\r\n<p><span style=\"font-size: small;\">v8:2023/10/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">9遺伝子領域</span></p>\r\n<p><span style=\"font-size: small;\">69遺伝子領域</span></p>\r\n<p><span style=\"font-size: small;\">90遺伝子領域</span></p>\r\n<p><span style=\"font-size: small;\">63遺伝子領域</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion PGM、Ion Proton、Ion S5）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Usher症候群：17症例</span></p>\r\n<p><span style=\"font-size: small;\">非症候群性難聴：3,156症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">宇佐美 真一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2100&amp;Itemid=2127&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0006.v5</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000004</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000106</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000146</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000325</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳腫瘍のゲノム・遺伝子解析と</span></p>\r\n<p><span style=\"font-size: small;\">その臨床病理学的意義の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/01/31</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/06/05</span></p>\r\n<p><span style=\"font-size: small;\">v3:2017/09/01</span></p>\r\n<p><span style=\"font-size: small;\">v4:2019/02/13</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/08/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、Target Capture）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500、HumanMethylation450）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳腫瘍：6症例＋16症例</span></p>\r\n<p><span style=\"font-size: small;\">グリオーマ（小脳：17症例、視床：14症例、大脳：8症例）</span></p>\r\n<p><span style=\"font-size: small;\">グリオーマ：94症例</span></p>\r\n<p><span style=\"font-size: small;\">脳海綿状血管奇形：12症例</span></p>\r\n<p><span style=\"font-size: small;\">椎体血管腫：1症例</span></p>\r\n<p><span style=\"font-size: small;\">眼窩内海綿状血管奇形：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">斉藤 延人</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=83&amp;Itemid=387\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0007.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000005</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒトTh17細胞の活性化前後の遺伝子発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/02/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Applied BioSystems</span></p>\r\n<p><span style=\"font-size: small;\">（5500 Genetic Analyzer）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：1名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">巌本 三壽</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=599&amp;Itemid=866&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0008.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000007</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒルシュスプルング病および</span></p>\r\n<p><span style=\"font-size: small;\">ヒルシュスプルング類縁疾患の</span></p>\r\n<p><span style=\"font-size: small;\">遺伝要因および発症機構解明に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/01/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒルシュスプルング：5症例</span></p>\r\n<p><span style=\"font-size: small;\">家族：6例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松藤 凡</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=215&amp;Itemid=482&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0009.v3</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>DRA003802</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト初期発生にかかわる細胞の</span></p>\r\n<p><span style=\"font-size: small;\">DNAメチル化解析基盤研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/12/24</span></p>\r\n<p><span style=\"font-size: small;\">v2:2015/01/07</span></p>\r\n<p><span style=\"font-size: small;\">v3:2015/08/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（PBAT-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化シトシン同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">11検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">有馬 隆博</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=207&amp;Itemid=476&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0010.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000008</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脾類上皮嚢腫関連遺伝子の探索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/06/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脾類上皮嚢腫：8症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松藤 凡</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=244&amp;Itemid=505&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0011.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000015</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">B型肝炎ウイルスのヒトゲノム内組み込み</span></p>\r\n<p><span style=\"font-size: small;\">によるエピジェネティックな修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/10/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HBV組込部位</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Roche GS FLX Titanium</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2検体（セルライン）</span></p>\r\n<p><span style=\"font-size: small;\">HBV感染肝癌：8症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山本 博幸</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=220&amp;Itemid=486&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0012.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000012</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ながはま0次コホート事業</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/08/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n<p><span style=\"font-size: small;\">健常者遺伝子型</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Human610-Quad、HumanOmni2.5-4/2.5-8/2.5S-8、HumanExome-12、HumanCoreExome-12）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：3712名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松田 文彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=85&amp;Itemid=340\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0013.v1</strong></span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本PGxデータサイエンスコンソーシアム</span></p>\r\n<p><span style=\"font-size: small;\">PGx研究のための日本人健常者2994名の</span></p>\r\n<p><span style=\"font-size: small;\">SNP遺伝子型データ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/10/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">健常者内頻度</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HumanOmni2.5-8）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：2994名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">末松 浩嗣</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3038&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0014.v37</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000101</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000114＊</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000140</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000203</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000293</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000327</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000346</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000381＊</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000414</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000347</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000592</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000647</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000698</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000699</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000700</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000701</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000703</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000738</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000746</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000782</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">オーダーメイド医療の実現プログラム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/09/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2015/12/28 （JSNP）</span></p>\r\n<p><span style=\"font-size: small;\">v3:2016/01/10</span></p>\r\n<p><span style=\"font-size: small;\">v4:2016/01/27</span></p>\r\n<p><span style=\"font-size: small;\">v5:2017/05/18</span></p>\r\n<p><span style=\"font-size: small;\">v6:2017/09/08</span></p>\r\n<p><span style=\"font-size: small;\">v7:2018/04/03</span></p>\r\n<p><span style=\"font-size: small;\">v8:2018/05/01</span></p>\r\n<p><span style=\"font-size: small;\">v9:2018/08/07</span></p>\r\n<p><span style=\"font-size: small;\">v10:2018/08/13</span></p>\r\n<p><span style=\"font-size: small;\">v11:2018/10/16</span></p>\r\n<p><span style=\"font-size: small;\">v12:2018/12/10</span></p>\r\n<p><span style=\"font-size: small;\">v13:2019/01/25</span></p>\r\n<p><span style=\"font-size: small;\">v14:2019/03/26</span></p>\r\n<p><span style=\"font-size: small;\">v15:2019/09/27</span></p>\r\n<p><span style=\"font-size: small;\">v16:2019/10/07</span></p>\r\n<p><span style=\"font-size: small;\">v17:2019/10/08</span></p>\r\n<p><span style=\"font-size: small;\">v18:2019/11/26</span></p>\r\n<p><span style=\"font-size: small;\">v19:2020/04/20</span></p>\r\n<p><span style=\"font-size: small;\">v20:2020/08/17</span></p>\r\n<p><span style=\"font-size: small;\">v21:2020/08/25</span></p>\r\n<p><span style=\"font-size: small;\">v22:2021/05/21</span></p>\r\n<p><span style=\"font-size: small;\">v23:2021/07/13</span></p>\r\n<p><span style=\"font-size: small;\">v24:2021/11/26</span></p>\r\n<p><span style=\"font-size: small;\">v25:2022/01/25</span></p>\r\n<p><span style=\"font-size: small;\">v26:2022/04/01</span></p>\r\n<p><span style=\"font-size: small;\">v27:2023/01/18</span></p>\r\n<p><span style=\"font-size: small;\">v28:2023/04/05</span></p>\r\n<p><span style=\"font-size: small;\">v29:2023/04/05</span></p>\r\n<p><span style=\"font-size: small;\">v30:2023/04/20</span></p>\r\n<p><span style=\"font-size: small;\">v31:2023/09/01</span></p>\r\n<p><span style=\"font-size: small;\">v32:2024/01/11</span></p>\r\n<p><span style=\"font-size: small;\">v33:2024/05/27</span></p>\r\n<p><span style=\"font-size: small;\">v34:2024/09/19</span></p>\r\n<p><span style=\"font-size: small;\">v35:2024/10/25</span></p>\r\n<p><span style=\"font-size: small;\">v36:2024/11/28</span></p>\r\n<p><span style=\"font-size: small;\">v37:2025/05/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">関連</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Human610-Quad, HumanHap550v3, HumanOmniExpress-12, HumanExome, OmniExpressExome, HumanExome-12, Infinium OmniExpress-24, Infinium HumanOmniExpressExome-8, HiSeq 2500/X Five, NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Perlegen Sciences</span></p>\r\n<p><span style=\"font-size: small;\">（high-density oligonucleotide array）</span></p>\r\n<p><span style=\"font-size: small;\">Hologic Japan</span></p>\r\n<p><span style=\"font-size: small;\">（Invader）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1：心筋梗塞1,666症例、対照3,198名</span></p>\r\n<p><span style=\"font-size: small;\">v2：健常者934名（JSNP）</span></p>\r\n<p><span style=\"font-size: small;\">v2：35疾患各約190症例（JSNP）</span></p>\r\n<p><span style=\"font-size: small;\">v2：食道癌182症例（JSNP）</span></p>\r\n<p><span style=\"font-size: small;\">v2：ALS92症例（JSNP）</span></p>\r\n<p><span style=\"font-size: small;\">v3：T2DM9,817症例、対照6,763名</span></p>\r\n<p><span style=\"font-size: small;\">v3：T2DM5,646症例、対照19,420名</span></p>\r\n<p><span style=\"font-size: small;\">v4：AD1,472症例、対照7,966名</span></p>\r\n<p><span style=\"font-size: small;\">v5：AF8,180症例、対照28,612名</span></p>\r\n<p><span style=\"font-size: small;\">v6：BMI158,284名</span></p>\r\n<p><span style=\"font-size: small;\">v6：Genotypeデータ182,505名</span></p>\r\n<p><span style=\"font-size: small;\">v7：POAG3980症例、対照18,815名</span></p>\r\n<p><span style=\"font-size: small;\">v8：58臨床検査値162,255名</span></p>\r\n<p><span style=\"font-size: small;\">v9：初潮年齢データを有する女性67,029名</span></p>\r\n<p><span style=\"font-size: small;\">v9：閉経年齢データを有する女性43,861名</span></p>\r\n<p><span style=\"font-size: small;\">v10：BBJ第1コホート1,026名</span></p>\r\n<p><span style=\"font-size: small;\">v11：乳癌7,104症例、対照23,731名</span></p>\r\n<p><span style=\"font-size: small;\">v12：2型糖尿病腎症2,809症例、2型糖尿病対照5,592名</span></p>\r\n<p><span style=\"font-size: small;\">v13：T2DM36,614症例、対照155,150名</span></p>\r\n<p><span style=\"font-size: small;\">v14：喫煙習慣データ165,436名</span></p>\r\n<p><span style=\"font-size: small;\">v15：BBJ第1コホート1,037名、1000ゲノムプロジェクト（Phase3v5）2,504名</span></p>\r\n<p><span style=\"font-size: small;\">v15：身長159,095名</span></p>\r\n<p><span style=\"font-size: small;\">v16：遺伝性前立腺癌7,636症例、対照12,366名</span></p>\r\n<p><span style=\"font-size: small;\">v17、v18、v21：42疾患212,453症例</span></p>\r\n<p><span style=\"font-size: small;\">v19：食習慣165,084名</span></p>\r\n<p><span style=\"font-size: small;\">v20：冠動脈疾患25,892症例、対照142,336名</span></p>\r\n<p><span style=\"font-size: small;\">v22：BBJ第1コホート11,234名</span></p>\r\n<p><span style=\"font-size: small;\">v23：BBJ第1コホート768名</span></p>\r\n<p><span style=\"font-size: small;\">v24：膵癌1,005症例、大腸癌12,503症例、対照23,705名</span></p>\r\n<p><span style=\"font-size: small;\">v25：心筋梗塞1,765症例、認知症199症例</span></p>\r\n<p><span style=\"font-size: small;\">v26：腎癌740症例、対照者5,996名</span></p>\r\n<p><span style=\"font-size: small;\">v27：BBJ第1コホート137,693名</span></p>\r\n<p><span style=\"font-size: small;\">v28：BBJ第1コホート4,880名</span></p>\r\n<p><span style=\"font-size: small;\">v29：AF8,180症例、対照28,612名（BBJ第1コホート）</span></p>\r\n<p><span style=\"font-size: small;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AF60,620症例、対照970,216名（欧米人）</span></p>\r\n<p><span style=\"font-size: small;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AF7,244症例、対照56,378名（FinnGen）</span></p>\r\n<p><span style=\"font-size: small;\">v30：リンパ腫1,982症例、胃癌10,366症例、対照者37,592名（BBJコホート）</span></p>\r\n<p><span style=\"font-size: small;\">v32：BBJ第1コホート1,007名</span></p>\r\n<p><span style=\"font-size: small;\">v33：胃癌256症例</span></p>\r\n<p><span style=\"font-size: small;\">v33：51疾患26.9万名</span></p>\r\n<p><span style=\"font-size: small;\">v33：大腸癌617症例</span></p>\r\n<p><span style=\"font-size: small;\">v33：糖尿病2,162症例</span></p>\r\n<p><span style=\"font-size: small;\">v33：胃癌2,067症例</span></p>\r\n<p><span style=\"font-size: small;\">v35：BBJ第1コホート7,472名</span></p>\r\n<p><span style=\"font-size: small;\">v36：BBJ第1コホート3,256名</span></p>\r\n<p><span style=\"font-size: small;\">v37：乳癌10,008症例、胃癌10,576症例、大腸癌13,929症例、心不全6,038症例、脳梗塞10,486症例などを含む計140,597名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人、欧米人、フィンランド人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">久保 充明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=797&amp;Itemid=1035&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0015.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000159</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト全ゲノム解析に基づく高精度の</span></p>\r\n<p><span style=\"font-size: small;\">住民ゲノム参照パネルの作成</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/10/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/12/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2019/01/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">健常者内頻度</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：3552名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山本 雅之</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=393&amp;Itemid=682&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0016.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">DRA002604</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 精巣に発現するタンパク質群の</span></p>\r\n<p><span style=\"font-size: small;\"> ヒト精子細胞における発現及び染色体局在解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/09/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、ChIP-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：1名（4検体）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大川 恭行</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=284&amp;Itemid=571&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0017.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000021</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中枢神経原発悪性リンパ腫のエクソーム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/02/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">PCNSL：41症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">間野 博行</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3140&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\"><strong>hum0018.v2</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000009</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000337</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000374</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000358</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000365</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000393</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000422</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000494</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 神経筋変性疾患の遺伝子解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/02/03</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/07/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、WGS、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">神経筋変性疾患：14症例</span></p>\r\n<p><span style=\"font-size: small;\">対照：7名</span></p>\r\n<p><span style=\"font-size: small;\">シャルコー・マリー・トゥース病：69症例</span></p>\r\n<p><span style=\"font-size: small;\">前頭側頭型認知症：21症例</span></p>\r\n<p><span style=\"font-size: small;\">家族性筋萎縮性側索硬化症：119症例</span></p>\r\n<p><span style=\"font-size: small;\">ミオパチー： 85症例</span></p>\r\n<p><span style=\"font-size: small;\">孤発性筋萎縮性側索硬化症：489症例</span></p>\r\n<p><span style=\"font-size: small;\">運動ニューロン病：9症例</span></p>\r\n<p><span style=\"font-size: small;\">痙性対麻痺：465症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">辻 省次</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=183&amp;Itemid=421&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0019.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000011</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化器癌の発癌や進展に</span></p>\r\n<p><span style=\"font-size: small;\">深く関与しうる遺伝子、並びに</span></p>\r\n<p><span style=\"font-size: small;\">非コードRNAの量的・質的な異常の探索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化器癌：17症例（32検体）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">篠村 恭久</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=104&amp;Itemid=367\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0020.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000013</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">筋萎縮性側索硬化症の遺伝子解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/01/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">家族性ALS：11症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">田中 章景</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1469&amp;Itemid=1602&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0021.v3</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000014</span></p>\r\n<p><span style=\"font-size: small;\"> JGAS000273</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">精神神経疾患の原因解明および</span></p>\r\n<p><span style=\"font-size: small;\">診断法・治療法の開発に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/01/26</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/05</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/04/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常一卵性双生児：3組6名</span></p>\r\n<p><span style=\"font-size: small;\">双極性障害発症者およびその両親（トリオ）：66＋78家系（198＋234名）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">加藤 忠史</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=111&amp;Itemid=379\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0022.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000017</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">同種造血幹細胞移植後</span></p>\r\n<p><span style=\"font-size: small;\">ドナー由来白血病発症にかかわる</span></p>\r\n<p><span style=\"font-size: small;\">分子機構の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/02/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">白血病：1症例</span></p>\r\n<p><span style=\"font-size: small;\">ドナー：1名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">清井 仁</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=116&amp;Itemid=383\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0023.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000016</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">生活習慣病、動脈硬化性疾患、ならびに</span></p>\r\n<p><span style=\"font-size: small;\">抗加齢に関する遺伝疫学研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/01/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">III度以上の本態性</span></p>\r\n<p><span style=\"font-size: small;\">高血圧：30症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三木 哲郎</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=186&amp;Itemid=424&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0024.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000023</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍における</span></p>\r\n<p><span style=\"font-size: small;\">遺伝子異常の網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/04/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Genome Analyzer IIx、HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MDS：13症例</span></p>\r\n<p><span style=\"font-size: small;\">CMML：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小川 誠司</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=330&amp;Itemid=622&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0027.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000024</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000040</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">侵襲性歯周炎のヒト全ゲノム解析と遺伝子多型解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/07/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">侵襲性歯周炎：44症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">村上 伸也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=696&amp;Itemid=946&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0028.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000018</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">オーダーメイド医療の実現プログラム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/06/02</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/06/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HLA領域</span></p>\r\n<p><span style=\"font-size: small;\">HLAアリルおよび</span></p>\r\n<p><span style=\"font-size: small;\">領域内遺伝子型決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HumanOmniExpress、HumanExome、Immunochip、HumanHap550v3 Genotyping BeadChip）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：908名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">久保 充明</span></p>\r\n<p><span style=\"font-size: small;\">（BBJ）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1344&amp;Itemid=1500&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0029.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Stevens-Johnson症候群に対する</span></p>\r\n<p><span style=\"font-size: small;\">遺伝子多型解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/03/09</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/12/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Axiom ASI）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X Ten）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SJS：117症例</span></p>\r\n<p><span style=\"font-size: small;\">対照：691名</span></p>\r\n<p><span style=\"font-size: small;\">SJS/TEN：133症例</span></p>\r\n<p><span style=\"font-size: small;\">対照：418名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">上田 真由美</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3104&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0030.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000022</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000560</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000789</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">婦人科臓器に発生する悪性腫瘍の発症に関連する分子生物学的異常の検索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/04/21</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/05/10</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/07/05</span></p>\r\n<p><span style=\"font-size: small;\">v4:2025/07/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n<p><span style=\"font-size: small;\">ヒト全ゲノム発現アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">CNV</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Human Mapping 250K Nsp Array、GeneChip® Human Genome U133 Plus 2.0 Array）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000、Infinium HumanMethylation450、NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">卵巣癌：57＋111＋31＋189症例 </span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">織田 克利</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=252:hum0031-v1&amp;catid=10:cat-researches&amp;lang=ja&amp;Itemid=513\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0031.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000042</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000043</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000044</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000045</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">磁気共鳴画像装置で得られた脳画像の臨床評価尺度データベース構築と多施設による共同運用</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳画像</span></p>\r\n<p><span style=\"font-size: small;\">臨床情報</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳画像ベースの病態解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Philips</span></p>\r\n<p><span style=\"font-size: small;\">（Achieva）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">統合失調症：37症例</span></p>\r\n<p><span style=\"font-size: small;\">単極うつ病：8症例</span></p>\r\n<p><span style=\"font-size: small;\">双極性障害：2症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：129名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">笠井 清登</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=335&amp;Itemid=626&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0032.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000026</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000027</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000028</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト消化器ならびに泌尿器上皮細胞の</span></p>\r\n<p><span style=\"font-size: small;\">標準エピゲノム解析</span></p>\r\n<p><span style=\"font-size: small;\">（HPCシリーズ）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/07/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（PBAT-seq、ChIP-seq、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝細胞：8種類</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">金井 弥栄</span></p>\r\n<p><span style=\"font-size: small;\">（IHEC）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=192&amp;Itemid=428&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0033.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>DRA003516</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト唾液由来エキソソームの</span></p>\r\n<p><span style=\"font-size: small;\">機能解析に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/05/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Genome Analyzer IIx）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：1名（3検体）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">矢ノ下 良平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=237&amp;Itemid=501&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0034.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000037</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小細胞肺癌の網羅的ゲノム解析による</span></p>\r\n<p><span style=\"font-size: small;\">新たな治療標的の探索を目指した研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/10/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SCLC：51症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">後藤 功一</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1339&amp;Itemid=1496&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0035.v5</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000036</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000046</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000088</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000188</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000204</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000246</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">固形腫瘍における遺伝子異常の網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/09/16</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/12/26</span></p>\r\n<p><span style=\"font-size: small;\">v3:2020/05/29</span></p>\r\n<p><span style=\"font-size: small;\">v4:2020/12/14</span></p>\r\n<p><span style=\"font-size: small;\">v5:2020/12/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、Target Capture、RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500、MiSeq、MethylationEPIC）</span></p>\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Human Mapping 250K Nsp、CytoScan HD）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">RMS：16症例</span></p>\r\n<p><span style=\"font-size: small;\">PPB：7症例</span></p>\r\n<p><span style=\"font-size: small;\">NB：522症例</span></p>\r\n<p><span style=\"font-size: small;\">NB細胞株：39検体</span></p>\r\n<p><span style=\"font-size: small;\">PBL：10症例</span></p>\r\n<p><span style=\"font-size: small;\">HBL：59症例</span></p>\r\n<p><span style=\"font-size: small;\">HBL細胞株：2検体</span></p>\r\n<p><span style=\"font-size: small;\">小児胚細胞腫瘍：51症例</span></p>\r\n<p><span style=\"font-size: small;\">小児高リスク神経芽腫：30症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">滝田 順子</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=210&amp;Itemid=478&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0036.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">DRA003736</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">全エクソームキャプチャプラットフォーム間の</span></p>\r\n<p><span style=\"font-size: small;\">性能比較</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">キャプチャ方法の</span><span style=\"font-size: small;\">性能比較</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HapMap-JPT：2検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">久保 充明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=225&amp;Itemid=491&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0037.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000035</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関節リウマチ感受性遺伝子を用いた</span></p>\r\n<p><span style=\"font-size: small;\">関節リウマチ病態の遺伝診断法の開発研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">RA：39症例</span></p>\r\n<p><span style=\"font-size: small;\">対照：10名（Pooled）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">光永 滋樹</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=247&amp;Itemid=509&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0038.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000041</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">家族性致死性不整脈の病因解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/11/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">家族性致死性不整脈：11症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">蒔田 直昌</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=301&amp;Itemid=579&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0039.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000039</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化管間質腫瘍のチロシンキナーゼ阻害剤に</span></p>\r\n<p><span style=\"font-size: small;\">対する獲得耐性機構の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/12/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">イマチニブ耐性消化管間質腫瘍：4症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">高橋 剛</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=358&amp;Itemid=650&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0040.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000038</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">生殖発生に関わる細胞のエピゲノム解析基盤研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/09/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、RNA-seq、WGBS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト胎盤：28検体</span></p>\r\n<p><span style=\"font-size: small;\">母体血：26検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">有馬 隆博</span></p>\r\n<p><span style=\"font-size: small;\">（IHEC）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=405&amp;Itemid=690&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0041.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000052</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝胆膵癌の早期発見、進行、予後予測、</span></p>\r\n<p><span style=\"font-size: small;\">治療効果予測に関わる因子の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/01/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">原発性肝細胞癌：33症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">田中 真二</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=289&amp;Itemid=573&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0042.v1</strong></span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">顎口腔領域の形質（性質や特徴）</span></p>\r\n<p><span style=\"font-size: small;\">に関与する遺伝子の探索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/03/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HumanOmniExpress）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">変性顎関節症：146症例</span></p>\r\n<p><span style=\"font-size: small;\">非罹患：374名</span></p>\r\n<p><span style=\"font-size: small;\">第三大臼歯先天性欠如有：149症例</span></p>\r\n<p><span style=\"font-size: small;\">無欠如：338名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人、韓国人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山口 徹太郎</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"/hum0043-v1\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0043.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000051</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アルツハイマー病総合診断体系実用化プロジェクト</span></p>\r\n<p><span style=\"font-size: small;\">（J-ADNI全国臨床研究）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/01/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳画像</span></p>\r\n<p><span style=\"font-size: small;\">臨床情報</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳画像ベースの病態解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><a href=\"hum0043-v1-release#mriscanners\" target=\"_blank\" rel=\"noopener noreferrer\">MRIスキャナー（15機種）</a></p>\r\n<p><a href=\"hum0043-v1-release#petscanners\" target=\"_blank\" rel=\"noopener noreferrer\">PETスキャナー（16機種）</a></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MCI：234名</span></p>\r\n<p><span style=\"font-size: small;\">AD：149名</span></p>\r\n<p><span style=\"font-size: small;\">健常高齢者群：154名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岩坪 威</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=402:hum0044-v1&amp;catid=10&amp;lang=ja-JP&amp;Itemid=688\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0044.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">DRA004162</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒトレトロウイルス感染症に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/10/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（ChIP-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ATL細胞株：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">佐藤 賢文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=310&amp;Itemid=596&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0045.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000047</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">思春期・若年成人急性リンパ芽球性白血病における</span><span style=\"font-size: small;\">トランスクリプトーム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/03/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">フィラデルフィア染色体陰性ALL：99症例</span></p>\r\n<p><span style=\"font-size: small;\">フィラデルフィア染色体陽性ALL：3症例</span></p>\r\n<p><span style=\"font-size: small;\">セルライン：5検体</span></p>\r\n<p><span style=\"font-size: small;\">正常血球細胞：8検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">間野 博行</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=279&amp;Itemid=565&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0048.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>DRA004251</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">次世代シークエンサーを用いた十二指腸・ファーター乳頭部腫瘍の全遺伝子のエクソン解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/02/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ファーター乳頭部癌：60症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人、米国人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">谷内田 真一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=388&amp;Itemid=678&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">hum0050.v1</a></strong></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000053</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">B型肝炎創薬へ向けてのトランスクリプトーム解析による病態解明と標的同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/09/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（CAGE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">転写開始点同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HBVキャリア：8症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松浦 知和</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1093&amp;Itemid=1286&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0053.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000062</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000176</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性中皮腫のプロファイリングによる新規分子標的の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/07/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/04/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Chromium Controller）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性胸膜中皮腫：38症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中野 孝司</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=446&amp;Itemid=724&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">hum0055.v1</a></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000059</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非アルコール性脂肪肝疾患のゲノム・エピゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/02/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、HumanMethylation450）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NAFLD：64症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">堀田 紀久子</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=616&amp;Itemid=879&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">hum0056.v1</a></strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト全ゲノム解析に基づく高精度の住民ゲノム参照パネルと3層オミックスパネルの作成</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/03/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、WGBS、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/X）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">197名 </span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">清水 厚志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=643&amp;Itemid=910&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0058.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000091</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸がんの転移/再発に特徴的な遺伝子変異の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：89症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山口 俊晴</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=636&amp;Itemid=906&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0059.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000104</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">卵巣がんの再発に特徴的な遺伝子変異の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">卵巣癌：65症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">加藤 一喜</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=621&amp;Itemid=885&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0060.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000075</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳がんの再発/転移に特徴的な遺伝子変異の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">再発・転移性乳癌：65症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三木 義男</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=717&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\"><strong>hum0061.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000057</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">全ゲノムあるいは全エクソン解析による家族性腫瘍原因遺伝子の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/02/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">多発性肺癌同胞：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">加藤 菊也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=348&amp;Itemid=642&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">hum0064.v1</a></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000061</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">高齢者がん治療アルゴリズム開発のためのガイドポスト・データベースの構築と必須情報及びその推定モデル</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/08/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">*サンガー</span></p>\r\n<p><span style=\"font-size: small;\">TaqMan</span></p>\r\n<p><span style=\"font-size: small;\">qRT-PCR</span></p>\r\n<p><span style=\"font-size: small;\">マイクロアレイ</span></p>\r\n<p><span style=\"font-size: small;\">COBRA</span></p>\r\n<p><span style=\"font-size: small;\">治療情報</span></p>\r\n<p><span style=\"font-size: small;\">臨床情報</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Applied BioSystems</span></p>\r\n<p><span style=\"font-size: small;\">（3130 Genetic Analyzer）</span></p>\r\n<p><span style=\"font-size: small;\">Roche</span></p>\r\n<p><span style=\"font-size: small;\">（LightCycler 480II）</span></p>\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">（Whole Human Genome DNAマイクロアレイ 4x44K）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">【ゲノム】</span></p>\r\n<p><span style=\"font-size: small;\">大腸癌：106症例</span></p>\r\n<p><span style=\"font-size: small;\">胃癌：62症例</span></p>\r\n<p><span style=\"font-size: small;\">肺癌：173症例</span></p>\r\n<p><span style=\"font-size: small;\">【後向き】</span></p>\r\n<p><span style=\"font-size: small;\">大腸癌：313 症例</span></p>\r\n<p><span style=\"font-size: small;\">胃癌：166 症例</span></p>\r\n<p><span style=\"font-size: small;\">肺癌：344 症例</span></p>\r\n<p><span style=\"font-size: small;\">糖尿・腎障害：300 症例</span></p>\r\n<p><span style=\"font-size: small;\">循環器疾患：357 症例</span></p>\r\n<p><span style=\"font-size: small;\">呼吸器疾患：49 症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西山 正彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=635&amp;Itemid=894&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0065.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000089</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">患者腫瘍移植モデルとex vivo培養間のシャトルシステムによる革新的な臨床効果評価技術の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：8症例</span></p>\r\n<p><span style=\"font-size: small;\">肺癌：2症例</span></p>\r\n<p><span style=\"font-size: small;\">子宮頸部小細胞癌：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">井上 正宏</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=345&amp;Itemid=1345&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0066.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000060</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">癌の再発・転移に関与するnon-coding RNAの同定とその機序の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：9症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三森 功士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=444&amp;Itemid=723&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0067.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000076</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">卵巣明細胞腺癌に対する新規バイオマーカーの検索と</span><span style=\"font-size: small;\">化学療法感受性に関する後方視的検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/05/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">卵巣明細胞腺癌：55症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">杉山 徹</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2715&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0068.v9</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000065＊</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000349</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000570</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000677</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノム解析に基づく肺がんの発生・進展の分子機構の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/07/10</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/10/19</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/12/14</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/03/23</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/12/27</span></p>\r\n<p><span style=\"font-size: small;\">v6:2023/02/10</span></p>\r\n<p><span style=\"font-size: small;\">v7:2023/06/19</span></p>\r\n<p><span style=\"font-size: small;\">v8:2023/09/22</span></p>\r\n<p><span style=\"font-size: small;\">v9:2024/04/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（PCR amplicon Seq、WGS、RNA-seq、scDNA-seq、Target Capture、Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n<p><span style=\"font-size: small;\">Multiplex Fluorescence Immunostaining</span></p>\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（MinION、PromethION）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、HiSeq 2000）</span></p>\r\n<p><span style=\"font-size: small;\">Akoya Biosciences</span></p>\r\n<p><span style=\"font-size: small;\">（PhenoCycler）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Xenium Analyzer）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺腺癌：8＋21＋74＋20症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">河野 隆志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=420&amp;Itemid=703&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong><strong>hum0069.v1</strong></strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000064</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">神経筋疾患、ウイルス性疾患におけるRNA発現プロファイル解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/12/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（small RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">神経筋疾患：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">横田 隆徳</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=676&amp;Itemid=930&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0070.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000115</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">バート・ホッグ・デュベ症候群の分子病態解明と新規の診断マーカーおよび治療標的分子の探索研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">バート・ホッグ・デュベ症候群：15症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">矢尾 正祐</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=376&amp;Itemid=666&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0072.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ナルコレプシーおよび各種睡眠障害の感受性遺伝子の同定と機能解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（SNP Array 6.0）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ナルコレプシー：409症例 </span></p>\r\n<p><span style=\"font-size: small;\">対照：1562名</span></p>\r\n<p><span style=\"font-size: small;\">真性過眠症：125症例</span></p>\r\n<p><span style=\"font-size: small;\">対照：562名 </span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 徳永 勝士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=742&amp;Itemid=987&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0074.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">テーラーメイド治療を目指した肝炎ウイルスデータベース構築に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/02/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（SNP Array 6.0、Axiom ASI）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NVR：78症例</span></p>\r\n<p><span style=\"font-size: small;\">VR：64症例</span></p>\r\n<p><span style=\"font-size: small;\">SVR：51症例</span></p>\r\n<p><span style=\"font-size: small;\">Plt減少-：196症例</span></p>\r\n<p><span style=\"font-size: small;\">Plt減少+：107症例</span></p>\r\n<p><span style=\"font-size: small;\"></span><span style=\"font-size: small;\">Hb減少-：209症例</span></p>\r\n<p><span style=\"font-size: small;\">Hb減少+：94症例</span></p>\r\n<p><span style=\"font-size: small;\">SVR後肝癌を発症した群：123症例</span></p>\r\n<p><span style=\"font-size: small;\">SVR後肝癌を発症していない群：333症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 田中 靖人</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1967&amp;Itemid=2026&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0075.v3</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">B型肝炎ウイルス感染の病態別における宿主遺伝因子の探索研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/09/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/02/19</span></p>\r\n<p><span style=\"font-size: small;\">v3:2022/05/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（SNP Array 6.0、Axiom ASI）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HBV保有：181症例</span></p>\r\n<p><span style=\"font-size: small;\">HBV排除：185症例</span></p>\r\n<p><span style=\"font-size: small;\">対照：184名</span></p>\r\n<p><span style=\"font-size: small;\">HBV陽性肝癌：473症例</span></p>\r\n<p><span style=\"font-size: small;\">HBV保有（慢性肝炎患者および無症候キャリア）：516症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">B型肝炎：329症例</span></p>\r\n<p><span style=\"font-size: small;\">健常対照者：318名</span></p>\r\n<p><span style=\"font-size: small;\">（タイ人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">溝上 雅史</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=380&amp;Itemid=671&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">hum0076.v1</a></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人原発性胆汁性肝硬変の発症・進展に関わる遺伝因子の網羅的遺伝子解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/10/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Axiom ASI）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">PBC：487症例</span></p>\r\n<p><span style=\"font-size: small;\">対照：476名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中村 稔</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1817&amp;Itemid=1893&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0079.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000068</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">神経筋変性疾患の遺伝子解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/02/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">封入体筋炎：53症例</span></p>\r\n<p><span style=\"font-size: small;\">多発筋炎：6症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：9名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">後藤 順</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=545&amp;Itemid=823&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">hum0082.v2</a></span></p>\r\n<p><span style=\"font-size: small;\"> JGAS000120</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人健常者におけるゲノム全域のSNP解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/09/26</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/10/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">健常者遺伝子型</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（SNP Array 6.0、Axiom ASI）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">419名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">徳永 勝士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1782&amp;Itemid=1865&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0083.v2</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000070</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000488</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">バイオマーカー探索に資する網羅的遺伝子解析研究（肺がん）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/10/28</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/01/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（CAGE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">転写開始点同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺癌：97＋38症例</span></p>\r\n<p><span style=\"font-size: small;\">胸膜中皮腫：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">林崎 良英</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=934&amp;Itemid=1150&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0085.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000108</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胸腹部腫瘍の長期治療成績に関する分子生物学的研究</span></p>\r\n<p><span style=\"font-size: small;\">環境因子が関与する腫瘍のゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/10/16</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アレイCGH</span></p>\r\n<p><span style=\"font-size: small;\">NGS（WGS、Target Capture、Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina </span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq、HiSeq 4000/X Ten）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性中皮腫患：72症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人、米国人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大村谷 昌樹</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=701&amp;Itemid=951&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0086.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000073<br />（JGA000074）</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000107<br />（JGA000117）</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">生殖発生にかかわる細胞のエピゲノム解析基盤研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/09/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/12/26</span></p>\r\n<p><span style=\"font-size: small;\">v3:2018/06/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS（PBAT-seq、ChIP-seq、RNA-seq、small RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胎盤もしくは子宮の細胞、ヒト胎盤幹細胞：計39検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">佐々木 裕之</span></p>\r\n<p><span style=\"font-size: small;\">（IHEC）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=944&amp;Itemid=1159&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0088.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000077</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000096</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">腫瘍細胞におけるTGF-βファミリーシグナルの網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/02/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/09/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Genome Analyzer IIx）</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳腫瘍：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">宮園 浩平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=411&amp;Itemid=696&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0090.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000078</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000079</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000080</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト消化器ならびに泌尿器上皮細胞の</span></p>\r\n<p><span style=\"font-size: small;\">標準エピゲノム解析</span></p>\r\n<p><span style=\"font-size: small;\">（COCシリーズ）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/11/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（PBAT-seq、ChIP-seq、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸粘膜吸収上皮細胞：12種類</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">金井 弥栄</span></p>\r\n<p><span style=\"font-size: small;\">（IHEC）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=425&amp;Itemid=711&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0091.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000082</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000165</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000081</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト消化器ならびに泌尿器上皮細胞の</span></p>\r\n<p><span style=\"font-size: small;\">標準エピゲノム解析</span></p>\r\n<p><span style=\"font-size: small;\">（GACシリーズ）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（PBAT-seq、ChIP-seq、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃粘膜表層粘液細胞：14種類</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">金井 弥栄</span></p>\r\n<p><span style=\"font-size: small;\">（IHEC）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2216&amp;Itemid=2237&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0094.v11</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000095</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000105</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000113</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000128</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000215</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000270</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000297</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000335</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000360</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000534</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性腫瘍のゲノム・エピゲノム解析による病態解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/09/04</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/01/22</span></p>\r\n<p><span style=\"font-size: small;\">v3:2019/02/12</span></p>\r\n<p><span style=\"font-size: small;\">v4:2020/08/14</span></p>\r\n<p><span style=\"font-size: small;\">v5:2020/10/26</span></p>\r\n<p><span style=\"font-size: small;\">v6:2021/01/29</span></p>\r\n<p><span style=\"font-size: small;\">v7:2021/07/02</span></p>\r\n<p><span style=\"font-size: small;\">v8:2021/10/22</span></p>\r\n<p><span style=\"font-size: small;\">v9:2021/10/26</span></p>\r\n<p><span style=\"font-size: small;\">v10:2022/05/23</span></p>\r\n<p><span style=\"font-size: small;\">v11:2022/11/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、RNA-seq、Target Capture、Iso-seq）、メチル化アレイ、SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">CNV</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500、MethylationEPIC、HumanOmni2.5-8）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Chromium Controller）</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">（Sequel）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌：68症例</span></p>\r\n<p><span style=\"font-size: small;\">肺腺癌：43＋126症例</span></p>\r\n<p><span style=\"font-size: small;\">大腸癌：150症例＋173症例</span></p>\r\n<p><span style=\"font-size: small;\">肝転移を有する大腸癌12症例、肝転移を有さない大腸癌16症例</span></p>\r\n<p><span style=\"font-size: small;\">デスモイド腫瘍：64症例</span></p>\r\n<p><span style=\"font-size: small;\">肺多形癌：35症例</span></p>\r\n<p><span style=\"font-size: small;\">唾液腺導管癌：67症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">間野 博行</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=711&amp;Itemid=960&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0095.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000092</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸前がん病変および早期大腸がんにおける遺伝子解析および発がん機序の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/07/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸腺腫、大腸癌早期病変：計10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三森 功士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=997&amp;Itemid=1201&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0096.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000090</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000138</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍における遺伝子異常の網羅的解析（小児T細胞性急性リンパ性白血病）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/05/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/11/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、MethylationEPIC）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児T-ALL：123症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">滝田 順子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=691&amp;Itemid=942&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0097.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000094</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">骨髄不全症候群における血球の質に関する検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/05/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">第6染色体短腕の片親性ダイソミー陽性再生不良性貧血：5症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中尾 眞二</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=474:hum0099-v1&amp;catid=10&amp;lang=ja-JP&amp;Itemid=747\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0099.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000085</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト免疫細胞における遺伝子多型と遺伝子発現の関連解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/04/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">eQTL</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、Infinium OmniExpressExome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：105名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山本 一彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=681&amp;Itemid=934&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0101.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000098</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">EBウイルス関連リンパ腫を発症した原発性免疫不全症候群の原因遺伝子探索に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 原発性免疫不全症：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岩谷 靖雅</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1771&amp;Itemid=1857&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0103.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000109</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000389</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">シークエンス解析によるがんゲノム研究：胆道がん</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/02/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/06/21</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/07/13</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/01/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胆道癌：98＋121症例</span></p>\r\n<p><span style=\"font-size: small;\">正常胆嚢：4名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2136&amp;Itemid=2155&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0106.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000139</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト大腸がん培養組織を用いたがん予防・治療法の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（患者由来3次元培養細胞）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">八尾 良司</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1168&amp;Itemid=1351&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0107.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000099</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000218</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">基底細胞母斑症候群患者からのinduced pluripotent stem （iPS）細胞の樹立および病態の解明、骨移植への臨床応用</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/10/02</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/06/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/4000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">基底細胞母斑症候群：4症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">東 俊文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=498&amp;Itemid=779&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0108.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000111</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">精神疾患発症にかかわる関連遺伝子の探索および解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/06/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HumanMethylation450）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">パニック症：48症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：48名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">徳永 勝士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1384&amp;Itemid=1534&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0111.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000103</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000141</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000242</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃腫瘍のゲノム・遺伝子解析とその臨床病理学的意義の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/07/31</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/05/31</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/02/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、Amplicon-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000、MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">びまん性胃癌：30症例</span></p>\r\n<p><span style=\"font-size: small;\">胃癌：60＋15症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">石川 俊平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=565:hum0112-v1&amp;catid=10:cat-researches&amp;lang=ja-JP\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0112.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000112</span></p>\r\n<p><span style=\"font-size: small;\">（JGA000122）</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト胎盤幹細胞の樹立と細胞特性に関する基礎的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS（PBAT-seq、ChIP-seq、RNA-seq、miRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト胎盤幹細胞：2系統</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">有馬 隆博</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2059&amp;Itemid=2098&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0113.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000119</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000142</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000318</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">パーキンソン病の代謝産物バイオマーカー創出およびその分子標的機構に基づく創薬シーズ同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/24</span></p>\r\n<p><span style=\"font-size: small;\">v1:2021/07/30</span></p>\r\n<p><span style=\"font-size: small;\">v3:2022/07/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（CAGE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">転写開始点同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">パーキンソン病：39症例、対照健常者：20名</span></p>\r\n<p><span style=\"font-size: small;\">iPS細胞由来神経細胞（パーキンソン病：3検体、対照健常者：3検体から樹立）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Piero Carninci</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1589&amp;Itemid=1700&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0114.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA007411</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000314</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人由来B細胞株DNAのゲノムデータを用いた遺伝統計解析手法の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/18</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/04/12</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/08/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HumanCoreExome、MiSeq、HiSeq X Ten、NovaSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乾癬：282症例</span></p>\r\n<p><span style=\"font-size: small;\">対照：426名</span></p>\r\n<p><span style=\"font-size: small;\">細胞株：1,173検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岡田 随象</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1129&amp;Itemid=1317&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0115.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000121</span></p>\r\n<p><span style=\"font-size: small;\">DRA006296</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">動的遺伝子ネットワークの多次元構造解析による高精度な細胞分化制御技術の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">マイクロアレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">（SurePrint G3 Human GE 8x60K v2 Microarray、SureScan G4900DA）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SEES3にTFを導入して樹立したES細胞株（TF-hESC）</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">洪 実</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1314&amp;Itemid=1476&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0116.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000122</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト化マウス（humanized mouse）の作製と免疫学研究への応用</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 急性骨髄性白血病：118症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">石川 文彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=555&amp;Itemid=831&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0117.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000125</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">神経変性疾患のエピジェネティクス解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HumanMethylation450）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アルツハイマー病：30症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：30名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岩田 淳</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=560&amp;Itemid=836&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0118.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000124</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">バイオマーカー探索に資する網羅的遺伝子解析研究（子宮体がん）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（CAGE-seq）</span></p>\r\n<p><span style=\"font-size: small;\">Sanger-seq</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">転写開始点同定</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific（3500 Genetic Analyzer）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮体癌：17症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">林崎 良英</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=812&amp;Itemid=1048&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0119.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000126</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NASHの発症、進展を規定するメカニズム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/01/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Human610-Quad、HumanCoreExome、HumanOmni2.5-Quad BeadChip）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NAFLD患者：902症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：7672名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松田 文彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2068&amp;Itemid=2102&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0120.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000221</span></p>\r\n<p><span style=\"font-size: small;\">DRA011183</span></p>\r\n<p><span style=\"font-size: small;\">DRA011184</span></p>\r\n<p><span style=\"font-size: small;\">DRA011185</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-396</span></p>\r\n<p><span style=\"font-size: small;\">DRA010902</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000549</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化器癌患者の末梢血液中における転移再発の予測因子候補に関する臨床的意義の確立</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/03</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/10/30</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/12/06</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/07/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、Target Capture、WGBS）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、iScan、HiSeq X Ten）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：10＋25＋10症例</span></p>\r\n<p><span style=\"font-size: small;\">胃癌：16症例</span></p>\r\n<p><span style=\"font-size: small;\">乳癌：16症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三森 功士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1043&amp;Itemid=1237&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0122.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA006622</span></p>\r\n<p><span style=\"font-size: small;\">DRA007336</span></p>\r\n<p><span style=\"font-size: small;\">DRA008459</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-311</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">市販ヒト初代細胞由来iPS 細胞のゲノム変異解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/01/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X Ten、Infinium Omni2.5-8）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">市販のヒト培養細胞、およびそれから誘導したiPS細胞株：計27検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">荒木 良子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=631&amp;Itemid=902&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0124.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000129</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト上皮成長因子受容体（EGFR）遺伝子変異をもつ肺癌家系における肺癌発癌関連遺伝子同定に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">EGFR遺伝子変異をもつ肺癌：3症例（1家系）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">菊地 利明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=762&amp;Itemid=1004&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0125.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000127</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制御性T細胞特異的エピゲノム誘導による免疫制御の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/11/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion S5）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">クローン病：3症例</span></p>\r\n<p><span style=\"font-size: small;\">大腸癌：4症例（非腫瘍組織）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">坂口 志文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1243&amp;Itemid=1417&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0126.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児ネフローゼ症候群の疾患感受性遺伝子及び薬剤感受性遺伝子同定研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/09/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Japonica Array v1/v2）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児ネフローゼ症候群：224＋3,206症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：419＋987名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">飯島 一誠</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2814&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0127.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000130</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000274</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000604</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000715</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">マルチオーミクス解析を用いたがん患者評価に基づく個別化治療と新技術開発に関する研究ープロジェクトHOPE（High-tech Omics-based Patients Evaluation）for Cancer Therapyー</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/08</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/01/22</span></p>\r\n<p><span style=\"font-size: small;\">v4:2024/07/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、DNA Amplicon-seq、RNA Amplicon-seq、WGS）</span></p>\r\n<p><span style=\"font-size: small;\">マイクロアレイ</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">（SurePrint G3 Human Gene Expression 8 × 60 K v2 Microarray、 DNA Microarray Scanner）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、Infinium MethylationEPIC array、iScan System）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">POLE変異および高変異症例の癌：91症例</span></p>\r\n<p><span style=\"font-size: small;\">癌：5143＋7症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山口 建</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=757&amp;Itemid=999&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0128.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000153</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">慢性好酸球性炎症疾患の網羅的遺伝子解析と網羅的蛋白質解析に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/10/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">慢性副鼻腔炎：6症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤枝 重治</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=655&amp;Itemid=900&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0129.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000131</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">神経疾患患者からのiPS細胞の樹立とそれを用いた疾患解析に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（ChIP-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">CHARGE症候群：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岡野 栄之</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2779&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0130.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000150</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000289</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ＰＯＥＭＳ症候群の骨髄細胞における遺伝子異常の網羅的解析</span></p>\r\n<p><span style=\"font-size: small;\">造血器腫瘍と骨髄ニッチ細胞の遺伝子異常解析による分子病態の解明と新規治療薬開発の基盤構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/01/18</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/09/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/06/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、Target Capture、RNA-seq、scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/2000/2500/3000、MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">POEMS症候群：20＋14症例</span></p>\r\n<p><span style=\"font-size: small;\">多発性骨髄腫：4＋5症例</span></p>\r\n<p><span style=\"font-size: small;\">MGUS：5＋2症例</span></p>\r\n<p><span style=\"font-size: small;\">骨髄浸潤のない悪性リンパ腫：4+3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">堺田 恵美子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=767&amp;Itemid=1008&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0131.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000132</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発達障害のエピゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Williams症候群：6症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：8名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">木村 亮</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=732&amp;Itemid=979&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0132.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000137</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ベトナムにおけるダイオキシン関連疾患のゲノムシークエンス解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/09/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ダイオキシン暴露者（退役軍人）とその妻と知的障害を持つ子の9トリオ（計27名）</span></p>\r\n<p><span style=\"font-size: small;\">（ベトナム人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=647&amp;Itemid=914&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0133.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000086</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃がんの転移/再発に特徴的な遺伝子変異の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃癌：75症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山口 俊晴</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=651&amp;Itemid=918&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0134.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000087</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Bリンパ腫の転移/再発に特徴的な遺伝子変異の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Bリンパ腫：60症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山口 俊晴</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1626&amp;Itemid=1728&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0136.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000341</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">B型肝炎に関する統合的臨床ゲノムデータベースの構築を目指す研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/05/22</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/05</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/10/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Axiom ASI）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">B型肝炎ワクチン接種者（ビームゲン）：1,193名</span></p>\r\n<p><span style=\"font-size: small;\">B型肝炎ワクチン接種者（ヘプタバックス）：555名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">溝上 雅史</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=787&amp;Itemid=1027&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0137.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000144</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1型糖尿病関連遺伝子群の多施設共同研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/12/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1型糖尿病：32症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">池上 博司</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1432&amp;Itemid=1572&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0138.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000134</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">固形腫瘍における遺伝子異常の網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/07/31</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Hiseq 2500/4000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝硬変：10症例</span></p>\r\n<p><span style=\"font-size: small;\">肝癌：4症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：7名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">高井 淳</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=706&amp;Itemid=956&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0139.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000136</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">疾患特異的iPS細胞を用いた創薬・疾患研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/07/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">RALD患者：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大津 真</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1002&amp;Itemid=1205&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0140.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000158</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">microRNA/mRNA網羅的発現解析及び全エクソンシークエンス解析に基づく直腸癌術前治療効果予測法の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/11/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">術前放射線化学療法施行直腸癌：74症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">秋吉 高志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=863&amp;Itemid=1089&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0141.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000135</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制御性T細胞特異的エピゲノム誘導による免疫制御の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/05/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion S5）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">頭頸部癌：4症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">坂口 志文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3046&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0143.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000143</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">膵臓癌の進展において(プロ)レニン受容体の発現亢進は、クロマチンリモデラーSMARCA5の発現増大を介してゲノム不安定性を生じる</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">不死化ヒト膵管上皮細胞：6検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西山 成</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1038&amp;Itemid=1233&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0144.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000147</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍における遺伝子異常の網羅的解析（ダウン症候群患者におけるB前駆細胞性急性リンパ性白血病）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/01/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500、Infinium MethylationEPIC BeadChip、Infinium HumanMethylation450 BeadChip）</span></p>\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Human Mapping 250K Nsp、CytoScan HD）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ダウン症候群患者のB前駆細胞性急性リンパ性白血病：43症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">滝田 順子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1073&amp;Itemid=1270&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0145.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000222</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化器癌患者の末梢血液中における転移再発の予測因子候補に関する臨床的意義の確立</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三森 功士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=828&amp;Itemid=1060&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0146.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA007187</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">先天性インプリント異常症の診断と生殖医療の安全性評価</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/02/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RRBS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">生殖補助医療を受けたSRS患者：5症例</span></p>\r\n<p><span style=\"font-size: small;\">生殖補助医療を受けていないSRS患者：5症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常児：10名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">有馬 隆博</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2440&amp;Itemid=2425&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0147.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000145</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000312</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000454</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制御性T細胞特異的エピゲノム誘導による免疫制御の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/18</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/05/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、ChIP-seq、PBAT-seq、ATAC-seq、scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion S5）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/3000/4000、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常人：4＋1名</span></p>\r\n<p><span style=\"font-size: small;\">癌患者：7＋3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">坂口 志文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=899&amp;Itemid=1121&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0148.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000149</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">泌尿器科腫瘍組織での遺伝子異常と発現解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/06/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Genome Analyzer IIx）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">腎癌：67症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">湯浅 健</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2226&amp;Itemid=2245&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0152.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000182</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000529</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノム・プロテオーム解析に基づく骨軟部腫瘍の分子病態把握とその臨床応用を目指す多施設共同研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/09/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/11/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脱分化型脂肪肉腫：37症例</span></p>\r\n<p><span style=\"font-size: small;\">lipoblastoma-like tumor of the vulva：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">市川 仁</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=955&amp;Itemid=1169&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0153.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000177</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">希少腫瘍の発症・予後に関する遺伝子の網羅的解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/09/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脱分化型脂肪肉腫：28症例</span></p>\r\n<p><span style=\"font-size: small;\">腱鞘巨細胞種：36症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松田 浩一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1583&amp;Itemid=1695&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0156.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000227</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">次世代シークエンサーを用いた遺伝子統合解析による食道癌化学放射線療法耐性の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/07/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道癌：33症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三森 功士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=939&amp;Itemid=1154&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0157.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000164</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">がんのクリニカルシークエンスと付随研究としての網羅的ゲノム・エピゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/08/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">癌：183症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">宮園 浩平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1563&amp;Itemid=1678&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0158.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000151</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">シークエンス解析によるがんゲノム研究：肝臓がん</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/10/22</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/06/21</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/07/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000、Genome Analyzer IIx、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝臓癌：263症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=2305&amp;Itemid=2311&amp;lang=ja\" target=\"_blank\">hum0159.v2</a></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000157＊</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">シークエンス解析によるがんゲノム研究：大腸がん</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/06/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/12/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1568&amp;Itemid=1682&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0160.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000155</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">シークエンス解析によるがんゲノム研究：食道がん</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/05/28</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/07/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500/X Five）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道癌：20症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2309&amp;Itemid=2315&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0161.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000156＊</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">シークエンス解析によるがんゲノム研究：肝芽腫</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/06/04</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/12/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝芽腫：33症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2430&amp;Itemid=2417&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0163.v3</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">精神・神経疾患治療薬及びがん治療薬におけるファーマコゲノミクス研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/12/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/02/09</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/04/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq、Infinium OmniExpressExome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">精神・神経疾患及び癌：計990症例</span></p>\r\n<p><span style=\"font-size: small;\">水疱性類天疱瘡：90症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者（日本人由来B細胞株）：737検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">莚田 泰誠</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=781&amp;Itemid=1023&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0164.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000160</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">東北メディカル・メガバンク事業地域住民コホート調査</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/12/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Infinium OmniExpressExome-8）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">住民コホートに参加した9,187名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">長﨑 正朗</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=858&amp;Itemid=1085&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0165.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000162</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">家族性骨髄異形成症候群の遺伝子解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/05/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">家族性骨髄異形成症候群：2症例（1家系）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">古屋 淳史</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2679&amp;Itemid=2610&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0166.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">炎症性腸疾患患者におけるチオプリン関連副作用とNUDT15遺伝子多型との相関性に関する多施設共同研究（MENDEL Study）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/07/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/01/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Japonica Array v1）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">炎症性腸疾患：1221＋2680症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">角田 洋一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=919&amp;Itemid=1137&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0167.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">痛風・高尿酸血症及び尿酸関連疾患の病態解明に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/07/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HumanOmniExpressExome-8、Human660W-Quad、HumanOmni2.5-8、HumanOmniExpress-12、HumanOmniExpress-24、HumanOmniExpressExome、HumanOmniExpress、HumanExome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人コホート（J-MICC study、KING study、BBJ）：計121,745名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松尾 洋孝</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=987&amp;Itemid=1193&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0168.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000169</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性腫瘍のゲノム・エピゲノム解析による病態解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/11/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮腺筋症：51症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">河津 正人</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1193&amp;Itemid=1375&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0169.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000178</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳脊髄腫瘍のバイオマーカーの探索と標的治療開発に向けた遺伝子解析及びヒト由来脳脊髄腫瘍細胞株を用いた前臨床研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/06/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/07/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中枢神経原発悪性リンパ腫：9症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山本 哲哉</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=853&amp;Itemid=1081&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0173.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000171</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胎児期に始まる子どもの健康と発達に関する調査</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/04/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RRBS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">臍帯組織（正常出産）：30検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">森 千里</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2668&amp;Itemid=2602&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0174.v6</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000173</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000580</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000286</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000505</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000596</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人ゲノム構造変異データベースの作成</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/06</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/11/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/06/29</span></p>\r\n<p><span style=\"font-size: small;\">v4:2023/07/06</span></p>\r\n<p><span style=\"font-size: small;\">v5:2023/07/10</span></p>\r\n<p><span style=\"font-size: small;\">v6:2023/12/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">（Sequel、Sequel II）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Chromium Controller）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人由来B細胞株・DNAバンクから分譲されたDNAサンプル：10＋11＋177＋141＋30検体</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">森下 真一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2718&amp;Itemid=2638&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0175.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000174</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000642</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">治療抵抗性・再発予測バイオマーカーならびに新規分子標的治療法開発のための婦人科腫瘍検体の収集、保管ならびにゲノム・エピゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/10/02</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/03/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮類内膜腺癌：69症例</span></p>\r\n<p><span style=\"font-size: small;\">子宮内膜増殖症：30症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">竹島 信宏</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=971&amp;Itemid=1181&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0176.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000172</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮及び卵巣がん肉腫におけるドライバー変異の体系的探索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/10/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮癌肉腫：92症例</span></p>\r\n<p><span style=\"font-size: small;\">卵巣癌肉腫：17症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">森 誠一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1115&amp;Itemid=1305&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0177.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000197</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳腫瘍の悪性化に関与する遺伝子の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（PBAT-seq、RNA-seq、ChIP-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X Ten、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性神経膠腫：14症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">伊藤 隆司</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1078&amp;Itemid=1274&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0179.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000186</span></p>\r\n<p><span style=\"font-size: small;\">DRA009794</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">薬剤関連顎骨壊死における口腔内微生物叢メタゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタゲノム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタゲノム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina </span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：4名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">矢原 耕史</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1414&amp;Itemid=1558&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0180.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000170</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">RNAスプライシングの異常によって生じる先天異常症候群および先天代謝異常症等の遺伝子解析と低分子化合物によるその治療法の開発研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">家族性自律神経異常症：2症例</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">網代 将彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=884&amp;Itemid=1107&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0181.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">副腎皮質におけるアルドステロン産生の老化の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">病理スライドガラス画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Dako</span></p>\r\n<p><span style=\"font-size: small;\">（Autostainer Link 48）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">病理解剖を施行された50歳以上の症例：85症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西本 紘嗣郎</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1962&amp;Itemid=2022&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0182.v5</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000180</span></p>\r\n<p><span style=\"font-size: small;\">DRA008482</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000516</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">全ゲノムシークエンスデータの解析による変異と遺伝的多様性の包括的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/06/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/05/12</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/01/06</span></p>\r\n<p><span style=\"font-size: small;\">v4:2021/11/12</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/05/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（MinION）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000、Genome Analyzer IIx）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝臓癌（正常細胞）：174＋42症例</span></p>\r\n<p><span style=\"font-size: small;\">肝臓癌（腫瘍組織）：11＋42症例</span></p>\r\n<p><span style=\"font-size: small;\">HapMap：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">乳癌細胞株：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤本 明洋</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1827&amp;Itemid=1901&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0184.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000239</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人全ゲノムデータベースの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/09/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">一般住民：4,566名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山本 雅之</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type II）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1519&amp;Itemid=1642&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0187.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000194</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000233</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化器癌のゲノム・遺伝子解析とその臨床病理学的意義の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/12</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/05/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture、Exome、RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq、HiSeq 2500、HumanMethylation450）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝癌：243＋160症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">油谷 浩幸</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=912&amp;Itemid=1133&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0188.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000179</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃がん細胞株のゲノム解析による治療標的同定 </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/06/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃癌細胞株：2検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">間野 博行</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1183&amp;Itemid=1363&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0191.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA008575</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">個々のがんの遺伝子変異に基づく固有抗原の同定と腫瘍内微小環境の解析に基づく免疫制御法を組み合わせた個別化がんワクチン治療の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/4000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">膵癌：17症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">垣見 和宏</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1474&amp;Itemid=1606&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0192.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000196</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸・直腸癌患者のオリゴメタスタシスに対する放射線・陽子線治療後予後予測バイオマーカーとしてcell free DNAの有用性を検証する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/04/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸・直腸癌：20症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中村 匡希</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1125&amp;Itemid=1313&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0194.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000189</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">分子プロファイリングによる薬剤抵抗性機構の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺癌：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">片山 量平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1886&amp;Itemid=1956&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0195.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000190</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000234</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000269</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化器癌における遺伝子異常についての網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/26</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/03/02</span></p>\r\n<p><span style=\"font-size: small;\">v3:2022/03/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、RNA-seq、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 4000、NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">結節内結節型肝癌：5症例</span></p>\r\n<p><span style=\"font-size: small;\">C型肝炎ウイルス排除後に肝癌を発症した慢性肝炎/肝硬変：20症例</span></p>\r\n<p><span style=\"font-size: small;\">C型肝炎ウイルス陽性肝硬変/肝癌：3症例</span></p>\r\n<p><span style=\"font-size: small;\">C型肝炎ウイルス陰性肝癌：2症例</span></p>\r\n<p><span style=\"font-size: small;\">胃癌：42 ＋ 1症例、胃粘膜下腫瘍：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">髙井 淳</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1022&amp;Itemid=1221&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0196.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">自殺者血液および死後脳標本を用いた自殺に関連した生物学的マーカーの同定と自殺予防への応用に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/12/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HumanOmniExpress-24、HumanOmniExpressExome-8）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">自殺者：746名</span></p>\r\n<p><span style=\"font-size: small;\">非自殺者：14,049名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">菱本 明豊</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3153&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0197.v25</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000205</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000260</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000316</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000415</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000504</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000530</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000531</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000543</span></p>\r\n<p><span style=\"font-size: small;\">DRA014184</span></p>\r\n<p><span style=\"font-size: small;\">DRA014186</span></p>\r\n<p><span style=\"font-size: small;\">DRA014188</span></p>\r\n<p><span style=\"font-size: small;\">DRA014191</span></p>\r\n<p><span style=\"font-size: small;\">DRA014192</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000593</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000600</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000741</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000751</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-887</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1054</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000783</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">多層的オミクス解析による疾患病態の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/11/15</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/11/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/03/22</span></p>\r\n<p><span style=\"font-size: small;\">v4:2021/12/10</span></p>\r\n<p><span style=\"font-size: small;\">v5:2021/12/21</span></p>\r\n<p><span style=\"font-size: small;\">v6:2022/02/08</span></p>\r\n<p><span style=\"font-size: small;\">v7:2022/05/23</span></p>\r\n<p><span style=\"font-size: small;\">v8:2022/06/03</span></p>\r\n<p><span style=\"font-size: small;\">v9:2022/06/10</span></p>\r\n<p><span style=\"font-size: small;\">v10:2022/06/16</span></p>\r\n<p><span style=\"font-size: small;\">v11:2022/07/21</span></p>\r\n<p><span style=\"font-size: small;\">v12:2022/12/01</span></p>\r\n<p><span style=\"font-size: small;\">v13:2023/02/14</span></p>\r\n<p><span style=\"font-size: small;\">v14:2023/02/16</span></p>\r\n<p><span style=\"font-size: small;\">v15:2023/03/29</span></p>\r\n<p><span style=\"font-size: small;\">v16:2023/06/06</span></p>\r\n<p><span style=\"font-size: small;\">v17:2023/06/27</span></p>\r\n<p><span style=\"font-size: small;\">v18:2023/10/02</span></p>\r\n<p><span style=\"font-size: small;\">v19:2024/05/29</span></p>\r\n<p><span style=\"font-size: small;\">v20:2024/05/30</span></p>\r\n<p><span style=\"font-size: small;\">v21:2024/10/28</span></p>\r\n<p><span style=\"font-size: small;\">v22:2024/11/11</span></p>\r\n<p><span style=\"font-size: small;\">v23:2024/12/18</span></p>\r\n<p><span style=\"font-size: small;\">v24:2025/05/07</span></p>\r\n<p><span style=\"font-size: small;\">v25:2025/07/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタゲノム</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、RNA-seq、scRNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">eHHV-6の有無、アネロウイルス量</span></p>\r\n<p><span style=\"font-size: small;\">プロテオミクス</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタゲノム</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">eQTL</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/3000/X Ten、NovaSeq 6000、Infinium Asian Screening Array、HumanOmniExpressExome BeadChip、HumanOmniExpress BeadChip、HumanExome BeadChip、iCOGS OncoArray）</span></p>\r\n<p><span style=\"font-size: small;\">Applied Biosystems</span></p>\r\n<p><span style=\"font-size: small;\">（UK BiLEVE Axiom Array、UK Biobank Axiom Array）</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（FinnGen1 ThermoFisher Arrayなど）</span></p>\r\n<p><span style=\"font-size: small;\"> MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-T7）</span></p>\r\n<p><span style=\"font-size: small;\">Olink</span></p>\r\n<p><span style=\"font-size: small;\">（Olink Explore 3072）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人集団：95＋103＋227＋30＋141＋136＋88＋5＋524名</span></p>\r\n<p><span style=\"font-size: small;\">BBJ：180,215名</span></p>\r\n<p><span style=\"font-size: small;\">UKバイオバンク：377,583名</span></p>\r\n<p><span style=\"font-size: small;\">FinnGen：136,000＋224,352名</span></p>\r\n<p><span style=\"font-size: small;\">BCAC：247,173名</span></p>\r\n<p><span style=\"font-size: small;\">PRACTICAL：140,254名</span></p>\r\n<p><span style=\"font-size: small;\">肺胞蛋白症：198症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：395名</span></p>\r\n<p><span style=\"font-size: small;\">潰瘍性大腸炎：35症例</span></p>\r\n<p><span style=\"font-size: small;\">クローン病：39症例</span></p>\r\n<p><span style=\"font-size: small;\">健常対照者：40名</span></p>\r\n<p><span style=\"font-size: small;\">頭蓋内胚細胞腫瘍：133症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：762名</span></p>\r\n<p><span style=\"font-size: small;\">COVID-19：30＋43＋15症例</span></p>\r\n<p><span style=\"font-size: small;\">健常対照者：31＋44＋27名</span></p>\r\n<p><span style=\"font-size: small;\">健常者：73名</span></p>\r\n<p><span style=\"font-size: small;\">間質性膀胱炎ハンナ型：144症例</span></p>\r\n<p><span style=\"font-size: small;\">2型糖尿病：27,642症例（BBJ）</span></p>\r\n<p><span style=\"font-size: small;\">対照者：70,242名（BBJ）</span></p>\r\n<p><span style=\"font-size: small;\">2型糖尿病：27,642症例（UKバイオバンク）</span></p>\r\n<p><span style=\"font-size: small;\">対照者：70,242名（UKバイオバンク）</span></p>\r\n<p><span style=\"font-size: small;\">不育症：1,728症例</span></p>\r\n<p><span style=\"font-size: small;\">自己免疫疾患：2,238症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：2,919名</span></p>\r\n<p><span style=\"font-size: small;\">HPV関連中咽頭癌：32症例</span></p>\r\n<p><span style=\"font-size: small;\">HPV非関連中咽頭癌：17症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：2名</span></p>\r\n<p><span style=\"font-size: small;\">視神経脊髄炎関連疾患：240症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：50,578名</span></p>\r\n<p><span style=\"font-size: small;\">乾癬：204症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：1,231名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人、イギリス人、フィンランド人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岡田 随象</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1188&amp;Itemid=1371&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0199.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000198</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">次世代シーケンサーを用いた泌尿器悪性腫瘍の治療標的分子の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">前立腺癌：25症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤村 哲也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2946&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0200.v6</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000202</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000265</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000290</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000387</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000758</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳腺腫瘍の表現型にかかわる体細胞変異および遺伝子発現異常の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/29</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/05/07</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/10/01</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/03/02</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/08/29</span></p>\r\n<p><span style=\"font-size: small;\">v6:2024/11/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、WGS、Target Capture、Visium Spatial Gene Expression、semibulk RNA-seq、scRNA-seq、EM-seq、t-nanoEM）</span></p>\r\n<p><span style=\"font-size: small;\">CNV</span></p>\r\n<p><span style=\"font-size: small;\">メチル化解析</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">CNV</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 3000、NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Chromium Controller）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非浸潤性乳管癌：96症例</span></p>\r\n<p><span style=\"font-size: small;\">浸潤性乳管癌：4＋1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">永澤 慧</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2864&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0201.v8</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000199</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000237＊</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000256</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000378</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000350</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000550</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000719</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト腫瘍試料の収集・分譲とゲノム情報を利用した研究</span></p>\r\n<p><span style=\"font-size: small;\">既存試料の分譲とゲノム情報を利用した研究</span></p>\r\n<p><span style=\"font-size: small;\">消化器慢性炎症性疾患における遺伝子変異の検索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/12/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/10/06</span></p>\r\n<p><span style=\"font-size: small;\">v3:2020/11/20</span></p>\r\n<p><span style=\"font-size: small;\">v4:2021/11/19</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/06/06</span></p>\r\n<p><span style=\"font-size: small;\">v6:2022/08/05</span></p>\r\n<p><span style=\"font-size: small;\">v7:2022/12/27</span></p>\r\n<p><span style=\"font-size: small;\">v8:2024/08/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、WGS、RNA-seq、ChIP-seq、scRNA-seq、ATAC-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/4000/X Ten、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">潰瘍性大腸炎：29症例</span></p>\r\n<p><span style=\"font-size: small;\">腫瘍を併発する潰瘍性大腸炎：26症例</span></p>\r\n<p><span style=\"font-size: small;\">下部消化管内視鏡検査を受けた患者（対照者）：16名</span></p>\r\n<p><span style=\"font-size: small;\">腫瘍性疾患：23＋1＋4＋2＋3症例</span></p>\r\n<p><span style=\"font-size: small;\">膵癌：50症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">佐藤 俊朗</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2151&amp;Itemid=2167&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0202.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000379</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">言語聴覚リハビリテーションの向上を目的とした先天性難聴の遺伝的原因と生後早期の経過の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/4000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">先天性難聴：3症例とその両親</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松永 達雄</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1150&amp;Itemid=1335&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0203.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000206</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍における臨床ゲノム情報統合データベースの構築に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">多発性骨髄腫：154症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">堀部 敬三</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1007&amp;Itemid=1209&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0206.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000207</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">妊娠関連疾患の胎盤栄養膜細胞株の樹立と細胞特性に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/11/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（PBAT-seq、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">全胞状奇胎：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">有馬 隆博</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1032&amp;Itemid=1229&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0207.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト免疫細胞における遺伝子多型と遺伝子発現の関連解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/01/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、ChIP-seq、Hi-C）</span></p>\r\n<p><span style=\"font-size: small;\">eQTL</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n<p><span style=\"font-size: small;\">eQTL</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、HiSeq series、Infinium OmniExpressExome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関節リウマチ：30症例</span></p>\r\n<p><span style=\"font-size: small;\">変形性関節症：30症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤尾 圭志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1048&amp;Itemid=1241&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0208.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000214</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">頭頚部悪性腫瘍に対する網羅的遺伝子解析およびデータベースの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/01/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X Ten）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">外耳道癌：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 尚志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1017&amp;Itemid=1217&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0209.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関節リウマチ治療におけるメトトレキサートの効果と副作用予測のための多施設研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/12/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">ダイレクトシークエンス</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（GeneChip® Scanner 3000 7G）</span></p>\r\n<p><span style=\"font-size: small;\">Applied Biosystems</span></p>\r\n<p><span style=\"font-size: small;\">（Veriti 96-Well Thermal Cycler and 3730XL DNA Analyzer）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関節リウマチ：166症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">熊谷 俊一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1083&amp;Itemid=1278&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0210.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000211</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍における遺伝子異常の網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">急性骨髄性白血病と縦隔胚細胞腫瘍の合併症例：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">下田 和哉</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2033&amp;Itemid=2078&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0213.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000238</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Demographic History and Local Adaptation in Asian Population</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/07/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X Ten）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">バルチ人：60名</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Min-Sheng Peng</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2692&amp;Itemid=2618&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0214.v9</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000220</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000296</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-397</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-398</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-420</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000486</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000598</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000485</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000626</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000627</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000648</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト免疫系の機能ゲノム学による統合的理解とこれを用いた免疫疾患の発症予防のためのインターベンション戦略の構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/09</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/05</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/04/28</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/01/21</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/03/09</span></p>\r\n<p><span style=\"font-size: small;\">v6:2022/08/25</span></p>\r\n<p><span style=\"font-size: small;\">v7:2023/03/28</span></p>\r\n<p><span style=\"font-size: small;\">v8:2023/07/06</span></p>\r\n<p><span style=\"font-size: small;\">v9:2024/02/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、scRNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">eQTL</span></p>\r\n<p><span style=\"font-size: small;\">B細胞受容体レパトア解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">eQTL</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10免疫疾患：544症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：185名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤尾 圭志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2191&amp;Itemid=2199&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0215.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000532</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人の全ゲノム、RNA解析を基盤とした老年病関連分子の同定と解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アルツハイマー病：317症例</span></p>\r\n<p><span style=\"font-size: small;\">軽度認知障害：432症例</span></p>\r\n<p><span style=\"font-size: small;\">認知機能正常：107名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">尾崎 浩一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1464&amp;Itemid=1598&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0216.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000216</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000244</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000279</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化管癌を含む固形癌患者における免疫状態の解明と臨床的意義に関する研究</span></p>\r\n<p><span style=\"font-size: small;\">新規免疫療法や併用療法開発を目指した固形癌患者の免疫状態の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/02/07</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/09/25</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/03/29</span></p>\r\n<p><span style=\"font-size: small;\">v4:2021/04/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺腺癌：17症例</span></p>\r\n<p><span style=\"font-size: small;\">胃癌：26＋23症例</span></p>\r\n<p><span style=\"font-size: small;\">肺癌：9症例</span></p>\r\n<p><span style=\"font-size: small;\">悪性黒色腫：5症例</span></p>\r\n<p><span style=\"font-size: small;\">大腸癌：7症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西川 博嘉</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1058&amp;Itemid=1256&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0217.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000217</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸ポリープから癌への進展を予測する遺伝子変化の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/03/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Torrent）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸鋸歯状病変（鋸歯状ポリープ）：50症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">澤田 武</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1268&amp;Itemid=1440&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0218.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-344</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">全身性強皮症患者の遺伝子発現解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">全身性強皮症：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤尾 圭志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1178&amp;Itemid=1359&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0220.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000223</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">採血後の試験管保存状態が試験管内の化合物濃度に与える影響の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">LC-MS/MS</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">質量分析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Sciex</span></p>\r\n<p><span style=\"font-size: small;\">（TripleTOF 5600）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常人：3名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大槻 純男</span></p>\r\n<p><span style=\"font-size: small;\">（AMED疾患代謝）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2561&amp;Itemid=2518&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0221.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000225</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト疾患特異的iPS細胞を用いた遺伝子解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ファブリー病患者由来iPS細胞株：3検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">粟屋 智就</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1063&amp;Itemid=1260&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0222.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000224</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS技術を駆使した遺伝学的解析による家族性乳がんの原因遺伝子同定と標準化医療構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/03/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌：115症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大野 真司</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1238&amp;Itemid=1413&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0223.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000232</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">血液がんにおける遺伝子変異の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/09/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">多発性骨髄腫：7症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">照井 康仁</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3197&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0225.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000226</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000835</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HTLV-1関連脊髄症（HAM）におけるゲノム異常及びエピゲノム異常の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture、RNA-seq、ATAC-seq、scRNA-seq、scATAC-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/3000、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HTLV-1関連脊髄症（HAM）：21＋15症例</span></p>\r\n<p><span style=\"font-size: small;\">無症候性HTLV-1感染者：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山岸 誠</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1529&amp;Itemid=1650&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0226.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000229</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">上部消化管腫瘍のゲノム・遺伝子解析とその臨床病理学的意義の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/06/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃癌：141症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">油谷 浩幸</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1533&amp;Itemid=1654&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0227.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000228</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃腫瘍のゲノム・遺伝子解析とその臨床病理学的意義の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/06/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃癌：102症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">油谷 浩幸</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1145&amp;Itemid=1329&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0229.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000230</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">老化・神経疾患における分子マーカーの探索と分子基盤の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">スーパーセンチナリアン（110歳以上）：7名</span></p>\r\n<p><span style=\"font-size: small;\">家族：2名</span></p>\r\n<p><span style=\"font-size: small;\">血縁関係のない対照群：2名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Piero Carninci</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2826&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0231.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000287</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト疾患特異的iPS細胞樹立に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常人：120名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">齋藤 潤</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1173&amp;Itemid=1355&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0232.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000231</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃癌由来循環腫瘍DNAモニタリングによる転移・再発の検証</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃癌：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西塚 哲</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1514&amp;Itemid=1638&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0233.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000236</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児肝癌に対する国際共同臨床試験（PHITT, JPLT4）付随研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/05/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、WGBS）</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、HumanMethylation450）</span></p>\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（SNP Array 6.0）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児肝腫瘍：165症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">檜山 英三</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1452&amp;Itemid=1588&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0235.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000272</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">プレクリニカル期におけるアルツハイマー病に対する客観的画像診断・評価法の確立を目指す臨床研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳画像</span></p>\r\n<p><span style=\"font-size: small;\">臨床情報</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳画像ベースの病態解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><a href=\"hum0235-v1-release#mriscanners\" target=\"_blank\" rel=\"noopener noreferrer\">MRIスキャナー（9機種）</a></p>\r\n<p><a href=\"hum0235-v1-release#petscanners\" target=\"_blank\" rel=\"noopener noreferrer\">PETスキャナー（11機種）</a></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常高齢者群：25名</span></p>\r\n<p><span style=\"font-size: small;\">プレクリニカルAD：3名</span></p>\r\n<p><span style=\"font-size: small;\">早期MCI：7名</span></p>\r\n<p><span style=\"font-size: small;\">後期MCI：5名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">嶋田 裕之</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1329&amp;Itemid=1488&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0236.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000245</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺がんの複雑な遺伝子変異を利用した腫瘍浸潤リンパ球療法の開発を目指した基礎的検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/12/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（MinION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非小細胞肺癌：7症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中面 哲也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1389&amp;Itemid=1538&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0237.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人の全ゲノム、RNA解析を基盤とした老年病関連分子の同定と解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Japonica Array、SNP Array 6.0）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アルツハイマー病：3,962症例</span></p>\r\n<p><span style=\"font-size: small;\">非アルツハイマー病：4,074名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">尾崎 浩一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1203&amp;Itemid=1383&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0238.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000240</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">オーダーメイド医療開発プロジェクト</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/07/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">BBJ：10名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">桃沢 幸秀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1198&amp;Itemid=1379&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0239.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000241</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">がん、感染症、難病、生活習慣病等に関する遺伝子とタンパク質などの網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/07/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">膀胱癌：19症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">弘津 陽介</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1284&amp;Itemid=1452&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0240.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000258</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中枢神経原発悪性リンパ腫の全ゲノムシーケンス解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Torrent）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中枢神経原発悪性リンパ腫：28症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山中 龍也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1354&amp;Itemid=1508&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0242.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000243</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">変異遺伝子のモニタリングによる大腸癌術後の微少転移及び再発の新たな評価法の検証</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/01/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：12症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西塚 哲</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1304&amp;Itemid=1468&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0243.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000253</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト化マウス（humanized mouse）の作製と免疫学研究への応用/ヒト・造血免疫系由来iPS細胞を用いた疾患と治療モデルの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、CAGE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">臍帯血：24名</span></p>\r\n<p><span style=\"font-size: small;\">急性骨髄性白血病：116症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">石川 文彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2202&amp;Itemid=2225&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0245.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000276</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">思春期・若年成人急性リンパ芽球性白血病における網羅的ゲノム解析（JALSG ALL202U-GWS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/10/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">フィラデルフィア染色体陰性ALL：46症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">早川 文彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1349&amp;Itemid=1504&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0247.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000249</span></p>\r\n<p><span style=\"font-size: small;\">DRA010773</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">がん患者免疫状態を反映するがん遺伝子変異の探索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/01/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性黒色腫：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岩田 卓</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1299&amp;Itemid=1464&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0248.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000259</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">高精度長鎖解読による日本人基準ゲノム配列策定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/11/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">PacBio（RS II）</span></p>\r\n<p><span style=\"font-size: small;\">Bionano（Irys、Saphyr）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人健常男性：3名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山本 雅之</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type II）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3002&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0249.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000248</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000663</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">硬組織・結合組織関連疾患患者由来iPS細胞を用いた病態解明と治療法開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/09/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/03/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（CAGE-seq、scRNA-seq、CUT&amp;RUN-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">転写開始点同定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">鎖骨頭蓋骨異形成症：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">東 俊文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1437&amp;Itemid=1576&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0250.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000277</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">革新脳脳老化ヒト画像研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳画像</span></p>\r\n<p><span style=\"font-size: small;\">臨床情報</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><a href=\"hum0250-v1-release#mriscanners\" target=\"_blank\" rel=\"noopener noreferrer\">MRIスキャナー（1機種）</a></p>\r\n<p><a href=\"hum0250-v1-release#petscanners\" target=\"_blank\" rel=\"noopener noreferrer\">PETスキャナー（1機種）</a></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MCI：11名</span></p>\r\n<p><span style=\"font-size: small;\">健常高齢者群：28名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 岩坪 威</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2206&amp;Itemid=2229&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0251.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000278</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">成人フィラデルフィア染色体陰性precursor B細胞性急性リンパ性白血病に対する多剤併用化学療法による第Ⅱ相臨床試験</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/10/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">フィラデルフィア染色体陰性B-ALL：153症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">八田 善弘</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2723&amp;Itemid=2642&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0252.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000301</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000553</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ATL、HTLV-1感染症の分子基盤創出のための研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/07/12</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/12/06</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/03/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture、RNA-seq、scRNA-seq、WGS、scATAC-seq、ChIP-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/3000、NovaSeq 6000、NextSeq 500）</span></p>\r\n<p><span style=\"font-size: small;\"> MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ATL：6＋4＋6症例（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">HTLV-1感染者：10症例（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">健常者3＋1名のCD4+T細胞（セルライン）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山岸 誠</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1610&amp;Itemid=1716&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0254.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000257</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">血中セルフリーDNAからの配列決定ライブラリー調製法の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq、HiSeq X Ten）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常人：5名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三浦 史仁</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2322&amp;Itemid=2329&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0257.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000262</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000263</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000264</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000514</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-414</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-415</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-416</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-417</span></p>\r\n<p><span style=\"font-size: small;\">GSE202023</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト膵・胆道由来微量検体を用いた培養増幅法の研究開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/12/24</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/01/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、ATAC-seq、ChIP-seq、Hi-C）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq6000、HiSeq 2500、NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">膵管癌：17症例</span></p>\r\n<p><span style=\"font-size: small;\">膵管内乳頭粘液性腫瘍：6症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">立石 敬介</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1364&amp;Itemid=1516&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0261.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">原発性胆汁性胆管炎の病態解明のためのゲノムワイド関連解析</span></p>\r\n<p><span style=\"font-size: small;\">― 1,000 症例の追加解析 ―</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/01/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/01/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">領域内遺伝率推定</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Axiom ASI、Japonica Array v1）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">原発性胆汁性胆管炎：1,953症例</span></p>\r\n<p><span style=\"font-size: small;\">健常対照者：3,690名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中村 稔</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1494&amp;Itemid=1622&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0262.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000267</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非小細胞肺癌における微小管阻害薬および葉酸代謝阻害薬感受性のバイオマーカー研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺腺癌：24症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">土原 一哉</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2539&amp;Itemid=2500&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0263.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000292</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">若年性骨髄単球性白血病における遺伝子異常の網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（DREAM-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">若年性骨髄単球性白血病：149症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">髙橋 義行</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1837&amp;Itemid=1909&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0264.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000508</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">過眠を呈する睡眠障害 (各種過眠症・概日リズム睡眠障害・睡眠時無呼吸症候群・睡眠関連運動障害・睡眠時随伴症など) の病態に関与する遺伝子の探索とその機能および末梢血リンパ球の自己抗原特異的増殖反応の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/02/07</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（SNP Array 6.0）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">特発性過眠症：129症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">本多 真</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2291&amp;Itemid=2299&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0266.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000281</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">患者検体を用いた自己免疫性皮膚疾患発症機序の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">天疱瘡：3症例</span></p>\r\n<p><span style=\"font-size: small;\">健常人：3名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">江上 将平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2986&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0267.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000284</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児がん・血液疾患患者に対するがん素因遺伝子およびがん細胞における原因遺伝子の網羅的遺伝子解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/02/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肉腫が疑われた小児：47症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">若松 学</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3181&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0268.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000280</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000766</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">がん組織を用いたネオアンチゲンスクリーニング</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/04/09</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/08/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Iso-seq、CAGE-seq、RNA-seq、scRNA-seq、scTCR-seq、Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500、NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">（Sequel）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト大腸癌細胞株：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（セルライン）</span></p>\r\n<p><span style=\"font-size: small;\">大腸癌：6症例</span></p>\r\n<p><span style=\"font-size: small;\">子宮体癌：5症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">金関 貴幸</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2735&amp;Itemid=2650&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0269.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000295</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000565</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000566</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000567</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">遺伝性心血管疾患の感受性遺伝子解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/05/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/03/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/3000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">遺伝性心血管疾患：13＋20症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">朝野 仁裕</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1930&amp;Itemid=1990&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0270.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000282</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムおよび遺伝子解析に基づく骨軟部腫瘍に特異的な分子病理学的異常の解明と、新規診断および治療法の開発を目指したトランスレーショナル研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児骨肉腫：16症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">米本 司</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1489&amp;Itemid=1618&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0271.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000288</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ハプロ不全により発症する常染色体優性遺伝性疾患における表現型発現の個体差に関する包括的ゲノム解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture、Target RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">神経線維腫症1型：20症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">新井田 要</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2926&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0272.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000285</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000589</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メラノーマ等、皮膚腫瘍病変の免疫状態の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/12/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/07</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/11/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、scRNA-seq、scTCR-seq、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Torrent Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メラノーマ：4＋9症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">猪爪 隆史</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1600&amp;Itemid=1708&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0273.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000300</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌の発生、進展に関する分子病理学的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/08/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Amplicon-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小葉癌乳管癌併存症例：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">増田 しのぶ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1921&amp;Itemid=1982&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0274.v1</span></a></p>\r\n<p><span style=\"font-size: small; font-weight: bold; text-align: center;\">JGAS000294</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">mRNA輸送因子UAP56とURH49による選択的mRNA輸送基盤の統合的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/04/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"><span style=\"font-size: small;\">発現</span></span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">目的遺伝子をノックダウンしたHeLa細胞：20検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤田 賢一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1594&amp;Itemid=1704&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0275.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000313</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">固形腫瘍における遺伝子異常の網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/08/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃癌既往の無いヘリコバクターピロリ未感染者（健常集団）：9名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小川 誠司</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1616&amp;Itemid=1720&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0276.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000308</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Gorlin症候群に対する汎用型遺伝子診断パネルの開発とリキッドバイオプシーへの応用</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/10/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Gorlin症候群：12症例</span></p>\r\n<p><span style=\"font-size: small;\">血縁者：3名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">東 俊文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3189&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0277.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000303</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000564</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000737</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">泌尿器科領域の腫瘍性疾患の発症、進展、及び薬剤の治療効果に関わる遺伝子の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/09</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/04/18</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/05/10</span></p>\r\n<p><span style=\"font-size: small;\">v4:2025/09/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、Exome、RNA-seq、WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500、HiSeq 2500、NovaSeq 6000/PE150）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">腎癌：15＋30＋167症例</span></p>\r\n<p><span style=\"font-size: small;\">腎オンコサイトーマ：7症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">蓮見 壽史</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2023&amp;Itemid=2070&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0278.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000304</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000305</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌幹細胞のゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/07/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 3000、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌：5症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">後藤 典子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2127&amp;Itemid=2147&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0279.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000307</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノム・エピゲノム解析と免疫組織染色による難治性悪性リンパ腫の層別化と新規治療法の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 550）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">びまん性大細胞型B細胞リンパ腫：177症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">堺田 恵美子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1758&amp;Itemid=1845&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0280.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA012560</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺癌患者における標的抗原の同定とがん微小環境の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺癌：113症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松下 博和</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2336&amp;Itemid=2341&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0284.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000309</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">生体維持機能の破綻による前がん病変から浸潤がんへの移行を制御する分子機序の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/01/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌：4症例</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中山 淳</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2221&amp;Itemid=2241&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0286.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000311</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000523</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非アルコール性脂肪性肝疾患患者における肝癌発症・進展機序の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/12</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/11/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Visium Spatial Gene Expression、Target Capture）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝細胞癌：55症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小玉 尚宏</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2723&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0287.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000310</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000573</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000690</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒトiPS細胞株のゲノム配列比較</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/02</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/03/29</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/05/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒトiPS細胞株：5＋1＋1株</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">横林 しほり</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2156&amp;Itemid=2171&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0289.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000317</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">慢性骨髄単球性白血病（CMML）における同種移植後再発メカニズムの探索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、Exome）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、MethylationEPIC）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">慢性骨髄単球性白血病（CMML）：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">赤星 佑</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3084&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0290.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000321</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000637</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1053</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1058</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1059</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1060</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒトゲノム・遺伝子発現および細菌叢の環境因子との相互作用に関する網羅的解析（２）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/04</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/06/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、scRNA-seq、TCR-seq、BCR-seq、scATAC-seq）</span></p>\r\n<p><span style=\"font-size: small;\">プロテオミクス</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000/X、MethylationEPIC）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Chromium Controller）</span></p>\r\n<p><span style=\"font-size: small;\">Fluidigm</span></p>\r\n<p><span style=\"font-size: small;\">（Helios, a CyTOF System）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-T7）</span></p>\r\n<p><span style=\"font-size: small;\">Olink</span></p>\r\n<p><span style=\"font-size: small;\">（Olink Explore 3072）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：7＋97名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">鈴木 穣</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2587&amp;Itemid=2538&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0291.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000359</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">網羅的ゲノム解析による膵腫瘍ならびに十二指腸腫瘍、胆道腫瘍の本態解明と新規診断・治療法の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/12/10</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/09/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">膵腫瘍：57＋6症例</span></p>\r\n<p><span style=\"font-size: small;\">十二指腸腫瘍：6＋1症例</span></p>\r\n<p><span style=\"font-size: small;\">胆道腫瘍：11症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">谷内田 真一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1605&amp;Itemid=1712&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0292.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000330</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">去勢抵抗性前立腺癌の最適医療の実現に向けた血液ゲノムマーカーの開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">去勢抵抗性前立腺癌：100症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">赤松 秀輔</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2038&amp;Itemid=2082&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0293.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000320</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍・難治性腫瘍の治療感受性を規定する遺伝学的宿主側因子、腫瘍側因子の探索研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/07/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X Ten）</span></p>\r\n<p><span style=\"font-size: small;\">BGI</span></p>\r\n<p><span style=\"font-size: small;\">（BGISEQ-500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">成人T細胞性白血病リンパ腫（ATL）：7症例</span></p>\r\n<p><span style=\"font-size: small;\">ATL細胞株（TL-om1）：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三田 貴臣</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2747&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0294.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000708</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">腫瘍浸潤T細胞サブセットのシングルセル解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/05/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道癌：28症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">熊谷 尚悟</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=1740&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0295.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000351</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">皮膚腫瘍の診断と治療効果の評価および経過観察のためのバイオマーカーの探索（前向き観察研究）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/10/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Amplicon-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion S5）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性黒色腫：98症例</span></p>\r\n<p><span style=\"font-size: small;\">脂腺母斑：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">宇原 久</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2171&amp;Itemid=2183&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0297.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000348</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">色覚多様性の総合的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：1名</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">平松 千尋</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2176&amp;Itemid=2187&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0299.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA012759</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ロングリードシークエンサーを用いたがん突然変異の染色体背景の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常白人由来B細胞株HG002（NA24385）：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">鈴木 穣</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1667&amp;Itemid=1764&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0300.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000367</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">がんの全ゲノム・全エキソンシークエンス解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道扁平上皮癌：89症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">稲澤 譲治</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1697&amp;Itemid=1788&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0301.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000368</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳がん患者および高リスク者におけるゲノム異常と免疫状態との統合的解析研究（免疫ゲノムアトラスプロジェクト）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌：26症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">間野 博行</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2740&amp;Itemid=2654&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0302.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000382</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000683</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">iPS細胞の高次特性解析と加工iPS細胞の作製</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/05</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/03/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ウイルソン病患者由来iPS細胞株：6検体</span></p>\r\n<p><span style=\"font-size: small;\">若年性ネフロン癆（NPH1）患者由来iPS細胞株：12検体</span></p>\r\n<p><span style=\"font-size: small;\">健常人由来iPS細胞株：6＋6検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">林 洋平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1754&amp;Itemid=1841&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0304.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000370</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳がんにおけるタキサン作用機序の解明に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/04/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌：6症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">鰐渕 友美</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1702&amp;Itemid=1792&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0305.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000377</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血細胞移植後二次がんの細胞遺伝学的特徴に関する多施設後方視的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">固形癌：14症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">稲本 賢弘</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1631&amp;Itemid=1732&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0306.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000361</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">国際連携によるがんゲノムシークエンス解析</span></p>\r\n<p><span style=\"font-size: small;\">（シークエンス解析によるがんゲノム研究）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/10/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（MinION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝臓癌：9症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1867&amp;Itemid=1933&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0307.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000416</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アトピー性皮膚炎患者における皮膚成分の解析（２）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion S5）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常男性：29名</span></p>\r\n<p><span style=\"font-size: small;\">男性のアトピー性皮膚炎：30症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">井上 高良</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1871&amp;Itemid=1937&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0308.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000417</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">皮膚成分の日間、日内変動解析試験</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion S5）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常女性：10名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">井上 高良</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1875&amp;Itemid=1941&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0309.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000418</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">皮脂及び角層由来成分のプロファイル比較試験</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion S5）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常男性：10名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">井上 高良</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3096&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0311.v7</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000412</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000541</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000561</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000785</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">バイオバンク・ジャパンの運営・管理と個別化医療の実現に向けた疾患バイオマーカー探索</span></p>\r\n<p><span style=\"font-size: small;\">疾患コホート研究ネットワークによる疾患マーカー探索研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/07/28</span></p>\r\n<p><span style=\"font-size: small;\">v3:2022/09/08</span></p>\r\n<p><span style=\"font-size: small;\">v4:2023/04/24</span></p>\r\n<p><span style=\"font-size: small;\">v5:2023/07/27</span></p>\r\n<p><span style=\"font-size: small;\">v6:2024/05/22</span></p>\r\n<p><span style=\"font-size: small;\">v7:2025/06/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">メタボローム</span></p>\r\n<p><span style=\"font-size: small;\">プロテオミクス</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">メタボローム</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n<p><span style=\"font-size: small;\">プロテオミクス</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Asian Screening Array、HumanOmniExpressExome、HumanOmniExpress、HumanExome）</span></p>\r\n<p><span style=\"font-size: small;\">Bruker</span></p>\r\n<p><span style=\"font-size: small;\">（AVANCE IIIHD）</span></p>\r\n<p><span style=\"font-size: small;\">Olink</span></p>\r\n<p><span style=\"font-size: small;\">（Explore 3072、Target 96）</span></p>\r\n<p><span style=\"font-size: small;\">Somalogic</span></p>\r\n<p><span style=\"font-size: small;\">（SomaScan）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">BBJ第一コホート：11,716名＋180,882＋1,285＋2,570＋40,907＋3,050名</span></p>\r\n<p><span style=\"font-size: small;\">BBJ第二コホート：42,689名</span></p>\r\n<p><span style=\"font-size: small;\">ToMMo：49,621名</span></p>\r\n<p><span style=\"font-size: small;\">UKバイオバンク：456,327名</span></p>\r\n<p><span style=\"font-size: small;\">FinnGen：230,635名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人、イギリス人、フィンランド人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松田 浩一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2801&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0312.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA016285</span></p>\r\n<p><span style=\"font-size: small;\">DRA016393</span></p>\r\n<p><span style=\"font-size: small;\">DRA016394</span></p>\r\n<p><span style=\"font-size: small;\">DRA016395</span></p>\r\n<p><span style=\"font-size: small;\">DRA018714</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">機能性遺伝子多型の網羅的解析を介した多因子疾患の病態解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/06/17</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/06/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、Iso-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（MinION）</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">（Sequel II/IIe）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人健常者不死化B細胞株：95検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n<p><span style=\"font-size: small;\">健常人：1名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">高地 雄太</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1677&amp;Itemid=1772&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0314.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000383</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アルツハイマー型認知症患者を対象とした疾患表現型と遺伝型の関連性解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Infinium OmniExpressExome-8）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">孤発性アルツハイマー病：102症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">井上 治久</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2053&amp;Itemid=2094&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0315.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000385</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍における遺伝子異常の網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/07/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、scRNA-seq、ChIP-seq、Target Capture）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/X Ten、MethylationEPIC、HumanMethylation450）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳児期発症のKMT2A遺伝子再構成陽性急性リンパ性白血病：84症例</span></p>\r\n<p><span style=\"font-size: small;\">乳児KMT2A遺伝子再構成陽性急性リンパ性白血病由来細胞株：3検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">滝田 順子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1952&amp;Itemid=2014&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0316.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000535</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道がんの全ゲノムシークエンス解析による病態解明と治療感受性マーカーの探索に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道扁平上皮癌：110症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2797&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0317.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000413</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000707</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">創薬研究に有用な患者検体移植モデルの構築に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/12/06</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/06/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非小細胞肺癌：4症例</span></p>\r\n<p><span style=\"font-size: small;\">癌：52症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 濱田 哲暢</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1862&amp;Itemid=1929&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0318.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000483</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">血液疾患のゲノム解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">B細胞性急性リンパ芽球性白血病（B-ALL）：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">東條 有伸</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1777&amp;Itemid=1861&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0319.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000487</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">遺伝子多型を用いた前立腺癌診断マーカーの開発</span></p>\r\n<p><span style=\"font-size: small;\">日本人の前立腺がん発症に関わるレアバリアントの同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">前立腺癌の確定診断のために前立腺生検を行う患者：1,336症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">赤松 秀輔</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1797&amp;Itemid=1877&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0320.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000480</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性腫瘍を有する患者を対象とした免疫モニタリング研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、TCR-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺腺癌：2症例</span></p>\r\n<p><span style=\"font-size: small;\">頭頸部癌：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">冨樫 庸介</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1972&amp;Itemid=2032&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0321.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000482</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胸腺組織を介した免疫系構築の遺伝子制御に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/06/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">重症筋無力症：4症例</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">奥野 龍禎</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1787&amp;Itemid=1869&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0323.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000489</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌の診断マーカーの探索研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（CAGE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">転写開始点同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：45症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">向後 泰司</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1911&amp;Itemid=1978&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0324.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000515</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳血管障害及び神経筋難病の遺伝子解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/04/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGBS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">AQP4抗体陽性の視神経脊髄炎（NMOSD）：10症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者（非発症血縁者）：8名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">奥野 龍禎</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1832&amp;Itemid=1905&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0327.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000507</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">個別化T細胞受容体遺伝子導入T細胞療法の臨床応用を目指した肝胆膵領域がんにおけるネオアンチゲンおよびそれを認識するT細胞受容体のスクリーニング</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/02/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 550）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝細胞癌：28症例</span></p>\r\n<p><span style=\"font-size: small;\">転移性肝癌：18症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">鈴木 利宙</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2450&amp;Itemid=2433&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0328.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000509</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人の進行性前立腺癌におけるDNA修復遺伝子異常の頻度に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">前立腺癌：129症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">赤松 秀輔</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1985&amp;Itemid=2040&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0329.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000522</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">未診断疾患の網羅的遺伝子解析による診断システムの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/06/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">未診断疾患の患者およびその両親（一部trioでない家系を含む）：177家系（522検体）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">村松 秀城</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=1916&amp;Itemid=1974&amp;lang=ja\" target=\"_blank\">hum0331.v1</a></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">がんや難病に関するゲノム医療の推進に必要な健常群 ・疾患コントロール群データの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/02/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">頻度情報</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者（難病や癌を罹患していない生活習慣病を持つ人を含む）：9290名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">徳永 勝士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1882&amp;Itemid=1945&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0332.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000510</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 遺伝子マーカーを用いた尿路性器癌の個別化治療法に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"><span style=\"font-size: small;\">配列決定</span></span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">去勢抵抗性前立腺癌：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">赤松 秀輔</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2122&amp;Itemid=2143&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0335.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA014819</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">遺伝子解析と免疫形質を組み合わせたリンパ増殖性疾患の新たな診断と臨床像の調査研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">原発性マクログロブリン血症：10症例</span></p>\r\n<p><span style=\"font-size: small;\">non IgM-type リンパ形質細胞性リンパ腫：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">横濱 章彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2822&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0337.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000521</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">難治性婦人科悪性腫瘍の包括的オミックス解析に基づく新規テーラーメード治療の創出を目指した基盤的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性転化を伴う卵巣成熟奇形腫：5症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">吉田 康将</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2235&amp;Itemid=2253&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0338.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000575</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">加齢またはピロリ感染の影響がない胃がんに対する包括的がんゲノム・エピゲノム・免疫ゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/11/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ピロリ菌未感染胃癌：27症例</span></p>\r\n<p><span style=\"font-size: small;\">ピロリ菌感染胃癌：36症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">森 誠一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2083&amp;Itemid=2115&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0340.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000520</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児固形腫瘍症例の次世代シークエンサーを用いた網羅的ゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Hiseq X Ten）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：24症例 （成人）</span></p>\r\n<p><span style=\"font-size: small;\">網膜芽腫：1症例 （小児）</span></p>\r\n<p><span style=\"font-size: small;\">膠芽腫：2症例 （成人）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大場 詩子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2012&amp;Itemid=2062&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0342.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000538</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化器腫瘍の免疫組織化学的・分子病理学的検索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/06/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：29症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関根 茂樹</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2892&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0343.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-759</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000739</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">新型コロナウイルス感染症の遺伝学的知見に基づいたCOVID19ワクチンの開発と評価系の構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/26</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/06/14</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/06/24</span></p>\r\n<p><span style=\"font-size: small;\">v4:2024/10/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">タンパク質発現量</span></p>\r\n<p><span style=\"font-size: small;\">eQTL/sQTL/pQTL</span></p>\r\n<p><span style=\"font-size: small;\">eHHV-6の有無、アネロウイルス量</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Infinium Asian Screening Array、NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Olink</span></p>\r\n<p><span style=\"font-size: small;\">（Olink Explore 3072）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">COVID-19感染者：2,393症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：3,289名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">福永 興壱</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2461&amp;Itemid=2441&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0344.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000533</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000611</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">シークエンス解析によるがんゲノム研究：腎臓がん</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/04</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/05/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、RNA-seq、Amplicon-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（MGISEQ-2000RS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">腎臓癌：38症例</span></p>\r\n<p><span style=\"font-size: small;\">慢性腎臓病：77症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">HEK293細胞株：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2095&amp;Itemid=2123&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0345.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000528</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000551</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">臍帯血を用いた再生医療に向けた基礎的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、ATAC-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：30名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大石 晃嗣</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2043&amp;Itemid=2086&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0347.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">急性脳症の包括的遺伝子解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/23</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/07/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">サンガー法</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Life Technologies</span></p>\r\n<p><span style=\"font-size: small;\">（310 Genetic Analyzer、3100 Genetic Analyzer、3130xl Genetic Analyzer）</span></p>\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Japonica Array v2）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">けいれん重積型急性脳症：283症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：799名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">水口 雅</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2456&amp;Itemid=2437&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0348.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000537</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">CD30陽性HTLV-1感染細胞のゲノム異常によるATL発症バイオマーカーの同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/05/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n<p><span style=\"font-size: small;\">アレイCGH</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">（GenetiSure Cancer Research CGH+SNP Microarray 2 x 400K）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ATL：8症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中島 誠</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2775&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0350.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000689</span></p>\r\n<p><span style=\"font-size: small;\">DRA018405</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-739</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-740</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-741</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-742</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-743</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-744</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-745</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-746</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> ヒト遺伝子多型とオミックスデータの統合解析のための基盤構築研究 </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/06/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（5' single-cell RNA-seq、3' single-cell RNA-seq、Micro-C and Region Capture Micro-C、CITE-seq、Multimodal assay（single-nucleus ATAC-seq、 3' and 5’ single-nucleus RNA-seq、 5' single-cell RNA-seq）、MAS-seq、CAGE-seq、NET-CAGE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">転写開始点同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、NextSeq 500）</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">（Sequel Ⅱ）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：3名</span></p>\r\n<p><span style=\"font-size: small;\">（男性：1名、女性：2名）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">CRISPR-activated Jurkat cells：15検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山本 一彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2141&amp;Itemid=2159&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0351.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000540</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">画像検査と RNF213 遺伝子検査の融合による閉塞性血管障害の新評価体系の確立</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタゲノム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタゲノム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">もやもや病：27症例</span></p>\r\n<p><span style=\"font-size: small;\">非もやもや脳血管障害：7症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：15名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">峰晴 陽平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2028&amp;Itemid=2074&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0352.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000545</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺癌放射線治療の治療効果および有害事象発症の予測に関与するタンパク機能、RNA発現の解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">原発性肺癌：5症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">染谷 正則</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2415&amp;Itemid=2405&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0354.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">泌尿器がんにおける血中循環がん細胞（CTC）の変化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/06/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/04/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">qRT-PCR</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">BioRad</span></p>\r\n<p><span style=\"font-size: small;\">（T100 Thermal cycler）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">進行転移性去勢抵抗性前立腺癌：127症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">永田 政義</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2478&amp;Itemid=2451&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0355.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000544</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">次世代シークエンスによる泌尿器科腫瘍のゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、RNA-seq）、マイクロアレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、NextSeq 500、HiSeq X Ten）</span></p>\r\n<p><span style=\"font-size: small;\">NanoString Technologies</span></p>\r\n<p><span style=\"font-size: small;\">（nCounter Digital Analyzer）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">VHL病に伴う遺伝性淡明細胞型腎細胞癌：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">片岡 圭亮</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2759&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0356.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA015288</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-579</span></p>\r\n<p><span style=\"font-size: small;\">DRA016520</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-619</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸発がんにおける遺伝子変化の解明と間質の臨床的意義の確立</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/05/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：1＋2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三森 功士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3034&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0357.v6</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000557</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000609</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000610</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺癌の遺伝子発現解析の生物学的特性ならびに診断・治療におけるバイオマーカーの研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/11/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/01/11</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/02/15</span></p>\r\n<p><span style=\"font-size: small;\">v4:2023/08/09</span></p>\r\n<p><span style=\"font-size: small;\">v5:2024/06/05</span></p>\r\n<p><span style=\"font-size: small;\">v6:2025/04/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、RNA-seq、scRNA-seq、ATAC-seq）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/X Ten、NovaSeq 6000、Infinium MethylationEPIC）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺癌：105＋2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">安田 浩之</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3201&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0358.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000582</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000586</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000640</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000824</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000825</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮頸部腺癌・扁平上皮癌、腟・外陰癌の発生及び予後決定に関わる遺伝子異常の検索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/10/19</span></p>\r\n<p><span style=\"font-size: small;\">v3:2025/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、scRNA-seq、Target bisulfite-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000/X Plus、MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮頸癌：19＋4＋96症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">NIKS18細胞株：5検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">曾根 献文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2073&amp;Itemid=2106&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0359.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000548</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">T/NK細胞リンパ腫におけるゲノム・エピゲノム異常の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">節外性NK/T細胞リンパ腫（鼻型）：67症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大石 直輝</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2271&amp;Itemid=2281&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0360.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000546</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">COVID-19 発病・重症化機構の探索的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、scVDJ-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">COVID-19：6症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">立川 愛</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3014&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0362.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000552</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺腫瘍、胸腺腫瘍患者の臨床検体（組織や血液など）を用いたゲノムプロファイリングに関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胸腺腫：98症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">谷内田 真一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2111&amp;Itemid=2135&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0364.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒトのマイクロサテライト多型の包括的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（公開済みbamファイルを使用した解析）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Simons Genome Diversity Project（SGDP）：276名</span></p>\r\n<p><span style=\"font-size: small;\">Human Genome Diversity Project（HGDP）：693名</span></p>\r\n<p><span style=\"font-size: small;\">縄文人：1名</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤本 明洋</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2212&amp;Itemid=2233&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0365.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000569</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">生活習慣病における腸内細菌の役割について</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（CAGE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">転写開始点同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：103名</span></p>\r\n<p><span style=\"font-size: small;\">肥満症：98症例</span></p>\r\n<p><span style=\"font-size: small;\">耐糖能異常：97症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大野 博司</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2365&amp;Itemid=2365&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0366.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-551</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-552</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">新型コロナウイルス感染症(COVID-19)の病態解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/03/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、RNA-seq、ATAC-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">COVID-19：16症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">加藤 保宏</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2181&amp;Itemid=2191&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0367.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000558</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">血液疾患のゲノム解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ランゲルハンス細胞組織球症：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">東條 有伸</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2245&amp;Itemid=2261&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0368.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000559</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">全ゲノム配列決定によるICF症候群の新規原因遺伝子の探索および機能解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/11/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（PBAT-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ICF症候群：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">鵜木 元香</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2196&amp;Itemid=2203&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0369.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000562</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">医療従事者の新型コロナウィルス感染抵抗性についての検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：139名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">川口 敦史</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=2286&amp;Itemid=2295&amp;lang=ja\" target=\"_blank\">hum0371.v1</a></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000574</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝臓疾患に関与する遺伝子とタンパク質の探索に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタゲノム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタゲノム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非アルコール性脂肪性肝炎：20症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">建石 良介</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2240&amp;Itemid=2257&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0372.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000572</span></p>\r\n<p><span style=\"font-size: small;\">MTBKS213</span></p>\r\n<p><span style=\"font-size: small;\">MTBKS214</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">多層的オミクス解析による疾患病態の解明</span></p>\r\n<p><span style=\"font-size: small;\">メタボリック・シンドローム関連疾患における個別化医療の実現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/11/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタボローム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタボローム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">（Agilent CE system、Agilent LC System）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2型糖尿病：300症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山内 敏正</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3068&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0375.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000688</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">超高速DNAシーケンサーを用いた疾患原因ゲノム領域の同定と情報解析法の確立、および参照配列データの作成に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">結節性硬化症：163症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">金田 眞理</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2380&amp;Itemid=2377&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0376.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000585</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">臨床検体からのゼノグラフト株・培養細胞株の樹立</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/03/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮内膜癌：2＋4症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">今井 俊夫</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2260&amp;Itemid=2273&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0377.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000579</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">不整脈症候群の遺伝子基盤に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Amplicon-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">QT延長症候群：556症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">田中 敏博</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2868&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0378.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000583</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000612</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">溶血性貧血の病態解明を目指した基礎研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/09/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">寒冷凝集素症：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小山 大輔</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2641&amp;Itemid=2580&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0379.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000578</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制御性T細胞特異的エピゲノム誘導による免疫制御の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、scVDJ-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">重症筋無力症：2症例</span></p>\r\n<p><span style=\"font-size: small;\">多発性硬化症：4症例</span></p>\r\n<p><span style=\"font-size: small;\">全身性エリテマトーデス：3症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：3名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">坂口 志文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2317&amp;Itemid=2324&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0381.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000588</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">切除不能または再発胸腺癌に対するニボルマブの多施設共同第II相試験（NCCH1505）附随研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/01/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胸腺癌：15症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">堀之内 秀仁</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2341&amp;Itemid=2345&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0382.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000587</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器疾患における遺伝子異常・エピジェネティクス異常の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/01/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">FUS-ERGを伴う急性骨髄性白血病：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">河原 真大</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=2375&amp;Itemid=2373&amp;lang=ja\" target=\"_blank\">hum0383.v1</a></span></p>\r\n<p><span style=\"font-size: small;\"> JGAS000602</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">生物学的製剤投与前後のリンパ球の遺伝子発現修飾の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/03/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関節リウマチ：5症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤尾 圭志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3124&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0384.v2</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000603</span></p>\r\n<p><span style=\"font-size: small;\"> JGAS000718</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍の分子病態の解明と新規治療薬開発の基盤構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/06/19</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/07/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、Target Capture、ATAC-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/2500、MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">急性骨髄芽球性白血病：4＋4症例</span></p>\r\n<p><span style=\"font-size: small;\">骨髄異形成症候群：30症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">正常細胞：6検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岩間 厚志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2658&amp;Itemid=2594&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0385.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000597</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000599</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">混合型肝癌、細胆管細胞癌、Cytokeratin19陽性肝細胞癌、SOX9陽性肝細胞癌の網羅的DNA変異解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/12/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/01/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">細胆管細胞癌：8症例</span></p>\r\n<p><span style=\"font-size: small;\">混合型肝癌：13症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">石井 隆道</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2410&amp;Itemid=2401&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0386.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA015813</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">長鎖リードの局所アセンブリによる一塩基解像度でのヒト反復配列のゲノムワイド解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/04/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Nanopore </span></p>\r\n<p><span style=\"font-size: small;\">（MinION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HapMap：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤本 明洋</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2395&amp;Itemid=2389&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0389.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000605</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胎児発育異常の遺伝子・ゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/04/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Capture Methyl-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常女性：4名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中林 一彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2509&amp;Itemid=2476&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0390.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000621</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノム・エピゲノム解析による慢性子宮内膜炎の関連遺伝子の解明とその診断法および治療法の検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X Ten）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">慢性子宮内膜炎：24症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：33名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">黒田 恵司</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2880&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0391.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000606</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト舌癌オルガノイドバイオバンクの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、scATAC-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">舌癌：4症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">佐藤 卓</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2858&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0393.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000693</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">膠原病類縁疾患患者検体を用いた新規バイオマーカーおよび治療標的分子探索に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関節リウマチ：6症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：6名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">坪井 洋人</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3136&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0394.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000613</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000757</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非小細胞肺癌における空間トランスクリプトーム解析に関する多施設共同研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/11/20</span></p>\r\n<p><span style=\"font-size: small;\">v3:2025/07/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Visium Spatial Gene Expression、WGS、t-nanoEM）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n<p><span style=\"font-size: small;\">Multiplex Fluorescence Immunostaining</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Xenium Analyzer）</span></p>\r\n<p><span style=\"font-size: small;\">Akoya Biosciences</span></p>\r\n<p><span style=\"font-size: small;\">（PhenoCycler）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非小細胞肺癌：8症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">鈴木 絢子</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2665&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0395.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000678</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食・腸内マイクロバイオーム・健康情報統合データベース構築に向けた網羅的研究調査（愛称：すこやか健康調査）：北海道情報大学</span></p>\r\n<p><span style=\"font-size: small;\">食と健康の関係性と遺伝的背景に関する検討：北海道情報大学</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">血液・尿検査</span></p>\r\n<p><span style=\"font-size: small;\">計測データ</span></p>\r\n<p><span style=\"font-size: small;\">アンケート調査</span></p>\r\n<p><span style=\"font-size: small;\">問診結果</span></p>\r\n<p><span style=\"font-size: small;\">被験者属性</span></p>\r\n<p><span style=\"font-size: small;\">睡眠日誌、睡眠時心拍・脳波</span></p>\r\n<p><span style=\"font-size: small;\">微生物組成</span></p>\r\n<p><span style=\"font-size: small;\">食事調査、食物摂取頻度調査</span></p>\r\n<p><span style=\"font-size: small;\">メタボロミクス</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健康調査</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Japonica Array v2）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常成人：963名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西平 順</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2669&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0396.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000679</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食・腸内マイクロバイオーム・健康情報統合データベース構築に向けた網羅的研究調査（愛称：すこやか健康調査）：宮崎大学</span></p>\r\n<p><span style=\"font-size: small;\">食と健康の関係性と遺伝的背景に関する検討：宮崎大学</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">血液・尿検査</span></p>\r\n<p><span style=\"font-size: small;\">計測データ</span></p>\r\n<p><span style=\"font-size: small;\">アンケート調査</span></p>\r\n<p><span style=\"font-size: small;\">問診結果</span></p>\r\n<p><span style=\"font-size: small;\">被験者属性</span></p>\r\n<p><span style=\"font-size: small;\">睡眠日誌、睡眠時心拍・脳波</span></p>\r\n<p><span style=\"font-size: small;\">微生物組成</span></p>\r\n<p><span style=\"font-size: small;\">食事調査、食物摂取頻度調査</span></p>\r\n<p><span style=\"font-size: small;\">メタボロミクス</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健康調査</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Japonica Array v2）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常成人：50名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">吉村 学</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2673&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0397.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000680</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食・腸内マイクロバイオーム・健康情報統合データベース構築に向けた網羅的研究調査（愛称：すこやか健康調査）：京都大学</span></p>\r\n<p><span style=\"font-size: small;\">食と健康の関係性と遺伝的背景に関する検討：京都大学</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">血液・尿検査</span></p>\r\n<p><span style=\"font-size: small;\">計測データ</span></p>\r\n<p><span style=\"font-size: small;\">アンケート調査</span></p>\r\n<p><span style=\"font-size: small;\">問診結果</span></p>\r\n<p><span style=\"font-size: small;\">被験者属性</span></p>\r\n<p><span style=\"font-size: small;\">睡眠日誌、睡眠時心拍・脳波</span></p>\r\n<p><span style=\"font-size: small;\">微生物組成</span></p>\r\n<p><span style=\"font-size: small;\">食事調査、食物摂取頻度調査</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健康調査</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Japonica Array v2）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常成人：50名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">稲垣 暢也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2677&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0398.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000681</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食・腸内マイクロバイオーム・健康情報統合データベース構築に向けた網羅的研究調査（愛称：すこやか健康調査）：長崎県立大学</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">血液・尿検査</span></p>\r\n<p><span style=\"font-size: small;\">計測データ</span></p>\r\n<p><span style=\"font-size: small;\">アンケート調査</span></p>\r\n<p><span style=\"font-size: small;\">問診結果</span></p>\r\n<p><span style=\"font-size: small;\">被験者属性</span></p>\r\n<p><span style=\"font-size: small;\">睡眠日誌、睡眠時心拍・脳波</span></p>\r\n<p><span style=\"font-size: small;\">微生物組成</span></p>\r\n<p><span style=\"font-size: small;\">食事調査、食物摂取頻度調査</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健康調査</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">-</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常成人：59名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">田中 一成</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2771&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0399.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000616</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳がん微小環境形成に関わる分子生物学的機序の生体試料を用いた探索研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/06/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">河岡 慎平</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2498&amp;Itemid=2467&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0401.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000618</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">創薬をめざした新規骨・軟部肉腫細胞株および疾患モデル動物の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性骨巨細胞腫：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">若松 透</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2707&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0402.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA016537</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-622</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸多段階発がん進化の過程においてドライバー変異を生じる機序の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：4症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三森 功士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2549&amp;Itemid=2508&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0403.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000622</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">泌尿器癌におけるリキッドバイオプシーの有用性の検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">転移性尿路上皮癌：16症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">濱田 和希</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3144&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0405.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000623</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000631</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児・成人悪性腫瘍がん幹細胞の同定に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/12/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/07/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、small RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X、NextSeq 550）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400RS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児B前駆細胞性急性リンパ性白血病：69症例</span></p>\r\n<p><span style=\"font-size: small;\">小児急性骨髄性白血病：9症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">滝田 順子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2577&amp;Itemid=2530&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0406.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000617</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-623</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト疾患特異的iPS細胞の作成とそれを用いた疾患解析に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/08/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SFTPCバリアントにおける家族性間質性肺炎：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">後藤 慎平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2488&amp;Itemid=2459&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0409.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000619</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">抗がん剤治療におけるExceptional Responseをもたらす遺伝子の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 550、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MDM2増幅内膜肉腫：11症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小山 隆文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2529&amp;Itemid=2492&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0411.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000625</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">対応可能（actionable）な内分泌疾患（腫瘍性のものを含む）の次世代シーケンサーを用いた分子生物学的解析による分子診断の検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">FBPase欠損症：1症例</span></p>\r\n<p><span style=\"font-size: small;\">家族：3名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">田中 知明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3010&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0413.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000628</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000780</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アトピー性皮膚炎患者の網羅的データ解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/03/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アトピー性皮膚炎：161＋41症例</span></p>\r\n<p><span style=\"font-size: small;\">乾癬：18症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：41＋10名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">古関 明彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2544&amp;Itemid=2504&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0414.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA016800</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノム解析に基づく肺がんの発生･進展の分子機構の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小気道上皮細胞株（SAEC）と派生細胞株：計5株</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">塩谷 文章</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3088&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0416.v5</span></a></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-635</span></p>\r\n<p><span style=\"font-size: small;\">DRA019233</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-867</span></p>\r\n<p><span style=\"font-size: small;\">DRA019274</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-872</span></p>\r\n<p><span style=\"font-size: small;\">DRA020399</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1051</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1057</span></p>\r\n<p><span style=\"font-size: small;\">DRA021372</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1076</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">経時的な多層的オミックス解析を通した免疫難病及びがんにおける生体反応の解明と新規治療法の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/08/10</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/09/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/10/16</span></p>\r\n<p><span style=\"font-size: small;\">v4:2025/05/19</span></p>\r\n<p><span style=\"font-size: small;\">v5:2025/06/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（CITE-seq、BD Ab-seq、scRNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">シングルセル空間トランスクリプトーム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Vizgen</span></p>\r\n<p><span style=\"font-size: small;\">（MERSCOPE）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">顕微鏡的多発血管炎：10症例</span></p>\r\n<p><span style=\"font-size: small;\">全身性強皮症：21症例</span></p>\r\n<p><span style=\"font-size: small;\">シェーグレン症候群：12症例</span></p>\r\n<p><span style=\"font-size: small;\">ベーチェット症候群：11症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：10名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">北沢 剛久</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2990&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0418.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000662</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">がん患者の臨床検体を用いた、治療効果および毒性に関する遺伝子のプロファイリング研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/02/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq、NextSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">抗悪性腫瘍薬による治療を予定している癌患者：507症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">河野 隆志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3006&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0419.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000641</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000653</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000664</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000749</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト消化器癌、胸部悪性腫瘍オルガノイド培養系のゲノム医療への応用</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/24</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/05/08</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/06/17</span></p>\r\n<p><span style=\"font-size: small;\">v4:2025/03/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺大細胞神経内分泌癌：3症例</span></p>\r\n<p><span style=\"font-size: small;\">粘液産生能を有する充実型肺腺癌：1症例</span></p>\r\n<p><span style=\"font-size: small;\">EML4-ALK variant 3（v3）をドライバー遺伝子にもつ肺腺癌：1症例</span></p>\r\n<p><span style=\"font-size: small;\">食道癌：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">深澤 拓也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2970&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0423.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000636</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">マルチオミックス的アプローチによる炎症性筋疾患の全容解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/10/23</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/12/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、snRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">サルコイドミオパチー：22＋1症例</span></p>\r\n<p><span style=\"font-size: small;\">筋疾患：400症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">飯田 有俊</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2838&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0426.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000654</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">家族性・若年性のがん及び遺伝性腫瘍に関する診断と研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（GridION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">遺伝性腫瘍：33症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">白石 友一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2624&amp;Itemid=2569&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0427.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000645</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">頭頸部悪性腫瘍細胞株の樹立</span></p>\r\n<p><span style=\"font-size: small;\">頭頸部悪性腫瘍に対する網羅的遺伝子解析およびデータベースの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/11/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">外耳道扁平上皮癌：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 尚志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2635&amp;Itemid=2575&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0429.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000643</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">CRISPR screening identifies mechanisms of resistance to KRASG12C and SHP2 inhibitor combinations in non-small cell lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/11/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト肺癌細胞株LU99を移植したマウスの腫瘍組織：計16検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Saskia Brachmann</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2684&amp;Itemid=2614&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0431.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000651</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">精神神経疾患における病態生理・発症脆弱性・治療反応性等の解明、および新規治療法・診断予防法の開発を目指した遺伝子解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/01/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">自閉スペクトラム症患者で同定された変異を導入した遺伝子改変ヒトiPS細胞株：5検体</span></p>\r\n<p><span style=\"font-size: small;\">コントロール遺伝子改変ヒトiPS細胞株：4検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">髙田 篤</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2876&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0433.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000659</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000660</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000667</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-665</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-667</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト胎盤幹細胞の樹立と細胞特性に関する基礎的研究</span></p>\r\n<p><span style=\"font-size: small;\">ヒト胎盤栄養膜細胞株の樹立と細胞特性に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、ChIP-seq、Hi-C、small RNA-seq、CUT&amp;TAG-seq、Methyl-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">人工妊娠中絶術後の初期胎盤：1検体</span></p>\r\n<p><span style=\"font-size: small;\">受精卵：1検体</span></p>\r\n<p><span style=\"font-size: small;\">妊娠高血圧症候群：14症例</span></p>\r\n<p><span style=\"font-size: small;\">正常妊娠：12名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小林 枝里</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3018&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0434.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000658</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000709</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">T/NK細胞が関連する各種疾患における遺伝子解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Torrent S5、Ion GeneStudio S5）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">赤芽球癆：53症例</span></p>\r\n<p><span style=\"font-size: small;\">再生不良性貧血：10症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：2名</span></p>\r\n<p><span style=\"font-size: small;\">大顆粒リンパ球性白血病：55症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">石田 文宏</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2708&amp;Itemid=2630&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0435.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000665</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">iPS細胞由来心筋細胞における網羅的核酸解析を用いた再生医療用細胞作製方法の検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/03/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 3000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HLAホモ健常ドナー1名の細胞から樹立されたヒトiPS細胞から分化誘導した心筋細胞：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">宮川 繁</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2703&amp;Itemid=2626&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0436.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000668</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">自閉症の発症原因解明のための遺伝子多形及び遺伝子転写についての研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/02/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">自閉症：16症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：17名</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">丸井 徹也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2728&amp;Itemid=2646&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0437.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000671</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性脳腫瘍の新たなバイオマーカー及び分子標的の探索とそれらの臨床応用に向けた多施設共同研究による遺伝子解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/03/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">グリオーマ：124症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">高阪 真路</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2713&amp;Itemid=2634&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0439.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA017996</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脂質異常症に関わる遺伝子と病態との関連の検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/02/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（MinION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">家族性高コレステロール血症：5症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：1名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">尾野 亘</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2735&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0440.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000672</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-747</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">神経・筋組織を用いた難治性神経筋疾患の臨床経過に関連する蛋白の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/05/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400RS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胸腺腫：7症例</span></p>\r\n<p><span style=\"font-size: small;\">胸腺過形成：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">奥野 龍禎</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2842&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0442.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000675</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-883</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">進行・再発非小細胞肺がんにおける免疫チェックポイント阻害剤の患者層別化マーカーに関する探索的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/12/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非小細胞肺癌：20症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">笹田 哲朗</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2731&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0443.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA017833</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-674</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">妊娠前後での制御性T細胞のT細胞受容体レパートリーの変化と妊娠予後との関係</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/05/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target RNA-seq、TCR-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">正常妊娠：7名</span></p>\r\n<p><span style=\"font-size: small;\">妊娠高血圧腎症：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中島 彰俊</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2703&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0444.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000684</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">遺伝学的変化を要因とする皮膚疾患のマルチオミックス解析による病態解明の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、ロングリードWGS、Amplicon-seq、RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">SNPアレイ</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-T7）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、MiSeq、Infinium Asian Screening Array、Infinium MethylationEPIC）</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">（Sequel II）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">汗孔角化症：8症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">久保 亮治</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3058&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0445.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000756</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノム解析に基づく肺がんの発生・進展の分子機構の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、Genome Analyzer IIx）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺腺癌：362症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">河野 隆志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2958&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0454.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000697</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">免疫異常に着目した炎症性腸疾患の病因解析および治療反応性解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/12/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Xenium Analyzer）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Crohn病：10症例</span></p>\r\n<p><span style=\"font-size: small;\">潰瘍性大腸炎：4症例</span></p>\r\n<p><span style=\"font-size: small;\">サイトメガロウィルス腸炎：1症例</span></p>\r\n<p><span style=\"font-size: small;\">癌：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">児玉 真</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3165&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0455.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000732</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000733</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺がんの遺伝子異常、分子標的、薬剤感受性を予測する、組織形態、バイオマーカーの探索 <br />肺癌の遺伝子異常とその生物学的意義の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Novaseq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Xenium）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺神経内分泌癌：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松原 大祐</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2818&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0456.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000722</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">傍鞍部頭蓋底腫瘍及び、悪性神経膠腫組織を用いた分子生物学的解析による腫瘍の形成と機能的分化における分子病態の検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">頭蓋咽頭腫：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松田 達磨</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2978&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0460.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000714</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">尿路上皮癌の免疫チェックポイント阻害薬治療におけるcfDNAを用いたリキッドバイオプシーによるCompanion/Complimentary Diagnosisプラットフォームの開発に向けたパイロット研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/01/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、HiSeq X）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">進行性尿路上皮癌（膀胱癌・上部尿路上皮癌）：82症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小林 恭</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2938&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0461.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000712</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道扁平上皮癌、大腸癌に対する放射線治療後のがん免疫応答の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/05/31</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/11/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n<p><span style=\"font-size: small;\">Multiplex Fluorescence Immunostaining</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 3000、NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Akoya Biosciences</span></p>\r\n<p><span style=\"font-size: small;\">（CODEX）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道扁平上皮癌：7症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">影山 俊一郎</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3116&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0464.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000723</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト造血器腫瘍細胞の体外増幅と病態再現モデルマウスの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/06/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、scRNA-seq、scBCR-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000、NextSeq 2000/500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">多発性骨髄腫：21症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">正常骨髄：3検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岩間 厚志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2834&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0465.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000721</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">混合形質性急性白血病細胞株の樹立とゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">急性混合型白血病：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">石井 敬人</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2934&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0466.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健康長寿社会の実現を目指した大規模認知症コホート研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Japanese Screening Array）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">JPSC-AD研究参加者：9,479名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">二宮 利治</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2888&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0467.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">骨盤臓器脱発症における遺伝学的背景</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/10/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Asian Screening Array、Infinium OmniExpress、HumanExome、Infinium OmniExpressExome v1.0、Infinium OmniExpressExome v1.2）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">骨盤臓器脱と診断された女性：771名（BBJ 447名、POP 324名）</span></p>\r\n<p><span style=\"font-size: small;\">骨盤臓器脱と診断されていない、または健常集団の女性：76,625名（BBJ 73,892名、OBi 2,733名）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">前田 士郎</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3161&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0468.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000727</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000774</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">免疫・炎症病態の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、bulk RNA-seq、scASAP-seq、CITE-seq、VDJ-seq）</span></p>\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、NextSeq 500/550）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Xenium v1）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関節リウマチ：23症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：4名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">吉富 啓之</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2846&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0469.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000728</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">妊娠中のサイトメガロウイルス免疫応答の検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">妊娠12週、16週、20週、28週、36週頃の妊婦：10名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">市瀬 茉里</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3132&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0470.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000725</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">免疫治療が施行された尿路上皮癌における予後調査とゲノムプロファイルの解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/07/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、WGS、scRNA-seq、Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X Ten、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">尿路上皮癌：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">田中 伸之</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2854&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0472.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000726</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">iPS細胞を用いた大脳皮質神経細胞製剤の開発に向けた非臨床研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者1名から樹立されたiPS細胞から分化誘導したオルガノイド：9個</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">髙橋 淳</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3112&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0473.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000724</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍患者の遺伝子解析による発症機序解明研究</span></p>\r\n<p><span style=\"font-size: small;\">血縁ドナーの微量残存骨髄液を正常コントロールとした造血器腫瘍特異的分子発現解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">骨髄異形成症候群：57症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：5名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">原田 結花</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2850&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0474.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000731</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">自閉スペクトラム症・統合失調症・双極性障害関連遺伝子の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（iSeq 100）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">自閉スペクトラム症児：32症例</span></p>\r\n<p><span style=\"font-size: small;\">低出生体重児：8名</span></p>\r\n<p><span style=\"font-size: small;\">閾値下自閉スペクトラム症児：3症例</span></p>\r\n<p><span style=\"font-size: small;\">定型発達児：36名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">横山 茂</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3100&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0476.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000736</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">腎臓構成細胞の生物学的機能理解のための先端的解析技術を用いた観察研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/01/07</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/06/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">腎臓癌：32症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">内藤 正吉</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3072&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0477.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000740</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化管癌・消化管腫瘍の組織培養による癌発育・進展メカニズムに関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/10/16</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/06/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 1000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌患者由来の腸管オルガノイド：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">Caco-2細胞：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">佐々木 伸雄</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3022&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0479.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000779</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">網羅的遺伝子解析技術を用いた抗EGFR抗体薬治療効果予測バイオマーカーの探索研究に関する多施設共同研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Hiseq 1500/2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">切除不能・進行再発大腸癌：242症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">土原 一哉</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2942&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0481.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000755</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人高齢者に多い疾患のゲノム解析および臨床ゲノム情報ストレージの整備</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/11/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アルツハイマー病：424症例</span></p>\r\n<p><span style=\"font-size: small;\">軽度認知障害：543症例</span></p>\r\n<p><span style=\"font-size: small;\">認知機能正常：260名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">重水 大智</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3092&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0483.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000764</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト試料の収集・分譲と臨床情報を利用した研究に関するご協力のお願い</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Hiseq X Ten、NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">卵巣明細胞腺癌：11症例</span></p>\r\n<p><span style=\"font-size: small;\">高異型度漿液性癌：7症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">千代田 達幸</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2994&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0484.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000775</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト体細胞から樹立したInduced Pluripotent Stem Cell Line（iPS細胞株）のバンク事業</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ALS：33症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中村 幸夫</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3030&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0485.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000754</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">シークエンス解析によるがんゲノム研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃癌：65症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2954&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0486.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000765</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胆道閉鎖症およびアラジール症候群特異的iPS細胞を用いた胆管発生およびその障害メカニズムの解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/11/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq X Plus 25B）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胆道閉鎖症：5症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">林 洋平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2966&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0490.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000770</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Progestin-primed ovarian stimulation（PPOS）法を用いた調節卵巣刺激下でプロゲスチン製剤が卵胞発育・卵子の成熟過程に及ぼす影響に関する検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/12/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">正常卵巣機能を有する不妊症：16症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">伴田 美佳</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3128&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0491.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000805</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1086</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アレルギー病態の分子機構解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/07/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、scRNA-TCR-seq、scATAC-RNA-seq、CITE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">慢性扁桃炎：8症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">上野 英樹</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3177&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0492.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000773</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">産学連携による免疫炎症性難病の新規医薬品開発を目指した探索研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq/TCR/BCRレパトア解析、Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">シェーグレン症候群：28症例</span></p>\r\n<p><span style=\"font-size: small;\">Sicca：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">竹下 勝</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3148&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0493.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000771</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">皮膚免疫担当細胞の機能解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/07/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Xenium Analyzer）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常皮膚：3例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">吉岡 華子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2982&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0495.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">心房細動と合併する脳梗塞予防のプレシジョン・メディシン</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/02/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発作性心房細動：1,176症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：1,172名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">田中 敏博</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2998&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0496.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">沖縄県におけるゲノム解析研究拠点形成のための沖縄バイオインフォメーションバンクの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/02/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Infinium Asian Screening Array、Infinium OmniExpress、HumanExome、Infinium OmniExpressExome v1.0、Infinium OmniExpressExome v1.2）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">OBi：8,715名</span></p>\r\n<p><span style=\"font-size: small;\">BBJ：7,004名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">前田 士郎</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3173&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0497.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000777</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト胎盤からの栄養膜幹細胞の単離と性状解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト妊娠後期胎盤：3名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">ヒト栄養膜幹細胞：3検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">依馬 正次</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3026&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0499.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000787</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">骨軟部腫瘍に対するバイオバンク作成および遺伝子発現解析に基づく分子病態の解明とその予後改善を目指した研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">サンガー法</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Applied Biosystems</span></p>\r\n<p><span style=\"font-size: small;\">（3730xl DNA Analyzer）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肉腫：6症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">長谷川 延彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3050&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0501.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000781</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムアジア100Kプロジェクト：アジア集団のDNA試料収集と全ゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">約100の民族集団に属する健常者：1,323名</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hie Lim Kim</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3080&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0502.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000803</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">体細胞ゲノム解析に基づく子宮頸がんの本態解明・治療標的の同定を目指す研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮頸癌：29症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">白石 航也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3054&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0505.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アレルギー疾患における遺伝要因の探索研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Infinium Asian Screening Array）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">成育コホート研究のゲノム解析研究参加者：564名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">野口 恵美子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3076&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0508.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000790</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">疾患特異的iPS細胞を用いた眼疾患の発症機序の解明および治療法の探索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">先天性無虹彩症：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西田 幸二</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3157&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0512.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000818</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">自己免疫疾患のリスク多型の同定と機能解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/07/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、ATAC-seq、scCITE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000/X Plus）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Chromium）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：3名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">石垣 和慶</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3193&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0514.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000814</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">骨格筋メッセンジャーRNAの発現解析による神経・筋疾患の病態解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/09/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">筋強直性ジストロフィー1型（DM1）：11症例</span></p>\r\n<p><span style=\"font-size: small;\">DM1以外の神経・筋疾患：9症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">高橋 正紀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3108&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0517.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000809</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">婦人科がん初代培養細胞を用いた新規治療法の評価および効果予測因子の探索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮体癌：30症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">長谷川 幸清</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3185&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0521.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000827</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1121</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">がん免疫の分子機構解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、scBCR-seq、scTCR-seq、CITE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮体癌：10症例</span></p>\r\n<p><span style=\"font-size: small;\">遺伝性乳癌卵巣癌：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">上野 英樹</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3120&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0522.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000720</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制御性T細胞特異的エピゲノム誘導による免疫制御の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、TCR-seq、CITE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道胃接合部癌：2症例</span></p>\r\n<p><span style=\"font-size: small;\">胃癌：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西塔 拓郎</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3169&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0527.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000823</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮頚部・腟部発生リンパ腫の遺伝子変異の検索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq X Plus）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮頸部・膣部の濾胞性リンパ腫：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">北岡 匠</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p><span style=\"font-size: small;\">・ <a href=\"https://ddbj.nig.ac.jp/search\" target=\"_blank\" rel=\"noopener\">DDBJ Search</a>において、the DDBJ Sequence Read Archive（DRA）、the European Sequence Read Archive（ERA）およびthe Sequence Read Archive（SRA）に登録済みデータを検索できます。</span></p>\r\n<p><span style=\"font-size: small;\">＊データ利用申請が承認されたデータ利用者が閲覧・利用できる、NBDCおよび生命情報・DDBJ センターが加工したデータ（例：特定の解析パイプラインにより加工したアライメントデータ・バリアントコールデータ・統計データ）を含む。加工データに関する詳細は<a href=\"index.php?option=com_content&amp;view=article&amp;id=2276&amp;Itemid=2285&amp;lang=ja\" target=\"_blank\">こちら</a></span></p>", "publish_up": "2013-01-03"}, {"lang": "en", "path": "data-use/all-researches", "title": "List of All Research Projects", "fulltext": "", "modified": "2025-09-24", "introtext": "<p><span style=\"font-family: helvetica; font-size: 10pt;\">*Data users need to apply an application for Using NBDC Human Data to reach the Controlled-access Data. <a href=\"index.php?option=com_content&amp;view=article&amp;id=3&amp;Itemid=104\" target=\"_blank\" rel=\"noopener noreferrer\">Learn more</a></span></p>\r\n<p>&nbsp;</p>\r\n<!--\r\n<table class=\"table-style style-greystripes\" style=\"width: 1300px; height: 510px;\">\r\n-->\r\n<table id=\"list-of-all-researches\" class=\"table-style style-greystripes\">\r\n<thead>\r\n<tr><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">Research ID</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">Study Title</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">Release Date</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">Type of Study</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">Platform</span></th><th class=\"”highlight”\" align=\"center\">\r\n<p><span style=\"font-size: small;\">Participants/Materials</span></p>\r\n<p><span style=\"font-size: small;\">(Ethnicity)</span></p>\r\n</th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">Data Provider</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">Type of Data</span></th></tr>\r\n</thead>\r\n<tbody>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=135&amp;Itemid=445&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0001.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000002</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Sequence Data of a SCA31 Patient</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2013/12/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Single Patient</span></p>\r\n<p><span style=\"font-size: small;\">NGS (WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 Patient</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinichi Morishita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=107&amp;Itemid=369&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0004.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000001</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Molecular Epidemiological Study of</span></p>\r\n<p><span style=\"font-size: small;\">Somatic Mutation Profiles of EGFR</span></p>\r\n<p><span style=\"font-size: small;\">Mutation Positive Lung Adenocarcinoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/07/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS (Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Analyzer IIx)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">97 Patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Koichi Goto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2610&amp;Itemid=2559&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0005.v8</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA001273</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000032</span></p>\r\n<p><span style=\"font-size: small;\">DRA003791</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000093</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000123</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000166</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000191</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000192</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000200</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000201</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000323</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000490</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic Analysis of Hearing Loss and Its Clinical Application</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/01/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/02/24</span></p>\r\n<p><span style=\"font-size: small;\">v3:2017/06/19</span></p>\r\n<p><span style=\"font-size: small;\">v4:2018/02/13</span></p>\r\n<p><span style=\"font-size: small;\">v5:2019/04/18</span></p>\r\n<p><span style=\"font-size: small;\">v6:2021/07/30</span></p>\r\n<p><span style=\"font-size: small;\">v7:2021/11/19</span></p>\r\n<p><span style=\"font-size: small;\">v8:2023/10/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion PGM, Ion Proton, Ion S5)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">17 UsherSyndrome patients</span></p>\r\n<p><span style=\"font-size: small;\">3,156 Non-syndromic hearing loss patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shin-ichi Usami</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2102&amp;Itemid=2129&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0006.v5</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000004</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000106</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000146</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000325</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genomic and Genetic Analysis of Brain Tumors and</span></p>\r\n<p><span style=\"font-size: small;\">Analysis of Their Clinicopathological Significance</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/01/31</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/06/05</span></p>\r\n<p><span style=\"font-size: small;\">v3:2017/09/01</span></p>\r\n<p><span style=\"font-size: small;\">v4:2019/02/13</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/08/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, Target Capture)</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500, HumanMethylation450)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">6 astrocytomas</span></p>\r\n<p><span style=\"font-size: small;\">16 oligodendrogliomas</span></p>\r\n<p><span style=\"font-size: small;\">gliomas (17 cerebellar gliomas, 8 cerebral glioblastomas and 14 thalamic gliomas)</span></p>\r\n<p><span style=\"font-size: small;\">94 gliomas</span></p>\r\n<p><span style=\"font-size: small;\">12 cerebral cavernous malformations</span></p>\r\n<p><span style=\"font-size: small;\">1 vertebral hemangioma</span></p>\r\n<p><span style=\"font-size: small;\">3 orbital cavernous malformations</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nobuhito Saito</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=145&amp;Itemid=455&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0007.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000005</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Gene Expression of Human Th17 Cells </span></p>\r\n<p><span style=\"font-size: small;\">Before and After Activation</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/02/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Applied BioSystems</span></p>\r\n<p><span style=\"font-size: small;\">(5500 Genetic Analyzer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 Participant </span></p>\r\n<p><span style=\"font-size: small;\">(4 Samples)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Sanju Iwamoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=601&amp;Itemid=868&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0008.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000007</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research for genetic causes and mechanisms of Hirschsprung's</span></p>\r\n<p>&nbsp;</p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/01/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">5 Patients with Hirschsprung's diseases</span></p>\r\n<p><span style=\"font-size: small;\">and 6 their families</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroshi Matsufuji</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=216&amp;Itemid=484&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0009.v3</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>DRA003802</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">DNA Methylation Analysis of Early Human Embryos</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/12/24</span></p>\r\n<p><span style=\"font-size: small;\">v2:2015/01/07</span></p>\r\n<p><span style=\"font-size: small;\">v3:2015/08/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">11 Libraries</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takahiro Arima</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=295&amp;Itemid=577&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0010.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000008</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research for candidate genes of splenic epidermoid cyst.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/06/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">8 Splenic epidermoid cysts </span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroshi Matsufuji</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=245&amp;Itemid=507&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0011.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000015</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Integrated hepatitis B virus is epigenomically regulated by the methylation status of the human genome </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/10/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Roche GS FLX Titanium</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 Cell lines</span></p>\r\n<p><span style=\"font-size: small;\">8 HB-HCC primary tissues</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Yamamoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=223&amp;Itemid=488&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0012.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000012</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nagahama Zero-ji Preventive Cohort Project</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/08/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Control Set</span></p>\r\n<p><span style=\"font-size: small;\">Cohort</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Human610-Quad, </span></p>\r\n<p><span style=\"font-size: small;\">HumanOmni2.5-4/2.5-8/2.5S-8, </span></p>\r\n<p><span style=\"font-size: small;\">HumanExome-12, </span></p>\r\n<p><span style=\"font-size: small;\">HumanCoreExome-12)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3712 Participants</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fumihiko Matsuda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=147&amp;Itemid=457&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0013.v1</strong></span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Japan PGx Data Science Consortium Database</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/10/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Control Set</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HumanOmni2.5-8)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2994 Participants</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koji Suematsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3040&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0014.v37</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000101</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000114*</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000140</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000203</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000293</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000327</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000346</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000381*</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000414</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000347</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000592</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000647</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000698</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000699</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000700</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000701</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000703</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000738</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000746</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000782</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Bio Bank Japan project</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/09/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2015/12/28</span></p>\r\n<p><span style=\"font-size: small;\">v3:2016/01/28</span></p>\r\n<p><span style=\"font-size: small;\">v4:2016/02/02</span></p>\r\n<p><span style=\"font-size: small;\">v5:2017/05/18</span></p>\r\n<p><span style=\"font-size: small;\">v6:2017/09/08</span></p>\r\n<p><span style=\"font-size: small;\">v7:2018/04/04</span></p>\r\n<p><span style=\"font-size: small;\">v8:2018/05/01</span></p>\r\n<p><span style=\"font-size: small;\">v9:2018/08/07</span></p>\r\n<p><span style=\"font-size: small;\">v10:2018/08/13</span></p>\r\n<p><span style=\"font-size: small;\">v11:2018/10/16</span></p>\r\n<p><span style=\"font-size: small;\">v12:2018/12/10</span></p>\r\n<p><span style=\"font-size: small;\">v13:2019/01/25</span></p>\r\n<p><span style=\"font-size: small;\">v14:2019/03/26</span></p>\r\n<p><span style=\"font-size: small;\">v15:2019/09/27</span></p>\r\n<p><span style=\"font-size: small;\">v16:2019/10/07</span></p>\r\n<p><span style=\"font-size: small;\">v17:2019/10/08</span></p>\r\n<p><span style=\"font-size: small;\">v18:2019/11/26</span></p>\r\n<p><span style=\"font-size: small;\">v19:2020/04/20</span></p>\r\n<p><span style=\"font-size: small;\">v20:2020/08/17</span></p>\r\n<p><span style=\"font-size: small;\">v21:2020/08/25</span></p>\r\n<p><span style=\"font-size: small;\">v22:2021/05/21</span></p>\r\n<p><span style=\"font-size: small;\">v23:2021/07/13</span></p>\r\n<p><span style=\"font-size: small;\">v24:2021/11/26</span></p>\r\n<p><span style=\"font-size: small;\">v25:2022/01/25</span></p>\r\n<p><span style=\"font-size: small;\">v26:2022/04/01</span></p>\r\n<p><span style=\"font-size: small;\">v27:2023/01/18</span></p>\r\n<p><span style=\"font-size: small;\">v28:2023/04/05</span></p>\r\n<p><span style=\"font-size: small;\">v29:2023/04/05</span></p>\r\n<p><span style=\"font-size: small;\">v30:2023/04/20</span></p>\r\n<p><span style=\"font-size: small;\">v31:2023/09/01</span></p>\r\n<p><span style=\"font-size: small;\">v32:2024/01/11</span></p>\r\n<p><span style=\"font-size: small;\">v33:2024/05/27</span></p>\r\n<p><span style=\"font-size: small;\">v34:2024/09/19</span></p>\r\n<p><span style=\"font-size: small;\">v35:2024/10/25</span></p>\r\n<p><span style=\"font-size: small;\">v36:2024/11/28</span></p>\r\n<p><span style=\"font-size: small;\">v37:2025/05/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Case-Control</span></p>\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Human610-Quad, HumanHap550v3, HumanOmniExpress-12, HumanExome, OmniExpressExome, HumanExome-12, Infinium OmniExpress-24, Infinium HumanOmniExpressExome-8, HiSeq 2500/X Five, NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">Perlegen Sciences</span></p>\r\n<p><span style=\"font-size: small;\">(high-density oligonucleotide arrays)</span></p>\r\n<p><span style=\"font-size: small;\">Hologic Japan</span></p>\r\n<p><span style=\"font-size: small;\">(Invader)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:1666 MIs and 3198 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v2:934 ctrls (JSNP)</span></p>\r\n<p><span style=\"font-size: small;\">v2:35 diseases (JSNP)</span></p>\r\n<p><span style=\"font-size: small;\">v2:182 esophageal cancers (JSNP)</span></p>\r\n<p><span style=\"font-size: small;\">v2:92 ALSs (JSNP)</span></p>\r\n<p><span style=\"font-size: small;\">v3:9817 T2DMs and 6763 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v3:5646 T2DMs and 19,420 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v4:1472 ADs and 7966 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v5:8180 AFs and 28,612 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v6:158,284 individuals for BMI study</span></p>\r\n<p><span style=\"font-size: small;\">v6:182,505 individuals' genotype data</span></p>\r\n<p><span style=\"font-size: small;\">v7:3980 POAGs and 18,815 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v8:162,255 individuals for 58 quantitative traits study</span></p>\r\n<p><span style=\"font-size: small;\">v9:67,029 females with information on age at menarche</span></p>\r\n<p><span style=\"font-size: small;\">v9:43,861 females with information on age at menopause</span></p>\r\n<p><span style=\"font-size: small;\">v10:1,026 individuals for WGS</span></p>\r\n<p><span style=\"font-size: small;\">v11:7,104 breast cancer patients and 23,731 controls</span></p>\r\n<p><span style=\"font-size: small;\">v12:2,809 T2DM with diabetic nephropathy patients and 5,592 T2DM ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v13:36,614 T2DMs and 155,150 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v14:165,436 individuals with information on smoking behaviour</span></p>\r\n<p><span style=\"font-size: small;\">v15:1,026 individuals from biobank Japan and 2,504 individuals from 1KGP p3v5 ALL</span></p>\r\n<p><span style=\"font-size: small;\">v15:159,095 individuals for height study</span></p>\r\n<p><span style=\"font-size: small;\">v16:7,636 prostate cancer patients and 12,366 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v17,18,21:212,453 individuals for 42 diseases</span></p>\r\n<p><span style=\"font-size: small;\">v19:165,084 individuals with information on dietary habits</span></p>\r\n<p><span style=\"font-size: small;\">v2025,892 CADs and 142,336 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v22:11,234 individuals from biobank Japan</span></p>\r\n<p><span style=\"font-size: small;\">v23:768 individuals from biobank Japan</span></p>\r\n<p><span style=\"font-size: small;\">v24:1,005 pancreatic cancer patients, 12,503 colorectal cancer patients and 23,705 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v25:1,765 myocardial infarction patients and 199 dementia patients</span></p>\r\n<p><span style=\"font-size: small;\">v26:740 renal cell cancer patients and 5,996 controls</span></p>\r\n<p><span style=\"font-size: small;\">v27:137,693 individuals from biobank Japan</span></p>\r\n<p><span style=\"font-size: small;\">v28:4,880 individuals from biobank Japan</span></p>\r\n<p><span style=\"font-size: small;\">v29:9,826 AFs and 140,446 ctrls (BBJ cohot)</span></p>\r\n<p><span style=\"font-size: small;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60,620 AFs and 970,216 ctrls (European)</span></p>\r\n<p><span style=\"font-size: small;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7,244 AFs and 56,378 ctrls (FinnGenn)</span></p>\r\n<p><span style=\"font-size: small;\">v30:1,982 lymphoma patients, 10,366 gastric cancer patients and 37,592 controls (BBJ cohot)</span></p>\r\n<p><span style=\"font-size: small;\">v32:1,007 individuals from biobank Japan</span></p>\r\n<p><span style=\"font-size: small;\">v33: 256 gastric cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">v33: 269,000 patients for 51 diseases</span></p>\r\n<p><span style=\"font-size: small;\">v33: 617 colorectal cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">v33: 2,162 diabetes patients</span></p>\r\n<p><span style=\"font-size: small;\">v33: 2,067 gastric cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">v35: 7,472 individuals from BBJ 1st cohort</span></p>\r\n<p><span style=\"font-size: small;\">v36: 3,256 individuals from BBJ 1st cohort</span></p>\r\n<p><span style=\"font-size: small;\">v37: breast cancer 10,008 cases, gastric cancer 10,576 cases, colorectal cancer 13,929 cases, heart failure 6,038 cases, stroke 10,486cases, etc. total 140,597 individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese, European, Finnish)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Michiaki Kubo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=799&amp;Itemid=1037&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0015.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000159</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Construction of the Whole-genome&nbsp;Reference</span></p>\r\n<p><span style=\"font-size: small;\">Panel of 3552 Japanese Individuals</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/10/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/12/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2019/01/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3552 Participants</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Masayuki Yamamoto</span></p>\r\n<p><span style=\"font-size: small;\">(ToMMo)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=395&amp;Itemid=684&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0016.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">DRA002604</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Epigenome analysis of proteins expressed in human testis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/09/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(ChIP-seq, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 Participant </span></p>\r\n<p><span style=\"font-size: small;\">(4 Samples)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yasuyuki Ohkawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=286&amp;Itemid=569&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0017.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000021</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exome sequencing of primary central nervous system lymphoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/02/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">41 PCNSLs</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Hiroyuki Mano</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3142&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\"><strong>hum0018.v2</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000009</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000337</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000374</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000358</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000365</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000393</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000422</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000494</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis in neurodegenerative disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/02/03</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/07/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, WGS, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 14 MSAs and 7 Controls</span></p>\r\n<p><span style=\"font-size: small;\">69 CMTs</span></p>\r\n<p><span style=\"font-size: small;\">21 FTDs</span></p>\r\n<p><span style=\"font-size: small;\">119 Familial ALSs</span></p>\r\n<p><span style=\"font-size: small;\">82 Myopathy</span></p>\r\n<p><span style=\"font-size: small;\">482 Sporadic ALSs</span></p>\r\n<p><span style=\"font-size: small;\">9 MNDs</span></p>\r\n<p><span style=\"font-size: small;\">464 Spastic paraplegia</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shoji Tsuji</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=263&amp;Itemid=460&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0019.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000011</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Systematic identification of long non-coding RNAs potentially involved in gastrointestinal cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Tumor vs. Matched-Normal</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">17 GICs </span></p>\r\n<p><span style=\"font-size: small;\">(32 Samples)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Yasuhisa Shinomura</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=157&amp;Itemid=464&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0020.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000013</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Genetic Analysis in Amyotrophic Lateral Sclerosis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/01/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">11 ALSs</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fumiaki Tanaka</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1471&amp;Itemid=1604&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0021.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000014</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000273</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Genetic Analysis in Psychiatric Disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/01/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/05</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/04/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Healthy Monozygotic Twins: 3 Pairs (6 Participants)</span></p>\r\n<p><span style=\"font-size: small;\">66 + 78 trios with bipolar disorder proband and unaffected parents</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tadafumi Kato</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=161&amp;Itemid=466&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0022.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000017</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Analysis of the Molecular Mechanism for Developing Donor-Origin Leukemia after Allogeneic Stem Cell Transplantation.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/02/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 DCL (5 Samples from Each Stage)</span></p>\r\n<p><span style=\"font-size: small;\">1 Donor</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hitoshi Kiyoi</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=163&amp;Itemid=431&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0023.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000016</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic Analysis in Lifestyle-Related Disease,</span></p>\r\n<p><span style=\"font-size: small;\">Arteriosclerotic Disease, and </span></p>\r\n<p><span style=\"font-size: small;\">Aging-Related Diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/01/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">30 Hypertensions</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tetsurou Miki</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=297:hum0024-v1&amp;catid=16&amp;lang=en-GB&amp;Itemid=468\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0024.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000023</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Comprehensive Analysis of Genetic Alterations in Hematological Malignancies</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/04/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Analyzer IIx, HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">13 MDSs and 1 CMML</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Seishi Ogawa</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=331&amp;Itemid=624&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0027.v1</a><br /></strong></span></p>\r\n<p><span style=\"font-size: small;\"> JGAS000024</span></p>\r\n<p><span style=\"font-size: small;\"> JGAS000040</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of genetic polymorphism on aggressive periodontitis </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/07/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Periodontitis patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Shinya Murakami</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=698&amp;Itemid=948&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0028.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000018</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Biobank Japan Project</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/06/02</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/06/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HumanOmniExpress, HumanExome, ImmunoChip, HumanHap550v3 Genotyping BeadChip)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">908 Participants</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Michiaki Kubo</span></p>\r\n<p><span style=\"font-size: small;\">(BBJ)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1346&amp;Itemid=1502&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0029.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Study of Genome Polymorphism/Variation on Stevens-Johnson Syndrome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/03/09</span></p>\r\n<p><span style=\"font-size: small;\">v1:2020/12/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Case-Control</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Axiom ASI)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X Ten)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">117 SJSs and 691 controls</span></p>\r\n<p><span style=\"font-size: small;\">133 SJS/TENs and 418 controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Mayumi Ueta</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3106&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0030.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000022</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000560</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000789</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> The Molecular Biological Analysis about Occurrence and Malignant Transformation in gynecological carcinogenesis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/04/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/05/10</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/07/05</span></p>\r\n<p><span style=\"font-size: small;\">v4:2025/07/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">CNV Analysis</span></p>\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n<p><span style=\"font-size: small;\">Expression array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Human Mapping 250K Nsp Array, GeneChip® Human Genome U133 Plus 2.0 Array)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000, Infinium HumanMethylation450, NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">57 + 111 + 31 + 189 Ovarian carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Katsutoshi Oda</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=254:hum0031-v1&amp;catid=16:cat-researches&amp;lang=en&amp;Itemid=514\" target=\"_blank\" rel=\"noopener noreferrer\" style=\"font-weight: bold; line-height: normal; text-align: center;\"><span style=\"font-size: small;\">hum0031.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000042<br />JGAS000043<br />JGAS000044<br />JGAS000045</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p style=\"font-size: small;\">Constructing database of magnetic resonance imaging of the brain and the ancillary clinical information for multisite collaboration studies</p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Neuroimage</span></p>\r\n<p><span style=\"font-size: small;\">Clinical Info</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Philips</span></p>\r\n<p><span style=\"font-size: small;\">(Achieva)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">129 normal controls, 37 schizophrenia, 8 unipolar and 2 bipolar disorders</span></p>\r\n<p>(Japanese)</p>\r\n</td>\r\n<td class=\"”highlight”\" style=\"font-size: small;\">Kiyoto Kasai</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=342&amp;Itemid=632&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0032.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000026</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000027</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000028</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Standard epigenome mapping in human epithelial cells of the digestive and urogenital organs </span></p>\r\n<p><span style=\"font-size: small;\">(HPC series)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/07/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq, ChIP-seq, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">8 partial hepatectomy specimens </span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yae Kanai</span></p>\r\n<p><span style=\"font-size: small;\">(IHEC)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=195&amp;Itemid=436&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0033.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>DRA003516</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Functional analysis of two types of exosome </span></p>\r\n<p><span style=\"font-size: small;\">in human whole saliva</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/05/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Analyzer IIx)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 Participant</span></p>\r\n<p><span style=\"font-size: small;\">(3 Samples)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ryohei Yanoshita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=240&amp;Itemid=503&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0034.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000037</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of novel therapeutic targets of</span></p>\r\n<p><span style=\"font-size: small;\">small cell lung cancer by comprehensive genomic analyses</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/10/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">51 SCLCs</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koichi Goto</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1341&amp;Itemid=1498&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0035.v5</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000036</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000046</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000088</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000188</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000204</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000246</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome wide analysis of gene mutations in solid tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/09/16</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/12/26</span></p>\r\n<p><span style=\"font-size: small;\">v3:2020/05/29</span></p>\r\n<p><span style=\"font-size: small;\">v4:2020/12/14</span></p>\r\n<p><span style=\"font-size: small;\">v5:2020/12/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, Target Capture, RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500, MiSeq, MethylationEPIC)</span></p>\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Human Mapping 250K Nsp, CytoScan HD)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">16 RMSs</span></p>\r\n<p><span style=\"font-size: small;\"> 7 PPBs</span></p>\r\n<p><span style=\"font-size: small;\">522 NBs</span></p>\r\n<p><span style=\"font-size: small;\">39 neuroblastoma cell lines</span></p>\r\n<p><span style=\"font-size: small;\">10 PBLs</span></p>\r\n<p><span style=\"font-size: small;\">59 HBLs</span></p>\r\n<p><span style=\"font-size: small;\">2 HBL cell lines</span></p>\r\n<p><span style=\"font-size: small;\">51 patients with pediatric germ cell tumors</span></p>\r\n<p><span style=\"font-size: small;\">30 patients with high-risk neuroblastoma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Junko Takita</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=213&amp;Itemid=480&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0036.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">DRA003736</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Performance Comparison of Four Commercial Human Whole-Exome Capture Platforms</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n<p><span style=\"font-size: small;\">Platform comparison</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 HapMap-JPT samples</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Michiaki Kubo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=235&amp;Itemid=499&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0037.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000035</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Diagnostic feasibility study for pathological prediction with rheumatoid arthritis-susceptible genes and genomic regions identified by the association analysis using microsatelite markers </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">39 RAs </span></p>\r\n<p><span style=\"font-size: small;\">10 Controls (pooled)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shigeki Mitsunagai</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=248&amp;Itemid=511&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0038.v1</a><br /></strong></span></p>\r\n<p><span style=\"font-size: small;\"> JGAS000041</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis in an inherited cardiac arrhythmia</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/11/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">11 Patients with an inherited cardiac arrhythmia </span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Naomasa Makita</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=303&amp;Itemid=580&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0039.v1</a></strong></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000039</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of TKI resistant mechanism for gastrointstinal stromal tumor (GIST)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/12/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina </span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500)</span>&nbsp;</p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">4 Imatinib resistant GIST</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tsuyoshi Takahashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=360&amp;Itemid=653&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0040.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000038</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Epigenomic analysis of the human placenta </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/09/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, RNA-seq, BS-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">28 human placenta</span></p>\r\n<p><span style=\"font-size: small;\">26 maternal blood samples</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takahiro Arima</span></p>\r\n<p><span style=\"font-size: small;\">(IHEC)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=407&amp;Itemid=692&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0041.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000052</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research of factors related to diagnosis, progression, prognosis and treatment of hepato-biliary-pancreatic malignancies</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/01/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">33 primary HCC</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinji Tanaka</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=291&amp;Itemid=575&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0042.v1</strong></span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome analysis for elucidation of genetic factors in orofacial traits and diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/03/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HumanOmniExpress)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">146 TMJ and 374 controls </span></p>\r\n<p><span style=\"font-size: small;\">149 third molar agenesis and 338 controls </span></p>\r\n<p><span style=\"font-size: small;\">(Japanese, Korean)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tetsutarou Yamaguchi</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"/en/hum0043-v1\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0043.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000051</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Japanese Alzheimer's disease neuroimaging initiative (J-ADNI)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/01/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Neuroimage</span></p>\r\n<p><span style=\"font-size: small;\">Clinical Info</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><a href=\"/en/hum0043-v1-release#mriscanners\" target=\"_blank\" rel=\"noopener noreferrer\">MRI Scanners (15 Models)</a></p>\r\n<p><a href=\"/en/hum0043-v1-release#petscanners\" target=\"_blank\" rel=\"noopener noreferrer\">PET Scanners (16 Models)</a></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">234 MCI </span></p>\r\n<p><span style=\"font-size: small;\">154 AD </span></p>\r\n<p><span style=\"font-size: small;\">149 healthly controls </span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takeshi Iwatsubo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=949&amp;Itemid=1163&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0044.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA004162</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Research about retrovirus infection</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/10/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(ChIP-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 ED (ATL cell line)</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yorifumi Satou </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=312&amp;Itemid=594&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0045.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000047</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Transcriptome analysis of acute lymphoblastic leukemia in adolescents and young adults</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/03/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">99 Ph(-) ALL</span></p>\r\n<p><span style=\"font-size: small;\">3 Ph(+) ALL </span></p>\r\n<p><span style=\"font-size: small;\">5 cell lines </span></p>\r\n<p><span style=\"font-size: small;\">8 normal hematopoietic cells</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Mano</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=281&amp;Itemid=567&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0048.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>DRA004251</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Whole exome sequencing on ampullary carcinomas</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/02/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">60 Patients with ampullary cancer </span></p>\r\n<p><span style=\"font-size: small;\"> (28 Japanese patients and 32 American patients)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinich Yachida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=390&amp;Itemid=680&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0050.v1</a></strong></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000053</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Transcriptome analysis of Hepatitis B for drug discovery and clinical applications</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/09/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(CAGE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">8 HBV (Genotype C) positive patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tomokazu Matsuura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1095&amp;Itemid=1288&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0053.v2</span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>JGAS000062</strong></span></p>\r\n<p><span style=\"font-size: small;\"><strong>JGAS000176</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of new molecular targets with profiling of malignant mesothelioma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/07/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/04/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Chromium Controller)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">38 Malignant pleural mesothelioma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Nakano</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=448&amp;Itemid=726&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0055.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000059</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic and epigentic analysis of non-alcoholic fatty liver disease</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/02/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, HumanMethylation450)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">64 NAFLD patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kikuko Hotta</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=618&amp;Itemid=881&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0056.v1</a></strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome and Multi-layer omics reference panels using blood samples from a population-based cohort study</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/03/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, WGBS, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/X)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">197 participants</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atsushi Shimizu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=645&amp;Itemid=912&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0058.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000091</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Identification of genetic mutations characteristic for recurrence and metastasis of colorectal cancer.</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">89 colorectal cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshiharu Yamaguchi</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=639&amp;Itemid=908&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0059.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>JGAS000104</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of genetic mutations characteristic for recurrence of serous ovarian cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">65 ovarian cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazuyoshi Kato</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=623&amp;Itemid=887&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0060.v1</a><br /></strong></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000075</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of genetic mutations characteristic for recurrence and metastasis of breast cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">65 recurrent / metastatic breast cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yoshio Miki</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=719&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\"><strong>hum0061.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>JGAS000057</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Searching causative genes of familial tumors using whole genome / exome sequencing</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/02/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Siblings developed multiple primary lung cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kikuya Kato</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=350&amp;Itemid=644&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0064.v1</a></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000061</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Construction of Geriatric Oncology Database for establishment of the Treatment Algorithm: Clinical Data and Questionnaire Survey Results in JapaneseElderly Cancer Patients Retrospective study</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/08/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Direct sequencing</span></p>\r\n<p><span style=\"font-size: small;\">TaqMan</span></p>\r\n<p><span style=\"font-size: small;\">qRT-PCR</span></p>\r\n<p><span style=\"font-size: small;\">COBRA</span></p>\r\n<p><span style=\"font-size: small;\">cDNA microarray</span></p>\r\n<p><span style=\"font-size: small;\">Clinical data</span></p>\r\n<p><span style=\"font-size: small;\">Treatment data</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Applied BioSystems</span></p>\r\n<p><span style=\"font-size: small;\">(3130 Genetic Analyzer)</span></p>\r\n<p><span style=\"font-size: small;\">Roche</span></p>\r\n<p><span style=\"font-size: small;\">(LightCycler 480II)</span></p>\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">(Whole Human Genome Microarray 4x44K)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">[GENOME]</span></p>\r\n<p><span style=\"font-size: small;\">106 colorectal cancer</span></p>\r\n<p><span style=\"font-size: small;\">62 gastric cancer</span></p>\r\n<p><span style=\"font-size: small;\">173 lung cancer</span></p>\r\n<p><span style=\"font-size: small;\">[Retrospective]</span></p>\r\n<p><span style=\"font-size: small;\">313 colorectal cancer</span></p>\r\n<p><span style=\"font-size: small;\">166 gastric cancer</span></p>\r\n<p><span style=\"font-size: small;\">344 lung cancer</span></p>\r\n<p><span style=\"font-size: small;\">300 diabetes and nephropathy</span></p>\r\n<p><span style=\"font-size: small;\">357 cardiovascular disorder</span></p>\r\n<p><span style=\"font-size: small;\">49 respiratory dysfunction</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masahiko Nishiyama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=641&amp;Itemid=896&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0065.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000089</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shuttle system between petient-derived xenograft and ex vivo culture for innovative platform of evaluating drug sensitivity</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">8 colorectal cancer</span></p>\r\n<p><span style=\"font-size: small;\">2 lung cancer</span></p>\r\n<p><span style=\"font-size: small;\">2 small cell carcinoma of uterine cervix&nbsp;</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masahiro Inoue</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1162&amp;Itemid=1343&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0066.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000060</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Investigating the mechanisms of tumor recurrence and metastasis by non-coding RNA</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">9 colorectal carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koshi Mimori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=483&amp;Itemid=764&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0067.v1</a><br /></strong></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000076</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Project for Development of Innovative Research on Cancer Therapeutics; identifiying the predictive factors for response to chemoherapy in ovarian cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/05/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">55 ovarian clear cell carcinoma patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toru Sugiyama</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2717&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0068.v9</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000065*</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000349</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000570</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000677</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cancer genomics for elucidation of molecular mechanisms of carcinogenecis and progression in lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/07/10</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/10/19</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/12/14</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/03/23</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/12/27</span></p>\r\n<p><span style=\"font-size: small;\">v6:2023/02/10</span></p>\r\n<p><span style=\"font-size: small;\">v7:2023/06/19</span></p>\r\n<p><span style=\"font-size: small;\">v8:2023/09/22</span></p>\r\n<p><span style=\"font-size: small;\">v9:2024/04/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PCR amplicon Seq, WGS, RNA-seq, scDNA-seq, Target Capture, Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n<p><span style=\"font-size: small;\">Multiplex Fluorescence Immunostaining</span></p>\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(MinION, PromethION)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, HiSeq 2000)</span></p>\r\n<p><span style=\"font-size: small;\">Akoya Biosciences</span></p>\r\n<p><span style=\"font-size: small;\">(PhenoCycler)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Xenium Analyzer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">8 + 21 + 74 + 20 lung adenocarcinoma patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Kono</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=423&amp;Itemid=705&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0069.v1</a></strong></span></p>\r\n<p><span style=\"font-size: small;\"><strong>JGAS000064</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">RNA expression profiling of neuromuscular diseases and viral diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/12/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(small RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 Neuromuscular disease (control group)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takanori Yokota</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=678&amp;Itemid=932&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0070.v1</a><br /></strong></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000115</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Molecular analysis of Birt-Hogg-Dube syndrome: Identification of new diagnostic marker and therapeutic target</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">15 Birt-Hogg-Dube associated kidney cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masahiro Yao</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=378&amp;Itemid=669&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0072.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification and functional analyses of susceptibility genes to narcolepsy and other sleep disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(SNP Array 6.0)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">409 narcolepsy patients </span></p>\r\n<p><span style=\"font-size: small;\">1562 controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">125 essential hypersomnia patients</span></p>\r\n<p><span style=\"font-size: small;\">562 controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Katsushi Tokunaga</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=744&amp;Itemid=989&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0074.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome-wide association studies on Hepatitis C virus-related diseases and construction of genome database</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/02/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(SNP Array 6.0, Axiom ASI)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">78 NVR, 64 VR, 51 SVR</span></p>\r\n<p><span style=\"font-size: small;\">107 patients with the decrease of PLT</span></p>\r\n<p><span style=\"font-size: small;\">196 patients without the decrease of PLT</span></p>\r\n<p><span style=\"font-size: small;\">94 HCV patients with an Hb reduction</span></p>\r\n<p><span style=\"font-size: small;\">209 HCV patients without Hb reduction</span></p>\r\n<p><span style=\"font-size: small;\">123 patients who developed HCC after eradication of HCV</span></p>\r\n<p><span style=\"font-size: small;\">333 patients who did not develop HCC after eradication of HCV</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yasuhito Tanaka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1969&amp;Itemid=2028&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0075.v3</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Search for susceptibility genes to hepatitis virus B-related diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/09/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/02/19</span></p>\r\n<p><span style=\"font-size: small;\">v3:2022/05/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(SNP Array 6.0, Axiom ASI)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">181 HBV carriers</span></p>\r\n<p><span style=\"font-size: small;\">185 spontaneously HBV-resolved individuals</span></p>\r\n<p><span style=\"font-size: small;\">184 controls</span></p>\r\n<p><span style=\"font-size: small;\">473 HBV-positive HCC patients</span></p>\r\n<p><span style=\"font-size: small;\">516 HBV carriers (chronic hepatitis and asymptomatic carriers)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">329 patients with chronic HBV infection</span></p>\r\n<p><span style=\"font-size: small;\">318 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Thailander)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masashi Mizokami</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=382&amp;Itemid=672&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0076.v1</a></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome-wide search for susceptibility genes to primary biliary chirrosis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/10/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Axiom ASI)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">487 PBCs</span></p>\r\n<p><span style=\"font-size: small;\">476 controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Minoru Nakamura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1819&amp;Itemid=1895&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0079.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000068</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis in neurodegeneraive disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/02/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">53 inclusion body myositis patients</span></p>\r\n<p><span style=\"font-size: small;\">6 polymyositis patients</span></p>\r\n<p><span style=\"font-size: small;\">9 controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Jun Goto</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=547&amp;Itemid=825&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0082.v2</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000120</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome-wide analysis of SNPs in Healthy Japanese</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/09/26</span></p>\r\n<p><span style=\"font-size: small;\">v1:2017/10/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Control Set</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(SNP Array 6.0, Axiom ASI)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">419 Participants</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Katsushi Tokunaga</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1784&amp;Itemid=1867&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0083.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000070</span></p>\r\n<p><span style=\"font-size: small;\"> JGAS000488</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome-wide analysis for biomarker exploration (lung cancer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/10/28</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/01/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS (CAGE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">lung cancer: 97 + 38 cases</span></p>\r\n<p><span style=\"font-size: small;\">malignant pleural mesothelioma: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yoshihide Hayashizaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=936&amp;Itemid=1152&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0085.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000108</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Molecular biological research affecting on long-term treatment to malignant tumors derived from the chest or abdomen</span></p>\r\n<p><span style=\"font-size: small;\">Genomic analysis of environment-associated tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/10/16</span></p>\r\n<p><span style=\"font-size: small;\">v1:2018/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Array CGH, NGS (WGS, Target Capture, Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq, HiSeq 4000/X Ten)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">72 malignant mesotheliomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese, Americans)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masaki Ohmuraya</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=703&amp;Itemid=953&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0086.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000073<br />(JGA000074)</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000107<br />(JGA000117)</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Epigenomic analysis of the human placenta and endometrium constituting the fetal-maternal interface</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/09/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/12/26</span></p>\r\n<p><span style=\"font-size: small;\">v3:2018/06/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq, ChIP-seq, RNA-seq, small RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">placenta and uterus cells, trophoblast stem cells: total 39 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Sasaki</span></p>\r\n<p><span style=\"font-size: small;\">(IHEC)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=946&amp;Itemid=1161&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0088.v2</a><br /></strong></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000077</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000096</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Global analysis of TGF-beta family signaling in cancer cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/02/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/09/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Analyzer IIx)</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 glioblastomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Kohei Miyazono</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=429&amp;Itemid=707&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0090.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000078</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000079</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000080</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Study of molecular-genetics, and molecular epidemiology for developing treatment of esophageal cancer</span></p>\r\n<p><span style=\"font-size: small;\">(COC series)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/11/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq, ChIP-seq, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">12 normal human absorptive epithelial cells</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yae Kanai</span></p>\r\n<p><span style=\"font-size: small;\">(IHEC)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=427&amp;Itemid=709&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0091.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000082</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000165</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000081</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Study of molecular-genetics, and molecular epidemiology for developing treatment of esophageal cancer</span></p>\r\n<p><span style=\"font-size: small;\">(GAC series)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq, ChIP-seq, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">14 Normal human foveolar epithelial cells of the stomach</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yae Kanai</span></p>\r\n<p><span style=\"font-size: small;\">(IHEC)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2218&amp;Itemid=2239&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0094.v11</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000095</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000105</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000113</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000128</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000215</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000270</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000297</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000335</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000360</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000534</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genomic and epigenomic analysis of different types of cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/09/04</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/01/22</span></p>\r\n<p><span style=\"font-size: small;\">v3:2019/02/12</span></p>\r\n<p><span style=\"font-size: small;\">v4:2020/08/14</span></p>\r\n<p><span style=\"font-size: small;\">v5:2020/10/26</span></p>\r\n<p><span style=\"font-size: small;\">v6:2021/01/29</span></p>\r\n<p><span style=\"font-size: small;\">v7:2021/07/02</span></p>\r\n<p><span style=\"font-size: small;\">v8:2021/10/22</span></p>\r\n<p><span style=\"font-size: small;\">v9:2021/10/26</span></p>\r\n<p><span style=\"font-size: small;\">v10:2022/05/23</span></p>\r\n<p><span style=\"font-size: small;\">v11:2022/11/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, RNA-seq, Target Capture, Iso-seq), Methylation array, SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500, MethylationEPIC, HumanOmni2.5-8)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Chromium Controller)</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">(Sequel)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">68 breast cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">43 + 126 lung adenocarcinoma patients</span></p>\r\n<p><span style=\"font-size: small;\">150 + 173 colorectal cancers</span></p>\r\n<p><span style=\"font-size: small;\">12 colorectal cancers with liver metastasis, 16 colorectal cancers without liver metastasis</span></p>\r\n<p><span style=\"font-size: small;\">64 desmoid tumor patients</span></p>\r\n<p><span style=\"font-size: small;\">35 pulmonary pleomorphic carcinoma patients</span></p>\r\n<p><span style=\"font-size: small;\">67 salivary duct carcinoma patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Mano</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=713&amp;Itemid=962&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0095.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000092</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis of colorectal precancerous lesion and early colorectal cancer to investigate mechanism of carcinogenesis of colorectal cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/07/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 cases of colorectal adenomas or PCRCs</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koshi Mimori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=999&amp;Itemid=1203&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0096.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000090</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000138</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive analysis of genetic alterations in hematological malignancies</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/05/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/11/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, MethylationEPIC)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">123 pediatric T-ALL patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Junko Takita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=693&amp;Itemid=944&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0097.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000094</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cytogenetic analysis of hematopoietic cells in bone marrow failure syndrome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/05/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">5 patients with aplastic anemia with uniparental disomy in 6p</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinji Nakao</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=475:hum0099-v1&amp;catid=16&amp;lang=en-GB&amp;Itemid=748\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0099.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000085</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Expression quantitative trait loci analysis using human immune cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/04/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, Infinium OmniExpressExome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">105 healthy volunteers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazuhiko Yamamoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=683&amp;Itemid=936&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0101.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000098</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of gene mutations in primary immunodeficiency characterized by EBV-associated B-cell lymphoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 patients with primary immunodeficiency</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yasumasa Iwatani</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1773&amp;Itemid=1859&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0103.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000109</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000389</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome sequencing analysis for biliary tract cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/02/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/06/21</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/07/13</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/01/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">98 + 121 biliary tract cancers</span></p>\r\n<p><span style=\"font-size: small;\">4 normal gallbladders</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2138&amp;Itemid=2157&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0106.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000139</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of the prevention and therapy of CRC using patient derived culture tissues.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 patients with colorectal cancer</span></p>\r\n<p><span style=\"font-size: small;\">(patient derived culture tissues)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ryoji Yao</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1170&amp;Itemid=1353&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0107.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000099</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000218</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Establish induced pluripotent stem (iPS) cells from patients with Gorlin syndrome and elucidate the pathology</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/10/02</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/06/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/4000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">4 patients with Gorlin syndrome</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshifumi Azuma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=500&amp;Itemid=781&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0108.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000111</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Search for new susceptibility genetic factors associated with psychiatric disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/06/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HumanMethylation450)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">48 panic disorder patients</span></p>\r\n<p><span style=\"font-size: small;\">48 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Katsushi Tokunaga</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1386&amp;Itemid=1536&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0111.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000103</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000141</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000242</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of gastric cancer genome and its clinicopathological significance</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/07/31</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/05/31</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/02/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq,</span></p>\r\n<p><span style=\"font-size: small;\">Amplicon-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000, MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">30 diffuse-type gastric carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">60 + 15 gastric carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shumpei Ishikawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=567:hum0112-v1&amp;catid=16:cat-researches&amp;lang=en-GB\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0112.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000112</span></p>\r\n<p><span style=\"font-size: small;\">(JGA000122)</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Basic research for the establishment and characterization of human trophoblast stem cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq, ChIP-seq, RNA-seq, miRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 trophoblast stem cells</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takahiro Arima</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2061&amp;Itemid=2100&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0113.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000119</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000142</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000318</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of metabolite biomarkers of Parkinson’s disease and identification of drug seeds from chemical screening based on the biomarkers</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/24</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/07/30</span></p>\r\n<p><span style=\"font-size: small;\">v3:2022/07/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(CAGE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">39 PD patients, 20 non-PD (healthy) contorols</span></p>\r\n<p><span style=\"font-size: small;\">iPS derived neurons: 3 PD samples and 3 controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Piero Carninci</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1591&amp;Itemid=1702&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0114.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA007411</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000314</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research on statistical genetics using B cell lines of Japanese ancestry</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/18</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/04/12</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/08/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HumanCoreExome, MiSeq, HiSeq X Ten, NovaSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">282 psoriasis patients</span></p>\r\n<p><span style=\"font-size: small;\">426 controls</span></p>\r\n<p><span style=\"font-size: small;\">1,173 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yukinori Okada</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1131&amp;Itemid=1319&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0115.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000121</span></p>\r\n<p><span style=\"font-size: small;\">DRA006296</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlling cell differentiation with precision through understanding the structure and dynamics of gene regulatory networks</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Microarray</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">(SurePrint G3 Human GE 8x60K v2 Microarray, SureScan G4900DA)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">TF-hESCs derived from SEES3</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Minoru S.H. Ko</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1316&amp;Itemid=1478&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0116.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000122</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of hunanized mice for human immunity research</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">118 AMLs</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fumihiko Ishikawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=557&amp;Itemid=833&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0117.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000125</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Epigenetics analysis of neurodegenerative diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HumanMethylation450)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">30 Alzheimer's disease patients</span></p>\r\n<p><span style=\"font-size: small;\">30 healty controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atsushi Iwata</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=562&amp;Itemid=838&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0118.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000124</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome-wide analysis for biomarker exploration (endometrial cancer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS (CAGE-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Sanger-seq</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(3500 Genetic Analyzer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">17 endometrial cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yoshihide Hayashizaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=814&amp;Itemid=1050&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0119.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000126</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis for mechanism of onset and progress for NASH</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/01/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Human610-Quad, HumanCoreExome, HumanOmni2.5-Quad BeadChip)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">902 NAFLDs</span></p>\r\n<p><span style=\"font-size: small;\">7672 healty controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fumihiko Matsuda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2070&amp;Itemid=2104&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0120.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000221</span></p>\r\n<p><span style=\"font-size: small;\">DRA011183</span></p>\r\n<p><span style=\"font-size: small;\">DRA011184</span></p>\r\n<p><span style=\"font-size: small;\">DRA011185</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-396</span></p>\r\n<p><span style=\"font-size: small;\">DRA010902</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000549</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">The genetic analysis of circulating tumor DNA in blood of the digestive cancer patients to investigate the prognostic factors of metastasis and reccurence.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/03</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/10/30</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/12/06</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/07/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, Target Capture, WGBS)</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, iScan, HiSeq X Ten)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 + 25 + 10 colorectal cancers</span></p>\r\n<p><span style=\"font-size: small;\">16 gastric cancers</span></p>\r\n<p><span style=\"font-size: small;\">16 breast cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koshi Mimori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1045&amp;Itemid=1239&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0122.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA006622</span></p>\r\n<p><span style=\"font-size: small;\">DRA007336</span></p>\r\n<p><span style=\"font-size: small;\">DRA008459</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-311</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Mutation analysis of iPS cells derived from commercially-avaialble human primary cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/01/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X Ten, Infinium Omni2.5-8)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">human iPS cells and their parental cells: total 27 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ryoko Araki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=633&amp;Itemid=904&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0124.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000129</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Study for exome sequencing in familial epidermal growth factor receptor-mutant lung cancer</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 EGFR-mutant lung cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshiaki Kikuchi</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=764&amp;Itemid=1006&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0125.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000127</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Immune regulation by cotrolling regulatory T cell-specific epigenome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/11/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion S5)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 Crohn's diseases</span></p>\r\n<p><span style=\"font-size: small;\">4 Colorectal cancers (normal cells)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shimon Sakaguchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1245&amp;Itemid=1419&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0126.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of the disease and drug susceptibility genes for the Childhood Idiopathic Nephrotic Syndrome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/09/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Japonica Array v1/v2)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">224 + 3,206 Childhood Idiopathic Nephrotic Syndrome patients</span></p>\r\n<p><span style=\"font-size: small;\">419 + 987 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazumoto Iijima</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2816&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0127.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000130</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000274</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000604</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000715</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Implementation of individualized medicine for cancer patients by multiomics-based analyses—the Project HOPE (High-tech Omics-based Patients Evaluation) for Cancer Therapy—</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/08</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/01/22</span></p>\r\n<p><span style=\"font-size: small;\">v4:2024/07/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, DNA Amplicon-seq, RNA Amplicon-seq, WGS)</span></p>\r\n<p><span style=\"font-size: small;\">Microarray</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">(SurePrint G3 Human Gene Expression 8 × 60 K v2 Microarray, DNA Microarray Scanner)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, Infinium MethylationEPIC array, iScan System)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">91 cancer patients with hypermutator tumors harborig <em>POLE</em> mutations</span></p>\r\n<p><span style=\"font-size: small;\">5143 + 7 cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ken Yamaguchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=759&amp;Itemid=1001&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0128.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000153</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">A study on comprehensive genome and proteome analyses of the chronic eosinophillic inflammatory diseases.</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/10/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">6 chronic rhinosinusitis with nasal polyps</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shigeharu Fujieda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=657&amp;Itemid=898&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0129.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000131</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Research for analyzing mechanistic insight into disease progression of neural disease based on iPS cell technology</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(ChIP-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 CHARGE syndrome patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hideyuki Okano</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2783&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0130.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000150</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000289</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genetic analyses of bone marrow cells in POEMS syndrome</span></p>\r\n<p><span style=\"font-size: small;\">Analyses of molecular mechanisms of hematological malignancies and bone marrow niche</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/01/18</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/09/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/06/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, Target Capture, RNA-seq, scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/2000/2500/3000, MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">20 + 14 POEMS syndromes</span></p>\r\n<p><span style=\"font-size: small;\">4 + 5 MMs</span></p>\r\n<p><span style=\"font-size: small;\">5 + 2 MGUSs</span></p>\r\n<p><span style=\"font-size: small;\">4 + 3 lymphomas without BM invasion</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Emiko Sakaida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=769&amp;Itemid=1010&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0131.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000132</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">The epigenetics of neurodevelopmental disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">6 Williams syndromes</span></p>\r\n<p><span style=\"font-size: small;\">8 healthy contorols</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ryo Kimura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=734&amp;Itemid=981&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0132.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000137</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Identification of genetic alterations in Vietnamese individuals with elevated blood dioxin level</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/09/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">9 trios of the father exposed to dioxin and his wife and child with mental retardation (total 27 individuals)</span></p>\r\n<p><span style=\"font-size: small;\">(Vietnamese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=649&amp;Itemid=916&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0133.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000086</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Identification of genetic mutations characteristic for recurrence and metastasis of gastric cancer.</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">75 gastric cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshiharu Yamaguchi</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=653&amp;Itemid=920&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0134.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000087</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Identification of genetic mutations characteristic for recurrence and metastasis of B cell lymphoma.</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">60 B cell lymphomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshiharu Yamaguchi</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1628&amp;Itemid=1730&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0136.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000341</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Construction of integrated clinical genome database regarding hepatitis B related diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/05/22</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/05</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/10/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Axiom ASI)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1,193 individuals vaccinated with a HB vaccine (Bimmugen)</span></p>\r\n<p><span style=\"font-size: small;\">555 individuals vaccinated with a HB vaccine (Heptavax)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masashi Mizokami</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=789&amp;Itemid=1029&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0137.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000144</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">a multicenter study of susceptibility genes to type 1 diabetes</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/12/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">32 type 1 diabetes patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroshi Ikegami</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1434&amp;Itemid=1574&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0138.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000134</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Clonal structure and oncogenic potential of liver cirrhosis tissues</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/07/31</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/4000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Liver cirrhosis: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">Hepatocellular carcinoma: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">7 healthy donors</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atsushi Takai</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=708&amp;Itemid=958&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0139.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000136</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Research for drug discovery and elucidation of pathophysiology using disease-specific iPS cells</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/07/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 RALD patient</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Makoto Otsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1004&amp;Itemid=1207&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0140.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000158</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Prediction of response to preoperative chemoradiotherapy in rectal cancer based on whole-exome sequencing and transcriptomic analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/11/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">74 rectal cancer treated with preoperative chemoraidotherapy</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Akiyoshi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=865&amp;Itemid=1091&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0141.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000135</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Immune regulation by cotrolling regulatory T cell-specific epigenome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/05/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion S5)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Head and neck cancer: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shimon Sakaguchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3048&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0143.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000143</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Aberrant (pro)renin receptor expression induces genomic instability by chromatin remodeler SMARCA5 disruption during the pancreatic ductal adenocarcinoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500, NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Human pancreatic ductal epithelial cells: 6 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akira Nishiyama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1040&amp;Itemid=1235&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0144.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000147</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive analysis of genetic alterations in hematological malignancies (pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/01/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq), </span></p>\r\n<p><span style=\"font-size: small;\">Methylation array, </span></p>\r\n<p><span style=\"font-size: small;\">SNP array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500, Infinium MethylationEPIC BeadChip, Infinium HumanMethylation450 BeadChip)</span></p>\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Human Mapping 250K Nsp, CytoScan HD)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrome: 43 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Junko Takita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1075&amp;Itemid=1272&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0145.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000222</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">The genetic analysis of circulating tumor DNA in blood of the digestive cancer patients to investigate the prognostic factors of metastasis and reccurence.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 colorectal cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koshi Mimori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=830&amp;Itemid=1062&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0146.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA007187</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Diagnosis of imprinting disorders and safety evaluation of assisted reproduction technologies (ART)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/02/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RRBS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">5 SRS patients born after ART</span></p>\r\n<p><span style=\"font-size: small;\">5 spontaneously conceived SRS patients</span></p>\r\n<p><span style=\"font-size: small;\">10 spontaneously conceived children</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takahiro Arima</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2442&amp;Itemid=2427&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0147.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000145</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000312</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000454</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Immune regulation by cotrolling regulatory T cell-specific epigenome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/18</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/05/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, ChIP-seq, PBAT-seq, ATAC-seq, scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion S5)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/3000/4000, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">4 + 1 healty donors</span></p>\r\n<p><span style=\"font-size: small;\">7 + 3 cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shimon Sakaguchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=901&amp;Itemid=1123&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0148.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000149</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of abnomal character and expression of genes in tissues of urologic carcinomas. </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/06/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Analyzer IIx)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">67 renal cell carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takeshi Yuasa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2228&amp;Itemid=2247&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0152.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000182</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000529</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Multi‐institutional study on molcular pathogenesis of bone and soft tissue tumors by genome and proteome analyses and its clinical application</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/09/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/11/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Dedifferentiated liposarcoma: 37 cases</span></p>\r\n<p><span style=\"font-size: small;\">lipoblastoma-like tumor of the vulva: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hitoshi Ichikawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=957&amp;Itemid=1171&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0153.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000177</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Multiomics analysis of rare cancers to identify genetic alterations related with pathogenesis and prognosis</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/09/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">28 Dedifferentiated liposarcoma patients</span></p>\r\n<p><span style=\"font-size: small;\">36 Tendon sheath giant cell tumor patient</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koichi Matsuda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1585&amp;Itemid=1697&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0156.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000227</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Integrative genetic analysis using next generation sequencer reveals mechanisms of resistance to chemoradiotherapy for esophageal cancer</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/07/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">33 esophageal cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koshi Mimori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=941&amp;Itemid=1156&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0157.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000164</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cancer clinical sequence and accompanying research for comprehensive genomic and epigenomic analyses</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/08/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">183 cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kohei Miyazono</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1565&amp;Itemid=1680&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0158.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000151</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome sequencing analysis for liver cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/10/22</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/06/21</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/07/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000, Genome Analyzer IIx, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">263 liver cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2307&amp;Itemid=2313&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0159.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000157*</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome sequencing analysis for colorectal cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/06/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/12/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Hiseq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 colorectal cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1570&amp;Itemid=1684&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0160.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000155</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome sequencing analysis for esophageal squamous cell carcinoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/05/28</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/07/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500/X Five)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">20 esophageal squamous cell carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2311&amp;Itemid=2317&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0161.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000156*</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome sequencing analysis for hepatoblastoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/06/04</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/12/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Hiseq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">33 hepatoblastomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2432&amp;Itemid=2419&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0163.v3</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Pharmacogenomics research for therapeutics in psychiatry, neurology and oncology</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/12/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/02/09</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/04/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq, Infinium OmniExpressExome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">990 patients with psychiatric/neurological disorders and cancers</span></p>\r\n<p><span style=\"font-size: small;\">90 bullous pemphigoid cases</span></p>\r\n<p><span style=\"font-size: small;\">737 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Taisei Mushiroda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=783&amp;Itemid=1025&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0164.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000160</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tohoku Medical Megabank Organization cohort study</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/12/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Infinium OmniExpressExome-8)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">9,187 participants</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masao Nagasaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=860&amp;Itemid=1087&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0165.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000162</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis of familial myelodysplastic syndromes</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/05/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS </span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 patients of familial myelodysplastic syndromes</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Junji Koya</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2681&amp;Itemid=2612&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0166.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Multicenter Evaluation of NUDT15-R139C genotyping efficiency to DEtect thiopurine-induced hair Loss and leukopenia (MENDEL study)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/07/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/01/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Japonica Array v1)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1221 + 2680 patients of Inflammatory bowel disease</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yoichi Kakuta</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=921&amp;Itemid=1139&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0167.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Study to clarify the pathophysiology of gout / hyperuricemia and uric acid related diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/07/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HumanOmniExpressExome-8, Human660W-Quad, HumanOmni2.5-8, HumanOmniExpress-12, HumanOmniExpress-24, HumanOmniExpressExome, HumanOmniExpress, HumanExome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">121,745 participants of 3 Japanese cohorts (J-MICC study, KING study, BBJ)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hirotaka Matsuo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=989&amp;Itemid=1195&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0168.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000169</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genomic analyses of cancers</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/11/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">51 adenomyosis patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masahito Kawazu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1195&amp;Itemid=1377&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0169.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000178</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Molecular analysis to identify novel biomarker and therapeutic target for cerebrospinal tumor and preclinical investigation using patient derived orthotopic xenograft models.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/06/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/07/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">9 PCNSL patinets</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tetsuya Yamamoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=855&amp;Itemid=1083&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0173.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000171</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A Study on the Health and Development of Children Beginning in the Fetal Period</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/04/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS </span></p>\r\n<p><span style=\"font-size: small;\">(RRBS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">human umbilical cords: 30 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Chisato Mori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2670&amp;Itemid=2604&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0174.v6</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000173</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000580</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000286</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000505</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000596</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Building a Database of Genomic Structural Variants in Japanese population</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/06</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/11/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/06/29</span></p>\r\n<p><span style=\"font-size: small;\">v4:2023/07/06</span></p>\r\n<p><span style=\"font-size: small;\">v5:2023/07/10</span></p>\r\n<p><span style=\"font-size: small;\">v6:2023/12/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">(Sequel, Sequel II)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Chromium Controller)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Purified DNA from Japanese-origin B cell lines: 10 + 11 + 177 + 141 + 30 samples</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinichi Morishita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2720&amp;Itemid=2640&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0175.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000174</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000642</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of actionable molecular targets and/or biomarkers for prognostication and patient stratification in gynecological cancer based on whole-exome sequencing and epigenomic analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/10/02</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/03/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">69 endometrial carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">30 endometrial hyperplasia patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nobuhiro Takeshima</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=973&amp;Itemid=1183&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0176.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000172</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive sequencing analyses of uterine and ovarian carcinosarcoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/10/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">92 uterine carcinosarcomas</span></p>\r\n<p><span style=\"font-size: small;\">17 ovarian carcinosarcomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Seiichi Mori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1117&amp;Itemid=1307&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0177.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000197</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis assciated with malignance of brain tumor</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq, RNA-seq, ChIP-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X Ten, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">14 malignant gliomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Ito</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1080&amp;Itemid=1276&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0179.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000186</span></p>\r\n<p><span style=\"font-size: small;\">DRA009794</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shotgun metagenome analysis of oral microbiome in MRONJ and healthy individuals</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Metagenome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">4 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koji Yahara</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1416&amp;Itemid=1560&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0180.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000170</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic study and evaluation of small molecule compounds for congenital diseases and metabolic disorders caused by an aberrant RNA splicing</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Familial Dysautonomia: 2 cases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masahiko Ajiro</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=886&amp;Itemid=1109&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0181.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Aging of steroid production in the adrenal bland.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Immunohistochemistry</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Dako</span></p>\r\n<p><span style=\"font-size: small;\">(Autostainer Link 48)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">85 anatomical cases who were more than 50 years old</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koshiro Nishimoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1964&amp;Itemid=2024&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0182.v5</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000180</span></p>\r\n<p><span style=\"font-size: small;\">DRA008482</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000516</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehansive analysis of somatic mutations and genetic variations with whole genome sequencing</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/06/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/05/12</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/01/06</span></p>\r\n<p><span style=\"font-size: small;\">v4:2021/11/12</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/05/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(MinION)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000, Genome Analyzer IIx)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">liver cancer (normal cell): 174+42 case</span></p>\r\n<p><span style=\"font-size: small;\">liver cancer (tumor tissue): 11+42 cases</span></p>\r\n<p><span style=\"font-size: small;\">HapMap: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">Breast cancer: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akihiro Fujimoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1829&amp;Itemid=1903&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0184.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000239</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Construction of Japanese Whole-Genome database</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/09/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">4,566 general residents</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masayuki Yamamoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type II)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1521&amp;Itemid=1644&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0187.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000194</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000233</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genomic and genetic analysis of digestive tract cancer and elucidation of its clinicopathological significance.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/12</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/05/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture, Exome, RNA-seq), Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq, HiSeq 2500, HumanMethylation450)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">243 + 160 hepatocellular carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Aburatani</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=914&amp;Itemid=1135&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0188.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000179</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exploration for molecular targets in gastric cancer cell lines</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/06/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 gastric cancer cell lines</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Mano</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1185&amp;Itemid=1365&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0191.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA008575</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of personalized cancer vaccine targeting individual somatic mutations combined with immunoregulation of tumor microenvironment </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/4000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Pancreatic cancer: 17 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazuhiro Kakimi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1476&amp;Itemid=1608&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0192.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000196</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A study to verify the usefulness of cell free DNA as a prognostic biomarker after radiation / proton therapy for oligometastasis in colorectal cancer patients</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/04/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Colon cancer: 20 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masaki Nakamura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1127&amp;Itemid=1315&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0194.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000189</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Molecular mechanisms of drug resistance in cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 lung adenocarcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ryohei Katayama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1888&amp;Itemid=1958&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0195.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000190</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000234</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000269</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genetic analysis of gastrointestinal and hepatobiliary tumor</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/26</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/28</span></p>\r\n<p><span style=\"font-size: small;\">v3:2022/03/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, RNA-seq, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 4000, NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">5 nodule-in-nodule hepatocellular carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">20 liver cirrhosis and hepatocellular carcinomas after hepatitis C virus eradication</span></p>\r\n<p><span style=\"font-size: small;\">3 hepatitis C virus positive cirrhosis and hepatocellular carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">2 hepatitis C virus negative hepatocellular carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">42 + 1 patients</span> with gastric cancer and 3 patients with gastric submucosal tumor</p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atsushi Takai</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1024&amp;Itemid=1223&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0196.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of biomarker for suicide prevention using blood and brain samples of completed suicide</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/12/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HumanOmniExpress-24, HumanOmniExpressExome-8)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Suicide: 746 cases</span></p>\r\n<p><span style=\"font-size: small;\">Non-suicide: 14,049 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akitoyo Hishimoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3155&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">h</span></a><span style=\"font-size: small;\"></span><a href=\"index.php?Itemid=3992&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">um0197.v25</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000205</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000260</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000316</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000415</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000504</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000530</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000531</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000543</span></p>\r\n<p><span style=\"font-size: small;\">DRA014184</span></p>\r\n<p><span style=\"font-size: small;\">DRA014186</span></p>\r\n<p><span style=\"font-size: small;\">DRA014188</span></p>\r\n<p><span style=\"font-size: small;\">DRA014191</span></p>\r\n<p><span style=\"font-size: small;\">DRA014192</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000593</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000600</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000741</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000751</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-887</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1054</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000783</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of disease state by multi-layered omics analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/11/15</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/11/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/03/22</span></p>\r\n<p><span style=\"font-size: small;\">v4:2021/12/10</span></p>\r\n<p><span style=\"font-size: small;\">v5:2021/12/21</span></p>\r\n<p><span style=\"font-size: small;\">v6:2022/02/08</span></p>\r\n<p><span style=\"font-size: small;\">v7:2022/05/23</span></p>\r\n<p><span style=\"font-size: small;\">v8:2022/06/03</span></p>\r\n<p><span style=\"font-size: small;\">v9:2022/06/10</span></p>\r\n<p><span style=\"font-size: small;\">v10:2022/06/16</span></p>\r\n<p><span style=\"font-size: small;\">v11:2022/07/21</span></p>\r\n<p><span style=\"font-size: small;\">v12:2022/12/01</span></p>\r\n<p><span style=\"font-size: small;\">v13:2023/02/14</span></p>\r\n<p><span style=\"font-size: small;\">v14:2023/02/16</span></p>\r\n<p><span style=\"font-size: small;\">v15:2023/03/29</span></p>\r\n<p><span style=\"font-size: small;\">v16:2023/06/06</span></p>\r\n<p><span style=\"font-size: small;\">v17:2023/06/27</span></p>\r\n<p><span style=\"font-size: small;\">v18:2023/10/02</span></p>\r\n<p><span style=\"font-size: small;\">v19:2024/05/29</span></p>\r\n<p><span style=\"font-size: small;\">v20:2024/05/30</span></p>\r\n<p><span style=\"font-size: small;\">v21:2024/10/28</span></p>\r\n<p><span style=\"font-size: small;\">v22:2024/11/11</span></p>\r\n<p><span style=\"font-size: small;\">v23:2024/12/18</span></p>\r\n<p><span style=\"font-size: small;\">v24:2025/05/07</span></p>\r\n<p><span style=\"font-size: small;\">v25:2025/07/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Metagenome</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, RNA-seq, scRNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Presence or absence of endogenous herpesvirus 6, anellovirus load</span></p>\r\n<p><span style=\"font-size: small;\">proteimics</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/3000/X Ten, NovaSeq 6000, Infinium Asian Screening Array, HumanOmniExpressExome BeadChip, HumanOmniExpress BeadChip, HumanExome BeadChip, 　iCOGS OncoArray)</span></p>\r\n<p><span style=\"font-size: small;\">Applied Biosystems</span></p>\r\n<p><span style=\"font-size: small;\">(UK BiLEVE Axiom Array, UK Biobank Axiom Array)</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(FinnGen1 ThermoFisher Array or other genotyping arrays)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-T7)</span></p>\r\n<p><span style=\"font-size: small;\">Olink</span></p>\r\n<p><span style=\"font-size: small;\">(Olink Explore 3072)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">95 + 103 + 227 + 30 + 141 + 136 + 88 + 5 + 524</span> individuals</p>\r\n<p><span style=\"font-size: small;\">BBJ: 180,215 individuals</span></p>\r\n<p><span style=\"font-size: small;\">UK biobank: 377,583 individuals</span></p>\r\n<p><span style=\"font-size: small;\">FinnGen: 136,000 + 224,352 individuals</span></p>\r\n<p><span style=\"font-size: small;\">BACC: 247,173 individuals</span></p>\r\n<p><span style=\"font-size: small;\">PRACTICAL: 140,254 individuals</span></p>\r\n<p><span style=\"font-size: small;\">Autoimmune pulmonary alveolar proteinosis: 198 cases</span></p>\r\n<p><span style=\"font-size: small;\">Control participants: 395</span></p>\r\n<p><span style=\"font-size: small;\">Ulcerative Colitis: 35 cases</span></p>\r\n<p><span style=\"font-size: small;\">Crohn's disease: 39 cases</span></p>\r\n<p><span style=\"font-size: small;\">Healthy controls: 40 individuals</span></p>\r\n<p><span style=\"font-size: small;\">Intracranial germ cell tumors: 133 cases</span></p>\r\n<p><span style=\"font-size: small;\">Control participants: 762</span></p>\r\n<p><span style=\"font-size: small;\">COVID-19: 30 + 43 + 15 cases</span></p>\r\n<p><span style=\"font-size: small;\">Healthy controls: 31 + 44 + 27 individuals</span></p>\r\n<p><span style=\"font-size: small;\">Healthy subjects: 73 individuals</span></p>\r\n<p><span style=\"font-size: small;\">Hunner-type interstitial cystitis: 144 cases</span></p>\r\n<p><span style=\"font-size: small;\">Type 2 diabetes: 27,642 cases (BBJ)</span></p>\r\n<p><span style=\"font-size: small;\">Control participants: 70,242 (BBJ)</span></p>\r\n<p><span style=\"font-size: small;\">Type 2 diabetes: 27,642 cases (UK biobank)</span></p>\r\n<p><span style=\"font-size: small;\">Control participants: 70,242 (UK biobank)</span></p>\r\n<p><span style=\"font-size: small;\">Recurrent pregnancy loss: 1,728 cases</span></p>\r\n<p><span style=\"font-size: small;\">Autoimmune diseases: 2,238 cases</span></p>\r\n<p><span style=\"font-size: small;\">Control participants: 2,919</span></p>\r\n<p><span style=\"font-size: small;\">HPV-associated oropharyngeal cancer: 32 cases</span></p>\r\n<p><span style=\"font-size: small;\">Non-HPV-associated oropharyngeal cancer: 17 cases</span></p>\r\n<p><span style=\"font-size: small;\">Control participants: 2</span></p>\r\n<p><span style=\"font-size: small;\">NMOSD: 240 cases</span></p>\r\n<p><span style=\"font-size: small;\">Control participants: 50,578</span></p>\r\n<p><span style=\"font-size: small;\">Psoriasis: 204 cases</span></p>\r\n<p><span style=\"font-size: small;\">Control participants: 1,231</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese, British, Finnish)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yukinori Okada</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1190&amp;Itemid=1373&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0199.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000198</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of therapeutic target molecules in urological malignancies by using next generation sequencer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Prostate cancer: 25 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tetsuya Fujimura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2948&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0200.v6</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000202</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000265</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000290</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000387</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000758</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of somatic mutations and gene expression abnormalities involved in mammary tumor phenotype</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/29</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/05/07</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/10/01</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/03/02</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/08/29</span></p>\r\n<p><span style=\"font-size: small;\">v6:2024/11/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, WGS, Target Capture, Visium Spatial Gene Expression, semi-bulk RNA-seq, scRNA-seq, EM-seq, t-nanoEM)</span></p>\r\n<p><span style=\"font-size: small;\">CNV</span></p>\r\n<p><span style=\"font-size: small;\">Methylation analysis</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 3000, NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Chromium Controller)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">96 Ductal Carcinoma In Situ</span></p>\r\n<p><span style=\"font-size: small;\">4 + 1 Invasive Ductal Carcinoma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Satoi Nagasawa</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2866&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0201.v8</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000199</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000237*</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000256</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000378</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000350</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000550</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000719</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Collection and transfer of human tumor samples and research using genomic information</span></p>\r\n<p><span style=\"font-size: small;\">Transfer of existing samples and research using genomic information</span></p>\r\n<p><span style=\"font-size: small;\">Reseach of searching gene mutations in gastrointestinal chronic inflammatory diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/12/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/10/06</span></p>\r\n<p><span style=\"font-size: small;\">v3:2020/11/20</span></p>\r\n<p><span style=\"font-size: small;\">v4:2021/11/19</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/06/06</span></p>\r\n<p><span style=\"font-size: small;\">v6:2022/08/05</span></p>\r\n<p><span style=\"font-size: small;\">v7:2022/12/27</span></p>\r\n<p><span style=\"font-size: small;\">v8:2024/08/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, WGS, RNA-seq, ChIP-seq, scRNA-seq, ATAC-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/4000/X Ten, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">gastrointestinal inflammatory disease: 29 cases</span></p>\r\n<p><span style=\"font-size: small;\">gastrointestinal inflammatory disease with neoplastic disease: 26 cases</span></p>\r\n<p><span style=\"font-size: small;\">control patients who underwent colonoscopy: 16 individuals</span></p>\r\n<p><span style=\"font-size: small;\">neoplastic disease: 23 + 1 + 4 + 2 + 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">pancreatic cancer: 50 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshiro Sato</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2153&amp;Itemid=2169&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0202.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000379</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Study of genetic background and time course of congenital hearing loss to increase efficacy of auditory, speech, and language therapy.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/4000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 congenital hearing loss patients and their parents</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tatsuo Matsunaga</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1152&amp;Itemid=1337&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0203.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000206</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Establishment of an integrated database for clinical and genomic data in cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">154 patients with multiple myeloma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Keizo Horibe</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1009&amp;Itemid=1211&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0206.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000207</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Establishment and characterization of cell lines derived from pregnancy related diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/11/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">complete hydatidiform mole: 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takahiro Arima</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1034&amp;Itemid=1231&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0207.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of gene polymorphism and gene expression in human immune cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/01/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, ChIP-seq, Hi-C)</span></p>\r\n<p><span style=\"font-size: small;\">eQTL</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, HiSeq series, Infinium OmniExpressExome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">rheumatoid arthritis: 30 cases</span></p>\r\n<p><span style=\"font-size: small;\">osteoarthritis: 30 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Keishi Fujio</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1050&amp;Itemid=1243&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0208.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000214</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genetic analysis and database construction for head and neck cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/01/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X Ten)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 patients with cancer of the external auditory canal</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1019&amp;Itemid=1219&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0209.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic and clinical prediction models for the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a multicenter cohort study</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/12/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Direct sequencing</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(GeneChip® Scanner 3000 7G)</span></p>\r\n<p><span style=\"font-size: small;\">Applied Biosystems</span></p>\r\n<p><span style=\"font-size: small;\">(Veriti 96-Well Thermal Cycler and 3730XL DNA Analyzer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Rheumatoid arthritis: 166 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shunichi Kumagai</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1085&amp;Itemid=1280&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0210.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000211</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genomic analysis of hematological malignancies</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 patient with concomitant acute myeloid leukemia and mediastinal germ cell tumor</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazuya Shimoda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2035&amp;Itemid=2080&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0213.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000238</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Demographic History and Local Adaptation in Asian Population</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/07/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X Ten)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">60 Baltis individuals</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Min-Sheng Peng</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2694&amp;Itemid=2620&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0214.v9</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000220</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000296</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-397</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-398</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-420</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000486</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000598</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000485</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000626</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000627</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000648</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/09</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/05</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/04/28</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/01/21</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/03/09</span></p>\r\n<p><span style=\"font-size: small;\">v6:2022/08/25</span></p>\r\n<p><span style=\"font-size: small;\">v7:2023/03/28</span></p>\r\n<p><span style=\"font-size: small;\">v8:2023/07/06</span></p>\r\n<p><span style=\"font-size: small;\">v9:2024/02/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, scRNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">eQTL</span></p>\r\n<p><span style=\"font-size: small;\">BCR repertoire analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 Immune-mediated diseases: 544 cases</span></p>\r\n<p><span style=\"font-size: small;\">185 normal controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Keishi Fujio</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2193&amp;Itemid=2201&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0215.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000532</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Whole genome and RNA analysis of geriatric disease in Japanese</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Alzheimer's disease: 317 cases</span></p>\r\n<p><span style=\"font-size: small;\">Mild cognitive impairment: 432 cases</span></p>\r\n<p><span style=\"font-size: small;\">107 Healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kouichi Ozaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1466&amp;Itemid=1600&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0216.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000216</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000244</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000279</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analyses of immune status of patients with solid tumors including gastrointestinal cancer</span></p>\r\n<p><span style=\"font-size: small;\">Investigation of anti-tumor immunological response in solid tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/02/07</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/09/25</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/03/29</span></p>\r\n<p><span style=\"font-size: small;\">v4:2021/04/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">17 patients with lung adenocarcinoma</span></p>\r\n<p><span style=\"font-size: small;\">26 + 23 patients with gastric cancer</span></p>\r\n<p><span style=\"font-size: small;\">9 patients with lung cancer</span></p>\r\n<p><span style=\"font-size: small;\">5 patients with malignant melanoma</span></p>\r\n<p><span style=\"font-size: small;\">7 patients with cololectal cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyoshi Nishikawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1060&amp;Itemid=1258&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0217.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000217</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of genetic alterations predicting cancer progression from colorectal polyps</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/03/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Torrent)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">50 colorectal serrated lesions</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takeshi Sawada</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1270&amp;Itemid=1442&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0218.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-344</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Gene expression analysis in systemic sclerosis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Systemic sclerosis: 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Keishi Fujio</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1180&amp;Itemid=1361&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0220.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000223</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A study of influence of storage condition after blood collection on the plasma/serum comcentrations of compounds</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">LC-MS/MS</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Sciex</span></p>\r\n<p><span style=\"font-size: small;\">(TripleTOF 5600)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 heathy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Sumio Ohtsuki</span></p>\r\n<p><span style=\"font-size: small;\">(AMED-Metabolites)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2563&amp;Itemid=2520&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0221.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000225</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic study using human disease-specific iPS cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">iPS cells derived from Fabry disease patients: 3 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yohei Hayashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1065&amp;Itemid=1262&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0222.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000224</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of responsible genes and development of standardized medicine for familial breast cancer by genetic analysis with NGS technology </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/03/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">115 breast cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinji Ohno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1240&amp;Itemid=1415&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0223.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000232</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">The analyses of gene mutations in hematology malignancy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/09/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">7 patients with multiple myeloma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yasuhito Terui</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3199&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0225.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000226</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000835</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Mortality and risk of progression to adult T-cell leukemia/lymphoma in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture, RNA-seq, ATAC-seq, scRNA-seq, scATAC-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/3000, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HAM: 21 + 15 cases</span></p>\r\n<p><span style=\"font-size: small;\">asymptomatic HTLV-1 carriers: 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Makoto Yamagishi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1531&amp;Itemid=1652&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0226.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000229</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genomic and genetic analysis of upper gastrointestinal tumors and elucidation of its clinicopathological significance.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/06/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">141 stomach adenocarcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Aburatani</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1535&amp;Itemid=1656&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0227.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000228</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genomic and genetic analysis of gastric tumors and elucidation of its clinicopathological significance.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/06/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">102 stomach adenocarcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Aburatani</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1147&amp;Itemid=1331&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0229.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000230</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification and characterization of molecular markers in aging and neuronal disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">7 supercentenarians</span></p>\r\n<p><span style=\"font-size: small;\">2 family members</span></p>\r\n<p><span style=\"font-size: small;\">2 unrelated donors</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Piero Carninci</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2828&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0231.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000287</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A study for the establishment of disease-specific iPS cells.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">120 Healthy volunteers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Megumu K. Saito</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1175&amp;Itemid=1357&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0232.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000231</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Evaluation of metastasis and recurrence by monitoring circulating tumor DNA of gastric cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 gastric cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Satsoshi Nishizuka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1516&amp;Itemid=1640&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0233.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000236</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Paediatric Hepatic International Tumour Trial (JPLT4: PHITT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/05/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, WGBS)</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, HumanMethylation450)</span></p>\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(SNP Array 6.0)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">165 pediatric hepatoblastomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Eiso Hiyama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1454&amp;Itemid=1590&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0235.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000272</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Evaluation and imaging study of the preclinical stage of Alzheimer's disease in Japan</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Neuroimage</span></p>\r\n<p><span style=\"font-size: small;\">Clinical Info</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><a href=\"/en/hum0235-v1-release#mriscanners\" target=\"_blank\" rel=\"noopener noreferrer\">MRI Scanners (9 Models)</a></p>\r\n<p><a href=\"/en/hum0235-v1-release#petscanners\" target=\"_blank\" rel=\"noopener noreferrer\">PET Scanners (11 Models)</a></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">25 healthly controls </span></p>\r\n<p><span style=\"font-size: small;\">3 preclinical AD </span></p>\r\n<p><span style=\"font-size: small;\">7 early MCI </span></p>\r\n<p><span style=\"font-size: small;\">5 late MCI </span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Shimada</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1331&amp;Itemid=1490&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0236.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000245</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of tumor infiltrating lymphocytes therapy targeting gene mutation of lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/12/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(MinION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">7 non-small cell lung cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tetsuya Nakatsura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1391&amp;Itemid=1540&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0237.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Whole genome and RNA analysis of geriatric disease in Japanese</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Japonica Array, SNP Array 6.0)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Alzheimer's disease: 3,962 cases</span></p>\r\n<p><span style=\"font-size: small;\">4,074 controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kouichi Ozaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1205&amp;Itemid=1385&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0238.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000240</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of personalized medicine</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/07/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 participants of BBJ</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yukihide Momozawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1200&amp;Itemid=1381&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0239.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000241</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genomic and Proteomic comprehensive analysis related to cancer, infectious diseases, intractable diseases and lifestyle-related diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/07/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">19 patients with urothelial bladder cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yosuke Hirotsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1286&amp;Itemid=1454&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0240.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000258</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Whole genome sequence analysis in patients with primary central nervous system lymphomas</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Torrent)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">28 PCNSL patinets</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ryuya Yamanaka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1356&amp;Itemid=1510&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0242.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000243</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Frequent post-treatment monitoring of colorectal cancer using individualized ctDNA validated by multi-regional molecular profiling</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/01/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">12 colorectal cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Satsoshi Nishizuka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1306&amp;Itemid=1470&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0243.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000253</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of humanized mice for human immunity research/Construction of disease and treatment model using iPS cells derived from human hematopoitec cells.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, CAGE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cord blood: 24 individuals</span></p>\r\n<p><span style=\"font-size: small;\">Acute Myeloid Leukemia: 116 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fumihiko Ishikawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2204&amp;Itemid=2227&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0245.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000276</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive Genome analysis of adult acute lymphoblastic leukemia (JALSG ALL202U-GWS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/10/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">46 patients with Ph-negative ALL</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fumihiko Hayakawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1351&amp;Itemid=1506&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0247.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000249</span></p>\r\n<p><span style=\"font-size: small;\">DRA010773</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research for gene mutations in cancer representing immune status of the patients</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/01/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 malignant melanoma patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Iwata</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1301&amp;Itemid=1466&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0248.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000259</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Establishment of a Japanese reference genome sequence by high-precision long-read sequencing</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/11/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">PacBio (RS II)</span></p>\r\n<p><span style=\"font-size: small;\">Bionano (Irys, Saphyr)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina (HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 Japanese male individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masayuki Yamamoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type II)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3004&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0249.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000248</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000663</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of pathological conditions and development of therapeutic methods using iPS cells derived from patients with hard tissue/connective tissue related diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/09/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/03/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(CAGE-seq, scRNA-seq, CUT＆RUN-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 patients with hard tissue/connective tissue related diseases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshifumi Azuma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1439&amp;Itemid=1578&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0250.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000277</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Brain Mapping by Integrated Neurotechnologies for Disease Studies: Human Brain Aging Imaging Study</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Neuroimage</span></p>\r\n<p><span style=\"font-size: small;\">Clinical Info</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><a href=\"/en/hum0250-v1-release#mriscanners\" target=\"_blank\" rel=\"noopener noreferrer\">MRI Scanners (1 Model)</a></p>\r\n<p><a href=\"/en/hum0250-v1-release#petscanners\" target=\"_blank\" rel=\"noopener noreferrer\">PET Scanners (1 Model)</a></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">11 MCI </span></p>\r\n<p><span style=\"font-size: small;\">28 healthly controls </span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takeshi Iwatsubo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=2208&amp;Itemid=2231&amp;lang=en\" target=\"_blank\">hum0251.v1</a></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000278</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Phase II clinical trial of adult Philadelphia chromosome-negative precursor B-cell acute lymphocytic leukemia with combination chemotherapy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/10/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">153 patients with Ph-negative B-ALL</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yoshihiro Hatta</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2725&amp;Itemid=2644&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0252.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000301</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000553</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Study for molecular characteristics of adult T-cell leukemia-lymphoma and HTLV-1-associated diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/07/12</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/12/06</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/03/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture, RNA-seq, scRNA-seq, WGS, scATAC-seq, ChIP-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/3000, NovaSeq 6000, NextSeq 500）</span></p>\r\n<p><span style=\"font-size: small;\"> MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ATL: 6 + 4 + 6 cases (Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">HTLV-1 infected carriers: 10 cases (Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">CD4+ T cells from 3 + 1 healthy donors (Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Makoto Yamagishi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1612&amp;Itemid=1718&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0254.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000257</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of sequencing library preparation method from cell-free DNA in blood</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq, HiSeq X Ten)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">5 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fumihito Miura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2324&amp;Itemid=2331&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0257.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000262</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000263</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000264</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000514</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-414</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-415</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-416</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-417</span></p>\r\n<p><span style=\"font-size: small;\">GSE202023</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of culturing methods amplifying micro-specimens derived from human pancreas and biliary tract tissues</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/12/24</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/01/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, ATAC-seq, ChIP-seq, Hi-C)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, HiSeq 2500, NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Pancreatic ductal adenocarcinoma: 17 cases</span></p>\r\n<p><span style=\"font-size: small;\">Intraductal papillary mucinous neoplasm: 6 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Keisuke Tateishi</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1366&amp;Itemid=1518&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0261.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome-wide association study of primary biliary cholangitis (PBC) －an additional study of 1,000 Japanese PBC patients－</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/01/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/01/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Axiom ASI, Japonica Array v1)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1,953 PBCs and 3,690 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Minoru Nakamura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1496&amp;Itemid=1624&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0262.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000267</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of biomarkers for prediction of efficacy of microtubule inhibitors and antifolates in non-small cell lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Lung Adenocarcinoma: 24 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Katsuya Tsuchihara</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2541&amp;Itemid=2502&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0263.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000292</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive analysis of the abnormality of the genes in juvenile myelomonocytic leukemia</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(DREAM-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Juvenile myelomonocytic Leukemia: 149 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yoshiyuki Takahashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1839&amp;Itemid=1911&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0264.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000508</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of the pathogenesis and identification of susceptibility genes for sleep disorders by genetic and functional analyses.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/02/07</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(SNP Array 6.0)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Idiopathic hypersomnia: 129 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Makoto Honda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2293&amp;Itemid=2301&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0266.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000281</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of the pathogenesis of autoimmune dermatosis using patient samples.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 patients with pemphigus</span></p>\r\n<p><span style=\"font-size: small;\">3 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shohei Egami</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2988&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0267.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000284</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive gene mutation analysis of cancer-predisposing genes and cancer-causing genes in pediatric cancer/hematologic disease.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/02/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">47 children who suspected of sarcoma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Manabu Wakamatsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3183&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0268.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000280</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000766</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Direct and comprehensive identification of neoantigens using cancer tissues</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/04/09</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/08/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Iso-seq, CAGE-seq, RNA-seq, scRNA-seq, scTCR-seq, Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500, NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">(Sequel)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Human colon cancer cell line: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n<p><span style=\"font-size: small;\">Colon cancer: 6 patients</span></p>\r\n<p><span style=\"font-size: small;\">Endometrial cancer: 5 patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takayuki Kanaseki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2737&amp;Itemid=2652&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0269.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000295</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000565</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000566</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000567</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Sensitive gene analysis of hereditary cardiovascular disease</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/05/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/03/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/3000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">hereditary cardiovascular disease: 13 + 20 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yoshihiro Asano</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1932&amp;Itemid=1992&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0270.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000282</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Translational research for elucidating molecular and pathological abnormalities specific to bone and soft tissue tumors based on genomic and genetic analysis, and for developing new diagnostic and therapeutic strategies</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">16 pediatric Osteosarcoma patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tsukasa Yonemoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1491&amp;Itemid=1620&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0271.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000288</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genome analysis related to individual differences in phenotypic expression in autosomal dominant diseases caused by haploinsufficiency</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture, Target RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">20 patients with neurofibromatosis type 1</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yo Niida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2928&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0272.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000285</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000589</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of the immune status of melanoma and other skin tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/12/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/07</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/11/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, scRNA-seq, scTCR-seq, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Torrent proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">melanoma: 4 + 9 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Inozume</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1602&amp;Itemid=1710&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0273.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000300</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A study of molecular pathology for carcinogenesis and progression of breast cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/08/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Amplicon-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 patients of lobular carcinoma in situ with ductal carcinoma in situ</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinobu Masuda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1923&amp;Itemid=1984&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0274.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000294</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Integrated analysis of selective mRNA export by mRNA export factors, UAP56 and URH49</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/04/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HeLa cells with knockdown of the target genes: 20 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kenichi Fujita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1596&amp;Itemid=1706&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0275.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000313</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive analysis of genetic abnormalities in solid tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/08/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nine subjects without Hp infection or gastric cancer (healthy population)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Seishi Ogawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1618&amp;Itemid=1722&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0276.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000308</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of a general-purpose genetic diagnostic panel for Gorlin syndrome and its application to liquid biopsy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/10/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">12 patients with Gorlin syndrome</span></p>\r\n<p><span style=\"font-size: small;\">3 blood relatives</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshifumi Azuma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3191&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0277.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000303</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000564</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000737</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of genes related to the oncogenesis, progression or effectiveness of drug therapies of urological tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/09</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/04/18</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/05/10</span></p>\r\n<p><span style=\"font-size: small;\">v4:2025/09/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, Exome, RNA-seq, WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500, HiSeq 2500, NovaSeq 6000/PE150)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">renal cell carcinoma: 15 + 30 + 167 cases</span></p>\r\n<p><span style=\"font-size: small;\">sporadic oncocytoma: 7 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hisashi Hasumi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2025&amp;Itemid=2072&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0278.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000304</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000305</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of genome of breast cancer stem cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/07/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 3000, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Breast cancer: 5 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Noriko Gotoh</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2129&amp;Itemid=2149&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0279.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000307</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Stratification of refractory malignant lymphoma by genomic/epigenomic analysis and immunohistochemistry and development of novel therapeutic approaches</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 550)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">177 patients with diffuse large B-cell lymphoma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Emiko Sakaida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1760&amp;Itemid=1847&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0280.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA012560</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">The research for the identification of neoantigen and tumor immune microenvironment in lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">lung cancer: 113 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hirokazu Matsushita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2338&amp;Itemid=2343&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0284.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000309</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of the molecular mechanism that controls the transition from precancerous lesions to invasive cancer due to disruption of biological maintenance function</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/01/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Breast cancer: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Jun Nakayama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2223&amp;Itemid=2243&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0286.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000311</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000523</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of molecular mechanism of NAFLD-HCC</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/12</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/11/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Visium Spatial Gene Expression, Target Capture)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">55 hepatocellular carcinoma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takahiro Kodama</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2725&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0287.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000310</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000573</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000690</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome sequence comparison of human iPS cell lines</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/02</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/03/29</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/05/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">5 +1 +1 Human iPS cell lines</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shihori Yokobayashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2158&amp;Itemid=2173&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0289.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000317</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Mechanisms on relapse after allogeneic hematopoietic cell transplantation in CMML</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, Exome)</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, MethylationEPIC)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">chronic myelomonocytic leukemia (CMML): 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yu Akahoshi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3086&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0290.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000321</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000637</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1053</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1058</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1059</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1060</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Comprehensive analysis of interaction between human gene expression and environmental metagenomes.</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/02/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/06/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, scRNA-seq, TCR-seq, BCR-seq, scATAC-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Proteomics</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000/X, MethylationEPIC)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Chromium Controller)</span></p>\r\n<p><span style=\"font-size: small;\">Fluidigm</span></p>\r\n<p><span style=\"font-size: small;\">(Helios, a CyTOF System)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-T7)</span></p>\r\n<p><span style=\"font-size: small;\">Olink</span></p>\r\n<p><span style=\"font-size: small;\">(Olink Explore 3072)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">7 + 97 healthy volunteers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yutaka Suzuki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2589&amp;Itemid=2540&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0291.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000359</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of molecular mechanisms of tumorigenesis and development of diagnoses and treatments based on comprehensive genomic analyses in pancreatic tumors, duodenal tumors and biliary tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/12/10</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/09/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Pancreatic tumor: 57+6 cases</span></p>\r\n<p><span style=\"font-size: small;\">Duodenal tumor: 6+1 cases</span></p>\r\n<p><span style=\"font-size: small;\">Biliary tumors: 11 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinichi Yachida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1607&amp;Itemid=1714&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0292.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000330</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of blood-based biomarkers for precision medicine in castration-resistant prostate cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">100 CRPC patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shusuke Akamatsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2040&amp;Itemid=2084&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0293.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000320</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exploratory research of genetic factors that regulate the therapeutic sensitivity of hematopoietic malignancy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/07/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X Ten)</span></p>\r\n<p><span style=\"font-size: small;\">BGI</span></p>\r\n<p><span style=\"font-size: small;\">(BGISEQ-500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ATL: 7 cases</span></p>\r\n<p><span style=\"font-size: small;\">ATL cell line: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takaomi Sanda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2749&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0294.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000708</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Single cell analysis of tumor-infiltrating T cells</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/05/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">esophageal cancer: 28 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shogo Kumagai</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=1742&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0295.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000351</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Search for biomarkers for diagnosis, evaluation of therapeutic effect, and follow-up of skin tumors (prospective observational study)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/10/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Amplicon-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion S5)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">melanoma: 98 cases</span></p>\r\n<p><span style=\"font-size: small;\">sebaceous nevus: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hisashi Uhara</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2173&amp;Itemid=2185&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0297.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000348</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive study of color vision diversity</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 healthy donor</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Chihiro Hiramatsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2178&amp;Itemid=2189&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0299.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA012759</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of chromosome background of cancerous mutations using a long read sequencer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Healthy white B-Lymphocyte cell line HG002 (NA24385): 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yutaka Suzuki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1669&amp;Itemid=1766&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0300.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000367</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Whole-genome and whole-exome analyses of cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">89 Esophageal squamous cell carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Johji Inazawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1699&amp;Itemid=1790&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0301.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000368</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">An integrative analysis study of genomic abnormalities and immune status in breast cancer patients and high-risk individuals (Immuno-Genome Atlas Project)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">26 patients with breast cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Mano</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2742&amp;Itemid=2656&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0302.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000382</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000683</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">iPS Cell Advanced Characterization and Development of modified iPS cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/05</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/03/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">iPS cells derived from patients with Wilson's disease: 6 samples</span></p>\r\n<p><span style=\"font-size: small;\">iPS cells derived from patients with juvenile nephron tabes (NPH1): 12 samples</span></p>\r\n<p><span style=\"font-size: small;\">iPS cells derived from healthy donors: 6+6 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yohei Hayashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1756&amp;Itemid=1843&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0304.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000370</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exome sequencing of human breast cancer tissues resistant to taxanes.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/04/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">6 breast cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yumi Wanifuchi-Endo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1704&amp;Itemid=1794&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0305.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000377</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A multicenter study of biological and genetic manifestations of subsequent solid cancers after hematopoietic cell transplantation</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">14 de novo cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yoshihiro Inamoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1633&amp;Itemid=1734&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0306.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000361</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cancer Genome Sequencing Analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/10/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(MinION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">9 liver cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1869&amp;Itemid=1935&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0307.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000416</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis for skin molecules in patients with atopic dermatitis No.2.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion S5)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">29 healthy male subjects</span></p>\r\n<p><span style=\"font-size: small;\">atopic dermatitis: 30 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takayoshi Inoue</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1873&amp;Itemid=1939&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0308.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000417</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Circadian rhythm of skin molecules.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion S5)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 healthy female subjects</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takayoshi Inoue</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1877&amp;Itemid=1943&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0309.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000418</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comparison between sebum and stratum corneum molecules.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion S5)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 healthy male subjects</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takayoshi Inoue</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3098&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0311.v7</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000412</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000541</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000561</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000785</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Management of Biobank Japan and the investigation of disease biomarkers for the realization of personalized medicine</span></p>\r\n<p><span style=\"font-size: small;\">Discovery of disease makers from disease cohort network</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/07/28</span></p>\r\n<p><span style=\"font-size: small;\">v3:2022/09/08</span></p>\r\n<p><span style=\"font-size: small;\">v4:2023/04/24</span></p>\r\n<p><span style=\"font-size: small;\">v5:2023/07/27</span></p>\r\n<p><span style=\"font-size: small;\">v6:2024/05/22</span></p>\r\n<p><span style=\"font-size: small;\">v7:2025/06/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Metabolome</span></p>\r\n<p><span style=\"font-size: small;\">Proteomics</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Asian Screening Array, HumanOmniExpressExome, HumanOmniExpress, HumanExome)</span></p>\r\n<p><span style=\"font-size: small;\">Bruker</span></p>\r\n<p><span style=\"font-size: small;\">(AVANCE IIIHD)</span></p>\r\n<p><span style=\"font-size: small;\">Olink</span></p>\r\n<p><span style=\"font-size: small;\"> (Explore 3072, Target 96)</span></p>\r\n<p><span style=\"font-size: small;\">Somalogic</span></p>\r\n<p><span style=\"font-size: small;\"> (SomaScan)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">11,716 + 180,882 + 1,285 + 2,570 + 40,907 + 3,050 patients from BBJ 1st cohort</span></p>\r\n<p><span style=\"font-size: small;\">42,689 patients from BBJ 2nd cohort</span></p>\r\n<p><span style=\"font-size: small;\">ToMMo: 49,621 individuals</span></p>\r\n<p><span style=\"font-size: small;\">UK biobank: 456,327 individuals</span></p>\r\n<p><span style=\"font-size: small;\">FinnGen: 230,635 individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese, British, Finnish)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koichi Matsuda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2803&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0312.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA016285</span></p>\r\n<p><span style=\"font-size: small;\">DRA016393</span></p>\r\n<p><span style=\"font-size: small;\">DRA016394</span></p>\r\n<p><span style=\"font-size: small;\">DRA016395</span></p>\r\n<p><span style=\"font-size: small;\">DRA018714</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic study of complex diseases through comprehensive analysis of functional variants</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/06/17</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/06/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, Iso-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\"> (NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(MinION)</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">(Sequel II/IIe)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">immortalized B cell lines from healthy Japanese volunteers: 95 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n<p><span style=\"font-size: small;\">1 healthy subject</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yuta Kochi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1679&amp;Itemid=1774&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0314.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000383</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of the relationship between disease phenotype and genotype in patients with Alzheimer's disease</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Infinium OmniExpressExome-8)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">102 patients with sporadic Alzheimer's disease</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Haruhisa Inoue</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2055&amp;Itemid=2096&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0315.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000385</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive analysis of genetic alterations in hematological malignancies</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/07/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, scRNA-seq, ChIP-seq, Target Capture)</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/X Ten, MethylationEPIC, HumanMethylation450)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">84 infants with KMT2A-rearranged acute lymphoblastic leukemia</span></p>\r\n<p><span style=\"font-size: small;\">3 cell lines derived from infants with KMT2A-rearranged acute lymphoblastic leukemia</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Junko Takita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1954&amp;Itemid=2016&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0316.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000535</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Whole-genome sequencing of esophageal cancer to elucidate pathogenesis and search for treatment-sensitive markers</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Esophageal squamous cell carcinoma: 110 cases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2799&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0317.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000413</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000707</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research on the establishment of patient derived xenograft models useful for drug discovery research</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/12/06</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/06/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Non-small cell lung cancer: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">Cancer: 52 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akinobu Hamada</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1864&amp;Itemid=1931&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0318.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000483</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Clinical sequence of hematological malignancy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">B-ALL: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Arinobu Tojo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1779&amp;Itemid=1863&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0319.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000487</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of diagnostic markers for prostate cancer using genetic polymorphisms</span></p>\r\n<p><span style=\"font-size: small;\">Identification of Rare Variants Involved in the Development of Prostate Cancer in Japanese</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1,336 men with suspected prostate cancer scheduled for prostate biopsy</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shusuke Akamatsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1799&amp;Itemid=1879&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0320.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000480</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Immunomonitoring study in patients with malignant tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, TCR-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">lung adenocarcinoma: 2 cases</span></p>\r\n<p><span style=\"font-size: small;\">head and neck cancer: 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yosuke Togashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1974&amp;Itemid=2034&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0321.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000482</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive analysis of interaction between human gene expression and environmental metagenomes</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/06/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Myasthenia gravis: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tatsusada Okuno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1789&amp;Itemid=1871&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0323.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000489</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Biomarker exploration of colon cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(CAGE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">45 colon cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yasushi Kogo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1913&amp;Itemid=1980&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0324.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000515</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis of cerebrovascular diseases and neuromuscular disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/04/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGBS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 neuromyelitis optica (NMOSD) positive for AQP4 antibody</span></p>\r\n<p><span style=\"font-size: small;\">8 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tatsusada Okuno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1834&amp;Itemid=1907&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0327.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000507</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Screening of neoantigens and neoantigen reactive T cell receptors in hepatobiliary and pancreatic cancer for clinical application of personalized T cell therapy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/02/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 550)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">hepatocellular carcinoma: 28 cases</span></p>\r\n<p><span style=\"font-size: small;\">metastatic colorectal carcinoma: 18 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshihiro Suzuki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2452&amp;Itemid=2435&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0328.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000509</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Frequency of germline variants in genes associated with DNA repair among adanced prostate cancer patients in Japan</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">prostate cancer: 129 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shusuke Akamatsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1987&amp;Itemid=2042&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0329.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000522</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Next-generation sequencing-based comprehensive genetic analysis of undiagnosed disease</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/06/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Patients with undiagnosed diseases and their parents: 177 families（522 samples）</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hideki Muramatsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1918&amp;Itemid=1976&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0331.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Construction of control data for the promotion of genomic medicine for cancers and rare diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/02/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">9290 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Katsushi Tokunaga</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1884&amp;Itemid=1947&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0332.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000510</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A study on personalized medicine in genitourinary cancers using genetic biomarkers.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 castration-resistant prostate cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shusuke Akamatsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2124&amp;Itemid=2145&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0335.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA014819</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research on new diagnosis and clinical picture of lymphoproliferative diseases by combining genetic analysis and immunological traits</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Waldenström macroglobulinemia: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">non IgM-type lymphoplasmacytic lymphoma: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akihiko Yokohama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2824&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0337.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000521</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fundamental research on establishment of a novel tailor-maid therapy for refractory gynecologic malignancy based on comprehensive omics analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">squamous cell carcinoma arising from mature teratoma of the ovary: 5 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kosuke Yoshida</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2237&amp;Itemid=2255&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0338.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000575</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive cancer genome, epigenome, and immunogenome analysis for gastric cancer unaffected by aging or Helicobacter pylori infection</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/11/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"><em>H. Pylori</em> uninfected gastric cancer: 27 cases</span></p>\r\n<p><span style=\"font-size: small;\"><em>H. Pylori</em> infected gastric cancer: 36 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Seiichi Mori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2085&amp;Itemid=2117&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0340.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000520</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genomic analysis using next-generation sequencer for pediatric solid tumor cases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Hiseq X Ten)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Colorectal cancer: 24 cases</span></p>\r\n<p><span style=\"font-size: small;\">Retinoblastoma: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">Glioblastoma: 2 cases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Utako Oba</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2014&amp;Itemid=2064&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0342.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000538</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Immunohistochemical and molecular pathological search in gastrointestinal tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/06/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Colorectal cancer: 29 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shigeki Sekine</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2894&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0343.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-759</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000739</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of COVID19 vaccine and evaluation system based on genetics of COVID-19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/26</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/06/14</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/06/24</span></p>\r\n<p><span style=\"font-size: small;\">v4:2024/10/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Protein expression</span></p>\r\n<p><span style=\"font-size: small;\">eQTL/sQTL/pQTL</span></p>\r\n<p><span style=\"font-size: small;\">Presence or absence of endogenous herpesvirus 6, anellovirus load</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Asian Screening Array, NovaSeq6000)</span></p>\r\n<p><span style=\"font-size: small;\">Olink</span></p>\r\n<p><span style=\"font-size: small;\">(Olink Explore 3072)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">COVID-19: 2,393 cases</span></p>\r\n<p><span style=\"font-size: small;\">Healthy controls: 3,289 individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koichi Fukunaga</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2463&amp;Itemid=2443&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0344.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000533</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000611</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome sequencing analysis for biliary tract cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/04</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/05/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, RNA-seq, Amplicon-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(MGISEQ-2000RS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">kidney cancers: 38 cases</span></p>\r\n<p><span style=\"font-size: small;\">chronic kidney disease: 77 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">HEK293 cell line: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2097&amp;Itemid=2125&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0345.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000528</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000551</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fundamental study for regenerative medicine utilizing cord blood</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, ATAC-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">30 healthy volunteers</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kohshi Ohishi</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2045&amp;Itemid=2088&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0347.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genetic analysis of acute encephalopathy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/23</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/07/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Sanger-seq</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Life Technologies</span></p>\r\n<p><span style=\"font-size: small;\">(310 Genetic Analyzer, 3100 Genetic Analyzer, 3130xl Genetic Analyzer)</span></p>\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Japonica Array v2)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD): 283 cases</span></p>\r\n<p><span style=\"font-size: small;\">Healthy controls: 799 individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masashi Mizuguchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2458&amp;Itemid=2439&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0348.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000537</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of ATL progression by CD30 signaling and its biomarkers</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/05/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n<p><span style=\"font-size: small;\">Array CGH</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">(GenetiSure Cancer Research CGH+SNP Microarray 2 x 400K)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ATL: 8 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Makoto Nakashima</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2777&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0350.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000689</span></p>\r\n<p><span style=\"font-size: small;\">DRA018405</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-739</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-740</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-741</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-742</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-743</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-744</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-745</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-746</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research to establish a foundation for integrated analysis of human genetic polymorphisms and omics data</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/06/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(5' single-cell RNA-seq, 3' single-cell RNA-seq, Micro-C and Region Capture Micro-C, CITE-seq, Multimodal assay including single-nucleus ATAC-seq, 3' and 5’ single-nucleus RNA-seq, and 5' single-cell RNA-seq, MAS-seq, CAGE-seq, and NET-CAGE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, NextSeq 500)</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">(Sequel Ⅱ)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 healthy individuals (1 male, 2 females)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">CRISPR-activated Jurkat cells: 15 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazuhiko Yamamoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2143&amp;Itemid=2161&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0351.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000540</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">New classification of occlusive cerebrovascular diseases by combining diagnostic imaging and genetic analysis of RNF213</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Metagenome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">moyamoya disease: 27 cases</span></p>\r\n<p><span style=\"font-size: small;\">non-moyamoya intracranial large artery disease: 7 cases</span></p>\r\n<p><span style=\"font-size: small;\">controls: 15 individuals.</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yohei Mineharu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2030&amp;Itemid=2076&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0352.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000545</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analytical study of protein function and RNA expression involved in predicting treatment efficacy and adverse event development in lung cancer radiotherapy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">primary lung cancer: 5 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masanori Someya</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2417&amp;Itemid=2407&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0354.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analyses of circulating tumor cells from patients with advanced urogenital cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/06/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/04/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">qRT-PCR</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">BioRad</span></p>\r\n<p><span style=\"font-size: small;\">(T100 Thermal cycler)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">127 patients with advanced metastatic castration-resistant prostate cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masayoshi Nagata</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2480&amp;Itemid=2453&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0355.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000544</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genomic analysis of genitourinary tumors by next generation sequencing</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Microarray</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, NextSeq 500, HiSeq X Ten)</span></p>\r\n<p><span style=\"font-size: small;\">NanoString Technologies</span></p>\r\n<p><span style=\"font-size: small;\">(nCounter Digital Analyzer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">hereditary clear cell renal cell carcinoma associated with VHL disease: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Keisuke Kataoka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2761&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0356.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA015288</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-579</span></p>\r\n<p><span style=\"font-size: small;\">DRA016520</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-619</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of genetic alterations in colorectal carcinogenesis and establishment of clinical significance of interstitial</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/05/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 + 2 colorectal cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koshi Mimori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3036&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0357.v6</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000557</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000609</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000610</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research for biological features by gene expression analysis and biomarkers at diagnosis/therapeutics in lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/11/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/01/11</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/02/15</span></p>\r\n<p><span style=\"font-size: small;\">v4:2023/08/09</span></p>\r\n<p><span style=\"font-size: small;\">v5:2024/06/05</span></p>\r\n<p><span style=\"font-size: small;\">v6:2025/04/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, RNA-seq, scRNA-seq, ATAC-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/X Ten, NovaSeq 6000, Infinium MethylationEPIC)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">lung cancer: 105 + 2 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Yasuda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3203&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0358.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000582</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000586</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000640</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000824</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000825</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research of genetic abnormalities related to the development and prognosis of adenocarcinoma and squamous cell carcinoma of the cervix and vaginal and vulvar cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/10/19</span></p>\r\n<p><span style=\"font-size: small;\">v3:2025/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, scRNA-seq, Target bisulfite-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000/X Plus, MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">cervical cancer: 19 + 4 + 96 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">NIKS18 cell line: 5 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kenbun Sone</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2075&amp;Itemid=2109&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0359.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000548</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genomic and Epigenetic Analysis on T/NK-cell lymphoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Extranodal NK/T-cell lymphoma, nasal type: 67 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Naoki Oishi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2273&amp;Itemid=2283&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0360.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000546</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exploratory research on COVID-19 pathogenesis and aggravation</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, scVDJ-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">COVID-19: 6 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ai Tachikawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3016&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0362.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000552</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">The study on genomic profiling using clinical specimens (tissue, blood, etc.) form patients with lung and thymic tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">thymoma: 98 cases </span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinichi Yachida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2113&amp;Itemid=2137&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0364.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive analysis of microsatellite polymorphisms in human populations</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(bam files were publicly available)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Simons Genome Diversity Project (SGDP): 276 samples</span></p>\r\n<p><span style=\"font-size: small;\">Human Genome Diversity Project (HGDP): 693 samples</span></p>\r\n<p><span style=\"font-size: small;\">Jomon Individual: 1 individual</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akihiro Fujimoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2214&amp;Itemid=2235&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0365.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000569</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">The role of gut microbiota in metabolic diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(CAGE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">normoglycemic lean group: 103 individuals</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">obese group: 98 cases</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">prediabetic group: 97 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroshi Ohno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2367&amp;Itemid=2367&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0366.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-511</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-512</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Pathogenesis of severe acute respiratory syndrome coronavirus 2 infection (COVID-19)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/03/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, RNA-seq, ATAC-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">COVID-19: 16 cases</span></p>\r\n<p><span style=\"font-size: small;\">10 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yasuhiro Kato</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2183&amp;Itemid=2193&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0367.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000558</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Clinical sequence of hematological malignancy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">langerhans cell histiocytosis: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Arinobu Tojo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2247&amp;Itemid=2263&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0368.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000559</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p>Identification and functional analysis of novel causative genes of ICF syndrome by whole genome sequencing</p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/11/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ICF syndrome: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Motoko Unoki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2198&amp;Itemid=2205&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0369.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000562</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A study of resistance to novel coronavirus infection in health care workers</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">139 healthy persons</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atsushi Kawaguchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2288&amp;Itemid=2297&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0371.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000574</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research on genes and proteins associated with liver disease.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Metagenome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NASH: 20 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ryosuke Tateishi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2242&amp;Itemid=2259&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0372.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000572</span></p>\r\n<p><span style=\"font-size: small;\">MTBKS213</span></p>\r\n<p><span style=\"font-size: small;\">MTBKS214</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of disease state by multi-layered omics analysis</span></p>\r\n<p>&nbsp;</p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/11/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Metabolome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">(Agilent CE system, Agilent LC System)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">type2 diabetes: 300 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshimasa Yamauchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3070&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0375.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000688</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">identification of disease responsible genome region and establishment of genome information technology by next generation DNA sequencer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">tuberous sclerosis complex: 163 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Mari Wataya-Kaneda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2382&amp;Itemid=2379&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0376.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000585</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Establishment of xenografts and cultured cell lines from clinical samples.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/03/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">endometrial cancer: 2 + 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshio Imai</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2262&amp;Itemid=2275&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0377.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000579</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research on the genetic basis of arrhythmia syndrome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Amplicon-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">LQTS: 556 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshihiro Tanaka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2870&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0378.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000583</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000612</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Basic research to elucidate the pathogenesis of hemolytic anemia</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/09/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cold agglutinin disease: 2 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Daisuke Koyama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2643&amp;Itemid=2582&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0379.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000578</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Immune regulation by cotrolling regulatory T cell-specific epigenome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, scVDJ-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">myasthenia gravis: 2 cases</span></p>\r\n<p><span style=\"font-size: small;\">multiple sclerosis: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">systemic lupus erythematosus: 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">3 healthy cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shimon Sakaguchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2319&amp;Itemid=2326&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0381.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000588</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A biomarker study of a multicenter Phase II Trial of Nivolumab for Unresectable or Recurrent Thymic Carcinoma (NCCH1505)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/01/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">thymic carcinoma: 2 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidehito Horinouchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2343&amp;Itemid=2347&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0382.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000587</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of genetic and epigenetic abnormalities in hematopoietic diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/01/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">AML with FUS-ERG: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masahiro Kawahara</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2377&amp;Itemid=2375&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0383.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000602</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of the effect of abatacept for the transcriptome of multiple lymphoid subsets</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/03/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Rheumatoid arthritis: 5 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Keishi Fujio</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3126&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0384.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000603</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000718</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Deciphering molecular mechanisms underlying hematological malignancies and development of novel therapeutic approaches</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/06/19</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/07/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, Target Capture, ATAC-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/2500, MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">AML: 4 + 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">MDS: 30 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">normal cell: 6 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atsushi Iwama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2660&amp;Itemid=2596&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0385.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000597</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000599</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genetic analysis of Combined hepatocellular-cholangiocarcinoma, Cholangiolocarcinoma, Keratin 19-expressing hepatocellular carcinoma, and SOX9-expressing hepatocellular carcinoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/12/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/01/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cholangiolocarcinoma: 8 cases</span></p>\r\n<p><span style=\"font-size: small;\">Combined hepatocellular-cholangiocarcinoma: 13 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takamichi Ishii</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2412&amp;Itemid=2403&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0386.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA015813</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Localized assembly for long reads enables genome-wide analysis of repetitive regions at single-base resolution in human genomes</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/04/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(MinION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HapMap: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akihiro Fujimoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2397&amp;Itemid=2391&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0389.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000605</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis of fetal developmental abnormalities</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/04/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Capture Methyl-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">4 healthy women</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazuhiko Nakabayashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2511&amp;Itemid=2478&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0390.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000621</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of genetic factors associated with chronic endometritis (CE) through genomic and epigenomic analyses, and investigation on novel diagnostic and therapeutic methods for CE</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X Ten)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">chronic endometritis: 24 cases</span></p>\r\n<p><span style=\"font-size: small;\">33 controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Keiji Kuroda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2882&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0391.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000606</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Establishment of a human tongue cancer organoid biobank</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, scATAC-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tongue cancer: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Taku Sato</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2860&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0393.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000693</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">To explore new biomarkers or therapeutic target molecules using samples with patients with autoimmune diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">treatment-naïve rheumatoid arthritis: 6 cases</span></p>\r\n<p><span style=\"font-size: small;\">6 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroto Tsuboi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3138&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0394.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000613</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000757</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Multi‐institutional joint research of spatial transcriptome analysis for non-small cell lung cancers</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/11/20</span></p>\r\n<p><span style=\"font-size: small;\">v3:2025/07/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Visium Spatial Gene Expression, WGS, t-nanoEM)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n<p><span style=\"font-size: small;\">Multiplex Fluorescence Immunostaining</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Xenium Analyzer)</span></p>\r\n<p><span style=\"font-size: small;\">Akoya Biosciences</span></p>\r\n<p><span style=\"font-size: small;\">(PhenoCycler)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">8 non-small cell lung cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ayako Suzuki</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2667&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0395.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000678</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive survey for the construction of an integrated database of food, gut microbiome, and health information (the \"Sukoyaka Health Survey\"): Hokkaido Information University</span></p>\r\n<p><span style=\"font-size: small;\">An epidemiological study examining the relationship among food, health, and genome: Hokkaido Information University</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Attributes, Blood and Urine Test</span></p>\r\n<p><span style=\"font-size: small;\">Body measurement</span></p>\r\n<p><span style=\"font-size: small;\">Questionnaire, Interview</span></p>\r\n<p><span style=\"font-size: small;\">Sleep diary, Heart rate/brain wave during sleep</span></p>\r\n<p><span style=\"font-size: small;\">Microbiome composition</span></p>\r\n<p><span style=\"font-size: small;\">Nutrient intake, Food frequency questionnaire</span></p>\r\n<p><span style=\"font-size: small;\">Metabolomics</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Japonica Array v2)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">963 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Jun Nishihira</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2671&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0396.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000679</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive survey for the construction of an integrated database of food, gut microbiome, and health information (the \"Sukoyaka Health Survey\"): University of Miyazaki</span></p>\r\n<p><span style=\"font-size: small;\">An epidemiological study examining the relationship among food, health, and genome: University of Miyazaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Attributes, Blood and Urine Test</span></p>\r\n<p><span style=\"font-size: small;\">Body measurement</span></p>\r\n<p><span style=\"font-size: small;\">Questionnaire, Interview</span></p>\r\n<p><span style=\"font-size: small;\">Sleep diary, Heart rate/brain wave during sleep</span></p>\r\n<p><span style=\"font-size: small;\">Microbiome composition</span></p>\r\n<p><span style=\"font-size: small;\">Nutrient intake, Food frequency questionnaire</span></p>\r\n<p><span style=\"font-size: small;\">Metabolomics</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Japonica Array v2)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">50 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Manabu Yoshimura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2675&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0397.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000680</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive survey for the construction of an integrated database of food, gut microbiome, and health information (the \"Sukoyaka Health Survey\"): Kyoto University</span></p>\r\n<p><span style=\"font-size: small;\">An epidemiological study examining the relationship among food, health, and genome: Kyoto University</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Attributes, Blood and Urine Test</span></p>\r\n<p><span style=\"font-size: small;\">Body measurement</span></p>\r\n<p><span style=\"font-size: small;\">Questionnaire, Interview</span></p>\r\n<p><span style=\"font-size: small;\">Sleep diary, Heart rate/brain wave during sleep</span></p>\r\n<p><span style=\"font-size: small;\">Microbiome composition</span></p>\r\n<p><span style=\"font-size: small;\">Nutrient intake, Food frequency questionnaire</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Japonica Array v2)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">50 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nobuya Inagaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2679&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0398.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000681</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive survey for the construction of an integrated database of food, gut microbiome, and health information (the \"Sukoyaka Health Survey\"): University of Nagasaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Attributes, Blood and Urine Test</span></p>\r\n<p><span style=\"font-size: small;\">Body measurement</span></p>\r\n<p><span style=\"font-size: small;\">Questionnaire, Interview</span></p>\r\n<p><span style=\"font-size: small;\">Sleep diary, Heart rate/brain wave during sleep</span></p>\r\n<p><span style=\"font-size: small;\">Microbiome composition</span></p>\r\n<p><span style=\"font-size: small;\">Nutrient intake, Food frequency questionnaire</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">-</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">59 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazunari Tanaka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2773&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0399.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000616</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exploratory studies of molecular biological mechanisms related to the breast cancer microenvironment</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/06/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">breast cancer: 2 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinpei Kawaoka</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2500&amp;Itemid=2469&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0401.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000618</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of cell lines and mouse models of bone and soft tissue sarcoma to establish novel treatment</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">giant cell tumor of bone: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toru Wakamatsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2709&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0402.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA016537</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-622</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of the mechanisms that give rise to driver mutations in colorectal carcinogenesis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">colorectal cancer: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koshi Mimori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2551&amp;Itemid=2510&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0403.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000622</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Investigation of the utility of liquid biopsy in urologic cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Metastatic urothelial carcinoma: 16 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazuki Hamada</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3146&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0405.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000623</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000631</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research on the identification of cancer stem cells for peidatric and adult malignancies</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/12/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/07/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, small RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X, NextSeq 550)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400RS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Pediatric B-cell precursor acute lymphocytic leukemia: 69 cases</span></p>\r\n<p><span style=\"font-size: small;\">Pediatric acute myeloid leukemia: 9 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Junko Takita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2579&amp;Itemid=2532&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0406.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000617</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-623</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">The Generation of Human Disease-Specific iPS Cells and the Use of Such iPS Cells for Disease Analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/08/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Familial interstitial pneumonia with SFTPC variant: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shimpei Gotoh</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2490&amp;Itemid=2461&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0409.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000619</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of genes that confer exceptional response in anticancer therapy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 550, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Intimal sarcoma with MDM2 amplification: 11 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takafumi Koyama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2531&amp;Itemid=2494&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0411.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000625</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Investigation of molecular diagnosis by molecular biological analysis using next-generation sequencer for actionable endocrine diseases (including neoplastic diseases)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">FBPase deficiency: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">3 family members</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tomoaki Tanaka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3012&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0413.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000628</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000780</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive analysis on medical and omics data from patients with atopic dermatitis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/03/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atopic dermatitis: 161 + 41 cases</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 10pt;\">Psoriasis: 18 cases</span></p>\r\n<p><span style=\"font-size: small;\">41 + 10 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Haruhiko Koseki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2546&amp;Itemid=2506&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0414.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA016800</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of molecular mechanisms of lung cancer development and progression based on genome analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SAEC and its derived cell lines: 5 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Bunsyo Shiotani</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3090&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0416.v5</span></a></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-635</span></p>\r\n<p><span style=\"font-size: small;\">DRA019233</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-867</span></p>\r\n<p><span style=\"font-size: small;\">DRA019274</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-872</span></p>\r\n<p><span style=\"font-size: small;\">DRA020399</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1051</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1057</span></p>\r\n<p><span style=\"font-size: small;\">DRA020399</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1076</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of biological responses in intractable immune disorders and cancer and development of novel therapies through sequential multilevel omics analysis.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/08/10</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/09/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/10/16</span></p>\r\n<p><span style=\"font-size: small;\">v4:2025/05/19</span></p>\r\n<p><span style=\"font-size: small;\">v5:2025/06/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(CITE-seq, BD Ab-seq, scRNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">single-cell spatial transcriptome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">Vizgen</span></p>\r\n<p><span style=\"font-size: small;\">(MERSCOPE)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">microscopic polyangiitis: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">systemic sclerosis: 21 cases</span></p>\r\n<p><span style=\"font-size: small;\">Sjögren's Syndrome: 12 cases</span></p>\r\n<p><span style=\"font-size: small;\">Behçet's Syndrome: 11 cases</span></p>\r\n<p><span style=\"font-size: small;\">10 healthy donors</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takehisa Kitazawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2992&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0418.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000662</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Trial of Onco-Panel for Geneprofiling to Estimate both Adverse events and Response by cancer treatment (TOP-GEAR)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/02/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq, NextSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cancer patient who will receive chemotherapy: 507 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Kohno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3008&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0419.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000641</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000653</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000664</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000749</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Application of organoid culture system of human gastrointestinal and thoracic cancer in genome medicine</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/24</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/05/08</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/06/17</span></p>\r\n<p><span style=\"font-size: small;\">v4:2025/03/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">pulmonary large cell neuroendocrine carcinoma: 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">mucus-producing solid-dominant adenocarcinoma of lung: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">pulmonary adenocarcinoma harboring EML4-ALK variant 3: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">esophageal cancer: 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takuya Fukazawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2972&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0423.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000636</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive elucidation of inflammatory muscle diseases by multi-omics analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/10/23</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/12/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, snRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">sarcoid myopathy: 22 + 1 cases</span></p>\r\n<p><span style=\"font-size: small;\">muscular disease: 400 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Aritoshi Iida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2840&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0426.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000654</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Diagnosis and Research on Familial, Young-onset and Hereditary Cancers</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(GridION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> hereditary cancer syndromes: 33cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yuichi Shiraishi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2626&amp;Itemid=2571&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0427.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000645</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Establishment of cell lines derived from head and neck malignancies</span></p>\r\n<p><span style=\"font-size: small;\">Comprehensive genetic analysis and database construction for head and neck malignancies</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/11/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">external auditory canal squamous cell carcinoma: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2637&amp;Itemid=2577&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0429.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000643</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">CRISPR screening identifies mechanisms of resistance to KRASG12C and SHP2 inhibitor combinations in non-small cell lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/11/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">tumor tissue collected from LU99 tumor-bearing mice: total 16 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Saskia Brachmann</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2686&amp;Itemid=2616&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0431.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000651</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis aimed at elucidating the pathophysiology, vulnerability to onset, treatment responsiveness of neuropsychiatric disorders, and developing new treatments and diagnostic and preventive methods</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/01/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">human iPS cells introduced single variants identified in patients with ASD: 5 samples</span></p>\r\n<p><span style=\"font-size: small;\">control human iPS cells: 4 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atsushi Takata</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2878&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0433.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000659</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000660</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000667</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-665</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-667</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Derivation of human trophoblast stem cells and analysis of those characteristics</span></p>\r\n<p><span style=\"font-size: small;\">Derivation of human trophoblast stem cells and those epigenomic landscape</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, ChIP-seq, Hi-C, small RNA-seq, CUT&amp;TAG-seq, Methyl-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">placenta after artificial abortion: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">discarded blastocyst: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">hypertensive disorders of pregnancy: 14 cases</span></p>\r\n<p><span style=\"font-size: small;\">normal pregnancy: 12 subjects</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Eri H Kobayashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3020&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0434.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000658</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000709</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analyses in patients with T or NK cells-associated disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Torrent S5, Ion GeneStudio S5）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">pure red cell aplasia: 53 cases</span></p>\r\n<p><span style=\"font-size: small;\">aplastic anemia: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">2 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">large granular lymphocytic leukemia: 55 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fumihiro Ishida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2710&amp;Itemid=2632&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0435.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000665</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Investigation of a method for generating cells for regenerative medicine using comprehensive nucleic acid analysis of iPS cell-derived cardiomyocytes</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/03/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 3000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cardiomyocytes differentiated from human iPS cells established from healthy donor cells: 1 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shigeru Miyagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2705&amp;Itemid=2628&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0436.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000668</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic polymorphism and gene transcriptome study on the etiology of autism</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/02/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Autistic disorder: 16 cases</span></p>\r\n<p><span style=\"font-size: small;\">17 Controls</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tetsuya Marui</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2730&amp;Itemid=2648&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0437.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000671</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis of novel biomarkers and molecular targets for malignant brain tumors and their clinical application through multicenter collaborative research</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/03/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">glioma: 124 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinji Kohsaka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2715&amp;Itemid=2636&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0439.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA017996</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Investigation of the relationship between the genes involved in dyslipidemia and the pathogenesis of the disease</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/02/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(MinION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Familial hypercholesterolemia: 5 cases</span></p>\r\n<p><span style=\"font-size: small;\">1 Control</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koh Ono</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2737&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0440.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000672</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-747</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of proteins associated with the clinical course of refractory neuromuscular diseases using nerve and muscle tissue</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/05/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400RS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thymoma: 7 cases</span></p>\r\n<p><span style=\"font-size: small;\">Thymic hyperplasia: 2 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tatsusada Okuno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2844&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0442.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000675</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-883</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exploratory study for stratification marker of immune checkpoint inhibitor in patients with advanced or recurrent non-small cell lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/12/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">non-small cell lung cancer: 20 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tetsuro Sasada</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2733&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0443.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA017833</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-674</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Relationship between changes in the T-cell receptor repertoire of regulatory T cells before and after pregnancy and pregnancy outcome.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/05/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target RNA-seq, TCR-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Healthy pregnancy: 7 subjects</span></p>\r\n<p><span style=\"font-size: small;\">Preeclampsia: 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akitoshi Nakashima</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2705&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0444.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000684</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research to elucidate pathological conditions of skin diseases caused by genetic alterations by multi-omics analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, Long-read WGS, Amplicon-seq, RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">SNP array</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-T7)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, MiSeq, Infinium Asian Screening Array, Infinium MethylationEPIC)</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">(Sequel II)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">8 porokeratosis patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akiharu Kubo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3060&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0445.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000756</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research to elucidate pathological conditions of skin diseases caused by genetic alterations by multi-omics analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, Genome Analyzer IIx)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">362 lung adenocarcinoma patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Kohno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2960&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0454.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000697</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Etiological and therapeutic response analysis of inflammatory bowel disease focusing on immune abnormalities</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/12/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Xenium Analyzer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Crohn's disease: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">ulcerative colitis: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">cytomegalovirus enteritis: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">cancer: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Makoto Kodama</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3167&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0455.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000732</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000733</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Explore genetic abnormalities, molecular targets, predictive of drug sensitivity, histomorphology, and biomarkers in lung cancer<br />Analysis of genetic abnormalities and their biological significance in lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Novaseq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Xenium)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">pulmonary neuroendocrine carcinoma: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Daisuke Matsubara</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2820&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0456.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000722</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Molecular Pathological exprolation of Tumor Formation and Functional Differentiation Using Parasellar Skull Base Tumors and Malignant Glioma Tissues</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">craniopharyngioma: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tatsuma Matsuda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2980&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0460.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000714</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Pilot study towards the development of a Companion/Complimentary Diagnosis platform using liquid biopsy with cfDNA for immune checkpoint inhibitor therapy in advanced urothelial cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/01/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, HiSeq X)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">advanced urothelial carcinoma: 82 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Kobayashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2940&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0461.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000712</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of the cancer immune response following radiation therapy for esophageal squamous cell carcinoma and colorectal cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/05/31</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/11/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n<p><span style=\"font-size: small;\">Multiplex Fluorescence Immunostaining</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 3000, NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">Akoya Biosciences</span></p>\r\n<p><span style=\"font-size: small;\">(CODEX)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">esophageal squamous cell carcinoma: 7 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shun-Ichiro Kageyama</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3118&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0464.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000723</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">In Vitro Amplification of Human Hematopoietic Tumor Cells and Construction of Mouse Models for Reproduction of Pathological Conditions</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/06/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, scRNA-seq, scBCR-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000, NextSeq 2000/500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">multiple myeloma: 21 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">normal bone marrow: 3 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atsushi Iwama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2836&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0465.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000721</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Establishment and genomic analysis of mixed phenotypic acute leukemia cell lines</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">mixed phenotype acute leukemiae: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroto Ishii</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2936&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0466.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Japan Prospective Studies for Aging and Dementia (JPSC-AD) study</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese Screening Array)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">9,479 participants in the JPSC-AD study</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshiharu Ninomiya</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2890&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0467.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic background of the development of pelvic organ prolapse</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/10/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Asian Screening Array, Infinium OmniExpress, HumanExome, Infinium OmniExpressExome v1.0, Infinium OmniExpressExome v1.2)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">female participants with a medical history of POP: 771 cases</span></p>\r\n<p><span style=\"font-size: small;\">76,625 control individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shiro Maeda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3163&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0468.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000727</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000774</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of immune and inflammatory pathology </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, bulk RNA-seq, scASAP-seq, CITE-seq, VDJ-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, NextSeq 500/550)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Xenium v1)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">23 rheumatoid arthritis</span></p>\r\n<p><span style=\"font-size: small;\">4 healty controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Yoshitomi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2848&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0469.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000721</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Investigation of immune response to cytomegalovirus during pregnancy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Pregnant women undergoing early pregnancy screening: 10 individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Mari Ichinose</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3134&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0470.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000725</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Prognostic Investigation and Genomic Profiling of Urothelial Carcinoma Treated with Immunotherapy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/07/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, WGS, scRNA-seq, Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X Ten, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Urothelial carcinoma: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nobuyuki Tanaka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2856&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0472.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000726</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Non-clinical research for the development of neuronal cells from human iPS cell derived cerebral cortical organoid</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Organoids derived from iPS cells of a single healthy individual: 9 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Jun Takahashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3114&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0473.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000724</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of the pathogenesis of hematopoietic neoplasms via genetic analysis</span></p>\r\n<p><span style=\"font-size: small;\">Molecular expression analysis of bone marrow cells from hematopoietic stem cell transplant donors as a normal control</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Myelodysplastic syndromes: 57 cases</span></p>\r\n<p><span style=\"font-size: small;\">5 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yuka Harada</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2852&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0474.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000731</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of genes associated with autistic spectrum disorder, schizophrenia, and bipolar disorder</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(iSeq 100)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">32 children with ASD</span></p>\r\n<p><span style=\"font-size: small;\">8 children with low birth weight</span></p>\r\n<p><span style=\"font-size: small;\">3 children with sub-threshold ASD</span></p>\r\n<p><span style=\"font-size: small;\">36 typically developing children</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shigeru Yokoyama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3102&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0476.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000736</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Observational studies using advanced analytical techniques to understand the biological functions of kidney component cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/01/07</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/06/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">32 renal cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shokichi Naito</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3074&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0477.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000740</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tumor tissue culture and its characterization in gastrointestinal cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/10/16</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/06/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 1000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Organoids from a colorectal cancer patient: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">Caco-2 cell: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nobuo Sasaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3024&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0479.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000779</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Biomarker Research for Anti EGFR Monoclonal Antibodies by Comprehensive Cancer Genomics</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Hiseq 1500/2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unresectable and advanced recurrent colorectal cancer: 242 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Katsuya Tsuchihara</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2944&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0481.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000755</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome analysis of common diseases among older Japanese adults and development of clinical genome information storage</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/11/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Alzheimer's disease: 424 cases</span></p>\r\n<p><span style=\"font-size: small;\">Mild cognitive impairment Alzheimer's disease: 543 cases</span></p>\r\n<p><span style=\"font-size: small;\">Mild cognitive impairment: 260 individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Daichi Shigemizu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3094&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0483.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000764</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Request for cooperation regarding collection and distribution of human specimens and research using clinical information</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Hiseq X Ten, NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ovarian clear cell carcinoma: 11 cases</span></p>\r\n<p><span style=\"font-size: small;\">High-grade serous carcinoma: 7 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tatsuyuki Chiyoda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2996&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0484.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000775</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Banking of induced pluripotent stem cell lines (iPS cell lines) established from human somatic cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">33 ALSs</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yukio Nakamura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3032&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0485.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000754</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome sequencing analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">65 gastric cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2956&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0486.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000765</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Bile duct development and its failure mechanisms using biliary atresia and Alagille syndrome-specific iPS cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/11/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq X Plus 25B)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">5 patients with biliary atresia</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yohei Hayashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2968&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0490.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000770</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">An investigation into the effects of progestin on follicular development and oocyte maturation during controlled ovarian stimulation using the Progestin-Primed Ovarian Stimulation (PPOS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/12/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">16 infertility patients with normal ovarian function</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Mika Handa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3130&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">HUM0491.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000805</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1086</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidating molecular mechanisms of allergy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/07/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, scRNA-TCR-seq, scATAC-RNA-seq, CITE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Chronic tonsillitis: 8 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hideki Ueno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3179&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0492.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000736</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exploratory research aimed at developing new drugs for difficult-to-treat immune-inflammatory diseases through industry-academia collaboration</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq/TCR/BCR repetoire, Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X)</span></p>\r\n<p><span style=\"font-size: small;\"> MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">28 Sjögren's syndrome</span></p>\r\n<p><span style=\"font-size: small;\">10 Sicca</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masaru Takeshita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3150&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0493.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000771</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Functional analysis of skin immunocompetent cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/07/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Xenium Analyzer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Healthy skin: 3 individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hanako Koguchi-Yoshioka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2984&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0495.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Precision medicine for preventing stroke in patients with atrial fibrillation</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/02/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1,176 PAF patients</span></p>\r\n<p><span style=\"font-size: small;\">1,172 non-PAF controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshihiro Tanaka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3000&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0496.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Okinawa Bioinformation Bank Project to establish a genome analysis research center in Okinawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/02/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Infinium Asian Screening Array, Infinium OmniExpress, HumanExome, Infinium OmniExpressExome v1.0, Infinium OmniExpressExome v1.2)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">OBi: 8,715 individuals</span></p>\r\n<p><span style=\"font-size: small;\">BBJ: 7,004 individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shiro Maeda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3175&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0497.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000777</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Isolation and characterization of trophoblast stem cells from human placenta</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">term placentas from three individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">three trophoblast stem cell lines</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masatsugu Ema</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3028&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0499.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000787</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research aimed at creating a biobank for bone and soft tissue tumors and elucidating the molecular pathology based on gene expression analysis, as well as improving prognosis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Sanger-seq</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Applied Biosystems</span></p>\r\n<p><span style=\"font-size: small;\">(3730xl DNA Analyzer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">6 sarcoma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nobuhiko Hasegawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3052&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0501.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000781</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">GenomeAsia 100K Project: Human DNA samples collecting and whole genome sequencing of Asian populations</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1,323 individuals of ~100 ethnic groups</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hie Lim Kim</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3082&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0502.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000803</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidating the development of cervical cancer and identifying therapeutic targets based on cancer genome analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">cervical cancer: 29 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kouya Shiraishi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3056&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0505.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exploratory study of genetic factors in allergic diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Infinium Asian Screening Array)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">564 individuals who participated in the genomic analysis study of the adult cohort study</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Emiko Noguchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3078&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0508.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000790</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of the pathogenesis of ocular diseases and exploration of therapeutic strategies using disease-specific iPS cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 congenital aniridia</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kohji Nishida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3159&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0512.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000818</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification and functional analysis of risk polymorphisms in autoimmune diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/07/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, ATAC-seq, scCITE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000/X Plus)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Chromium)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 healthy donors</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazuyoshi Ishigaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3195&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0514.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000814</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of skeletal muscle messenger RNA expression to elucidate pathophysiology of neuromuscular diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/09/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">11 myotonic dystrophy type 1 patients</span></p>\r\n<p><span style=\"font-size: small;\">9 control patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masanori P Takahashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3110&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0517.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000809</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Evaluation of novel therapies using primary cultured gynecological cancer cells and search for predictors of efficacy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Endometrial cancer: 30 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kosei Hasegawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3187&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0521.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000827</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1121</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of Molecular Mechanisms of Cancer Immunity</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, scBCR-seq, scTCR-seq, CITE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">uterine cancer: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">hereditary breast and ovarian cancer syndrome: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hideki Ueno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3122&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0522.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000720</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Immune regulation by cotrolling regulatory T cell-specific epigenome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, TCR-seq, CITE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 esophagogastric junction cancer</span></p>\r\n<p><span style=\"font-size: small;\">3 Ggastric cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takuro Saito</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3171&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0527.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000823</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic mutation profiling of lymphomas arising in the uterine cervix and vagina</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq X Plus)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Follicle center lymphoma of the lower female genital tract: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takumi Kitaoka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p><span style=\"font-size: small;\"># You can search the data in the DDBJ Sequence Read Archive (DRA), the European Sequence Read Archive (ERA), and the Sequence Read Archive (SRA) through the <a href=\"https://ddbj.nig.ac.jp/search\" target=\"_blank\" rel=\"noopener\">DDBJ Search</a> site. </span></p>\r\n<p><span style=\"font-size: small;\">* The study including processed data by JGA (e.g. alignment results [CRAM], variant call results per sample [gVCF], variant call results per dataset [aggregated VCF] processed in a certain workflow) <a href=\"index.php?option=com_content&amp;view=article&amp;id=2281&amp;Itemid=2290&amp;lang=en\" target=\"_blank\">Learn more</a></span></p>", "publish_up": "2015-03-30"}, {"lang": "ja", "path": "faq", "title": "FAQ", "fulltext": "", "modified": "2025-05-28", "introtext": "<p><span style=\"font-family: helvetica; font-size: 15pt;\"><strong>よくあるご質問（FAQ）</strong></span></p>\r\n<p>&nbsp;<span style=\"font-family: helvetica; font-size: 11pt;\">データ共有ついて、お問い合わせの多い質問と回答を掲載しております。</span></p>\r\n<p>&nbsp;</p>\r\n<p><a href=\"#faq-1\">１．NBDCヒトデータベースの目的と意義は？</a></p>\r\n<p><a href=\"#faq-2\">２．NBDCヒトデータベースで扱うデータの種類は？</a></p>\r\n<p><a href=\"#faq-3\">３．NBDCヒトデータベースに登録されているデータを利用できる者の範囲は？</a></p>\r\n<p><a href=\"#faq-4\">４．NBDCヒトデータベースの責任者は？</a></p>\r\n<p><a href=\"#faq-5\">５．個人情報の保護に関する法律、行政機関の保有する個人情報の保護に関する法律、ならびに、独立行政法人等の保有する個人情報の保護に関する法律（以下「個人情報保護法」という。）の2015年（平成27年）改正に伴ない、医学研究を実施する上で何が大きく変わったのか？</a></p>\r\n<p><a href=\"#faq-6\">６．NBDCヒトデータベースを通じて共有されるデータを用いた研究を実施する上で、何を参照すればよいのか？</a></p>\r\n<p><a href=\"#faq-7\">７．「個人情報としての取扱い」とは？</a></p>\r\n<p><a href=\"#faq-8\">８．【<strong><span style=\"color: #000000; text-decoration: underline;\">新規試料</span></strong>から産出したデータの登録】研究で個人識別符号や要配慮個人情報に該当する情報を用いる。また、将来、研究の成果を論文等で発表・使用データのデータベースへの登録を考えているが、研究対象者からどのような同意を受けておく必要があるのか？</a></p>\r\n<p><a href=\"#faq-9\">９．【<span style=\"text-decoration: underline;\"><strong><span style=\"color: #000000; text-decoration: underline;\">既存試料</span></strong></span>から産出した、<strong><span style=\"color: #000000; text-decoration: underline;\">特定の個人を識別できない匿名化データ</span></strong>の登録】データベースを介したデータ共有について同意を受けていない既存試料から産出されたデータをデータベースへ登録する際の手続きは？</a></p>\r\n<p><a href=\"#faq-10\">１０．【<span style=\"text-decoration: underline; color: #000000;\"><strong>既存試料</strong></span>から産出した<strong><span style=\"text-decoration: underline;\"><span style=\"color: #000000; text-decoration: underline;\">個人</span></span><span style=\"color: #000000; text-decoration: underline;\">識別符号に該当するゲノムデータを含むデータ</span></strong>の登録】データベースを介したデータ共有について同意を受けていない既存試料から産出されたデータをデータベースへ登録する際の手続きは？</a></p>\r\n<p><a href=\"#faq-11\">１１．2020年・2021年（令和2年・3年）改正個人情報保護法や改正倫理指針に伴ない、既にNBDCヒトデータベースへ登録したデータに対して、何か手続きが必要か？</a></p>\r\n<p><a href=\"#faq-12\">１２．NBDCヒトデータベースに登録されているデータの利用に関して、2015年（平成27年）改正個人情報保護法や改正倫理指針に伴う変更点は？</a></p>\r\n<p><a href=\"#faq-13\">１３．既存試料・情報とは？</a></p>\r\n<p><a href=\"#faq-14\">１４．匿名化と匿名加工情報は同じなのか？</a></p>\r\n<p><a href=\"#faq-15\">１５．匿名化時の対応表の適切な管理とは？</a></p>\r\n<p><a href=\"#faq-16\">１６．一般に入手可能な試料・情報の扱いは？</a></p>\r\n<p><a href=\"#faq-17\">１７．同意撤回について</a></p>\r\n<p><a href=\"#faq-18\">１８．開示請求について</a></p>\r\n<p><a href=\"#faq-19\">１９．インフォームドコンセントの説明文書にどのように記載すればよいのか？</a></p>\r\n<p><a href=\"#faq-20\">２０．登録したデータを、投稿論文の査読担当者（Reviewer）がアクセスすることは可能か？</a></p>\r\n<p><a href=\"#faq-21\">２１．「個人識別性・一次データ（NBDCを通じて共有される制限公開データ）復元性のない、あるいは非常に低い加工データ（NBDCヒトデータ共有ガイドライン５－３－３制限公開　４．）」とは？</a></p>\r\n<p><a href=\"#faq-22\">２２．制限公開データベース（Japanese Genotype-phenotype Archive：JGA）からダウンロードしたデータを復号化できない時はどうしたら良いのか？</a></p>\r\n<p><a href=\"#faq-23\">２３．NBDCヒトデータベースを通じて提供されたデータを含む解析結果を学術論文等で公表する際の謝辞や引用はどうすれば良いのか？</a></p>\r\n<p><a href=\"#faq-24\">２４．NBDCヒトデータベースを通じて入手したデータを「仮名加工情報」に含め、当初のデータ利用目的とは異なる研究に用いることは可能か？</a></p>\r\n<p><a href=\"#faq-25\">２５．外国における個人情報保護制度はどのようになっているか？</a></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-1\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>１．NBDCヒトデータベースの目的と意義は？</strong></span></a></h1>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　様々なプロジェクトから産出されたデータを多角的な視点で捉えることで、新たな知見を得られる可能性があります。特にヒト由来データの場合、病気の発症や進展に関与する因子を探索し、創薬等治療に向けた新たな知見につながる可能性や、少子高齢社会を乗り切るための健康長寿社会の実現に向けた取り組みにつながる効果的な要因の発見に繋がる可能性があります。また、そういった研究・解析を実施するための研究資金には限りがあるため、効率的にデータを産出し、それらのデータの散逸を防ぐことで最大限に活用する必要があります。しかし、これまで日本には公的資金を使用して実施された研究から産出された多くの貴重なヒトに関するデータを一元管理するデータベースは存在せず、プロジェクトの終了と共にデータが散逸してしまったケースが少なくありませんでした。一方、世界的に、研究の効率化や論文の検証のためのオープンサイエンス・オープンデータの声も高まってきています。そのような潮流の中、国内においても研究データを共有するための公的データベースの構築が必須となりました。一方で、ヒトに関するデータは付随情報によって個人が特定されてしまう可能性があります。そのため、そのような機微情報を扱うためのセキュリティ環境や体制を整える必要があります。基礎医学研究や臨床研究、ゲノムコホート研究など、ヒト由来試料を用いた研究から産出されるデータ（ヒトデータ）は、次世代シークエンサーをはじめとした解析技術の飛躍的な進歩に伴い、膨大かつ多様になってきています。それらのヒトデータを整理すると共にセキュアに保管し、<span style=\"text-decoration: underline;\"><strong>国内外、民間利用を問わず広く研究に活用し、生命科学の進展や公衆衛生の向上のために有効に活用</strong></span>していくためのシステムが必要です。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　ROIS-DS DBCLSでは、個人情報の保護や倫理的側面に配慮しつつ、ヒトの個人毎のデータ（個別データ）を様々な切り口から解析することで、上述の目的のためにデータを最大限に活用できるよう、ヒトデータを共有するためのプラットフォーム（以下、『NBDCヒトデータベース』）を運用しています。また、データベースの運用ルールとして、ガイドライン（NBDCヒトデータ共有ガイドライン及びNBDCヒトデータ取扱いセキュリティガイドライン）を策定しています。ガイドラインの改定にあたっては、ヒト由来試料を用いた研究を実施する上で準拠すべき『人を対象とする生命科学・医学系研究に関する倫理指針』を基礎とし、海外におけるデータ共有方針との整合性の観点から、米国国立衛生研究所（National Institute of Health: NIH）や欧州分子生物研究所(European Molecular Biology Laboratory- European Bioinformatics Institute: EMBL-EBI)、英国Wellcome Trust等で示されているデータ共有ポリシーを参照しています。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-2\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>２．NBDCヒトデータベースで扱うデータの種類は？</strong></span></a></h1>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　ヒト試料を用いた解析データ全般（塩基配列情報、変異データ、遺伝子発現アレイデータ、生化学検査値、臨床情報、質問票、心理検査、画像データ、音声データ、コホート研究から継続的に産出されるデータ等）を対象としております。データの詳細は、各研究の専用ページをご参照ください。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-3\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>３．NBDCヒトデータベースに登録されているデータを利用できる者の範囲は？</strong></span></a></h1>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　NBDCヒトデータベースには、データへのアクセスに制限を設けることなく誰でも利用することが可能な公開データ（非制限公開データ）と、ヒトデータ審査委員会による審査（利用者要件を満たすか、セキュリティ環境は整っているか等に関する審査）及び承認を受けた者のみが利用することが可能な公開データ（制限公開データ）の２種類があります。制限公開データの利用者情報（研究代表者氏名、所属機関、国・州名、研究題目、利用データのID、利用期間）は、各研究内容のページに掲載されます。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-4\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>４．NBDCヒトデータベースの責任者は？</strong></span></a></h1>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">情報・システム研究機構データサイエンス共同利用基盤施設（ROIS-DS）ライフサイエンス統合データベースセンター（DBCLS）五斗 進 です。お問い合わせにつきましては<a href=\"/contact-us\" target=\"_blank\" rel=\"noopener noreferrer\">こちら</a>からお願いします。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-5\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>５．個人情報の保護に関する法律、行政機関の保有する個人情報の保護に関する法律、ならびに、独立行政法人等の保有する個人情報の保護に関する法律</strong></span><strong style=\"font-size: 12pt; background-color: initial;\">（以下「個人情報保護法」という。）</strong><strong style=\"font-size: 12pt; background-color: initial;\">の2015年（平成27年）改正に伴ない、医学研究を実施する上で何が大きく変わったのか？</strong></a></h1>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　2015年改正の中でも医学研究を遂行する上で大きな影響を及ぼし得る改正点は、新たに個人情報の定義として設定された『<span style=\"text-decoration: underline;\"><strong>個人識別符号</strong></span>』に一部のゲノムデータが該当し、『<span style=\"text-decoration: underline;\"><strong>要配慮個人情報</strong></span>』に病歴や健康状態が判明する検査の結果、医療を提供する施設において診療の過程で患者の身体の状況・病状・治療状況等について医療従事者が知り得た情報全て、等が該当することになりました。そのため、個人識別符号に該当するゲノムデータを含む場合は、氏名、生年月日その他の特定の個人を識別することができる記述等の全部又は一部を削除したとしても個人情報に該当するため、個人情報としての取扱い（７．参照）が必要となります。併せて、以下の2点にも留意しなければなりません。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">１．個人識別符号に該当するゲノムデータに単一遺伝子疾患、疾患へのかかりやすさ、治療薬の選択に関するものなどの解釈を付加し、医学的意味合いを持った「ゲノム情報」が要配慮個人情報に該当する場合があること</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">２．氏名等の個人識別子から切り離したDNA検体であっても、解析により個人識別符号に該当するゲノムデータを取得した段階で『個人識別符号』に該当するため、ゲノムデータを含む情報は個人情報としての取り扱いが必須となること</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">なお、差別・偏見につながりうる情報が氏名や住所等の個人識別子や、個人識別符号と紐付いた際に要配慮個人情報となります。</span></p>\r\n<div style=\"border-style: solid; border-width: 1px; margin-top: 11px; padding-left: 5px; padding-right: 5px;\">\r\n<h3><strong><span style=\"font-family: helvetica;\">個人識別符号</span></strong></h3>\r\n<h5><strong><span style=\"font-family: helvetica; font-size: 11pt; color: #000000;\">＜個人情報保護法 第二条 第二項＞</span></strong></h5>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　この法律において「個人識別符号」とは、次の各号のいずれかに該当する文字、番号、記号その他の符号のうち、<span style=\"text-decoration: underline;\"><strong>政令で定めるもの</strong></span>をいう。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">（一）　特定の個人の身体の一部の特徴を電子計算機の用に供するために変換した文字、番号、記号その他の符号であって、当該特定の個人を識別することができるもの（例：指紋データ及び顔認識データ）</span></p>\r\n<p>&nbsp;</p>\r\n<h5><strong><span style=\"font-family: helvetica; font-size: 11pt; color: #000000;\">＜個人情報の保護に関する法律施行令 第一条 第一号＞</span></strong></h5>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　次に掲げる身体の特徴のいずれかを電子計算機の用に供するために変換した文字、番号、記号その他の符号であって、特定の個人を識別するに足りるものとして<span style=\"text-decoration: underline;\"><strong>個人情報保護委員会規則で定める基準に適合するもの</strong> </span>　</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">イ　細胞から採取されたデオキシリボ核酸（別名ＤＮＡ）を構成する塩基の配列</span></p>\r\n<p>&nbsp;</p>\r\n<h5><strong><span style=\"font-family: helvetica; font-size: 11pt; color: #000000;\">＜個人情報の保護に関する法律施行規則 第二条＞</span></strong></h5>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　身体の特徴を電子計算機の用に供するために変換した符号のうち個人識別符号に該当するものの基準は、特定の個人を識別することができる水準が確保されるよう、適切な範囲を適切な手法により電子計算機の用に供するために変換することとする。</span></p>\r\n<p>&nbsp;</p>\r\n<h5><strong><span style=\"font-family: helvetica; font-size: 11pt; color: #000000;\">＜個人情報の保護に関する法律についてのガイドライン（通則編）＞</span></strong></h5>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　規則第 2 条において定められているところ、この基準に適合し、個人識別符号に該当することとなるものは次のとおりである。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">イ　細胞から採取されたデオキシリボ核酸（別名 DNA）を構成する塩基の配列</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　ゲノムデータ（細胞から採取されたデオキシリボ核酸（別名 DNA）を構成する塩基 の配列を文字列で表記したもの）のうち、全核ゲノムシークエンスデータ、全エクソームシークエンスデータ、全ゲノム一塩基多型（single nucleotide polymorphism： SNP）データ、互いに独立な４０箇所以上の SNP から構成されるシークエンスデータ、９座位以上の４塩基単位の繰り返し配列（short tandem repeat：STR）等の遺伝型情報により本人を認証することができるようにしたもの</span></p>\r\n<p>&nbsp;</p>\r\n<h3><strong><span style=\"font-family: helvetica;\">要配慮個人情報</span></strong></h3>\r\n<h5><strong><span style=\"font-family: helvetica; font-size: 11pt; color: #000000;\">＜個人情報保護法 第二条 第三項＞</span></strong></h5>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　この法律において「要配慮個人情報」とは、本人の人種、信条、社会的身分、病歴、犯罪の経歴、犯罪により害を被った事実その他本人に対する不当な差別、偏見その他の不利益が生じないようにその取扱いに特に配慮を要するものとして<span style=\"text-decoration: underline;\"><strong>政令で定める記述等が含まれる個人情報</strong></span>をいう。</span></p>\r\n<p>&nbsp;</p>\r\n<h5><strong><span style=\"font-family: helvetica; font-size: 11pt; color: #000000;\">＜個人情報の保護に関する法律施行令 第二条＞</span></strong></h5>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　法第 2 条第 3 項の政令で定める記述等は、次に掲げる事項のいずれかを内容とする記述等（本人の病歴又は犯罪の経歴に該当するものを除く。）とする。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">一　身体障害、知的障害、精神障害（発達障害を含む。）その他の<span style=\"text-decoration: underline;\"><strong>個人情報保護委員会規則で定める</strong></span>心身の機能の障害があること。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">二　本人に対して医師その他医療に関連する職務に従事する者（次号において 「医師等」という。）により行われた疾病の予防及び早期発見のための健康診断その他の検査（同号において「健康診断等」という。）の結果 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">三　健康診断等の結果に基づき、又は疾病、負傷その他の心身の変化を理由として、本人に対して医師等により心身の状態の改善のための指導又は診療若しくは調剤が行われたこと。</span></p>\r\n<p>&nbsp;</p>\r\n<h5><strong><span style=\"font-family: helvetica; font-size: 11pt; color: #000000;\">＜個人情報の保護に関する法律施行規則 第五条＞</span></strong></h5>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　令第 2 条第 1 号の個人情報保護委員会規則で定める心身の機能の障害は、次に掲げる障害とする。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">（１）　身体障害者福祉法（昭和 24 年法律第 283 号）別表に掲げる身体上の障害 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">（２）　知的障害者福祉法（昭和 35 年法律第 37 号）にいう知的障害 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">（３）　精神保健及び精神障害者福祉に関する法律（昭和 25 年法律第 123 号）にいう精神障害（発達障害者支援法（平成 16 年法律第 167 号）第 2 条第 2 項に規定する発達障害を含み、前号に掲げるものを除く。） </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">（４）　治療方法が確立していない疾病その他の特殊の疾病であって障害者の日常生活 及び社会生活を総合的に支援するための法律（平成 17 年法律第 123 号）第 4 条第 1 項の政令で定めるものによる障害の程度が同項の厚生労働大臣が定める程度であるもの</span></p>\r\n<p>&nbsp;</p>\r\n<h5><strong><span style=\"font-family: helvetica; font-size: 11pt; color: #000000;\">＜個人情報の保護に関する法律についてのガイドライン（通則編）＞</span></strong></h5>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　「要配慮個人情報」とは、不当な差別や偏見その他の不利益が生じないようにその取扱い に特に配慮を要するものとして次の（1）から（11）までの記述等が含まれる個人情報をいう。<span style=\"text-decoration: underline;\"><strong> 要配慮個人情報の取得や第三者提供には、</strong><strong>原則として本人の同意</strong></span>が必要であり、法第 23 条第 2 項の規定による第三者提供（オプトアウトによる第三者提供）は認められていないの で、注意が必要である（3-2-2（要配慮個人情報の取得）、3-4-1（第三者提供の制限の原則）、 3-4-2（オプトアウトによる第三者提供）参照）。 なお、次に掲げる情報を推知させる情報にすぎないもの（例：宗教に関する書籍の購買や 貸出しに係る情報等）は、要配慮個人情報には含まない。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">（１）人種</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　人種、世系又は民族的若しくは種族的出身を広く意味する。なお、単純な国籍や「外国人」という情報は法的地位であり、それだけでは人種には含まない。また、肌の色 は、人種を推知させる情報にすぎないため、人種には含まない。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">（４）病歴　</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　病気に罹患した経歴を意味するもので、特定の病歴を示した部分（<strong>例：特定の個人 ががんに罹患している、統合失調症を患っている等</strong>）が該当する。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">（７）身体障害、知的障害、精神障害（発達障害を含む。）その他の個人情報保護委員会規則で定める心身の機能の障害があること（政令第 2 条第 1 号関係） </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　次の①から④までに掲げる情報をいう。この他、当該障害があること又は過去にあ ったことを特定させる情報（例：障害者の日常生活及び社会生活を総合的に支援する ための法律（平成 17 年法律第 123 号）に基づく障害福祉サービスを受けていること又は過去に受けていたこと）も該当する。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">①「身体障害者福祉法（昭和 24 年法律第 283 号）別表に掲げる身体上の障害」があることを特定させる情報 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">②「知的障害者福祉法（昭和 35 年法律第 37 号）にいう知的障害」があることを特定させる情報</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">③「精神保健及び精神障害者福祉に関する法律（昭和 25 年法律第 123 号）にいう精神障害（発達障害者支援法（平成 16 年法律第 167 号）第 2 条第 2 項に規定する発達障害を含み、知的障害者福祉法にいう知的障害を除く。）」があることを特定させる情報</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">④「治療方法が確立していない疾病その他の特殊の疾病であって障害者の日常生活及び社会生活を総合的に支援するための法律第 4 条第 1 項の政令で定めるも のによる障害の程度が同項の厚生労働大臣が定める程度であるもの」があることを特定させる情報</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">（８）本人に対して医師その他医療に関連する職務に従事する者（次号において「医師等」 という。）により行われた疾病の予防及び早期発見のための健康診断その他の検査 （同号において「健康診断等」という。）の結果（政令第 2 条第 2 号関係）（※） </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　疾病の予防や早期発見を目的として行われた健康診査、健康診断、特定健康診査、 健康測定、ストレスチェック、遺伝子検査（診療の過程で行われたものを除く。）等、 受診者本人の健康状態が判明する検査の結果が該当する。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　また、法律に定められた健康診査の結果等に限定されるものではなく、人間ドックなど保険者や事業主が任意で実施又は助成する検査の結果も 該当する。さらに、医療機関を介さないで行われた遺伝子検査により得られた本人の遺伝型とその遺伝型の疾患へのかかりやすさに該当する結果等も含まれる。（一部抜粋）</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">（９）健康診断等の結果に基づき、又は疾病、負傷その他の心身の変化を理由として、本 人に対して医師等により心身の状態の改善のための指導又は診療若しくは調剤が行 われたこと（政令第 2 条第 3 号関係）（※） </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　「健康診断等の結果に基づき、本人に対して医師等により心身の状態の改善のための指導が行われたこと」とは、健康診断等の結果、特に健康の保持に努める必要がある者に対し、医師又は保健師が行う保健指導等の内容が該当する。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　「健康診断等の結果に基づき、又は疾病、負傷その他の心身の変化を理由として、 本人に対して医師等により診療が行われたこと」とは、病院、診療所、その他の医療 を提供する施設において診療の過程で、患者の身体の状況、病状、治療状況等につい て、医師、歯科医師、薬剤師、看護師その他の医療従事者が知り得た情報全てを指し、 例えば診療記録等がこれに該当する。また、病院等を受診したという事実も該当する。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\"> 　「健康診断等の結果に基づき、又は疾病、負傷その他の心身の変化を理由として、 本人に対して医師等により調剤が行われたこと」とは、病院、診療所、薬局、その他の医療を提供する施設において調剤の過程で患者の身体の状況、病状、治療状況等に ついて、薬剤師（医師又は歯科医師が自己の処方箋により自ら調剤する場合を含む。） が知り得た情報全てを指し、調剤録、薬剤服用歴、お薬手帳に記載された情報等が該当する。また、薬局等で調剤を受けたという事実も該当する。（一部抜粋）</span></p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　（※）遺伝子検査により判明する情報の中には、差別、偏見につながり得るもの（例： 将来発症し得る可能性のある病気、治療薬の選択に関する情報等）が含まれ得るが、当該情報は、「本人に対して医師その他医療に関連する職務に従事する者により行われた疾病の予防及び早期発見のための健康診断その他の検査の結果」 （政令第 2 条第 2 号関係）又は「健康診断等の結果に基づき、又は疾病、負傷そ の他の心身の変化を理由として、本人に対して医師等により心身の状態の改善のための指導又は診療若しくは調剤が行われたこと」（政令第 2 条第 3 号関係） に該当し得る。</span></p>\r\n</div>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">上記条文は一部抜粋したものです。条文の全文やその他詳細は個人情報保護委員会ホームページをご参照ください。<a href=\"https://www.ppc.go.jp/personalinfo/legal/\" target=\"_blank\" rel=\"noopener noreferrer\">https://www.ppc.go.jp/personalinfo/legal/</a></span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-6\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>６．NBDCヒトデータベースを通じて共有されるデータを用いた研究を実施する上で、何を参照すればよいのか？</strong></span></a></h1>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　個人情報保護法を根拠法とする『人を対象とする生命科学・医学系研究に関する倫理指針』（『ヒトゲノム・遺伝子解析研究に関する倫理指針』と『人を対象とする医学系研究に関する倫理指針』が統合され、2021年[令和3年]6月30日に施行された。その後、個人情報保護法の令和2年・令和3年の改正を受けて指針も改正され、2022年[令和4年]4月1日に施行された。）です。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">※倫理指針の規定のほか、個人情報保護法を遵守するようご留意下さい。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">※倫理指針は厚生労働省の当該ページをご参照ください。<a href=\"http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/i-kenkyu/\" target=\"_blank\" rel=\"noopener noreferrer\">http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/i-kenkyu/</a></span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-7\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>７．「個人情報としての取扱い」とは？</strong></span></a></h1>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　個人情報としての取扱いに当たっての留意点を以下に記します。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt; background-color: initial;\">１）要配慮個人情報に該当する情報を用いる場合は（解析をすることで要配慮個人情報に該当する場合も含む）、情報の取得時（試料を取得した後に情報を産出する場合は試料取得時）に、取得の同意、利用目的の明示、外国を含む第三者提供等について、原則同意が必要です。</span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">２）情報の提供、及び、提供を受ける際には、既定の記録の作成（もしくは代用となる書類の入手）の上、一定期間の保管が必要です。記録の作成及び保管については、『人を対象とする生命科学・医学系研究に関する倫理指針』の<a href=\"https://www.mhlw.go.jp/content/000769923.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">ガイダンス</a>第８（インフォームド・コンセントを受ける手続き等）をご参照ください。</span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">３）同意撤回への対応</span><span style=\"font-family: helvetica; font-size: 14.6667px;\">（拒否できる機会の保障）</span><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">が必要です。既にデータベースへ登録したデータについて同意撤回があった際には、当該データを取り除いた上で、再度登録するようご協力ください。お問い合わせ先は<a href=\"/contact-us\" target=\"_blank\" rel=\"noopener noreferrer\">こちら</a>です。</span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">４）保有する個人情報に対する開示等求めへの対応が必要です。</span><span style=\"font-family: helvetica; font-size: 14.6667px;\">個人情報の訂正、追加、削除、利用停止等を求められた場合であって、その求めが適正と認められるときは、遅滞なく対応する必要があります。</span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">５）匿名加工情報・非識別加工情報を作成する際は、個人識別符号に該当する情報を全部削除してください。</span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">６）適切な安全管理措置の実施が必要です。詳細は、『人を対象とする生命科学・医学系研究に関する倫理指針』の<a href=\"https://www.mhlw.go.jp/content/000769923.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">ガイダンス</a>第１９をご参照ください。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-8\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>８．【新規試料から産出したデータの登録】研究で個人識別符号や要配慮個人情報に該当する情報を用いる。また、将来、研究の成果を論文等で発表・使用データのデータベースへの登録を考えているが、研究対象者からどのような同意を受けておく必要があるのか？</strong></span></a></h1>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">１）研究目的（試料・情報の利用目的）を必要な範囲で合理的な方法によって明示する。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　研究目的や、取得する情報の項目についてできるだけ明確に説明し、情報の取得や研究への参加について適切な同意を受けてください。個人識別符号に該当するゲノムデータを研究に用いる場合、そのデータに付随する疾患情報や検査情報等は要配慮個人情報にあたります。要配慮個人情報の取得や第三者提供には本人同意が必要です。</span></p>\r\n<p><span style=\"color: #000000;\"><a style=\"color: #000000;\" name=\"faq-8-2\"><span style=\"font-family: helvetica; font-size: 11pt;\">２）研究成果であるデータを公的データベースへ登録し、外国にある機関や民間企業等を含め、様々な（研究）者と共有する旨。</span></a></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　研究成果を論文として学術誌に投稿する際、公的データベースへデータを登録することが国際的に推奨されています。また、個人識別符号に該当するゲノムデータ（個人情報）を公的データベースへ登録して世界中の研究者と共有する場合、事前に『外国の第三者提供』及び『他の研究への利用』について、研究対象者から明確な同意を受けておく必要があります。NBDCヒトデータベースでは、国内の研究機関における研究利用だけではなく、<span style=\"text-decoration: underline;\"><strong>学術研究や公衆衛生の向上に資する民間企業や外国の機関に所属する研究者が実施する研究へのデータ利用も促進</strong></span>しています。NBDCヒトデータベースへデータを登録するということは、国内外の研究者等と情報を共有することであることを踏まえ、インフォームド・コンセントの際には、研究対象者にその旨をご理解いただいた上で同意いただけるよう、ご協力をお願い致します。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">３）公開方法について。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　データの種類によって登録先データベースを区別する際は、誰でも閲覧・利用可能なデータとして登録するか（不特定多数への配布）、審査等を経た、一定の利用者要件を満たした研究者等により利用可能なデータとして登録するか（制限付き配布）、データの種類を明確にした上で同意を受けてください。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-9\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>９．【既存試料から産出した、特定の個人を識別できない匿名化データの登録】データベースを介したデータ共有について同意を受けていない既存試料から産出されたデータをデータベースへ登録する際の手続きは？</strong></span></a></h1>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">１）可能な限り、研究対象者又はその代諾者等から、データベースを介したデータ共有についての同意を受けて下さい。その際は、NBDCヒトデータベースの共有方針（上記、<a href=\"#faq-8-2\" target=\"_blank\" rel=\"noopener noreferrer\">８．２）</a>を参照のこと）をご理解いただいた上で同意を受けてください。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">２）適切な同意を受けることが困難な場合（例えば、研究対象者から試料を取得してから相当の年月が経過しているため、死亡、退職及び転居等により当該研究対象者等と連絡を取ることが困難な場合など）は、準拠する倫理指針によって、以下のいずれかの手続きを実施した上でデータ提供申請をして下さい。</span></p>\r\n<p><strong><span style=\"font-family: helvetica; font-size: 11pt;\">【人を対象とする医学系研究に関する倫理指針】</span></strong></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">（１）～（３）に該当する場合は、機関の長が当該情報の提供について把握できるようにする。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　（１）提供するデータが匿名化されているもの（特定の個人を識別することができないものに限る。）である。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　（２）匿名加工情報又は非識別加工情報である。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　（３) （１）及び（２）に該当せず、以下に当てはまる場合。</span></p>\r\n<p><strong><span style=\"font-family: helvetica; font-size: 11pt;\">〈登録を予定しているデータ〉</span></strong></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　✔ <a href=\"#faq-13-tokumei\" target=\"_blank\" rel=\"noopener noreferrer\">「匿名化されているもの（どの研究対象者の試料・情報であるかが直ちに判別できないよう、加工又は管理されたものに限る。）」</a>に<span style=\"text-decoration: underline;\"><strong>該当する</strong></span>とき。</span><span style=\"font-family: helvetica; font-size: 11pt;\">かつ、</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　✔ 学術研究の用に<span style=\"text-decoration: underline;\"><strong>供する</strong></span>とき、もしくは、その他の当該情報を提供することに特段の理由（公衆衛生の向上のために特に必要がある場合であって、本人の同意を得ることが困難であるとき等が該当する。）が<span style=\"text-decoration: underline;\"><strong>ある</strong></span>とき。 </span></p>\r\n<p><strong><span style=\"font-family: helvetica; font-size: 11pt;\">〈必要な手続き〉 </span></strong></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　✔ 以下の項目について研究対象者等に通知し、又は公開する。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　①データベースへ登録する情報の提供・利用方法 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　NBDCヒトデータベースへデータを登録し、世界中の研究者等と共有する旨を記載してください。なお、NBDCヒトデータベースでは、提供いただいたデータを広くかつ有効に活用していただくことを推奨しており、国内の医学研究機関におけるデータ利用のみならず、学術研究や公衆衛生の向上に資する民間企業や海外の機関における研究へのデータ利用も促進しています。詳細は、<a href=\"#faq-1\" target=\"_blank\" rel=\"noopener noreferrer\">FAQ１．</a>をご参照ください。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　②提供する情報の項目 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　登録を予定しているデータの項目を記載してください。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　③情報を利用する者の範囲 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　・非制限公開データ：不特定多数により使用される。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　・制限公開データ：ヒトデータ審査委員会において、『データ利用者要件』や『データを扱う機関のセキュリティ環境』等について審査され、承認された研究者のみが利用可能。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　④情報の管理について責任を有する者 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">情報・システム研究機構データサイエンス共同利用基盤施設（ROIS-DS）ライフサイエンス統合データベースセンター（DBCLS）五斗 進 です。お問い合わせにつきましては<a href=\"/contact-us\" target=\"_blank\" rel=\"noopener noreferrer\">こちら</a>からお願いします。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-10\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>１０．【既存試料から産出した個人識別符号に該当するゲノムデータを含むデータの登録】データベースを介したデータ共有について同意を受けていない既存試料から産出されたデータをデータベースへ登録する際の手続きは？</strong></span></a></h1>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">１）可能な限り、研究対象者又はその代諾者等から、データベースを介したデータ共有についての同意を受けて下さい。その際は、NBDCヒトデータベースの共有方針（上記、<a href=\"#faq-8-2\" target=\"_blank\" rel=\"noopener noreferrer\">８．２）</a>を参照のこと）をご理解いただいた上で同意を受けてください。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">２）適切な同意を受けることが困難な場合（例えば、研究対象者から試料を取得してから相当の年月が経過しているため、死亡、退職及び転居等により当該研究対象者等と連絡を取ることが困難な場合など）は、準拠する倫理指針によって、以下のいずれかの手続きを実施した上でデータ提供申請をして下さい。</span></p>\r\n<p><strong><span style=\"font-family: helvetica; font-size: 11pt;\">【人を対象とする医学系研究に関する倫理指針】</span></strong></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">（１） </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\"><strong>〈登録を予定しているデータ〉</strong></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　✔ 学術研究の用に<span style=\"text-decoration: underline;\"><strong>供する</strong></span>とき、もしくは、その他の当該情報を提供することに特段の理由（公衆衛生の向上のために特に必要がある場合であって、本人の同意を得ることが困難であるとき等が該当する。）が<span style=\"text-decoration: underline;\"><strong>ある</strong></span>とき。 </span></p>\r\n<p><strong><span style=\"font-family: helvetica; font-size: 11pt;\">〈必要な手続き〉 </span></strong></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　✔ 以下の項目について研究対象者等に通知又は公開した上で、研究対象者等が拒否できる機会を保障していることを満たしていることについて、倫理審査委員会の意見を聴いた上で所属機関の長の許可を得る。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　①データベースへ登録する情報の提供・利用方法 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　NBDCヒトデータベースへデータを登録し、世界中の研究者等と共有する旨を記載してください。なお、NBDCヒトデータベースでは、提供いただいたデータを広くかつ有効に活用していただくことを推奨しており、国内の医学研究機関におけるデータ利用のみならず、学術研究や公衆衛生の向上に資する民間企業や海外の機関における研究へのデータ利用も促進しています。詳細は、<a href=\"#faq-1\" target=\"_blank\" rel=\"noopener noreferrer\">FAQ１．</a>をご参照ください。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　②提供する情報の項目 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　登録を予定しているデータの項目を記載してください。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　③情報を利用する者の範囲 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　・非制限公開データ：不特定多数により使用される。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　・制限公開データ：ヒトデータ審査委員会において、『データ利用者要件』や『データを扱う機関のセキュリティ環境』等について審査され、承認された研究者のみが利用可能。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　④情報の管理について責任を有する者</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">情報・システム研究機構データサイエンス共同利用基盤施設（ROIS-DS）ライフサイエンス統合データベースセンター（DBCLS）五斗 進 です。お問い合わせにつきましては<a href=\"/contact-us\" target=\"_blank\" rel=\"noopener noreferrer\">こちら</a>からお願いします。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　⑤研究対象者又はその代理人の求めに応じて、研究対象者が識別される試料・情報の利用又は他の研究機関への提供を停止すること </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　⑥⑤の研究対象者又はその代理人の求めを受け付ける方法 </span></p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">（２） </span></p>\r\n<p><strong><span style=\"font-family: helvetica; font-size: 11pt;\">〈登録を予定しているデータ〉 </span></strong></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　✔ 学術研究の用に<span style=\"text-decoration: underline;\"><strong>供さない</strong></span>とき、かつ、その他の当該情報を提供することに特段の理由（公衆衛生の向上のために特に必要がある場合であって、本人の同意を得ることが困難であるとき等が該当する。）が<span style=\"text-decoration: underline;\"><strong>無い</strong></span>とき。かつ、</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　✔ 社会的に重要性の高い研究に用いられる既存情報が提供される。かつ、</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　✔ 以下の要件の全てに該当する。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　① 研究の実施に侵襲（軽微な侵襲を除く。）を伴わないこと。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　② 手続を簡略化することが、研究対象者の不利益とならないこと。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　③ 手続を簡略化しなければ、研究の実施が困難であり、又は研究の価値を著しく損ねること。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　④ 社会的に重要性が高い研究と認められるものであること。 </span></p>\r\n<p><strong><span style=\"font-family: helvetica; font-size: 11pt;\">〈必要な手続き〉</span></strong></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　✔ 以下の必要な範囲で他の適切な措置を講じることについて、倫理審査委員会の意見を聴いた上で所属機関の長の許可を得る。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　① 研究対象者等が含まれる集団に対し、情報の収集及び利用の目的及び内容（方法を含む。）について広報すること。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　② 研究対象者等に対し、速やかに、事後的説明（集団に対するものを含む。）を行うこと。 </span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　③ 長期間にわたって継続的に情報が収集され、又は利用される場合には、社会に対し、その実情を当該試料・情報の収集又は利用の目的及び方法を含めて広報し、社会に周知されるよう努めること。</span></p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-11\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>１１．2020年・2021年（令和2年・3年）改正個人情報保護法や改正倫理指針に伴ない、既にNBDCヒトデータベースへ登録したデータに対して、何か手続きが必要か？</strong></span></a></h1>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　特にありませんが、過去に登録いただいているデータについて、改正倫理指針に適合していないことが判明した際には、速やかに倫理審査委員会の意見を聴き、必要な手続きを実施してください。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-12\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>１２．NBDCヒトデータベースに登録されているデータの利用に関して、2015年（平成27年）改正個人情報保護法や改正倫理指針に伴う変更点は？</strong></span></a></h1>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　データ利用申請自体に必要な手続きや書類は、これまでと同じ（提供を受ける既存試料・情報の内容及び提供を受ける必要性を研究計画書に記載し、倫理審査委員会の承認を得た上で所属機関の長の許可を受ける）ですが、NBDCヒトデータベースに登録されているデータの提供を受ける際には、研究責任者は記録を作成し、当該研究の終了について報告された日から5年を経過した日までの期間保管しなければなりません。詳細は、『人を対象とする医学系研究に関する倫理指針』の<a href=\"http://www.mhlw.go.jp/file/06-Seisakujouhou-10600000-Daijinkanboukouseikagakuka/0000166072.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">ガイダンス</a>第１２（90～91頁・106～107頁）、『ヒトゲノム・遺伝子解析研究に関する倫理指針』<a href=\"http://www.mhlw.go.jp/file/06-Seisakujouhou-10600000-Daijinkanboukouseikagakuka/0000162456.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">別紙２</a>をご参照ください。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-13\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>１３．既存試料・情報とは？</strong></span></a></h1>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　既存試料・情報とは、次に掲げるいずれかに該当するものを指します。</span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　１）研究計画書が作成されるまでに既に存在する試料・情報</span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　２）研究計画書の作成以降に取得された試料・情報であって、取得の時点においては当該研究計画書の研究に用いられることを目的としていなかったもの。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-14\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>１４．匿名化と匿名加工情報は同じなのか？</strong></span></a></h1>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\"><strong><span style=\"text-decoration: underline;\">違います。</span></strong></span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　『匿名加工情報』を保有し又は自らの判断で作成することができるのは、個人情報保護法が適用となる民間事業者に限られます。また、同法が適用される民間事業者が『匿名加工情報』を作成した場合は法に沿ってその旨を公表することが求められるため、少なくともこのような措置を講じない限り<span style=\"font-family: helvetica; font-size: 14.6667px;\">『</span>匿名加工情報<span style=\"font-family: helvetica; font-size: 14.6667px;\">』</span>に該当することにはなりません。また、『匿名加工情報』とは、個人情報保護法等に定める匿名加工基準を満たすように個人情報を加工したものを指します。加工基準につきましては、<a href=\"https://www.ppc.go.jp/personalinfo/legal/guidelines_anonymous/\" target=\"_blank\" rel=\"noopener noreferrer\">個人情報の保護に関する法律についてのガイドライン（仮名加工情報・匿名加工情報編）</a>や、個人情報保護委員会のホームページに掲載されている、個人情報保護委員会事務局の協力の下、大学共同利用機関法人 情報・システム研究機構 国立情報学研究所に設置された「匿名加工情報に関する技術検討ワーキンググループ」により実施された</span><span style=\"font-family: helvetica; font-size: 14.6667px;\">匿名加工情報に関する技術的な検討に基づき</span><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">作成された「匿名加工情報の適正な加工の方法に関する報告書 2017年2月21日版」をご参照ください。</span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\"><span style=\"color: #000000;\">　<a style=\"color: #000000;\" name=\"faq-13-tokumei\">一方『匿名化</a>』</span>は、「特定の個人（死者を含む。以下同じ。）を識別することができることとなる記述等（個人識別符号を含む。）の全部又は一部を削除すること（当該記述等の全部又は一部を当該個人と関わりのない記述等に置き換えることを含む。）」と、倫理指針に定義されています。「匿名化」がなされた試料・情報を｢匿名化されているもの｣と表記しますが、「匿名化されているもの」の中には、特定の個人を識別することができるものとできないものの両者が含まれています。それらを区別するため、<span style=\"text-decoration: underline;\">「特定の個人を識別できないもの」を指す場合には、<strong>｢匿名化されているもの（特定の個人を識別することができないものに限る。）｣</strong>と表記</span>されます。更に、匿名化の際に対応表（匿名化された情報から、必要な場合に研究対象者を識別することができるよう、当該研究対象者と匿名化の際に置き換えられた記述等とを照合することができるようにする表その他これに類するもの）が作成されていない場合には（対応表が作成されたものの、既に破棄され、世の中に存在していない場合も含まれる。）<span style=\"text-decoration: underline;\"><strong>「匿名化されているもの（特定の個人を識別することができないものであって、対応表が作成されていないものに限る。）」</strong></span>と表記されます。</span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　また、匿名化されているもののうち、その記述単体で特定の研究対象者を直ちに判別できる記述等（氏名、顔画像、個人識別符号に該当するゲノムデータ、保険証番号等が該当する。病名、検査データ等については、その記述等が比較的特異な場合であっても基本的には該当しない。）を全部取り除くような加工がなされているもの、又は、</span><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">対応表の適切な管理がなされている場合は、<span style=\"text-decoration: underline;\"><strong>「匿名化されているもの（どの研究対象者の試料・情報であるかが直ちに判別できないよう、加工又は管理されたものに限る。）」</strong></span>と表記されます。これにも特定の個人を識別できるものとできないものの両方が含まれます。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-15\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>１５．匿名化時の対応表の適切な管理とは？</strong></span></a></h1>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　匿名化の際の対応表（必要な場合に研究対象者を識別することができるよう、当該 研究対象者と匿名化の際に置き換えられた記述等とを照合することができるようにする表その他これに類するもの）の管理は、適切に実施する必要があります。</span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　・対応表の安全管理措置が適切に行われている（必要かつ適切な物理的安全管理、技術的安全管理、組織的安全管理、人的安全管理。<a href=\"https://www.mhlw.go.jp/file/06-Seisakujouhou-10600000-Daijinkanboukouseikagakuka/0000166072.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">137-8頁参照</a>）</span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　・他の機関から元データに関する照合があった場合の規定が適切に整備されている（研究機関の長は、安全管理に必要な体制及び規定を整備すると共に、必要かつ適切な監督を行う必要がある）</span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　<span style=\"text-decoration: underline;\">なお、<strong>同一法人内の別の組織が「対応表」を保有している場合は、</strong></span>当該研究機関において対応表を保有するものとみなされます。つまり、当該匿名化された診療情報は、当該研究機関内において特定の個人を識別することができる者が限定的であるか、また、当該研究機関内の誰がアクセスすることができるかによらず、<span style=\"text-decoration: underline;\"><strong>特定の個人を識別することができないものには該当しません</strong></span>。例えば、同一法人が管轄するＡ病院とＢ研究所に おいて、Ａ病院で取得された試料・情報を、「対応表」を作成して匿名化し、Ｂ研究所に提供する場合には、Ｂ研究所で対応表を保管していなくても、当該法人（研究機関）として対応表を保有することに変わりなく、個人情報等として適正に取り扱う必要があります。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-16\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>１６．一般に入手可能な試料・情報の扱いは？</strong></span></a></h1>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　学術的な価値が定まり、研究実績として十分に認められ、研究用に広く一般に利用され、かつ、一般に入手可能な組織、細胞、体液及び排泄物並びにこれらから抽出した人のDNA（試料）や情報は『人を対象とする医学系研究に関する倫理指針』や『ヒトゲノム・遺伝子解析研究に関する倫理指針』の対象にはなりません。例えば、当該試料を用いてゲノム解析を実施した際のゲノムデータは、引き続き指針の対象外になります。 </span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-17\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>１７．同意撤回について</strong></span></a></h1>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　NBDCヒトデータベースでは、一部、個人識別符号に該当するゲノムデータや、それに付随する要配慮個人情報に該当する疾患名・人種・投薬情報等を保有しますが、全て氏名等の特定の個人を識別することができる記述等の全部又は一部が削除された情報であるため、同意撤回の機会を保障することができません。研究参加へのインフォームド・コンセントが行われた医療機関・研究機関に直接お問い合わせください。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-18\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>１８．開示請求について</strong></span></a></h1>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　NBDCヒトデータベースでは、一部、個人識別符号に該当するゲノムデータや、それに付随する要配慮個人情報に該当する疾患名・人種・投薬情報等を保有しますが、全て氏名等の特定の個人を識別することができる記述等が削除された情報であり、容易に照合することが困難ですので、開示請求に応じることができません。研究参加へのインフォームド・コンセントが行われた医療機関・研究機関に直接お問い合わせください。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-19\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>１９．インフォームドコンセントの説明文書にどのように記載すればよいのか？</strong></span></a></h1>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　2015年（平成27年）改正個人情報保護法や改正研究倫理指針の変更点を反映した同意説明文書のひな形を<a href=\"https://www.genome-sci.jp/ethic\" target=\"_blank\" rel=\"noopener noreferrer\">先進ゲノム支援</a>との協力の下、作成しました。参考にして下さい。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-20\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>２０．登録したデータを、投稿論文の査読担当者（Reviewer）がアクセスすることは可能か？</strong></span></a></h1>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　制限公開データベースである<a href=\"https://www.ddbj.nig.ac.jp/jga/index.html\" target=\"_blank\" rel=\"noopener noreferrer\">Japanese Genotype-phenotype Archive（JGA）</a>は機微データを格納するためのデータベースであり、データを取り扱うためのセキュリティ環境が整っているか等を確認した上でヒトデータ審査委員会により承認された者のみ、データへのアクセスが可能になります。従って、Reviewer等による匿名でのデータアクセスはできません。</span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　一方、発現データを格納する非制限公開データベースである<a href=\"https://www.ddbj.nig.ac.jp/gea/index.html\" target=\"_blank\" rel=\"noopener noreferrer\">Genomic Expression Archive（GEA）</a>は、データ格納時に通知される <a href=\"https://www.ddbj.nig.ac.jp/gea/reviewer-access.html\" target=\"_blank\" rel=\"noopener noreferrer\">tokenをReviewer等にお知らせいただく</a>事で、Reviewer等によるデータアクセスが可能です。</span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　また、NGSの配列情報を格納する非制限公開データベースである<a href=\"https://www.ddbj.nig.ac.jp/dra/index.html\" target=\"_blank\" rel=\"noopener noreferrer\">DDBJ Sequence Rear Archive（DRA）</a>では、データ公開前でも提供者自身がデータをダウンロードすることが可能なので、データアクセスのための情報をReviewer等にお知らせいただく事でデータアクセスが可能になりますが、あまり推奨は致しません。 </span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-21\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>２１．「個人識別性・一次データ（NBDCを通じて共有される制限公開データ）復元性のない、あるいは非常に低い加工データ（NBDCヒトデータ共有ガイドライン５－３－３制限公開　４．）」とは？</strong></span></a></h1>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　例えば、人工知能を使用した学習モデルとして搭載される重み情報や、一般的な研究成果の発表時（論文等）に添付する情報が含まれます。 「個人識別性・一次データ（NBDCヒトデータベースを通じて共有される制限公開データ）復元性のない、あるいは非常に復元性の低い加工データ」を保管・配布する場合は、一般的な研究成果の発表時（論文等）に添付する場合を除き、二次データ保管・加工データ配布申請が必要です。 「個人識別性・一次データ復元性のない、あるいは非常に復元性の低い加工データ」に該当するかどうかについて、並びに、配布する場合の二次データ保管・加工データ配布申請について、ご不明点がありましたら、<a href=\"contact-us\" target=\"_blank\" rel=\"noopener noreferrer\">お問い合わせ</a>ください。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-22\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>２２．制限公開データベース（Japanese Genotype-phenotype Archive：JGA）からダウンロードしたデータを復号化できない時はどうしたら良いのか？</strong></span></a></h1>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　JGA データの復号で PuTTY 形式の秘密鍵を使用した場合、”Unable to load Private Key” というエラーになります。<a href=\"https://www.ddbj.nig.ac.jp/account.html#convert-private-key\" target=\"_blank\" rel=\"noopener noreferrer\">秘密鍵を PuTTY 形式から OpenSSH 形式に変換</a>し、OpenSSH 形式の秘密鍵を使用してください。利用申請時に登録する公開鍵は OpenSSH/PuTTY どちらの形式にも対応しているため、公開鍵の形式変換は必要ありません。</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-23\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>２３．NBDCヒトデータベースを通じて提供されたデータを含む解析結果を学術論文等で公表する際の謝辞や引用はどうすれば良いのか？</strong></span></a></h1>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">　<span style=\"text-decoration: underline;\"><strong>使用したデータセットのアクセッション番号を記載して下さい</strong></span>。また、当該データセットについて報告された論文（当該データセットのデータ提供者等が当該データセットを根拠データとして作成した論文）の引用、もしくは謝辞（Acknowledgement）として以下の内容を記述して下さい。 </span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">【謝辞の例】 </span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">日本語：本研究に使用したデータ（の一部）はAAAAプロジェクト/研究グループ（代表者 BBBB）によって取得され、情報・システム研究機構 データサイエンス共同利用基盤施設 ライフサイエンス統合データベースセンター（DBCLS）の『NBDCヒトデータベース』ウェブサイト（https://humandbs.dbcls.jp/）を通じて提供されたものです。 </span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">英語：(A part of) The data used for this research was originally obtained by AAAA research project/group led by Prof./Dr. BBBB and available at the website of the NBDC Human Database (https://humandbs.dbcls.jp/en/) of the Database Center for Life Science (DBCLS) / the Joint Support-Center for Data Science Research (DS) of the Research Organization of Information and Systems (ROIS).</span></p>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">なお、JGAのサービスを利用した場合は以下の論文を引用してください。 <a href=\"https://academic.oup.com/nar/article/43/D1/D18/2437855\" target=\"_blank\" rel=\"noopener noreferrer\">Nucleic Acids Res. 2015, 43 Database issue: D18-D22</a>.</span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-24\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>２４．NBDCヒトデータベースを通じて入手したデータを「仮名加工情報」に含め、当初のデータ利用目的とは異なる研究に用いることは可能か？</strong></span></a></h1>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">NBDCヒトデータ共有ガイドラインの５－３．データ利用者の責務の「データの利用にあたって遵守すべき基本的事項」に記載があるように、申請した利用目的以外への使用は禁止されています。そのため、NBDCヒトデータベースを通じて入手したデータを「仮名加工情報」として含め、他の目的の研究に用いることはできません。他の目的で使用したい場合は、改めてデータ利用申請を実施下さい。 </span></p>\r\n<p>&nbsp;</p>\r\n<h1><a name=\"faq-25\"><span style=\"text-decoration: font-family: helvetica; font-size: 12pt;\"><strong>２５．外国における個人情報保護制度はどのようになっているか？</strong></span></a></h1>\r\n<p><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">日本の個人情報保護委員会が調査した、一定の国又は地域における個人情報の保護に関する制度について、下記サイトより公開しておりますのでご参照ください。日本の個人情報保護法との間の本質的な差異の把握に資する一定の情報が公開されております。なお、どの国の研究者に対しても、日本国内の法令や指針に沿って作成された<a href=\"guidelines\" target=\"_blank\" rel=\"noopener\">データベースのガイドライン等</a>に準じた利用が求められます。</span></p>\r\n<p><a href=\"https://www.ppc.go.jp/personalinfo/legal/kaiseihogohou/#gaikoku\" target=\"_blank\" rel=\"noopener\"><span style=\"background-color: initial; font-family: helvetica; font-size: 11pt;\">https://www.ppc.go.jp/personalinfo/legal/kaiseihogohou/#gaikoku</span></a></p>", "publish_up": "2015-02-25"}, {"lang": "ja", "path": "guidelines", "title": "ガイドライン", "fulltext": "", "modified": "2024-04-01", "introtext": "<ul>\r\n<li>\r\n<p><a href=\"index.php?Itemid=265&amp;lang=ja\" target=\"_blank\"><span style=\"text-decoration: underline;\"><span style=\"font-family: helvetica; font-size: 15pt;\">NBDCヒトデータ共有ガイドライン</span></span></a></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　『NBDCヒトデータベース』へのデータ提供および『NBDCヒトデータベース』からのデータ利用に関する運用ルールについて示したものです。</span></p>\r\n<p>&nbsp;</p>\r\n</li>\r\n<li>\r\n<p><span style=\"text-decoration: underline;\"><span style=\"font-family: helvetica; font-size: 15pt;\">NBDCヒトデータ取扱いセキュリティガイドライン</span></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　ヒトに関するデータを外部に漏えいすることなく安全に研究活動に利用するために最低限遵守すべきシステムセキュリティについて示したものです。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　<a href=\"/guidelines/security-guidelines-for-users\" target=\"_blank\" rel=\"noopener noreferrer\">NBDCヒトデータ取扱いセキュリティガイドライン（データ利用者向け）</a><br />　<a href=\"/guidelines/security-guidelines-for-submitters\" target=\"_blank\" rel=\"noopener noreferrer\">NBDCヒトデータ取扱いセキュリティガイドライン（データ提供者向け）</a><br />　<a href=\"/guidelines/security-guidelines-for-dbcenters\" target=\"_blank\" rel=\"noopener noreferrer\">NBDCヒトデータ取扱いセキュリティガイドライン（データベースセンター運用責任者ならびに「機関外サーバ」運用責任者向け）</a></span></p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 15pt;\">ガイドラインの改定</span></p>\r\n<ol>\r\n<li>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=125&amp;Itemid=390&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">２０１５年２月２７日改定</a></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">→<a href=\"files/revision_guidelines_150225.xlsx\">新旧対照表</a></span></p>\r\n</li>\r\n<li>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=320&amp;Itemid=604&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">２０１６年２月２９日改定</a></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">→<a href=\"files/Guidelines_v3/guidelinesv2to3_160229.xlsx\">新旧対照表</a></span></p>\r\n</li>\r\n<li>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\"><a href=\"/guideline-revision4\" target=\"_blank\" rel=\"noopener noreferrer\">２０１８年８月３１日改定</a></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">→<a href=\"files/Guidelines_v4/guidelinesv3.0to4.0_180831.xlsx\">新旧対照表</a></span></p>\r\n</li>\r\n<li>\r\n<p><a href=\"/guideline-revision5\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 11pt;\">２０１９年４月１日改定</span></a></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">→<a href=\"files/Guidelines_v5/guidelines_v4to5_190401.xlsx\">新旧対照表</a></span></p>\r\n</li>\r\n<li>\r\n<p><a href=\"/guideline-revision6\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 11pt;\">２０２１年６月２２日改定</span></a></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">→<a href=\"files/Guidelines_v6/guidelines_v5to6.xlsx\">新旧対照表</a></span></p>\r\n</li>\r\n<li>\r\n<p><a href=\"/guideline-revision7\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 11pt;\">２０２２年４月１日改定</span></a></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">→<a href=\"files/Guidelines_v7/guidelines_v6tov7.xlsx\">新旧対照表</a></span></p>\r\n</li>\r\n</ol>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">DBCLS事業運営委員会では「NBDCヒトデータ共有ガイドライン」ならびに「NBDCヒトデータ取扱いセキュリティガイドライン」の策定に際して、データ共有分科会を設置して検討を行っています。</span></p>\r\n</li>\r\n</ul>", "publish_up": "2013-03-15"}, {"lang": "en", "path": "guidelines", "title": "Guidelines", "fulltext": "", "modified": "2024-04-04", "introtext": "<ul>\r\n<li>\r\n<p><a href=\"index.php?Itemid=401&amp;lang=en\" target=\"_blank\"><span style=\"text-decoration: underline;\"><span style=\"font-family: helvetica; font-size: 15pt;\">NBDC Guidelines for Human Data Sharing</span></span></a></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">These guidelines discuss the administrative rules applied in the submission of data to the NBDC Human Database and the use of data from the Database.</span></p>\r\n<p>&nbsp;</p>\r\n</li>\r\n<li>\r\n<p><span style=\"text-decoration: underline;\"><span style=\"font-family: helvetica; font-size: 15pt;\">NBDC Security Guidelines for Human Data</span></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">These guidelines discuss the minimum system security measures that should be taken in order to securely use human data for the purpose of research activities, without data being leaked to third parties.</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　<a href=\"/en/guidelines/security-guidelines-for-users\" target=\"_blank\" rel=\"noopener noreferrer\">NBDC Security Guidelines for Human Data (for Data Users)</a><br />　<a href=\"/en/guidelines/security-guidelines-for-submitters\" target=\"_blank\" rel=\"noopener noreferrer\">NBDC Security Guidelines for Human Data (for Data Submitters)</a><br />　<a href=\"/en/guidelines/security-guidelines-for-dbcenters\" target=\"_blank\" rel=\"noopener noreferrer\">NBDC Security Guidelines for Human Data (for Database Center Operation Managers and “Off-Premise-Server” Operation Managers)</a></span></p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 15pt;\">Revision of Guidelines</span></p>\r\n<ol>\r\n<li>\r\n<p><a href=\"/en/guideline-revision\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 11pt;\">June 10, 2019</span></a></p>\r\n</li>\r\n<li>\r\n<p><a href=\"/en/guideline-revision-2\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 11pt;\">June 22, 2021</span></a></p>\r\n</li>\r\n<li>\r\n<p><a href=\"/en/guideline-revision-3\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 11pt;\">April 1, 2022</span></a></p>\r\n</li>\r\n</ol>\r\n<p>&nbsp;</p>\r\n<p>In creating the NBDC Guidelines for Human Data Sharing and the NBDC Security Guidelines for Human Data, the DBCLS Steering Committee set up the Data-Sharing Subcommittee&nbsp;in order to examine various issues.</p>\r\n</li>\r\n</ul>", "publish_up": "2013-03-15"}, {"lang": "ja", "path": "guidelines/data-sharing-guidelines", "title": "NBDCヒトデータ共有ガイドライン ver. 8.0", "fulltext": "", "modified": "2025-01-09", "introtext": "<p class=\"text-info\">　<span style=\"color: #000000;\">NBDCヒトデータベースでは、ご提供いただいたデータを広くかつ有効に活用していただくことを推奨しているため、国内の研究機関におけるデータ利用のみならず、<span style=\"text-decoration: underline;\"><strong>学術研究や公衆衛生の向上に資する民間企業や海外の機関における研究へのデータ利用も促進</strong></span>しております。</span></p>\r\n<p class=\"text-info\">　<span style=\"color: #000000;\">「個人情報の保護に関する法律」（平成15 年法律第57 号。）、「行政機関の保有する個人情報の保護に関する法律」（平成15 年法律第58 号。）及び「独立行政法人等の保有する個人情報の保護に関する法律」（平成15 年法律第59 号。）（以下「個人情報保護法」という。）が改正され、2017年5月30日に施行されました。本改正において新たに定義された個人識別符号に該当するゲノムデータを扱う際には、個人情報として取り扱う必要があります。また、個人識別符号に該当するゲノムデータに付随する診断名や検査値等は<span style=\"text-decoration: underline;\"><strong>要配慮個人情報</strong></span>にあたりますので、情報の取得の際には原則同意が必要になります。詳細は<span style=\"text-decoration: underline;\"><a href=\"faq\" target=\"_blank\" rel=\"noopener noreferrer\">FAQ</a></span>をご参照ください。</span></p>\r\n<p style=\"text-align: right;\">2024.4.1<br />Ver. 8.0</p>\r\n<h3><strong><span style=\"color: #000000;\">はじめに</span></strong></h3>\r\n<p>ヒトに関するデータは、次世代シークエンサーをはじめとした解析技術の発達に伴って膨大な量が産生されつつあり、それらを整理・格納して、生命科学の進展や公衆衛生の向上のために有効に活用するためのルールや仕組みが必要である。<br /><a href=\"https://www.rois.ac.jp/\" target=\"_blank\" rel=\"noopener noreferrer\">大学共同利用機関法人 情報・システム研究機構（以下、ROIS）</a> <a href=\"https://ds.rois.ac.jp/\" target=\"_blank\" rel=\"noopener noreferrer\">データサイエンス共同利用基盤施設（以下、DS）</a> <a href=\"https://dbcls.rois.ac.jp/\" target=\"_blank\" rel=\"noopener noreferrer\"> ライフサイエンス統合データベースセンター（以下、DBCLS）</a>では、これまで国立研究開発法人科学技術振興機構（JST）NBDC事業推進部が運用してきた、個人情報の保護に配慮しつつ上述の目的でヒトに関する様々なデータの共有や利用を推進するためのプラットフォーム（以下、『NBDCヒトデータベース』）事業の運用主体を引き継ぎ、運用やガイドラインの改定を実施する。<br />なお、本ガイドラインは、公的資金を用いて産生されたヒトに関するデータ一般に適用することを目的として作成した。ただし、全てのガイドラインとの整合性が確認できているわけではなく、さらには生命科学データに関する世界的な動向、一般社会の科学データに対する考え方も変化していくことが考えられるので、これらに対応していくため、随時必要な修正を加えていくものとする。</p>\r\n<h4><span style=\"color: #000000;\">＜本ガイドラインに関する連絡先＞</span></h4>\r\n<p>データ共有分科会事務局<br />humandbs@dbcls. jp</p>\r\n<h4><span style=\"color: #000000;\">＜『NBDCヒトデータベース』へのデータ提供やデータ利用等に関する連絡先＞</span></h4>\r\n<p>ヒトデータ審査委員会事務局<br /> humandbs@dbcls. jp</p>\r\n<h3><strong><span style=\"color: #000000;\">目次</span></strong></h3>\r\n<ol>\r\n<li>運用原則</li>\r\n<li>用語定義</li>\r\n<li>受け入れるデータについて</li>\r\n<li>『NBDCヒトデータベース』へのデータの提供について</li>\r\n<li>『NBDCヒトデータベース』からのデータの利用について</li>\r\n<li>本ガイドラインの改訂手続きについて</li>\r\n<li>その他</li>\r\n</ol><hr />\r\n<h3><strong><span style=\"color: #000000;\">１．運用原則</span></strong></h3>\r\n<ol>\r\n<li>『NBDCヒトデータベース』は以下の原則に基づいて運用される。\r\n<ul>\r\n<li>原則1　公的資金により産生されたヒトに関するデータを広く収集すること</li>\r\n<li>原則2　収集したデータを広く共有できるようにすること</li>\r\n<li>原則3　研究対象者の権利を可能な限り尊重すること</li>\r\n</ul>\r\n</li>\r\n<li>DBCLSは『NBDCヒトデータベース』の運用において以下の項目を実施する。<ol style=\"list-style-type: lower-roman;\">\r\n<li>ガイドラインの整備および必要に応じた見直し</li>\r\n<li>データ提供およびデータ利用申請についての審査</li>\r\n<li>ウェブサイトの整備等データへのアクセス手段の維持</li>\r\n</ol></li>\r\n</ol>\r\n<h3><strong><span style=\"color: #000000;\">２．用語定義</span></strong></h3>\r\n<ol>\r\n<li>ヒトに関するデータ\r\n<ul>\r\n<li>ヒト由来試料を用いた研究等の成果として産生されたデータ。ゲノム等の遺伝情報や、臨床情報、画像情報等を含む。</li>\r\n</ul>\r\n</li>\r\n<li>公的資金\r\n<ul>\r\n<li>国、地方公共団体、独立行政法人またはこれらに準ずる組織から提供される資金。</li>\r\n</ul>\r\n</li>\r\n<li>研究対象者\r\n<ul>\r\n<li>研究や事業等の活動に自身由来の組織・血液・尿などの試料、もしくは、自身のデータを提供した者。</li>\r\n</ul>\r\n</li>\r\n<li>データ提供者\r\n<ul>\r\n<li>『NBDCヒトデータベース』へヒトに関するデータを提供する研究代表者。</li>\r\n</ul>\r\n</li>\r\n<li>データ利用者\r\n<ul>\r\n<li>『NBDCヒトデータベース』のヒトに関するデータを利用する研究代表者および研究代表者がデータ利用申請時に登録した研究代表者と同一機関に所属する研究分担者。</li>\r\n</ul>\r\n</li>\r\n<li>研究代表者\r\n<ul>\r\n<li>当該研究について責任を負う研究者（所属機関等の倫理審査委員会へ研究内容を申請し、申請内容が承認された研究者、もしくは倫理審査申請書内に名前を連ねる研究分担者）。</li>\r\n</ul>\r\n</li>\r\n<li>非制限公開データ\r\n<ul>\r\n<li>アクセスに制限を設けることなく、利用することが可能な公開データ。例えば、すでに発表された論文の集計・統計解析データ等が含まれる。</li>\r\n</ul>\r\n</li>\r\n<li>登録済みユーザがアクセス可能なデータ（登録者公開データ）\r\n<ul>\r\n<li>制限公開データの利用についてヒトデータ審査委員会による承認を受けたデータ利用期間中の研究者が利用可能なデータ。制限公開データとしてヒトデータに関するNBDCヒトデータベースに登録された各データセットを加工して作成した統計データが含まれる。</li>\r\n</ul>\r\n</li>\r\n<li>制限公開データ\r\n<ul>\r\n<li>データ利用者、利用目的等を明らかにしたうえで、関連研究に従事したことのある研究者が研究のために利用することが可能な公開データ。利用の際には、ヒトデータ審査委員会による審査において承認される必要がある。例えば、次世代シークエンサーから出力されたデータを含む塩基配列データ、ゲノムワイドな変異データ、画像データ、質問票等の個人毎のデータが含まれる。</li>\r\n</ul>\r\n</li>\r\n<li>公開待機データ\r\n<ul>\r\n<li>論文発表や知的財産権取得等、データ提供者による成果の公開の後、非制限公開データあるいは制限公開データとして公開される予定のデータ。</li>\r\n</ul>\r\n</li>\r\n<li>二次データ\r\n<ul>\r\n<li>一次データ（NBDCヒトデータベースを介して共有される制限公開データ）を復元することができないよう加工したデータ。</li>\r\n</ul>\r\n</li>\r\n<li>所属機関外利用可能サーバ（『機関外サーバ』）\r\n<ul>\r\n<li>データ利用者が、所属機関が所有するサーバ以外に、制限公開データの保管や計算処理を行うことが可能なサーバであって、ヒトに関するデータを解析する環境が整っており、かつ、NBDCヒトデータ取扱いセキュリティガイドラインの遵守を含む、運用に関する覚書をROISあるいはDSと締結した機関が所有する計算機環境であり、ハイレベル【Type Ⅱ】セキュリティにおいて必要な対策が実施されているサーバ。 （『機関外サーバ』：<a href=\"off-premise-server\" target=\"_blank\" rel=\"noopener noreferrer\">https://humandbs.dbcls.jp/off-premise-server</a>）</li>\r\n</ul>\r\n</li>\r\n<li>受託者\r\n<ul>\r\n<li>情報の保管、統計処理その他の研究に関する業務の一部についてのみ、データ利用者からの委託を受けてその監督のもと従事する者。海外（日本国外）にある者に委託する場合、利用申請の際の研究代表者は、研究対象者等の適切な同意を受けるなど、倫理的手続きを実施しなければならない。</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<h3><strong><span style=\"color: #000000;\">３．受け入れるデータについて</span></strong></h3>\r\n<h4><span style=\"color: #000000;\">対象データの概要</span></h4>\r\n<p>『NBDCヒトデータベース』には、公的資金を用いたプロジェクト等で産生されたヒトに関するデータを広く受け入れる。多くの研究者間におけるデータの活用を目的としているため、一部の研究グループやコンソーシアム等の共同研究者間に限定されたデータ共有のためのリポジトリとしての利用を目的としたデータ提供は受け付けない。</p>\r\n<p>当該データの種類は公開の有無、アクセス制限のレベルによって以下の4つに分類される（下図参照）。</p>\r\n<ol>\r\n<li>非制限公開データ</li>\r\n<li>登録者公開データ</li>\r\n<li>制限公開データ</li>\r\n<li>公開待機データ</li>\r\n</ol>\r\n<p>『NBDCヒトデータベース』では、１．非制限公開データ、３．制限公開データおよび４．公開待機データを受け入れの対象とする。NBDCヒトデータベースでは、データ提供者が特定の個人（死者を含む。以下同じ）を識別することができることとなる記述等の全部又は一部を取り除き、代わりに当該個人とかかわりのない符号又は番号を付し、その後、さらに符号又は番号の振りなおしを施したデータのみを受け入れている。２．登録者公開データは、受け入れたデータに対し、データベースセンターがデータ利用促進を目的として実施する加工により作成されたデータである。</p>\r\n<p><img src=\"files/images/dataClassification_6.png\" alt=\"dataClassification\" width=\"520\" height=\"344\" style=\"vertical-align: middle; display: block; margin-left: auto; margin-right: auto;\" /></p>\r\n<h3><strong><span style=\"color: #000000;\">４．『NBDCヒトデータベース』へのデータの提供について</span></strong></h3>\r\n<h4><strong><span style=\"color: #000000;\">４－１．データ提供者の権利</span></strong></h4>\r\n<ol>\r\n<li>データ提供者は、インフォームドコンセントの説明文書の中で指定している制限項目（研究対象疾患の限定等）に準じて、データ利用時の制限事項を設定することができる。</li>\r\n<li>データ提供者は、データを即時公開することが求められるが、論文等による成果公開や知的財産権取得等のために、公開待機データとすることを要求することができる。ただし公開待機の期間については、上記の観点から合理的に必要な期間に限定することとし、具体的にはヒトデータ審査委員会と別途協議し、決定する。</li>\r\n</ol>\r\n<h4><strong><span style=\"color: #000000;\">４－２．データ提供者の責務</span></strong></h4>\r\n<ol>\r\n<li>データ提供者は、ヒトに関するデータの由来となる研究対象者に下記＜同意文書・説明文書の記載内容例について＞の必須項目について説明したうえで、データベースへのデータ登録と国内外の研究者によるデータ共有についての同意を文書で取得し、かつ、当該データ登録とデータ共有について所属機関等の倫理審査委員会の審査・承認を得たうえで、所属機関の長の許可を得ること。ただし、研究全体の当初の倫理審査等においてデータベースへのデータ登録とデータ共有が許可されている場合には、改めて審査を実施する必要はない。</li>\r\n<li>データ提供者は、データベースへの登録をあらかじめ意図せずに得られた試料等（説明文書においてデータベースへのデータの登録やデータ共有が述べられていない場合等）から得られたヒトに関するデータをNBDCヒトデータベースに提供するときは、研究を実施する上で遵守すべき倫理指針に準じた手続きを行うこと（例：再同意の取得、再同意の取得が困難な場合は情報の公開および拒否の機会の保障を行った後、データ提供者の所属機関等の倫理審査委員会の審査・承認を得たうえで、所属機関の長の許可を得ること）。</li>\r\n<li>データ提供者は、明らかに『人を対象とする生命科学・医学系研究に関する倫理指針（新指針）』の対象にならないヒト由来試料<sup>※１</sup>からのデータをNBDCヒトデータベースへ提供する場合、研究代表者の署名済み『データ提供申請簡易審査希望届』（自由書式）を提出すること（<a href=\"files/deposit_exemption.docx\">例参照</a>）。提出することで、所属機関等の倫理審査関係書類（研究計画書、インフォームドコンセントの説明文書・同意文書、承認通知書）に替えることができる。\r\n<ul style=\"list-style-type: none;\">\r\n<li>※１：【新指針】既に学術的な価値が定まり、研究用として広く利用され、かつ、一般に入手可能な試料・情報</li>\r\n</ul>\r\n</li>\r\n<li>ヒトデータ審査委員会では、提供申請時にインフォームドコンセントの説明文書・同意文書のフォームを提出いただき、制限事項の記載内容との整合性の確認を行なうが、インフォームドコンセントに沿った提供内容であるかということについての責任はデータ提供者にあるものとする。</li>\r\n<li>データ提供者は、NBDCヒトデータ提供申請書への記載内容に沿ったデータを提供すること。</li>\r\n<li>データ提供者は、NBDCヒトデータベースへのデータ提供に際して、特定の個人（死者を含む。以下同じ）を識別することができることとなる記述等の全部又は一部を取り除き、代わりに当該個人とかかわりのない符号又は番号を付し、その後、さらに符号又は番号の振りなおしを施したデータであることを確認すること。また、同意撤回があった際に該当する研究対象者由来のデータを削除するため、原則、対応表は保管すること。</li>\r\n<li>データ提供者は、ヒトデータ審査委員会との協議に基づいて非制限公開データ、制限公開データ等の分類を選択したうえ、データと共に必要な付随データ（データの説明のためのメタデータおよびクオリティコントロールに必要な情報）をNBDCヒトデータベースに提供すること。なお、制限公開データについては、ヒトデータ審査委員会との協議に基づいて、セキュリティレベル（Type Ⅰ、Type Ⅱ）の分類も実施すること。</li>\r\n<li>データ提供者が登録したデータが、NBDCヒトデータ共有ガイドライン等に違反したデータであることが判明した場合、または、故意もしくは過失により瑕疵（隠れたる瑕疵を含む）のあるデータであることが判明した場合、DBCLSは当該データを公開停止とし、当該データを削除する。データ提供者は、必要な変更や手続き等を実施した上でデータの再登録を一定の期間内に行うこと。再登録が行われない場合は、当該データに対するアクセッション番号を取消すこととする。</li>\r\n<li>データ提供者は、NBDCヒトデータベースへ提供したデータの由来となる研究対象者から同意撤回もしくはオプトアウトでの拒否があった際には、以降のデータ利用を避けるため、当該データの破棄に協力すること。</li>\r\n<li>データ提供者は、提供したデータに対してDBCLSおよび生命情報・DDBJ センターが実施する、データ利用者の利便性向上を目的としたデータ加工（データの概要を公開するための統計データ作成、ならびに、データ利用についてヒトデータ審査委員会より承認を受けたデータ利用者が希望する場合に利用可能な、特定の解析パイプラインにより加工したアライメントデータ・バリアントコールデータ・統計データ等データの作成）を承諾すること。</li>\r\n</ol>\r\n<p>データ提供者が、NBDCヒトデータ共有ガイドライン等に違反してヒトに関するデータを提供した場合、または、データ提供にあたって故意により瑕疵のあるヒトに関するデータを提供した場合には、DBCLSは、当該データのデータ提供者の所属機関の長への当該事実の報告や、当該事実のウェブサイト等での公表を実施することがある。また、これらの事由により、１．運用原則に記載の『NBDCヒトデータベース』の運用を行えない等の損害を受けたとDBCLSが判断した場合には、DBCLSはデータ提供者に対して、その賠償を求めることがある。</p>\r\n<div class=\"text-tip\">セキュリティレベル（Type Ⅰ、Type Ⅱ）については、「<a href=\"/guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">NBDCヒトデータ取扱いセキュリティガイドライン</a><span>」</span>を参照すること。</div>\r\n<div style=\"border-style: solid; border-width: 1px; margin-top: 10px; padding-left: 5px; padding-right: 5px;\">\r\n<h5><strong><span style=\"color: #000000;\">＜同意文書・説明文書の記載内容例について＞</span></strong></h5>\r\n<h6><strong><span style=\"color: #000000;\">◆同意文書</span></strong></h6>\r\n<div><strong>【必須項目】</strong></div>\r\n<div>\r\n<ul style=\"list-style-type: circle;\">\r\n<li>データベースへの研究データの登録及び国内外の多くの研究者間におけるデータの共有について</li>\r\n</ul>\r\n</div>\r\n<h6><strong><span style=\"color: #000000;\">◆説明文書</span></strong></h6>\r\n<div><strong>【必須項目】</strong></div>\r\n<div>\r\n<ul style=\"list-style-type: circle;\">\r\n<li>\r\n<p>データベースへの研究データの登録及び国内外の多くの研究者間における共有について</p>\r\n<ul>\r\n<li>\r\n<p>[具体的な記述例：本研究で得られたデータは、公衆衛生の向上に貢献する他の研究を行う上でも重要なデータとなるため、データを公的データベース（あるいは：情報・システム研究機構 データサイエンス共同利用基盤施設 ライフサイエンス統合データベースセンター（DBCLS）が運用するデータベース）に登録し、国内外の多くの研究者と共有します。]</p>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>\r\n<p>外国にある第三者による利用について</p>\r\n<ul>\r\n<li>\r\n<p>[具体的な記述例：将来、どの国の研究者がデータを利用するか現時点ではわかりません。しかし、どの国の研究者に対しても、日本国内の法令や指針に沿って作成されたデータベースのガイドライン等に準じた利用が求められます。]</p>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>\r\n<div><strong>【含まれることが望ましい項目】</strong></div>\r\n<ul style=\"list-style-type: circle;\">\r\n<li>\r\n<div>DBCLSについて</div>\r\n<ul>\r\n<li>[具体的な記述例：情報・システム研究機構 データサイエンス共同利用基盤施設 ライフサイエンス統合データベースセンター（DBCLS）は様々な研究成果を広く共有することを目的とした事業を実施しており、様々な研究成果を格納する公的なデータベースを運用することで、迅速な研究の推進を目指しています。DBCLSが運用するデータベースの1つであるNBDCヒトデータベースでは、個人情報の保護に配慮しつつヒトに関する様々なデータを広く共有し、本研究を含む貴重なデータを最大限に活用することで、医学研究等の迅速な発展を目指しています。そのため、国内の研究機関における研究利用に留まらず、学術研究や公衆衛生の向上に貢献する製薬等民間企業や海外の機関における研究へのデータ利用も促進しています。なお、NBDCヒトデータベースでは、日本の法令や指針に準拠した厳格なガイドラインに基づいてデータの管理・公開を行っています。詳しくは、DBCLSホームページ[<a href=\"https://dbcls.rois.ac.jp/\" target=\"_blank\" rel=\"noopener noreferrer\">https://dbcls.jp/</a>]をご覧ください。]</li>\r\n</ul>\r\n</li>\r\n<li>\r\n<div>データを共有することの必要性・重要性</div>\r\n<ul>\r\n<li><span>[具体的な記述例：研究結果がデータベースを介して国内外の研究者に利用されることによって研究全体が推進され、新規技術の開発が進むとともに、今まで不可能であった疾患の原因の解明や治療法・予防法の確立に貢献する可能性があります。]</span></li>\r\n</ul>\r\n</li>\r\n<li>\r\n<div>公開されるデータについて</div>\r\n<ul>\r\n<li>[具体的な記述例：研究から得られたデータをデータベースから公開する際には、データの種類によってアクセスレベル（制限公開、非制限公開）が異なります。個人の特定につながらない、頻度情報・統計情報等は非制限公開データとして不特定多数の者に利用され、個人毎のゲノムデータ等は制限公開データとし、科学的観点と研究体制の妥当性に関する審査を経た上で、データの利用を承認された研究者に利用されます。]</li>\r\n</ul>\r\n</li>\r\n<li>\r\n<div>撤回が不可能なデータについて</div>\r\n<ul>\r\n<li>[具体的な記述例：研究成果が論文や学会等で発表された場合は、同意を撤回されても論文や学会で発表された内容を取り下げることはできません。また、公的データベースから個人毎のデータが公開されている場合であっても、あなたのデータを特定できない場合は破棄できない可能性があります。]</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>\r\n<h4><strong><span style=\"color: #000000;\">４－３．提供の手順</span></strong></h4>\r\n<ol>\r\n<li>データ提供者は、「４－２．データ提供者の責務」に示している責務を満たしていることを確認する。</li>\r\n<li>データ提供者は、非制限公開データ・制限公開データ選択、公開待機データの場合の公開時期の設定などについて、ヒトデータ審査委員会事務局と調整等を行う。</li>\r\n<li>データ提供者は、<a href=\"/data-submission\">データ提供申請の手順</a>に沿ってデータ提供申請を行う。その際に、研究計画書（倫理審査申請書）写し、承認通知書写しおよびインフォームドコンセントの同意文書・説明文書のフォームを添付すること。ただし、研究全体の当初の倫理審査等においてデータベースへのデータ登録とデータ共有が許可されている場合には、その旨を示す書類を承認通知書写しに代えることが出来る。</li>\r\n<li>ヒトデータ審査委員会は、データ受入れ可否について審査する。</li>\r\n<li>データ提供申請が承認された場合、データ提供者は提供するデータセット（非制限公開データあるいは制限公開データ）を作成する。</li>\r\n<li>データ提供者は、DBCLSが指示する方法に従って、データおよび必要な付随データを送付する。</li>\r\n<li>データのアップデートおよび分類見直し等のデータの変更については、データ提供者とヒトデータ審査委員会事務局との協議に基づき、必要に応じて実施する。</li>\r\n</ol>\r\n<h3><strong><span style=\"color: #000000;\">５．『NBDCヒトデータベース』からのデータの利用について</span></strong></h3>\r\n<h4><strong><span style=\"color: #000000;\">５－１．利用資格</span></strong></h4>\r\n<h5><strong><span style=\"color: #000000;\">５－１－１　非制限公開データ</span></strong></h5>\r\n<p>誰でも利用可能である。</p>\r\n<h5><strong><span style=\"color: #000000;\">５－１－２　登録者公開データ</span></strong></h5>\r\n<p>制限公開データの利用についてヒトデータ審査委員会による承認を受けたデータ利用期間中の研究者が利用可能とする。登録の際には、所属機関が発行するメールアドレスを提示すること。</p>\r\n<ol>\r\n<li>研究に従事したことのある研究者（大学、公的研究機関、または民間企業等に所属しており、関連研究に関する研究歴のある人）。学術研究もしくは公衆衛生の向上に貢献する研究への利用に限る。</li>\r\n</ol>\r\n<h5><strong><span style=\"color: #000000;\">５－１－３　制限公開データ</span></strong></h5>\r\n<p>研究代表者として利用申請できるのは、データセット毎に付加された制限事項に示されるデータ利用者要件を満たす研究者とする。データ利用申請の際には所属機関が発行するメールアドレスを提示すること。</p>\r\n<ol>\r\n<li>関連研究に従事したことのある研究者（大学、公的研究機関、または民間企業等に所属しており、関連研究に関する研究歴のある人）。学術研究もしくは公衆衛生の向上に貢献する研究への利用に限る。申請の際に、利用を希望するデータと関係のある研究に関するこれまでの論文等を提示すること。</li>\r\n</ol>\r\n<h4><strong><span style=\"color: #000000;\">５－２．データ利用者の権利</span></strong></h4>\r\n<h5><strong><span style=\"color: #000000;\">５－２－１　非制限公開データ</span></strong></h5>\r\n<ol>\r\n<li>データ利用者は、『NBDCヒトデータベース』のデータを利用した研究成果をデータ利用者の責務及びデータ毎に付加された制限事項を遵守する限り自由に発表できる。</li>\r\n<li>データ利用者は、『NBDCヒトデータベース』のデータを利用した研究結果をもとにした知的財産権を、データ利用者の責務及びデータ毎に付加された制限事項を遵守する限り自由に取得できる。</li>\r\n</ol>\r\n<h5><strong><span style=\"color: #000000;\">５－２－２　登録者公開データ</span></strong></h5>\r\n<ol>\r\n<li>データ利用の登録が完了した者は、登録者公開データを閲覧することができる。</li>\r\n</ol>\r\n<h5><strong><span style=\"color: #000000;\">５－２－３　制限公開データ</span></strong></h5>\r\n<ol>\r\n<li>データ利用者は、『NBDCヒトデータベース』のデータを利用した研究成果をデータ利用者の責務及びデータ毎に付加された制限事項を遵守する限り自由に発表できる。</li>\r\n<li>データ利用者は、『NBDCヒトデータベース』のデータを利用した研究結果をもとにした知的財産権を、データ利用者の責務及びデータ毎に付加された制限事項を遵守する限り自由に取得できる。</li>\r\n<li>データ利用者は、所属組織LANに接続するデータサーバの他、『機関外サーバ』の指定領域に、データベースセンターからデータをダウンロードして保管・利用することができる。</li>\r\n<li>データ利用者は、DBCLSおよび生命情報・DDBJ センターが加工したデータ（特定の解析パイプラインにより加工したアライメントデータ・バリアントコールデータ・統計データ等）を利用することができる。</li>\r\n</ol>\r\n<h4><strong><span style=\"color: #000000;\">５－３．データ利用者の責務</span></strong></h4>\r\n<h5><strong><span style=\"color: #000000;\">５－３－１　非制限公開データ</span></strong></h5>\r\n<ol>\r\n<li>データ利用者は、データ利用に際してのデータの品質・内容・科学的妥当性について、データ利用者の責任と判断のもとで活用すること。</li>\r\n<li>データ利用者は、NBDCヒトデータベースから取得したデータおよび当該データを加工したデータについて、下記の事項を遵守すること。\r\n<div style=\"border-style: solid; border-width: 1px; margin-left: 20px; padding-left: 5px;\">\r\n<p>データの利用にあたって遵守すべき基本的事項</p>\r\n<ul>\r\n<li style=\"list-style-type: none;\">\r\n<ul style=\"list-style-type: circle;\">\r\n<li>研究・開発利用への限定</li>\r\n<li>武器開発・軍事への利用禁止</li>\r\n<li>個人同定の禁止</li>\r\n<li>最新データのダウンロード及び使用</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>\r\n</li>\r\n<li>データ利用者は、NBDCヒトデータベースを通じて提供されたデータを含む解析結果を論文等で公表する際は、使用したデータセットのアクセッション番号を記載すること。また、当該データセットについて報告した論文の引用、もしくは謝辞（Acknowledgement）として以下の内容**を記述すること。\r\n<div style=\"border-style: solid; border-width: 1px; margin-left: 20px; padding-left: 5px;\">\r\n<p>**【謝辞の例】</p>\r\n<p>「本研究に使用したデータ（の一部）はAAAAプロジェクト/研究グループ（代表者 BBBB）によって取得され、情報・システム研究機構 データサイエンス共同利用基盤施設 ライフサイエンス統合データベースセンター（DBCLS）の『NBDCヒトデータベース』ウェブサイトを通じて提供されたものです。」</p>\r\n<p>\"(A part of) The data used for this research was originally obtained by AAAA research project/group led by Prof./Dr. BBBB and available at the website of the NBDC Human Database website of the Database Center for Life Science (DBCLS) / the Joint Support-Center for Data Science Research of the Research Organization of Information and Systems.\"</p>\r\n</div>\r\n</li>\r\n</ol>\r\n<h5><strong><span style=\"color: #000000;\">５－３－２　登録者公開データ</span></strong></h5>\r\n<ol>\r\n<li>データ利用者は、データ利用に際してのデータの品質・内容・科学的妥当性について、データ利用者の責任と判断のもとで活用すること。</li>\r\n<li>データ利用者は、登録者公開データを使用した研究を実施する場合、元データの利用申請を行い、ヒトデータ審査委員会の承認を受ける必要がある。</li>\r\n<li>データ利用者は、登録者公開データを使用するための登録を実施した本人以外の者が登録者公開データを閲覧しないようにすること。</li>\r\n<li>データ利用者は、登録者公開データを論文等で引用する際は、引用するデータセットのアクセッション番号を記載すること。</li>\r\n</ol>\r\n<h5><strong><span style=\"color: #000000;\">５－３－３　制限公開データ</span></strong></h5>\r\n<ol>\r\n<li>データ利用者は、データ利用に際してのデータの品質・内容・科学的妥当性について、データ利用者の責任と判断のもとで活用すること。</li>\r\n<li>データ利用者は、データ利用者の全責任（第三者に対する責任を含む）のもとでデータを使用すること（受託者の監督も含む）。なお、データの管理及び取扱いに問題が発生した際は、データ利用者だけではなく、所属機関長にもその責任が及ぶことを理解し了承すること。</li>\r\n<li>データ利用者は、NBDCヒトデータベースに登録されている制限公開データを利用する際には、人を対象とする生命科学・医学系研究に関する倫理指針を遵守しなければならない。すなわち、データ利用者は、『NBDCヒトデータベース』から取得したデータを含む人を対象とする生命科学・医学系研究を実施する際は、あらかじめ研究計画書を作成し、所属機関等の倫理審査委員会の審査・承認、ならびに、所属機関の長の許可を受けなければならないことを含む。</li>\r\n<li>データ利用者は、NBDCヒトデータベースから取得したデータおよび当該データを加工したデータについて、下記の事項を遵守すること。\r\n<div style=\"border-style: solid; border-width: 1px; margin-left: 20px; padding-left: 5px;\">\r\n<p>データの利用にあたって遵守すべき基本的事項</p>\r\n<ul>\r\n<li style=\"list-style-type: none;\">\r\n<ul style=\"list-style-type: circle;\">\r\n<li>データ利用者の限定（申請された研究代表者および研究代表者と同一機関に所属する研究分担者、および受託者に限る）</li>\r\n<li>利用目的の明示</li>\r\n<li>申請した利用目的以外への使用の禁止</li>\r\n<li>研究・開発利用への限定</li>\r\n<li>武器開発・軍事への利用禁止</li>\r\n<li>個人同定の禁止</li>\r\n<li>再配布の禁止（個人識別性・一次データ復元性のない、あるいは非常に低い加工データ※の配布は禁止の対象となる再配布にはあたらない。ただし、原則として別途、二次データ保管・加工データ配布申請が必要である）</li>\r\n</ul>\r\n<p>※<a href=\"faq#faq-21\" target=\"_blank\" rel=\"noopener\">FAQ</a>を参照のこと</p>\r\n</li>\r\n</ul>\r\n</div>\r\n</li>\r\n<li>データ利用者は、「NBDCヒトデータ取扱いセキュリティガイドライン（データ利用者向け）」を遵守しデータを安全に取り扱うこと（受託者の施設での保管・利用も含む）。なお、データごとに守るべきセキュリティレベル*が異なるので留意すること。また、ヒトデータ審査委員会あるいはDBCLSから依頼された第三者が実施するセキュリティ対策の実施状況についての監査に応じなければならない。\r\n<div style=\"border-style: solid; border-width: 1px; margin-left: 20px; padding-left: 5px;\">\r\n<p>*【セキュリティレベルについて】</p>\r\n<p>原則として標準レベル[Type Ⅰ]のセキュリティが求められるが、データ提供者とヒトデータ審査委員会との協議に基づき、ハイレベル[Type Ⅱ]のセキュリティが求められる場合がある。[Type Ⅰ]、[Type Ⅱ]の詳細については「NBDCヒトデータ取扱いセキュリティガイドライン（データ利用者向け）」を参照すること。</p>\r\n</div>\r\n</li>\r\n<li>データ利用者は、セキュリティレベル（Type Ⅰ、Type Ⅱ）に応じたセキュリティ管理体制を構築し、DBCLSが提示する基準に適合していることを確認するため、\"NBDCヒトデータ取扱いセキュリティガイドラインチェックリスト\"をヒトデータ審査委員会事務局へ提出しなければならない。受託者がデータを利用する場合や、受託者の施設が保有するデータサーバにデータを保管する場合は、当該施設の“NBDCヒトデータ取扱いセキュリティガイドラインチェックリスト”もヒトデータ審査委員会事務局へ提出しなければならない。</li>\r\n<li>データ利用者は、データ利用に際して『機関外サーバ』を利用する場合、NBDCヒトデータ共有ガイドライン及びNBDCヒトデータ取扱いセキュリティガイドラインに加えて、各『機関外サーバ』のシステム利用規約に従うこと。</li>\r\n<li>データ利用者は、万が一、利用データの漏えい等セキュリティに関する事故が生じた場合は直ちにネットワークから対象機器を切り離し、DBCLSに通報すること。その後の事故処理については、DBCLSの指示に従い、速やかに実施すること（受託者の施設での事故も含む）。『機関外サーバ』利用の場合には、サーバの利用規程等に従って、直ちに対策を実施するものとする。</li>\r\n<li>データ利用者がNBDCヒトデータベースからダウンロードして利用中のデータセットの中に、同意撤回やオプトアウトにおける拒否等についての連絡があった場合は、それ以降当該データを利用しないこと。</li>\r\n<li>データ利用者は、データ利用終了時には『NBDCヒトデータベース』から取得したすべてのデータ（データ全体あるいはデータの一部が保管してあればそのデータすべて。機関外サーバを利用した場合は、機関外サーバ内に保管したデータならびに機関外サーバ側のバックアップデータを含むすべて。）及び当該データを復元可能なすべてのデータをNBDCヒトデータ取扱いセキュリティガイドラインに沿って削除し（機関外サーバ側のバックアップデータについては削除される時期を確認し）、データ利用終了申請によりデータ使用（および破棄）の報告を行うこと（受託者の施設での保管および利用も含む）。データを利用した集計・統計解析結果等の二次データの保管や、個人識別性・一次データ復元性のない、あるいは非常に低い加工データの配布については「５－４．利用の手順」の「５－４－３　制限公開データ」を参照のこと。なお、二次データに個人識別符号に該当するデータを含む場合は個人情報として適切に管理するとともに、当該二次データの配布を禁止する。</li>\r\n<li>データ利用者は、NBDCヒトデータベースを通じて提供されたデータを含む解析結果を論文等で公表する際は、使用したデータセットのアクセッション番号を記載すること。また、当該データセットについて報告した論文の引用、もしくは謝辞（Acknowledgement）として以下の内容**を記述すること。\r\n<div style=\"border-style: solid; border-width: 1px; margin-left: 20px; padding-left: 5px;\">\r\n<p>**【謝辞の例】</p>\r\n<p>「本研究に使用したデータ（の一部）はAAAAプロジェクト/研究グループ（代表者 BBBB）によって取得され、情報・システム研究機構 データサイエンス共同利用基盤施設 ライフサイエンス統合データベースセンター（DBCLS）の『NBDCヒトデータベース』ウェブサイトを通じて提供されたものです。」</p>\r\n<p>\"(A part of) The data used for this research was originally obtained by AAAA research project/group led by Prof./Dr. BBBB and available at the website of the NBDC Human Database website of the Database Center for Life Science (DBCLS) / the Joint Support-Center for Data Science Research of the Research Organization of Information and Systems.\"</p>\r\n</div>\r\nなお、JGAのサービスを利用した場合は以下の論文を引用することが望ましい。 <a href=\"http://nar.oxfordjournals.org/content/43/D1/D18\" target=\"_blank\" rel=\"noopener noreferrer\">Nucleic Acids Res. 2015, 43 Database issue: D18-D22.</a></li>\r\n<li>データ利用者は、『NBDCヒトデータベース』利用状況の公開にあたり、DBCLSが個別情報あるいは統計情報を公表することについて了承すること（公開される個別情報の例：利用データのDataset ID、データ利用者氏名、所属機関、国・州名、データ利用期間、研究題目）。</li>\r\n<li>データ利用者は、『NBDCヒトデータベース』利用状況の公開に資するため、DBCLSが、データ利用者の申請時から利用終了報告時の情報、事故発生時の情報等データ利用に関する情報を保持していることを了承すること（受託者に関する情報も含む）。</li>\r\n</ol>\r\n<p>データ利用者が、NBDCヒトデータ共有ガイドライン等に違反してヒトに関するデータを利用した場合、または、データ利用にあたって故意もしくは過失により情報漏洩等が起きた場合には、DBCLSは、データ利用の許可の取り消しや、データ利用者の所属機関の長への当該事実の報告や、当該事実のウェブサイト等での公表を実施することがある。また、これらの事由により、１．運用原則に記載の『NBDCヒトデータベース』の運用を行えない等の損害を受けたとDBCLSが判断した場合には、DBCLSはデータ利用者に対して、その損害の賠償を求めることがある。なお、以上の内容は研究代表者だけでなく研究分担者や受託者にも適用され、研究代表者は研究分担者や受託者が本ガイドラインおよび「NBDCヒトデータ取扱いセキュリティガイドライン（データ利用者向け）」を遵守することに対して責任を持つものとする。</p>\r\n<h4><strong><span style=\"color: #000000;\">５－４．利用の手順</span></strong></h4>\r\n<h5><strong><span style=\"color: #000000;\">５－４－１　非制限公開データ</span></strong></h5>\r\n<p>データ利用者は、『NBDCヒトデータベース』ウェブサイト（<a href=\"https://humandbs.dbcls.jp/\" target=\"_blank\" rel=\"noopener noreferrer\">https://humandbs.dbcls.jp/</a>）から、法令の範囲内において自由に利用することが可能である。</p>\r\n<h5><strong><span style=\"color: #000000;\">５－４－２　登録者公開データ</span></strong></h5>\r\n<ol>\r\n<li>ヒトデータ審査委員会の承認を受けたデータ利用期間中の研究者のうち、登録者公開データの利用を希望する者は、DBCLSが指定する研究者情報を登録する。</li>\r\n<li>データへのアクセスに必要な情報が提供されるので、データ利用者はデータにアクセスする。</li>\r\n</ol>\r\n<h5><strong><span style=\"color: #000000;\">５－４－３　制限公開データ</span></strong></h5>\r\n<ol>\r\n<li>データ利用者は、<a href=\"/data-use\">データ利用申請の手順</a>に沿ってデータ利用申請を行う。この時、別組織に所属する複数の研究者が共同研究を行う場合は、それぞれの組織毎にデータ利用申請を行う。受託者がいる場合は、データ利用申請に含めること。</li>\r\n<li>データ利用者は、『NBDCヒトデータベース』利用に関連して、所属機関等の倫理審査委員会の審査・承認を得たうえで、所属機関の長が許可した通知書の写しをデータ利用申請の際に提出する。ただし、審査免除であることが倫理審査委員会で決定された場合は、その旨が記載された書面等を提出する。</li>\r\n<li>データ利用者は、利用申請に際して、\"<a href=\"files/security_checklist_for_users.xlsx\">NBDCヒトデータ取扱いセキュリティガイドラインチェックリスト</a>\"やその他ヒトデータ審査委員会が求める情報や資料を提出する。</li>\r\n<li>ヒトデータ審査委員会は、データ利用可否について審査する。</li>\r\n<li>ヒトデータ審査委員会によりデータ利用申請が認められた後に、データへのアクセス権限が付与されるので、データ利用者はデータにアクセスする。</li>\r\n<li>データ利用者は、1年毎にデータの利用状況を、データ利用報告申請（制限公開データ用）により報告する。また、その際に\"<a href=\"files/security_checklist_for_users.xlsx\">NBDCヒトデータ取扱いセキュリティガイドラインチェックリスト</a>\"を再度提出する。</li>\r\n<li>データ利用者は、個人識別性・一次データ復元性のない、あるいは非常に低い加工データの配布を希望する場合は、データ利用終了申請の中の加工データ配布申請にて、ヒトデータ審査委員会事務局へ申請する。</li>\r\n<li>データ利用者は、当初のデータ利用期間を超えて当該データセットの利用を希望する場合は、データ利用期間満了の一か月前までに、所属機関等の倫理審査の承認通知書等（承認された研究期間がわかる書類）と共にデータ利用継続希望期間をヒトデータ審査委員会事務局に申請する。</li>\r\n<li>データ利用者は、データの利用が終了した場合、速やかにすべてのデータ（データ全体あるいはデータの一部が保管してあればそのデータすべて。機関外サーバを利用した場合は、機関外サーバ内に保管したデータならびに機関外サーバ側のバックアップデータを含むすべて。）及び当該データを復元可能なすべてのデータをNBDCヒトデータ取扱いセキュリティガイドラインに沿って削除し（機関外サーバ側のバックアップデータについては削除される時期を確認し）、データ利用終了申請によりヒトデータ審査委員会事務局へデータ使用（および破棄）の報告を行う（受託者の施設での保管および利用も含む）。この時、データを利用することによって生じた集計・統計解析結果等の二次データの保管や、個人識別性・一次データ復元性のない、あるいは非常に低い加工データの配布についてはデータ利用終了申請の中の二次データ保管・加工データ配布申請内容を記載し、ヒトデータ審査委員会事務局へ保管・配布申請を行うことで保管・配布できる。ただし、加工の程度や保管期間によっては申請を却下することがある。</li>\r\n</ol>\r\n<h4><strong><span style=\"color: #000000;\">５－５．利用に関する費用</span></strong></h4>\r\n<p>データの利用に際して実費が発生する場合（データの転送にメディア等が必要となる場合や、『機関外サーバ』利用をする場合など）はデータ利用者の負担とする。</p>\r\n<h4><strong><span style=\"color: #000000;\">５－６．利用の停止</span></strong></h4>\r\n<ol>\r\n<li>データ利用者に「５－３．データ利用者の責務」の各事項に対する違反、またはセキュリティガイドラインに反することが疑われる場合、DBCLSにおいて不正に関する調査を行ない、調査結果に基づいてヒトデータ審査委員会が不正の有無を判断する（受託者も含む）。不正と判断した場合は、<ol>\r\n<li>データ利用者に対しデータの利用停止を命じ、利用中のデータへのアクセス許可を取消す。</li>\r\n<li>不正を行なった研究者からの新規利用申請を一定期間受け付けない。期間についてはヒトデータ審査委員会において決定する。</li>\r\n<li>必要に応じてデータ利用者の所属機関長に報告する。</li>\r\n</ol>\r\n<p>ただし、状況に応じて、疑いがある段階で利用停止を命じることがある。データ利用者は利用停止の連絡を受け次第、直ちに取得済みデータおよび二次データの全てを消去しなければならない（受託者の施設での保管も含む）。また、データ利用終了申請にてヒトデータ審査委員会事務局へデータの破棄状況を速やかに報告すること。</p>\r\n</li>\r\n<li>データ利用者が利用中のデータがデータ提供者の責務違反により公開停止となった場合は、データ利用者にデータの利用停止を求めることがある。その際は、データ利用者に対しデータ利用終了時の手続きと同様の手続きを求める。データ提供者の責務違反により生じたあらゆる損害等については、理由の如何に関わらず、DBCLSは一切責任を負わないこととする。</li>\r\n</ol>\r\n<h3><strong><span style=\"color: #000000;\">６．本ガイドラインの改訂手続きについて</span></strong></h3>\r\n<h4><strong><span style=\"color: #000000;\">６－１．改訂内容の提案</span></strong></h4>\r\n<p>データ提供者、データ利用者あるいはデータの利用を検討している者は本ガイドラインを改訂することによって、ヒトに関するデータがより円滑に提供・利用できると考えられる点があれば、事務局へ提案することができる。その際、具体的な提案や該当箇所等を示すこと。</p>\r\n<h4><strong><span style=\"color: #000000;\">６－２．改訂内容の検討</span></strong></h4>\r\n<p>上記の提案を受けた場合、速やかにその内容をデータ共有分科会で検討し、提案内容の採否あるいは修正について決定するものとする。</p>\r\n<h4><strong><span style=\"color: #000000;\">６－３．改訂内容の公表・適用</span></strong></h4>\r\n<p>改訂内容が決定した場合、速やかにその改訂内容をウェブサイトにおいて告知し、データ共有分科会が定める一定の期間ののち適用する。なお、適用前にデータ提供あるいはデータ利用の申請を行って許可された者に対しても、改訂後のガイドラインが適用されるものとする。</p>\r\n<h3><strong><span style=\"color: #000000;\">７．その他</span></strong></h3>\r\n<h4><strong><span style=\"color: #000000;\">７－１．データ提供申請情報およびデータ利用申請情報の公開について</span></strong></h4>\r\n<p>『NBDCヒトデータベース』に対する個別の申請情報のうち、申請者の承諾が得られた情報は公開されるものとする。その他の情報に関しては、ヒトデータ審査委員会委員およびヒトデータ審査委員会事務局員はこれを関係者以外に公開してはならない。</p>\r\n<h4><strong><span style=\"color: #000000;\">７－２．不正確なデータ等の指摘について</span></strong></h4>\r\n<p>『NBDCヒトデータベース』における不正確なデータについてのデータ利用者からの指摘は、ヒトデータ審査委員会が受付けて、データ提供者に通知し、対応を協議するものとする。同意取得方法の不備や同意の捏造の可能性等に関する同意者等からの指摘についても同様とする。<br />連絡先： ヒトデータ審査委員会事務局　humandbs@dbcls.jp</p>\r\n<h4><strong><span style=\"color: #000000;\">７－３．ねつ造や改ざん等による研究不正に関する調査について</span></strong></h4>\r\n<ol>\r\n<li>『NBDCヒトデータベース』に格納されているデータについて、DBCLSに研究不正に関する調査への協力依頼があった際には、DBCLSは協力することがある。</li>\r\n<li>不正調査委員会等の責任者は、検証を実施するために必要なデータのDataset IDと検証の必要性についてDBCLSへ申し出ると共に、データを保管するサーバのセキュリティ状況を\"<a href=\"files/security_checklist_for_users.xlsx\">NBDCヒトデータ取扱いセキュリティガイドラインチェックリスト</a>\"を用いて報告すること。</li>\r\n<li>不正調査委員会等の責任者の全責任のもとでデータを使用すること。</li>\r\n<li>不正調査委員会等の責任者は、５－３．データ利用者の責務５－３－３．制限公開データ４．『データの利用にあたって遵守すべき基本的事項』を遵守すること。</li>\r\n</ol>\r\n<h3><strong><span style=\"color: #000000;\">参照</span></strong></h3>\r\n<p><a href=\"/guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">NBDCヒトデータ取扱いセキュリティガイドライン</a></p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p style=\"text-align: right;\">以上</p>", "publish_up": "2022-04-01"}, {"lang": "en", "path": "guidelines/data-sharing-guidelines", "title": "NBDC Guidelines for Human Data Sharing ver. 8.0", "fulltext": "", "modified": "2025-01-09", "introtext": "<p style=\"text-align: right;\">April 1, 2024<br />Ver. 8.0</p>\r\n<h3><strong><span style=\"color: #000000;\">Introduction</span></strong></h3>\r\n<p>An enormous amount of human data is being generated as advancements are made in analytical techniques such as next-generation sequencing. Rules and systems are therefore needed for storing such data in an organized manner and for effectively utilizing them to make progress in life sciences and to improve public health.</p>\r\n<p>To promote sharing and utilization of human data for the above purposes while considering protection of personal information, <a href=\"https://biosciencedbc.jp/en/\" target=\"_blank\" rel=\"noopener noreferrer\">the Department of NBDC Program (hereinafter, NBDC)</a> of the Japan Science and Technology Agency (JST) has been operating a platform for sharing various human-related data (hereinafter, the NBDC Human Database). The operational entity of the NBDC Human Database has changed from NBDC to <a href=\"https://dbcls.rois.ac.jp/index-en.html\" target=\"_blank\" rel=\"noopener noreferrer\">the Database Center for Life Science (DBCLS)</a> / the Joint Support-Center for Data Science Research (DS) of the Research Organization of Information and Systems (ROIS) and from now on DBCLS will operate the database and implement revisions to rules and guidelines (hereinafter, the Guidelines).</p>\r\n<p>The Guidelines are designed to be applied to human data in general that were generated using public funds. Because the relevant guidelines, policies, and laws are amended as necessary to appropriately reflect, the consistency has not been verified between the Guidelines and all of them. In addition, global trends concerning life science data as well as the attitude of the general public toward scientific data are expected to change. To respond to such changes, the Guidelines are reviewed and revised whenever it becomes necessary.</p>\r\n<h4><span style=\"color: #000000;\"> Contact information:</span></h4>\r\n<p>For information on the Guidelines</p>\r\n<p>Data Sharing Subcommittee Office <br />humandbs@dbcls.jp</p>\r\n<p>For information on data use or data submission for the NBDC Human Database</p>\r\n<p>Human Data Review Board Office <br />humandbs@dbcls.jp</p>\r\n<h3><strong><span style=\"color: #000000;\">Contents</span></strong></h3>\r\n<ol>\r\n<li>Principles</li>\r\n<li>Definitions</li>\r\n<li>Acceptable Data</li>\r\n<li>Data Submission to the NBDC Human Database</li>\r\n<li>Using Data in the NBDC Human Database</li>\r\n<li>Procedure for Revising the Guidelines</li>\r\n<li>Other Topics</li>\r\n</ol><hr />\r\n<h3><strong><span style=\"color: #000000;\"> 1. Principles </span></strong></h3>\r\n<ol>\r\n<li>The NBDC Human Database is administered toward the following goals.\r\n<ul style=\"list-style: none;\">\r\n<li>1: Collecting human data generated using public funds as much as possible</li>\r\n<li>2: Promoting wide sharing of collected data</li>\r\n<li>3: Respecting to the greatest extent possible the rights of individuals who are research subjects</li>\r\n</ul>\r\n</li>\r\n<li>The DBCLS performs the following in administering the NBDC Human Database.<ol style=\"list-style-type: lower-roman;\">\r\n<li>Maintaining the Guidelines and reexamining them as the need arises</li>\r\n<li>Reviewing applications for data use and data submission</li>\r\n<li>Maintaining a means to access data, e.g., website maintenance</li>\r\n</ol></li>\r\n</ol>\r\n<h3><strong><span style=\"color: #000000;\"> 2. Definitions </span></strong></h3>\r\n<ol>\r\n<li>Human data\r\n<ul style=\"list-style: none;\">\r\n<li>Data generated as a result of a study using human-derived specimens. Such data include genomic and genetic information, clinical information, image information, and so on.</li>\r\n</ul>\r\n</li>\r\n<li>Public funds/grants\r\n<ul style=\"list-style: none;\">\r\n<li>Funds provided by national and local governments, incorporated administrative agencies, and equivalent organizations.</li>\r\n</ul>\r\n</li>\r\n<li>Research subject\r\n<ul style=\"list-style: none;\">\r\n<li>A person who has provided a sample such as his/her own tissue, blood, and urine, or his/her own data, for an activity such as a study or research project.</li>\r\n</ul>\r\n</li>\r\n<li>Data submitter\r\n<ul style=\"list-style: none;\">\r\n<li>A principal investigator (hereinafter, PI), who provides human data to the NBDC Human Database.</li>\r\n</ul>\r\n</li>\r\n<li>Data user\r\n<ul style=\"list-style: none;\">\r\n<li>A PI and his/her research collaborators, who use human data from the NBDC Human Database. Research collaborators must belong to the same organization as the PI, and have been listed as data users in the application for data use filed by the PI.</li>\r\n</ul>\r\n</li>\r\n<li>Principal investigator (PI)\r\n<ul style=\"list-style: none;\">\r\n<li>An investigator responsible for the study. (The investigator who submitted a research protocol to the Ethical Review Committee of his/her affiliated or an equivalent organization and obtained its approval, or a research collaborator who is listed in the application for the ethical review of the study.)</li>\r\n</ul>\r\n</li>\r\n<li>Unrestricted-access data\r\n<ul style=\"list-style: none;\">\r\n<li>Data available for use without any access restrictions. Examples include statistical data or reference data previously disclosed in a published paper.</li>\r\n</ul>\r\n</li>\r\n<li>Data accessible to registered users （Registered-access data）\r\n<ul style=\"list-style: none;\">\r\n<li>Data available to investigators who have been approved by the Human Data Review Board for the usage of controlled-access data, during the data usage period. Included are statistical data created by processing each dataset registered as the controlled-access data at the NBDC Human Database.</li>\r\n</ul>\r\n</li>\r\n<li>Controlled-access data\r\n<ul style=\"list-style: none;\">\r\n<li>Data available only to investigators for use for research purposes. The access-granted investigators must have research experience in related studies and can use the data for their studies, after clarifying information such as the purpose of data use and data users. For use, approval is required at the review by the Human Data Review Board. Controlled-access data include individual data like nucleotide sequence data containing output from next-generation sequencer, genome-wide variant data, image information, answers to a questionnaire, and so on.</li>\r\n</ul>\r\n</li>\r\n<li>Data for future release\r\n<ul style=\"list-style: none;\">\r\n<li>Data that are planned to be released as unrestricted-access data or controlled-access data after the data submitter makes the results public, e.g., by publication of a paper, acquisition of intellectual property rights, and so on.</li>\r\n</ul>\r\n</li>\r\n<li>Secondary data\r\n<ul style=\"list-style: none;\">\r\n<li>Data that are processed not to be able to restore primary data (controlled-access data shared via NBDC Human Database).</li>\r\n</ul>\r\n</li>\r\n<li>Available server outside of affiliated organization (“Off-premise-server”)\r\n<ul style=\"list-style: none;\">\r\n<li>A server that is not owned by data users’ affiliated organization and that is available to the data users to store and/or process controlled-access data, which “off-premise-server” has a computing environment for analyzing human data. The computing environment is owned by an organization that has concluded with ROIS or DS a memorandum concerning operation including the compliance with the NBDC Security Guidelines for Human Data (for Database Center Operation Managers and “Off-Premise-Server” Operation Managers). In addition, and measures necessary for high level (Type II) security are being implemented in the “off-premise-server.”</li>\r\n</ul>\r\n</li>\r\n<li>Entrustee\r\n<ul style=\"list-style: none;\">\r\n<li>An entity or person who is entrusted by a data user to perform only a part of the work related to a research, such as storage of data or data processing, under the supervision of the data user. When entrusting the work to an entrustee located overseas (outside Japan), the PI at the time of application for data use must implement ethical procedures such as receiving appropriate consent from the research participants and others.</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<h3><strong><span style=\"color: #000000;\">3. Acceptable Data </span></strong></h3>\r\n<h4><span style=\"color: #000000;\"> Overview of acceptable data</span></h4>\r\n<p>The NBDC Human Database accepts a wide range of human data generated in projects that receive public funds. Because this database is aimed for data utilization among many investigators, it cannot be used as a repository for data shared among only limited collaborators of a research group or a consortium. Therefore, data that are provided for such a purpose cannot be accepted.</p>\r\n<p>Data are classified into the following four types according to the state of data release and the level of access restriction (see the figure below).</p>\r\n<ol>\r\n<li>Unrestricted-access data</li>\r\n<li>Registered-access data</li>\r\n<li>Controlled-access data</li>\r\n<li>Data for future release</li>\r\n</ol>\r\n<p>The NBDC Human Database accepts: 1) unrestricted-access data, 3) controlled-access data, and 4) data for future release. The NBDC Human Database accepts only these data that have been pseudonymized by the data submitter by replacing a part or all of personal information which enable identification of a specific individual (including a specific deceased individual) with descriptions, e.g., a code or number which is unrelated to the specific individual, and then by assigning another code or number again. Registered-access data (2.) are data created by the database center from the controlled-access data through processing for the purpose of promoting data use.</p>\r\n<p><img src=\"files/images/dataClassification_e6.png\" alt=\"dataClassification e\" width=\"480\" height=\"270\" style=\"vertical-align: middle; display: block; margin-left: auto; margin-right: auto;\" /></p>\r\n<h3><strong><span style=\"color: #000000;\"> 4. Data Submission to the NBDC Human Database </span></strong></h3>\r\n<h4><strong><span style=\"color: #000000;\"> 4.1 Rights of the Data Submitters </span></strong></h4>\r\n<ol>\r\n<li>Data submitters can designate data use restrictions that conform to those specified in the informed consent form (e.g., limitation on the scope of diseases for data use).</li>\r\n<li>Data submitters, while being asked to agree with prompt release of their data, can request that the data be designated as data for future release for the purpose of publication of research results, acquisition of intellectual property rights, etc. It is noted, however, the release may be delayed only for a term reasonable and necessary for such purposes. Concrete details are determined in a consultation with the Human Data Review Board.</li>\r\n</ol>\r\n<h4><strong><span style=\"color: #000000;\"> 4.2 Responsibilities of Data Submitters </span></strong></h4>\r\n<ol>\r\n<li>The data submitter must obtain permission from the head of his/her affiliated organization after taking the following steps: (1) Explain the required descriptions in the “Examples of Content for Informed Consent Forms” (shown below) to a research subject from whom the human data are collected; (2) Obtain written consent from the research subject regarding submission of the data to databases and sharing of the data by domestic and/or foreign investigators; and (3) Obtain approval regarding such data submission and data sharing from the Ethical Review Committee of the affiliated or an equivalent organization. However, if the data submission and data sharing were approved for the entire research project after an ethical review conducted at the start point of the project, then another review is not required.</li>\r\n<li>When the data submitter provides data to the NBDC Human Database collected from specimens, e.g., human biological specimens, diagnostic specimens, that were obtained without prior intention to submit such data to databases (e.g., in cases where the informed consent form does not refer to data submission or data sharing), the data submitter must follow procedures that conform to the ethical guidelines that must be complied with in conducting the research (for example, the data submitter obtain re-consent. Alternatively, if it is difficult to do re-consent, he/she must ensure information disclosure and opportunities of rejections (opt-out), and obtain permission from the head of his/her affiliated organization after obtaining approval of the Ethical Review Committee of the affiliated or an equivalent organization).</li>\r\n<li>When the data submitter provides data that is clearly not the subject of \"Ethical Guidelines for Medical and Biological Research Involving Human Subjects\" <sup>*[1]</sup> to the NBDC Human Database, the data submitter must submit a \"statement requesting a simplified review of an application for data submission\" (in an arbitrary format) signed by the PI. Submission of this statement can be a substitute for submission of documents concerning ethics review of the affiliated organization (e.g., research protocol, informed consent form, and notice of approval).<br />*[1]: In \"Ethical Guidelines for Medical and Biological Research Involving Human Subjects\", specimens and information, the value of which has already been established academically, widely utilized in research and generally available.</li>\r\n<li>While the Human Data Review Board reviews the descriptions of the informed consent form submitted at the time of application for data submission in terms of the consistency with the restrictions on data use, the data submitter is responsible for ensuring that the data are provided in accordance with the conditions of the consent.</li>\r\n<li>The data submitter must provide data according to the content of the \"application form for submitting data\" to the DBCLS.</li>\r\n<li>The data submitter must confirm that the data to be submitted have been pseudonymized by replacing a part or all of personal information which enables identification of a specific individual (including a specific deceased individual) with descriptions, e.g., a code or number which is unrelated to the specific individual and further by assigning another code or number. In case of withdrawal of consent, in order to delete the data derived from the corresponding research subject, in principle, the data submitter must keep the decoding index.</li>\r\n<li>After selecting the type of data such as unrestricted-access data, controlled-access data, or so on based on consultation with the Human Data Review Board, the data submitter must provide the DBCLS with the data along with any necessary accompanying data (e.g., metadata that explain the main data, as well as information needed for quality control). In addition, for controlled-access data, the data submitter must designate an appropriate security level (Type I or Type II) based on consultation with the Human Data Review Board.</li>\r\n<li>In case the data provided by the data submitter is found to be data that violate the NBDC Human Data Sharing Guidelines etc. or found to be data that contain a defect (including hidden defects) intentionally or with negligence, the DBCLS will suspend publication of the provided data and delete the data. The data submitter must re-provide the data within a certain period of time after fixing data and/or necessary procedures. If re-provided is not done, the DBCLS will cancel the accession number for the data.</li>\r\n<li>When there is a rejection by opt-out or a withdrawal of consent from a research subject from whom the data provided to the NBDC Human Database were derived, the data submitter must cooperate in the disposal of the data in order to avoid subsequent data use.</li>\r\n<li>The data submitter shall consent to the processing of the data conducted by the DBCLS and the DDBJ Center for the purpose of improving the convenience of data users (creation of statistical data for the purpose of publishing an overview of the data, and creation of data, such as alignment data, variant call data, and statistical data processed by a specific analysis pipeline, that can be used by a data user who has been approved for data use by the Human Data Review Board if the user so desires).</li>\r\n</ol>\r\n<p>In case the data submitter provided human data in violation of the NBDC Human Data Sharing Guidelines etc., or provided human data that contain a defect (including hidden defects) intentionally or with negligence, the DBCLS may take one or more further actions such as reporting of the fact to the head of the organization to which the data submitter belongs, announcing of the fact on the website etc., and so on. Besides, the DBCLS may seek compensation from the data submitter, if the DBCLS determines that due to these reasons it has suffered damages such as inability of operation of “the NBDC Human Database” as stated in the section “1. Principles.”</p>\r\n<div class=\"text-tip\">* For the description of the security levels (Type I and Type II), see <a href=\"en/guidelines/security-guidelines-for-users\" target=\"_blank\" rel=\"noopener noreferrer\">the NBDC Security Guidelines for Human Data. </a></div>\r\n<div style=\"border-style: solid; border-width: 1px; margin-top: 10px; padding-left: 5px; padding-right: 5px;\">\r\n<h5><strong><span style=\"color: #000000;\">Examples of Content for Informed Consent Forms</span></strong></h5>\r\n<h5><strong><span style=\"color: #000000;\">Informed Consent Forms</span></strong></h5>\r\n<div><strong> Required description:</strong></div>\r\n<ul style=\"list-style-type: circle;\">\r\n<li>\r\n<div>Registration to a database and sharing of research data among many investigators internationally.</div>\r\n<ul>\r\n<li>Sample statement: Since the data obtained for this study are also important for other studies which contribute to improved public health, they will be submitted to a public database or the database managed by the Database Center for Life Science (hereinafter, DBCLS) / the Joint Support-Center for Data Science Research of the Research Organization of Information and Systems and will be shared with many investigators internationally.</li>\r\n</ul>\r\n</li>\r\n<li>\r\n<div>Use by a third party in a foreign country (outside Japan).</div>\r\n<ul>\r\n<li>Sample statement: It is unknown at this time which countries’ investigators will use the data in the future. However, investigators from any country are required to use the data in accordance with the guidelines of the database that are developed in accordance with the laws and guidelines in Japan.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<div><strong> Items desirable for inclusion:</strong></div>\r\n<ul style=\"list-style-type: circle;\">\r\n<li>\r\n<div>Description of the DBCLS</div>\r\n<ul>\r\n<li>Sample statement: Aiming for rapid advancement in research, the Database Center for Life Science (hereinafter, DBCLS) / the Joint Support-Center for Data Science Research of the Research Organization of Information and Systems conducts projects in order for broad sharing of various research data and operates public databases that store data obtained from various studies. The NBDC Human Database, one of the databases operated by the DBCLS, aims for rapid development of medical research and others by widely sharing various data on humans while paying attention to the protection of personal information and making full use of valuable data including those from this (our) research. For that reason, we are also promoting not only research use in domestic research institutions but also the use of data for research in private companies such as pharmaceuticals and overseas institutions that contribute to academic research or public health improvement. In the NBDC Human Database, data are managed and released based on strict guidelines that conform to Japanese laws, regulations, and so on. For details, please see the DBCLS website (<a href=\"https://dbcls.jp/en/\" target=\"_blank\" rel=\"noopener noreferrer\">https://dbcls.jp/en/</a>).</li>\r\n</ul>\r\n</li>\r\n<li>\r\n<div>The necessity and importance of data sharing</div>\r\n<ul>\r\n<li>Sample statement: The sharing of research data with other domestic and/or foreign investigators through a database can help advance related studies overall and can aid in the development of new technologies. Data sharing may contribute to the elucidation of causes of diseases and the development of new treatments and prevention methods, which have not been enabled.</li>\r\n</ul>\r\n</li>\r\n<li>\r\n<div>Data released to the public</div>\r\n<ul>\r\n<li>Sample statement: When data obtained from research are released from the database, the access level (controlled-access or unrestricted-access) differs depending on the type of data. Aggregated information, e.g., frequency data/statistical data, that does not lead to the identification of individuals are handled as unrestricted-access data and used by many unspecified persons. The genetic information of individuals is handled as controlled-access data and used by researchers approved for data use after passing through a review on the validity of scientific viewpoint and research system.</li>\r\n</ul>\r\n</li>\r\n<li>\r\n<div>Impossibility to remove data</div>\r\n<ul>\r\n<li>Sample statement: When research results have been published in a paper or at an academic conference, even if the consent is withdrawn, the content published in the paper or the conference cannot be withdrawn. In addition, even when data for each individual are published from the public database, your data may not be deleted if your data cannot be identified.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</div>\r\n<h4><strong><span style=\"color: #000000;\"> 4.3 Procedure for Data Submission to NBDC Human Database </span></strong></h4>\r\n<ol>\r\n<li>The data submitter confirms that the responsibilities listed in the above section “4.2 Responsibilities of Data Submitters” are fulfilled.</li>\r\n<li>The data submitter consults and agrees with the Human Data Review Board Office, with regard to the data classification (unrestricted-access data or controlled-access data), the timing of the release in the case of data for future release, and so on.</li>\r\n<li>The data submitter applies for data submission in accordance with <a href=\"/en/data-submission\" target=\"_blank\" rel=\"noopener noreferrer\">the procedure for data submission application</a>. At the time of application, a copy of the research protocol (the application form for ethical review), a copy of the ethical review approval notification, and the informed consent form must be attached. If, however, data submission and data sharing have been approved by an ethical review or equivalent examination held at the beginning of the entire research project, a document indicating that fact may be used instead of a copy of the approval notification.</li>\r\n<li>The Human Data Review Board decides whether the data can be accepted.</li>\r\n<li>When the data submission application is approved, the data submitter prepares the data set to be provided (unrestricted-access data and/or controlled-access data).</li>\r\n<li>The data submitter sends the data with the required accompanying data as instructed by the DBCLS.</li>\r\n<li>Changes to data, such as those due to updating or reclassifying the data, are made as the need arises based on consultation between the data submitter and the Human Data Review Board Office.</li>\r\n</ol>\r\n<h3><strong><span style=\"color: #000000;\"> 5. Using Data in the NBDC Human Database</span></strong></h3>\r\n<h4><strong><span style=\"color: #000000;\"> 5.1 Eligibility for Data Use</span></strong></h4>\r\n<h5><strong><span style=\"color: #000000;\"> 5.1.1 Unrestricted-access data</span></strong></h5>\r\n<p>Anyone can use unrestricted-access data.</p>\r\n<h5><strong><span style=\"color: #000000;\"> 5.1.2 Registered-access data</span></strong></h5>\r\n<p>Data are available to investigators during the data usage period who have been approved by the Human Data Review Board for the usage of controlled-access data. At the time of registration, the investigator needs to present an e-mail address issued by the organization to which he/she belongs.</p>\r\n<ol>\r\n<li>An investigator who has research experience (one who belongs to a university, public research institute, private-sector company, or the like, and who has research experience in conducting relevant studies). The use is limited to academic research or research that contributes to the improvement of public health.</li>\r\n</ol>\r\n<h5><strong><span style=\"color: #000000;\"> 5.1.3 Controlled-access Data</span></strong></h5>\r\n<p>An investigator can apply for data use as the PI if he/she satisfies the data user requirements indicated in the limitation added for each data set. When applying for data use, the investigator must present the mail address issued by his/her affiliated organization.</p>\r\n<ol>\r\n<li>An investigator who has research experience in relevant studies (one who belongs to a university, public research institute, private-sector company, or the like and who has research experience in conducting relevant studies). The use is limited to academic research or research that contributes to the improvement of public health. At the time of application, publications related to the data that the investigator plans to use must be presented.</li>\r\n</ol>\r\n<h4><strong><span style=\"color: #000000;\"> 5.2 Rights of Data Users </span></strong></h4>\r\n<h5><strong><span style=\"color: #000000;\"> 5.2.1 Unrestricted-access data</span></strong></h5>\r\n<ol>\r\n<li>Data users can freely make the result of the study for which data from the NBDC Human Database are used public, as long as the responsibilities of data users and the limitation added for each data set are fulfilled.</li>\r\n<li>Data users can freely acquire intellectual property rights based on the result of the study for which data from the NBDC Human Database are used, as long as the responsibilities of data users and the limitation added for each data set are fulfilled.</li>\r\n</ol>\r\n<h5><strong><span style=\"color: #000000;\"> 5.2.2 Registered-access Data</span></strong></h5>\r\n<ol>\r\n<li>Data users who have completed the registration for registered-access data use can view the data.</li>\r\n</ol>\r\n<h5><strong><span style=\"color: #000000;\"> 5.2.3 Controlled-access Data</span></strong></h5>\r\n<ol>\r\n<li>Data users can freely make the result of the study for which data from the NBDC Human Database are used public, as long as the responsibilities of data users and the limitation added for each data set are fulfilled.</li>\r\n<li>Data users can freely acquire intellectual property rights based on the result of the study for which data from the NBDC Human Database are used, as long as the responsibilities of data users and the limitation added for each data set are fulfilled.</li>\r\n<li>Data users can download, store, and use the data from the database center in the designated area of an “off-premise-server,” in addition to the data server connected to the affiliated organization LAN.</li>\r\n<li>Data users can use the data processed by the DBCLS and the DDBJ Center (data such as alignment data, variant call data, and statistical data, processed by a specific analysis pipeline).</li>\r\n</ol>\r\n<h4><strong><span style=\"color: #000000;\"> 5.3 Responsibilities of Data Users</span></strong></h4>\r\n<h5><strong><span style=\"color: #000000;\"> 5.3.1 Unrestricted-access data</span></strong></h5>\r\n<ol>\r\n<li>In using data, the data user must utilize the data with his/her own responsibility and evaluation of the quality, content, and scientific validity of the data.</li>\r\n<li>The data user must comply with the following rules for the data obtained from the NBDC Human Database as well as any data derived therefrom.\r\n<div style=\"border-style: solid; border-width: 1px; margin-left: 20px; padding-left: 5px;\">\r\n<p>Basic rules to be complied with in using data</p>\r\n<ul style=\"list-style-type: circle;\">\r\n<li>The use of data is limited to research and/or development purposes only.</li>\r\n<li>The use of data for weapons development or military applications is prohibited.</li>\r\n<li>Identification of individuals is prohibited.</li>\r\n<li>The latest data should be downloaded and used.</li>\r\n</ul>\r\n</div>\r\n</li>\r\n<li>When the research results including data downloaded from the NBDC Human Databases (the DDBJ Sequence Read Archive, the NBDC Human data Archive, the Genomic Expression Archive, and so on) are made public in a publication or a presentation, the data user must state the accession number of the data set used. In addition, a statement such as the following** must be included as references to the paper in which the data set was originally reported, or as acknowledgments.\r\n<div style=\"border-style: solid; border-width: 1px; margin-left: 20px; padding-left: 5px;\">\r\n<p>** Example of acknowledgment</p>\r\n<p>(A part of) The data used for this research was originally obtained by AAAA research project/group led by Prof. /Dr. BBBB and available at the website of the NBDC Human Database of the Database Center for Life Science (DBCLS) / the Joint Support-Center for Data Science Research (DS) of the Research Organization of Information and Systems (ROIS).</p>\r\n</div>\r\n</li>\r\n</ol>\r\n<h5><strong><span style=\"color: #000000;\"> 5.3.2 Registered-access Data </span></strong></h5>\r\n<ol>\r\n<li>In using data, the data user must utilize the data with his/her own responsibility and evaluation of the quality, content, and scientific validity of the data.</li>\r\n<li>When conducting research that uses registered-access data, it is necessary to apply for the use of the original data and receive approval from the Human Data Review Board.</li>\r\n<li>The data user must ensure that no one other than the person who has completed the registration to use the registered-access data may view the registered-access data.</li>\r\n<li>When citing registered-access data in a publication or the like, the data user must state the accession number of the data set being cited.</li>\r\n</ol>\r\n<h5><strong><span style=\"color: #000000;\"> 5.3.3 Controlled-access Data </span></strong></h5>\r\n<ol>\r\n<li>In using data, the data user must utilize the data with his/her own responsibility and evaluation of the quality, content, and scientific validity of the data.</li>\r\n<li>The data user must take full responsibility (including responsibilities to entrustees) for using data. The data user should understand that his/her responsibility will be extended to the head of his/her affiliated organization in case any problem occurs in data management and handling.</li>\r\n<li>When using controlled-access data contained in the NBDC Human Database, the data user must comply with the “Ethical Guidelines for Medical and Biological Research Involving Human Subjects” in Japan. That is, among others, before carrying out any medical or biological research involving human subjects using data obtained from the NBDC Human Database, the data user must prepare the research protocol, go through a review by an Ethical Review Committee of his/her affiliated or an equivalent organization, and obtain approval therefrom and authorization from the head of his/her affiliated organization.</li>\r\n<li>The data user must comply with the following rules for the data obtained from the NBDC Human Database as well as any data derived therefrom.\r\n<div style=\"border-style: solid; border-width: 1px; margin-left: 20px; padding-left: 5px;\">\r\n<p>Basic rules to be complied with in using data</p>\r\n<ul style=\"list-style-type: circle;\">\r\n<li>The data users must be limited. (Access is granted only to the PI and his/her research collaborators who belong to the same organization as the PI.)</li>\r\n<li>The purpose of data use must be explicitly stated.</li>\r\n<li>The use of data for purposes other than those stated in the application is prohibited.</li>\r\n<li>The use of data is limited to research and/or development purposes only.</li>\r\n<li>The use of data for weapons development or military applications is prohibited.</li>\r\n<li>Identification of individuals is prohibited.</li>\r\n<li>Redistribution of data is prohibited. (Distribution of processed data with no or very low personal identifiability or primary data recoverability does not constitute redistribution subject to prohibition. However, in principle, an application for retention of secondary data or distribution of processed data is required.)</li>\r\n</ul>\r\n</div>\r\n</li>\r\n<li>The data user must securely handle data, complying with the NBDC Security Guidelines for Human Data (for Data Users). Attention should be paid to the fact that the security level to be maintained varies for different data.* The data user must accept an inspection conducted by the Human Data Review Board or a third party commissioned by the DBCLS with regard to the state of implementation of security measures.\r\n<div style=\"border-style: solid; border-width: 1px; margin-left: 20px; padding-left: 5px;\">\r\n<p>* Security levels:</p>\r\n<p>Standard-level (Type I) security is required in principle, but high-level (Type II) security may be required based on consultation between the data submitter and the Human Data Review Board. For details on Type I and Type II security, see <a href=\"en/guidelines/security-guidelines-for-users\" target=\"_blank\" rel=\"noopener noreferrer\">the NBDC Security Guidelines for Human Data (for Data Users)</a>.</p>\r\n</div>\r\n</li>\r\n<li>The data user must establish a security control system depending on the security level (Type I, Type II) and submit \"Checklist for the NBDC Security Guidelines for Human Data\"&nbsp;to the Human Data Review Board Office in order to demonstrate that the system conforms to the standards set forth by the DBCLS.</li>\r\n<li>The data user must follow the terms of each ”off-premise-server” use in addition to the NBDC Human Data Sharing Guidelines and the NBDC Human Data Security Guidelines when using the ”off-premise-server” for his/her data use.</li>\r\n<li>Should a security incident such as data breach occur, the data user must immediately disconnect relevant devices from the network and report the incident to the DBCLS. The data user must promptly implement post-incident measures, following instructions from the DBCLS. When the “off-premise-server” is used, the data user must immediately take measures according to the terms of use etc.</li>\r\n<li>When the data user is informed of withdrawal of consent, rejection by opt-out in relation to the data that he/she downloaded from the NBDC Human Database and is using, the data user must not use the relevant data thereafter.</li>\r\n<li>When finished with using data, the data user must delete all data obtained from the NBDC Human Database (whole data, or any part of the data stored. When the off-premise-server is used, all the data stored on the off-premise-server, including backup data on the off-premise-server.) and all the data that can restore the data in accordance with the NBDC Security Guidelines for Human Data (for backup data on the off-premise-server, confirm when the data will be deleted), and report on the use (and deletion) of the data, using \"Reporting on the completion of the data use\". With regard to keeping secondary data (e.g., results of calculations or statistical analyses based on controlled-access data) or distribution of processed data with no or very low personal identifiability or primary data recoverability, see the section on the procedure for using controlled-access data (“5.4 Procedure for Data Use”; Subsection “5.4.3 Controlled-access Data”). When the secondary data contains genetic data, the data must be properly managed as personal information and redistribution of the secondary data is prohibited.</li>\r\n<li>When the research results including data downloaded from the NBDC Human Databases (the Japanese Genotype-phenotype Archive, the NBDC Human data Archive, and so on) are made public in a publication or a presentation, the data user must state the accession number of the data set used. In addition, a statement such as the following** must be included as a reference to the paper in which the data set was originally reported, or as acknowledgment.\r\n<div style=\"border-style: solid; border-width: 1px; margin-left: 20px; padding-left: 5px;\">\r\n<p>** Example of acknowledgment</p>\r\n<p>(A part of) The data used for this research was originally obtained by AAAA research project/group led by Prof. /Dr. BBBB and available at the website of the NBDC Human Database of the Database Center for Life Science (DBCLS) / the Joint Support-Center for Data Science Research (DS) of the Research Organization of Information and Systems (ROIS).</p>\r\n</div>\r\n<p>When the service of JGA was used, it is desirable to refer to the following paper: <a href=\"http://nar.oxfordjournals.org/content/43/D1/D18\" target=\"_blank\" rel=\"noopener noreferrer\">Nucleic Acids Res. 2015, 43 Database issue: D18-22.</a></p>\r\n</li>\r\n<li>The data user agrees that the DBCLS may make certain statistical information or information about data user public upon release of the utilization conditions of the NBDC Human Database. Such information on data user that may be laid open includes the Dataset ID of the data used, the data user’s name, the data user's affiliated organization, country and state, the period of the data use, and the research title.</li>\r\n<li>The data user agrees that, for the purpose of release of the utilization conditions of the NBDC Human Database, the DBCLS holds information on data usage, including information on the data users that is obtained from the time of application to the time of reporting the end of data use and information gathered at the time of incidents.</li>\r\n</ol>\r\n<p>In case the data user used human data in violation of the NBDC Human Data Sharing Guidelines etc., or caused information leakage etc. in using data intentionally or with negligence, the DBCLS may take one or more further actions such as rescinding of permission for data use, reporting of the fact to the head of the organization to which the data user belongs, announcing of the fact on the website etc., and so on. Besides, the DBCLS may seek compensation from the data user, if the DBCLS determines that due to these reasons it has suffered damages such as inability of operation of “the NBDC Human Database” as stated in the section “1. Principles.” The above conditions are applied to not only the PI but also his/her research collaborators. The PI is responsible for his/her research collaborators' compliance with the Guidelines (this document) and <a href=\"en/guidelines/security-guidelines-for-users\" target=\"_blank\" rel=\"noopener noreferrer\">the NBDC Security Guidelines for Human Data (for Data Users)</a>.</p>\r\n<h4><strong><span style=\"color: #000000;\"> 5.4 Procedure for Data Use</span></strong></h4>\r\n<h5><strong><span style=\"color: #000000;\"> 5.4.1 Unrestricted-access data</span></strong></h5>\r\n<p>The data user can freely use unrestricted-access data available from the website for the NBDC Human Database, as permitted under laws and regulations.</p>\r\n<h5><strong><span style=\"color: #000000;\"> 5.4.2 Registered-access Data </span></strong></h5>\r\n<ol>\r\n<li>Among investigators who have been approved by the Human Data Review Board and are during the data use period, those who wish to use the registered-access data register their investigator information as designated by the DBCLS.</li>\r\n<li>The information necessary to access the data is provided, and the data user can access the data.</li>\r\n</ol>\r\n<h5><strong><span style=\"color: #000000;\"> 5.4.3 Controlled-access Data </span></strong></h5>\r\n<ol>\r\n<li>The data user applies for data use in accordance with the procedure of application for data use. If multiple investigators from different organizations conduct a collaborative study, an application for data use must be submitted for each organization.</li>\r\n<li>After going through a review by the Ethical Review Committee of his/her affiliated or an equivalent organization with regard to the use of the NBDC Human Database and obtaining approval from the Ethical Review Committee, the data user submits, at the time of application for data use, a copy of a notification of permission obtained from the head of his/her affiliated organization. However, if the Ethical Review Committee decided to waive the review, the data user submits a document such as a notification of the fact.</li>\r\n<li>At the time of application for data use, the data user submits \"<a href=\"files/security_checklist_for_users_e.xlsx\" target=\"_blank\" rel=\"noopener\">Checklist for the NBDC Security Guidelines for Human Data</a>\"&nbsp;as well as other information and documents required by the Human Data Review Board.</li>\r\n<li>The Human Data Review Board decides whether access to the controlled-access data may be granted.</li>\r\n<li>After the Human Data Review Board approves the application for data use, the data user is granted access to the data and can access the data.</li>\r\n<li>In principle, the data user reports on data use status every year, using \"Reporting on the Use of Controlled-access Data\". In addition, at the time of reporting, the data user resubmits \"<a href=\"files/security_checklist_for_users_e.xlsx\" target=\"_blank\" rel=\"noopener\">Checklist for the NBDC Security Guidelines for Human Data</a>\".</li>\r\n<li>When the data user plans to distribute processed data with no or very low personal identifiability or primary data recoverability, the data user must apply to the Human Data Review Board Office using the \"application for reporting on the completion of data use\".</li>\r\n<li>When the data user needs to use the data set beyond the term originally stated in the application for data use, the data user may file an application with the Human Data Review Board Office, at least a month before the original expiration date, with a document such as the approval notification by the Ethical Review Committee of the affiliated organization or an equivalent organization (by which document the term approved can be confirmed) and a statement of desired term to be extended.</li>\r\n<li>When the data use is finished, the data user must promptly delete all data (whole data, or any part of the data stored. When the off-premise-server is used, all the data stored on the off-premise-server, including backup data on the off-premise-server.) and all data that can restore the data according to the NBDC Human Data Security Guidelines (for backup data on the off-premise-server, confirm when the data will be deleted) and report his/her data use (and deletion) to the Human Data Review Board Office, using the \"application for reporting on the completion of data use\". At the same time, the data user may apply for retention of secondary data (e.g., results of calculations based on controlled-access data) or distribution of processed data with no or very low personal identifiability or primary data recoverability by submitting \"keep secondary data derived from controlled-access data\" or \"distributing processed data\" in the \"application for reporting on the completion of data use\" to the Human Data Review Board Office, and may retain the secondary data. Depending on the degree of data processing and the storage period, however, the application may be rejected.</li>\r\n</ol>\r\n<h4><strong><span style=\"color: #000000;\"> 5.5 Cost of Data Use</span></strong></h4>\r\n<p>The data user bears costs incurred in connection with data use, if any (e.g., in cases where data media are needed for sending data or where an ”off-premise-server” is used).</p>\r\n<h4><strong><span style=\"color: #000000;\"> 5.6 Termination of Data Use </span></strong></h4>\r\n<ol>\r\n<li>If the data user is suspected of a breach of any of the responsibilities listed in the section “5.3 Responsibilities of Data Users” or the NBDC Security Guidelines for Human Data, the DBCLS investigates the matter. The Human Data Review Board makes a judgement on whether there was any misconduct, based on the result of the investigation, and if it is determined that misconduct occurred, the DBCLS:\r\n<ul style=\"list-style-type: circle;\">\r\n<li>Orders the data user to stop using the data and revokes the permission to access the data set being used.</li>\r\n<li>Do not accept, for a certain period, a new application for data use from the data user who committed the misconduct. This period is determined by the Human Data Review Board.</li>\r\n<li>Report the misconduct to the head of the data user's affiliated organization, if necessary.</li>\r\n</ul>\r\nDepending on the situation, termination of data use may be ordered at the stage when suspicion is raised. Upon receiving an order to terminate data use, the data user must immediately delete all data that have been obtained and all secondary data. In addition, the data user must promptly report the state of data deletion to the Human Data Review Board Office, using \"Report on the Use (and Deletion) of Controlled-access Data\".</li>\r\n<li>In case the data in use are made unavailable due to a breach of the responsibilities of the data submitter, the data users may be requested to stop using the data. In that case, the data users are requested to follow the same procedure as those at the time of data use termination. Regardless of the reason, the DBCLS shall not bear any responsibility for any damage or the like caused by the breach of responsibility of the data submitter.</li>\r\n</ol>\r\n<h3><strong><span style=\"color: #000000;\"> 6. Procedure for Revising the Guidelines</span></strong></h3>\r\n<h4><strong><span style=\"color: #000000;\"> 6.1 Proposal for Revision </span></strong></h4>\r\n<p>Data submitters, data users, and potential users who are considering data use may propose revision of the Guidelines to the Office if they think it may lead to smoother provision or use of human data. It is requested to provide concrete proposals and references to the relevant parts of the Guidelines.</p>\r\n<h4><strong><span style=\"color: #000000;\"> 6.2 Review of Revision Proposals </span></strong></h4>\r\n<p>Upon receipt of a revision proposal, the Data Sharing Subcommittee promptly reviews its content and decides whether the proposal is adopted or rejected or should be modified.</p>\r\n<h4><strong><span style=\"color: #000000;\"> 6.3 Announcement and Implementation of a Revision </span></strong></h4>\r\n<p>Once the details of a revision are decided, they are promptly announced on our website and will be implemented after a certain period set by the Data Sharing Subcommittee. It should be noted that the revised Guidelines are also applied to those entities or persons who obtained approval for their application for data submission or data use before the implementation.</p>\r\n<h3><strong><span style=\"color: #000000;\"> 7. Other Topics</span></strong></h3>\r\n<h4><strong><span style=\"color: #000000;\"> 7.1 Disclosure of Information Obtained from applications for data submission and data use</span></strong></h4>\r\n<p>From the applications received regarding the NBDC Human Database, the DBCLS discloses some input items for which applicants' consent is obtained. The members of the Human Data Review Board and the staff of the Human Data Review Board Office must not disclose any other information on applications than the information disclosed by the DBCLS to anyone other than those who are concerned.</p>\r\n<h4><strong><span style=\"color: #000000;\"> 7.2 Notification of Inaccurate Data</span></strong></h4>\r\n<p>The Human Data Review Board accepts notifications about inaccurate data in the NBDC Human Database from data users and informs the relevant data submitters of the issue to discuss the response. Similar actions are taken in cases where people who gave consent point out a possibility of improperly obtained consent or fabricated consent.</p>\r\n<p>Contact information: the Human Data Review Board Office humandbs@dbcls.jp</p>\r\n<h4><strong><span style=\"color: #000000;\"> 7.3 Investigation concerning Research Fraud by Fabrication or Falsification etc.</span></strong></h4>\r\n<ol><ol>\r\n<li>The DBCLS may cooperate on an investigation of research fraud regarding data stored in the NBDC Human Database, when requested.</li>\r\n<li>The head of the fraud investigation committee etc. should inform the DBCLS of the Dataset ID of data necessary for conducting the verification and the necessity for verification, and report the security status of the server for storing the data using \"<a href=\"files/security_checklist_for_users_e.xlsx\" target=\"_blank\" rel=\"noopener\">Checklist for the NBDC Security Guidelines for Human Data</a>\".</li>\r\n<li>The Data should be used under full responsibility of the head of the fraud investigation committee etc.</li>\r\n<li>The head of the fraud investigation committee etc. should comply with rules under “Basic rules to be complied with in using data,” item (4) of “5.3.3 Controlled-access Data” in “5.3 Responsibilities of Data Users.”</li>\r\n</ol></ol>\r\n<h3><strong><span style=\"color: #000000;\"> See also:</span></strong></h3>\r\n<p><a href=\"/en/guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">The NBDC Security Guidelines for Human Data</a></p>", "publish_up": "2022-04-01"}, {"lang": "ja", "path": "guidelines/security-guidelines-for-dbcenters", "title": "NBDCヒトデータ取扱いセキュリティガイドライン（データベースセンター運用責任者ならびに「機関外サーバ」運用責任者向け）ver. 4.0", "fulltext": "", "modified": "2024-04-01", "introtext": "<p style=\"text-align: right;\">2024.4.1<br />Ver. 4.0</p>\r\n<h3><strong><span style=\"color: #000000;\">はじめに</span></strong></h3>\r\n<p><a href=\"https://dbcls.rois.ac.jp/\" target=\"_blank\" rel=\"noopener noreferrer\">大学共同利用機関法人 情報・システム研究機構 データサイエンス共同利用基盤施設 ライフサイエンス統合データベースセンター（以下、DBCLS）</a>は、<a href=\"/guidelines/data-sharing-guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">NBDCヒトデータ共有ガイドライン（以下、共有ガイドライン）</a>に則ってヒトデータベースを運営している。データ利用者向けには、<a href=\"/guidelines/security-guidelines-for-users\" target=\"_blank\" rel=\"noopener noreferrer\">「NBDCヒトデータ取扱いデータ取扱いセキュリティガイドライン（データ利用者向け）」（以下、データ利用者ガイドライン）</a>を定めている。一方、データ提供者からデータを預かりデータ利用者に提供するデータベースセンター（以下、DBセンター）に対しては、共有ガイドラインで定義する制限公開データや公開待機データ（特許取得や論文発表前のデータ）も扱うため、データ利用者と同等以上のセキュリティが求められる。なお、DBセンターが取扱うデータ（以下、取扱いデータ）は、特定の個人（死者を含む）を識別することができることとなる記述等の全部又は一部を除き、代わりに当該個人とかかわりのない符号又は番号を付し、その後、さらに符号又は番号の振りなおしを施したデータに限るものとする。</p>\r\n<p>この文書は、データ利用者ガイドラインをベースにDBセンターが講じるべきセキュリティ対策について示したものである。また、データ利用者に対して、データの保存や計算処理を行うためのリソースを提供する、共有ガイドラインで定義している「所属機関外利用可能サーバ（以下「機関外サーバ」）」についても、本ガイドラインに準拠するものとする。</p>\r\n<p>なお、DBセンターやデータ利用者をとりまくIT環境は千差万別で、日々変化しているため、このガイドラインを遵守するだけでセキュリティが十分に保証されるとは限らない。DBセンター毎に、必要に応じて追加のセキュリティ対策を講じることが求められる。このガイドラインについては、IT環境の進展に応じ、適宜見直しを行うものとする。</p>\r\n<h3><strong><span style=\"color: #000000;\">１. 用語定義</span></strong></h3>\r\n<ol>\r\n<li>制限公開データ、データ\r\n<ul style=\"list-style: none;\">\r\n<li>共有ガイドラインで定義している「制限公開データ」。</li>\r\n</ul>\r\n</li>\r\n<li>運用責任者\r\n<ul style=\"list-style: none;\">\r\n<li>DBセンター責任者、または、「機関外サーバ」責任者。</li>\r\n</ul>\r\n</li>\r\n<li>作業者\r\n<ul style=\"list-style: none;\">\r\n<li>DBセンターまたは「機関外サーバ」の運用に係る作業のため、運用責任者がデータサーバに保存されたデータへのアクセスを許可した者。</li>\r\n</ul>\r\n</li>\r\n<li>データ利用者\r\n<ul style=\"list-style: none;\">\r\n<li>共有ガイドラインで定義している「データ利用者」。</li>\r\n</ul>\r\n</li>\r\n<li>データサーバ\r\n<ul style=\"list-style: none;\">\r\n<li>DBセンターにおいて、データ提供者から提供されたデータの保存や暗号化等の処理、データ利用者への制限公開データの送信、などを行うための計算機環境。または、「機関外サーバ」において、データ利用者が制限公開データの保存や計算処理を行うための計算機環境。</li>\r\n</ul>\r\n</li>\r\n<li>データアクセス端末\r\n<ul style=\"list-style: none;\">\r\n<li>データがローカルに永続的に保存されることなく、作業者がデータサーバ内の取扱いデータにアクセスするための機器。尚、データアクセス端末とデータサーバ間のデータ伝送の際に、データサーバ設置LAN外の通信経路を介する場合は、全ての通信経路を十分な強度で暗号化する、またはデータ自体を暗号化した上で伝送することが必要。</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<h3><strong><span style=\"color: #000000;\">２. セキュリティ対策について</span></strong></h3>\r\n<p><span style=\"text-decoration: underline;\">原則、データ利用者ガイドライン「3．ハイレベル【TypeⅡ】セキュリティにおいて必要な対策」と同等の対策</span>を実施すること。</p>\r\n<h4><strong><span style=\"color: #000000;\">２－１．運用責任者が遵守すべきこと</span></strong></h4>\r\n<p>＜運用全般について＞</p>\r\n<ol>\r\n<li>運用責任者は、NBDCヒトデータ共有ガイドライン及びNBDCヒトデータ取扱いセキュリティガイドラインに準拠した運用を行うこと。</li>\r\n<li>運用責任者は、作業者一覧を作成し、常に最新の状態を維持すること。</li>\r\n<li>運用責任者は、NBDCヒトデータ取扱いセキュリティガイドラインを、作業者に周知して遵守させること。</li>\r\n<li>運用責任者は、運用責任者及び全ての作業者に、所属機関等が実施する情報セキュリティに関する教育を受講させること。</li>\r\n<li>運用責任者は、作業者とデータサーバ（ファイルシステム内での格納場所を含む）に関する情報を、運用責任者及び作業者のみがアクセス可能な電子ファイル等で台帳管理し、変更が発生する都度、内容を更新すること。なお、変更履歴が確認できるように管理を行うこと。</li>\r\n<li>運用責任者は、DBCLSあるいはDBCLSから依頼された第三者が実施する、セキュリティ対策の実施状況についての監査に応じること。</li>\r\n<li>運用責任者は、システム構築時及び2~3年に一度を目途に、システムセキュリティの専門家による監査を自主的に実施すること。監査結果の写しを、DBCLSに提出すること。</li>\r\n<li>データの漏えい等セキュリティに関する事故が発生した場合、運用責任者は直ちに対策を実施するものとし、速やかにDBCLSに報告すること。</li>\r\n</ol>\r\n<p>＜データサーバについて＞</p>\r\n<ol>\r\n<li>運用責任者は、以下の条件①～③を全て満たすサーバ室にデータサーバを設置すること。\r\n<ul style=\"list-style: none;\">\r\n<li>① 以下の３つの認証方法の内、2つ以上を組み合わせた多要素認証で、入室者を限定すること。\r\n<ul>\r\n<li>生体認証（例：静脈、指紋、虹彩、顔）</li>\r\n<li>所有物認証（例：ICカード、ワンタイムパスワード、USBトークン）</li>\r\n<li>知識認証（例：パスワード）</li>\r\n</ul>\r\n</li>\r\n<li>② 入室記録を自動取得し、後日監査可能であること。</li>\r\n<li>③ 専用のサーバ室であること。専用のサーバ室を確保できない場合は、常時施錠された専用の サーバラックにデータサーバを格納すること。</li>\r\n</ul>\r\n</li>\r\n<li>運用責任者は、データサーバのデータ保存領域、及びデータ利用者がデータの保存や計算処理に利用する領域について、適切にアクセス制御を行うこと。データサーバやインターネットを介して、作業者及びデータ利用者のみが、許可されたデータのみにアクセスできるよう管理すること。</li>\r\n<li>運用責任者は、データサーバを設置しているLANと外部ネットワークとの間にファイアウォールを設置し、外部とのアクセスを必要最小限（例：アクセス元、アクセス先のIPアドレスやポートが限定されている）に管理して高いセキュリティを保つこと。</li>\r\n<li>運用責任者は、データサーバを設置しているLANからの通信に対しても、最低限OS付属のファイアウォール機能（例：iptables（Linuxの場合））等により、適切に制限を行うこと。</li>\r\n<li>運用責任者は、データサーバのユーザIDやパスワードは、データ利用者間での共有を認めないこと、かつ、パスワードは他人が類推できない十分な強度に設定させること。（８文字以上とすること。数値、英大小文字と記号を組合せたものが望ましい。氏名、電話番号、誕生日等の推測し易いものを利用しないこと。）</li>\r\n<li>運用責任者は、データサーバにインストールした全てのソフトウェアについて、できる限り最新のセキュリティパッチを適用すること。</li>\r\n<li>運用責任者は、サービスに不要なソフトウェアをインストールしないこと。特にファイル共有（ファイル交換、P2P）ソフト（例：Winny、BitTorrent）をインストールしないこと。</li>\r\n<li>運用責任者は、ウィルス対策ソフトをインストールし、データサーバ外からNBDCヒトデータベースを介して入手したデータ（制限公開データ[Japanese Genotype-phenotype Archive: JGA]、制限共有データ[AMED Genome AGD]、非制限公開データ[DDBJ Sequence Read Archive: DRA, Genomic Expression Archive: GEA]）以外のファイルを取り込む場合はその場でウイルススキャンを実施すること。また、ウィルス対策ソフト及びウィルス定義ファイルは最新の状態を維持すること。</li>\r\n<li>運用責任者は、OS起動時等に不要なプロセスはできるだけ起動させないこと。</li>\r\n<li>運用責任者は、データサーバでのアクセスログを取得し、定期的に確認すること。</li>\r\n<li>運用責任者は、取扱いデータを保存した機器を廃棄する場合には、データの保存領域を復元不可能な方法で初期化すること。もしくは、復元不可能となるように物理的に破壊すること。</li>\r\n<li>運用責任者は、データの漏えい等セキュリティに関する事故が発生した場合、直ちに対策を実施するものとする。</li>\r\n</ol>\r\n<h4><strong><span style=\"color: #000000;\">２－２．作業者が遵守すべきこと</span></strong></h4>\r\n<ol>\r\n<li>作業者は、所属機関等が実施する情報セキュリティに関する教育を受講すること。</li>\r\n<li>作業者は、データアクセス端末から、データサーバが設置されているLAN外の通信経路を介してデータサーバにログインする場合は、データアクセス端末とデータサーバ間のデータ伝送の都度、全ての通信経路を十分な強度で暗号化する、またはデータ自体を暗号化した上で伝送すること。データサーバが設置されているLAN内からデータサーバにログインする場合も、同様の暗号化を行うことが望ましい。</li>\r\n<li>作業者は、不特定多数が利用する機器（例：ネットカフェのPC）上の端末からデータにアクセスしないこと。</li>\r\n<li>作業者は、データアクセス端末には出来る限り最新のセキュリティパッチを適用すること。</li>\r\n<li>作業者は、データアクセス端末から離れる場合は、データサーバからログアウトするか、データアクセス端末をロックすること。また、一定時間（１５分程度を目安）以上無操作の場合はデータアクセス端末画面がロックされるように設定すること。</li>\r\n<li>作業者は、運用責任者またはデータ利用者から許可を得ていないデータにはアクセスしないこと。</li>\r\n<li>作業者は、データアクセス端末画面上の取扱いデータをコピーしてローカルディスクに保存しないこと。データアクセス端末画面上に表示された取扱いデータを、コピーしてローカルディスクに保存することができないデータアクセス端末の利用が望ましい。</li>\r\n<li>作業者は、データアクセス端末にデータを自動的に保存する機能（いわゆるキャッシュ機能）がある場合は当該機能を無効にすること。</li>\r\n<li>作業者は、取扱いデータのコピーを作成したり、取扱いデータをデータサーバ外に移動したりしないこと。　但し、以下の場合は例外とする。これらの場合も、利用後速やかに復元不可能な方法で消去すること。\r\n<ul>\r\n<li>取扱いデータをバックアップする場合</li>\r\n<li>取扱いデータの移動時に一時的に作成する場合</li>\r\n<li>ソフトウェアによって一時的に作成される場合</li>\r\n</ul>\r\n</li>\r\n<li>作業者は、データのバックアップ取得の際は、以下のいずれかの条件を満たすこと。\r\n<ul>\r\n<li>データサーバに保存すること。</li>\r\n<li>移動可能機器（例：テープ、USBメモリ、CD-ROM、ノートPC）に保存する場合は、取扱いデータを暗号化し、使用後は復元不可能な方法で消去すること。また、移動可能機器及びバックアップした取扱いデータについて、「２－１．運用責任者が遵守すべきこと ＜運用全般について＞５．」に記載の台帳に記録し、盗難や紛失の可能性を最小限にするとともに、当該事実が発生した場合の早期発見を可能にすること。</li>\r\n</ul>\r\n</li>\r\n<li>作業者は、やむを得ず一時的なデータ移動に移動可能機器を利用する場合も、バックアップデータと同様に取り扱うこと。</li>\r\n<li>作業者は、やむを得ず取扱いデータを印刷する場合には、作業者以外の目に触れることがないよう印刷物を厳重に管理し、利用終了時にはシュレッダ処理すること。</li>\r\n<li>作業者は、データの漏えい等セキュリティに関する事故が発生した場合、直ちに対策を実施するものとし、運用責任者に報告すること。</li>\r\n</ol>\r\n<p>但し、上記９．～１２．については、「機関外サーバ」は対象外とする。</p>\r\n<p>&nbsp;</p>\r\n<p style=\"text-align: right;\">以上</p>", "publish_up": "2021-06-22"}, {"lang": "en", "path": "guidelines/security-guidelines-for-dbcenters", "title": "NBDC Security Guidelines for Human Data (for Database Center Operation Managers and “Off-Premise-Server” Operation Managers) ver. 4.0", "fulltext": "", "modified": "2024-04-01", "introtext": "<p style=\"text-align: right;\">April 1, 2024<br />Ver. 4.0</p>\r\n<h3><strong><span style=\"color: #000000;\">Introduction</span></strong></h3>\r\n<p><a href=\"https://dbcls.rois.ac.jp/index-en.html\" target=\"_blank\" rel=\"noopener noreferrer\">The Database Center for Life Science (DBCLS) / the Joint Support-Center for Data Science Research (DS) of the Research Organization of Information and Systems (ROIS)</a> operates the NBDC Human Database in accordance with <a href=\"/en/guidelines/data-sharing-guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">the NBDC Guidelines for Human Data Sharing</a> (hereinafter, the Data Sharing Guidelines). For data users, we have <a href=\"/en/guidelines/security-guidelines-for-users\" target=\"_blank\" rel=\"noopener noreferrer\">the NBDC Security Guidelines for Human Data (for Data Users)</a> (hereinafter, the Data User Security Guidelines). For database centers (hereinafter, DB centers), which receive data from data submitters and offer them to data users, security measures that are stronger than those taken by data users are required because DB centers handle not only controlled-access data, which are defined in the Data Sharing Guidelines, but also data for future release (data held prior to publication of a paper or acquisition of a patent). Data handled by DB centers (hereinafter, handled data) must be assigned codes or numbers that are unrelated to the individuals in lieu of all or part of the description or the like that may lead to identification of a particular individual (including one deceased) and further assigned another set of codes or numbers.</p>\r\n<p>Based on the Data User Security Guidelines, the guidelines in this document set forth the security measures to be implemented by DB centers. The “available server outside of affiliated organization (hereinafter, “off-premise-server”)” defined in the Data Sharing Guidelines, which provides the data users with resources for saving and computing data, must also comply with these guidelines.</p>\r\n<p>Because the information technology (IT) environments surrounding DB centers or data users are diverse and ever-changing, merely complying with these guidelines may not be sufficient for data security. Each DB center is responsible for taking additional security measures as deemed necessary. These guidelines will be updated appropriately in response to advances in IT environments.</p>\r\n<h3><strong><span style=\"color: #000000;\">1. Definitions</span></strong></h3>\r\n<ol>\r\n<li>Controlled-access data, Data\r\n<ul style=\"list-style: none;\">\r\n<li>The “controlled-access data” as defined in the Data Sharing Guidelines.</li>\r\n</ul>\r\n</li>\r\n<li>Operation manager\r\n<ul style=\"list-style: none;\">\r\n<li>The person in charge of a DB center or an “off-premise-server”.</li>\r\n</ul>\r\n</li>\r\n<li>Operator\r\n<ul style=\"list-style: none;\">\r\n<li>A person who has been granted by the operation manager access to the data stored in the data server for works related to the operation of the DB center or the “off-premise-server.”</li>\r\n</ul>\r\n</li>\r\n<li>Data user\r\n<ul style=\"list-style: none;\">\r\n<li>The “data user” as defined in the Data Sharing Guidelines.</li>\r\n</ul>\r\n</li>\r\n<li>Data server\r\n<ul style=\"list-style: none;\">\r\n<li>A computer environment for processing such as storing and encrypting data provided by data submitters, sending controlled-access data to data users, and so on at the DB center. Alternatively, in the “off-premise-server,” a computer environment for data users to store and calculate controlled-access data.</li>\r\n</ul>\r\n</li>\r\n<li>Data access terminal\r\n<ul style=\"list-style: none;\">\r\n<li>A device that is for operators to access data in the data server and that does not permanently save the data locally. When transmitting data between the data access terminal and the data server, via a communication path outside the data server-installed LAN, it is necessary that all communication paths are encrypted with sufficient strength or that the data themselves are encrypted before being transmitted.</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<h3><strong><span style=\"color: #000000;\">2. Security Measures</span></strong></h3>\r\n<p><span style=\"text-decoration: underline;\">As a general rule, measures equivalent to “3. Measures to Be Taken under High-level (Type II) Security” in the Data User Security Guideline must be implemented.</span></p>\r\n<h4><strong><span style=\"color: #000000;\">2.1 What the Operation Manager Must Do</span></strong></h4>\r\n<h5><strong><span style=\"color: #000000;\">Operation in general</span></strong></h5>\r\n<ol>\r\n<li>The operation manager must operate in compliance with the Data Sharing Guidelines and the NBDC Security Guidelines for Human Data.</li>\r\n<li>The operation manager should create a list of operators and keep it up-to-date at all times.</li>\r\n<li>The operation manager should make the operators fully understand and comply with the NBDC Security Guidelines for Human Data.</li>\r\n<li>The operation manager should receive an education on information security implemented by the affiliated or equivalent organization, and have all operators receive the same education.</li>\r\n<li>The operation manager should keep a record of information on the operators and the data server (including the storage location in the file system) in an electronic file or the like accessible only to the operation manager and the operators, and update the record every time a change occurs. The record should be managed so that the update history can be reviewed.</li>\r\n<li>The operation manager should accept an audit conducted by the DBCLS or a third party commissioned by the DBCLS with regard to the state of implementation of security measures.</li>\r\n<li>The operation manager should voluntarily perform audits by system security experts at the time of system construction and every two to three years. A copy of the audit result should be submitted to the DBCLS.</li>\r\n<li>In case of a security incident such as data breach, the operation manager must immediately take measures and promptly report the incident to the DBCLS.</li>\r\n</ol>\r\n<h5><strong><span style=\"color: #000000;\">Data Server</span></strong></h5>\r\n<ol>\r\n<li>The operation manager should place the data server in a server room that meets all of the following requirements (1) to (3).\r\n<ul style=\"list-style: none;\">\r\n<li>(1) Access to the room is limited using multi-factorial authentication with at least two of the following three authentication methods.\r\n<ul>\r\n<li>Biometric authentication (e.g., vein, fingerprint, iris, and face recognition)</li>\r\n<li>Property-based authentication (e.g., IC card, one-time password, and USB token)</li>\r\n<li>Knowledge -based authentication (e.g., password)</li>\r\n</ul>\r\n</li>\r\n<li>(2) Record of access to the room is automatically obtained and made available for later audit.</li>\r\n<li>(3) The server room must be dedicated to this purpose. If a dedicated server room cannot be set up, the data server must be stored in a locked dedicated server rack.</li>\r\n</ul>\r\n</li>\r\n<li>The operation manager should control the access to/from the data storage area of the data server and the area that the data users use for data storage and calculation appropriately. It is necessary to manage so that only operators and data users can access only authorized data via the data server or the Internet.</li>\r\n<li>The operation manager should install a firewall between the LAN where the data server is installed and the external network, and manage the access to/from the outside to the minimum necessary (e.g., the IP address and port of source and destination are limited) to keep high security.</li>\r\n<li>The operation manager should restrict even communication from/to the LAN where the data server is installed appropriately at least by a firewall function (e.g., iptables in Linux) provided by the OS etc.</li>\r\n<li>The operation manager should not allow sharing of a user ID or a password for the data server among data users, and have them set the password to a sufficient strength that others cannot guess. (It must be at least 8 characters. Combination of numbers, upper case letters, lower case letters, and symbols is preferable. Do not use that are easy to guess such as name, phone number, birthday, and the like.)</li>\r\n<li>The operation manager should apply the latest security patches insofar as possible for all software installed on the data server.</li>\r\n<li>The operation manager should not install software unnecessary for service, particularly, file sharing software (also called file exchange or P2P software; e.g., Winny, BitTorrent).</li>\r\n<li>The operation manager should install antivirus software and perform virus scan at once whenever incorporating a data file other than the one which was downloaded from the Japanese Genotype-phenotype Archive (JGA), the DDBJ Sequence Read Archive (DRA), and the Genomic Expression Archive (GEA),&nbsp;from the outside of the data server. The operation manager must keep the antivirus software and virus definition file up to date.</li>\r\n<li>The operation manager should not start unnecessary processes as many as possible when the OS boots up etc.</li>\r\n<li>The operation manager should acquire the access log of the data server and check it regularly.</li>\r\n<li>When discarding a device that stored handled data, the operation manager should initialize the data storage area or physically destroyed in a way that cannot be restored.</li>\r\n<li>In case of a security incident such as data breach, the operation manager should immediately take measures.</li>\r\n</ol>\r\n<h4><strong><span style=\"color: #000000;\">2.2 What the Operator Must Do</span></strong></h4>\r\n<ol>\r\n<li>The operator should receive an education on information security implemented by the affiliated organization and the like.</li>\r\n<li>When logging in to the data server from a data access terminal via communication paths outside the LAN where the data server is installed, the operator should encrypt all the communication paths using a sufficiently strong encryption method every time data are transmitted between the data access terminal and the data server or encrypt the data themselves before transmitting them. It is desirable to perform similar encryption even when logging in to the data server from the inside of the LAN where the data server is installed.</li>\r\n<li>The operator should not access data from a terminal application on a device that can be used by many and unspecified persons (e.g., a PC in an Internet cafe).</li>\r\n<li>The operator should apply the latest security patches to the data access terminal whenever possible.</li>\r\n<li>When leaving a data access terminal, the operator should log out from the data server or lock the terminal. In addition, the terminal should be configured so that the screen is locked after a certain period of inactivity (around 15 minutes).</li>\r\n<li>The operator should not access data that he/she does not have permission from the Operation manager or data user.</li>\r\n<li>The operator should not copy or save handled data displayed on a data access terminal screen to the local disk. It is desirable to use a data access terminal application that does not permit copying and saving of handled data displayed on the terminal screen to the local disk.</li>\r\n<li>The operator should disable a cache function which automatically saves data on the data access terminal.</li>\r\n<li>The operator should not make copies of handled data or move handled data outside the data server, except in the following cases. In these cases, delete the copies promptly after use in a way that cannot be recovered.\r\n<ul>\r\n<li>Creation of a backup copy of handled data</li>\r\n<li>Temporary duplication at the time of transfer of handled data</li>\r\n<li>Temporary duplication performed by software</li>\r\n</ul>\r\n</li>\r\n<li>When obtaining a backup data, the operator should ensure that one of the following requirements is met.\r\n<ul>\r\n<li>The backup is saved on the data server.</li>\r\n<li>When the backup is saved in a mobile device (e.g., a tape, USB memory, CD-ROM, notebook PC), the handled data is encrypted and deleted after use in a way that does not allow restoration. A record of information regarding the mobile device and the backed-up handled data should be kept in the file described in the section “2.1 What the Operation Manager Must Do,” Operation in general, item (5), to minimize the risk of theft or loss and to enable early detection when such an incident occurred.</li>\r\n</ul>\r\n</li>\r\n<li>When it is inevitable to use a mobile device for temporary data transfer, the operator should handle the data in the same way as backup data.</li>\r\n<li>When it is inevitable to print handled data out, the operator should strictly manage the printout to protect confidentiality of the data, and shred the printout after use.</li>\r\n<li>In case of a security incident such as data breach, the operator should immediately take measures and report the incident to the operation manager.</li>\r\n</ol>\r\n<p>Be noted the above items (9) to (12) are not applied to the “off-premise-server.”</p>\r\n<p>&nbsp;</p>", "publish_up": "2021-06-22"}, {"lang": "ja", "path": "guidelines/security-guidelines-for-submitters", "title": "NBDCヒトデータ取扱いセキュリティガイドライン（データ提供者向け）ver. 3.0", "fulltext": "", "modified": "2024-04-01", "introtext": "<p style=\"text-align: right;\">2024.4.1<br />Ver. 3.0</p>\r\n<h3><strong><span style=\"font-size: 1.3em; line-height: 1.5; color: #000000;\">はじめに</span></strong></h3>\r\n<p><a href=\"https://dbcls.rois.ac.jp/\" target=\"_blank\" rel=\"noopener noreferrer\">大学共同利用機関法人 情報・システム研究機構 データサイエンス共同利用基盤施設 ライフサイエンス統合データベースセンター（以下、DBCLS）</a>は、<a href=\"/guidelines/data-sharing-guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">NBDCヒトデータ共有ガイドライン（以下、共有ガイドライン）</a>に則ってヒトデータベースを運営している。データ利用者向けには<a href=\"/guidelines/security-guidelines-for-users\" target=\"_blank\" rel=\"noopener noreferrer\">NBDCヒトデータ取扱いセキュリティガイドライン（データ利用者向け）（以下、データ利用者ガイドライン）</a>を定めている。一方、データ提供者（以下、提供者）に対しては、共有ガイドラインで定義する制限公開データに加えて、公開待機データ（特許取得や論文発表前のデータ）も扱うため、データ利用者と同等以上のセキュリティが求められる。本ガイドラインは、データ利用者向けガイドラインをベースに提供者が講じるべきセキュリティ対策について示したものである。</p>\r\n<h3><strong><span style=\"color: #000000;\">１. データ利用者ガイドラインの適用について</span></strong></h3>\r\n<p>制限公開データならびに公開待機データを扱う場合は、<span style=\"text-decoration: underline;\"><a href=\"/guidelines/security-guidelines-for-users#typeI\" target=\"_blank\" rel=\"noopener noreferrer\">データ利用者ガイドラインの標準レベル [Type Ⅰ]</a>の適用を原則とし、必要に応じて<a href=\"/guidelines/security-guidelines-for-users#typeII\" target=\"_blank\" rel=\"noopener noreferrer\">ハイレベル[Type Ⅱ] セキュリティ対策</a></span>を実施すること。また、提供するデータは特定の個人（死者を含む）を識別することができることとなる記述等の全部又は一部を除き、代わりに当該個人とかかわりのない符号又は番号を付し、その後、さらに符号又は番号の振りなおしを施したデータに限定する。</p>\r\n<p>また、「<a href=\"/guidelines/security-guidelines-for-users#yougo\" target=\"_blank\" rel=\"noopener noreferrer\">１．用語定義</a>」の一部を以下のように読み替え、データ利用者ガイドラインの「２．標準レベル [Type Ⅰ]セキュリティにおいて必要な対策」以降の部分を準用する。</p>\r\n<ul style=\"list-style: none;\">\r\n<li>４．データ利用者\r\n<ul style=\"list-style: none;\">\r\n<li>&nbsp;&nbsp;&nbsp;&nbsp;研究代表者ならびに研究代表者の管理下でデータにアクセスする者。</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p>&nbsp;</p>\r\n<p style=\"text-align: right;\">以上</p>", "publish_up": "2018-08-31"}, {"lang": "en", "path": "guidelines/security-guidelines-for-submitters", "title": "NBDC Security Guidelines for Human Data (for Data Submitters) ver. 3.0", "fulltext": "", "modified": "2024-04-01", "introtext": "<p style=\"text-align: right;\">April 1, 2024<br />Ver. 3.0</p>\r\n<h3><strong><span style=\"font-size: 1.3em; line-height: 1.5; color: #000000;\">Introduction</span></strong></h3>\r\n<p><a href=\"https://dbcls.rois.ac.jp/index-en.html\" target=\"_blank\" rel=\"noopener noreferrer\">The Database Center for Life Science (DBCLS) / the Joint Support-Center for Data Science Research (DS) of the Research Organization of Information and Systems (ROIS)</a> operates the NBDC Human Database in accordance with <a href=\"/en/guidelines/data-sharing-guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">the NBDC Guidelines for Human Data Sharing</a> (hereinafter, the Data Sharing Guidelines). For data users, we have <a href=\"/en/guidelines/security-guidelines-for-users\" target=\"_blank\" rel=\"noopener noreferrer\">the NBDC Security Guidelines for Human Data (for Data Users)</a> (hereinafter, the Data User Security Guidelines). For data submitters, security measures that are stronger than those taken by data users are required because data submitters handle not only controlled-access data, which are defined in the Data Sharing Guidelines, but also data for future release (data held prior to publication of a paper or acquisition of a patent). Based on the Data User Security Guidelines, the “NBDC Security Guidelines for Human Data (for Data Submitters)” set forth the security measures to be taken by the data submitters.</p>\r\n<h3><strong><span style=\"color: #000000;\">1. Application of the User Security Guidelines</span></strong></h3>\r\n<p>When controlled-access data or data for future release are handled, in principle <span style=\"text-decoration: underline;\">the <a href=\"/en/guidelines/security-guidelines-for-users#typeI\" target=\"_blank\" rel=\"noopener noreferrer\">standard-level (Type I) security measures</a>, which are listed in the Data User Security Guidelines, must be put in place, and the <a href=\"/en/guidelines/security-guidelines-for-users#typeII\" target=\"_blank\" rel=\"noopener noreferrer\">high-level (Type II) security measures</a> are implemented as needed</span>. Data to be provided must be assigned codes or numbers that are unrelated to the individuals in lieu of all or part of the description or the like that may lead to identification of a particular individual (including one deceased) and further assigned another set of codes or numbers.</p>\r\n<p>Some definitions in the <a href=\"/en/guidelines/security-guidelines-for-users#yougo\" target=\"_blank\" rel=\"noopener noreferrer\">section 1 (Definitions)</a> of the Data User Security Guidelines are changed as follows, and the sections starting with the section 2 (Measures to Be Taken under Standard-Level (Type I) Security) are applied to this document.</p>\r\n<ul style=\"list-style: none;\">\r\n<li>3. Data user\r\n<ul style=\"list-style: none;\">\r\n<li>The PI or a person who accesses data under supervision of the PI.</li>\r\n</ul>\r\n</li>\r\n</ul>", "publish_up": "2019-06-10"}, {"lang": "ja", "path": "guidelines/security-guidelines-for-users", "title": "NBDCヒトデータ取扱いセキュリティガイドライン（データ利用者向け） ver. 7.0", "fulltext": "", "modified": "2025-01-09", "introtext": "<p style=\"text-align: right;\">2024.4.1<br />Ver. 7.0</p>\r\n<h3><strong><span style=\"color: #000000;\">はじめに</span></strong></h3>\r\n<p><a href=\"https://dbcls.rois.ac.jp/\" target=\"_blank\" rel=\"noopener noreferrer\">大学共同利用機関法人 情報・システム研究機構 データサイエンス共同利用基盤施設 ライフサイエンス統合データベースセンター（以下、DBCLS）</a>は、<a href=\"/guidelines/data-sharing-guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">NBDCヒトデータ共有ガイドライン（以下、共有ガイドライン）</a>に則ってNBDCヒトデータベースを運営している。このガイドラインは、共有ガイドラインで定義する登録者公開データならびに制限公開データを、外部に漏えいすることなく安全に研究活動に利用するために最低限遵守すべき内容を示したものである。</p>\r\n<p>制限公開データには、他の情報と照合されることによって個人識別が可能になるデータが含まれている場合もあり、データごとにデータ提供者が指定したセキュリティレベル（標準レベル【TypeⅠ】又はハイレベル【TypeⅡ】）の対策を講じることが求められる。</p>\r\n<p>なお、データ利用者をとりまくIT環境は千差万別で、日々変化しているため、このガイドラインを遵守するだけでセキュリティが十分に保証されるとは限らない。データ利用者は、制限公開データの保存や計算処理で利用するIT環境をよく理解し、各IT環境の管理者が定めるセキュリティ規則や他のガイドライン<a href=\"#NCBI\"><sup>[1] [2]</sup></a>も参考にしながら、必要に応じて追加のセキュリティ対策を講じることが求められる。<br />このガイドラインについては、IT環境の進展に応じ、適宜見直しを行うものとする。</p>\r\n<h3><a name=\"yougo\"><strong><span style=\"color: #000000;\"><span>１. 用語定義</span></span></strong></a></h3>\r\n<ol>\r\n<li>制限公開データ、データ\r\n<ul>\r\n<li>共有ガイドラインで定義している「制限公開データ」。</li>\r\n</ul>\r\n</li>\r\n<li>登録者公開データ\r\n<ul>\r\n<li>共有ガイドラインで定義している「登録者公開データ」。</li>\r\n</ul>\r\n</li>\r\n<li>研究代表者\r\n<ul>\r\n<li>共有ガイドラインで定義している「研究代表者」。</li>\r\n</ul>\r\n</li>\r\n<li>データ利用者\r\n<ul>\r\n<li>制限公開データの利用がヒトデータ審査委員会による審査において承認されたデータ利用者、データ利用者からの委託を受けてその監督のもと従事する者、ならびに、登録者公開データ利用の登録が完了した登録者公開データ利用者。</li>\r\n</ul>\r\n</li>\r\n<li>データサーバ（図１参照）\r\n<ul>\r\n<li>データ利用者が制限公開データの保存や計算処理を行うためのコンピュータで、データ利用者またはデータ利用者の所属機関が所有するもの、または、共有ガイドラインで定義している「所属機関外利用可能サーバ（以下、「機関外サーバ」）」。 なお、データサーバを含むIT環境は、前提条件として以下の（１）～（４）を満たすことが必要（「機関外サーバ」のみ利用の場合は除く）。\r\n<ul style=\"list-style: none;\">\r\n<li>（１）ノートPC等の移動性が高く紛失や盗難のリスクが高い機器を利用していないこと。</li>\r\n<li>（２）データサーバの機器およびデータを格納する記憶装置/媒体は、それらを所有する機関によって管理されていること。</li>\r\n<li>（３）データサーバをLAN内に設置する場合、LANはデータ利用者の所属機関が所有するものであること。また、データサーバを設置したLAN（以下、データサーバ設置LAN）は、所属機関のネットワーク管理者によって、外部ネットワークとデータサーバ設置LAN間の通信を制限するファイアウォールが設置され、外部とのアクセスが必要最小限（例：アクセス元、アクセス先のIPアドレスやポートが限定されている）に管理されており、高いセキュリティが保たれていること。</li>\r\n<li>（４）データサーバ設置LAN内に、データ利用者以外の者が利用するコンピュータが存在する場合は、ファイアウォール機能で他のコンピュータとの間の通信が適切に管理されていること。</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>データアクセス端末（図１参照）\r\n<ul>\r\n<li>データがローカルに永続的に保存されることなく、データ利用者がデータサーバ内のデータにアクセスするための機器。尚、データアクセス端末とデータサーバ間のデータ伝送の際に、データサーバ設置LAN外の通信経路を介する場合は、全ての通信経路を十分な強度で暗号化する、またはデータ自体を暗号化した上で伝送する、ことが必要。</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<p>&nbsp;<img src=\"files/images/orgLAN2.png\" alt=\"orgLAN\" width=\"521\" height=\"344\" style=\"border: 1px solid #000000; display: block; margin-left: auto; margin-right: auto;\" /></p>\r\n<p style=\"text-align: center;\"><strong>図 1　データサーバ設置LAN、機関外サーバ、データサーバ、データアクセス端末</strong></p>\r\n<h3><a name=\"typeI\"><strong><span style=\"color: #000000;\"><span>２. 標準レベル [Type Ⅰ]セキュリティにおいて必要な対策</span></span></strong></a></h3>\r\n<h4><strong><span style=\"color: #000000;\">２－１. データ利用の原則</span></strong></h4>\r\n<p>データ利用者は、制限公開データを以下の原則に基づいて利用すること。</p>\r\n<ol>\r\n<li>データ利用者は、制限公開データをデータサーバに保存し、原則、データサーバ外に移動しないこと。</li>\r\n<li>データ利用者は、制限公開データを、やむを得ず一時的に、データサーバ設置LAN内でデータサーバ外に移動しなければならない場合は、利用後速やかに復元不可能な方法で消去すること。</li>\r\n<li>データ利用者は、データのコピーは作成しないこと。ただし、以下の場合は例外とする。これらの場合も、利用後速やかに復元不可能な方法で消去すること。\r\n<ul>\r\n<li>データをバックアップする場合。</li>\r\n<li>データ移動時に一時的に作成する場合。</li>\r\n<li>ソフトウェアによって一時的に作成される場合。</li>\r\n</ul>\r\n</li>\r\n<li>制限公開データへのアクセスはデータ利用者に限定し、データサーバまたはデータアクセス端末からのみ行うこと。</li>\r\n<li>データ利用者をとりまくIT環境は千差万別で、日々変化しているため、このガイドラインを遵守するだけでセキュリティが十分に保証されるとは限らない。データ利用者はデータの保存やデータの計算処理で利用するIT環境をよく理解し、各IT環境の管理者が定めるセキュリティ規則や他のガイドライン<a href=\"#NCBI\"><sup>[1] [2]</sup></a>も参考にしながら、必要に応じて追加のセキュリティ対策を講じること。</li>\r\n</ol>\r\n<h4><strong><span style=\"color: #000000;\">２－２. 研究代表者が遵守すべきこと</span></strong></h4>\r\n<h5><strong><span style=\"color: #000000;\">＜利用全般について＞</span></strong></h5>\r\n<ol>\r\n<li>研究代表者は、NBDCヒトデータ取扱いセキュリティガイドライン（データ利用者向け）を、データ利用者に周知して遵守させること。</li>\r\n<li>研究代表者は、データ利用者が、所属機関等の実施する情報セキュリティに関する教育を、受講していることを確認すること。</li>\r\n<li>研究代表者は、データ利用者とデータサーバ（ファイルシステム内での格納場所を含む）に関する情報をデータ利用者のみがアクセス可能な電子ファイル等で台帳管理し、変更が発生する都度、内容を更新すること。なお、変更履歴が確認できるように管理を行うこと。</li>\r\n<li>研究代表者は、ヒトデータ審査委員会、あるいはDBCLSから依頼された第三者が実施する、セキュリティ対策の実施状況についての監査に応じること。</li>\r\n<li>研究代表者は、データ利用申請時ならびに、1年毎に、\"<a href=\"files/security_checklist_for_users.xlsx\">NBDCヒトデータ取扱いセキュリティガイドラインチェックリスト</a>\"をヒトデータ審査委員会事務局に提出すること。</li>\r\n<li>研究代表者は、データの漏えい等セキュリティに関する事故が発生した場合、共有ガイドライン「データ利用者の責務」に記載の手順に従い、DBCLSへの通知等の処置を実施すること。</li>\r\n</ol>\r\n<h5><strong><span style=\"color: #000000;\">＜データサーバについて＞</span></strong></h5>\r\n<p>「機関外サーバ」を利用する場合には、研究代表者が「機関外サーバ」との責任分担を利用規約等で整理しておくこと。</p>\r\n<ol>\r\n<li>研究代表者は、データ利用申請で申請した用途専用のデータサーバ（仮想サーバを含む）やファイルシステムを用意すること。やむを得ずデータ利用者でないユーザと共同でサーバ等を利用する場合は、データが保存されたフォルダのアクセス権限をデータ利用者に限定すること。</li>\r\n<li>研究代表者は、データサーバ設置LAN内にデータ利用者以外の者が利用するコンピュータが存在する場合は、最低限OS付属のファイアウォール機能（例：iptables（Linuxの場合））や同等の機能を有効にし、データサーバ設置LAN内からの通信を適切に制限すること。</li>\r\n<li>研究代表者は、データサーバのユーザIDやパスワードをデータ利用者間であっても共有せず、かつ、他人が類推できない十分な強度のパスワードを設定すること。（８文字以上であること。数字、英大小文字と記号を組合せたものが望ましい。氏名、電話番号、誕生日等の推測し易いものを利用しないこと。）</li>\r\n<li>研究代表者は、データサーバにインストールした全てのソフトウェアについて、できる限り最新のセキュリティパッチを適用すること。</li>\r\n<li>研究代表者は、不要なソフトウェアをインストールしないこと。特にファイル共有（ファイル交換、P2P）ソフト（例：Winny、BitTorrent）をインストールしないこと。</li>\r\n<li>研究代表者は、ウィルス対策ソフトをインストールし、データサーバ外からファイルを取り込む場合はその場でウイルススキャンを実施すること。またウィルス対策ソフト及びウィルス定義ファイルは最新の状態を維持すること。</li>\r\n<li>研究代表者は、OS起動時等に不要なプロセスはできるだけ起動させないこと。</li>\r\n<li>研究代表者は、セキュリティ監視として、データサーバの各種ログの取得・分析を定期的に行うことが望ましい。</li>\r\n<li>研究代表者は、制限公開データを保存した機器を廃棄する場合には、データの保存領域を復元不可能な方法で初期化すること。もしくは、復元不可能となるように物理的に破壊すること。</li>\r\n<li>データの漏えい等セキュリティに関する事故が発生した場合、研究代表者は、直ちにデータサーバ設置LANからデータサーバやデータアクセス端末を切り離すこと。</li>\r\n</ol>\r\n<h4><strong><span style=\"color: #000000;\">２－３. データ利用者が遵守すべきこと</span></strong></h4>\r\n<p>１．から７．は登録者公開データのデータ利用者ならびに制限公開データのデータ利用者が遵守する項目、また、８．から１３．は制限公開データのデータ利用者のみが遵守する項目とする。</p>\r\n<ol>\r\n<li>データ利用者は、所属機関等が実施する情報セキュリティに関する教育を受講し、所属機関が定めるセキュリティ規則を遵守すること。</li>\r\n<li>データ利用者は、ユーザIDやパスワードをデータ利用者間であっても共有せず、かつ、他人が類推できない十分な強度のパスワードを設定すること。（８文字以上であること。数字、英大小文字と記号を組合せたものが望ましい。氏名、電話番号、誕生日等の推測し易いものを利用しないこと。）</li>\r\n<li>データ利用者は、不特定多数が利用する機器（例：ネットカフェのPC）上の端末からデータにアクセスしないこと。</li>\r\n<li>データ利用者は、データアクセス端末には、できる限り最新のセキュリティパッチを適用すること。</li>\r\n<li>データ利用者は、データアクセス端末から離れる場合は、データサーバからログアウトするか、データアクセス端末をロックすること。また、一定時間（１５分程度を目安）以上無操作の場合はデータアクセス端末画面がロックされるように設定すること。</li>\r\n<li>データ利用者は、データアクセス端末にデータを自動的に保存する機能（いわゆるキャッシュ機能）がある場合は当該機能を無効にすること。</li>\r\n<li>データ利用者は、やむを得ず登録者公開データ閲覧画面や制限公開データを印刷する場合には、登録者公開データのデータ利用者もしくは制限公開データのデータ利用者以外の目に触れることがないよう印刷物を厳重に管理し、利用終了時にはシュレッダ処理すること。</li>\r\n<li>データ利用者は、データアクセス端末から、データサーバ設置LAN外の通信経路を介してデータサーバにログインする場合は、データアクセス端末とデータサーバ間のデータ伝送の都度、全ての通信経路を十分な強度で暗号化する、またはデータ自体を暗号化した上で伝送すること。データサーバ設置LAN内からデータサーバにログインする場合も、同様の暗号化を行うことが望ましい。</li>\r\n<li>データ利用者は、データアクセス端末画面上のデータをコピーしてローカルディスクに保存しないこと。データアクセス端末画面上に表示されたデータをコピーしてローカルディスクに保存できないデータアクセス端末の利用が望ましい。</li>\r\n<li>データ利用者は、データのバックアップ取得の際は、以下のいずれかの条件を満たすこと。\r\n<ul>\r\n<li>データサーバに保存すること。</li>\r\n<li>移動可能機器（例：テープ、USBメモリ、CD-ROM、ノートPC）に保存する場合は、データを暗号化し、使用後はデータを復元不可能な方法で消去すること。また、移動可能機器はデータ利用者のみがアクセス可能な電子ファイル等で台帳管理し、盗難や紛失の可能性を最小限にするとともに、当該事実が発生した場合の早期発見を可能にすること。</li>\r\n</ul>\r\n</li>\r\n<li>データ利用者は、やむを得ず一時的なデータ移動に移動可能機器を利用する場合もバックアップデータと同様に取り扱うこと。</li>\r\n<li>データ利用者は、データの利用を終了した場合は、バックアップも含めてデータを全機器から復元不可能な方法で消去すること。紙や移動可能機器で、上記方法での消去ができない場合には、裁断等により復元不可能となるように物理的に破壊すること。また計算途中で発生した一時ファイルもこまめに消去することが望ましい。</li>\r\n<li>データ利用者は、データの漏えい等セキュリティに関する事故が発生した場合、直ちにデータサーバ設置LANからデータサーバやデータアクセス端末を切り離したのち、研究代表者に報告すること。「機関外サーバ」利用の場合には、機関外サーバの利用規程等に従って、直ちに対策を実施するものとする。</li>\r\n</ol>\r\n<h3><a name=\"typeII\"><strong><span style=\"color: #000000;\"><span>３. ハイレベル[Type Ⅱ] セキュリティにおいて必要な対策（「機関外サーバ」のみ利用の場合は除く）</span></span></strong></a></h3>\r\n<p>上記「２. 標準レベル [Type Ⅰ]セキュリティにおいて必要な対策」に加え、データサーバに関して以下の対策を講じること。</p>\r\n<p>１. 研究代表者は、以下の条件を全て満たすサーバ室にデータサーバを設置すること。</p>\r\n<ul style=\"list-style-type: none;\">\r\n<li>①以下の３つの認証方法の内、２つ以上を組み合わせた多要素認証により入室者を限定すること。\r\n<ul>\r\n<li>生体認証（例：静脈、指紋、虹彩、顔）</li>\r\n<li>所有物認証（例：ICカード、ワンタイムパスワード、USBトークン）</li>\r\n<li>知識認証（例：パスワード）</li>\r\n</ul>\r\n</li>\r\n<li>②入室記録を自動取得し、後日監査可能であること。</li>\r\n<li>③申請した用途専用のサーバ室であること。専用サーバ室を確保できない場合は、常時施錠された専用のサーバラックにデータサーバを格納すること。</li>\r\n</ul>\r\n<h3><strong><span style=\"color: #000000;\">４. 本ガイドラインに関する連絡先</span></strong></h3>\r\n<p>データ共有分科会事務局<br />humandbs＠dbcls.jp</p>\r\n<h3><strong><span style=\"color: #000000;\">参考文献</span></strong></h3>\r\n<p><a name=\"NCBI\">[1]</a>.&nbsp;<strong>NCBI</strong>. NIH Security Best Practices for Controlled-Access Data Subject to the NIH Genomic Data Sharing (GDS) Policy. (オンライン) 2021年11月29日.<br /><a href=\"https://sharing.nih.gov/sites/default/files/flmngr/NIH_Best_Practices_for_Controlled-Access_Data_Subject_to_the_NIH_GDS_Policy.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">https://sharing.nih.gov/sites/default/files/flmngr/NIH_Best_Practices_for_Controlled-Access_Data_Subject_to_the_NIH_GDS_Policy.pdf</a><br /><a name=\"mhlw\">[2]</a>.&nbsp;<strong>厚生労働省.</strong> 医療情報システムの安全管理に関するガイドライン第5版 2017年5月.<br /><a href=\"https://www.mhlw.go.jp/file/05-Shingikai-12601000-Seisakutoukatsukan-Sanjikanshitsu_Shakaihoshoutantou/0000166260.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">https://www.mhlw.go.jp/file/05-Shingikai-12601000-Seisakutoukatsukan-Sanjikanshitsu_Shakaihoshoutantou/0000166260.pdf</a></p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p style=\"text-align: right;\">以上</p>", "publish_up": "2022-04-01"}, {"lang": "en", "path": "guidelines/security-guidelines-for-users", "title": "NBDC Security Guidelines for Human Data (for Data Users) ver. 7.0", "fulltext": "", "modified": "2025-01-09", "introtext": "<p style=\"text-align: right;\">April 1, 2024<br />Ver. 7.0</p>\r\n<h3><strong><span style=\"color: #000000;\"> Introduction </span></strong></h3>\r\n<p><a href=\"https://dbcls.rois.ac.jp/index-en.html\" target=\"_blank\" rel=\"noopener noreferrer\">The Database Center for Life Science (DBCLS) / the Joint Support-Center for Data Science Research (DS) of the Research Organization of Information and Systems (ROIS)</a> operates the NBDC Human Database in accordance with <a href=\"/en/guidelines/data-sharing-guidelines\" target=\"_blank\" rel=\"noopener noreferrer\">the NBDC Guidelines for Human Data Sharing</a> (hereinafter, the Data Sharing Guidelines). This “NBDC Security Guidelines for Human Data (for Data Users)” (hereinafter, the User Security Guidelines) provides <span style=\"text-decoration: underline;\">the minimum set of requirements</span> that should be fulfilled in order to safely utilize the registered-access data and controlled-access data defined in the Data Sharing Guidelines for the purpose of research activities, while protecting data confidentiality.</p>\r\n<p>The controlled-access data may contain data that could be used to identify individuals in combination with other information. Therefore, measures must be implemented as required for the security level (standard-level (Type I) or high-level (Type II)) designated by a data submitter for each data set.</p>\r\n<p>Because the information technology (IT) environments surrounding data users are diverse and ever-changing, merely complying with the User Security Guidelines may not be sufficient for data security. Data users are responsible for understanding their IT environments to be used for saving and calculating controlled-access data well, and taking additional security measures as deemed necessary, e.g., by referring to the security rules defined by the administrator of each IT environment as well as other guidelines<sup><a href=\"#ref1\">[1]</a><a href=\"#ref2\">[2]</a></sup>.</p>\r\n<p>The User Security Guidelines will be updated appropriately in response to IT developments.</p>\r\n<h3><a name=\"yougo\"><strong><span style=\"color: #000000;\"><span>1. Definitions</span></span></strong></a></h3>\r\n<ol>\r\n<li>Controlled-access data, Data\r\n<ul style=\"list-style: none;\">\r\n<li>The “controlled-access data” as defined in the Data Sharing Guidelines.</li>\r\n</ul>\r\n</li>\r\n<li>Data accessible to registered users （Registered-access data）\r\n<ul style=\"list-style: none;\">\r\n<li>The “registered-access data” as defined in the Data Sharing Guidelines.</li>\r\n</ul>\r\n</li>\r\n<li>Principal investigator (PI)\r\n<ul style=\"list-style: none;\">\r\n<li>The “PI” as defined in the Data Sharing Guidelines.</li>\r\n</ul>\r\n</li>\r\n<li>Data user\r\n<ul style=\"list-style: none;\">\r\n<li>Data users who have been approved by the Human Data Review Board for the use of the controlled-access data, persons who have been entrusted by a data user to perform a work under the supervision of the data user, and data users of the registered-access data who have completed the registration for the use of the registered-access data.</li>\r\n</ul>\r\n</li>\r\n<li>Data server (see Figure 1)\r\n<ul style=\"list-style: none;\">\r\n<li>A computer for data users to store and calculate controlled-access data, owned by the data user or the organization to which data users belong, or the “available server outside of affiliated organization (hereinafter, “off-premise-server”)” as defined in the Data Sharing Guidelines. In the IT environment including the data server, it is necessary to satisfy the following (1) to (4) as preconditions (except in the case of using only the off-premise-server).\r\n<ul style=\"list-style: none;\">\r\n<li>(1) Devices with high mobility, such as notebook PCs that are at high risk of loss or theft are not used.</li>\r\n<li>(2) The equipment of the data server and the storage device / medium storing the data are managed by the organization that owns them.</li>\r\n<li>(3) When installing the data server in a LAN, the LAN must be owned by the data users’ affiliated organization. In addition, on the LAN on which the data server is installed (hereinafter, data server-installed LAN), a firewall that restricts communication between the external network and the data server-installed LAN must be installed by the network administrator in the affiliated organization, and access from/to the outside is kept necessary minimal (Example: IP address and port of source and destination are limited) to maintain high security.</li>\r\n<li>(4) In the data server-installed LAN, if there is a computer used by a person other than the data users, the communication with other computers is appropriately managed by the firewall function.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>Data access terminal (see Figure 1)\r\n<ul style=\"list-style: none;\">\r\n<li>A device that is for data users to access data in the data server and that does not permanently save the data locally. When transmitting data between the data access terminal and the data server, via a communication path outside the data server-installed LAN, it is necessary that all communication paths are encrypted with sufficient strength or that the data themselves are encrypted before being transmitted.</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<p>&nbsp;<img src=\"files/images/org_LAN_e2.png\" alt=\"org LAN e\" width=\"480\" height=\"327\" style=\"border: 1px solid #000000; display: block; margin-left: auto; margin-right: auto;\" /></p>\r\n<p style=\"text-align: center;\"><strong> Figure 1 Data server-installed LAN, off-premise-server, data server and data access terminal</strong></p>\r\n<h3><a name=\"typeI\"><strong><span style=\"color: #000000;\"><span>2. Measures to Be Taken under Standard-Level (Type I) Security</span></span></strong></a></h3>\r\n<h4><strong><span style=\"color: #000000;\"> 2.1 Basic Rules for Data Use</span></strong></h4>\r\n<p>Data users must use the controlled-access data based on the following basic rules.</p>\r\n<ol>\r\n<li>Data users must store the controlled-access data in the data server and, in principle, must not move outside of the data server.</li>\r\n<li>In cases where it is unavoidable to temporarily move the controlled-access data outside of the data server but within the data server-installed LAN, data users must delete the data outside of the server promptly after use in a way that does not allow restoration.</li>\r\n<li>Data users must not duplicate data except for the following cases. In any case, however, duplicated data must be deleted promptly after use in a way that does not allow restoration.\r\n<ul>\r\n<li>Creation of a backup copy of the data</li>\r\n<li>Temporary duplication for data transfer</li>\r\n<li>Temporary duplication performed by software</li>\r\n</ul>\r\n</li>\r\n<li>Access to the controlled-access data is granted exclusively to the data users and must be conducted solely from data servers or data access terminals.</li>\r\n<li>Because IT environments surrounding data users are diverse and ever changing, data security is not necessarily guaranteed only by complying with these guidelines. Therefore, data users must understand the IT environment used for data storage and data calculation well, and take additional security measures as deemed necessary based on the security rules specified by the administrator of each IT environment and other guidelines<sup><a href=\"#ref1\">[1]</a><a href=\"#ref2\">[2]</a></sup>.</li>\r\n</ol>\r\n<h4><strong><span style=\"color: #000000;\"> 2.2 What the Principal Investigator Must Do </span></strong></h4>\r\n<h5><strong><span style=\"color: #000000;\"> Data use in general </span></strong></h5>\r\n<ol>\r\n<li>The PI should ensure that all data users fully understand and comply with the User Security Guidelines (For Data Users).</li>\r\n<li>The PI should confirm that the data users have received an education on information security implemented by their affiliated organization or the like.</li>\r\n<li>The PI should keep a record of information regarding data users and the data server (including information on the data storage place in the file system) in an electronic file or the like accessible to only data users, and update the record every time a change occurs. The record must be managed so that the update history can be reviewed.</li>\r\n<li>The PI should accept an audit conducted by the Human Data Review Board or a third party commissioned by the DBCLS with regard to the state of implementation of security measures.</li>\r\n<li>The PI should submit \"Checklist for the NBDC Security Guidelines for Human Data\" to the Human Data Review Board Office at the time of application for data use and, in principle, every year thereafter.</li>\r\n<li>In case of a security incident such as data breach, the PI must follow the procedure described in “Responsibilities of Data Users” in the Data Sharing Guidelines and take measures such as notification to the DBCLS.</li>\r\n</ol>\r\n<h5><strong><span style=\"color: #000000;\">Data server</span></strong></h5>\r\n<p>When an “off-premise-server” is used, the PI must clarify the responsibility sharing with the “off-premise-server“ by means of the server usage rules etc.</p>\r\n<ol>\r\n<li>The PI should prepare for a data server (including a virtual server) and file system that are dedicated to the study as described in the Application Form for Data Use. When there is no choice but to use a server shared with other persons who are not data users, the access to the folders containing the controlled-access data should be limited only to the data users.</li>\r\n<li>If a computer used by a person other than data users exists within the data server-installed LAN, the PI should at least enable the firewall functions provided by the operating system (OS) (e.g., iptables in Linux) or equivalent to the function, and restrict communication from/to the inside of the data server-installed LAN properly.</li>\r\n<li>The PI should not allow sharing of a user ID or a password for the data server, even among data users. In addition, the PI must set a sufficiently strong password that cannot be guessed by others. (It must be at least 8 characters long. It is desirable to combine numbers, upper case letters, lower case letters and symbols. Do not use those that are easy to guess such as name, phone number, birthday, and the like.)</li>\r\n<li>The PI should apply the latest security patches insofar as possible for all software installed on the data server.</li>\r\n<li>The PI should not install unnecessary software, particularly, file sharing software (also called file exchange or P2P software; e.g., Winny, BitTorrent).</li>\r\n<li>The PI should install antivirus software, and perform virus scan at once whenever moving a file from the outside of the data server. The PI must keep the antivirus software and virus definition file up to date.</li>\r\n<li>The PI should not start unnecessary processes as many as possible when the OS boots up etc.</li>\r\n<li>Desirably, as security monitoring, the PI should periodically acquire and analyze various logs of the data server.</li>\r\n<li>When discarding a device that saved the controlled-access data, the PI should initialize the data storage or physically destroyed in a way that cannot be restored.</li>\r\n<li>In case of a security incident such as data breach, the PI should disconnect the relevant data server or data access terminal immediately from the data server-installed LAN.</li>\r\n</ol>\r\n<h4><strong><span style=\"color: #000000;\"> 2.3 What the Data User Must Do</span></strong></h4>\r\n<p>Items 1. through 7. are to be complied with by data users of the registered-access data and data users of the controlled-access data, and items 8. through 13. are to be complied with only by data users of the controlled-access data.</p>\r\n<ol>\r\n<li>The data user should receive an education on information security implemented by the affiliated organization and the like and comply with the security rules set by the affiliated organization.</li>\r\n<li>The data user should not allow sharing of a user ID or a password for the data server, even among data users. In addition, the user must set a sufficiently strong password that cannot be guessed by others. (It must be at least 8 characters long. It is desirable to combine numbers, upper case letters, lower case letters, and symbols. Do not use those that are easy to guess such as name, phone number, birthday, and the like.)</li>\r\n<li>The data user should not access data from a terminal application on a device that can be used by many and unspecified persons (e.g., a PC in an Internet cafe).</li>\r\n<li>The data user should apply the latest security patches to the data access terminal whenever possible.</li>\r\n<li>When leaving a data access terminal, the data user should log out from the data server or lock the terminal. In addition, the terminal should be configured so that the screen is locked after a certain period of inactivity (around 15 minutes).</li>\r\n<li>The data user should disable a cache function, if any, which automatically saves data on the data access terminal.</li>\r\n<li>When it is inevitable to print data out (including the browse screen capture), the data user should strictly manage the printout to protect the confidentiality of the data, and shred the printout after use.</li>\r\n<li>When logging in to the data server from a data access terminal via computational network outside the data server-installed LAN, the data user should encrypt all the communication paths using a sufficiently strong encryption method every time data are transmitted between the data access terminal and the data server or encrypt the data themselves before transmitting them. It is desirable to perform similar encryption when logging in to the data server from the inside of the data server-installed LAN.</li>\r\n<li>The data user should not copy or save data displayed on a data access terminal screen to the local disk. It is desirable to use a data access terminal application that does not permit copying and saving of data displayed on the terminal screen to the local disk.</li>\r\n<li>When obtaining backup data, the data user should ensure that one of the following requirements is met:\r\n<ul>\r\n<li>The backup is saved on the data server.</li>\r\n<li>When the backup is saved in a mobile device (e.g., a tape, USB memory, CD-ROM, notebook PC), the data is encrypted and deleted after use in a way that does not allow restoration. A record of information regarding the mobile device should be kept, e.g., in an electronic file accessible to only the data user, to minimize the risk of theft or loss and to enable early detection of an incident of data theft or data loss.</li>\r\n</ul>\r\n</li>\r\n<li>When it is inevitable to use a mobile device for temporary data transfer, the data user should handle the data in the same way as backup data.</li>\r\n<li>After finishing data use, the data user should delete all data including all backups from all the devices in a way that does not allow restoration of the data. If the data cannot be deleted by the above method, such as for paper or a mobile device, the data should be physically destroyed in a way that cannot be restored by cutting or the like. It is preferable to delete any temporary file that was generated during computations as soon as it becomes unnecessary.</li>\r\n<li>In case of a security incident such as data breach, the data user should immediately disconnect the relevant data server or data access terminal from the data server-installed LAN and report the incident to the PI. In case where an “off-premise-server” is used, the data user should immediately take actions according to the off-premise-server usage measures etc.</li>\r\n</ol>\r\n<h3><a name=\"typeII\"><strong><span style=\"color: #000000;\"><span>3. Measures to Be Taken under High-Level (Type II) Security (except for using only an “off-premise-server”)</span></span></strong></a></h3>\r\n<p>In addition to the measures listed in the previous section, “2. Measures to Be Taken under Standard-Level (Type I) Security,” the following measures must be taken with regard to the data server.</p>\r\n<ol>\r\n<li>The PI should place the data server in a server room that meets all of the following requirements.\r\n<ul style=\"list-style: none;\">\r\n<li>(1) Access to the room is limited, using multi-factor authentication with at least two of the following three authentication methods.\r\n<ul>\r\n<li>Biometric authentication (e.g., vein, fingerprint, iris, and face recognition).</li>\r\n<li>Property-based authentication (e.g., IC card, one-time password, and USB token).</li>\r\n<li>Knowledge-based authentication (e.g., password).</li>\r\n</ul>\r\n</li>\r\n<li>(2) Record of access to the room is automatically obtained and made available for later audit.</li>\r\n<li>(3) The server room must be dedicated to the purpose as described in the Application Form for Data Use. If a dedicated server room cannot be set up, the data server must be stored in a locked dedicated server rack.</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<h3><strong><span style=\"color: #000000;\"> 4. Contact Information for Inquiries about the User Security Guidelines</span></strong></h3>\r\n<p>The Data Sharing Subcommittee Office<br />humandbs@dbcls.jp</p>\r\n<h3><strong><span style=\"color: #000000;\"> References </span></strong></h3>\r\n<p><a name=\"ref1\">[1]</a> NCBI. NIH Security Best Practices for Controlled-Access Data Subject to the NIH Genomic Data Sharing (GDS) Policy. (Online) November 29, 2021.<br /><a href=\"https://sharing.nih.gov/sites/default/files/flmngr/NIH_Best_Practices_for_Controlled-Access_Data_Subject_to_the_NIH_GDS_Policy.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">https://sharing.nih.gov/sites/default/files/flmngr/NIH_Best_Practices_for_Controlled-Access_Data_Subject_to_the_NIH_GDS_Policy.pdf</a></p>\r\n<p><a name=\"ref2\">[2]</a> Ministry of Health, Labor, and Welfare. <em>Iryojoho shisutemu no anzenkanri ni kansuru gaidorain</em> (Guidelines for Security Management for Medical Information Systems) [in Japanese]. Version 5, May 2017.<br /><a href=\"http://www.mhlw.go.jp/file/05-Shingikai-12601000-Seisakutoukatsukan-Sanjikanshitsu_Shakaihoshoutantou/0000166260.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">http://www.mhlw.go.jp/file/05-Shingikai-12601000-Seisakutoukatsukan-Sanjikanshitsu_Shakaihoshoutantou/0000166260.pdf</a></p>\r\n<p>&nbsp;</p>", "publish_up": "2022-04-01"}, {"lang": "ja", "path": "home", "title": "利用可能な研究データ一覧", "fulltext": "", "modified": "2025-09-24", "introtext": "<p>データ利用方法は<a href=\"data-use\">こちら</a>をご覧下さい。</p>\r\n<!--\r\n<table class=\"table-style style-greystripes\" style=\"width: 1500px; height: 333px;\">\r\n-->\r\n<table id=\"list-of-all-researches\" class=\"table-style style-greystripes\">\r\n<thead>\r\n<tr><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">Research ID</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">研究題目</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">公開日</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">データの種類</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">研究方法</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">手法</span></th><th class=\"”highlight”\" align=\"center\">\r\n<p><span style=\"font-size: small;\">参加者</span></p>\r\n<p><span style=\"font-size: small;\">（対象集団）</span></p>\r\n</th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">提供者</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">アクセス制限</span></th></tr>\r\n</thead>\r\n<tbody>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=41&amp;Itemid=262\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0001.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000002</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SCA31罹患患者のゲノム解析データ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2013/12/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SCA31：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">森下 真一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=53&amp;Itemid=264\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0003.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">DRA000908</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関節リウマチ患者及び健常人における</span></p>\r\n<p><span style=\"font-size: small;\">HLA領域の塩基配列比較解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2013/07/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HLA領域</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">33検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">井ノ上 逸朗</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=55&amp;Itemid=294\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0004.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000001</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">上皮成長因子受容体遺伝子異変を有する</span></p>\r\n<p><span style=\"font-size: small;\">肺腺癌の体細胞性遺伝子変異プロファイル</span></p>\r\n<p><span style=\"font-size: small;\">解明のための分子疫学的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/07/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Genome Analyzer IIx）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺腺癌：97症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">後藤 功一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2608&amp;Itemid=2557&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0005.v8</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA001273</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000032</span></p>\r\n<p><span style=\"font-size: small;\">DRA003791</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000093</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000123</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000166</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000191</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000192</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000200</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000201</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000323</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000490</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">難聴の遺伝子解析と臨床応用に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/01/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/02/24</span></p>\r\n<p><span style=\"font-size: small;\">v3:2017/06/19</span></p>\r\n<p><span style=\"font-size: small;\">v4:2018/02/13</span></p>\r\n<p><span style=\"font-size: small;\">v5:2019/04/18</span></p>\r\n<p><span style=\"font-size: small;\">v6:2021/07/30</span></p>\r\n<p><span style=\"font-size: small;\">v7:2021/11/19</span></p>\r\n<p><span style=\"font-size: small;\">v8:2023/10/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">9遺伝子領域</span></p>\r\n<p><span style=\"font-size: small;\">69遺伝子領域</span></p>\r\n<p><span style=\"font-size: small;\">90遺伝子領域</span></p>\r\n<p><span style=\"font-size: small;\">63遺伝子領域</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion PGM、Ion Proton、Ion S5）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Usher症候群：17症例</span></p>\r\n<p><span style=\"font-size: small;\">非症候群性難聴：3,156症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">宇佐美 真一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2100&amp;Itemid=2127&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0006.v5</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000004</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000106</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000146</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000325</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳腫瘍のゲノム・遺伝子解析と</span></p>\r\n<p><span style=\"font-size: small;\">その臨床病理学的意義の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/01/31</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/06/05</span></p>\r\n<p><span style=\"font-size: small;\">v3:2017/09/01</span></p>\r\n<p><span style=\"font-size: small;\">v4:2019/02/13</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/08/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、Target Capture）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500、HumanMethylation450）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳腫瘍：6症例＋16症例</span></p>\r\n<p><span style=\"font-size: small;\">グリオーマ（小脳：17症例、視床：14症例、大脳：8症例）</span></p>\r\n<p><span style=\"font-size: small;\">グリオーマ：94症例</span></p>\r\n<p><span style=\"font-size: small;\">脳海綿状血管奇形：12症例</span></p>\r\n<p><span style=\"font-size: small;\">椎体血管腫：1症例</span></p>\r\n<p><span style=\"font-size: small;\">眼窩内海綿状血管奇形：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">斉藤 延人</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=83&amp;Itemid=387\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0007.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000005</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒトTh17細胞の活性化前後の遺伝子発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/02/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Applied BioSystems</span></p>\r\n<p><span style=\"font-size: small;\">（5500 Genetic Analyzer）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：1名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">巌本 三壽</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=599&amp;Itemid=866&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0008.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000007</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒルシュスプルング病および</span></p>\r\n<p><span style=\"font-size: small;\">ヒルシュスプルング類縁疾患の</span></p>\r\n<p><span style=\"font-size: small;\">遺伝要因および発症機構解明に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/01/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒルシュスプルング：5症例</span></p>\r\n<p><span style=\"font-size: small;\">家族：6例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松藤 凡</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=215&amp;Itemid=482&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0009.v3</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>DRA003802</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト初期発生にかかわる細胞の</span></p>\r\n<p><span style=\"font-size: small;\">DNAメチル化解析基盤研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/12/24</span></p>\r\n<p><span style=\"font-size: small;\">v2:2015/01/07</span></p>\r\n<p><span style=\"font-size: small;\">v3:2015/08/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（PBAT-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化シトシン同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">11検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">有馬 隆博</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=207&amp;Itemid=476&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0010.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000008</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脾類上皮嚢腫関連遺伝子の探索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/06/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脾類上皮嚢腫：8症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松藤 凡</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=244&amp;Itemid=505&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0011.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000015</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">B型肝炎ウイルスのヒトゲノム内組み込み</span></p>\r\n<p><span style=\"font-size: small;\">によるエピジェネティックな修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/10/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HBV組込部位</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Roche GS FLX Titanium</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2検体（セルライン）</span></p>\r\n<p><span style=\"font-size: small;\">HBV感染肝癌：8症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山本 博幸</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=220&amp;Itemid=486&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0012.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000012</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ながはま0次コホート事業</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/08/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n<p><span style=\"font-size: small;\">健常者遺伝子型</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Human610-Quad、HumanOmni2.5-4/2.5-8/2.5S-8、HumanExome-12、HumanCoreExome-12）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：3712名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松田 文彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=85&amp;Itemid=340\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0013.v1</strong></span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本PGxデータサイエンスコンソーシアム</span></p>\r\n<p><span style=\"font-size: small;\">PGx研究のための日本人健常者2994名の</span></p>\r\n<p><span style=\"font-size: small;\">SNP遺伝子型データ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/10/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">健常者内頻度</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HumanOmni2.5-8）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：2994名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">末松 浩嗣</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3038&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0014.v37</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000101</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000114＊</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000140</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000203</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000293</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000327</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000346</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000381＊</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000414</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000347</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000592</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000647</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000698</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000699</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000700</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000701</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000703</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000738</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000746</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000782</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">オーダーメイド医療の実現プログラム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/09/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2015/12/28 （JSNP）</span></p>\r\n<p><span style=\"font-size: small;\">v3:2016/01/10</span></p>\r\n<p><span style=\"font-size: small;\">v4:2016/01/27</span></p>\r\n<p><span style=\"font-size: small;\">v5:2017/05/18</span></p>\r\n<p><span style=\"font-size: small;\">v6:2017/09/08</span></p>\r\n<p><span style=\"font-size: small;\">v7:2018/04/03</span></p>\r\n<p><span style=\"font-size: small;\">v8:2018/05/01</span></p>\r\n<p><span style=\"font-size: small;\">v9:2018/08/07</span></p>\r\n<p><span style=\"font-size: small;\">v10:2018/08/13</span></p>\r\n<p><span style=\"font-size: small;\">v11:2018/10/16</span></p>\r\n<p><span style=\"font-size: small;\">v12:2018/12/10</span></p>\r\n<p><span style=\"font-size: small;\">v13:2019/01/25</span></p>\r\n<p><span style=\"font-size: small;\">v14:2019/03/26</span></p>\r\n<p><span style=\"font-size: small;\">v15:2019/09/27</span></p>\r\n<p><span style=\"font-size: small;\">v16:2019/10/07</span></p>\r\n<p><span style=\"font-size: small;\">v17:2019/10/08</span></p>\r\n<p><span style=\"font-size: small;\">v18:2019/11/26</span></p>\r\n<p><span style=\"font-size: small;\">v19:2020/04/20</span></p>\r\n<p><span style=\"font-size: small;\">v20:2020/08/17</span></p>\r\n<p><span style=\"font-size: small;\">v21:2020/08/25</span></p>\r\n<p><span style=\"font-size: small;\">v22:2021/05/21</span></p>\r\n<p><span style=\"font-size: small;\">v23:2021/07/13</span></p>\r\n<p><span style=\"font-size: small;\">v24:2021/11/26</span></p>\r\n<p><span style=\"font-size: small;\">v25:2022/01/25</span></p>\r\n<p><span style=\"font-size: small;\">v26:2022/04/01</span></p>\r\n<p><span style=\"font-size: small;\">v27:2023/01/18</span></p>\r\n<p><span style=\"font-size: small;\">v28:2023/04/05</span></p>\r\n<p><span style=\"font-size: small;\">v29:2023/04/05</span></p>\r\n<p><span style=\"font-size: small;\">v30:2023/04/20</span></p>\r\n<p><span style=\"font-size: small;\">v31:2023/09/01</span></p>\r\n<p><span style=\"font-size: small;\">v32:2024/01/11</span></p>\r\n<p><span style=\"font-size: small;\">v33:2024/05/27</span></p>\r\n<p><span style=\"font-size: small;\">v34:2024/09/19</span></p>\r\n<p><span style=\"font-size: small;\">v35:2024/10/25</span></p>\r\n<p><span style=\"font-size: small;\">v36:2024/11/28</span></p>\r\n<p><span style=\"font-size: small;\">v37:2025/05/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">関連</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Human610-Quad, HumanHap550v3, HumanOmniExpress-12, HumanExome, OmniExpressExome, HumanExome-12, Infinium OmniExpress-24, Infinium HumanOmniExpressExome-8, HiSeq 2500/X Five, NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Perlegen Sciences</span></p>\r\n<p><span style=\"font-size: small;\">（high-density oligonucleotide array）</span></p>\r\n<p><span style=\"font-size: small;\">Hologic Japan</span></p>\r\n<p><span style=\"font-size: small;\">（Invader）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1：心筋梗塞1,666症例、対照3,198名</span></p>\r\n<p><span style=\"font-size: small;\">v2：健常者934名（JSNP）</span></p>\r\n<p><span style=\"font-size: small;\">v2：35疾患各約190症例（JSNP）</span></p>\r\n<p><span style=\"font-size: small;\">v2：食道癌182症例（JSNP）</span></p>\r\n<p><span style=\"font-size: small;\">v2：ALS92症例（JSNP）</span></p>\r\n<p><span style=\"font-size: small;\">v3：T2DM9,817症例、対照6,763名</span></p>\r\n<p><span style=\"font-size: small;\">v3：T2DM5,646症例、対照19,420名</span></p>\r\n<p><span style=\"font-size: small;\">v4：AD1,472症例、対照7,966名</span></p>\r\n<p><span style=\"font-size: small;\">v5：AF8,180症例、対照28,612名</span></p>\r\n<p><span style=\"font-size: small;\">v6：BMI158,284名</span></p>\r\n<p><span style=\"font-size: small;\">v6：Genotypeデータ182,505名</span></p>\r\n<p><span style=\"font-size: small;\">v7：POAG3980症例、対照18,815名</span></p>\r\n<p><span style=\"font-size: small;\">v8：58臨床検査値162,255名</span></p>\r\n<p><span style=\"font-size: small;\">v9：初潮年齢データを有する女性67,029名</span></p>\r\n<p><span style=\"font-size: small;\">v9：閉経年齢データを有する女性43,861名</span></p>\r\n<p><span style=\"font-size: small;\">v10：BBJ第1コホート1,026名</span></p>\r\n<p><span style=\"font-size: small;\">v11：乳癌7,104症例、対照23,731名</span></p>\r\n<p><span style=\"font-size: small;\">v12：2型糖尿病腎症2,809症例、2型糖尿病対照5,592名</span></p>\r\n<p><span style=\"font-size: small;\">v13：T2DM36,614症例、対照155,150名</span></p>\r\n<p><span style=\"font-size: small;\">v14：喫煙習慣データ165,436名</span></p>\r\n<p><span style=\"font-size: small;\">v15：BBJ第1コホート1,037名、1000ゲノムプロジェクト（Phase3v5）2,504名</span></p>\r\n<p><span style=\"font-size: small;\">v15：身長159,095名</span></p>\r\n<p><span style=\"font-size: small;\">v16：遺伝性前立腺癌7,636症例、対照12,366名</span></p>\r\n<p><span style=\"font-size: small;\">v17、v18、v21：42疾患212,453症例</span></p>\r\n<p><span style=\"font-size: small;\">v19：食習慣165,084名</span></p>\r\n<p><span style=\"font-size: small;\">v20：冠動脈疾患25,892症例、対照142,336名</span></p>\r\n<p><span style=\"font-size: small;\">v22：BBJ第1コホート11,234名</span></p>\r\n<p><span style=\"font-size: small;\">v23：BBJ第1コホート768名</span></p>\r\n<p><span style=\"font-size: small;\">v24：膵癌1,005症例、大腸癌12,503症例、対照23,705名</span></p>\r\n<p><span style=\"font-size: small;\">v25：心筋梗塞1,765症例、認知症199症例</span></p>\r\n<p><span style=\"font-size: small;\">v26：腎癌740症例、対照者5,996名</span></p>\r\n<p><span style=\"font-size: small;\">v27：BBJ第1コホート137,693名</span></p>\r\n<p><span style=\"font-size: small;\">v28：BBJ第1コホート4,880名</span></p>\r\n<p><span style=\"font-size: small;\">v29：AF8,180症例、対照28,612名（BBJ第1コホート）</span></p>\r\n<p><span style=\"font-size: small;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AF60,620症例、対照970,216名（欧米人）</span></p>\r\n<p><span style=\"font-size: small;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AF7,244症例、対照56,378名（FinnGen）</span></p>\r\n<p><span style=\"font-size: small;\">v30：リンパ腫1,982症例、胃癌10,366症例、対照者37,592名（BBJコホート）</span></p>\r\n<p><span style=\"font-size: small;\">v32：BBJ第1コホート1,007名</span></p>\r\n<p><span style=\"font-size: small;\">v33：胃癌256症例</span></p>\r\n<p><span style=\"font-size: small;\">v33：51疾患26.9万名</span></p>\r\n<p><span style=\"font-size: small;\">v33：大腸癌617症例</span></p>\r\n<p><span style=\"font-size: small;\">v33：糖尿病2,162症例</span></p>\r\n<p><span style=\"font-size: small;\">v33：胃癌2,067症例</span></p>\r\n<p><span style=\"font-size: small;\">v35：BBJ第1コホート7,472名</span></p>\r\n<p><span style=\"font-size: small;\">v36：BBJ第1コホート3,256名</span></p>\r\n<p><span style=\"font-size: small;\">v37：乳癌10,008症例、胃癌10,576症例、大腸癌13,929症例、心不全6,038症例、脳梗塞10,486症例などを含む計140,597名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人、欧米人、フィンランド人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">久保 充明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=797&amp;Itemid=1035&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0015.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000159</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト全ゲノム解析に基づく高精度の</span></p>\r\n<p><span style=\"font-size: small;\">住民ゲノム参照パネルの作成</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/10/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/12/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2019/01/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">健常者内頻度</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：3552名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山本 雅之</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=393&amp;Itemid=682&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0016.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">DRA002604</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 精巣に発現するタンパク質群の</span></p>\r\n<p><span style=\"font-size: small;\"> ヒト精子細胞における発現及び染色体局在解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/09/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、ChIP-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：1名（4検体）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大川 恭行</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=284&amp;Itemid=571&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0017.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000021</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中枢神経原発悪性リンパ腫のエクソーム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/02/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">PCNSL：41症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">間野 博行</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3140&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\"><strong>hum0018.v2</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000009</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000337</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000374</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000358</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000365</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000393</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000422</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000494</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 神経筋変性疾患の遺伝子解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/02/03</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/07/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、WGS、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">神経筋変性疾患：14症例</span></p>\r\n<p><span style=\"font-size: small;\">対照：7名</span></p>\r\n<p><span style=\"font-size: small;\">シャルコー・マリー・トゥース病：69症例</span></p>\r\n<p><span style=\"font-size: small;\">前頭側頭型認知症：21症例</span></p>\r\n<p><span style=\"font-size: small;\">家族性筋萎縮性側索硬化症：119症例</span></p>\r\n<p><span style=\"font-size: small;\">ミオパチー： 85症例</span></p>\r\n<p><span style=\"font-size: small;\">孤発性筋萎縮性側索硬化症：489症例</span></p>\r\n<p><span style=\"font-size: small;\">運動ニューロン病：9症例</span></p>\r\n<p><span style=\"font-size: small;\">痙性対麻痺：465症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">辻 省次</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=183&amp;Itemid=421&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0019.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000011</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化器癌の発癌や進展に</span></p>\r\n<p><span style=\"font-size: small;\">深く関与しうる遺伝子、並びに</span></p>\r\n<p><span style=\"font-size: small;\">非コードRNAの量的・質的な異常の探索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化器癌：17症例（32検体）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">篠村 恭久</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=104&amp;Itemid=367\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0020.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000013</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">筋萎縮性側索硬化症の遺伝子解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/01/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">家族性ALS：11症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">田中 章景</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1469&amp;Itemid=1602&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0021.v3</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000014</span></p>\r\n<p><span style=\"font-size: small;\"> JGAS000273</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">精神神経疾患の原因解明および</span></p>\r\n<p><span style=\"font-size: small;\">診断法・治療法の開発に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/01/26</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/05</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/04/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常一卵性双生児：3組6名</span></p>\r\n<p><span style=\"font-size: small;\">双極性障害発症者およびその両親（トリオ）：66＋78家系（198＋234名）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">加藤 忠史</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=111&amp;Itemid=379\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0022.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000017</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">同種造血幹細胞移植後</span></p>\r\n<p><span style=\"font-size: small;\">ドナー由来白血病発症にかかわる</span></p>\r\n<p><span style=\"font-size: small;\">分子機構の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/02/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">白血病：1症例</span></p>\r\n<p><span style=\"font-size: small;\">ドナー：1名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">清井 仁</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=116&amp;Itemid=383\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0023.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000016</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">生活習慣病、動脈硬化性疾患、ならびに</span></p>\r\n<p><span style=\"font-size: small;\">抗加齢に関する遺伝疫学研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/01/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">III度以上の本態性</span></p>\r\n<p><span style=\"font-size: small;\">高血圧：30症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三木 哲郎</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=186&amp;Itemid=424&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0024.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000023</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍における</span></p>\r\n<p><span style=\"font-size: small;\">遺伝子異常の網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/04/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Genome Analyzer IIx、HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MDS：13症例</span></p>\r\n<p><span style=\"font-size: small;\">CMML：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小川 誠司</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=330&amp;Itemid=622&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0027.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000024</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000040</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">侵襲性歯周炎のヒト全ゲノム解析と遺伝子多型解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/07/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">侵襲性歯周炎：44症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">村上 伸也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=696&amp;Itemid=946&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0028.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000018</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">オーダーメイド医療の実現プログラム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/06/02</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/06/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HLA領域</span></p>\r\n<p><span style=\"font-size: small;\">HLAアリルおよび</span></p>\r\n<p><span style=\"font-size: small;\">領域内遺伝子型決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HumanOmniExpress、HumanExome、Immunochip、HumanHap550v3 Genotyping BeadChip）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：908名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">久保 充明</span></p>\r\n<p><span style=\"font-size: small;\">（BBJ）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1344&amp;Itemid=1500&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0029.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Stevens-Johnson症候群に対する</span></p>\r\n<p><span style=\"font-size: small;\">遺伝子多型解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/03/09</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/12/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Axiom ASI）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X Ten）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SJS：117症例</span></p>\r\n<p><span style=\"font-size: small;\">対照：691名</span></p>\r\n<p><span style=\"font-size: small;\">SJS/TEN：133症例</span></p>\r\n<p><span style=\"font-size: small;\">対照：418名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">上田 真由美</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3104&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0030.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000022</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000560</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000789</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">婦人科臓器に発生する悪性腫瘍の発症に関連する分子生物学的異常の検索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/04/21</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/05/10</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/07/05</span></p>\r\n<p><span style=\"font-size: small;\">v4:2025/07/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n<p><span style=\"font-size: small;\">ヒト全ゲノム発現アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">CNV</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Human Mapping 250K Nsp Array、GeneChip® Human Genome U133 Plus 2.0 Array）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000、Infinium HumanMethylation450、NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">卵巣癌：57＋111＋31＋189症例 </span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">織田 克利</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=252:hum0031-v1&amp;catid=10:cat-researches&amp;lang=ja&amp;Itemid=513\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0031.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000042</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000043</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000044</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000045</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">磁気共鳴画像装置で得られた脳画像の臨床評価尺度データベース構築と多施設による共同運用</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳画像</span></p>\r\n<p><span style=\"font-size: small;\">臨床情報</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳画像ベースの病態解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Philips</span></p>\r\n<p><span style=\"font-size: small;\">（Achieva）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">統合失調症：37症例</span></p>\r\n<p><span style=\"font-size: small;\">単極うつ病：8症例</span></p>\r\n<p><span style=\"font-size: small;\">双極性障害：2症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：129名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">笠井 清登</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=335&amp;Itemid=626&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0032.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000026</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000027</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000028</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト消化器ならびに泌尿器上皮細胞の</span></p>\r\n<p><span style=\"font-size: small;\">標準エピゲノム解析</span></p>\r\n<p><span style=\"font-size: small;\">（HPCシリーズ）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/07/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（PBAT-seq、ChIP-seq、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝細胞：8種類</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">金井 弥栄</span></p>\r\n<p><span style=\"font-size: small;\">（IHEC）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=192&amp;Itemid=428&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0033.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>DRA003516</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト唾液由来エキソソームの</span></p>\r\n<p><span style=\"font-size: small;\">機能解析に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/05/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Genome Analyzer IIx）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：1名（3検体）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">矢ノ下 良平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=237&amp;Itemid=501&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0034.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000037</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小細胞肺癌の網羅的ゲノム解析による</span></p>\r\n<p><span style=\"font-size: small;\">新たな治療標的の探索を目指した研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/10/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SCLC：51症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">後藤 功一</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1339&amp;Itemid=1496&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0035.v5</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000036</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000046</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000088</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000188</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000204</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000246</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">固形腫瘍における遺伝子異常の網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/09/16</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/12/26</span></p>\r\n<p><span style=\"font-size: small;\">v3:2020/05/29</span></p>\r\n<p><span style=\"font-size: small;\">v4:2020/12/14</span></p>\r\n<p><span style=\"font-size: small;\">v5:2020/12/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、Target Capture、RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500、MiSeq、MethylationEPIC）</span></p>\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Human Mapping 250K Nsp、CytoScan HD）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">RMS：16症例</span></p>\r\n<p><span style=\"font-size: small;\">PPB：7症例</span></p>\r\n<p><span style=\"font-size: small;\">NB：522症例</span></p>\r\n<p><span style=\"font-size: small;\">NB細胞株：39検体</span></p>\r\n<p><span style=\"font-size: small;\">PBL：10症例</span></p>\r\n<p><span style=\"font-size: small;\">HBL：59症例</span></p>\r\n<p><span style=\"font-size: small;\">HBL細胞株：2検体</span></p>\r\n<p><span style=\"font-size: small;\">小児胚細胞腫瘍：51症例</span></p>\r\n<p><span style=\"font-size: small;\">小児高リスク神経芽腫：30症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">滝田 順子</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=210&amp;Itemid=478&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0036.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">DRA003736</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">全エクソームキャプチャプラットフォーム間の</span></p>\r\n<p><span style=\"font-size: small;\">性能比較</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">キャプチャ方法の</span><span style=\"font-size: small;\">性能比較</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HapMap-JPT：2検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">久保 充明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=225&amp;Itemid=491&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0037.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000035</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関節リウマチ感受性遺伝子を用いた</span></p>\r\n<p><span style=\"font-size: small;\">関節リウマチ病態の遺伝診断法の開発研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">RA：39症例</span></p>\r\n<p><span style=\"font-size: small;\">対照：10名（Pooled）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">光永 滋樹</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=247&amp;Itemid=509&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0038.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000041</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">家族性致死性不整脈の病因解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/11/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">家族性致死性不整脈：11症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">蒔田 直昌</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=301&amp;Itemid=579&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0039.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000039</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化管間質腫瘍のチロシンキナーゼ阻害剤に</span></p>\r\n<p><span style=\"font-size: small;\">対する獲得耐性機構の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/12/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">イマチニブ耐性消化管間質腫瘍：4症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">高橋 剛</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=358&amp;Itemid=650&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0040.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000038</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">生殖発生に関わる細胞のエピゲノム解析基盤研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/09/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、RNA-seq、WGBS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト胎盤：28検体</span></p>\r\n<p><span style=\"font-size: small;\">母体血：26検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">有馬 隆博</span></p>\r\n<p><span style=\"font-size: small;\">（IHEC）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=405&amp;Itemid=690&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0041.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000052</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝胆膵癌の早期発見、進行、予後予測、</span></p>\r\n<p><span style=\"font-size: small;\">治療効果予測に関わる因子の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/01/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">原発性肝細胞癌：33症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">田中 真二</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=289&amp;Itemid=573&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0042.v1</strong></span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">顎口腔領域の形質（性質や特徴）</span></p>\r\n<p><span style=\"font-size: small;\">に関与する遺伝子の探索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/03/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HumanOmniExpress）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">変性顎関節症：146症例</span></p>\r\n<p><span style=\"font-size: small;\">非罹患：374名</span></p>\r\n<p><span style=\"font-size: small;\">第三大臼歯先天性欠如有：149症例</span></p>\r\n<p><span style=\"font-size: small;\">無欠如：338名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人、韓国人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山口 徹太郎</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"/hum0043-v1\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0043.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000051</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アルツハイマー病総合診断体系実用化プロジェクト</span></p>\r\n<p><span style=\"font-size: small;\">（J-ADNI全国臨床研究）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/01/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳画像</span></p>\r\n<p><span style=\"font-size: small;\">臨床情報</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳画像ベースの病態解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><a href=\"hum0043-v1-release#mriscanners\" target=\"_blank\" rel=\"noopener noreferrer\">MRIスキャナー（15機種）</a></p>\r\n<p><a href=\"hum0043-v1-release#petscanners\" target=\"_blank\" rel=\"noopener noreferrer\">PETスキャナー（16機種）</a></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MCI：234名</span></p>\r\n<p><span style=\"font-size: small;\">AD：149名</span></p>\r\n<p><span style=\"font-size: small;\">健常高齢者群：154名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岩坪 威</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=402:hum0044-v1&amp;catid=10&amp;lang=ja-JP&amp;Itemid=688\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0044.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">DRA004162</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒトレトロウイルス感染症に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/10/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（ChIP-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ATL細胞株：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">佐藤 賢文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=310&amp;Itemid=596&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0045.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000047</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">思春期・若年成人急性リンパ芽球性白血病における</span><span style=\"font-size: small;\">トランスクリプトーム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/03/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">フィラデルフィア染色体陰性ALL：99症例</span></p>\r\n<p><span style=\"font-size: small;\">フィラデルフィア染色体陽性ALL：3症例</span></p>\r\n<p><span style=\"font-size: small;\">セルライン：5検体</span></p>\r\n<p><span style=\"font-size: small;\">正常血球細胞：8検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">間野 博行</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=279&amp;Itemid=565&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0048.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>DRA004251</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">次世代シークエンサーを用いた十二指腸・ファーター乳頭部腫瘍の全遺伝子のエクソン解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/02/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ファーター乳頭部癌：60症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人、米国人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">谷内田 真一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=388&amp;Itemid=678&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">hum0050.v1</a></strong></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000053</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">B型肝炎創薬へ向けてのトランスクリプトーム解析による病態解明と標的同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/09/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（CAGE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">転写開始点同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HBVキャリア：8症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松浦 知和</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1093&amp;Itemid=1286&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0053.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000062</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000176</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性中皮腫のプロファイリングによる新規分子標的の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/07/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/04/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Chromium Controller）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性胸膜中皮腫：38症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中野 孝司</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=446&amp;Itemid=724&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">hum0055.v1</a></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000059</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非アルコール性脂肪肝疾患のゲノム・エピゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/02/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、HumanMethylation450）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NAFLD：64症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">堀田 紀久子</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=616&amp;Itemid=879&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">hum0056.v1</a></strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト全ゲノム解析に基づく高精度の住民ゲノム参照パネルと3層オミックスパネルの作成</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/03/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、WGBS、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/X）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">197名 </span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">清水 厚志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=643&amp;Itemid=910&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0058.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000091</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸がんの転移/再発に特徴的な遺伝子変異の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：89症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山口 俊晴</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=636&amp;Itemid=906&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0059.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000104</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">卵巣がんの再発に特徴的な遺伝子変異の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">卵巣癌：65症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">加藤 一喜</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=621&amp;Itemid=885&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0060.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000075</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳がんの再発/転移に特徴的な遺伝子変異の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">再発・転移性乳癌：65症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三木 義男</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=717&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\"><strong>hum0061.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000057</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">全ゲノムあるいは全エクソン解析による家族性腫瘍原因遺伝子の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/02/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">多発性肺癌同胞：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">加藤 菊也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=348&amp;Itemid=642&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">hum0064.v1</a></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000061</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">高齢者がん治療アルゴリズム開発のためのガイドポスト・データベースの構築と必須情報及びその推定モデル</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/08/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">*サンガー</span></p>\r\n<p><span style=\"font-size: small;\">TaqMan</span></p>\r\n<p><span style=\"font-size: small;\">qRT-PCR</span></p>\r\n<p><span style=\"font-size: small;\">マイクロアレイ</span></p>\r\n<p><span style=\"font-size: small;\">COBRA</span></p>\r\n<p><span style=\"font-size: small;\">治療情報</span></p>\r\n<p><span style=\"font-size: small;\">臨床情報</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Applied BioSystems</span></p>\r\n<p><span style=\"font-size: small;\">（3130 Genetic Analyzer）</span></p>\r\n<p><span style=\"font-size: small;\">Roche</span></p>\r\n<p><span style=\"font-size: small;\">（LightCycler 480II）</span></p>\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">（Whole Human Genome DNAマイクロアレイ 4x44K）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">【ゲノム】</span></p>\r\n<p><span style=\"font-size: small;\">大腸癌：106症例</span></p>\r\n<p><span style=\"font-size: small;\">胃癌：62症例</span></p>\r\n<p><span style=\"font-size: small;\">肺癌：173症例</span></p>\r\n<p><span style=\"font-size: small;\">【後向き】</span></p>\r\n<p><span style=\"font-size: small;\">大腸癌：313 症例</span></p>\r\n<p><span style=\"font-size: small;\">胃癌：166 症例</span></p>\r\n<p><span style=\"font-size: small;\">肺癌：344 症例</span></p>\r\n<p><span style=\"font-size: small;\">糖尿・腎障害：300 症例</span></p>\r\n<p><span style=\"font-size: small;\">循環器疾患：357 症例</span></p>\r\n<p><span style=\"font-size: small;\">呼吸器疾患：49 症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西山 正彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=635&amp;Itemid=894&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0065.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000089</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">患者腫瘍移植モデルとex vivo培養間のシャトルシステムによる革新的な臨床効果評価技術の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：8症例</span></p>\r\n<p><span style=\"font-size: small;\">肺癌：2症例</span></p>\r\n<p><span style=\"font-size: small;\">子宮頸部小細胞癌：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">井上 正宏</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=345&amp;Itemid=1345&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0066.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000060</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">癌の再発・転移に関与するnon-coding RNAの同定とその機序の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：9症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三森 功士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=444&amp;Itemid=723&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0067.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000076</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">卵巣明細胞腺癌に対する新規バイオマーカーの検索と</span><span style=\"font-size: small;\">化学療法感受性に関する後方視的検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/05/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">卵巣明細胞腺癌：55症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">杉山 徹</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2715&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0068.v9</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000065＊</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000349</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000570</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000677</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノム解析に基づく肺がんの発生・進展の分子機構の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/07/10</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/10/19</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/12/14</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/03/23</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/12/27</span></p>\r\n<p><span style=\"font-size: small;\">v6:2023/02/10</span></p>\r\n<p><span style=\"font-size: small;\">v7:2023/06/19</span></p>\r\n<p><span style=\"font-size: small;\">v8:2023/09/22</span></p>\r\n<p><span style=\"font-size: small;\">v9:2024/04/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（PCR amplicon Seq、WGS、RNA-seq、scDNA-seq、Target Capture、Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n<p><span style=\"font-size: small;\">Multiplex Fluorescence Immunostaining</span></p>\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（MinION、PromethION）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、HiSeq 2000）</span></p>\r\n<p><span style=\"font-size: small;\">Akoya Biosciences</span></p>\r\n<p><span style=\"font-size: small;\">（PhenoCycler）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Xenium Analyzer）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺腺癌：8＋21＋74＋20症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">河野 隆志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=420&amp;Itemid=703&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong><strong>hum0069.v1</strong></strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000064</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">神経筋疾患、ウイルス性疾患におけるRNA発現プロファイル解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/12/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（small RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">神経筋疾患：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">横田 隆徳</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=676&amp;Itemid=930&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0070.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000115</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">バート・ホッグ・デュベ症候群の分子病態解明と新規の診断マーカーおよび治療標的分子の探索研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">バート・ホッグ・デュベ症候群：15症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">矢尾 正祐</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=376&amp;Itemid=666&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0072.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ナルコレプシーおよび各種睡眠障害の感受性遺伝子の同定と機能解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（SNP Array 6.0）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ナルコレプシー：409症例 </span></p>\r\n<p><span style=\"font-size: small;\">対照：1562名</span></p>\r\n<p><span style=\"font-size: small;\">真性過眠症：125症例</span></p>\r\n<p><span style=\"font-size: small;\">対照：562名 </span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 徳永 勝士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=742&amp;Itemid=987&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0074.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">テーラーメイド治療を目指した肝炎ウイルスデータベース構築に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/02/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（SNP Array 6.0、Axiom ASI）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NVR：78症例</span></p>\r\n<p><span style=\"font-size: small;\">VR：64症例</span></p>\r\n<p><span style=\"font-size: small;\">SVR：51症例</span></p>\r\n<p><span style=\"font-size: small;\">Plt減少-：196症例</span></p>\r\n<p><span style=\"font-size: small;\">Plt減少+：107症例</span></p>\r\n<p><span style=\"font-size: small;\"></span><span style=\"font-size: small;\">Hb減少-：209症例</span></p>\r\n<p><span style=\"font-size: small;\">Hb減少+：94症例</span></p>\r\n<p><span style=\"font-size: small;\">SVR後肝癌を発症した群：123症例</span></p>\r\n<p><span style=\"font-size: small;\">SVR後肝癌を発症していない群：333症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 田中 靖人</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1967&amp;Itemid=2026&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0075.v3</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">B型肝炎ウイルス感染の病態別における宿主遺伝因子の探索研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/09/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/02/19</span></p>\r\n<p><span style=\"font-size: small;\">v3:2022/05/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（SNP Array 6.0、Axiom ASI）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HBV保有：181症例</span></p>\r\n<p><span style=\"font-size: small;\">HBV排除：185症例</span></p>\r\n<p><span style=\"font-size: small;\">対照：184名</span></p>\r\n<p><span style=\"font-size: small;\">HBV陽性肝癌：473症例</span></p>\r\n<p><span style=\"font-size: small;\">HBV保有（慢性肝炎患者および無症候キャリア）：516症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">B型肝炎：329症例</span></p>\r\n<p><span style=\"font-size: small;\">健常対照者：318名</span></p>\r\n<p><span style=\"font-size: small;\">（タイ人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">溝上 雅史</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=380&amp;Itemid=671&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">hum0076.v1</a></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人原発性胆汁性肝硬変の発症・進展に関わる遺伝因子の網羅的遺伝子解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/10/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Axiom ASI）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">PBC：487症例</span></p>\r\n<p><span style=\"font-size: small;\">対照：476名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中村 稔</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1817&amp;Itemid=1893&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0079.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000068</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">神経筋変性疾患の遺伝子解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/02/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">封入体筋炎：53症例</span></p>\r\n<p><span style=\"font-size: small;\">多発筋炎：6症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：9名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">後藤 順</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=545&amp;Itemid=823&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">hum0082.v2</a></span></p>\r\n<p><span style=\"font-size: small;\"> JGAS000120</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人健常者におけるゲノム全域のSNP解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/09/26</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/10/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">健常者遺伝子型</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（SNP Array 6.0、Axiom ASI）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">419名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">徳永 勝士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1782&amp;Itemid=1865&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0083.v2</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000070</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000488</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">バイオマーカー探索に資する網羅的遺伝子解析研究（肺がん）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/10/28</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/01/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（CAGE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">転写開始点同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺癌：97＋38症例</span></p>\r\n<p><span style=\"font-size: small;\">胸膜中皮腫：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">林崎 良英</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=934&amp;Itemid=1150&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0085.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000108</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胸腹部腫瘍の長期治療成績に関する分子生物学的研究</span></p>\r\n<p><span style=\"font-size: small;\">環境因子が関与する腫瘍のゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/10/16</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アレイCGH</span></p>\r\n<p><span style=\"font-size: small;\">NGS（WGS、Target Capture、Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina </span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq、HiSeq 4000/X Ten）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性中皮腫患：72症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人、米国人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大村谷 昌樹</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=701&amp;Itemid=951&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0086.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000073<br />（JGA000074）</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000107<br />（JGA000117）</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">生殖発生にかかわる細胞のエピゲノム解析基盤研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/09/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/12/26</span></p>\r\n<p><span style=\"font-size: small;\">v3:2018/06/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS（PBAT-seq、ChIP-seq、RNA-seq、small RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胎盤もしくは子宮の細胞、ヒト胎盤幹細胞：計39検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">佐々木 裕之</span></p>\r\n<p><span style=\"font-size: small;\">（IHEC）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=944&amp;Itemid=1159&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0088.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000077</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000096</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">腫瘍細胞におけるTGF-βファミリーシグナルの網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/02/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/09/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Genome Analyzer IIx）</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳腫瘍：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">宮園 浩平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=411&amp;Itemid=696&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0090.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000078</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000079</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000080</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト消化器ならびに泌尿器上皮細胞の</span></p>\r\n<p><span style=\"font-size: small;\">標準エピゲノム解析</span></p>\r\n<p><span style=\"font-size: small;\">（COCシリーズ）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/11/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（PBAT-seq、ChIP-seq、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸粘膜吸収上皮細胞：12種類</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">金井 弥栄</span></p>\r\n<p><span style=\"font-size: small;\">（IHEC）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=425&amp;Itemid=711&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0091.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000082</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000165</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000081</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト消化器ならびに泌尿器上皮細胞の</span></p>\r\n<p><span style=\"font-size: small;\">標準エピゲノム解析</span></p>\r\n<p><span style=\"font-size: small;\">（GACシリーズ）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（PBAT-seq、ChIP-seq、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃粘膜表層粘液細胞：14種類</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">金井 弥栄</span></p>\r\n<p><span style=\"font-size: small;\">（IHEC）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2216&amp;Itemid=2237&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0094.v11</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000095</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000105</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000113</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000128</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000215</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000270</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000297</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000335</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000360</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000534</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性腫瘍のゲノム・エピゲノム解析による病態解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/09/04</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/01/22</span></p>\r\n<p><span style=\"font-size: small;\">v3:2019/02/12</span></p>\r\n<p><span style=\"font-size: small;\">v4:2020/08/14</span></p>\r\n<p><span style=\"font-size: small;\">v5:2020/10/26</span></p>\r\n<p><span style=\"font-size: small;\">v6:2021/01/29</span></p>\r\n<p><span style=\"font-size: small;\">v7:2021/07/02</span></p>\r\n<p><span style=\"font-size: small;\">v8:2021/10/22</span></p>\r\n<p><span style=\"font-size: small;\">v9:2021/10/26</span></p>\r\n<p><span style=\"font-size: small;\">v10:2022/05/23</span></p>\r\n<p><span style=\"font-size: small;\">v11:2022/11/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、RNA-seq、Target Capture、Iso-seq）、メチル化アレイ、SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">CNV</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500、MethylationEPIC、HumanOmni2.5-8）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Chromium Controller）</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">（Sequel）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌：68症例</span></p>\r\n<p><span style=\"font-size: small;\">肺腺癌：43＋126症例</span></p>\r\n<p><span style=\"font-size: small;\">大腸癌：150症例＋173症例</span></p>\r\n<p><span style=\"font-size: small;\">肝転移を有する大腸癌12症例、肝転移を有さない大腸癌16症例</span></p>\r\n<p><span style=\"font-size: small;\">デスモイド腫瘍：64症例</span></p>\r\n<p><span style=\"font-size: small;\">肺多形癌：35症例</span></p>\r\n<p><span style=\"font-size: small;\">唾液腺導管癌：67症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">間野 博行</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=711&amp;Itemid=960&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0095.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000092</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸前がん病変および早期大腸がんにおける遺伝子解析および発がん機序の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/07/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸腺腫、大腸癌早期病変：計10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三森 功士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=997&amp;Itemid=1201&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0096.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000090</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000138</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍における遺伝子異常の網羅的解析（小児T細胞性急性リンパ性白血病）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/05/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/11/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、MethylationEPIC）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児T-ALL：123症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">滝田 順子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=691&amp;Itemid=942&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0097.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000094</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">骨髄不全症候群における血球の質に関する検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/05/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">第6染色体短腕の片親性ダイソミー陽性再生不良性貧血：5症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中尾 眞二</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=474:hum0099-v1&amp;catid=10&amp;lang=ja-JP&amp;Itemid=747\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0099.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000085</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト免疫細胞における遺伝子多型と遺伝子発現の関連解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/04/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">eQTL</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、Infinium OmniExpressExome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：105名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山本 一彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=681&amp;Itemid=934&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0101.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000098</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">EBウイルス関連リンパ腫を発症した原発性免疫不全症候群の原因遺伝子探索に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 原発性免疫不全症：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岩谷 靖雅</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1771&amp;Itemid=1857&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0103.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000109</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000389</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">シークエンス解析によるがんゲノム研究：胆道がん</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/02/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/06/21</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/07/13</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/01/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胆道癌：98＋121症例</span></p>\r\n<p><span style=\"font-size: small;\">正常胆嚢：4名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2136&amp;Itemid=2155&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0106.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000139</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト大腸がん培養組織を用いたがん予防・治療法の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（患者由来3次元培養細胞）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">八尾 良司</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1168&amp;Itemid=1351&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0107.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000099</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000218</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">基底細胞母斑症候群患者からのinduced pluripotent stem （iPS）細胞の樹立および病態の解明、骨移植への臨床応用</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/10/02</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/06/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/4000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">基底細胞母斑症候群：4症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">東 俊文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=498&amp;Itemid=779&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0108.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000111</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">精神疾患発症にかかわる関連遺伝子の探索および解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/06/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HumanMethylation450）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">パニック症：48症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：48名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">徳永 勝士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1384&amp;Itemid=1534&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0111.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000103</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000141</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000242</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃腫瘍のゲノム・遺伝子解析とその臨床病理学的意義の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/07/31</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/05/31</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/02/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、Amplicon-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000、MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">びまん性胃癌：30症例</span></p>\r\n<p><span style=\"font-size: small;\">胃癌：60＋15症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">石川 俊平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=565:hum0112-v1&amp;catid=10:cat-researches&amp;lang=ja-JP\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0112.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000112</span></p>\r\n<p><span style=\"font-size: small;\">（JGA000122）</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト胎盤幹細胞の樹立と細胞特性に関する基礎的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS（PBAT-seq、ChIP-seq、RNA-seq、miRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト胎盤幹細胞：2系統</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">有馬 隆博</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2059&amp;Itemid=2098&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0113.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000119</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000142</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000318</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">パーキンソン病の代謝産物バイオマーカー創出およびその分子標的機構に基づく創薬シーズ同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/24</span></p>\r\n<p><span style=\"font-size: small;\">v1:2021/07/30</span></p>\r\n<p><span style=\"font-size: small;\">v3:2022/07/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（CAGE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">転写開始点同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">パーキンソン病：39症例、対照健常者：20名</span></p>\r\n<p><span style=\"font-size: small;\">iPS細胞由来神経細胞（パーキンソン病：3検体、対照健常者：3検体から樹立）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Piero Carninci</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1589&amp;Itemid=1700&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0114.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA007411</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000314</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人由来B細胞株DNAのゲノムデータを用いた遺伝統計解析手法の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/18</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/04/12</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/08/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HumanCoreExome、MiSeq、HiSeq X Ten、NovaSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乾癬：282症例</span></p>\r\n<p><span style=\"font-size: small;\">対照：426名</span></p>\r\n<p><span style=\"font-size: small;\">細胞株：1,173検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岡田 随象</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1129&amp;Itemid=1317&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0115.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000121</span></p>\r\n<p><span style=\"font-size: small;\">DRA006296</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">動的遺伝子ネットワークの多次元構造解析による高精度な細胞分化制御技術の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">マイクロアレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">（SurePrint G3 Human GE 8x60K v2 Microarray、SureScan G4900DA）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SEES3にTFを導入して樹立したES細胞株（TF-hESC）</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">洪 実</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1314&amp;Itemid=1476&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0116.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000122</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト化マウス（humanized mouse）の作製と免疫学研究への応用</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 急性骨髄性白血病：118症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">石川 文彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=555&amp;Itemid=831&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0117.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000125</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">神経変性疾患のエピジェネティクス解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HumanMethylation450）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アルツハイマー病：30症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：30名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岩田 淳</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=560&amp;Itemid=836&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0118.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000124</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">バイオマーカー探索に資する網羅的遺伝子解析研究（子宮体がん）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（CAGE-seq）</span></p>\r\n<p><span style=\"font-size: small;\">Sanger-seq</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">転写開始点同定</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific（3500 Genetic Analyzer）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮体癌：17症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">林崎 良英</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=812&amp;Itemid=1048&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0119.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000126</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NASHの発症、進展を規定するメカニズム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/01/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Human610-Quad、HumanCoreExome、HumanOmni2.5-Quad BeadChip）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NAFLD患者：902症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：7672名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松田 文彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2068&amp;Itemid=2102&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0120.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000221</span></p>\r\n<p><span style=\"font-size: small;\">DRA011183</span></p>\r\n<p><span style=\"font-size: small;\">DRA011184</span></p>\r\n<p><span style=\"font-size: small;\">DRA011185</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-396</span></p>\r\n<p><span style=\"font-size: small;\">DRA010902</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000549</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化器癌患者の末梢血液中における転移再発の予測因子候補に関する臨床的意義の確立</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/03</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/10/30</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/12/06</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/07/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、Target Capture、WGBS）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、iScan、HiSeq X Ten）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：10＋25＋10症例</span></p>\r\n<p><span style=\"font-size: small;\">胃癌：16症例</span></p>\r\n<p><span style=\"font-size: small;\">乳癌：16症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三森 功士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1043&amp;Itemid=1237&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0122.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA006622</span></p>\r\n<p><span style=\"font-size: small;\">DRA007336</span></p>\r\n<p><span style=\"font-size: small;\">DRA008459</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-311</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">市販ヒト初代細胞由来iPS 細胞のゲノム変異解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/01/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X Ten、Infinium Omni2.5-8）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">市販のヒト培養細胞、およびそれから誘導したiPS細胞株：計27検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">荒木 良子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=631&amp;Itemid=902&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0124.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000129</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト上皮成長因子受容体（EGFR）遺伝子変異をもつ肺癌家系における肺癌発癌関連遺伝子同定に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">EGFR遺伝子変異をもつ肺癌：3症例（1家系）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">菊地 利明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=762&amp;Itemid=1004&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0125.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000127</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制御性T細胞特異的エピゲノム誘導による免疫制御の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/11/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion S5）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">クローン病：3症例</span></p>\r\n<p><span style=\"font-size: small;\">大腸癌：4症例（非腫瘍組織）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">坂口 志文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1243&amp;Itemid=1417&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0126.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児ネフローゼ症候群の疾患感受性遺伝子及び薬剤感受性遺伝子同定研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/09/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Japonica Array v1/v2）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児ネフローゼ症候群：224＋3,206症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：419＋987名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">飯島 一誠</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2814&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0127.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000130</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000274</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000604</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000715</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">マルチオーミクス解析を用いたがん患者評価に基づく個別化治療と新技術開発に関する研究ープロジェクトHOPE（High-tech Omics-based Patients Evaluation）for Cancer Therapyー</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/08</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/01/22</span></p>\r\n<p><span style=\"font-size: small;\">v4:2024/07/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、DNA Amplicon-seq、RNA Amplicon-seq、WGS）</span></p>\r\n<p><span style=\"font-size: small;\">マイクロアレイ</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">（SurePrint G3 Human Gene Expression 8 × 60 K v2 Microarray、 DNA Microarray Scanner）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、Infinium MethylationEPIC array、iScan System）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">POLE変異および高変異症例の癌：91症例</span></p>\r\n<p><span style=\"font-size: small;\">癌：5143＋7症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山口 建</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=757&amp;Itemid=999&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0128.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000153</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">慢性好酸球性炎症疾患の網羅的遺伝子解析と網羅的蛋白質解析に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/10/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">慢性副鼻腔炎：6症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤枝 重治</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=655&amp;Itemid=900&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0129.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000131</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">神経疾患患者からのiPS細胞の樹立とそれを用いた疾患解析に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（ChIP-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">CHARGE症候群：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岡野 栄之</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2779&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0130.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000150</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000289</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ＰＯＥＭＳ症候群の骨髄細胞における遺伝子異常の網羅的解析</span></p>\r\n<p><span style=\"font-size: small;\">造血器腫瘍と骨髄ニッチ細胞の遺伝子異常解析による分子病態の解明と新規治療薬開発の基盤構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/01/18</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/09/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/06/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、Target Capture、RNA-seq、scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/2000/2500/3000、MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">POEMS症候群：20＋14症例</span></p>\r\n<p><span style=\"font-size: small;\">多発性骨髄腫：4＋5症例</span></p>\r\n<p><span style=\"font-size: small;\">MGUS：5＋2症例</span></p>\r\n<p><span style=\"font-size: small;\">骨髄浸潤のない悪性リンパ腫：4+3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">堺田 恵美子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=767&amp;Itemid=1008&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0131.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000132</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発達障害のエピゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Williams症候群：6症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：8名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">木村 亮</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=732&amp;Itemid=979&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0132.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000137</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ベトナムにおけるダイオキシン関連疾患のゲノムシークエンス解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/09/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ダイオキシン暴露者（退役軍人）とその妻と知的障害を持つ子の9トリオ（計27名）</span></p>\r\n<p><span style=\"font-size: small;\">（ベトナム人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=647&amp;Itemid=914&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0133.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000086</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃がんの転移/再発に特徴的な遺伝子変異の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃癌：75症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山口 俊晴</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=651&amp;Itemid=918&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0134.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000087</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Bリンパ腫の転移/再発に特徴的な遺伝子変異の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Bリンパ腫：60症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山口 俊晴</span></p>\r\n<p><span style=\"font-size: small;\">（P-DIRECT）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1626&amp;Itemid=1728&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0136.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000341</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">B型肝炎に関する統合的臨床ゲノムデータベースの構築を目指す研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/05/22</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/05</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/10/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Axiom ASI）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">B型肝炎ワクチン接種者（ビームゲン）：1,193名</span></p>\r\n<p><span style=\"font-size: small;\">B型肝炎ワクチン接種者（ヘプタバックス）：555名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">溝上 雅史</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=787&amp;Itemid=1027&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0137.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000144</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1型糖尿病関連遺伝子群の多施設共同研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/12/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1型糖尿病：32症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">池上 博司</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1432&amp;Itemid=1572&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0138.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000134</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">固形腫瘍における遺伝子異常の網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/07/31</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Hiseq 2500/4000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝硬変：10症例</span></p>\r\n<p><span style=\"font-size: small;\">肝癌：4症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：7名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">高井 淳</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=706&amp;Itemid=956&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0139.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000136</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">疾患特異的iPS細胞を用いた創薬・疾患研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/07/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">RALD患者：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大津 真</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1002&amp;Itemid=1205&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0140.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000158</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">microRNA/mRNA網羅的発現解析及び全エクソンシークエンス解析に基づく直腸癌術前治療効果予測法の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/11/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">術前放射線化学療法施行直腸癌：74症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">秋吉 高志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=863&amp;Itemid=1089&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0141.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000135</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制御性T細胞特異的エピゲノム誘導による免疫制御の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/05/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion S5）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">頭頸部癌：4症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">坂口 志文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3046&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0143.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000143</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">膵臓癌の進展において(プロ)レニン受容体の発現亢進は、クロマチンリモデラーSMARCA5の発現増大を介してゲノム不安定性を生じる</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">不死化ヒト膵管上皮細胞：6検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西山 成</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1038&amp;Itemid=1233&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0144.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000147</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍における遺伝子異常の網羅的解析（ダウン症候群患者におけるB前駆細胞性急性リンパ性白血病）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/01/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500、Infinium MethylationEPIC BeadChip、Infinium HumanMethylation450 BeadChip）</span></p>\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Human Mapping 250K Nsp、CytoScan HD）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ダウン症候群患者のB前駆細胞性急性リンパ性白血病：43症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">滝田 順子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1073&amp;Itemid=1270&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0145.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000222</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化器癌患者の末梢血液中における転移再発の予測因子候補に関する臨床的意義の確立</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三森 功士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=828&amp;Itemid=1060&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0146.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA007187</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">先天性インプリント異常症の診断と生殖医療の安全性評価</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/02/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RRBS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">生殖補助医療を受けたSRS患者：5症例</span></p>\r\n<p><span style=\"font-size: small;\">生殖補助医療を受けていないSRS患者：5症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常児：10名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">有馬 隆博</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2440&amp;Itemid=2425&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0147.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000145</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000312</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000454</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制御性T細胞特異的エピゲノム誘導による免疫制御の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/18</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/05/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、ChIP-seq、PBAT-seq、ATAC-seq、scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion S5）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/3000/4000、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常人：4＋1名</span></p>\r\n<p><span style=\"font-size: small;\">癌患者：7＋3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">坂口 志文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=899&amp;Itemid=1121&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0148.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000149</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">泌尿器科腫瘍組織での遺伝子異常と発現解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/06/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Genome Analyzer IIx）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">腎癌：67症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">湯浅 健</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2226&amp;Itemid=2245&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0152.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000182</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000529</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノム・プロテオーム解析に基づく骨軟部腫瘍の分子病態把握とその臨床応用を目指す多施設共同研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/09/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/11/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脱分化型脂肪肉腫：37症例</span></p>\r\n<p><span style=\"font-size: small;\">lipoblastoma-like tumor of the vulva：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">市川 仁</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=955&amp;Itemid=1169&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0153.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000177</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">希少腫瘍の発症・予後に関する遺伝子の網羅的解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/09/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脱分化型脂肪肉腫：28症例</span></p>\r\n<p><span style=\"font-size: small;\">腱鞘巨細胞種：36症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松田 浩一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1583&amp;Itemid=1695&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0156.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000227</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">次世代シークエンサーを用いた遺伝子統合解析による食道癌化学放射線療法耐性の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/07/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道癌：33症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三森 功士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=939&amp;Itemid=1154&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0157.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000164</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">がんのクリニカルシークエンスと付随研究としての網羅的ゲノム・エピゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/08/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">癌：183症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">宮園 浩平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1563&amp;Itemid=1678&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0158.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000151</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">シークエンス解析によるがんゲノム研究：肝臓がん</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/10/22</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/06/21</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/07/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000、Genome Analyzer IIx、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝臓癌：263症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=2305&amp;Itemid=2311&amp;lang=ja\" target=\"_blank\">hum0159.v2</a></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000157＊</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">シークエンス解析によるがんゲノム研究：大腸がん</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/06/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/12/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1568&amp;Itemid=1682&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0160.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000155</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">シークエンス解析によるがんゲノム研究：食道がん</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/05/28</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/07/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500/X Five）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道癌：20症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2309&amp;Itemid=2315&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0161.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000156＊</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">シークエンス解析によるがんゲノム研究：肝芽腫</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/06/04</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/12/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝芽腫：33症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2430&amp;Itemid=2417&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0163.v3</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">精神・神経疾患治療薬及びがん治療薬におけるファーマコゲノミクス研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/12/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/02/09</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/04/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq、Infinium OmniExpressExome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">精神・神経疾患及び癌：計990症例</span></p>\r\n<p><span style=\"font-size: small;\">水疱性類天疱瘡：90症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者（日本人由来B細胞株）：737検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">莚田 泰誠</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=781&amp;Itemid=1023&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0164.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000160</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">東北メディカル・メガバンク事業地域住民コホート調査</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/12/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Infinium OmniExpressExome-8）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">住民コホートに参加した9,187名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">長﨑 正朗</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=858&amp;Itemid=1085&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0165.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000162</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">家族性骨髄異形成症候群の遺伝子解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/05/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">家族性骨髄異形成症候群：2症例（1家系）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">古屋 淳史</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2679&amp;Itemid=2610&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0166.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">炎症性腸疾患患者におけるチオプリン関連副作用とNUDT15遺伝子多型との相関性に関する多施設共同研究（MENDEL Study）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/07/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/01/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Japonica Array v1）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">炎症性腸疾患：1221＋2680症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">角田 洋一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=919&amp;Itemid=1137&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0167.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">痛風・高尿酸血症及び尿酸関連疾患の病態解明に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/07/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HumanOmniExpressExome-8、Human660W-Quad、HumanOmni2.5-8、HumanOmniExpress-12、HumanOmniExpress-24、HumanOmniExpressExome、HumanOmniExpress、HumanExome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人コホート（J-MICC study、KING study、BBJ）：計121,745名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松尾 洋孝</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=987&amp;Itemid=1193&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0168.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000169</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性腫瘍のゲノム・エピゲノム解析による病態解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/11/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮腺筋症：51症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">河津 正人</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1193&amp;Itemid=1375&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0169.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000178</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳脊髄腫瘍のバイオマーカーの探索と標的治療開発に向けた遺伝子解析及びヒト由来脳脊髄腫瘍細胞株を用いた前臨床研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/06/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/07/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中枢神経原発悪性リンパ腫：9症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山本 哲哉</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=853&amp;Itemid=1081&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0173.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000171</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胎児期に始まる子どもの健康と発達に関する調査</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/04/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RRBS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">臍帯組織（正常出産）：30検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">森 千里</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2668&amp;Itemid=2602&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0174.v6</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000173</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000580</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000286</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000505</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000596</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人ゲノム構造変異データベースの作成</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/06</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/11/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/06/29</span></p>\r\n<p><span style=\"font-size: small;\">v4:2023/07/06</span></p>\r\n<p><span style=\"font-size: small;\">v5:2023/07/10</span></p>\r\n<p><span style=\"font-size: small;\">v6:2023/12/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">（Sequel、Sequel II）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Chromium Controller）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人由来B細胞株・DNAバンクから分譲されたDNAサンプル：10＋11＋177＋141＋30検体</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">森下 真一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2718&amp;Itemid=2638&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0175.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000174</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000642</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">治療抵抗性・再発予測バイオマーカーならびに新規分子標的治療法開発のための婦人科腫瘍検体の収集、保管ならびにゲノム・エピゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/10/02</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/03/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮類内膜腺癌：69症例</span></p>\r\n<p><span style=\"font-size: small;\">子宮内膜増殖症：30症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">竹島 信宏</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=971&amp;Itemid=1181&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0176.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000172</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮及び卵巣がん肉腫におけるドライバー変異の体系的探索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/10/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮癌肉腫：92症例</span></p>\r\n<p><span style=\"font-size: small;\">卵巣癌肉腫：17症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">森 誠一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1115&amp;Itemid=1305&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0177.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000197</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳腫瘍の悪性化に関与する遺伝子の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（PBAT-seq、RNA-seq、ChIP-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X Ten、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性神経膠腫：14症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">伊藤 隆司</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1078&amp;Itemid=1274&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0179.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000186</span></p>\r\n<p><span style=\"font-size: small;\">DRA009794</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">薬剤関連顎骨壊死における口腔内微生物叢メタゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタゲノム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタゲノム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina </span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：4名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">矢原 耕史</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1414&amp;Itemid=1558&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0180.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000170</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">RNAスプライシングの異常によって生じる先天異常症候群および先天代謝異常症等の遺伝子解析と低分子化合物によるその治療法の開発研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">家族性自律神経異常症：2症例</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">網代 将彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=884&amp;Itemid=1107&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0181.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">副腎皮質におけるアルドステロン産生の老化の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">病理スライドガラス画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Dako</span></p>\r\n<p><span style=\"font-size: small;\">（Autostainer Link 48）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">病理解剖を施行された50歳以上の症例：85症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西本 紘嗣郎</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1962&amp;Itemid=2022&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0182.v5</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000180</span></p>\r\n<p><span style=\"font-size: small;\">DRA008482</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000516</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">全ゲノムシークエンスデータの解析による変異と遺伝的多様性の包括的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/06/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/05/12</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/01/06</span></p>\r\n<p><span style=\"font-size: small;\">v4:2021/11/12</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/05/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（MinION）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000、Genome Analyzer IIx）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝臓癌（正常細胞）：174＋42症例</span></p>\r\n<p><span style=\"font-size: small;\">肝臓癌（腫瘍組織）：11＋42症例</span></p>\r\n<p><span style=\"font-size: small;\">HapMap：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">乳癌細胞株：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤本 明洋</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1827&amp;Itemid=1901&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0184.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000239</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人全ゲノムデータベースの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/09/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">一般住民：4,566名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山本 雅之</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type II）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1519&amp;Itemid=1642&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0187.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000194</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000233</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化器癌のゲノム・遺伝子解析とその臨床病理学的意義の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/12</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/05/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture、Exome、RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq、HiSeq 2500、HumanMethylation450）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝癌：243＋160症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">油谷 浩幸</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=912&amp;Itemid=1133&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0188.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000179</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃がん細胞株のゲノム解析による治療標的同定 </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/06/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃癌細胞株：2検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">間野 博行</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1183&amp;Itemid=1363&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0191.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA008575</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">個々のがんの遺伝子変異に基づく固有抗原の同定と腫瘍内微小環境の解析に基づく免疫制御法を組み合わせた個別化がんワクチン治療の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/4000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">膵癌：17症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">垣見 和宏</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1474&amp;Itemid=1606&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0192.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000196</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸・直腸癌患者のオリゴメタスタシスに対する放射線・陽子線治療後予後予測バイオマーカーとしてcell free DNAの有用性を検証する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/04/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸・直腸癌：20症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中村 匡希</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1125&amp;Itemid=1313&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0194.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000189</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">分子プロファイリングによる薬剤抵抗性機構の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺癌：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">片山 量平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1886&amp;Itemid=1956&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0195.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000190</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000234</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000269</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化器癌における遺伝子異常についての網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/26</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/03/02</span></p>\r\n<p><span style=\"font-size: small;\">v3:2022/03/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、RNA-seq、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 4000、NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">結節内結節型肝癌：5症例</span></p>\r\n<p><span style=\"font-size: small;\">C型肝炎ウイルス排除後に肝癌を発症した慢性肝炎/肝硬変：20症例</span></p>\r\n<p><span style=\"font-size: small;\">C型肝炎ウイルス陽性肝硬変/肝癌：3症例</span></p>\r\n<p><span style=\"font-size: small;\">C型肝炎ウイルス陰性肝癌：2症例</span></p>\r\n<p><span style=\"font-size: small;\">胃癌：42 ＋ 1症例、胃粘膜下腫瘍：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">髙井 淳</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1022&amp;Itemid=1221&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0196.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">自殺者血液および死後脳標本を用いた自殺に関連した生物学的マーカーの同定と自殺予防への応用に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/12/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HumanOmniExpress-24、HumanOmniExpressExome-8）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">自殺者：746名</span></p>\r\n<p><span style=\"font-size: small;\">非自殺者：14,049名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">菱本 明豊</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3153&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0197.v25</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000205</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000260</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000316</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000415</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000504</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000530</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000531</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000543</span></p>\r\n<p><span style=\"font-size: small;\">DRA014184</span></p>\r\n<p><span style=\"font-size: small;\">DRA014186</span></p>\r\n<p><span style=\"font-size: small;\">DRA014188</span></p>\r\n<p><span style=\"font-size: small;\">DRA014191</span></p>\r\n<p><span style=\"font-size: small;\">DRA014192</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000593</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000600</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000741</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000751</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-887</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1054</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000783</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">多層的オミクス解析による疾患病態の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/11/15</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/11/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/03/22</span></p>\r\n<p><span style=\"font-size: small;\">v4:2021/12/10</span></p>\r\n<p><span style=\"font-size: small;\">v5:2021/12/21</span></p>\r\n<p><span style=\"font-size: small;\">v6:2022/02/08</span></p>\r\n<p><span style=\"font-size: small;\">v7:2022/05/23</span></p>\r\n<p><span style=\"font-size: small;\">v8:2022/06/03</span></p>\r\n<p><span style=\"font-size: small;\">v9:2022/06/10</span></p>\r\n<p><span style=\"font-size: small;\">v10:2022/06/16</span></p>\r\n<p><span style=\"font-size: small;\">v11:2022/07/21</span></p>\r\n<p><span style=\"font-size: small;\">v12:2022/12/01</span></p>\r\n<p><span style=\"font-size: small;\">v13:2023/02/14</span></p>\r\n<p><span style=\"font-size: small;\">v14:2023/02/16</span></p>\r\n<p><span style=\"font-size: small;\">v15:2023/03/29</span></p>\r\n<p><span style=\"font-size: small;\">v16:2023/06/06</span></p>\r\n<p><span style=\"font-size: small;\">v17:2023/06/27</span></p>\r\n<p><span style=\"font-size: small;\">v18:2023/10/02</span></p>\r\n<p><span style=\"font-size: small;\">v19:2024/05/29</span></p>\r\n<p><span style=\"font-size: small;\">v20:2024/05/30</span></p>\r\n<p><span style=\"font-size: small;\">v21:2024/10/28</span></p>\r\n<p><span style=\"font-size: small;\">v22:2024/11/11</span></p>\r\n<p><span style=\"font-size: small;\">v23:2024/12/18</span></p>\r\n<p><span style=\"font-size: small;\">v24:2025/05/07</span></p>\r\n<p><span style=\"font-size: small;\">v25:2025/07/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタゲノム</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、RNA-seq、scRNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">eHHV-6の有無、アネロウイルス量</span></p>\r\n<p><span style=\"font-size: small;\">プロテオミクス</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタゲノム</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">eQTL</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/3000/X Ten、NovaSeq 6000、Infinium Asian Screening Array、HumanOmniExpressExome BeadChip、HumanOmniExpress BeadChip、HumanExome BeadChip、iCOGS OncoArray）</span></p>\r\n<p><span style=\"font-size: small;\">Applied Biosystems</span></p>\r\n<p><span style=\"font-size: small;\">（UK BiLEVE Axiom Array、UK Biobank Axiom Array）</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（FinnGen1 ThermoFisher Arrayなど）</span></p>\r\n<p><span style=\"font-size: small;\"> MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-T7）</span></p>\r\n<p><span style=\"font-size: small;\">Olink</span></p>\r\n<p><span style=\"font-size: small;\">（Olink Explore 3072）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人集団：95＋103＋227＋30＋141＋136＋88＋5＋524名</span></p>\r\n<p><span style=\"font-size: small;\">BBJ：180,215名</span></p>\r\n<p><span style=\"font-size: small;\">UKバイオバンク：377,583名</span></p>\r\n<p><span style=\"font-size: small;\">FinnGen：136,000＋224,352名</span></p>\r\n<p><span style=\"font-size: small;\">BCAC：247,173名</span></p>\r\n<p><span style=\"font-size: small;\">PRACTICAL：140,254名</span></p>\r\n<p><span style=\"font-size: small;\">肺胞蛋白症：198症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：395名</span></p>\r\n<p><span style=\"font-size: small;\">潰瘍性大腸炎：35症例</span></p>\r\n<p><span style=\"font-size: small;\">クローン病：39症例</span></p>\r\n<p><span style=\"font-size: small;\">健常対照者：40名</span></p>\r\n<p><span style=\"font-size: small;\">頭蓋内胚細胞腫瘍：133症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：762名</span></p>\r\n<p><span style=\"font-size: small;\">COVID-19：30＋43＋15症例</span></p>\r\n<p><span style=\"font-size: small;\">健常対照者：31＋44＋27名</span></p>\r\n<p><span style=\"font-size: small;\">健常者：73名</span></p>\r\n<p><span style=\"font-size: small;\">間質性膀胱炎ハンナ型：144症例</span></p>\r\n<p><span style=\"font-size: small;\">2型糖尿病：27,642症例（BBJ）</span></p>\r\n<p><span style=\"font-size: small;\">対照者：70,242名（BBJ）</span></p>\r\n<p><span style=\"font-size: small;\">2型糖尿病：27,642症例（UKバイオバンク）</span></p>\r\n<p><span style=\"font-size: small;\">対照者：70,242名（UKバイオバンク）</span></p>\r\n<p><span style=\"font-size: small;\">不育症：1,728症例</span></p>\r\n<p><span style=\"font-size: small;\">自己免疫疾患：2,238症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：2,919名</span></p>\r\n<p><span style=\"font-size: small;\">HPV関連中咽頭癌：32症例</span></p>\r\n<p><span style=\"font-size: small;\">HPV非関連中咽頭癌：17症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：2名</span></p>\r\n<p><span style=\"font-size: small;\">視神経脊髄炎関連疾患：240症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：50,578名</span></p>\r\n<p><span style=\"font-size: small;\">乾癬：204症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：1,231名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人、イギリス人、フィンランド人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岡田 随象</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1188&amp;Itemid=1371&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0199.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000198</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">次世代シーケンサーを用いた泌尿器悪性腫瘍の治療標的分子の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">前立腺癌：25症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤村 哲也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2946&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0200.v6</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000202</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000265</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000290</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000387</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000758</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳腺腫瘍の表現型にかかわる体細胞変異および遺伝子発現異常の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/29</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/05/07</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/10/01</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/03/02</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/08/29</span></p>\r\n<p><span style=\"font-size: small;\">v6:2024/11/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、WGS、Target Capture、Visium Spatial Gene Expression、semibulk RNA-seq、scRNA-seq、EM-seq、t-nanoEM）</span></p>\r\n<p><span style=\"font-size: small;\">CNV</span></p>\r\n<p><span style=\"font-size: small;\">メチル化解析</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">CNV</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 3000、NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Chromium Controller）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非浸潤性乳管癌：96症例</span></p>\r\n<p><span style=\"font-size: small;\">浸潤性乳管癌：4＋1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">永澤 慧</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2864&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0201.v8</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000199</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000237＊</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000256</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000378</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000350</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000550</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000719</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト腫瘍試料の収集・分譲とゲノム情報を利用した研究</span></p>\r\n<p><span style=\"font-size: small;\">既存試料の分譲とゲノム情報を利用した研究</span></p>\r\n<p><span style=\"font-size: small;\">消化器慢性炎症性疾患における遺伝子変異の検索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/12/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/10/06</span></p>\r\n<p><span style=\"font-size: small;\">v3:2020/11/20</span></p>\r\n<p><span style=\"font-size: small;\">v4:2021/11/19</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/06/06</span></p>\r\n<p><span style=\"font-size: small;\">v6:2022/08/05</span></p>\r\n<p><span style=\"font-size: small;\">v7:2022/12/27</span></p>\r\n<p><span style=\"font-size: small;\">v8:2024/08/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、WGS、RNA-seq、ChIP-seq、scRNA-seq、ATAC-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/4000/X Ten、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">潰瘍性大腸炎：29症例</span></p>\r\n<p><span style=\"font-size: small;\">腫瘍を併発する潰瘍性大腸炎：26症例</span></p>\r\n<p><span style=\"font-size: small;\">下部消化管内視鏡検査を受けた患者（対照者）：16名</span></p>\r\n<p><span style=\"font-size: small;\">腫瘍性疾患：23＋1＋4＋2＋3症例</span></p>\r\n<p><span style=\"font-size: small;\">膵癌：50症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">佐藤 俊朗</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2151&amp;Itemid=2167&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0202.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000379</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">言語聴覚リハビリテーションの向上を目的とした先天性難聴の遺伝的原因と生後早期の経過の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/4000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">先天性難聴：3症例とその両親</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松永 達雄</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1150&amp;Itemid=1335&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0203.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000206</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍における臨床ゲノム情報統合データベースの構築に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">多発性骨髄腫：154症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">堀部 敬三</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1007&amp;Itemid=1209&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0206.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000207</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">妊娠関連疾患の胎盤栄養膜細胞株の樹立と細胞特性に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/11/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（PBAT-seq、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">全胞状奇胎：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">有馬 隆博</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1032&amp;Itemid=1229&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0207.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト免疫細胞における遺伝子多型と遺伝子発現の関連解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/01/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、ChIP-seq、Hi-C）</span></p>\r\n<p><span style=\"font-size: small;\">eQTL</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n<p><span style=\"font-size: small;\">eQTL</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、HiSeq series、Infinium OmniExpressExome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関節リウマチ：30症例</span></p>\r\n<p><span style=\"font-size: small;\">変形性関節症：30症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤尾 圭志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1048&amp;Itemid=1241&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0208.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000214</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">頭頚部悪性腫瘍に対する網羅的遺伝子解析およびデータベースの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/01/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X Ten）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">外耳道癌：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 尚志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1017&amp;Itemid=1217&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0209.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関節リウマチ治療におけるメトトレキサートの効果と副作用予測のための多施設研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/12/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">ダイレクトシークエンス</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（GeneChip® Scanner 3000 7G）</span></p>\r\n<p><span style=\"font-size: small;\">Applied Biosystems</span></p>\r\n<p><span style=\"font-size: small;\">（Veriti 96-Well Thermal Cycler and 3730XL DNA Analyzer）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関節リウマチ：166症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">熊谷 俊一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1083&amp;Itemid=1278&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0210.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000211</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍における遺伝子異常の網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">急性骨髄性白血病と縦隔胚細胞腫瘍の合併症例：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">下田 和哉</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2033&amp;Itemid=2078&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0213.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000238</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Demographic History and Local Adaptation in Asian Population</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/07/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X Ten）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">バルチ人：60名</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Min-Sheng Peng</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2692&amp;Itemid=2618&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0214.v9</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000220</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000296</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-397</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-398</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-420</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000486</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000598</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000485</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000626</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000627</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000648</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト免疫系の機能ゲノム学による統合的理解とこれを用いた免疫疾患の発症予防のためのインターベンション戦略の構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/09</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/05</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/04/28</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/01/21</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/03/09</span></p>\r\n<p><span style=\"font-size: small;\">v6:2022/08/25</span></p>\r\n<p><span style=\"font-size: small;\">v7:2023/03/28</span></p>\r\n<p><span style=\"font-size: small;\">v8:2023/07/06</span></p>\r\n<p><span style=\"font-size: small;\">v9:2024/02/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、scRNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">eQTL</span></p>\r\n<p><span style=\"font-size: small;\">B細胞受容体レパトア解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">eQTL</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10免疫疾患：544症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：185名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤尾 圭志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2191&amp;Itemid=2199&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0215.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000532</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人の全ゲノム、RNA解析を基盤とした老年病関連分子の同定と解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アルツハイマー病：317症例</span></p>\r\n<p><span style=\"font-size: small;\">軽度認知障害：432症例</span></p>\r\n<p><span style=\"font-size: small;\">認知機能正常：107名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">尾崎 浩一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1464&amp;Itemid=1598&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0216.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000216</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000244</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000279</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化管癌を含む固形癌患者における免疫状態の解明と臨床的意義に関する研究</span></p>\r\n<p><span style=\"font-size: small;\">新規免疫療法や併用療法開発を目指した固形癌患者の免疫状態の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/02/07</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/09/25</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/03/29</span></p>\r\n<p><span style=\"font-size: small;\">v4:2021/04/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺腺癌：17症例</span></p>\r\n<p><span style=\"font-size: small;\">胃癌：26＋23症例</span></p>\r\n<p><span style=\"font-size: small;\">肺癌：9症例</span></p>\r\n<p><span style=\"font-size: small;\">悪性黒色腫：5症例</span></p>\r\n<p><span style=\"font-size: small;\">大腸癌：7症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西川 博嘉</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1058&amp;Itemid=1256&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0217.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000217</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸ポリープから癌への進展を予測する遺伝子変化の同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/03/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Torrent）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸鋸歯状病変（鋸歯状ポリープ）：50症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">澤田 武</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1268&amp;Itemid=1440&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0218.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-344</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">全身性強皮症患者の遺伝子発現解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">全身性強皮症：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤尾 圭志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1178&amp;Itemid=1359&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0220.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000223</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">採血後の試験管保存状態が試験管内の化合物濃度に与える影響の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">LC-MS/MS</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">質量分析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Sciex</span></p>\r\n<p><span style=\"font-size: small;\">（TripleTOF 5600）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常人：3名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大槻 純男</span></p>\r\n<p><span style=\"font-size: small;\">（AMED疾患代謝）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2561&amp;Itemid=2518&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0221.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000225</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト疾患特異的iPS細胞を用いた遺伝子解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ファブリー病患者由来iPS細胞株：3検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">粟屋 智就</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1063&amp;Itemid=1260&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0222.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000224</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS技術を駆使した遺伝学的解析による家族性乳がんの原因遺伝子同定と標準化医療構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/03/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌：115症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大野 真司</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1238&amp;Itemid=1413&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0223.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000232</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">血液がんにおける遺伝子変異の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/09/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">多発性骨髄腫：7症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">照井 康仁</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3197&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0225.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000226</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000835</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HTLV-1関連脊髄症（HAM）におけるゲノム異常及びエピゲノム異常の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture、RNA-seq、ATAC-seq、scRNA-seq、scATAC-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/3000、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HTLV-1関連脊髄症（HAM）：21＋15症例</span></p>\r\n<p><span style=\"font-size: small;\">無症候性HTLV-1感染者：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山岸 誠</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1529&amp;Itemid=1650&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0226.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000229</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">上部消化管腫瘍のゲノム・遺伝子解析とその臨床病理学的意義の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/06/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃癌：141症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">油谷 浩幸</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1533&amp;Itemid=1654&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0227.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000228</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃腫瘍のゲノム・遺伝子解析とその臨床病理学的意義の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/06/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃癌：102症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">油谷 浩幸</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1145&amp;Itemid=1329&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0229.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000230</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">老化・神経疾患における分子マーカーの探索と分子基盤の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">スーパーセンチナリアン（110歳以上）：7名</span></p>\r\n<p><span style=\"font-size: small;\">家族：2名</span></p>\r\n<p><span style=\"font-size: small;\">血縁関係のない対照群：2名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Piero Carninci</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2826&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0231.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000287</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト疾患特異的iPS細胞樹立に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常人：120名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">齋藤 潤</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1173&amp;Itemid=1355&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0232.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000231</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃癌由来循環腫瘍DNAモニタリングによる転移・再発の検証</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃癌：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西塚 哲</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1514&amp;Itemid=1638&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0233.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000236</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児肝癌に対する国際共同臨床試験（PHITT, JPLT4）付随研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/05/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、WGBS）</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、HumanMethylation450）</span></p>\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（SNP Array 6.0）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児肝腫瘍：165症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">檜山 英三</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1452&amp;Itemid=1588&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0235.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000272</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">プレクリニカル期におけるアルツハイマー病に対する客観的画像診断・評価法の確立を目指す臨床研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳画像</span></p>\r\n<p><span style=\"font-size: small;\">臨床情報</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳画像ベースの病態解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><a href=\"hum0235-v1-release#mriscanners\" target=\"_blank\" rel=\"noopener noreferrer\">MRIスキャナー（9機種）</a></p>\r\n<p><a href=\"hum0235-v1-release#petscanners\" target=\"_blank\" rel=\"noopener noreferrer\">PETスキャナー（11機種）</a></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常高齢者群：25名</span></p>\r\n<p><span style=\"font-size: small;\">プレクリニカルAD：3名</span></p>\r\n<p><span style=\"font-size: small;\">早期MCI：7名</span></p>\r\n<p><span style=\"font-size: small;\">後期MCI：5名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">嶋田 裕之</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1329&amp;Itemid=1488&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0236.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000245</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺がんの複雑な遺伝子変異を利用した腫瘍浸潤リンパ球療法の開発を目指した基礎的検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/12/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（MinION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非小細胞肺癌：7症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中面 哲也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1389&amp;Itemid=1538&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0237.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人の全ゲノム、RNA解析を基盤とした老年病関連分子の同定と解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Japonica Array、SNP Array 6.0）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アルツハイマー病：3,962症例</span></p>\r\n<p><span style=\"font-size: small;\">非アルツハイマー病：4,074名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">尾崎 浩一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1203&amp;Itemid=1383&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0238.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000240</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">オーダーメイド医療開発プロジェクト</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/07/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">BBJ：10名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">桃沢 幸秀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1198&amp;Itemid=1379&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0239.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000241</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">がん、感染症、難病、生活習慣病等に関する遺伝子とタンパク質などの網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/07/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">膀胱癌：19症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">弘津 陽介</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1284&amp;Itemid=1452&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0240.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000258</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中枢神経原発悪性リンパ腫の全ゲノムシーケンス解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Torrent）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中枢神経原発悪性リンパ腫：28症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山中 龍也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1354&amp;Itemid=1508&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0242.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000243</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">変異遺伝子のモニタリングによる大腸癌術後の微少転移及び再発の新たな評価法の検証</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/01/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：12症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西塚 哲</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1304&amp;Itemid=1468&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0243.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000253</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト化マウス（humanized mouse）の作製と免疫学研究への応用/ヒト・造血免疫系由来iPS細胞を用いた疾患と治療モデルの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、CAGE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">臍帯血：24名</span></p>\r\n<p><span style=\"font-size: small;\">急性骨髄性白血病：116症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">石川 文彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2202&amp;Itemid=2225&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0245.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000276</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">思春期・若年成人急性リンパ芽球性白血病における網羅的ゲノム解析（JALSG ALL202U-GWS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/10/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">フィラデルフィア染色体陰性ALL：46症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">早川 文彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1349&amp;Itemid=1504&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0247.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000249</span></p>\r\n<p><span style=\"font-size: small;\">DRA010773</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">がん患者免疫状態を反映するがん遺伝子変異の探索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/01/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性黒色腫：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岩田 卓</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1299&amp;Itemid=1464&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0248.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000259</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">高精度長鎖解読による日本人基準ゲノム配列策定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/11/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">PacBio（RS II）</span></p>\r\n<p><span style=\"font-size: small;\">Bionano（Irys、Saphyr）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人健常男性：3名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山本 雅之</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type II）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3002&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0249.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000248</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000663</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">硬組織・結合組織関連疾患患者由来iPS細胞を用いた病態解明と治療法開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/09/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/03/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（CAGE-seq、scRNA-seq、CUT&amp;RUN-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">転写開始点同定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">鎖骨頭蓋骨異形成症：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">東 俊文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1437&amp;Itemid=1576&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0250.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000277</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">革新脳脳老化ヒト画像研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳画像</span></p>\r\n<p><span style=\"font-size: small;\">臨床情報</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><a href=\"hum0250-v1-release#mriscanners\" target=\"_blank\" rel=\"noopener noreferrer\">MRIスキャナー（1機種）</a></p>\r\n<p><a href=\"hum0250-v1-release#petscanners\" target=\"_blank\" rel=\"noopener noreferrer\">PETスキャナー（1機種）</a></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MCI：11名</span></p>\r\n<p><span style=\"font-size: small;\">健常高齢者群：28名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 岩坪 威</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2206&amp;Itemid=2229&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0251.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000278</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">成人フィラデルフィア染色体陰性precursor B細胞性急性リンパ性白血病に対する多剤併用化学療法による第Ⅱ相臨床試験</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/10/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">フィラデルフィア染色体陰性B-ALL：153症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">八田 善弘</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2723&amp;Itemid=2642&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0252.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000301</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000553</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ATL、HTLV-1感染症の分子基盤創出のための研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/07/12</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/12/06</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/03/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture、RNA-seq、scRNA-seq、WGS、scATAC-seq、ChIP-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/3000、NovaSeq 6000、NextSeq 500）</span></p>\r\n<p><span style=\"font-size: small;\"> MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ATL：6＋4＋6症例（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">HTLV-1感染者：10症例（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">健常者3＋1名のCD4+T細胞（セルライン）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山岸 誠</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1610&amp;Itemid=1716&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0254.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000257</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">血中セルフリーDNAからの配列決定ライブラリー調製法の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq、HiSeq X Ten）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常人：5名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三浦 史仁</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2322&amp;Itemid=2329&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0257.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000262</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000263</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000264</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000514</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-414</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-415</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-416</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-417</span></p>\r\n<p><span style=\"font-size: small;\">GSE202023</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト膵・胆道由来微量検体を用いた培養増幅法の研究開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/12/24</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/01/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、ATAC-seq、ChIP-seq、Hi-C）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq6000、HiSeq 2500、NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">膵管癌：17症例</span></p>\r\n<p><span style=\"font-size: small;\">膵管内乳頭粘液性腫瘍：6症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">立石 敬介</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1364&amp;Itemid=1516&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0261.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">原発性胆汁性胆管炎の病態解明のためのゲノムワイド関連解析</span></p>\r\n<p><span style=\"font-size: small;\">― 1,000 症例の追加解析 ―</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/01/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/01/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">領域内遺伝率推定</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Axiom ASI、Japonica Array v1）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">原発性胆汁性胆管炎：1,953症例</span></p>\r\n<p><span style=\"font-size: small;\">健常対照者：3,690名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中村 稔</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1494&amp;Itemid=1622&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0262.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000267</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非小細胞肺癌における微小管阻害薬および葉酸代謝阻害薬感受性のバイオマーカー研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺腺癌：24症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">土原 一哉</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2539&amp;Itemid=2500&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0263.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000292</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">若年性骨髄単球性白血病における遺伝子異常の網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（DREAM-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">若年性骨髄単球性白血病：149症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">髙橋 義行</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1837&amp;Itemid=1909&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0264.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000508</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">過眠を呈する睡眠障害 (各種過眠症・概日リズム睡眠障害・睡眠時無呼吸症候群・睡眠関連運動障害・睡眠時随伴症など) の病態に関与する遺伝子の探索とその機能および末梢血リンパ球の自己抗原特異的増殖反応の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/02/07</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（SNP Array 6.0）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">特発性過眠症：129症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">本多 真</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2291&amp;Itemid=2299&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0266.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000281</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">患者検体を用いた自己免疫性皮膚疾患発症機序の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">天疱瘡：3症例</span></p>\r\n<p><span style=\"font-size: small;\">健常人：3名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">江上 将平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2986&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0267.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000284</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児がん・血液疾患患者に対するがん素因遺伝子およびがん細胞における原因遺伝子の網羅的遺伝子解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/02/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肉腫が疑われた小児：47症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">若松 学</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3181&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0268.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000280</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000766</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">がん組織を用いたネオアンチゲンスクリーニング</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/04/09</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/08/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Iso-seq、CAGE-seq、RNA-seq、scRNA-seq、scTCR-seq、Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500、NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">（Sequel）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト大腸癌細胞株：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（セルライン）</span></p>\r\n<p><span style=\"font-size: small;\">大腸癌：6症例</span></p>\r\n<p><span style=\"font-size: small;\">子宮体癌：5症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">金関 貴幸</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2735&amp;Itemid=2650&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0269.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000295</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000565</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000566</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000567</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">遺伝性心血管疾患の感受性遺伝子解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/05/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/03/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/3000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">遺伝性心血管疾患：13＋20症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">朝野 仁裕</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1930&amp;Itemid=1990&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0270.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000282</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムおよび遺伝子解析に基づく骨軟部腫瘍に特異的な分子病理学的異常の解明と、新規診断および治療法の開発を目指したトランスレーショナル研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児骨肉腫：16症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">米本 司</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1489&amp;Itemid=1618&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0271.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000288</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ハプロ不全により発症する常染色体優性遺伝性疾患における表現型発現の個体差に関する包括的ゲノム解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture、Target RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">神経線維腫症1型：20症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">新井田 要</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2926&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0272.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000285</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000589</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メラノーマ等、皮膚腫瘍病変の免疫状態の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/12/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/07</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/11/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、scRNA-seq、scTCR-seq、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Torrent Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メラノーマ：4＋9症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">猪爪 隆史</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1600&amp;Itemid=1708&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0273.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000300</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌の発生、進展に関する分子病理学的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/08/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Amplicon-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小葉癌乳管癌併存症例：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">増田 しのぶ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1921&amp;Itemid=1982&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0274.v1</span></a></p>\r\n<p><span style=\"font-size: small; font-weight: bold; text-align: center;\">JGAS000294</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">mRNA輸送因子UAP56とURH49による選択的mRNA輸送基盤の統合的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/04/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"><span style=\"font-size: small;\">発現</span></span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">目的遺伝子をノックダウンしたHeLa細胞：20検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤田 賢一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1594&amp;Itemid=1704&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0275.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000313</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">固形腫瘍における遺伝子異常の網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/08/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃癌既往の無いヘリコバクターピロリ未感染者（健常集団）：9名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小川 誠司</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1616&amp;Itemid=1720&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0276.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000308</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Gorlin症候群に対する汎用型遺伝子診断パネルの開発とリキッドバイオプシーへの応用</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/10/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Gorlin症候群：12症例</span></p>\r\n<p><span style=\"font-size: small;\">血縁者：3名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">東 俊文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3189&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0277.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000303</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000564</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000737</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">泌尿器科領域の腫瘍性疾患の発症、進展、及び薬剤の治療効果に関わる遺伝子の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/09</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/04/18</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/05/10</span></p>\r\n<p><span style=\"font-size: small;\">v4:2025/09/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、Exome、RNA-seq、WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500、HiSeq 2500、NovaSeq 6000/PE150）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">腎癌：15＋30＋167症例</span></p>\r\n<p><span style=\"font-size: small;\">腎オンコサイトーマ：7症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">蓮見 壽史</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2023&amp;Itemid=2070&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0278.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000304</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000305</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌幹細胞のゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/07/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 3000、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌：5症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">後藤 典子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2127&amp;Itemid=2147&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0279.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000307</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノム・エピゲノム解析と免疫組織染色による難治性悪性リンパ腫の層別化と新規治療法の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 550）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">びまん性大細胞型B細胞リンパ腫：177症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">堺田 恵美子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1758&amp;Itemid=1845&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0280.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA012560</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺癌患者における標的抗原の同定とがん微小環境の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺癌：113症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松下 博和</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2336&amp;Itemid=2341&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0284.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000309</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">生体維持機能の破綻による前がん病変から浸潤がんへの移行を制御する分子機序の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/01/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌：4症例</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中山 淳</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2221&amp;Itemid=2241&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0286.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000311</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000523</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非アルコール性脂肪性肝疾患患者における肝癌発症・進展機序の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/12</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/11/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Visium Spatial Gene Expression、Target Capture）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝細胞癌：55症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小玉 尚宏</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2723&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0287.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000310</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000573</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000690</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒトiPS細胞株のゲノム配列比較</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/02</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/03/29</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/05/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒトiPS細胞株：5＋1＋1株</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">横林 しほり</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2156&amp;Itemid=2171&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0289.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000317</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">慢性骨髄単球性白血病（CMML）における同種移植後再発メカニズムの探索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、Exome）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、MethylationEPIC）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">慢性骨髄単球性白血病（CMML）：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">赤星 佑</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3084&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0290.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000321</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000637</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1053</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1058</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1059</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1060</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒトゲノム・遺伝子発現および細菌叢の環境因子との相互作用に関する網羅的解析（２）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/04</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/06/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、scRNA-seq、TCR-seq、BCR-seq、scATAC-seq）</span></p>\r\n<p><span style=\"font-size: small;\">プロテオミクス</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000/X、MethylationEPIC）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Chromium Controller）</span></p>\r\n<p><span style=\"font-size: small;\">Fluidigm</span></p>\r\n<p><span style=\"font-size: small;\">（Helios, a CyTOF System）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-T7）</span></p>\r\n<p><span style=\"font-size: small;\">Olink</span></p>\r\n<p><span style=\"font-size: small;\">（Olink Explore 3072）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：7＋97名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">鈴木 穣</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2587&amp;Itemid=2538&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0291.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000359</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">網羅的ゲノム解析による膵腫瘍ならびに十二指腸腫瘍、胆道腫瘍の本態解明と新規診断・治療法の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/12/10</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/09/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">膵腫瘍：57＋6症例</span></p>\r\n<p><span style=\"font-size: small;\">十二指腸腫瘍：6＋1症例</span></p>\r\n<p><span style=\"font-size: small;\">胆道腫瘍：11症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">谷内田 真一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1605&amp;Itemid=1712&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0292.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000330</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">去勢抵抗性前立腺癌の最適医療の実現に向けた血液ゲノムマーカーの開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">去勢抵抗性前立腺癌：100症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">赤松 秀輔</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2038&amp;Itemid=2082&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0293.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000320</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍・難治性腫瘍の治療感受性を規定する遺伝学的宿主側因子、腫瘍側因子の探索研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/07/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X Ten）</span></p>\r\n<p><span style=\"font-size: small;\">BGI</span></p>\r\n<p><span style=\"font-size: small;\">（BGISEQ-500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">成人T細胞性白血病リンパ腫（ATL）：7症例</span></p>\r\n<p><span style=\"font-size: small;\">ATL細胞株（TL-om1）：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三田 貴臣</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2747&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0294.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000708</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">腫瘍浸潤T細胞サブセットのシングルセル解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/05/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道癌：28症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">熊谷 尚悟</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=1740&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0295.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000351</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">皮膚腫瘍の診断と治療効果の評価および経過観察のためのバイオマーカーの探索（前向き観察研究）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/10/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Amplicon-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion S5）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性黒色腫：98症例</span></p>\r\n<p><span style=\"font-size: small;\">脂腺母斑：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">宇原 久</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2171&amp;Itemid=2183&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0297.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000348</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">色覚多様性の総合的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：1名</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">平松 千尋</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2176&amp;Itemid=2187&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0299.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA012759</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ロングリードシークエンサーを用いたがん突然変異の染色体背景の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常白人由来B細胞株HG002（NA24385）：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">鈴木 穣</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1667&amp;Itemid=1764&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0300.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000367</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">がんの全ゲノム・全エキソンシークエンス解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道扁平上皮癌：89症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">稲澤 譲治</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1697&amp;Itemid=1788&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0301.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000368</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳がん患者および高リスク者におけるゲノム異常と免疫状態との統合的解析研究（免疫ゲノムアトラスプロジェクト）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌：26症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">間野 博行</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2740&amp;Itemid=2654&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0302.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000382</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000683</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">iPS細胞の高次特性解析と加工iPS細胞の作製</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/05</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/03/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ウイルソン病患者由来iPS細胞株：6検体</span></p>\r\n<p><span style=\"font-size: small;\">若年性ネフロン癆（NPH1）患者由来iPS細胞株：12検体</span></p>\r\n<p><span style=\"font-size: small;\">健常人由来iPS細胞株：6＋6検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">林 洋平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1754&amp;Itemid=1841&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0304.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000370</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳がんにおけるタキサン作用機序の解明に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/04/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌：6症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">鰐渕 友美</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1702&amp;Itemid=1792&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0305.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000377</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血細胞移植後二次がんの細胞遺伝学的特徴に関する多施設後方視的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">固形癌：14症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">稲本 賢弘</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1631&amp;Itemid=1732&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0306.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000361</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">国際連携によるがんゲノムシークエンス解析</span></p>\r\n<p><span style=\"font-size: small;\">（シークエンス解析によるがんゲノム研究）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/10/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（MinION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝臓癌：9症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1867&amp;Itemid=1933&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0307.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000416</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アトピー性皮膚炎患者における皮膚成分の解析（２）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion S5）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常男性：29名</span></p>\r\n<p><span style=\"font-size: small;\">男性のアトピー性皮膚炎：30症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">井上 高良</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1871&amp;Itemid=1937&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0308.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000417</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">皮膚成分の日間、日内変動解析試験</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion S5）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常女性：10名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">井上 高良</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1875&amp;Itemid=1941&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0309.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000418</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">皮脂及び角層由来成分のプロファイル比較試験</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion S5）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常男性：10名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">井上 高良</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3096&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0311.v7</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000412</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000541</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000561</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000785</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">バイオバンク・ジャパンの運営・管理と個別化医療の実現に向けた疾患バイオマーカー探索</span></p>\r\n<p><span style=\"font-size: small;\">疾患コホート研究ネットワークによる疾患マーカー探索研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/07/28</span></p>\r\n<p><span style=\"font-size: small;\">v3:2022/09/08</span></p>\r\n<p><span style=\"font-size: small;\">v4:2023/04/24</span></p>\r\n<p><span style=\"font-size: small;\">v5:2023/07/27</span></p>\r\n<p><span style=\"font-size: small;\">v6:2024/05/22</span></p>\r\n<p><span style=\"font-size: small;\">v7:2025/06/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">メタボローム</span></p>\r\n<p><span style=\"font-size: small;\">プロテオミクス</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">メタボローム</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n<p><span style=\"font-size: small;\">プロテオミクス</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Asian Screening Array、HumanOmniExpressExome、HumanOmniExpress、HumanExome）</span></p>\r\n<p><span style=\"font-size: small;\">Bruker</span></p>\r\n<p><span style=\"font-size: small;\">（AVANCE IIIHD）</span></p>\r\n<p><span style=\"font-size: small;\">Olink</span></p>\r\n<p><span style=\"font-size: small;\">（Explore 3072、Target 96）</span></p>\r\n<p><span style=\"font-size: small;\">Somalogic</span></p>\r\n<p><span style=\"font-size: small;\">（SomaScan）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">BBJ第一コホート：11,716名＋180,882＋1,285＋2,570＋40,907＋3,050名</span></p>\r\n<p><span style=\"font-size: small;\">BBJ第二コホート：42,689名</span></p>\r\n<p><span style=\"font-size: small;\">ToMMo：49,621名</span></p>\r\n<p><span style=\"font-size: small;\">UKバイオバンク：456,327名</span></p>\r\n<p><span style=\"font-size: small;\">FinnGen：230,635名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人、イギリス人、フィンランド人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松田 浩一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2801&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0312.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA016285</span></p>\r\n<p><span style=\"font-size: small;\">DRA016393</span></p>\r\n<p><span style=\"font-size: small;\">DRA016394</span></p>\r\n<p><span style=\"font-size: small;\">DRA016395</span></p>\r\n<p><span style=\"font-size: small;\">DRA018714</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">機能性遺伝子多型の網羅的解析を介した多因子疾患の病態解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/06/17</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/06/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、Iso-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（MinION）</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">（Sequel II/IIe）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人健常者不死化B細胞株：95検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n<p><span style=\"font-size: small;\">健常人：1名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">高地 雄太</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1677&amp;Itemid=1772&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0314.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000383</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アルツハイマー型認知症患者を対象とした疾患表現型と遺伝型の関連性解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Infinium OmniExpressExome-8）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">孤発性アルツハイマー病：102症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">井上 治久</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2053&amp;Itemid=2094&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0315.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000385</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍における遺伝子異常の網羅的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/07/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、scRNA-seq、ChIP-seq、Target Capture）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500/X Ten、MethylationEPIC、HumanMethylation450）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳児期発症のKMT2A遺伝子再構成陽性急性リンパ性白血病：84症例</span></p>\r\n<p><span style=\"font-size: small;\">乳児KMT2A遺伝子再構成陽性急性リンパ性白血病由来細胞株：3検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">滝田 順子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1952&amp;Itemid=2014&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0316.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000535</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道がんの全ゲノムシークエンス解析による病態解明と治療感受性マーカーの探索に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道扁平上皮癌：110症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2797&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0317.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000413</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000707</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">創薬研究に有用な患者検体移植モデルの構築に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/12/06</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/06/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非小細胞肺癌：4症例</span></p>\r\n<p><span style=\"font-size: small;\">癌：52症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 濱田 哲暢</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1862&amp;Itemid=1929&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0318.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000483</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">血液疾患のゲノム解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">B細胞性急性リンパ芽球性白血病（B-ALL）：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">東條 有伸</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1777&amp;Itemid=1861&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0319.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000487</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">遺伝子多型を用いた前立腺癌診断マーカーの開発</span></p>\r\n<p><span style=\"font-size: small;\">日本人の前立腺がん発症に関わるレアバリアントの同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">前立腺癌の確定診断のために前立腺生検を行う患者：1,336症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">赤松 秀輔</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1797&amp;Itemid=1877&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0320.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000480</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性腫瘍を有する患者を対象とした免疫モニタリング研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、TCR-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺腺癌：2症例</span></p>\r\n<p><span style=\"font-size: small;\">頭頸部癌：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">冨樫 庸介</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1972&amp;Itemid=2032&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0321.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000482</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胸腺組織を介した免疫系構築の遺伝子制御に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/06/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">重症筋無力症：4症例</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">奥野 龍禎</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1787&amp;Itemid=1869&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0323.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000489</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌の診断マーカーの探索研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（CAGE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">転写開始点同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：45症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">向後 泰司</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1911&amp;Itemid=1978&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0324.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000515</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脳血管障害及び神経筋難病の遺伝子解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/04/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGBS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">AQP4抗体陽性の視神経脊髄炎（NMOSD）：10症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者（非発症血縁者）：8名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">奥野 龍禎</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1832&amp;Itemid=1905&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0327.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000507</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">個別化T細胞受容体遺伝子導入T細胞療法の臨床応用を目指した肝胆膵領域がんにおけるネオアンチゲンおよびそれを認識するT細胞受容体のスクリーニング</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/02/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 550）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝細胞癌：28症例</span></p>\r\n<p><span style=\"font-size: small;\">転移性肝癌：18症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">鈴木 利宙</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2450&amp;Itemid=2433&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0328.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000509</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人の進行性前立腺癌におけるDNA修復遺伝子異常の頻度に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">前立腺癌：129症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">赤松 秀輔</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1985&amp;Itemid=2040&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0329.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000522</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">未診断疾患の網羅的遺伝子解析による診断システムの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/06/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">未診断疾患の患者およびその両親（一部trioでない家系を含む）：177家系（522検体）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">村松 秀城</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=1916&amp;Itemid=1974&amp;lang=ja\" target=\"_blank\">hum0331.v1</a></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">がんや難病に関するゲノム医療の推進に必要な健常群 ・疾患コントロール群データの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/02/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">頻度情報</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者（難病や癌を罹患していない生活習慣病を持つ人を含む）：9290名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">徳永 勝士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1882&amp;Itemid=1945&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0332.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000510</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 遺伝子マーカーを用いた尿路性器癌の個別化治療法に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"><span style=\"font-size: small;\">配列決定</span></span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">去勢抵抗性前立腺癌：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">赤松 秀輔</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2122&amp;Itemid=2143&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0335.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA014819</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">遺伝子解析と免疫形質を組み合わせたリンパ増殖性疾患の新たな診断と臨床像の調査研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">原発性マクログロブリン血症：10症例</span></p>\r\n<p><span style=\"font-size: small;\">non IgM-type リンパ形質細胞性リンパ腫：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">横濱 章彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2822&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0337.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000521</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">難治性婦人科悪性腫瘍の包括的オミックス解析に基づく新規テーラーメード治療の創出を目指した基盤的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性転化を伴う卵巣成熟奇形腫：5症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">吉田 康将</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2235&amp;Itemid=2253&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0338.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000575</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">加齢またはピロリ感染の影響がない胃がんに対する包括的がんゲノム・エピゲノム・免疫ゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/11/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ピロリ菌未感染胃癌：27症例</span></p>\r\n<p><span style=\"font-size: small;\">ピロリ菌感染胃癌：36症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">森 誠一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2083&amp;Itemid=2115&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0340.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000520</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児固形腫瘍症例の次世代シークエンサーを用いた網羅的ゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Hiseq X Ten）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：24症例 （成人）</span></p>\r\n<p><span style=\"font-size: small;\">網膜芽腫：1症例 （小児）</span></p>\r\n<p><span style=\"font-size: small;\">膠芽腫：2症例 （成人）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大場 詩子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2012&amp;Itemid=2062&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0342.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000538</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化器腫瘍の免疫組織化学的・分子病理学的検索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/06/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：29症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関根 茂樹</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2892&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0343.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-759</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000739</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">新型コロナウイルス感染症の遺伝学的知見に基づいたCOVID19ワクチンの開発と評価系の構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/26</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/06/14</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/06/24</span></p>\r\n<p><span style=\"font-size: small;\">v4:2024/10/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">タンパク質発現量</span></p>\r\n<p><span style=\"font-size: small;\">eQTL/sQTL/pQTL</span></p>\r\n<p><span style=\"font-size: small;\">eHHV-6の有無、アネロウイルス量</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Infinium Asian Screening Array、NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Olink</span></p>\r\n<p><span style=\"font-size: small;\">（Olink Explore 3072）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">COVID-19感染者：2,393症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：3,289名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">福永 興壱</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2461&amp;Itemid=2441&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0344.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000533</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000611</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">シークエンス解析によるがんゲノム研究：腎臓がん</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/04</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/05/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、RNA-seq、Amplicon-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（MGISEQ-2000RS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">腎臓癌：38症例</span></p>\r\n<p><span style=\"font-size: small;\">慢性腎臓病：77症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">HEK293細胞株：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2095&amp;Itemid=2123&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0345.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000528</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000551</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">臍帯血を用いた再生医療に向けた基礎的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、ATAC-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：30名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大石 晃嗣</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2043&amp;Itemid=2086&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0347.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">急性脳症の包括的遺伝子解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/23</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/07/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">サンガー法</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Life Technologies</span></p>\r\n<p><span style=\"font-size: small;\">（310 Genetic Analyzer、3100 Genetic Analyzer、3130xl Genetic Analyzer）</span></p>\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Japonica Array v2）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">けいれん重積型急性脳症：283症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：799名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">水口 雅</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2456&amp;Itemid=2437&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0348.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000537</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">CD30陽性HTLV-1感染細胞のゲノム異常によるATL発症バイオマーカーの同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/05/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n<p><span style=\"font-size: small;\">アレイCGH</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">（GenetiSure Cancer Research CGH+SNP Microarray 2 x 400K）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ATL：8症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中島 誠</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2775&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0350.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000689</span></p>\r\n<p><span style=\"font-size: small;\">DRA018405</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-739</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-740</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-741</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-742</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-743</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-744</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-745</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-746</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> ヒト遺伝子多型とオミックスデータの統合解析のための基盤構築研究 </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/06/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（5' single-cell RNA-seq、3' single-cell RNA-seq、Micro-C and Region Capture Micro-C、CITE-seq、Multimodal assay（single-nucleus ATAC-seq、 3' and 5’ single-nucleus RNA-seq、 5' single-cell RNA-seq）、MAS-seq、CAGE-seq、NET-CAGE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">転写開始点同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、NextSeq 500）</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">（Sequel Ⅱ）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：3名</span></p>\r\n<p><span style=\"font-size: small;\">（男性：1名、女性：2名）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">CRISPR-activated Jurkat cells：15検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山本 一彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2141&amp;Itemid=2159&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0351.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000540</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">画像検査と RNF213 遺伝子検査の融合による閉塞性血管障害の新評価体系の確立</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタゲノム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタゲノム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">もやもや病：27症例</span></p>\r\n<p><span style=\"font-size: small;\">非もやもや脳血管障害：7症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：15名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">峰晴 陽平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2028&amp;Itemid=2074&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0352.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000545</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺癌放射線治療の治療効果および有害事象発症の予測に関与するタンパク機能、RNA発現の解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">原発性肺癌：5症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">染谷 正則</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2415&amp;Itemid=2405&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0354.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">泌尿器がんにおける血中循環がん細胞（CTC）の変化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/06/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/04/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">qRT-PCR</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">BioRad</span></p>\r\n<p><span style=\"font-size: small;\">（T100 Thermal cycler）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">進行転移性去勢抵抗性前立腺癌：127症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">永田 政義</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2478&amp;Itemid=2451&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0355.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000544</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">次世代シークエンスによる泌尿器科腫瘍のゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、RNA-seq）、マイクロアレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、NextSeq 500、HiSeq X Ten）</span></p>\r\n<p><span style=\"font-size: small;\">NanoString Technologies</span></p>\r\n<p><span style=\"font-size: small;\">（nCounter Digital Analyzer）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">VHL病に伴う遺伝性淡明細胞型腎細胞癌：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">片岡 圭亮</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2759&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0356.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA015288</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-579</span></p>\r\n<p><span style=\"font-size: small;\">DRA016520</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-619</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸発がんにおける遺伝子変化の解明と間質の臨床的意義の確立</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/05/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：1＋2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三森 功士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3034&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0357.v6</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000557</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000609</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000610</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺癌の遺伝子発現解析の生物学的特性ならびに診断・治療におけるバイオマーカーの研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/11/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/01/11</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/02/15</span></p>\r\n<p><span style=\"font-size: small;\">v4:2023/08/09</span></p>\r\n<p><span style=\"font-size: small;\">v5:2024/06/05</span></p>\r\n<p><span style=\"font-size: small;\">v6:2025/04/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、RNA-seq、scRNA-seq、ATAC-seq）</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/X Ten、NovaSeq 6000、Infinium MethylationEPIC）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺癌：105＋2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">安田 浩之</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3201&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0358.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000582</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000586</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000640</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000824</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000825</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮頸部腺癌・扁平上皮癌、腟・外陰癌の発生及び予後決定に関わる遺伝子異常の検索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/10/19</span></p>\r\n<p><span style=\"font-size: small;\">v3:2025/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、scRNA-seq、Target bisulfite-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000/X Plus、MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮頸癌：19＋4＋96症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">NIKS18細胞株：5検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">曾根 献文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2073&amp;Itemid=2106&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0359.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000548</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">T/NK細胞リンパ腫におけるゲノム・エピゲノム異常の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">節外性NK/T細胞リンパ腫（鼻型）：67症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大石 直輝</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2271&amp;Itemid=2281&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0360.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000546</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">COVID-19 発病・重症化機構の探索的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、scVDJ-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">COVID-19：6症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">立川 愛</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3014&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0362.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000552</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺腫瘍、胸腺腫瘍患者の臨床検体（組織や血液など）を用いたゲノムプロファイリングに関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胸腺腫：98症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">谷内田 真一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2111&amp;Itemid=2135&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0364.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒトのマイクロサテライト多型の包括的解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（公開済みbamファイルを使用した解析）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Simons Genome Diversity Project（SGDP）：276名</span></p>\r\n<p><span style=\"font-size: small;\">Human Genome Diversity Project（HGDP）：693名</span></p>\r\n<p><span style=\"font-size: small;\">縄文人：1名</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤本 明洋</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2212&amp;Itemid=2233&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0365.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000569</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">生活習慣病における腸内細菌の役割について</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（CAGE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">転写開始点同定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：103名</span></p>\r\n<p><span style=\"font-size: small;\">肥満症：98症例</span></p>\r\n<p><span style=\"font-size: small;\">耐糖能異常：97症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大野 博司</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2365&amp;Itemid=2365&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0366.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-551</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-552</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">新型コロナウイルス感染症(COVID-19)の病態解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/03/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、RNA-seq、ATAC-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">COVID-19：16症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">加藤 保宏</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2181&amp;Itemid=2191&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0367.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000558</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">血液疾患のゲノム解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ランゲルハンス細胞組織球症：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">東條 有伸</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2245&amp;Itemid=2261&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0368.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000559</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">全ゲノム配列決定によるICF症候群の新規原因遺伝子の探索および機能解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/11/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（PBAT-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ICF症候群：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">鵜木 元香</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2196&amp;Itemid=2203&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0369.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000562</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">医療従事者の新型コロナウィルス感染抵抗性についての検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：139名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">川口 敦史</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=2286&amp;Itemid=2295&amp;lang=ja\" target=\"_blank\">hum0371.v1</a></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000574</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肝臓疾患に関与する遺伝子とタンパク質の探索に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタゲノム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタゲノム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非アルコール性脂肪性肝炎：20症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">建石 良介</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2240&amp;Itemid=2257&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0372.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000572</span></p>\r\n<p><span style=\"font-size: small;\">MTBKS213</span></p>\r\n<p><span style=\"font-size: small;\">MTBKS214</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">多層的オミクス解析による疾患病態の解明</span></p>\r\n<p><span style=\"font-size: small;\">メタボリック・シンドローム関連疾患における個別化医療の実現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/11/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタボローム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メタボローム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">（Agilent CE system、Agilent LC System）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2型糖尿病：300症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">山内 敏正</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3068&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0375.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000688</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">超高速DNAシーケンサーを用いた疾患原因ゲノム領域の同定と情報解析法の確立、および参照配列データの作成に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">結節性硬化症：163症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">金田 眞理</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2380&amp;Itemid=2377&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0376.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000585</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">臨床検体からのゼノグラフト株・培養細胞株の樹立</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/03/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮内膜癌：2＋4症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">今井 俊夫</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2260&amp;Itemid=2273&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0377.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000579</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">不整脈症候群の遺伝子基盤に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Amplicon-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Proton）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">QT延長症候群：556症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">田中 敏博</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2868&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0378.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000583</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000612</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">溶血性貧血の病態解明を目指した基礎研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/09/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">寒冷凝集素症：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小山 大輔</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2641&amp;Itemid=2580&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0379.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000578</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制御性T細胞特異的エピゲノム誘導による免疫制御の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、scVDJ-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">重症筋無力症：2症例</span></p>\r\n<p><span style=\"font-size: small;\">多発性硬化症：4症例</span></p>\r\n<p><span style=\"font-size: small;\">全身性エリテマトーデス：3症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：3名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">坂口 志文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2317&amp;Itemid=2324&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0381.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000588</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">切除不能または再発胸腺癌に対するニボルマブの多施設共同第II相試験（NCCH1505）附随研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/01/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胸腺癌：15症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">堀之内 秀仁</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2341&amp;Itemid=2345&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0382.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000587</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器疾患における遺伝子異常・エピジェネティクス異常の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/01/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">FUS-ERGを伴う急性骨髄性白血病：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">河原 真大</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=2375&amp;Itemid=2373&amp;lang=ja\" target=\"_blank\">hum0383.v1</a></span></p>\r\n<p><span style=\"font-size: small;\"> JGAS000602</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">生物学的製剤投与前後のリンパ球の遺伝子発現修飾の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/03/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関節リウマチ：5症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤尾 圭志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3124&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0384.v2</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000603</span></p>\r\n<p><span style=\"font-size: small;\"> JGAS000718</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍の分子病態の解明と新規治療薬開発の基盤構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/06/19</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/07/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、Target Capture、ATAC-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/2500、MiSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">急性骨髄芽球性白血病：4＋4症例</span></p>\r\n<p><span style=\"font-size: small;\">骨髄異形成症候群：30症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">正常細胞：6検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岩間 厚志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2658&amp;Itemid=2594&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0385.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000597</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000599</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">混合型肝癌、細胆管細胞癌、Cytokeratin19陽性肝細胞癌、SOX9陽性肝細胞癌の網羅的DNA変異解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/12/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/01/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">細胆管細胞癌：8症例</span></p>\r\n<p><span style=\"font-size: small;\">混合型肝癌：13症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">石井 隆道</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2410&amp;Itemid=2401&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0386.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA015813</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">長鎖リードの局所アセンブリによる一塩基解像度でのヒト反復配列のゲノムワイド解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/04/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Nanopore </span></p>\r\n<p><span style=\"font-size: small;\">（MinION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HapMap：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">藤本 明洋</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2395&amp;Itemid=2389&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0389.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000605</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胎児発育異常の遺伝子・ゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/04/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Capture Methyl-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常女性：4名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中林 一彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2509&amp;Itemid=2476&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0390.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000621</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノム・エピゲノム解析による慢性子宮内膜炎の関連遺伝子の解明とその診断法および治療法の検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X Ten）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">慢性子宮内膜炎：24症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：33名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">黒田 恵司</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2880&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0391.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000606</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト舌癌オルガノイドバイオバンクの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、scATAC-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">舌癌：4症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">佐藤 卓</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2858&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0393.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000693</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">膠原病類縁疾患患者検体を用いた新規バイオマーカーおよび治療標的分子探索に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関節リウマチ：6症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：6名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">坪井 洋人</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3136&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0394.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000613</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000757</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非小細胞肺癌における空間トランスクリプトーム解析に関する多施設共同研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/11/20</span></p>\r\n<p><span style=\"font-size: small;\">v3:2025/07/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Visium Spatial Gene Expression、WGS、t-nanoEM）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n<p><span style=\"font-size: small;\">Multiplex Fluorescence Immunostaining</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Xenium Analyzer）</span></p>\r\n<p><span style=\"font-size: small;\">Akoya Biosciences</span></p>\r\n<p><span style=\"font-size: small;\">（PhenoCycler）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非小細胞肺癌：8症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">鈴木 絢子</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2665&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0395.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000678</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食・腸内マイクロバイオーム・健康情報統合データベース構築に向けた網羅的研究調査（愛称：すこやか健康調査）：北海道情報大学</span></p>\r\n<p><span style=\"font-size: small;\">食と健康の関係性と遺伝的背景に関する検討：北海道情報大学</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">血液・尿検査</span></p>\r\n<p><span style=\"font-size: small;\">計測データ</span></p>\r\n<p><span style=\"font-size: small;\">アンケート調査</span></p>\r\n<p><span style=\"font-size: small;\">問診結果</span></p>\r\n<p><span style=\"font-size: small;\">被験者属性</span></p>\r\n<p><span style=\"font-size: small;\">睡眠日誌、睡眠時心拍・脳波</span></p>\r\n<p><span style=\"font-size: small;\">微生物組成</span></p>\r\n<p><span style=\"font-size: small;\">食事調査、食物摂取頻度調査</span></p>\r\n<p><span style=\"font-size: small;\">メタボロミクス</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健康調査</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Japonica Array v2）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常成人：963名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西平 順</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2669&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0396.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000679</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食・腸内マイクロバイオーム・健康情報統合データベース構築に向けた網羅的研究調査（愛称：すこやか健康調査）：宮崎大学</span></p>\r\n<p><span style=\"font-size: small;\">食と健康の関係性と遺伝的背景に関する検討：宮崎大学</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">血液・尿検査</span></p>\r\n<p><span style=\"font-size: small;\">計測データ</span></p>\r\n<p><span style=\"font-size: small;\">アンケート調査</span></p>\r\n<p><span style=\"font-size: small;\">問診結果</span></p>\r\n<p><span style=\"font-size: small;\">被験者属性</span></p>\r\n<p><span style=\"font-size: small;\">睡眠日誌、睡眠時心拍・脳波</span></p>\r\n<p><span style=\"font-size: small;\">微生物組成</span></p>\r\n<p><span style=\"font-size: small;\">食事調査、食物摂取頻度調査</span></p>\r\n<p><span style=\"font-size: small;\">メタボロミクス</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健康調査</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Japonica Array v2）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常成人：50名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">吉村 学</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2673&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0397.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000680</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食・腸内マイクロバイオーム・健康情報統合データベース構築に向けた網羅的研究調査（愛称：すこやか健康調査）：京都大学</span></p>\r\n<p><span style=\"font-size: small;\">食と健康の関係性と遺伝的背景に関する検討：京都大学</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">血液・尿検査</span></p>\r\n<p><span style=\"font-size: small;\">計測データ</span></p>\r\n<p><span style=\"font-size: small;\">アンケート調査</span></p>\r\n<p><span style=\"font-size: small;\">問診結果</span></p>\r\n<p><span style=\"font-size: small;\">被験者属性</span></p>\r\n<p><span style=\"font-size: small;\">睡眠日誌、睡眠時心拍・脳波</span></p>\r\n<p><span style=\"font-size: small;\">微生物組成</span></p>\r\n<p><span style=\"font-size: small;\">食事調査、食物摂取頻度調査</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健康調査</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">（Japonica Array v2）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常成人：50名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">稲垣 暢也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2677&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0398.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000681</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食・腸内マイクロバイオーム・健康情報統合データベース構築に向けた網羅的研究調査（愛称：すこやか健康調査）：長崎県立大学</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">血液・尿検査</span></p>\r\n<p><span style=\"font-size: small;\">計測データ</span></p>\r\n<p><span style=\"font-size: small;\">アンケート調査</span></p>\r\n<p><span style=\"font-size: small;\">問診結果</span></p>\r\n<p><span style=\"font-size: small;\">被験者属性</span></p>\r\n<p><span style=\"font-size: small;\">睡眠日誌、睡眠時心拍・脳波</span></p>\r\n<p><span style=\"font-size: small;\">微生物組成</span></p>\r\n<p><span style=\"font-size: small;\">食事調査、食物摂取頻度調査</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健康調査</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">-</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常成人：59名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">田中 一成</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2771&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0399.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000616</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳がん微小環境形成に関わる分子生物学的機序の生体試料を用いた探索研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/06/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">乳癌：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">河岡 慎平</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2498&amp;Itemid=2467&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0401.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000618</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">創薬をめざした新規骨・軟部肉腫細胞株および疾患モデル動物の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性骨巨細胞腫：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">若松 透</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2707&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0402.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA016537</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-622</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸多段階発がん進化の過程においてドライバー変異を生じる機序の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌：4症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">三森 功士</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2549&amp;Itemid=2508&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0403.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000622</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">泌尿器癌におけるリキッドバイオプシーの有用性の検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">転移性尿路上皮癌：16症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">濱田 和希</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3144&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0405.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000623</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000631</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児・成人悪性腫瘍がん幹細胞の同定に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/12/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/07/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、small RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X、NextSeq 550）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400RS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小児B前駆細胞性急性リンパ性白血病：69症例</span></p>\r\n<p><span style=\"font-size: small;\">小児急性骨髄性白血病：9症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">滝田 順子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2577&amp;Itemid=2530&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0406.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000617</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-623</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト疾患特異的iPS細胞の作成とそれを用いた疾患解析に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/08/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SFTPCバリアントにおける家族性間質性肺炎：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">後藤 慎平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2488&amp;Itemid=2459&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0409.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000619</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">抗がん剤治療におけるExceptional Responseをもたらす遺伝子の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 550、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MDM2増幅内膜肉腫：11症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小山 隆文</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2529&amp;Itemid=2492&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0411.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000625</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">対応可能（actionable）な内分泌疾患（腫瘍性のものを含む）の次世代シーケンサーを用いた分子生物学的解析による分子診断の検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">FBPase欠損症：1症例</span></p>\r\n<p><span style=\"font-size: small;\">家族：3名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">田中 知明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3010&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0413.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000628</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000780</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アトピー性皮膚炎患者の網羅的データ解析研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/03/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 1500/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アトピー性皮膚炎：161＋41症例</span></p>\r\n<p><span style=\"font-size: small;\">乾癬：18症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：41＋10名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">古関 明彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2544&amp;Itemid=2504&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0414.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA016800</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノム解析に基づく肺がんの発生･進展の分子機構の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小気道上皮細胞株（SAEC）と派生細胞株：計5株</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">塩谷 文章</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3088&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0416.v5</span></a></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-635</span></p>\r\n<p><span style=\"font-size: small;\">DRA019233</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-867</span></p>\r\n<p><span style=\"font-size: small;\">DRA019274</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-872</span></p>\r\n<p><span style=\"font-size: small;\">DRA020399</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1051</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1057</span></p>\r\n<p><span style=\"font-size: small;\">DRA021372</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1076</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">経時的な多層的オミックス解析を通した免疫難病及びがんにおける生体反応の解明と新規治療法の開発</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/08/10</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/09/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/10/16</span></p>\r\n<p><span style=\"font-size: small;\">v4:2025/05/19</span></p>\r\n<p><span style=\"font-size: small;\">v5:2025/06/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（CITE-seq、BD Ab-seq、scRNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">シングルセル空間トランスクリプトーム</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Vizgen</span></p>\r\n<p><span style=\"font-size: small;\">（MERSCOPE）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">顕微鏡的多発血管炎：10症例</span></p>\r\n<p><span style=\"font-size: small;\">全身性強皮症：21症例</span></p>\r\n<p><span style=\"font-size: small;\">シェーグレン症候群：12症例</span></p>\r\n<p><span style=\"font-size: small;\">ベーチェット症候群：11症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：10名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">北沢 剛久</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2990&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0418.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000662</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">がん患者の臨床検体を用いた、治療効果および毒性に関する遺伝子のプロファイリング研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/02/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（MiSeq、NextSeq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">抗悪性腫瘍薬による治療を予定している癌患者：507症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">河野 隆志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3006&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0419.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000641</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000653</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000664</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000749</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト消化器癌、胸部悪性腫瘍オルガノイド培養系のゲノム医療への応用</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/24</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/05/08</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/06/17</span></p>\r\n<p><span style=\"font-size: small;\">v4:2025/03/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺大細胞神経内分泌癌：3症例</span></p>\r\n<p><span style=\"font-size: small;\">粘液産生能を有する充実型肺腺癌：1症例</span></p>\r\n<p><span style=\"font-size: small;\">EML4-ALK variant 3（v3）をドライバー遺伝子にもつ肺腺癌：1症例</span></p>\r\n<p><span style=\"font-size: small;\">食道癌：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">深澤 拓也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2970&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0423.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000636</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">マルチオミックス的アプローチによる炎症性筋疾患の全容解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/10/23</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/12/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、snRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（PromethION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">サルコイドミオパチー：22＋1症例</span></p>\r\n<p><span style=\"font-size: small;\">筋疾患：400症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">飯田 有俊</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2838&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0426.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000654</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">家族性・若年性のがん及び遺伝性腫瘍に関する診断と研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（GridION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">遺伝性腫瘍：33症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">白石 友一</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2624&amp;Itemid=2569&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0427.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000645</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">頭頸部悪性腫瘍細胞株の樹立</span></p>\r\n<p><span style=\"font-size: small;\">頭頸部悪性腫瘍に対する網羅的遺伝子解析およびデータベースの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/11/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">外耳道扁平上皮癌：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 尚志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2635&amp;Itemid=2575&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0429.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000643</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">CRISPR screening identifies mechanisms of resistance to KRASG12C and SHP2 inhibitor combinations in non-small cell lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/11/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト肺癌細胞株LU99を移植したマウスの腫瘍組織：計16検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Saskia Brachmann</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2684&amp;Itemid=2614&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0431.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000651</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">精神神経疾患における病態生理・発症脆弱性・治療反応性等の解明、および新規治療法・診断予防法の開発を目指した遺伝子解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/01/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">自閉スペクトラム症患者で同定された変異を導入した遺伝子改変ヒトiPS細胞株：5検体</span></p>\r\n<p><span style=\"font-size: small;\">コントロール遺伝子改変ヒトiPS細胞株：4検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">髙田 篤</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2876&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0433.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000659</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000660</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000667</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-665</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-667</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト胎盤幹細胞の樹立と細胞特性に関する基礎的研究</span></p>\r\n<p><span style=\"font-size: small;\">ヒト胎盤栄養膜細胞株の樹立と細胞特性に関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、ChIP-seq、Hi-C、small RNA-seq、CUT&amp;TAG-seq、Methyl-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n<p><span style=\"font-size: small;\">ヒストン修飾</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、HiSeq 2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">人工妊娠中絶術後の初期胎盤：1検体</span></p>\r\n<p><span style=\"font-size: small;\">受精卵：1検体</span></p>\r\n<p><span style=\"font-size: small;\">妊娠高血圧症候群：14症例</span></p>\r\n<p><span style=\"font-size: small;\">正常妊娠：12名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小林 枝里</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3018&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0434.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000658</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000709</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">T/NK細胞が関連する各種疾患における遺伝子解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Torrent S5、Ion GeneStudio S5）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">赤芽球癆：53症例</span></p>\r\n<p><span style=\"font-size: small;\">再生不良性貧血：10症例</span></p>\r\n<p><span style=\"font-size: small;\">健常者：2名</span></p>\r\n<p><span style=\"font-size: small;\">大顆粒リンパ球性白血病：55症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">石田 文宏</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2708&amp;Itemid=2630&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0435.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000665</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">iPS細胞由来心筋細胞における網羅的核酸解析を用いた再生医療用細胞作製方法の検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/03/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 3000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HLAホモ健常ドナー1名の細胞から樹立されたヒトiPS細胞から分化誘導した心筋細胞：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">宮川 繁</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2703&amp;Itemid=2626&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0436.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000668</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">自閉症の発症原因解明のための遺伝子多形及び遺伝子転写についての研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/02/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">自閉症：16症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：17名</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">丸井 徹也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2728&amp;Itemid=2646&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0437.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000671</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">悪性脳腫瘍の新たなバイオマーカー及び分子標的の探索とそれらの臨床応用に向けた多施設共同研究による遺伝子解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/03/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">グリオーマ：124症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">高阪 真路</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2713&amp;Itemid=2634&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0439.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA017996</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">脂質異常症に関わる遺伝子と病態との関連の検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/02/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">（MinION）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">家族性高コレステロール血症：5症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：1名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">尾野 亘</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2735&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0440.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000672</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-747</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">神経・筋組織を用いた難治性神経筋疾患の臨床経過に関連する蛋白の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/05/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400RS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胸腺腫：7症例</span></p>\r\n<p><span style=\"font-size: small;\">胸腺過形成：2症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">奥野 龍禎</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2842&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0442.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000675</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-883</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">進行・再発非小細胞肺がんにおける免疫チェックポイント阻害剤の患者層別化マーカーに関する探索的研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/12/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非小細胞肺癌：20症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">笹田 哲朗</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2731&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0443.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA017833</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-674</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">妊娠前後での制御性T細胞のT細胞受容体レパートリーの変化と妊娠予後との関係</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/05/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target RNA-seq、TCR-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">正常妊娠：7名</span></p>\r\n<p><span style=\"font-size: small;\">妊娠高血圧腎症：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中島 彰俊</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2703&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0444.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000684</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">遺伝学的変化を要因とする皮膚疾患のマルチオミックス解析による病態解明の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、Exome、ロングリードWGS、Amplicon-seq、RNA-seq）</span></p>\r\n<p><span style=\"font-size: small;\">SNPアレイ</span></p>\r\n<p><span style=\"font-size: small;\">メチル化アレイ</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">メチル化</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-T7）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、MiSeq、Infinium Asian Screening Array、Infinium MethylationEPIC）</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">（Sequel II）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">汗孔角化症：8症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">久保 亮治</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3058&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0445.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000756</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノム解析に基づく肺がんの発生・進展の分子機構の解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500、Genome Analyzer IIx）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺腺癌：362症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">河野 隆志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2958&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0454.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000697</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">免疫異常に着目した炎症性腸疾患の病因解析および治療反応性解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/12/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Xenium Analyzer）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Crohn病：10症例</span></p>\r\n<p><span style=\"font-size: small;\">潰瘍性大腸炎：4症例</span></p>\r\n<p><span style=\"font-size: small;\">サイトメガロウィルス腸炎：1症例</span></p>\r\n<p><span style=\"font-size: small;\">癌：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">児玉 真</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3165&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0455.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000732</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000733</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺がんの遺伝子異常、分子標的、薬剤感受性を予測する、組織形態、バイオマーカーの探索 <br />肺癌の遺伝子異常とその生物学的意義の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Novaseq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Xenium）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肺神経内分泌癌：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松原 大祐</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2818&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0456.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000722</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">傍鞍部頭蓋底腫瘍及び、悪性神経膠腫組織を用いた分子生物学的解析による腫瘍の形成と機能的分化における分子病態の検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">頭蓋咽頭腫：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">松田 達磨</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2978&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0460.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000714</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">尿路上皮癌の免疫チェックポイント阻害薬治療におけるcfDNAを用いたリキッドバイオプシーによるCompanion/Complimentary Diagnosisプラットフォームの開発に向けたパイロット研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/01/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、HiSeq X）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">進行性尿路上皮癌（膀胱癌・上部尿路上皮癌）：82症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">小林 恭</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2938&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0461.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000712</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道扁平上皮癌、大腸癌に対する放射線治療後のがん免疫応答の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/05/31</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/11/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n<p><span style=\"font-size: small;\">Multiplex Fluorescence Immunostaining</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 3000、NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">Akoya Biosciences</span></p>\r\n<p><span style=\"font-size: small;\">（CODEX）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道扁平上皮癌：7症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">影山 俊一郎</span></p>\r\n<p><span style=\"font-size: small;\">（ゲノム支援）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3116&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0464.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000723</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト造血器腫瘍細胞の体外増幅と病態再現モデルマウスの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/06/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、scRNA-seq、scBCR-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000、NextSeq 2000/500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">多発性骨髄腫：21症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">正常骨髄：3検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">岩間 厚志</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2834&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0465.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000721</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">混合形質性急性白血病細胞株の樹立とゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">急性混合型白血病：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">石井 敬人</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2934&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0466.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健康長寿社会の実現を目指した大規模認知症コホート研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Japanese Screening Array）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">JPSC-AD研究参加者：9,479名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">二宮 利治</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2888&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0467.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">骨盤臓器脱発症における遺伝学的背景</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/10/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Asian Screening Array、Infinium OmniExpress、HumanExome、Infinium OmniExpressExome v1.0、Infinium OmniExpressExome v1.2）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">骨盤臓器脱と診断された女性：771名（BBJ 447名、POP 324名）</span></p>\r\n<p><span style=\"font-size: small;\">骨盤臓器脱と診断されていない、または健常集団の女性：76,625名（BBJ 73,892名、OBi 2,733名）</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">前田 士郎</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3161&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0468.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000727</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000774</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">免疫・炎症病態の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、bulk RNA-seq、scASAP-seq、CITE-seq、VDJ-seq）</span></p>\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000、NextSeq 500/550）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Xenium v1）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">関節リウマチ：23症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：4名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">吉富 啓之</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2846&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0469.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000728</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">妊娠中のサイトメガロウイルス免疫応答の検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">妊娠12週、16週、20週、28週、36週頃の妊婦：10名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">市瀬 茉里</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3132&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0470.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000725</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">免疫治療が施行された尿路上皮癌における予後調査とゲノムプロファイルの解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/07/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq、WGS、scRNA-seq、Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X Ten、NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">尿路上皮癌：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">田中 伸之</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2854&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0472.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000726</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">iPS細胞を用いた大脳皮質神経細胞製剤の開発に向けた非臨床研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者1名から樹立されたiPS細胞から分化誘導したオルガノイド：9個</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">髙橋 淳</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3112&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0473.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000724</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">造血器腫瘍患者の遺伝子解析による発症機序解明研究</span></p>\r\n<p><span style=\"font-size: small;\">血縁ドナーの微量残存骨髄液を正常コントロールとした造血器腫瘍特異的分子発現解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">骨髄異形成症候群：57症例</span></p>\r\n<p><span style=\"font-size: small;\">対照健常者：5名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">原田 結花</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2850&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0474.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000731</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">自閉スペクトラム症・統合失調症・双極性障害関連遺伝子の解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（iSeq 100）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">自閉スペクトラム症児：32症例</span></p>\r\n<p><span style=\"font-size: small;\">低出生体重児：8名</span></p>\r\n<p><span style=\"font-size: small;\">閾値下自閉スペクトラム症児：3症例</span></p>\r\n<p><span style=\"font-size: small;\">定型発達児：36名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">横山 茂</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3100&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0476.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000736</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">腎臓構成細胞の生物学的機能理解のための先端的解析技術を用いた観察研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/01/07</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/06/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">腎臓癌：32症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">内藤 正吉</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3072&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0477.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000740</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">消化管癌・消化管腫瘍の組織培養による癌発育・進展メカニズムに関する研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/10/16</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/06/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NextSeq 1000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">大腸癌患者由来の腸管オルガノイド：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">Caco-2細胞：1検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">佐々木 伸雄</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3022&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0479.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000779</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">網羅的遺伝子解析技術を用いた抗EGFR抗体薬治療効果予測バイオマーカーの探索研究に関する多施設共同研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、Target Capture）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Hiseq 1500/2000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">切除不能・進行再発大腸癌：242症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">土原 一哉</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2942&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0481.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000755</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">日本人高齢者に多い疾患のゲノム解析および臨床ゲノム情報ストレージの整備</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/11/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アルツハイマー病：424症例</span></p>\r\n<p><span style=\"font-size: small;\">軽度認知障害：543症例</span></p>\r\n<p><span style=\"font-size: small;\">認知機能正常：260名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">重水 大智</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3092&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0483.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000764</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト試料の収集・分譲と臨床情報を利用した研究に関するご協力のお願い</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Hiseq X Ten、NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">卵巣明細胞腺癌：11症例</span></p>\r\n<p><span style=\"font-size: small;\">高異型度漿液性癌：7症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">千代田 達幸</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2994&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0484.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000775</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト体細胞から樹立したInduced Pluripotent Stem Cell Line（iPS細胞株）のバンク事業</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ALS：33症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中村 幸夫</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3030&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0485.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000754</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">シークエンス解析によるがんゲノム研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS、RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2000/2500）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胃癌：65症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">中川 英刀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2954&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0486.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000765</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胆道閉鎖症およびアラジール症候群特異的iPS細胞を用いた胆管発生およびその障害メカニズムの解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/11/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq X Plus 25B）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">胆道閉鎖症：5症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">林 洋平</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2966&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0490.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000770</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Progestin-primed ovarian stimulation（PPOS）法を用いた調節卵巣刺激下でプロゲスチン製剤が卵胞発育・卵子の成熟過程に及ぼす影響に関する検討</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/12/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">正常卵巣機能を有する不妊症：16症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">伴田 美佳</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3128&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0491.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000805</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1086</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アレルギー病態の分子機構解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/07/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、scRNA-TCR-seq、scATAC-RNA-seq、CITE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">慢性扁桃炎：8症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">上野 英樹</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3177&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0492.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000773</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">産学連携による免疫炎症性難病の新規医薬品開発を目指した探索研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq/TCR/BCRレパトア解析、Visium Spatial Gene Expression）</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">病理画像</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">シェーグレン症候群：28症例</span></p>\r\n<p><span style=\"font-size: small;\">Sicca：10症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">竹下 勝</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3148&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0493.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000771</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">皮膚免疫担当細胞の機能解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/07/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Xenium Analyzer）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常皮膚：3例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">吉岡 華子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2982&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0495.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">心房細動と合併する脳梗塞予防のプレシジョン・メディシン</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/02/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発作性心房細動：1,176症例</span></p>\r\n<p><span style=\"font-size: small;\">対照者：1,172名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">田中 敏博</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2998&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0496.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">沖縄県におけるゲノム解析研究拠点形成のための沖縄バイオインフォメーションバンクの構築</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/02/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Infinium Asian Screening Array、Infinium OmniExpress、HumanExome、Infinium OmniExpressExome v1.0、Infinium OmniExpressExome v1.2）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">OBi：8,715名</span></p>\r\n<p><span style=\"font-size: small;\">BBJ：7,004名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">前田 士郎</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3173&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0497.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000777</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト胎盤からの栄養膜幹細胞の単離と性状解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ヒト妊娠後期胎盤：3名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n<p><span style=\"font-size: small;\">ヒト栄養膜幹細胞：3検体</span></p>\r\n<p><span style=\"font-size: small;\">（細胞株）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">依馬 正次</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3026&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0499.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000787</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">骨軟部腫瘍に対するバイオバンク作成および遺伝子発現解析に基づく分子病態の解明とその予後改善を目指した研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">サンガー法</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Applied Biosystems</span></p>\r\n<p><span style=\"font-size: small;\">（3730xl DNA Analyzer）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">肉腫：6症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">長谷川 延彦</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3050&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0501.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000781</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムアジア100Kプロジェクト：アジア集団のDNA試料収集と全ゲノム解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（WGS）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq X）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">約100の民族集団に属する健常者：1,323名</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hie Lim Kim</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3080&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0502.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000803</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">体細胞ゲノム解析に基づく子宮頸がんの本態解明・治療標的の同定を目指す研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮頸癌：29症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">白石 航也</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3054&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0505.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">アレルギー疾患における遺伝要因の探索研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ゲノムワイド</span></p>\r\n<p><span style=\"font-size: small;\">関連</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（Infinium Asian Screening Array）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">成育コホート研究のゲノム解析研究参加者：564名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">野口 恵美子</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3076&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0508.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000790</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">疾患特異的iPS細胞を用いた眼疾患の発症機序の解明および治療法の探索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">先天性無虹彩症：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西田 幸二</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3157&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0512.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000818</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">自己免疫疾患のリスク多型の同定と機能解析</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/07/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq、ATAC-seq、scCITE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n<p><span style=\"font-size: small;\">クロマチン構造</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000/X Plus）</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">（Chromium）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">健常者：3名</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">石垣 和慶</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3193&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0514.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000814</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">骨格筋メッセンジャーRNAの発現解析による神経・筋疾患の病態解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/09/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（RNA-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">筋強直性ジストロフィー1型（DM1）：11症例</span></p>\r\n<p><span style=\"font-size: small;\">DM1以外の神経・筋疾患：9症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">高橋 正紀</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3108&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0517.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000809</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">婦人科がん初代培養細胞を用いた新規治療法の評価および効果予測因子の探索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮体癌：30症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">長谷川 幸清</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3185&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0521.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000827</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1121</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">がん免疫の分子機構解明</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、scBCR-seq、scTCR-seq、CITE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮体癌：10症例</span></p>\r\n<p><span style=\"font-size: small;\">遺伝性乳癌卵巣癌：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">上野 英樹</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">非制限公開</span></p>\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3120&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0522.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000720</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制御性T細胞特異的エピゲノム誘導による免疫制御の研究</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（scRNA-seq、TCR-seq、CITE-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">発現</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">食道胃接合部癌：2症例</span></p>\r\n<p><span style=\"font-size: small;\">胃癌：3症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">西塔 拓郎</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3169&amp;lang=ja\" target=\"_blank\"><span style=\"font-size: small;\">hum0527.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000823</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮頚部・腟部発生リンパ腫の遺伝子変異の検索</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Exome）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">配列決定</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq X Plus）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">子宮頸部・膣部の濾胞性リンパ腫：1症例</span></p>\r\n<p><span style=\"font-size: small;\">（日本人）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">北岡 匠</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">制限（Type I）</span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p><span style=\"font-size: small;\">・ <a href=\"https://ddbj.nig.ac.jp/search\" target=\"_blank\" rel=\"noopener\">DDBJ Search</a>において、the DDBJ Sequence Read Archive（DRA）、the European Sequence Read Archive（ERA）およびthe Sequence Read Archive（SRA）に登録済みデータを検索できます。</span></p>\r\n<p><span style=\"font-size: small;\">＊データ利用申請が承認されたデータ利用者が閲覧・利用できる、NBDCおよび生命情報・DDBJ センターが加工したデータ（例：特定の解析パイプラインにより加工したアライメントデータ・バリアントコールデータ・統計データ）を含む。加工データに関する詳細は<a href=\"index.php?option=com_content&amp;view=article&amp;id=2276&amp;Itemid=2285&amp;lang=ja\" target=\"_blank\">こちら</a></span></p>", "publish_up": "2013-01-03"}, {"lang": "en", "path": "home", "title": "List of All Research Projects", "fulltext": "", "modified": "2025-09-24", "introtext": "<p><span style=\"font-family: helvetica; font-size: 10pt;\">*Data users need to apply an application for Using NBDC Human Data to reach the Controlled-access Data. <a href=\"index.php?option=com_content&amp;view=article&amp;id=3&amp;Itemid=104\" target=\"_blank\" rel=\"noopener noreferrer\">Learn more</a></span></p>\r\n<p>&nbsp;</p>\r\n<!--\r\n<table class=\"table-style style-greystripes\" style=\"width: 1300px; height: 510px;\">\r\n-->\r\n<table id=\"list-of-all-researches\" class=\"table-style style-greystripes\">\r\n<thead>\r\n<tr><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">Research ID</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">Study Title</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">Release Date</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">Type of Study</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">Platform</span></th><th class=\"”highlight”\" align=\"center\">\r\n<p><span style=\"font-size: small;\">Participants/Materials</span></p>\r\n<p><span style=\"font-size: small;\">(Ethnicity)</span></p>\r\n</th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">Data Provider</span></th><th class=\"”highlight”\" align=\"center\"><span style=\"font-size: small;\">Type of Data</span></th></tr>\r\n</thead>\r\n<tbody>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=135&amp;Itemid=445&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0001.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000002</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Sequence Data of a SCA31 Patient</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2013/12/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Single Patient</span></p>\r\n<p><span style=\"font-size: small;\">NGS (WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 Patient</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinichi Morishita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=107&amp;Itemid=369&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0004.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000001</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Molecular Epidemiological Study of</span></p>\r\n<p><span style=\"font-size: small;\">Somatic Mutation Profiles of EGFR</span></p>\r\n<p><span style=\"font-size: small;\">Mutation Positive Lung Adenocarcinoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/07/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS (Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Analyzer IIx)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">97 Patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Koichi Goto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2610&amp;Itemid=2559&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0005.v8</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA001273</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000032</span></p>\r\n<p><span style=\"font-size: small;\">DRA003791</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000093</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000123</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000166</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000191</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000192</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000200</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000201</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000323</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000490</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic Analysis of Hearing Loss and Its Clinical Application</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/01/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/02/24</span></p>\r\n<p><span style=\"font-size: small;\">v3:2017/06/19</span></p>\r\n<p><span style=\"font-size: small;\">v4:2018/02/13</span></p>\r\n<p><span style=\"font-size: small;\">v5:2019/04/18</span></p>\r\n<p><span style=\"font-size: small;\">v6:2021/07/30</span></p>\r\n<p><span style=\"font-size: small;\">v7:2021/11/19</span></p>\r\n<p><span style=\"font-size: small;\">v8:2023/10/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion PGM, Ion Proton, Ion S5)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">17 UsherSyndrome patients</span></p>\r\n<p><span style=\"font-size: small;\">3,156 Non-syndromic hearing loss patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shin-ichi Usami</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2102&amp;Itemid=2129&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0006.v5</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000004</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000106</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000146</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000325</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genomic and Genetic Analysis of Brain Tumors and</span></p>\r\n<p><span style=\"font-size: small;\">Analysis of Their Clinicopathological Significance</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/01/31</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/06/05</span></p>\r\n<p><span style=\"font-size: small;\">v3:2017/09/01</span></p>\r\n<p><span style=\"font-size: small;\">v4:2019/02/13</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/08/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, Target Capture)</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500, HumanMethylation450)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">6 astrocytomas</span></p>\r\n<p><span style=\"font-size: small;\">16 oligodendrogliomas</span></p>\r\n<p><span style=\"font-size: small;\">gliomas (17 cerebellar gliomas, 8 cerebral glioblastomas and 14 thalamic gliomas)</span></p>\r\n<p><span style=\"font-size: small;\">94 gliomas</span></p>\r\n<p><span style=\"font-size: small;\">12 cerebral cavernous malformations</span></p>\r\n<p><span style=\"font-size: small;\">1 vertebral hemangioma</span></p>\r\n<p><span style=\"font-size: small;\">3 orbital cavernous malformations</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nobuhito Saito</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=145&amp;Itemid=455&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0007.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000005</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Gene Expression of Human Th17 Cells </span></p>\r\n<p><span style=\"font-size: small;\">Before and After Activation</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/02/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Applied BioSystems</span></p>\r\n<p><span style=\"font-size: small;\">(5500 Genetic Analyzer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 Participant </span></p>\r\n<p><span style=\"font-size: small;\">(4 Samples)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Sanju Iwamoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=601&amp;Itemid=868&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0008.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000007</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research for genetic causes and mechanisms of Hirschsprung's</span></p>\r\n<p>&nbsp;</p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/01/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">5 Patients with Hirschsprung's diseases</span></p>\r\n<p><span style=\"font-size: small;\">and 6 their families</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroshi Matsufuji</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=216&amp;Itemid=484&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0009.v3</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>DRA003802</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">DNA Methylation Analysis of Early Human Embryos</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/12/24</span></p>\r\n<p><span style=\"font-size: small;\">v2:2015/01/07</span></p>\r\n<p><span style=\"font-size: small;\">v3:2015/08/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">11 Libraries</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takahiro Arima</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=295&amp;Itemid=577&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0010.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000008</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research for candidate genes of splenic epidermoid cyst.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/06/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">8 Splenic epidermoid cysts </span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroshi Matsufuji</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=245&amp;Itemid=507&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0011.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000015</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Integrated hepatitis B virus is epigenomically regulated by the methylation status of the human genome </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/10/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Roche GS FLX Titanium</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 Cell lines</span></p>\r\n<p><span style=\"font-size: small;\">8 HB-HCC primary tissues</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Yamamoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=223&amp;Itemid=488&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0012.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000012</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nagahama Zero-ji Preventive Cohort Project</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/08/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Control Set</span></p>\r\n<p><span style=\"font-size: small;\">Cohort</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Human610-Quad, </span></p>\r\n<p><span style=\"font-size: small;\">HumanOmni2.5-4/2.5-8/2.5S-8, </span></p>\r\n<p><span style=\"font-size: small;\">HumanExome-12, </span></p>\r\n<p><span style=\"font-size: small;\">HumanCoreExome-12)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3712 Participants</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fumihiko Matsuda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=147&amp;Itemid=457&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0013.v1</strong></span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Japan PGx Data Science Consortium Database</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/10/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Control Set</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HumanOmni2.5-8)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2994 Participants</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koji Suematsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3040&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0014.v37</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000101</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000114*</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000140</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000203</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000293</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000327</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000346</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000381*</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000414</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000347</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000592</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000647</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000698</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000699</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000700</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000701</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000703</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000738</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000746</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000782</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Bio Bank Japan project</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/09/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2015/12/28</span></p>\r\n<p><span style=\"font-size: small;\">v3:2016/01/28</span></p>\r\n<p><span style=\"font-size: small;\">v4:2016/02/02</span></p>\r\n<p><span style=\"font-size: small;\">v5:2017/05/18</span></p>\r\n<p><span style=\"font-size: small;\">v6:2017/09/08</span></p>\r\n<p><span style=\"font-size: small;\">v7:2018/04/04</span></p>\r\n<p><span style=\"font-size: small;\">v8:2018/05/01</span></p>\r\n<p><span style=\"font-size: small;\">v9:2018/08/07</span></p>\r\n<p><span style=\"font-size: small;\">v10:2018/08/13</span></p>\r\n<p><span style=\"font-size: small;\">v11:2018/10/16</span></p>\r\n<p><span style=\"font-size: small;\">v12:2018/12/10</span></p>\r\n<p><span style=\"font-size: small;\">v13:2019/01/25</span></p>\r\n<p><span style=\"font-size: small;\">v14:2019/03/26</span></p>\r\n<p><span style=\"font-size: small;\">v15:2019/09/27</span></p>\r\n<p><span style=\"font-size: small;\">v16:2019/10/07</span></p>\r\n<p><span style=\"font-size: small;\">v17:2019/10/08</span></p>\r\n<p><span style=\"font-size: small;\">v18:2019/11/26</span></p>\r\n<p><span style=\"font-size: small;\">v19:2020/04/20</span></p>\r\n<p><span style=\"font-size: small;\">v20:2020/08/17</span></p>\r\n<p><span style=\"font-size: small;\">v21:2020/08/25</span></p>\r\n<p><span style=\"font-size: small;\">v22:2021/05/21</span></p>\r\n<p><span style=\"font-size: small;\">v23:2021/07/13</span></p>\r\n<p><span style=\"font-size: small;\">v24:2021/11/26</span></p>\r\n<p><span style=\"font-size: small;\">v25:2022/01/25</span></p>\r\n<p><span style=\"font-size: small;\">v26:2022/04/01</span></p>\r\n<p><span style=\"font-size: small;\">v27:2023/01/18</span></p>\r\n<p><span style=\"font-size: small;\">v28:2023/04/05</span></p>\r\n<p><span style=\"font-size: small;\">v29:2023/04/05</span></p>\r\n<p><span style=\"font-size: small;\">v30:2023/04/20</span></p>\r\n<p><span style=\"font-size: small;\">v31:2023/09/01</span></p>\r\n<p><span style=\"font-size: small;\">v32:2024/01/11</span></p>\r\n<p><span style=\"font-size: small;\">v33:2024/05/27</span></p>\r\n<p><span style=\"font-size: small;\">v34:2024/09/19</span></p>\r\n<p><span style=\"font-size: small;\">v35:2024/10/25</span></p>\r\n<p><span style=\"font-size: small;\">v36:2024/11/28</span></p>\r\n<p><span style=\"font-size: small;\">v37:2025/05/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Case-Control</span></p>\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Human610-Quad, HumanHap550v3, HumanOmniExpress-12, HumanExome, OmniExpressExome, HumanExome-12, Infinium OmniExpress-24, Infinium HumanOmniExpressExome-8, HiSeq 2500/X Five, NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">Perlegen Sciences</span></p>\r\n<p><span style=\"font-size: small;\">(high-density oligonucleotide arrays)</span></p>\r\n<p><span style=\"font-size: small;\">Hologic Japan</span></p>\r\n<p><span style=\"font-size: small;\">(Invader)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:1666 MIs and 3198 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v2:934 ctrls (JSNP)</span></p>\r\n<p><span style=\"font-size: small;\">v2:35 diseases (JSNP)</span></p>\r\n<p><span style=\"font-size: small;\">v2:182 esophageal cancers (JSNP)</span></p>\r\n<p><span style=\"font-size: small;\">v2:92 ALSs (JSNP)</span></p>\r\n<p><span style=\"font-size: small;\">v3:9817 T2DMs and 6763 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v3:5646 T2DMs and 19,420 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v4:1472 ADs and 7966 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v5:8180 AFs and 28,612 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v6:158,284 individuals for BMI study</span></p>\r\n<p><span style=\"font-size: small;\">v6:182,505 individuals' genotype data</span></p>\r\n<p><span style=\"font-size: small;\">v7:3980 POAGs and 18,815 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v8:162,255 individuals for 58 quantitative traits study</span></p>\r\n<p><span style=\"font-size: small;\">v9:67,029 females with information on age at menarche</span></p>\r\n<p><span style=\"font-size: small;\">v9:43,861 females with information on age at menopause</span></p>\r\n<p><span style=\"font-size: small;\">v10:1,026 individuals for WGS</span></p>\r\n<p><span style=\"font-size: small;\">v11:7,104 breast cancer patients and 23,731 controls</span></p>\r\n<p><span style=\"font-size: small;\">v12:2,809 T2DM with diabetic nephropathy patients and 5,592 T2DM ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v13:36,614 T2DMs and 155,150 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v14:165,436 individuals with information on smoking behaviour</span></p>\r\n<p><span style=\"font-size: small;\">v15:1,026 individuals from biobank Japan and 2,504 individuals from 1KGP p3v5 ALL</span></p>\r\n<p><span style=\"font-size: small;\">v15:159,095 individuals for height study</span></p>\r\n<p><span style=\"font-size: small;\">v16:7,636 prostate cancer patients and 12,366 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v17,18,21:212,453 individuals for 42 diseases</span></p>\r\n<p><span style=\"font-size: small;\">v19:165,084 individuals with information on dietary habits</span></p>\r\n<p><span style=\"font-size: small;\">v2025,892 CADs and 142,336 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v22:11,234 individuals from biobank Japan</span></p>\r\n<p><span style=\"font-size: small;\">v23:768 individuals from biobank Japan</span></p>\r\n<p><span style=\"font-size: small;\">v24:1,005 pancreatic cancer patients, 12,503 colorectal cancer patients and 23,705 ctrls</span></p>\r\n<p><span style=\"font-size: small;\">v25:1,765 myocardial infarction patients and 199 dementia patients</span></p>\r\n<p><span style=\"font-size: small;\">v26:740 renal cell cancer patients and 5,996 controls</span></p>\r\n<p><span style=\"font-size: small;\">v27:137,693 individuals from biobank Japan</span></p>\r\n<p><span style=\"font-size: small;\">v28:4,880 individuals from biobank Japan</span></p>\r\n<p><span style=\"font-size: small;\">v29:9,826 AFs and 140,446 ctrls (BBJ cohot)</span></p>\r\n<p><span style=\"font-size: small;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60,620 AFs and 970,216 ctrls (European)</span></p>\r\n<p><span style=\"font-size: small;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7,244 AFs and 56,378 ctrls (FinnGenn)</span></p>\r\n<p><span style=\"font-size: small;\">v30:1,982 lymphoma patients, 10,366 gastric cancer patients and 37,592 controls (BBJ cohot)</span></p>\r\n<p><span style=\"font-size: small;\">v32:1,007 individuals from biobank Japan</span></p>\r\n<p><span style=\"font-size: small;\">v33: 256 gastric cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">v33: 269,000 patients for 51 diseases</span></p>\r\n<p><span style=\"font-size: small;\">v33: 617 colorectal cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">v33: 2,162 diabetes patients</span></p>\r\n<p><span style=\"font-size: small;\">v33: 2,067 gastric cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">v35: 7,472 individuals from BBJ 1st cohort</span></p>\r\n<p><span style=\"font-size: small;\">v36: 3,256 individuals from BBJ 1st cohort</span></p>\r\n<p><span style=\"font-size: small;\">v37: breast cancer 10,008 cases, gastric cancer 10,576 cases, colorectal cancer 13,929 cases, heart failure 6,038 cases, stroke 10,486cases, etc. total 140,597 individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese, European, Finnish)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Michiaki Kubo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=799&amp;Itemid=1037&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0015.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000159</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Construction of the Whole-genome&nbsp;Reference</span></p>\r\n<p><span style=\"font-size: small;\">Panel of 3552 Japanese Individuals</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2014/10/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/12/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2019/01/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3552 Participants</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Masayuki Yamamoto</span></p>\r\n<p><span style=\"font-size: small;\">(ToMMo)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=395&amp;Itemid=684&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0016.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">DRA002604</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Epigenome analysis of proteins expressed in human testis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/09/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(ChIP-seq, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 Participant </span></p>\r\n<p><span style=\"font-size: small;\">(4 Samples)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yasuyuki Ohkawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=286&amp;Itemid=569&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0017.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000021</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exome sequencing of primary central nervous system lymphoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/02/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">41 PCNSLs</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Hiroyuki Mano</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3142&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\"><strong>hum0018.v2</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000009</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000337</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000374</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000358</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000365</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000393</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000422</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000494</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis in neurodegenerative disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/02/03</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/07/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, WGS, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> 14 MSAs and 7 Controls</span></p>\r\n<p><span style=\"font-size: small;\">69 CMTs</span></p>\r\n<p><span style=\"font-size: small;\">21 FTDs</span></p>\r\n<p><span style=\"font-size: small;\">119 Familial ALSs</span></p>\r\n<p><span style=\"font-size: small;\">82 Myopathy</span></p>\r\n<p><span style=\"font-size: small;\">482 Sporadic ALSs</span></p>\r\n<p><span style=\"font-size: small;\">9 MNDs</span></p>\r\n<p><span style=\"font-size: small;\">464 Spastic paraplegia</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shoji Tsuji</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=263&amp;Itemid=460&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0019.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000011</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Systematic identification of long non-coding RNAs potentially involved in gastrointestinal cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Tumor vs. Matched-Normal</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">17 GICs </span></p>\r\n<p><span style=\"font-size: small;\">(32 Samples)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Yasuhisa Shinomura</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=157&amp;Itemid=464&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0020.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000013</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Genetic Analysis in Amyotrophic Lateral Sclerosis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/01/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">11 ALSs</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fumiaki Tanaka</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1471&amp;Itemid=1604&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0021.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000014</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000273</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Genetic Analysis in Psychiatric Disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/01/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/05</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/04/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Healthy Monozygotic Twins: 3 Pairs (6 Participants)</span></p>\r\n<p><span style=\"font-size: small;\">66 + 78 trios with bipolar disorder proband and unaffected parents</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tadafumi Kato</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=161&amp;Itemid=466&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0022.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000017</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Analysis of the Molecular Mechanism for Developing Donor-Origin Leukemia after Allogeneic Stem Cell Transplantation.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/02/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 DCL (5 Samples from Each Stage)</span></p>\r\n<p><span style=\"font-size: small;\">1 Donor</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hitoshi Kiyoi</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=163&amp;Itemid=431&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0023.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000016</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic Analysis in Lifestyle-Related Disease,</span></p>\r\n<p><span style=\"font-size: small;\">Arteriosclerotic Disease, and </span></p>\r\n<p><span style=\"font-size: small;\">Aging-Related Diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/01/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">30 Hypertensions</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tetsurou Miki</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=297:hum0024-v1&amp;catid=16&amp;lang=en-GB&amp;Itemid=468\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0024.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000023</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Comprehensive Analysis of Genetic Alterations in Hematological Malignancies</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/04/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Analyzer IIx, HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">13 MDSs and 1 CMML</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Seishi Ogawa</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=331&amp;Itemid=624&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0027.v1</a><br /></strong></span></p>\r\n<p><span style=\"font-size: small;\"> JGAS000024</span></p>\r\n<p><span style=\"font-size: small;\"> JGAS000040</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of genetic polymorphism on aggressive periodontitis </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/07/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Periodontitis patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Shinya Murakami</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=698&amp;Itemid=948&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0028.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000018</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Biobank Japan Project</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/06/02</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/06/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HumanOmniExpress, HumanExome, ImmunoChip, HumanHap550v3 Genotyping BeadChip)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">908 Participants</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Michiaki Kubo</span></p>\r\n<p><span style=\"font-size: small;\">(BBJ)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1346&amp;Itemid=1502&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0029.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Study of Genome Polymorphism/Variation on Stevens-Johnson Syndrome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/03/09</span></p>\r\n<p><span style=\"font-size: small;\">v1:2020/12/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Case-Control</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Axiom ASI)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X Ten)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">117 SJSs and 691 controls</span></p>\r\n<p><span style=\"font-size: small;\">133 SJS/TENs and 418 controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Mayumi Ueta</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3106&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0030.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000022</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000560</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000789</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> The Molecular Biological Analysis about Occurrence and Malignant Transformation in gynecological carcinogenesis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/04/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/05/10</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/07/05</span></p>\r\n<p><span style=\"font-size: small;\">v4:2025/07/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">CNV Analysis</span></p>\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n<p><span style=\"font-size: small;\">Expression array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Human Mapping 250K Nsp Array, GeneChip® Human Genome U133 Plus 2.0 Array)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000, Infinium HumanMethylation450, NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">57 + 111 + 31 + 189 Ovarian carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Katsutoshi Oda</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=254:hum0031-v1&amp;catid=16:cat-researches&amp;lang=en&amp;Itemid=514\" target=\"_blank\" rel=\"noopener noreferrer\" style=\"font-weight: bold; line-height: normal; text-align: center;\"><span style=\"font-size: small;\">hum0031.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000042<br />JGAS000043<br />JGAS000044<br />JGAS000045</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p style=\"font-size: small;\">Constructing database of magnetic resonance imaging of the brain and the ancillary clinical information for multisite collaboration studies</p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Neuroimage</span></p>\r\n<p><span style=\"font-size: small;\">Clinical Info</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Philips</span></p>\r\n<p><span style=\"font-size: small;\">(Achieva)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">129 normal controls, 37 schizophrenia, 8 unipolar and 2 bipolar disorders</span></p>\r\n<p>(Japanese)</p>\r\n</td>\r\n<td class=\"”highlight”\" style=\"font-size: small;\">Kiyoto Kasai</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=342&amp;Itemid=632&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0032.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000026</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000027</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000028</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Standard epigenome mapping in human epithelial cells of the digestive and urogenital organs </span></p>\r\n<p><span style=\"font-size: small;\">(HPC series)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/07/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq, ChIP-seq, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">8 partial hepatectomy specimens </span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yae Kanai</span></p>\r\n<p><span style=\"font-size: small;\">(IHEC)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=195&amp;Itemid=436&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0033.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>DRA003516</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Functional analysis of two types of exosome </span></p>\r\n<p><span style=\"font-size: small;\">in human whole saliva</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/05/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Analyzer IIx)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 Participant</span></p>\r\n<p><span style=\"font-size: small;\">(3 Samples)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ryohei Yanoshita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=240&amp;Itemid=503&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0034.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000037</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of novel therapeutic targets of</span></p>\r\n<p><span style=\"font-size: small;\">small cell lung cancer by comprehensive genomic analyses</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/10/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">51 SCLCs</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koichi Goto</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1341&amp;Itemid=1498&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0035.v5</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000036</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000046</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000088</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000188</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000204</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000246</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome wide analysis of gene mutations in solid tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/09/16</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/12/26</span></p>\r\n<p><span style=\"font-size: small;\">v3:2020/05/29</span></p>\r\n<p><span style=\"font-size: small;\">v4:2020/12/14</span></p>\r\n<p><span style=\"font-size: small;\">v5:2020/12/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, Target Capture, RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500, MiSeq, MethylationEPIC)</span></p>\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Human Mapping 250K Nsp, CytoScan HD)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">16 RMSs</span></p>\r\n<p><span style=\"font-size: small;\"> 7 PPBs</span></p>\r\n<p><span style=\"font-size: small;\">522 NBs</span></p>\r\n<p><span style=\"font-size: small;\">39 neuroblastoma cell lines</span></p>\r\n<p><span style=\"font-size: small;\">10 PBLs</span></p>\r\n<p><span style=\"font-size: small;\">59 HBLs</span></p>\r\n<p><span style=\"font-size: small;\">2 HBL cell lines</span></p>\r\n<p><span style=\"font-size: small;\">51 patients with pediatric germ cell tumors</span></p>\r\n<p><span style=\"font-size: small;\">30 patients with high-risk neuroblastoma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Junko Takita</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=213&amp;Itemid=480&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0036.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">DRA003736</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Performance Comparison of Four Commercial Human Whole-Exome Capture Platforms</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n<p><span style=\"font-size: small;\">Platform comparison</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 HapMap-JPT samples</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Michiaki Kubo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=235&amp;Itemid=499&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0037.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000035</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Diagnostic feasibility study for pathological prediction with rheumatoid arthritis-susceptible genes and genomic regions identified by the association analysis using microsatelite markers </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">39 RAs </span></p>\r\n<p><span style=\"font-size: small;\">10 Controls (pooled)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shigeki Mitsunagai</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=248&amp;Itemid=511&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0038.v1</a><br /></strong></span></p>\r\n<p><span style=\"font-size: small;\"> JGAS000041</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis in an inherited cardiac arrhythmia</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2015/11/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">11 Patients with an inherited cardiac arrhythmia </span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Naomasa Makita</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=303&amp;Itemid=580&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0039.v1</a></strong></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000039</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of TKI resistant mechanism for gastrointstinal stromal tumor (GIST)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/12/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina </span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500)</span>&nbsp;</p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">4 Imatinib resistant GIST</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tsuyoshi Takahashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=360&amp;Itemid=653&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0040.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000038</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Epigenomic analysis of the human placenta </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/09/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, RNA-seq, BS-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">28 human placenta</span></p>\r\n<p><span style=\"font-size: small;\">26 maternal blood samples</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takahiro Arima</span></p>\r\n<p><span style=\"font-size: small;\">(IHEC)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=407&amp;Itemid=692&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0041.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000052</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research of factors related to diagnosis, progression, prognosis and treatment of hepato-biliary-pancreatic malignancies</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/01/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">33 primary HCC</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinji Tanaka</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=291&amp;Itemid=575&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0042.v1</strong></span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome analysis for elucidation of genetic factors in orofacial traits and diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/03/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HumanOmniExpress)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">146 TMJ and 374 controls </span></p>\r\n<p><span style=\"font-size: small;\">149 third molar agenesis and 338 controls </span></p>\r\n<p><span style=\"font-size: small;\">(Japanese, Korean)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tetsutarou Yamaguchi</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"/en/hum0043-v1\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0043.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000051</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Japanese Alzheimer's disease neuroimaging initiative (J-ADNI)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/01/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Neuroimage</span></p>\r\n<p><span style=\"font-size: small;\">Clinical Info</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><a href=\"/en/hum0043-v1-release#mriscanners\" target=\"_blank\" rel=\"noopener noreferrer\">MRI Scanners (15 Models)</a></p>\r\n<p><a href=\"/en/hum0043-v1-release#petscanners\" target=\"_blank\" rel=\"noopener noreferrer\">PET Scanners (16 Models)</a></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">234 MCI </span></p>\r\n<p><span style=\"font-size: small;\">154 AD </span></p>\r\n<p><span style=\"font-size: small;\">149 healthly controls </span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takeshi Iwatsubo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=949&amp;Itemid=1163&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0044.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA004162</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Research about retrovirus infection</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/10/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(ChIP-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 ED (ATL cell line)</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yorifumi Satou </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=312&amp;Itemid=594&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0045.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000047</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Transcriptome analysis of acute lymphoblastic leukemia in adolescents and young adults</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/03/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">99 Ph(-) ALL</span></p>\r\n<p><span style=\"font-size: small;\">3 Ph(+) ALL </span></p>\r\n<p><span style=\"font-size: small;\">5 cell lines </span></p>\r\n<p><span style=\"font-size: small;\">8 normal hematopoietic cells</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Mano</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=281&amp;Itemid=567&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0048.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>DRA004251</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Whole exome sequencing on ampullary carcinomas</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/02/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">60 Patients with ampullary cancer </span></p>\r\n<p><span style=\"font-size: small;\"> (28 Japanese patients and 32 American patients)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinich Yachida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=390&amp;Itemid=680&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0050.v1</a></strong></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000053</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Transcriptome analysis of Hepatitis B for drug discovery and clinical applications</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/09/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(CAGE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">8 HBV (Genotype C) positive patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tomokazu Matsuura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1095&amp;Itemid=1288&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0053.v2</span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>JGAS000062</strong></span></p>\r\n<p><span style=\"font-size: small;\"><strong>JGAS000176</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of new molecular targets with profiling of malignant mesothelioma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/07/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/04/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Chromium Controller)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">38 Malignant pleural mesothelioma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Nakano</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=448&amp;Itemid=726&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0055.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000059</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic and epigentic analysis of non-alcoholic fatty liver disease</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/02/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, HumanMethylation450)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">64 NAFLD patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kikuko Hotta</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=618&amp;Itemid=881&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0056.v1</a></strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome and Multi-layer omics reference panels using blood samples from a population-based cohort study</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/03/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, WGBS, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/X)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">197 participants</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atsushi Shimizu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=645&amp;Itemid=912&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0058.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000091</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Identification of genetic mutations characteristic for recurrence and metastasis of colorectal cancer.</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">89 colorectal cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshiharu Yamaguchi</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=639&amp;Itemid=908&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0059.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>JGAS000104</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of genetic mutations characteristic for recurrence of serous ovarian cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">65 ovarian cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazuyoshi Kato</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=623&amp;Itemid=887&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0060.v1</a><br /></strong></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000075</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of genetic mutations characteristic for recurrence and metastasis of breast cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">65 recurrent / metastatic breast cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yoshio Miki</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=719&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\"><strong>hum0061.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"><strong>JGAS000057</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Searching causative genes of familial tumors using whole genome / exome sequencing</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/02/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Siblings developed multiple primary lung cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kikuya Kato</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=350&amp;Itemid=644&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0064.v1</a></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000061</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Construction of Geriatric Oncology Database for establishment of the Treatment Algorithm: Clinical Data and Questionnaire Survey Results in JapaneseElderly Cancer Patients Retrospective study</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/08/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Direct sequencing</span></p>\r\n<p><span style=\"font-size: small;\">TaqMan</span></p>\r\n<p><span style=\"font-size: small;\">qRT-PCR</span></p>\r\n<p><span style=\"font-size: small;\">COBRA</span></p>\r\n<p><span style=\"font-size: small;\">cDNA microarray</span></p>\r\n<p><span style=\"font-size: small;\">Clinical data</span></p>\r\n<p><span style=\"font-size: small;\">Treatment data</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Applied BioSystems</span></p>\r\n<p><span style=\"font-size: small;\">(3130 Genetic Analyzer)</span></p>\r\n<p><span style=\"font-size: small;\">Roche</span></p>\r\n<p><span style=\"font-size: small;\">(LightCycler 480II)</span></p>\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">(Whole Human Genome Microarray 4x44K)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">[GENOME]</span></p>\r\n<p><span style=\"font-size: small;\">106 colorectal cancer</span></p>\r\n<p><span style=\"font-size: small;\">62 gastric cancer</span></p>\r\n<p><span style=\"font-size: small;\">173 lung cancer</span></p>\r\n<p><span style=\"font-size: small;\">[Retrospective]</span></p>\r\n<p><span style=\"font-size: small;\">313 colorectal cancer</span></p>\r\n<p><span style=\"font-size: small;\">166 gastric cancer</span></p>\r\n<p><span style=\"font-size: small;\">344 lung cancer</span></p>\r\n<p><span style=\"font-size: small;\">300 diabetes and nephropathy</span></p>\r\n<p><span style=\"font-size: small;\">357 cardiovascular disorder</span></p>\r\n<p><span style=\"font-size: small;\">49 respiratory dysfunction</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masahiko Nishiyama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=641&amp;Itemid=896&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0065.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000089</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shuttle system between petient-derived xenograft and ex vivo culture for innovative platform of evaluating drug sensitivity</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">8 colorectal cancer</span></p>\r\n<p><span style=\"font-size: small;\">2 lung cancer</span></p>\r\n<p><span style=\"font-size: small;\">2 small cell carcinoma of uterine cervix&nbsp;</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masahiro Inoue</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1162&amp;Itemid=1343&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0066.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000060</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Investigating the mechanisms of tumor recurrence and metastasis by non-coding RNA</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">9 colorectal carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koshi Mimori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=483&amp;Itemid=764&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0067.v1</a><br /></strong></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000076</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Project for Development of Innovative Research on Cancer Therapeutics; identifiying the predictive factors for response to chemoherapy in ovarian cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/05/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">55 ovarian clear cell carcinoma patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toru Sugiyama</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2717&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0068.v9</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000065*</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000349</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000570</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000677</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cancer genomics for elucidation of molecular mechanisms of carcinogenecis and progression in lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/07/10</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/10/19</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/12/14</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/03/23</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/12/27</span></p>\r\n<p><span style=\"font-size: small;\">v6:2023/02/10</span></p>\r\n<p><span style=\"font-size: small;\">v7:2023/06/19</span></p>\r\n<p><span style=\"font-size: small;\">v8:2023/09/22</span></p>\r\n<p><span style=\"font-size: small;\">v9:2024/04/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PCR amplicon Seq, WGS, RNA-seq, scDNA-seq, Target Capture, Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n<p><span style=\"font-size: small;\">Multiplex Fluorescence Immunostaining</span></p>\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(MinION, PromethION)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, HiSeq 2000)</span></p>\r\n<p><span style=\"font-size: small;\">Akoya Biosciences</span></p>\r\n<p><span style=\"font-size: small;\">(PhenoCycler)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Xenium Analyzer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">8 + 21 + 74 + 20 lung adenocarcinoma patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Kono</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=423&amp;Itemid=705&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0069.v1</a></strong></span></p>\r\n<p><span style=\"font-size: small;\"><strong>JGAS000064</strong></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">RNA expression profiling of neuromuscular diseases and viral diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/12/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(small RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 Neuromuscular disease (control group)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takanori Yokota</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=678&amp;Itemid=932&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0070.v1</a><br /></strong></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000115</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Molecular analysis of Birt-Hogg-Dube syndrome: Identification of new diagnostic marker and therapeutic target</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">15 Birt-Hogg-Dube associated kidney cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masahiro Yao</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=378&amp;Itemid=669&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0072.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification and functional analyses of susceptibility genes to narcolepsy and other sleep disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(SNP Array 6.0)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">409 narcolepsy patients </span></p>\r\n<p><span style=\"font-size: small;\">1562 controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">125 essential hypersomnia patients</span></p>\r\n<p><span style=\"font-size: small;\">562 controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Katsushi Tokunaga</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=744&amp;Itemid=989&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0074.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome-wide association studies on Hepatitis C virus-related diseases and construction of genome database</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/02/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(SNP Array 6.0, Axiom ASI)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">78 NVR, 64 VR, 51 SVR</span></p>\r\n<p><span style=\"font-size: small;\">107 patients with the decrease of PLT</span></p>\r\n<p><span style=\"font-size: small;\">196 patients without the decrease of PLT</span></p>\r\n<p><span style=\"font-size: small;\">94 HCV patients with an Hb reduction</span></p>\r\n<p><span style=\"font-size: small;\">209 HCV patients without Hb reduction</span></p>\r\n<p><span style=\"font-size: small;\">123 patients who developed HCC after eradication of HCV</span></p>\r\n<p><span style=\"font-size: small;\">333 patients who did not develop HCC after eradication of HCV</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yasuhito Tanaka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1969&amp;Itemid=2028&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0075.v3</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Search for susceptibility genes to hepatitis virus B-related diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/09/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/02/19</span></p>\r\n<p><span style=\"font-size: small;\">v3:2022/05/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(SNP Array 6.0, Axiom ASI)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">181 HBV carriers</span></p>\r\n<p><span style=\"font-size: small;\">185 spontaneously HBV-resolved individuals</span></p>\r\n<p><span style=\"font-size: small;\">184 controls</span></p>\r\n<p><span style=\"font-size: small;\">473 HBV-positive HCC patients</span></p>\r\n<p><span style=\"font-size: small;\">516 HBV carriers (chronic hepatitis and asymptomatic carriers)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">329 patients with chronic HBV infection</span></p>\r\n<p><span style=\"font-size: small;\">318 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Thailander)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masashi Mizokami</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=382&amp;Itemid=672&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0076.v1</a></span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome-wide search for susceptibility genes to primary biliary chirrosis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/10/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Axiom ASI)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">487 PBCs</span></p>\r\n<p><span style=\"font-size: small;\">476 controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Minoru Nakamura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1819&amp;Itemid=1895&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0079.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000068</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis in neurodegeneraive disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/02/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">53 inclusion body myositis patients</span></p>\r\n<p><span style=\"font-size: small;\">6 polymyositis patients</span></p>\r\n<p><span style=\"font-size: small;\">9 controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Jun Goto</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=547&amp;Itemid=825&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0082.v2</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000120</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome-wide analysis of SNPs in Healthy Japanese</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/09/26</span></p>\r\n<p><span style=\"font-size: small;\">v1:2017/10/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Control Set</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(SNP Array 6.0, Axiom ASI)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">419 Participants</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Katsushi Tokunaga</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1784&amp;Itemid=1867&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0083.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000070</span></p>\r\n<p><span style=\"font-size: small;\"> JGAS000488</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome-wide analysis for biomarker exploration (lung cancer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/10/28</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/01/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS (CAGE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">lung cancer: 97 + 38 cases</span></p>\r\n<p><span style=\"font-size: small;\">malignant pleural mesothelioma: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yoshihide Hayashizaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=936&amp;Itemid=1152&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0085.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000108</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Molecular biological research affecting on long-term treatment to malignant tumors derived from the chest or abdomen</span></p>\r\n<p><span style=\"font-size: small;\">Genomic analysis of environment-associated tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/10/16</span></p>\r\n<p><span style=\"font-size: small;\">v1:2018/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Array CGH, NGS (WGS, Target Capture, Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq, HiSeq 4000/X Ten)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">72 malignant mesotheliomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese, Americans)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masaki Ohmuraya</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=703&amp;Itemid=953&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0086.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000073<br />(JGA000074)</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000107<br />(JGA000117)</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Epigenomic analysis of the human placenta and endometrium constituting the fetal-maternal interface</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/09/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2017/12/26</span></p>\r\n<p><span style=\"font-size: small;\">v3:2018/06/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq, ChIP-seq, RNA-seq, small RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">placenta and uterus cells, trophoblast stem cells: total 39 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Sasaki</span></p>\r\n<p><span style=\"font-size: small;\">(IHEC)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><strong><a href=\"index.php?option=com_content&amp;view=article&amp;id=946&amp;Itemid=1161&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\">hum0088.v2</a><br /></strong></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000077</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000096</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Global analysis of TGF-beta family signaling in cancer cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/02/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/09/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Analyzer IIx)</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 glioblastomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Kohei Miyazono</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=429&amp;Itemid=707&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0090.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000078</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000079</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000080</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Study of molecular-genetics, and molecular epidemiology for developing treatment of esophageal cancer</span></p>\r\n<p><span style=\"font-size: small;\">(COC series)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2016/11/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq, ChIP-seq, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">12 normal human absorptive epithelial cells</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yae Kanai</span></p>\r\n<p><span style=\"font-size: small;\">(IHEC)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=427&amp;Itemid=709&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0091.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000082</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000165</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000081</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Study of molecular-genetics, and molecular epidemiology for developing treatment of esophageal cancer</span></p>\r\n<p><span style=\"font-size: small;\">(GAC series)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq, ChIP-seq, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">14 Normal human foveolar epithelial cells of the stomach</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yae Kanai</span></p>\r\n<p><span style=\"font-size: small;\">(IHEC)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2218&amp;Itemid=2239&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0094.v11</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000095</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000105</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000113</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000128</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000215</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000270</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000297</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000335</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000360</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000534</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genomic and epigenomic analysis of different types of cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/09/04</span></p>\r\n<p><span style=\"font-size: small;\">v2:2018/01/22</span></p>\r\n<p><span style=\"font-size: small;\">v3:2019/02/12</span></p>\r\n<p><span style=\"font-size: small;\">v4:2020/08/14</span></p>\r\n<p><span style=\"font-size: small;\">v5:2020/10/26</span></p>\r\n<p><span style=\"font-size: small;\">v6:2021/01/29</span></p>\r\n<p><span style=\"font-size: small;\">v7:2021/07/02</span></p>\r\n<p><span style=\"font-size: small;\">v8:2021/10/22</span></p>\r\n<p><span style=\"font-size: small;\">v9:2021/10/26</span></p>\r\n<p><span style=\"font-size: small;\">v10:2022/05/23</span></p>\r\n<p><span style=\"font-size: small;\">v11:2022/11/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, RNA-seq, Target Capture, Iso-seq), Methylation array, SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500, MethylationEPIC, HumanOmni2.5-8)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Chromium Controller)</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">(Sequel)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">68 breast cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">43 + 126 lung adenocarcinoma patients</span></p>\r\n<p><span style=\"font-size: small;\">150 + 173 colorectal cancers</span></p>\r\n<p><span style=\"font-size: small;\">12 colorectal cancers with liver metastasis, 16 colorectal cancers without liver metastasis</span></p>\r\n<p><span style=\"font-size: small;\">64 desmoid tumor patients</span></p>\r\n<p><span style=\"font-size: small;\">35 pulmonary pleomorphic carcinoma patients</span></p>\r\n<p><span style=\"font-size: small;\">67 salivary duct carcinoma patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Mano</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=713&amp;Itemid=962&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0095.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000092</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis of colorectal precancerous lesion and early colorectal cancer to investigate mechanism of carcinogenesis of colorectal cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/07/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 cases of colorectal adenomas or PCRCs</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koshi Mimori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=999&amp;Itemid=1203&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0096.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000090</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000138</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive analysis of genetic alterations in hematological malignancies</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/05/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/11/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, MethylationEPIC)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">123 pediatric T-ALL patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Junko Takita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=693&amp;Itemid=944&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0097.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000094</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cytogenetic analysis of hematopoietic cells in bone marrow failure syndrome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/05/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">5 patients with aplastic anemia with uniparental disomy in 6p</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinji Nakao</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=475:hum0099-v1&amp;catid=16&amp;lang=en-GB&amp;Itemid=748\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\"><strong>hum0099.v1</strong></span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000085</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Expression quantitative trait loci analysis using human immune cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/04/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, Infinium OmniExpressExome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">105 healthy volunteers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazuhiko Yamamoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=683&amp;Itemid=936&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0101.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000098</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of gene mutations in primary immunodeficiency characterized by EBV-associated B-cell lymphoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 patients with primary immunodeficiency</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yasumasa Iwatani</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1773&amp;Itemid=1859&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0103.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000109</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000389</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome sequencing analysis for biliary tract cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/02/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/06/21</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/07/13</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/01/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">98 + 121 biliary tract cancers</span></p>\r\n<p><span style=\"font-size: small;\">4 normal gallbladders</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2138&amp;Itemid=2157&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0106.v1</span></a></p>\r\n<p><span style=\"font-size: small;\"> JGAS000139</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of the prevention and therapy of CRC using patient derived culture tissues.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 patients with colorectal cancer</span></p>\r\n<p><span style=\"font-size: small;\">(patient derived culture tissues)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ryoji Yao</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1170&amp;Itemid=1353&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0107.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000099</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000218</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Establish induced pluripotent stem (iPS) cells from patients with Gorlin syndrome and elucidate the pathology</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/10/02</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/06/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/4000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">4 patients with Gorlin syndrome</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshifumi Azuma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=500&amp;Itemid=781&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0108.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000111</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Search for new susceptibility genetic factors associated with psychiatric disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/06/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HumanMethylation450)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">48 panic disorder patients</span></p>\r\n<p><span style=\"font-size: small;\">48 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Katsushi Tokunaga</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1386&amp;Itemid=1536&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0111.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000103</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000141</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000242</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of gastric cancer genome and its clinicopathological significance</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/07/31</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/05/31</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/02/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq,</span></p>\r\n<p><span style=\"font-size: small;\">Amplicon-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000, MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">30 diffuse-type gastric carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">60 + 15 gastric carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shumpei Ishikawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=567:hum0112-v1&amp;catid=16:cat-researches&amp;lang=en-GB\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0112.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000112</span></p>\r\n<p><span style=\"font-size: small;\">(JGA000122)</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Basic research for the establishment and characterization of human trophoblast stem cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq, ChIP-seq, RNA-seq, miRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 trophoblast stem cells</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takahiro Arima</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2061&amp;Itemid=2100&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0113.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000119</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000142</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000318</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of metabolite biomarkers of Parkinson’s disease and identification of drug seeds from chemical screening based on the biomarkers</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/24</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/07/30</span></p>\r\n<p><span style=\"font-size: small;\">v3:2022/07/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(CAGE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">39 PD patients, 20 non-PD (healthy) contorols</span></p>\r\n<p><span style=\"font-size: small;\">iPS derived neurons: 3 PD samples and 3 controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Piero Carninci</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1591&amp;Itemid=1702&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0114.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA007411</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000314</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research on statistical genetics using B cell lines of Japanese ancestry</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/18</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/04/12</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/08/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HumanCoreExome, MiSeq, HiSeq X Ten, NovaSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">282 psoriasis patients</span></p>\r\n<p><span style=\"font-size: small;\">426 controls</span></p>\r\n<p><span style=\"font-size: small;\">1,173 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yukinori Okada</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1131&amp;Itemid=1319&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0115.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000121</span></p>\r\n<p><span style=\"font-size: small;\">DRA006296</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlling cell differentiation with precision through understanding the structure and dynamics of gene regulatory networks</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Microarray</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">(SurePrint G3 Human GE 8x60K v2 Microarray, SureScan G4900DA)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">TF-hESCs derived from SEES3</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Minoru S.H. Ko</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1316&amp;Itemid=1478&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0116.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000122</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of hunanized mice for human immunity research</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">118 AMLs</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fumihiko Ishikawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=557&amp;Itemid=833&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0117.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000125</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Epigenetics analysis of neurodegenerative diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HumanMethylation450)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">30 Alzheimer's disease patients</span></p>\r\n<p><span style=\"font-size: small;\">30 healty controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atsushi Iwata</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=562&amp;Itemid=838&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0118.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000124</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome-wide analysis for biomarker exploration (endometrial cancer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2017/12/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS (CAGE-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Sanger-seq</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(3500 Genetic Analyzer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">17 endometrial cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yoshihide Hayashizaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=814&amp;Itemid=1050&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0119.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000126</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis for mechanism of onset and progress for NASH</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/01/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Human610-Quad, HumanCoreExome, HumanOmni2.5-Quad BeadChip)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">902 NAFLDs</span></p>\r\n<p><span style=\"font-size: small;\">7672 healty controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fumihiko Matsuda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2070&amp;Itemid=2104&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0120.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000221</span></p>\r\n<p><span style=\"font-size: small;\">DRA011183</span></p>\r\n<p><span style=\"font-size: small;\">DRA011184</span></p>\r\n<p><span style=\"font-size: small;\">DRA011185</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-396</span></p>\r\n<p><span style=\"font-size: small;\">DRA010902</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000549</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">The genetic analysis of circulating tumor DNA in blood of the digestive cancer patients to investigate the prognostic factors of metastasis and reccurence.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/03</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/10/30</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/12/06</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/07/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, Target Capture, WGBS)</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, iScan, HiSeq X Ten)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 + 25 + 10 colorectal cancers</span></p>\r\n<p><span style=\"font-size: small;\">16 gastric cancers</span></p>\r\n<p><span style=\"font-size: small;\">16 breast cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koshi Mimori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1045&amp;Itemid=1239&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0122.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA006622</span></p>\r\n<p><span style=\"font-size: small;\">DRA007336</span></p>\r\n<p><span style=\"font-size: small;\">DRA008459</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-311</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Mutation analysis of iPS cells derived from commercially-avaialble human primary cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/01/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X Ten, Infinium Omni2.5-8)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">human iPS cells and their parental cells: total 27 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ryoko Araki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=633&amp;Itemid=904&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0124.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000129</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Study for exome sequencing in familial epidermal growth factor receptor-mutant lung cancer</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 EGFR-mutant lung cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshiaki Kikuchi</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=764&amp;Itemid=1006&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0125.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000127</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Immune regulation by cotrolling regulatory T cell-specific epigenome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/11/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion S5)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 Crohn's diseases</span></p>\r\n<p><span style=\"font-size: small;\">4 Colorectal cancers (normal cells)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shimon Sakaguchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1245&amp;Itemid=1419&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0126.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of the disease and drug susceptibility genes for the Childhood Idiopathic Nephrotic Syndrome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/09/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Japonica Array v1/v2)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">224 + 3,206 Childhood Idiopathic Nephrotic Syndrome patients</span></p>\r\n<p><span style=\"font-size: small;\">419 + 987 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazumoto Iijima</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2816&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0127.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000130</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000274</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000604</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000715</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Implementation of individualized medicine for cancer patients by multiomics-based analyses—the Project HOPE (High-tech Omics-based Patients Evaluation) for Cancer Therapy—</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/08</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/01/22</span></p>\r\n<p><span style=\"font-size: small;\">v4:2024/07/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, DNA Amplicon-seq, RNA Amplicon-seq, WGS)</span></p>\r\n<p><span style=\"font-size: small;\">Microarray</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">(SurePrint G3 Human Gene Expression 8 × 60 K v2 Microarray, DNA Microarray Scanner)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, Infinium MethylationEPIC array, iScan System)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">91 cancer patients with hypermutator tumors harborig <em>POLE</em> mutations</span></p>\r\n<p><span style=\"font-size: small;\">5143 + 7 cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ken Yamaguchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=759&amp;Itemid=1001&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0128.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000153</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">A study on comprehensive genome and proteome analyses of the chronic eosinophillic inflammatory diseases.</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/10/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">6 chronic rhinosinusitis with nasal polyps</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shigeharu Fujieda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=657&amp;Itemid=898&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0129.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000131</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Research for analyzing mechanistic insight into disease progression of neural disease based on iPS cell technology</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(ChIP-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 CHARGE syndrome patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hideyuki Okano</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2783&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0130.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000150</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000289</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genetic analyses of bone marrow cells in POEMS syndrome</span></p>\r\n<p><span style=\"font-size: small;\">Analyses of molecular mechanisms of hematological malignancies and bone marrow niche</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/01/18</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/09/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/06/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, Target Capture, RNA-seq, scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/2000/2500/3000, MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">20 + 14 POEMS syndromes</span></p>\r\n<p><span style=\"font-size: small;\">4 + 5 MMs</span></p>\r\n<p><span style=\"font-size: small;\">5 + 2 MGUSs</span></p>\r\n<p><span style=\"font-size: small;\">4 + 3 lymphomas without BM invasion</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Emiko Sakaida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=769&amp;Itemid=1010&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0131.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000132</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">The epigenetics of neurodevelopmental disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">6 Williams syndromes</span></p>\r\n<p><span style=\"font-size: small;\">8 healthy contorols</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ryo Kimura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=734&amp;Itemid=981&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0132.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000137</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Identification of genetic alterations in Vietnamese individuals with elevated blood dioxin level</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/09/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">9 trios of the father exposed to dioxin and his wife and child with mental retardation (total 27 individuals)</span></p>\r\n<p><span style=\"font-size: small;\">(Vietnamese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=649&amp;Itemid=916&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0133.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000086</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Identification of genetic mutations characteristic for recurrence and metastasis of gastric cancer.</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">75 gastric cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshiharu Yamaguchi</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=653&amp;Itemid=920&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0134.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000087</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Identification of genetic mutations characteristic for recurrence and metastasis of B cell lymphoma.</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">60 B cell lymphomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshiharu Yamaguchi</span></p>\r\n<p><span style=\"font-size: small;\">(P-DIRECT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1628&amp;Itemid=1730&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0136.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000341</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Construction of integrated clinical genome database regarding hepatitis B related diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/05/22</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/05</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/10/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Axiom ASI)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1,193 individuals vaccinated with a HB vaccine (Bimmugen)</span></p>\r\n<p><span style=\"font-size: small;\">555 individuals vaccinated with a HB vaccine (Heptavax)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masashi Mizokami</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=789&amp;Itemid=1029&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0137.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000144</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">a multicenter study of susceptibility genes to type 1 diabetes</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/12/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">32 type 1 diabetes patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroshi Ikegami</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1434&amp;Itemid=1574&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0138.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000134</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Clonal structure and oncogenic potential of liver cirrhosis tissues</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/07/31</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/4000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Liver cirrhosis: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">Hepatocellular carcinoma: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">7 healthy donors</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atsushi Takai</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=708&amp;Itemid=958&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0139.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000136</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Research for drug discovery and elucidation of pathophysiology using disease-specific iPS cells</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/07/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 RALD patient</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Makoto Otsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1004&amp;Itemid=1207&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0140.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000158</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Prediction of response to preoperative chemoradiotherapy in rectal cancer based on whole-exome sequencing and transcriptomic analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/11/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">74 rectal cancer treated with preoperative chemoraidotherapy</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Akiyoshi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=865&amp;Itemid=1091&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0141.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000135</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Immune regulation by cotrolling regulatory T cell-specific epigenome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/05/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion S5)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Head and neck cancer: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shimon Sakaguchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3048&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0143.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000143</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Aberrant (pro)renin receptor expression induces genomic instability by chromatin remodeler SMARCA5 disruption during the pancreatic ductal adenocarcinoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（HiSeq 2500, NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Human pancreatic ductal epithelial cells: 6 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akira Nishiyama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1040&amp;Itemid=1235&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0144.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000147</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive analysis of genetic alterations in hematological malignancies (pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/01/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq), </span></p>\r\n<p><span style=\"font-size: small;\">Methylation array, </span></p>\r\n<p><span style=\"font-size: small;\">SNP array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500, Infinium MethylationEPIC BeadChip, Infinium HumanMethylation450 BeadChip)</span></p>\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Human Mapping 250K Nsp, CytoScan HD)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrome: 43 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Junko Takita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1075&amp;Itemid=1272&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0145.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000222</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">The genetic analysis of circulating tumor DNA in blood of the digestive cancer patients to investigate the prognostic factors of metastasis and reccurence.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 colorectal cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koshi Mimori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=830&amp;Itemid=1062&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0146.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA007187</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Diagnosis of imprinting disorders and safety evaluation of assisted reproduction technologies (ART)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/02/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RRBS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">5 SRS patients born after ART</span></p>\r\n<p><span style=\"font-size: small;\">5 spontaneously conceived SRS patients</span></p>\r\n<p><span style=\"font-size: small;\">10 spontaneously conceived children</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takahiro Arima</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2442&amp;Itemid=2427&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0147.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000145</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000312</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000454</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Immune regulation by cotrolling regulatory T cell-specific epigenome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/18</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/05/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, ChIP-seq, PBAT-seq, ATAC-seq, scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion S5)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/3000/4000, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">4 + 1 healty donors</span></p>\r\n<p><span style=\"font-size: small;\">7 + 3 cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shimon Sakaguchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=901&amp;Itemid=1123&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0148.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000149</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of abnomal character and expression of genes in tissues of urologic carcinomas. </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/06/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Analyzer IIx)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">67 renal cell carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takeshi Yuasa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2228&amp;Itemid=2247&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0152.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000182</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000529</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Multi‐institutional study on molcular pathogenesis of bone and soft tissue tumors by genome and proteome analyses and its clinical application</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/09/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/11/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Dedifferentiated liposarcoma: 37 cases</span></p>\r\n<p><span style=\"font-size: small;\">lipoblastoma-like tumor of the vulva: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hitoshi Ichikawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=957&amp;Itemid=1171&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0153.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000177</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Multiomics analysis of rare cancers to identify genetic alterations related with pathogenesis and prognosis</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/09/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">28 Dedifferentiated liposarcoma patients</span></p>\r\n<p><span style=\"font-size: small;\">36 Tendon sheath giant cell tumor patient</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koichi Matsuda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1585&amp;Itemid=1697&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0156.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000227</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Integrative genetic analysis using next generation sequencer reveals mechanisms of resistance to chemoradiotherapy for esophageal cancer</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/07/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">33 esophageal cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koshi Mimori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=941&amp;Itemid=1156&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0157.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000164</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cancer clinical sequence and accompanying research for comprehensive genomic and epigenomic analyses</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/08/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">183 cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kohei Miyazono</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1565&amp;Itemid=1680&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0158.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000151</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome sequencing analysis for liver cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/10/22</span></p>\r\n<p><span style=\"font-size: small;\">v2:2019/06/21</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/07/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000, Genome Analyzer IIx, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">263 liver cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2307&amp;Itemid=2313&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0159.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000157*</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome sequencing analysis for colorectal cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/06/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/12/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Hiseq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 colorectal cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1570&amp;Itemid=1684&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0160.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000155</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome sequencing analysis for esophageal squamous cell carcinoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/05/28</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/07/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500/X Five)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">20 esophageal squamous cell carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2311&amp;Itemid=2317&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0161.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000156*</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome sequencing analysis for hepatoblastoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/06/04</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/12/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Hiseq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">33 hepatoblastomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2432&amp;Itemid=2419&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0163.v3</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Pharmacogenomics research for therapeutics in psychiatry, neurology and oncology</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/12/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/02/09</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/04/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq, Infinium OmniExpressExome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">990 patients with psychiatric/neurological disorders and cancers</span></p>\r\n<p><span style=\"font-size: small;\">90 bullous pemphigoid cases</span></p>\r\n<p><span style=\"font-size: small;\">737 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Taisei Mushiroda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=783&amp;Itemid=1025&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0164.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000160</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tohoku Medical Megabank Organization cohort study</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2018/12/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Infinium OmniExpressExome-8)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">9,187 participants</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masao Nagasaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=860&amp;Itemid=1087&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0165.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000162</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis of familial myelodysplastic syndromes</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/05/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS </span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 patients of familial myelodysplastic syndromes</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Junji Koya</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2681&amp;Itemid=2612&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0166.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Multicenter Evaluation of NUDT15-R139C genotyping efficiency to DEtect thiopurine-induced hair Loss and leukopenia (MENDEL study)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/07/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/01/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Japonica Array v1)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1221 + 2680 patients of Inflammatory bowel disease</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yoichi Kakuta</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=921&amp;Itemid=1139&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0167.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Study to clarify the pathophysiology of gout / hyperuricemia and uric acid related diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/07/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HumanOmniExpressExome-8, Human660W-Quad, HumanOmni2.5-8, HumanOmniExpress-12, HumanOmniExpress-24, HumanOmniExpressExome, HumanOmniExpress, HumanExome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">121,745 participants of 3 Japanese cohorts (J-MICC study, KING study, BBJ)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hirotaka Matsuo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=989&amp;Itemid=1195&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0168.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000169</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genomic analyses of cancers</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/11/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">51 adenomyosis patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masahito Kawazu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1195&amp;Itemid=1377&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0169.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000178</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Molecular analysis to identify novel biomarker and therapeutic target for cerebrospinal tumor and preclinical investigation using patient derived orthotopic xenograft models.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/06/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/07/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">9 PCNSL patinets</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tetsuya Yamamoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=855&amp;Itemid=1083&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0173.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000171</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A Study on the Health and Development of Children Beginning in the Fetal Period</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/04/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS </span></p>\r\n<p><span style=\"font-size: small;\">(RRBS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">human umbilical cords: 30 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Chisato Mori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2670&amp;Itemid=2604&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0174.v6</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000173</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000580</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000286</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000505</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000596</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Building a Database of Genomic Structural Variants in Japanese population</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/06</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/11/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/06/29</span></p>\r\n<p><span style=\"font-size: small;\">v4:2023/07/06</span></p>\r\n<p><span style=\"font-size: small;\">v5:2023/07/10</span></p>\r\n<p><span style=\"font-size: small;\">v6:2023/12/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">(Sequel, Sequel II)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Chromium Controller)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Purified DNA from Japanese-origin B cell lines: 10 + 11 + 177 + 141 + 30 samples</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinichi Morishita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2720&amp;Itemid=2640&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0175.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000174</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000642</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of actionable molecular targets and/or biomarkers for prognostication and patient stratification in gynecological cancer based on whole-exome sequencing and epigenomic analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/10/02</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/03/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">69 endometrial carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">30 endometrial hyperplasia patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nobuhiro Takeshima</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=973&amp;Itemid=1183&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0176.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000172</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive sequencing analyses of uterine and ovarian carcinosarcoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/10/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">92 uterine carcinosarcomas</span></p>\r\n<p><span style=\"font-size: small;\">17 ovarian carcinosarcomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Seiichi Mori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1117&amp;Itemid=1307&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0177.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000197</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis assciated with malignance of brain tumor</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq, RNA-seq, ChIP-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X Ten, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">14 malignant gliomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Ito</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1080&amp;Itemid=1276&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0179.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000186</span></p>\r\n<p><span style=\"font-size: small;\">DRA009794</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shotgun metagenome analysis of oral microbiome in MRONJ and healthy individuals</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Metagenome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">4 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koji Yahara</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1416&amp;Itemid=1560&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0180.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000170</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic study and evaluation of small molecule compounds for congenital diseases and metabolic disorders caused by an aberrant RNA splicing</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Familial Dysautonomia: 2 cases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masahiko Ajiro</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=886&amp;Itemid=1109&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0181.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Aging of steroid production in the adrenal bland.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Immunohistochemistry</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Dako</span></p>\r\n<p><span style=\"font-size: small;\">(Autostainer Link 48)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">85 anatomical cases who were more than 50 years old</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koshiro Nishimoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1964&amp;Itemid=2024&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0182.v5</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000180</span></p>\r\n<p><span style=\"font-size: small;\">DRA008482</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000516</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehansive analysis of somatic mutations and genetic variations with whole genome sequencing</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/06/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/05/12</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/01/06</span></p>\r\n<p><span style=\"font-size: small;\">v4:2021/11/12</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/05/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(MinION)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000, Genome Analyzer IIx)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">liver cancer (normal cell): 174+42 case</span></p>\r\n<p><span style=\"font-size: small;\">liver cancer (tumor tissue): 11+42 cases</span></p>\r\n<p><span style=\"font-size: small;\">HapMap: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">Breast cancer: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akihiro Fujimoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1829&amp;Itemid=1903&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0184.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000239</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Construction of Japanese Whole-Genome database</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/09/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">4,566 general residents</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masayuki Yamamoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type II)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1521&amp;Itemid=1644&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0187.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000194</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000233</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genomic and genetic analysis of digestive tract cancer and elucidation of its clinicopathological significance.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/12</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/05/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture, Exome, RNA-seq), Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq, HiSeq 2500, HumanMethylation450)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">243 + 160 hepatocellular carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Aburatani</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=914&amp;Itemid=1135&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0188.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000179</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exploration for molecular targets in gastric cancer cell lines</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/06/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 gastric cancer cell lines</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Mano</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1185&amp;Itemid=1365&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0191.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA008575</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of personalized cancer vaccine targeting individual somatic mutations combined with immunoregulation of tumor microenvironment </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/4000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Pancreatic cancer: 17 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazuhiro Kakimi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1476&amp;Itemid=1608&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0192.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000196</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A study to verify the usefulness of cell free DNA as a prognostic biomarker after radiation / proton therapy for oligometastasis in colorectal cancer patients</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/04/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Colon cancer: 20 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masaki Nakamura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1127&amp;Itemid=1315&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0194.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000189</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Molecular mechanisms of drug resistance in cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 lung adenocarcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ryohei Katayama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1888&amp;Itemid=1958&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0195.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000190</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000234</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000269</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genetic analysis of gastrointestinal and hepatobiliary tumor</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/26</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/28</span></p>\r\n<p><span style=\"font-size: small;\">v3:2022/03/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, RNA-seq, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 4000, NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">5 nodule-in-nodule hepatocellular carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">20 liver cirrhosis and hepatocellular carcinomas after hepatitis C virus eradication</span></p>\r\n<p><span style=\"font-size: small;\">3 hepatitis C virus positive cirrhosis and hepatocellular carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">2 hepatitis C virus negative hepatocellular carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">42 + 1 patients</span> with gastric cancer and 3 patients with gastric submucosal tumor</p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atsushi Takai</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1024&amp;Itemid=1223&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0196.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of biomarker for suicide prevention using blood and brain samples of completed suicide</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/12/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HumanOmniExpress-24, HumanOmniExpressExome-8)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Suicide: 746 cases</span></p>\r\n<p><span style=\"font-size: small;\">Non-suicide: 14,049 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akitoyo Hishimoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3155&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">h</span></a><span style=\"font-size: small;\"></span><a href=\"index.php?Itemid=3992&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">um0197.v25</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000205</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000260</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000316</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000415</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000504</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000530</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000531</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000543</span></p>\r\n<p><span style=\"font-size: small;\">DRA014184</span></p>\r\n<p><span style=\"font-size: small;\">DRA014186</span></p>\r\n<p><span style=\"font-size: small;\">DRA014188</span></p>\r\n<p><span style=\"font-size: small;\">DRA014191</span></p>\r\n<p><span style=\"font-size: small;\">DRA014192</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000593</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000600</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000741</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000751</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-887</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1054</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000783</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of disease state by multi-layered omics analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/11/15</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/11/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/03/22</span></p>\r\n<p><span style=\"font-size: small;\">v4:2021/12/10</span></p>\r\n<p><span style=\"font-size: small;\">v5:2021/12/21</span></p>\r\n<p><span style=\"font-size: small;\">v6:2022/02/08</span></p>\r\n<p><span style=\"font-size: small;\">v7:2022/05/23</span></p>\r\n<p><span style=\"font-size: small;\">v8:2022/06/03</span></p>\r\n<p><span style=\"font-size: small;\">v9:2022/06/10</span></p>\r\n<p><span style=\"font-size: small;\">v10:2022/06/16</span></p>\r\n<p><span style=\"font-size: small;\">v11:2022/07/21</span></p>\r\n<p><span style=\"font-size: small;\">v12:2022/12/01</span></p>\r\n<p><span style=\"font-size: small;\">v13:2023/02/14</span></p>\r\n<p><span style=\"font-size: small;\">v14:2023/02/16</span></p>\r\n<p><span style=\"font-size: small;\">v15:2023/03/29</span></p>\r\n<p><span style=\"font-size: small;\">v16:2023/06/06</span></p>\r\n<p><span style=\"font-size: small;\">v17:2023/06/27</span></p>\r\n<p><span style=\"font-size: small;\">v18:2023/10/02</span></p>\r\n<p><span style=\"font-size: small;\">v19:2024/05/29</span></p>\r\n<p><span style=\"font-size: small;\">v20:2024/05/30</span></p>\r\n<p><span style=\"font-size: small;\">v21:2024/10/28</span></p>\r\n<p><span style=\"font-size: small;\">v22:2024/11/11</span></p>\r\n<p><span style=\"font-size: small;\">v23:2024/12/18</span></p>\r\n<p><span style=\"font-size: small;\">v24:2025/05/07</span></p>\r\n<p><span style=\"font-size: small;\">v25:2025/07/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Metagenome</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, RNA-seq, scRNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Presence or absence of endogenous herpesvirus 6, anellovirus load</span></p>\r\n<p><span style=\"font-size: small;\">proteimics</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/3000/X Ten, NovaSeq 6000, Infinium Asian Screening Array, HumanOmniExpressExome BeadChip, HumanOmniExpress BeadChip, HumanExome BeadChip, 　iCOGS OncoArray)</span></p>\r\n<p><span style=\"font-size: small;\">Applied Biosystems</span></p>\r\n<p><span style=\"font-size: small;\">(UK BiLEVE Axiom Array, UK Biobank Axiom Array)</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(FinnGen1 ThermoFisher Array or other genotyping arrays)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-T7)</span></p>\r\n<p><span style=\"font-size: small;\">Olink</span></p>\r\n<p><span style=\"font-size: small;\">(Olink Explore 3072)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">95 + 103 + 227 + 30 + 141 + 136 + 88 + 5 + 524</span> individuals</p>\r\n<p><span style=\"font-size: small;\">BBJ: 180,215 individuals</span></p>\r\n<p><span style=\"font-size: small;\">UK biobank: 377,583 individuals</span></p>\r\n<p><span style=\"font-size: small;\">FinnGen: 136,000 + 224,352 individuals</span></p>\r\n<p><span style=\"font-size: small;\">BACC: 247,173 individuals</span></p>\r\n<p><span style=\"font-size: small;\">PRACTICAL: 140,254 individuals</span></p>\r\n<p><span style=\"font-size: small;\">Autoimmune pulmonary alveolar proteinosis: 198 cases</span></p>\r\n<p><span style=\"font-size: small;\">Control participants: 395</span></p>\r\n<p><span style=\"font-size: small;\">Ulcerative Colitis: 35 cases</span></p>\r\n<p><span style=\"font-size: small;\">Crohn's disease: 39 cases</span></p>\r\n<p><span style=\"font-size: small;\">Healthy controls: 40 individuals</span></p>\r\n<p><span style=\"font-size: small;\">Intracranial germ cell tumors: 133 cases</span></p>\r\n<p><span style=\"font-size: small;\">Control participants: 762</span></p>\r\n<p><span style=\"font-size: small;\">COVID-19: 30 + 43 + 15 cases</span></p>\r\n<p><span style=\"font-size: small;\">Healthy controls: 31 + 44 + 27 individuals</span></p>\r\n<p><span style=\"font-size: small;\">Healthy subjects: 73 individuals</span></p>\r\n<p><span style=\"font-size: small;\">Hunner-type interstitial cystitis: 144 cases</span></p>\r\n<p><span style=\"font-size: small;\">Type 2 diabetes: 27,642 cases (BBJ)</span></p>\r\n<p><span style=\"font-size: small;\">Control participants: 70,242 (BBJ)</span></p>\r\n<p><span style=\"font-size: small;\">Type 2 diabetes: 27,642 cases (UK biobank)</span></p>\r\n<p><span style=\"font-size: small;\">Control participants: 70,242 (UK biobank)</span></p>\r\n<p><span style=\"font-size: small;\">Recurrent pregnancy loss: 1,728 cases</span></p>\r\n<p><span style=\"font-size: small;\">Autoimmune diseases: 2,238 cases</span></p>\r\n<p><span style=\"font-size: small;\">Control participants: 2,919</span></p>\r\n<p><span style=\"font-size: small;\">HPV-associated oropharyngeal cancer: 32 cases</span></p>\r\n<p><span style=\"font-size: small;\">Non-HPV-associated oropharyngeal cancer: 17 cases</span></p>\r\n<p><span style=\"font-size: small;\">Control participants: 2</span></p>\r\n<p><span style=\"font-size: small;\">NMOSD: 240 cases</span></p>\r\n<p><span style=\"font-size: small;\">Control participants: 50,578</span></p>\r\n<p><span style=\"font-size: small;\">Psoriasis: 204 cases</span></p>\r\n<p><span style=\"font-size: small;\">Control participants: 1,231</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese, British, Finnish)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yukinori Okada</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1190&amp;Itemid=1373&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0199.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000198</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of therapeutic target molecules in urological malignancies by using next generation sequencer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Prostate cancer: 25 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tetsuya Fujimura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2948&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0200.v6</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000202</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000265</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000290</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000387</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000758</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of somatic mutations and gene expression abnormalities involved in mammary tumor phenotype</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/29</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/05/07</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/10/01</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/03/02</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/08/29</span></p>\r\n<p><span style=\"font-size: small;\">v6:2024/11/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, WGS, Target Capture, Visium Spatial Gene Expression, semi-bulk RNA-seq, scRNA-seq, EM-seq, t-nanoEM)</span></p>\r\n<p><span style=\"font-size: small;\">CNV</span></p>\r\n<p><span style=\"font-size: small;\">Methylation analysis</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 3000, NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Chromium Controller)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">96 Ductal Carcinoma In Situ</span></p>\r\n<p><span style=\"font-size: small;\">4 + 1 Invasive Ductal Carcinoma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Satoi Nagasawa</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2866&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0201.v8</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000199</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000237*</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000256</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000378</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000350</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000550</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000719</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Collection and transfer of human tumor samples and research using genomic information</span></p>\r\n<p><span style=\"font-size: small;\">Transfer of existing samples and research using genomic information</span></p>\r\n<p><span style=\"font-size: small;\">Reseach of searching gene mutations in gastrointestinal chronic inflammatory diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/12/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/10/06</span></p>\r\n<p><span style=\"font-size: small;\">v3:2020/11/20</span></p>\r\n<p><span style=\"font-size: small;\">v4:2021/11/19</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/06/06</span></p>\r\n<p><span style=\"font-size: small;\">v6:2022/08/05</span></p>\r\n<p><span style=\"font-size: small;\">v7:2022/12/27</span></p>\r\n<p><span style=\"font-size: small;\">v8:2024/08/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, WGS, RNA-seq, ChIP-seq, scRNA-seq, ATAC-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/4000/X Ten, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">gastrointestinal inflammatory disease: 29 cases</span></p>\r\n<p><span style=\"font-size: small;\">gastrointestinal inflammatory disease with neoplastic disease: 26 cases</span></p>\r\n<p><span style=\"font-size: small;\">control patients who underwent colonoscopy: 16 individuals</span></p>\r\n<p><span style=\"font-size: small;\">neoplastic disease: 23 + 1 + 4 + 2 + 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">pancreatic cancer: 50 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshiro Sato</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2153&amp;Itemid=2169&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0202.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000379</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Study of genetic background and time course of congenital hearing loss to increase efficacy of auditory, speech, and language therapy.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/4000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 congenital hearing loss patients and their parents</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tatsuo Matsunaga</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1152&amp;Itemid=1337&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0203.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000206</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Establishment of an integrated database for clinical and genomic data in cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">154 patients with multiple myeloma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Keizo Horibe</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1009&amp;Itemid=1211&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0206.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000207</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Establishment and characterization of cell lines derived from pregnancy related diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/11/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">complete hydatidiform mole: 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takahiro Arima</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1034&amp;Itemid=1231&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0207.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of gene polymorphism and gene expression in human immune cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/01/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, ChIP-seq, Hi-C)</span></p>\r\n<p><span style=\"font-size: small;\">eQTL</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, HiSeq series, Infinium OmniExpressExome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">rheumatoid arthritis: 30 cases</span></p>\r\n<p><span style=\"font-size: small;\">osteoarthritis: 30 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Keishi Fujio</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1050&amp;Itemid=1243&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0208.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000214</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genetic analysis and database construction for head and neck cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/01/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X Ten)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 patients with cancer of the external auditory canal</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1019&amp;Itemid=1219&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0209.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic and clinical prediction models for the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a multicenter cohort study</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2019/12/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Direct sequencing</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(GeneChip® Scanner 3000 7G)</span></p>\r\n<p><span style=\"font-size: small;\">Applied Biosystems</span></p>\r\n<p><span style=\"font-size: small;\">(Veriti 96-Well Thermal Cycler and 3730XL DNA Analyzer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Rheumatoid arthritis: 166 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shunichi Kumagai</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1085&amp;Itemid=1280&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0210.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000211</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genomic analysis of hematological malignancies</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 patient with concomitant acute myeloid leukemia and mediastinal germ cell tumor</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazuya Shimoda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2035&amp;Itemid=2080&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0213.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000238</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Demographic History and Local Adaptation in Asian Population</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/07/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X Ten)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">60 Baltis individuals</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Min-Sheng Peng</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2694&amp;Itemid=2620&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0214.v9</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000220</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000296</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-397</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-398</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-420</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000486</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000598</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000485</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000626</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000627</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000648</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/09</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/03/05</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/04/28</span></p>\r\n<p><span style=\"font-size: small;\">v4:2022/01/21</span></p>\r\n<p><span style=\"font-size: small;\">v5:2022/03/09</span></p>\r\n<p><span style=\"font-size: small;\">v6:2022/08/25</span></p>\r\n<p><span style=\"font-size: small;\">v7:2023/03/28</span></p>\r\n<p><span style=\"font-size: small;\">v8:2023/07/06</span></p>\r\n<p><span style=\"font-size: small;\">v9:2024/02/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, scRNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">eQTL</span></p>\r\n<p><span style=\"font-size: small;\">BCR repertoire analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 Immune-mediated diseases: 544 cases</span></p>\r\n<p><span style=\"font-size: small;\">185 normal controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Keishi Fujio</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2193&amp;Itemid=2201&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0215.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000532</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Whole genome and RNA analysis of geriatric disease in Japanese</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Alzheimer's disease: 317 cases</span></p>\r\n<p><span style=\"font-size: small;\">Mild cognitive impairment: 432 cases</span></p>\r\n<p><span style=\"font-size: small;\">107 Healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kouichi Ozaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1466&amp;Itemid=1600&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0216.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000216</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000244</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000279</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analyses of immune status of patients with solid tumors including gastrointestinal cancer</span></p>\r\n<p><span style=\"font-size: small;\">Investigation of anti-tumor immunological response in solid tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/02/07</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/09/25</span></p>\r\n<p><span style=\"font-size: small;\">v3:2021/03/29</span></p>\r\n<p><span style=\"font-size: small;\">v4:2021/04/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">17 patients with lung adenocarcinoma</span></p>\r\n<p><span style=\"font-size: small;\">26 + 23 patients with gastric cancer</span></p>\r\n<p><span style=\"font-size: small;\">9 patients with lung cancer</span></p>\r\n<p><span style=\"font-size: small;\">5 patients with malignant melanoma</span></p>\r\n<p><span style=\"font-size: small;\">7 patients with cololectal cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyoshi Nishikawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1060&amp;Itemid=1258&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0217.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000217</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of genetic alterations predicting cancer progression from colorectal polyps</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/03/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Torrent)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">50 colorectal serrated lesions</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takeshi Sawada</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1270&amp;Itemid=1442&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0218.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-344</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Gene expression analysis in systemic sclerosis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Systemic sclerosis: 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Keishi Fujio</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1180&amp;Itemid=1361&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0220.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000223</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A study of influence of storage condition after blood collection on the plasma/serum comcentrations of compounds</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">LC-MS/MS</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Sciex</span></p>\r\n<p><span style=\"font-size: small;\">(TripleTOF 5600)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 heathy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Sumio Ohtsuki</span></p>\r\n<p><span style=\"font-size: small;\">(AMED-Metabolites)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2563&amp;Itemid=2520&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0221.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000225</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic study using human disease-specific iPS cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">iPS cells derived from Fabry disease patients: 3 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yohei Hayashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1065&amp;Itemid=1262&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0222.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000224</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of responsible genes and development of standardized medicine for familial breast cancer by genetic analysis with NGS technology </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/03/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">115 breast cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinji Ohno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1240&amp;Itemid=1415&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0223.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000232</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">The analyses of gene mutations in hematology malignancy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/09/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">7 patients with multiple myeloma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yasuhito Terui</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3199&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0225.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000226</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000835</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Mortality and risk of progression to adult T-cell leukemia/lymphoma in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture, RNA-seq, ATAC-seq, scRNA-seq, scATAC-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/3000, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HAM: 21 + 15 cases</span></p>\r\n<p><span style=\"font-size: small;\">asymptomatic HTLV-1 carriers: 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Makoto Yamagishi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1531&amp;Itemid=1652&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0226.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000229</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genomic and genetic analysis of upper gastrointestinal tumors and elucidation of its clinicopathological significance.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/06/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">141 stomach adenocarcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Aburatani</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1535&amp;Itemid=1656&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0227.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000228</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genomic and genetic analysis of gastric tumors and elucidation of its clinicopathological significance.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/06/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">102 stomach adenocarcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Aburatani</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1147&amp;Itemid=1331&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0229.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000230</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification and characterization of molecular markers in aging and neuronal disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/05/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">7 supercentenarians</span></p>\r\n<p><span style=\"font-size: small;\">2 family members</span></p>\r\n<p><span style=\"font-size: small;\">2 unrelated donors</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Piero Carninci</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2828&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0231.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000287</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A study for the establishment of disease-specific iPS cells.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">120 Healthy volunteers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Megumu K. Saito</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1175&amp;Itemid=1357&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0232.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000231</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Evaluation of metastasis and recurrence by monitoring circulating tumor DNA of gastric cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/06/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 gastric cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Satsoshi Nishizuka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1516&amp;Itemid=1640&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0233.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000236</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Paediatric Hepatic International Tumour Trial (JPLT4: PHITT)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/05/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, WGBS)</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, HumanMethylation450)</span></p>\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(SNP Array 6.0)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">165 pediatric hepatoblastomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Eiso Hiyama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1454&amp;Itemid=1590&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0235.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000272</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Evaluation and imaging study of the preclinical stage of Alzheimer's disease in Japan</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/04/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Neuroimage</span></p>\r\n<p><span style=\"font-size: small;\">Clinical Info</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><a href=\"/en/hum0235-v1-release#mriscanners\" target=\"_blank\" rel=\"noopener noreferrer\">MRI Scanners (9 Models)</a></p>\r\n<p><a href=\"/en/hum0235-v1-release#petscanners\" target=\"_blank\" rel=\"noopener noreferrer\">PET Scanners (11 Models)</a></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">25 healthly controls </span></p>\r\n<p><span style=\"font-size: small;\">3 preclinical AD </span></p>\r\n<p><span style=\"font-size: small;\">7 early MCI </span></p>\r\n<p><span style=\"font-size: small;\">5 late MCI </span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Shimada</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1331&amp;Itemid=1490&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0236.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000245</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of tumor infiltrating lymphocytes therapy targeting gene mutation of lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/12/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(MinION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">7 non-small cell lung cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tetsuya Nakatsura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1391&amp;Itemid=1540&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0237.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Whole genome and RNA analysis of geriatric disease in Japanese</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Japonica Array, SNP Array 6.0)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Alzheimer's disease: 3,962 cases</span></p>\r\n<p><span style=\"font-size: small;\">4,074 controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kouichi Ozaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1205&amp;Itemid=1385&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0238.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000240</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of personalized medicine</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/07/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 participants of BBJ</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yukihide Momozawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1200&amp;Itemid=1381&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0239.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000241</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genomic and Proteomic comprehensive analysis related to cancer, infectious diseases, intractable diseases and lifestyle-related diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/07/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">19 patients with urothelial bladder cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yosuke Hirotsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1286&amp;Itemid=1454&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0240.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000258</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Whole genome sequence analysis in patients with primary central nervous system lymphomas</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Torrent)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">28 PCNSL patinets</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ryuya Yamanaka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1356&amp;Itemid=1510&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0242.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000243</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Frequent post-treatment monitoring of colorectal cancer using individualized ctDNA validated by multi-regional molecular profiling</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/01/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">12 colorectal cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Satsoshi Nishizuka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1306&amp;Itemid=1470&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0243.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000253</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of humanized mice for human immunity research/Construction of disease and treatment model using iPS cells derived from human hematopoitec cells.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, CAGE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cord blood: 24 individuals</span></p>\r\n<p><span style=\"font-size: small;\">Acute Myeloid Leukemia: 116 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fumihiko Ishikawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2204&amp;Itemid=2227&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0245.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000276</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive Genome analysis of adult acute lymphoblastic leukemia (JALSG ALL202U-GWS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/10/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">46 patients with Ph-negative ALL</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fumihiko Hayakawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1351&amp;Itemid=1506&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0247.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000249</span></p>\r\n<p><span style=\"font-size: small;\">DRA010773</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research for gene mutations in cancer representing immune status of the patients</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/01/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 malignant melanoma patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Iwata</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1301&amp;Itemid=1466&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0248.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000259</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Establishment of a Japanese reference genome sequence by high-precision long-read sequencing</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/10/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2020/11/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">PacBio (RS II)</span></p>\r\n<p><span style=\"font-size: small;\">Bionano (Irys, Saphyr)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina (HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 Japanese male individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masayuki Yamamoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type II)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3004&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0249.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000248</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000663</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of pathological conditions and development of therapeutic methods using iPS cells derived from patients with hard tissue/connective tissue related diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2020/09/01</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/03/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(CAGE-seq, scRNA-seq, CUT＆RUN-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 patients with hard tissue/connective tissue related diseases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshifumi Azuma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1439&amp;Itemid=1578&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0250.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000277</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Brain Mapping by Integrated Neurotechnologies for Disease Studies: Human Brain Aging Imaging Study</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/03/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Neuroimage</span></p>\r\n<p><span style=\"font-size: small;\">Clinical Info</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><a href=\"/en/hum0250-v1-release#mriscanners\" target=\"_blank\" rel=\"noopener noreferrer\">MRI Scanners (1 Model)</a></p>\r\n<p><a href=\"/en/hum0250-v1-release#petscanners\" target=\"_blank\" rel=\"noopener noreferrer\">PET Scanners (1 Model)</a></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">11 MCI </span></p>\r\n<p><span style=\"font-size: small;\">28 healthly controls </span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takeshi Iwatsubo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><span style=\"font-size: small;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=2208&amp;Itemid=2231&amp;lang=en\" target=\"_blank\">hum0251.v1</a></span></p>\r\n<p><span style=\"font-size: small;\">JGAS000278</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Phase II clinical trial of adult Philadelphia chromosome-negative precursor B-cell acute lymphocytic leukemia with combination chemotherapy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/10/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">153 patients with Ph-negative B-ALL</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yoshihiro Hatta</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2725&amp;Itemid=2644&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0252.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000301</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000553</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Study for molecular characteristics of adult T-cell leukemia-lymphoma and HTLV-1-associated diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/07/12</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/12/06</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/03/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">（Target Capture, RNA-seq, scRNA-seq, WGS, scATAC-seq, ChIP-seq）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/3000, NovaSeq 6000, NextSeq 500）</span></p>\r\n<p><span style=\"font-size: small;\"> MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ATL: 6 + 4 + 6 cases (Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">HTLV-1 infected carriers: 10 cases (Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">CD4+ T cells from 3 + 1 healthy donors (Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Makoto Yamagishi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1612&amp;Itemid=1718&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0254.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000257</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of sequencing library preparation method from cell-free DNA in blood</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq, HiSeq X Ten)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">5 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fumihito Miura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2324&amp;Itemid=2331&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0257.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000262</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000263</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000264</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000514</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-414</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-415</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-416</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-417</span></p>\r\n<p><span style=\"font-size: small;\">GSE202023</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of culturing methods amplifying micro-specimens derived from human pancreas and biliary tract tissues</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/12/24</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/01/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, ATAC-seq, ChIP-seq, Hi-C)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, HiSeq 2500, NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Pancreatic ductal adenocarcinoma: 17 cases</span></p>\r\n<p><span style=\"font-size: small;\">Intraductal papillary mucinous neoplasm: 6 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Keisuke Tateishi</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1366&amp;Itemid=1518&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0261.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome-wide association study of primary biliary cholangitis (PBC) －an additional study of 1,000 Japanese PBC patients－</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/01/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2021/01/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Axiom ASI, Japonica Array v1)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1,953 PBCs and 3,690 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Minoru Nakamura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1496&amp;Itemid=1624&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0262.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000267</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification of biomarkers for prediction of efficacy of microtubule inhibitors and antifolates in non-small cell lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Lung Adenocarcinoma: 24 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Katsuya Tsuchihara</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2541&amp;Itemid=2502&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0263.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000292</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive analysis of the abnormality of the genes in juvenile myelomonocytic leukemia</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(DREAM-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Juvenile myelomonocytic Leukemia: 149 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yoshiyuki Takahashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1839&amp;Itemid=1911&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0264.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000508</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of the pathogenesis and identification of susceptibility genes for sleep disorders by genetic and functional analyses.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/02/07</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(SNP Array 6.0)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Idiopathic hypersomnia: 129 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Makoto Honda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2293&amp;Itemid=2301&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0266.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000281</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of the pathogenesis of autoimmune dermatosis using patient samples.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 patients with pemphigus</span></p>\r\n<p><span style=\"font-size: small;\">3 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shohei Egami</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2988&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0267.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000284</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive gene mutation analysis of cancer-predisposing genes and cancer-causing genes in pediatric cancer/hematologic disease.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/02/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">47 children who suspected of sarcoma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Manabu Wakamatsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3183&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0268.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000280</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000766</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Direct and comprehensive identification of neoantigens using cancer tissues</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/04/09</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/08/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Iso-seq, CAGE-seq, RNA-seq, scRNA-seq, scTCR-seq, Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500, NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">(Sequel)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> Human colon cancer cell line: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n<p><span style=\"font-size: small;\">Colon cancer: 6 patients</span></p>\r\n<p><span style=\"font-size: small;\">Endometrial cancer: 5 patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takayuki Kanaseki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2737&amp;Itemid=2652&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0269.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000295</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000565</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000566</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000567</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Sensitive gene analysis of hereditary cardiovascular disease</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/05/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/03/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/3000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">hereditary cardiovascular disease: 13 + 20 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yoshihiro Asano</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1932&amp;Itemid=1992&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0270.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000282</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Translational research for elucidating molecular and pathological abnormalities specific to bone and soft tissue tumors based on genomic and genetic analysis, and for developing new diagnostic and therapeutic strategies</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">16 pediatric Osteosarcoma patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tsukasa Yonemoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1491&amp;Itemid=1620&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0271.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000288</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genome analysis related to individual differences in phenotypic expression in autosomal dominant diseases caused by haploinsufficiency</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture, Target RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">20 patients with neurofibromatosis type 1</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yo Niida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2928&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0272.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000285</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000589</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of the immune status of melanoma and other skin tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/12/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/02/07</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/11/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, scRNA-seq, scTCR-seq, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Torrent proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">melanoma: 4 + 9 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Inozume</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1602&amp;Itemid=1710&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0273.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000300</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A study of molecular pathology for carcinogenesis and progression of breast cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/08/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Amplicon-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 patients of lobular carcinoma in situ with ductal carcinoma in situ</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinobu Masuda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1923&amp;Itemid=1984&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0274.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000294</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Integrated analysis of selective mRNA export by mRNA export factors, UAP56 and URH49</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/04/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HeLa cells with knockdown of the target genes: 20 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kenichi Fujita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1596&amp;Itemid=1706&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0275.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000313</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive analysis of genetic abnormalities in solid tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/08/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nine subjects without Hp infection or gastric cancer (healthy population)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Seishi Ogawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1618&amp;Itemid=1722&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0276.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000308</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of a general-purpose genetic diagnostic panel for Gorlin syndrome and its application to liquid biopsy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/10/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">12 patients with Gorlin syndrome</span></p>\r\n<p><span style=\"font-size: small;\">3 blood relatives</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshifumi Azuma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3191&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0277.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000303</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000564</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000737</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of genes related to the oncogenesis, progression or effectiveness of drug therapies of urological tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/09</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/04/18</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/05/10</span></p>\r\n<p><span style=\"font-size: small;\">v4:2025/09/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, Exome, RNA-seq, WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500, HiSeq 2500, NovaSeq 6000/PE150)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">renal cell carcinoma: 15 + 30 + 167 cases</span></p>\r\n<p><span style=\"font-size: small;\">sporadic oncocytoma: 7 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hisashi Hasumi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2025&amp;Itemid=2072&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0278.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000304</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000305</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of genome of breast cancer stem cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/07/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 3000, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Breast cancer: 5 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Noriko Gotoh</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2129&amp;Itemid=2149&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0279.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000307</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Stratification of refractory malignant lymphoma by genomic/epigenomic analysis and immunohistochemistry and development of novel therapeutic approaches</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 550)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">177 patients with diffuse large B-cell lymphoma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Emiko Sakaida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1760&amp;Itemid=1847&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0280.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA012560</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">The research for the identification of neoantigen and tumor immune microenvironment in lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/07</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">lung cancer: 113 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hirokazu Matsushita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2338&amp;Itemid=2343&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0284.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000309</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of the molecular mechanism that controls the transition from precancerous lesions to invasive cancer due to disruption of biological maintenance function</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/01/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Breast cancer: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Jun Nakayama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2223&amp;Itemid=2243&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0286.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000311</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000523</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of molecular mechanism of NAFLD-HCC</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/12</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/11/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Visium Spatial Gene Expression, Target Capture)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">55 hepatocellular carcinoma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takahiro Kodama</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2725&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0287.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000310</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000573</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000690</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome sequence comparison of human iPS cell lines</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/02</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/03/29</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/05/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">5 +1 +1 Human iPS cell lines</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shihori Yokobayashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2158&amp;Itemid=2173&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0289.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000317</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Mechanisms on relapse after allogeneic hematopoietic cell transplantation in CMML</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, Exome)</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, MethylationEPIC)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">chronic myelomonocytic leukemia (CMML): 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yu Akahoshi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3086&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0290.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000321</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000637</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1053</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1058</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1059</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1060</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Comprehensive analysis of interaction between human gene expression and environmental metagenomes.</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/02/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/06/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, scRNA-seq, TCR-seq, BCR-seq, scATAC-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Proteomics</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000/X, MethylationEPIC)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Chromium Controller)</span></p>\r\n<p><span style=\"font-size: small;\">Fluidigm</span></p>\r\n<p><span style=\"font-size: small;\">(Helios, a CyTOF System)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-T7)</span></p>\r\n<p><span style=\"font-size: small;\">Olink</span></p>\r\n<p><span style=\"font-size: small;\">(Olink Explore 3072)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">7 + 97 healthy volunteers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yutaka Suzuki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2589&amp;Itemid=2540&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0291.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000359</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of molecular mechanisms of tumorigenesis and development of diagnoses and treatments based on comprehensive genomic analyses in pancreatic tumors, duodenal tumors and biliary tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/12/10</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/09/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Pancreatic tumor: 57+6 cases</span></p>\r\n<p><span style=\"font-size: small;\">Duodenal tumor: 6+1 cases</span></p>\r\n<p><span style=\"font-size: small;\">Biliary tumors: 11 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinichi Yachida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1607&amp;Itemid=1714&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0292.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000330</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of blood-based biomarkers for precision medicine in castration-resistant prostate cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">100 CRPC patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shusuke Akamatsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2040&amp;Itemid=2084&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0293.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000320</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exploratory research of genetic factors that regulate the therapeutic sensitivity of hematopoietic malignancy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/07/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X Ten)</span></p>\r\n<p><span style=\"font-size: small;\">BGI</span></p>\r\n<p><span style=\"font-size: small;\">(BGISEQ-500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ATL: 7 cases</span></p>\r\n<p><span style=\"font-size: small;\">ATL cell line: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takaomi Sanda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2749&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0294.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000708</span></p>\r\n</th>\r\n<td class=\"”highlight”\"><span style=\"font-size: small;\">Single cell analysis of tumor-infiltrating T cells</span></td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/05/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">esophageal cancer: 28 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shogo Kumagai</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=1742&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0295.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000351</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Search for biomarkers for diagnosis, evaluation of therapeutic effect, and follow-up of skin tumors (prospective observational study)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/10/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Amplicon-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion S5)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">melanoma: 98 cases</span></p>\r\n<p><span style=\"font-size: small;\">sebaceous nevus: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hisashi Uhara</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2173&amp;Itemid=2185&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0297.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000348</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive study of color vision diversity</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 healthy donor</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Chihiro Hiramatsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2178&amp;Itemid=2189&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0299.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA012759</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of chromosome background of cancerous mutations using a long read sequencer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Healthy white B-Lymphocyte cell line HG002 (NA24385): 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yutaka Suzuki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1669&amp;Itemid=1766&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0300.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000367</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Whole-genome and whole-exome analyses of cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">89 Esophageal squamous cell carcinomas</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Johji Inazawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1699&amp;Itemid=1790&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0301.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000368</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">An integrative analysis study of genomic abnormalities and immune status in breast cancer patients and high-risk individuals (Immuno-Genome Atlas Project)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">26 patients with breast cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Mano</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2742&amp;Itemid=2656&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0302.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000382</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000683</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">iPS Cell Advanced Characterization and Development of modified iPS cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/05</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/03/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">iPS cells derived from patients with Wilson's disease: 6 samples</span></p>\r\n<p><span style=\"font-size: small;\">iPS cells derived from patients with juvenile nephron tabes (NPH1): 12 samples</span></p>\r\n<p><span style=\"font-size: small;\">iPS cells derived from healthy donors: 6+6 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yohei Hayashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1756&amp;Itemid=1843&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0304.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000370</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exome sequencing of human breast cancer tissues resistant to taxanes.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/04/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">6 breast cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yumi Wanifuchi-Endo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1704&amp;Itemid=1794&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0305.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000377</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A multicenter study of biological and genetic manifestations of subsequent solid cancers after hematopoietic cell transplantation</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">14 de novo cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yoshihiro Inamoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1633&amp;Itemid=1734&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0306.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000361</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cancer Genome Sequencing Analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/10/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(MinION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">9 liver cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1869&amp;Itemid=1935&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0307.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000416</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis for skin molecules in patients with atopic dermatitis No.2.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion S5)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">29 healthy male subjects</span></p>\r\n<p><span style=\"font-size: small;\">atopic dermatitis: 30 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takayoshi Inoue</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1873&amp;Itemid=1939&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0308.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000417</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Circadian rhythm of skin molecules.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion S5)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 healthy female subjects</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takayoshi Inoue</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1877&amp;Itemid=1943&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0309.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000418</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comparison between sebum and stratum corneum molecules.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion S5)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 healthy male subjects</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takayoshi Inoue</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3098&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0311.v7</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000412</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000541</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000561</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000785</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Management of Biobank Japan and the investigation of disease biomarkers for the realization of personalized medicine</span></p>\r\n<p><span style=\"font-size: small;\">Discovery of disease makers from disease cohort network</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/07/28</span></p>\r\n<p><span style=\"font-size: small;\">v3:2022/09/08</span></p>\r\n<p><span style=\"font-size: small;\">v4:2023/04/24</span></p>\r\n<p><span style=\"font-size: small;\">v5:2023/07/27</span></p>\r\n<p><span style=\"font-size: small;\">v6:2024/05/22</span></p>\r\n<p><span style=\"font-size: small;\">v7:2025/06/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Metabolome</span></p>\r\n<p><span style=\"font-size: small;\">Proteomics</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Asian Screening Array, HumanOmniExpressExome, HumanOmniExpress, HumanExome)</span></p>\r\n<p><span style=\"font-size: small;\">Bruker</span></p>\r\n<p><span style=\"font-size: small;\">(AVANCE IIIHD)</span></p>\r\n<p><span style=\"font-size: small;\">Olink</span></p>\r\n<p><span style=\"font-size: small;\"> (Explore 3072, Target 96)</span></p>\r\n<p><span style=\"font-size: small;\">Somalogic</span></p>\r\n<p><span style=\"font-size: small;\"> (SomaScan)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">11,716 + 180,882 + 1,285 + 2,570 + 40,907 + 3,050 patients from BBJ 1st cohort</span></p>\r\n<p><span style=\"font-size: small;\">42,689 patients from BBJ 2nd cohort</span></p>\r\n<p><span style=\"font-size: small;\">ToMMo: 49,621 individuals</span></p>\r\n<p><span style=\"font-size: small;\">UK biobank: 456,327 individuals</span></p>\r\n<p><span style=\"font-size: small;\">FinnGen: 230,635 individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese, British, Finnish)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koichi Matsuda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2803&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0312.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA016285</span></p>\r\n<p><span style=\"font-size: small;\">DRA016393</span></p>\r\n<p><span style=\"font-size: small;\">DRA016394</span></p>\r\n<p><span style=\"font-size: small;\">DRA016395</span></p>\r\n<p><span style=\"font-size: small;\">DRA018714</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic study of complex diseases through comprehensive analysis of functional variants</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/06/17</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/06/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, Iso-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\"> (NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(MinION)</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">(Sequel II/IIe)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">immortalized B cell lines from healthy Japanese volunteers: 95 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n<p><span style=\"font-size: small;\">1 healthy subject</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yuta Kochi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1679&amp;Itemid=1774&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0314.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000383</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of the relationship between disease phenotype and genotype in patients with Alzheimer's disease</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/11/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Infinium OmniExpressExome-8)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">102 patients with sporadic Alzheimer's disease</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Haruhisa Inoue</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2055&amp;Itemid=2096&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0315.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000385</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive analysis of genetic alterations in hematological malignancies</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/07/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, scRNA-seq, ChIP-seq, Target Capture)</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500/X Ten, MethylationEPIC, HumanMethylation450)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">84 infants with KMT2A-rearranged acute lymphoblastic leukemia</span></p>\r\n<p><span style=\"font-size: small;\">3 cell lines derived from infants with KMT2A-rearranged acute lymphoblastic leukemia</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Junko Takita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1954&amp;Itemid=2016&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0316.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000535</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Whole-genome sequencing of esophageal cancer to elucidate pathogenesis and search for treatment-sensitive markers</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Esophageal squamous cell carcinoma: 110 cases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2799&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0317.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000413</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000707</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research on the establishment of patient derived xenograft models useful for drug discovery research</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2021/12/06</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/06/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Non-small cell lung cancer: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">Cancer: 52 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akinobu Hamada</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1864&amp;Itemid=1931&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0318.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000483</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Clinical sequence of hematological malignancy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/03/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">B-ALL: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Arinobu Tojo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1779&amp;Itemid=1863&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0319.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000487</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of diagnostic markers for prostate cancer using genetic polymorphisms</span></p>\r\n<p><span style=\"font-size: small;\">Identification of Rare Variants Involved in the Development of Prostate Cancer in Japanese</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1,336 men with suspected prostate cancer scheduled for prostate biopsy</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shusuke Akamatsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1799&amp;Itemid=1879&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0320.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000480</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Immunomonitoring study in patients with malignant tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, TCR-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">lung adenocarcinoma: 2 cases</span></p>\r\n<p><span style=\"font-size: small;\">head and neck cancer: 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yosuke Togashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1974&amp;Itemid=2034&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0321.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000482</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive analysis of interaction between human gene expression and environmental metagenomes</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/06/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Myasthenia gravis: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tatsusada Okuno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1789&amp;Itemid=1871&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0323.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000489</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Biomarker exploration of colon cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/01/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(CAGE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">45 colon cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yasushi Kogo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1913&amp;Itemid=1980&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0324.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000515</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis of cerebrovascular diseases and neuromuscular disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/04/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGBS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10 neuromyelitis optica (NMOSD) positive for AQP4 antibody</span></p>\r\n<p><span style=\"font-size: small;\">8 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tatsusada Okuno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1834&amp;Itemid=1907&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0327.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000507</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Screening of neoantigens and neoantigen reactive T cell receptors in hepatobiliary and pancreatic cancer for clinical application of personalized T cell therapy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/02/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 550)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">hepatocellular carcinoma: 28 cases</span></p>\r\n<p><span style=\"font-size: small;\">metastatic colorectal carcinoma: 18 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshihiro Suzuki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2452&amp;Itemid=2435&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0328.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000509</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Frequency of germline variants in genes associated with DNA repair among adanced prostate cancer patients in Japan</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/05/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">prostate cancer: 129 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shusuke Akamatsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1987&amp;Itemid=2042&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0329.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000522</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Next-generation sequencing-based comprehensive genetic analysis of undiagnosed disease</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/06/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Patients with undiagnosed diseases and their parents: 177 families（522 samples）</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hideki Muramatsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1918&amp;Itemid=1976&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0331.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Construction of control data for the promotion of genomic medicine for cancers and rare diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/02/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">9290 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Katsushi Tokunaga</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=1884&amp;Itemid=1947&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0332.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000510</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A study on personalized medicine in genitourinary cancers using genetic biomarkers.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 castration-resistant prostate cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shusuke Akamatsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2124&amp;Itemid=2145&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0335.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA014819</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research on new diagnosis and clinical picture of lymphoproliferative diseases by combining genetic analysis and immunological traits</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Waldenström macroglobulinemia: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">non IgM-type lymphoplasmacytic lymphoma: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akihiko Yokohama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2824&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0337.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000521</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fundamental research on establishment of a novel tailor-maid therapy for refractory gynecologic malignancy based on comprehensive omics analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">squamous cell carcinoma arising from mature teratoma of the ovary: 5 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kosuke Yoshida</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2237&amp;Itemid=2255&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0338.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000575</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive cancer genome, epigenome, and immunogenome analysis for gastric cancer unaffected by aging or Helicobacter pylori infection</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/11/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"><em>H. Pylori</em> uninfected gastric cancer: 27 cases</span></p>\r\n<p><span style=\"font-size: small;\"><em>H. Pylori</em> infected gastric cancer: 36 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Seiichi Mori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2085&amp;Itemid=2117&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0340.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000520</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genomic analysis using next-generation sequencer for pediatric solid tumor cases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Hiseq X Ten)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Colorectal cancer: 24 cases</span></p>\r\n<p><span style=\"font-size: small;\">Retinoblastoma: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">Glioblastoma: 2 cases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Utako Oba</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2014&amp;Itemid=2064&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0342.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000538</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Immunohistochemical and molecular pathological search in gastrointestinal tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/06/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Colorectal cancer: 29 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shigeki Sekine</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2894&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0343.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-759</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000739</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of COVID19 vaccine and evaluation system based on genetics of COVID-19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/26</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/06/14</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/06/24</span></p>\r\n<p><span style=\"font-size: small;\">v4:2024/10/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n<p><span style=\"font-size: small;\">Protein expression</span></p>\r\n<p><span style=\"font-size: small;\">eQTL/sQTL/pQTL</span></p>\r\n<p><span style=\"font-size: small;\">Presence or absence of endogenous herpesvirus 6, anellovirus load</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Asian Screening Array, NovaSeq6000)</span></p>\r\n<p><span style=\"font-size: small;\">Olink</span></p>\r\n<p><span style=\"font-size: small;\">(Olink Explore 3072)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">COVID-19: 2,393 cases</span></p>\r\n<p><span style=\"font-size: small;\">Healthy controls: 3,289 individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koichi Fukunaga</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2463&amp;Itemid=2443&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0344.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000533</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000611</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome sequencing analysis for biliary tract cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/04</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/05/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, RNA-seq, Amplicon-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(MGISEQ-2000RS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">kidney cancers: 38 cases</span></p>\r\n<p><span style=\"font-size: small;\">chronic kidney disease: 77 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">HEK293 cell line: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2097&amp;Itemid=2125&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0345.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000528</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000551</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fundamental study for regenerative medicine utilizing cord blood</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, ATAC-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">30 healthy volunteers</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kohshi Ohishi</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2045&amp;Itemid=2088&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0347.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genetic analysis of acute encephalopathy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/05/23</span></p>\r\n<p><span style=\"font-size: small;\">v2:2022/07/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Sanger-seq</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Life Technologies</span></p>\r\n<p><span style=\"font-size: small;\">(310 Genetic Analyzer, 3100 Genetic Analyzer, 3130xl Genetic Analyzer)</span></p>\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Japonica Array v2)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD): 283 cases</span></p>\r\n<p><span style=\"font-size: small;\">Healthy controls: 799 individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masashi Mizuguchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2458&amp;Itemid=2439&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0348.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000537</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of ATL progression by CD30 signaling and its biomarkers</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/05/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n<p><span style=\"font-size: small;\">Array CGH</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">(GenetiSure Cancer Research CGH+SNP Microarray 2 x 400K)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ATL: 8 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Makoto Nakashima</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2777&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0350.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000689</span></p>\r\n<p><span style=\"font-size: small;\">DRA018405</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-739</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-740</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-741</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-742</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-743</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-744</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-745</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-746</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research to establish a foundation for integrated analysis of human genetic polymorphisms and omics data</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/06/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(5' single-cell RNA-seq, 3' single-cell RNA-seq, Micro-C and Region Capture Micro-C, CITE-seq, Multimodal assay including single-nucleus ATAC-seq, 3' and 5’ single-nucleus RNA-seq, and 5' single-cell RNA-seq, MAS-seq, CAGE-seq, and NET-CAGE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, NextSeq 500)</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">(Sequel Ⅱ)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 healthy individuals (1 male, 2 females)</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">CRISPR-activated Jurkat cells: 15 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazuhiko Yamamoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2143&amp;Itemid=2161&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0351.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000540</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">New classification of occlusive cerebrovascular diseases by combining diagnostic imaging and genetic analysis of RNF213</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Metagenome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">moyamoya disease: 27 cases</span></p>\r\n<p><span style=\"font-size: small;\">non-moyamoya intracranial large artery disease: 7 cases</span></p>\r\n<p><span style=\"font-size: small;\">controls: 15 individuals.</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yohei Mineharu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2030&amp;Itemid=2076&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0352.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000545</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analytical study of protein function and RNA expression involved in predicting treatment efficacy and adverse event development in lung cancer radiotherapy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">primary lung cancer: 5 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masanori Someya</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2417&amp;Itemid=2407&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0354.v2</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analyses of circulating tumor cells from patients with advanced urogenital cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/06/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/04/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">qRT-PCR</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">BioRad</span></p>\r\n<p><span style=\"font-size: small;\">(T100 Thermal cycler)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">127 patients with advanced metastatic castration-resistant prostate cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masayoshi Nagata</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2480&amp;Itemid=2453&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0355.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000544</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genomic analysis of genitourinary tumors by next generation sequencing</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Microarray</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, NextSeq 500, HiSeq X Ten)</span></p>\r\n<p><span style=\"font-size: small;\">NanoString Technologies</span></p>\r\n<p><span style=\"font-size: small;\">(nCounter Digital Analyzer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">hereditary clear cell renal cell carcinoma associated with VHL disease: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Keisuke Kataoka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2761&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0356.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA015288</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-579</span></p>\r\n<p><span style=\"font-size: small;\">DRA016520</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-619</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of genetic alterations in colorectal carcinogenesis and establishment of clinical significance of interstitial</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/05/31</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 + 2 colorectal cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koshi Mimori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3036&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0357.v6</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000557</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000609</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000610</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research for biological features by gene expression analysis and biomarkers at diagnosis/therapeutics in lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/11/30</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/01/11</span></p>\r\n<p><span style=\"font-size: small;\">v3:2023/02/15</span></p>\r\n<p><span style=\"font-size: small;\">v4:2023/08/09</span></p>\r\n<p><span style=\"font-size: small;\">v5:2024/06/05</span></p>\r\n<p><span style=\"font-size: small;\">v6:2025/04/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, RNA-seq, scRNA-seq, ATAC-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/X Ten, NovaSeq 6000, Infinium MethylationEPIC)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">lung cancer: 105 + 2 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Yasuda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3203&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0358.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000582</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000586</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000640</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000824</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000825</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research of genetic abnormalities related to the development and prognosis of adenocarcinoma and squamous cell carcinoma of the cervix and vaginal and vulvar cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/10/19</span></p>\r\n<p><span style=\"font-size: small;\">v3:2025/09/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, scRNA-seq, Target bisulfite-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000/X Plus, MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">cervical cancer: 19 + 4 + 96 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">NIKS18 cell line: 5 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kenbun Sone</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2075&amp;Itemid=2109&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0359.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000548</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genomic and Epigenetic Analysis on T/NK-cell lymphoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Extranodal NK/T-cell lymphoma, nasal type: 67 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Naoki Oishi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2273&amp;Itemid=2283&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0360.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000546</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exploratory research on COVID-19 pathogenesis and aggravation</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, scVDJ-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">COVID-19: 6 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ai Tachikawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3016&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0362.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000552</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">The study on genomic profiling using clinical specimens (tissue, blood, etc.) form patients with lung and thymic tumors</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">thymoma: 98 cases </span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinichi Yachida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2113&amp;Itemid=2137&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0364.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive analysis of microsatellite polymorphisms in human populations</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/08/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(bam files were publicly available)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Simons Genome Diversity Project (SGDP): 276 samples</span></p>\r\n<p><span style=\"font-size: small;\">Human Genome Diversity Project (HGDP): 693 samples</span></p>\r\n<p><span style=\"font-size: small;\">Jomon Individual: 1 individual</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akihiro Fujimoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2214&amp;Itemid=2235&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0365.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000569</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">The role of gut microbiota in metabolic diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(CAGE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">normoglycemic lean group: 103 individuals</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">obese group: 98 cases</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">prediabetic group: 97 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroshi Ohno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2367&amp;Itemid=2367&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0366.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-511</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-512</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Pathogenesis of severe acute respiratory syndrome coronavirus 2 infection (COVID-19)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/03/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, RNA-seq, ATAC-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">COVID-19: 16 cases</span></p>\r\n<p><span style=\"font-size: small;\">10 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yasuhiro Kato</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2183&amp;Itemid=2193&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0367.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000558</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Clinical sequence of hematological malignancy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">langerhans cell histiocytosis: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Arinobu Tojo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2247&amp;Itemid=2263&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0368.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000559</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p>Identification and functional analysis of novel causative genes of ICF syndrome by whole genome sequencing</p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/11/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(PBAT-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">ICF syndrome: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Motoko Unoki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2198&amp;Itemid=2205&amp;lang=en\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: small;\">hum0369.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000562</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A study of resistance to novel coronavirus infection in health care workers</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/09/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">139 healthy persons</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atsushi Kawaguchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2288&amp;Itemid=2297&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0371.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000574</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research on genes and proteins associated with liver disease.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Metagenome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NASH: 20 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ryosuke Tateishi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2242&amp;Itemid=2259&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0372.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000572</span></p>\r\n<p><span style=\"font-size: small;\">MTBKS213</span></p>\r\n<p><span style=\"font-size: small;\">MTBKS214</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of disease state by multi-layered omics analysis</span></p>\r\n<p>&nbsp;</p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/11/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Metabolome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Agilent Technologies</span></p>\r\n<p><span style=\"font-size: small;\">(Agilent CE system, Agilent LC System)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">type2 diabetes: 300 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshimasa Yamauchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3070&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0375.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000688</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">identification of disease responsible genome region and establishment of genome information technology by next generation DNA sequencer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">tuberous sclerosis complex: 163 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Mari Wataya-Kaneda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2382&amp;Itemid=2379&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0376.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000585</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Establishment of xenografts and cultured cell lines from clinical samples.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/27</span></p>\r\n<p><span style=\"font-size: small;\">v2:2023/03/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">endometrial cancer: 2 + 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshio Imai</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2262&amp;Itemid=2275&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0377.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000579</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research on the genetic basis of arrhythmia syndrome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2022/12/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Amplicon-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">(Ion Proton)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">LQTS: 556 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshihiro Tanaka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2870&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0378.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000583</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000612</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Basic research to elucidate the pathogenesis of hemolytic anemia</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/09/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cold agglutinin disease: 2 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Daisuke Koyama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2643&amp;Itemid=2582&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0379.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000578</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Immune regulation by cotrolling regulatory T cell-specific epigenome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, scVDJ-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">myasthenia gravis: 2 cases</span></p>\r\n<p><span style=\"font-size: small;\">multiple sclerosis: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">systemic lupus erythematosus: 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">3 healthy cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shimon Sakaguchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2319&amp;Itemid=2326&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0381.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000588</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">A biomarker study of a multicenter Phase II Trial of Nivolumab for Unresectable or Recurrent Thymic Carcinoma (NCCH1505)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/01/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">thymic carcinoma: 2 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidehito Horinouchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2343&amp;Itemid=2347&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0382.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000587</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of genetic and epigenetic abnormalities in hematopoietic diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/01/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">AML with FUS-ERG: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masahiro Kawahara</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2377&amp;Itemid=2375&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0383.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000602</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of the effect of abatacept for the transcriptome of multiple lymphoid subsets</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/03/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Rheumatoid arthritis: 5 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Keishi Fujio</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3126&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0384.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000603</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000718</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Deciphering molecular mechanisms underlying hematological malignancies and development of novel therapeutic approaches</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/06/19</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/07/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, Target Capture, ATAC-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/2500, MiSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">AML: 4 + 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">MDS: 30 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">normal cell: 6 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atsushi Iwama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2660&amp;Itemid=2596&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0385.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000597</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000599</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive genetic analysis of Combined hepatocellular-cholangiocarcinoma, Cholangiolocarcinoma, Keratin 19-expressing hepatocellular carcinoma, and SOX9-expressing hepatocellular carcinoma</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/12/14</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/01/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cholangiolocarcinoma: 8 cases</span></p>\r\n<p><span style=\"font-size: small;\">Combined hepatocellular-cholangiocarcinoma: 13 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takamichi Ishii</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2412&amp;Itemid=2403&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0386.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA015813</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Localized assembly for long reads enables genome-wide analysis of repetitive regions at single-base resolution in human genomes</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/04/11</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(MinION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">HapMap: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akihiro Fujimoto</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2397&amp;Itemid=2391&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0389.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000605</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis of fetal developmental abnormalities</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/04/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Capture Methyl-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">4 healthy women</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazuhiko Nakabayashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2511&amp;Itemid=2478&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0390.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000621</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of genetic factors associated with chronic endometritis (CE) through genomic and epigenomic analyses, and investigation on novel diagnostic and therapeutic methods for CE</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X Ten)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">chronic endometritis: 24 cases</span></p>\r\n<p><span style=\"font-size: small;\">33 controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Keiji Kuroda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2882&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0391.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000606</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Establishment of a human tongue cancer organoid biobank</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, scATAC-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tongue cancer: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Taku Sato</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2860&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0393.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000693</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">To explore new biomarkers or therapeutic target molecules using samples with patients with autoimmune diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">treatment-naïve rheumatoid arthritis: 6 cases</span></p>\r\n<p><span style=\"font-size: small;\">6 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroto Tsuboi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3138&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0394.v3</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000613</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000757</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Multi‐institutional joint research of spatial transcriptome analysis for non-small cell lung cancers</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/08</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/11/20</span></p>\r\n<p><span style=\"font-size: small;\">v3:2025/07/09</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Visium Spatial Gene Expression, WGS, t-nanoEM)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n<p><span style=\"font-size: small;\">Multiplex Fluorescence Immunostaining</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Xenium Analyzer)</span></p>\r\n<p><span style=\"font-size: small;\">Akoya Biosciences</span></p>\r\n<p><span style=\"font-size: small;\">(PhenoCycler)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">8 non-small cell lung cancer patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ayako Suzuki</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2667&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0395.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000678</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive survey for the construction of an integrated database of food, gut microbiome, and health information (the \"Sukoyaka Health Survey\"): Hokkaido Information University</span></p>\r\n<p><span style=\"font-size: small;\">An epidemiological study examining the relationship among food, health, and genome: Hokkaido Information University</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Attributes, Blood and Urine Test</span></p>\r\n<p><span style=\"font-size: small;\">Body measurement</span></p>\r\n<p><span style=\"font-size: small;\">Questionnaire, Interview</span></p>\r\n<p><span style=\"font-size: small;\">Sleep diary, Heart rate/brain wave during sleep</span></p>\r\n<p><span style=\"font-size: small;\">Microbiome composition</span></p>\r\n<p><span style=\"font-size: small;\">Nutrient intake, Food frequency questionnaire</span></p>\r\n<p><span style=\"font-size: small;\">Metabolomics</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Japonica Array v2)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">963 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Jun Nishihira</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2671&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0396.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000679</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive survey for the construction of an integrated database of food, gut microbiome, and health information (the \"Sukoyaka Health Survey\"): University of Miyazaki</span></p>\r\n<p><span style=\"font-size: small;\">An epidemiological study examining the relationship among food, health, and genome: University of Miyazaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Attributes, Blood and Urine Test</span></p>\r\n<p><span style=\"font-size: small;\">Body measurement</span></p>\r\n<p><span style=\"font-size: small;\">Questionnaire, Interview</span></p>\r\n<p><span style=\"font-size: small;\">Sleep diary, Heart rate/brain wave during sleep</span></p>\r\n<p><span style=\"font-size: small;\">Microbiome composition</span></p>\r\n<p><span style=\"font-size: small;\">Nutrient intake, Food frequency questionnaire</span></p>\r\n<p><span style=\"font-size: small;\">Metabolomics</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Japonica Array v2)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">50 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Manabu Yoshimura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2675&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0397.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000680</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive survey for the construction of an integrated database of food, gut microbiome, and health information (the \"Sukoyaka Health Survey\"): Kyoto University</span></p>\r\n<p><span style=\"font-size: small;\">An epidemiological study examining the relationship among food, health, and genome: Kyoto University</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Attributes, Blood and Urine Test</span></p>\r\n<p><span style=\"font-size: small;\">Body measurement</span></p>\r\n<p><span style=\"font-size: small;\">Questionnaire, Interview</span></p>\r\n<p><span style=\"font-size: small;\">Sleep diary, Heart rate/brain wave during sleep</span></p>\r\n<p><span style=\"font-size: small;\">Microbiome composition</span></p>\r\n<p><span style=\"font-size: small;\">Nutrient intake, Food frequency questionnaire</span></p>\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Affymetrix</span></p>\r\n<p><span style=\"font-size: small;\">(Japonica Array v2)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">50 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nobuya Inagaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2679&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0398.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000681</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive survey for the construction of an integrated database of food, gut microbiome, and health information (the \"Sukoyaka Health Survey\"): University of Nagasaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Attributes, Blood and Urine Test</span></p>\r\n<p><span style=\"font-size: small;\">Body measurement</span></p>\r\n<p><span style=\"font-size: small;\">Questionnaire, Interview</span></p>\r\n<p><span style=\"font-size: small;\">Sleep diary, Heart rate/brain wave during sleep</span></p>\r\n<p><span style=\"font-size: small;\">Microbiome composition</span></p>\r\n<p><span style=\"font-size: small;\">Nutrient intake, Food frequency questionnaire</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">-</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">59 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazunari Tanaka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2773&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0399.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000616</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exploratory studies of molecular biological mechanisms related to the breast cancer microenvironment</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/06/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">breast cancer: 2 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinpei Kawaoka</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2500&amp;Itemid=2469&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0401.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000618</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Development of cell lines and mouse models of bone and soft tissue sarcoma to establish novel treatment</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">giant cell tumor of bone: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toru Wakamatsu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2709&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0402.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA016537</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-622</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of the mechanisms that give rise to driver mutations in colorectal carcinogenesis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">colorectal cancer: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koshi Mimori</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2551&amp;Itemid=2510&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0403.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000622</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Investigation of the utility of liquid biopsy in urologic cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Metastatic urothelial carcinoma: 16 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazuki Hamada</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3146&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0405.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000623</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000631</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research on the identification of cancer stem cells for peidatric and adult malignancies</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/12/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/07/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, small RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X, NextSeq 550)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400RS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Pediatric B-cell precursor acute lymphocytic leukemia: 69 cases</span></p>\r\n<p><span style=\"font-size: small;\">Pediatric acute myeloid leukemia: 9 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Junko Takita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2579&amp;Itemid=2532&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0406.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000617</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-623</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">The Generation of Human Disease-Specific iPS Cells and the Use of Such iPS Cells for Disease Analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/08/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Familial interstitial pneumonia with SFTPC variant: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shimpei Gotoh</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2490&amp;Itemid=2461&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0409.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000619</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of genes that confer exceptional response in anticancer therapy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/06/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 550, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Intimal sarcoma with MDM2 amplification: 11 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takafumi Koyama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2531&amp;Itemid=2494&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0411.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000625</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Investigation of molecular diagnosis by molecular biological analysis using next-generation sequencer for actionable endocrine diseases (including neoplastic diseases)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">FBPase deficiency: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">3 family members</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tomoaki Tanaka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3012&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0413.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000628</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000780</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive analysis on medical and omics data from patients with atopic dermatitis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/20</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/03/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 1500/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atopic dermatitis: 161 + 41 cases</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 10pt;\">Psoriasis: 18 cases</span></p>\r\n<p><span style=\"font-size: small;\">41 + 10 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Haruhiko Koseki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2546&amp;Itemid=2506&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0414.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA016800</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of molecular mechanisms of lung cancer development and progression based on genome analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/07/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SAEC and its derived cell lines: 5 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Bunsyo Shiotani</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3090&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0416.v5</span></a></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-635</span></p>\r\n<p><span style=\"font-size: small;\">DRA019233</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-867</span></p>\r\n<p><span style=\"font-size: small;\">DRA019274</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-872</span></p>\r\n<p><span style=\"font-size: small;\">DRA020399</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1051</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1057</span></p>\r\n<p><span style=\"font-size: small;\">DRA020399</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1076</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of biological responses in intractable immune disorders and cancer and development of novel therapies through sequential multilevel omics analysis.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/08/10</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/09/27</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/10/16</span></p>\r\n<p><span style=\"font-size: small;\">v4:2025/05/19</span></p>\r\n<p><span style=\"font-size: small;\">v5:2025/06/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(CITE-seq, BD Ab-seq, scRNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">single-cell spatial transcriptome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">Vizgen</span></p>\r\n<p><span style=\"font-size: small;\">(MERSCOPE)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">microscopic polyangiitis: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">systemic sclerosis: 21 cases</span></p>\r\n<p><span style=\"font-size: small;\">Sjögren's Syndrome: 12 cases</span></p>\r\n<p><span style=\"font-size: small;\">Behçet's Syndrome: 11 cases</span></p>\r\n<p><span style=\"font-size: small;\">10 healthy donors</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takehisa Kitazawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2992&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0418.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000662</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Trial of Onco-Panel for Geneprofiling to Estimate both Adverse events and Response by cancer treatment (TOP-GEAR)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/02/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(MiSeq, NextSeq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cancer patient who will receive chemotherapy: 507 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Kohno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3008&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0419.v4</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000641</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000653</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000664</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000749</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Application of organoid culture system of human gastrointestinal and thoracic cancer in genome medicine</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/24</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/05/08</span></p>\r\n<p><span style=\"font-size: small;\">v3:2024/06/17</span></p>\r\n<p><span style=\"font-size: small;\">v4:2025/03/21</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">pulmonary large cell neuroendocrine carcinoma: 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">mucus-producing solid-dominant adenocarcinoma of lung: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">pulmonary adenocarcinoma harboring EML4-ALK variant 3: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">esophageal cancer: 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takuya Fukazawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2972&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0423.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000636</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Comprehensive elucidation of inflammatory muscle diseases by multi-omics analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/10/23</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/12/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, snRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(PromethION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">sarcoid myopathy: 22 + 1 cases</span></p>\r\n<p><span style=\"font-size: small;\">muscular disease: 400 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Aritoshi Iida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2840&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0426.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000654</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Diagnosis and Research on Familial, Young-onset and Hereditary Cancers</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(GridION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\"> hereditary cancer syndromes: 33cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yuichi Shiraishi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2626&amp;Itemid=2571&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0427.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000645</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Establishment of cell lines derived from head and neck malignancies</span></p>\r\n<p><span style=\"font-size: small;\">Comprehensive genetic analysis and database construction for head and neck malignancies</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/11/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">external auditory canal squamous cell carcinoma: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2637&amp;Itemid=2577&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0429.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000643</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">CRISPR screening identifies mechanisms of resistance to KRASG12C and SHP2 inhibitor combinations in non-small cell lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2023/11/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">tumor tissue collected from LU99 tumor-bearing mice: total 16 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Saskia Brachmann</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2686&amp;Itemid=2616&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0431.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000651</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis aimed at elucidating the pathophysiology, vulnerability to onset, treatment responsiveness of neuropsychiatric disorders, and developing new treatments and diagnostic and preventive methods</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/01/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">human iPS cells introduced single variants identified in patients with ASD: 5 samples</span></p>\r\n<p><span style=\"font-size: small;\">control human iPS cells: 4 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atsushi Takata</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2878&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0433.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000659</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000660</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000667</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-665</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-667</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Derivation of human trophoblast stem cells and analysis of those characteristics</span></p>\r\n<p><span style=\"font-size: small;\">Derivation of human trophoblast stem cells and those epigenomic landscape</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/09/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, ChIP-seq, Hi-C, small RNA-seq, CUT&amp;TAG-seq, Methyl-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, HiSeq 2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">placenta after artificial abortion: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">discarded blastocyst: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">hypertensive disorders of pregnancy: 14 cases</span></p>\r\n<p><span style=\"font-size: small;\">normal pregnancy: 12 subjects</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Eri H Kobayashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3020&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0434.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000658</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000709</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analyses in patients with T or NK cells-associated disorders</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thermo Fisher Scientific</span></p>\r\n<p><span style=\"font-size: small;\">（Ion Torrent S5, Ion GeneStudio S5）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">pure red cell aplasia: 53 cases</span></p>\r\n<p><span style=\"font-size: small;\">aplastic anemia: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">2 healthy controls</span></p>\r\n<p><span style=\"font-size: small;\">large granular lymphocytic leukemia: 55 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Fumihiro Ishida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2710&amp;Itemid=2632&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0435.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000665</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Investigation of a method for generating cells for regenerative medicine using comprehensive nucleic acid analysis of iPS cell-derived cardiomyocytes</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/03/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 3000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Cardiomyocytes differentiated from human iPS cells established from healthy donor cells: 1 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shigeru Miyagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2705&amp;Itemid=2628&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0436.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000668</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic polymorphism and gene transcriptome study on the etiology of autism</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/02/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Autistic disorder: 16 cases</span></p>\r\n<p><span style=\"font-size: small;\">17 Controls</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tetsuya Marui</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2730&amp;Itemid=2648&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0437.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000671</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic analysis of novel biomarkers and molecular targets for malignant brain tumors and their clinical application through multicenter collaborative research</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/03/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">glioma: 124 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shinji Kohsaka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?option=com_content&amp;view=article&amp;id=2715&amp;Itemid=2636&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0439.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA017996</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Investigation of the relationship between the genes involved in dyslipidemia and the pathogenesis of the disease</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/02/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nanopore</span></p>\r\n<p><span style=\"font-size: small;\">(MinION)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Familial hypercholesterolemia: 5 cases</span></p>\r\n<p><span style=\"font-size: small;\">1 Control</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Koh Ono</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2737&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0440.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000672</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-747</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of proteins associated with the clinical course of refractory neuromuscular diseases using nerve and muscle tissue</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/05/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400RS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Thymoma: 7 cases</span></p>\r\n<p><span style=\"font-size: small;\">Thymic hyperplasia: 2 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tatsusada Okuno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2844&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0442.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000675</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-883</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exploratory study for stratification marker of immune checkpoint inhibitor in patients with advanced or recurrent non-small cell lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/12/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">non-small cell lung cancer: 20 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tetsuro Sasada</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2733&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0443.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">DRA017833</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-674</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Relationship between changes in the T-cell receptor repertoire of regulatory T cells before and after pregnancy and pregnancy outcome.</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/05/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target RNA-seq, TCR-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Healthy pregnancy: 7 subjects</span></p>\r\n<p><span style=\"font-size: small;\">Preeclampsia: 3 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akitoshi Nakashima</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2705&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0444.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000684</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research to elucidate pathological conditions of skin diseases caused by genetic alterations by multi-omics analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/04/03</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, Exome, Long-read WGS, Amplicon-seq, RNA-seq)</span></p>\r\n<p><span style=\"font-size: small;\">SNP array</span></p>\r\n<p><span style=\"font-size: small;\">Methylation array</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-T7)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, MiSeq, Infinium Asian Screening Array, Infinium MethylationEPIC)</span></p>\r\n<p><span style=\"font-size: small;\">PacBio</span></p>\r\n<p><span style=\"font-size: small;\">(Sequel II)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">8 porokeratosis patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Akiharu Kubo</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3060&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0445.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000756</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research to elucidate pathological conditions of skin diseases caused by genetic alterations by multi-omics analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/19</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2500, Genome Analyzer IIx)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">362 lung adenocarcinoma patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Kohno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2960&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0454.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000697</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Etiological and therapeutic response analysis of inflammatory bowel disease focusing on immune abnormalities</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/12/16</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Xenium Analyzer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Crohn's disease: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">ulcerative colitis: 4 cases</span></p>\r\n<p><span style=\"font-size: small;\">cytomegalovirus enteritis: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">cancer: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Makoto Kodama</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3167&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0455.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000732</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000733</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Explore genetic abnormalities, molecular targets, predictive of drug sensitivity, histomorphology, and biomarkers in lung cancer<br />Analysis of genetic abnormalities and their biological significance in lung cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Novaseq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Xenium)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">pulmonary neuroendocrine carcinoma: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Daisuke Matsubara</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2820&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0456.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000722</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Molecular Pathological exprolation of Tumor Formation and Functional Differentiation Using Parasellar Skull Base Tumors and Malignant Glioma Tissues</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">craniopharyngioma: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tatsuma Matsuda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2980&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0460.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000714</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Pilot study towards the development of a Companion/Complimentary Diagnosis platform using liquid biopsy with cfDNA for immune checkpoint inhibitor therapy in advanced urothelial cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/01/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, HiSeq X)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">advanced urothelial carcinoma: 82 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takashi Kobayashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2940&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0461.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000712</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of the cancer immune response following radiation therapy for esophageal squamous cell carcinoma and colorectal cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/05/31</span></p>\r\n<p><span style=\"font-size: small;\">v2:2024/11/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n<p><span style=\"font-size: small;\">Multiplex Fluorescence Immunostaining</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 3000, NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">Akoya Biosciences</span></p>\r\n<p><span style=\"font-size: small;\">(CODEX)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">esophageal squamous cell carcinoma: 7 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shun-Ichiro Kageyama</span></p>\r\n<p><span style=\"font-size: small;\">(Genome Science)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3118&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0464.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000723</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">In Vitro Amplification of Human Hematopoietic Tumor Cells and Construction of Mouse Models for Reproduction of Pathological Conditions</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/25</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/06/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, scRNA-seq, scBCR-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000, NextSeq 2000/500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">multiple myeloma: 21 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">normal bone marrow: 3 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Atsushi Iwama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2836&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0465.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000721</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Establishment and genomic analysis of mixed phenotypic acute leukemia cell lines</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/07/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">mixed phenotype acute leukemiae: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroto Ishii</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2936&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0466.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Japan Prospective Studies for Aging and Dementia (JPSC-AD) study</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/11/20</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese Screening Array)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">9,479 participants in the JPSC-AD study</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshiharu Ninomiya</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2890&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0467.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic background of the development of pelvic organ prolapse</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/10/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Asian Screening Array, Infinium OmniExpress, HumanExome, Infinium OmniExpressExome v1.0, Infinium OmniExpressExome v1.2)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">female participants with a medical history of POP: 771 cases</span></p>\r\n<p><span style=\"font-size: small;\">76,625 control individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shiro Maeda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3163&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0468.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000727</span></p>\r\n<p><span style=\"font-size: small;\">JGAS000774</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of immune and inflammatory pathology </span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/01</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, bulk RNA-seq, scASAP-seq, CITE-seq, VDJ-seq)</span></p>\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000, NextSeq 500/550)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Xenium v1)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">23 rheumatoid arthritis</span></p>\r\n<p><span style=\"font-size: small;\">4 healty controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hiroyuki Yoshitomi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2848&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0469.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000721</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Investigation of immune response to cytomegalovirus during pregnancy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Pregnant women undergoing early pregnancy screening: 10 individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Mari Ichinose</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3134&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0470.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000725</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Prognostic Investigation and Genomic Profiling of Urothelial Carcinoma Treated with Immunotherapy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/07/08</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq, WGS, scRNA-seq, Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X Ten, NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Urothelial carcinoma: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nobuyuki Tanaka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2856&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0472.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000726</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Non-clinical research for the development of neuronal cells from human iPS cell derived cerebral cortical organoid</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/23</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Organoids derived from iPS cells of a single healthy individual: 9 samples</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Jun Takahashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3114&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0473.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000724</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of the pathogenesis of hematopoietic neoplasms via genetic analysis</span></p>\r\n<p><span style=\"font-size: small;\">Molecular expression analysis of bone marrow cells from hematopoietic stem cell transplant donors as a normal control</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Myelodysplastic syndromes: 57 cases</span></p>\r\n<p><span style=\"font-size: small;\">5 healthy individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yuka Harada</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2852&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0474.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000731</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of genes associated with autistic spectrum disorder, schizophrenia, and bipolar disorder</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/08/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(iSeq 100)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">32 children with ASD</span></p>\r\n<p><span style=\"font-size: small;\">8 children with low birth weight</span></p>\r\n<p><span style=\"font-size: small;\">3 children with sub-threshold ASD</span></p>\r\n<p><span style=\"font-size: small;\">36 typically developing children</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shigeru Yokoyama</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3102&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0476.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000736</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Observational studies using advanced analytical techniques to understand the biological functions of kidney component cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/01/07</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/06/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">32 renal cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shokichi Naito</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3074&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0477.v2</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000740</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tumor tissue culture and its characterization in gastrointestinal cancer</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/10/16</span></p>\r\n<p><span style=\"font-size: small;\">v2:2025/06/02</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NextSeq 1000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Organoids from a colorectal cancer patient: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">Caco-2 cell: 1 sample</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nobuo Sasaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3024&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0479.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000779</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Biomarker Research for Anti EGFR Monoclonal Antibodies by Comprehensive Cancer Genomics</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/14</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, Target Capture)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Hiseq 1500/2000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unresectable and advanced recurrent colorectal cancer: 242 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Katsuya Tsuchihara</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2944&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0481.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000755</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome analysis of common diseases among older Japanese adults and development of clinical genome information storage</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/11/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Alzheimer's disease: 424 cases</span></p>\r\n<p><span style=\"font-size: small;\">Mild cognitive impairment Alzheimer's disease: 543 cases</span></p>\r\n<p><span style=\"font-size: small;\">Mild cognitive impairment: 260 individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Daichi Shigemizu</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3094&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0483.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000764</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Request for cooperation regarding collection and distribution of human specimens and research using clinical information</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/10</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Hiseq X Ten, NovaSeq 6000)</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Ovarian clear cell carcinoma: 11 cases</span></p>\r\n<p><span style=\"font-size: small;\">High-grade serous carcinoma: 7 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Tatsuyuki Chiyoda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2996&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0484.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000775</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Banking of induced pluripotent stem cell lines (iPS cell lines) established from human somatic cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">33 ALSs</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yukio Nakamura</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3032&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0485.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000754</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genome sequencing analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/28</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS, RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq 2000/2500)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">65 gastric cancers</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hidewaki Nakagawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2956&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0486.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000765</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Bile duct development and its failure mechanisms using biliary atresia and Alagille syndrome-specific iPS cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/11/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq X Plus 25B)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">5 patients with biliary atresia</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Yohei Hayashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2968&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0490.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000770</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">An investigation into the effects of progestin on follicular development and oocyte maturation during controlled ovarian stimulation using the Progestin-Primed Ovarian Stimulation (PPOS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2024/12/18</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">16 infertility patients with normal ovarian function</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Mika Handa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3130&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">HUM0491.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000805</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1086</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidating molecular mechanisms of allergy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/07/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, scRNA-TCR-seq, scATAC-RNA-seq, CITE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Chronic tonsillitis: 8 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hideki Ueno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3179&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0492.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000736</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exploratory research aimed at developing new drugs for difficult-to-treat immune-inflammatory diseases through industry-academia collaboration</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/12</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq/TCR/BCR repetoire, Visium Spatial Gene Expression)</span></p>\r\n<p><span style=\"font-size: small;\">Histological image</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X)</span></p>\r\n<p><span style=\"font-size: small;\"> MGI</span></p>\r\n<p><span style=\"font-size: small;\">(DNBSEQ-G400)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">28 Sjögren's syndrome</span></p>\r\n<p><span style=\"font-size: small;\">10 Sicca</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masaru Takeshita</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3150&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0493.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000771</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Functional analysis of skin immunocompetent cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/07/24</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Xenium In Situ Gene Expression</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Xenium Analyzer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Healthy skin: 3 individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hanako Koguchi-Yoshioka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=2984&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0495.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Precision medicine for preventing stroke in patients with atrial fibrillation</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/02/13</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1,176 PAF patients</span></p>\r\n<p><span style=\"font-size: small;\">1,172 non-PAF controls</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Toshihiro Tanaka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3000&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0496.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Okinawa Bioinformation Bank Project to establish a genome analysis research center in Okinawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/02/27</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Infinium Asian Screening Array, Infinium OmniExpress, HumanExome, Infinium OmniExpressExome v1.0, Infinium OmniExpressExome v1.2)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">OBi: 8,715 individuals</span></p>\r\n<p><span style=\"font-size: small;\">BBJ: 7,004 individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Shiro Maeda</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3175&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0497.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000777</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Isolation and characterization of trophoblast stem cells from human placenta</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/06</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">term placentas from three individuals</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n<p><span style=\"font-size: small;\">three trophoblast stem cell lines</span></p>\r\n<p><span style=\"font-size: small;\">(Cell-line)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masatsugu Ema</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3028&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0499.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000787</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Research aimed at creating a biobank for bone and soft tissue tumors and elucidating the molecular pathology based on gene expression analysis, as well as improving prognosis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/04/25</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Sanger-seq</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Applied Biosystems</span></p>\r\n<p><span style=\"font-size: small;\">(3730xl DNA Analyzer)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">6 sarcoma</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Nobuhiko Hasegawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3052&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0501.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000781</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">GenomeAsia 100K Project: Human DNA samples collecting and whole genome sequencing of Asian populations</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/15</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(WGS)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(HiSeq X)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1,323 individuals of ~100 ethnic groups</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hie Lim Kim</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3082&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0502.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000803</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidating the development of cervical cancer and identifying therapeutic targets based on cancer genome analysis</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">cervical cancer: 29 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kouya Shiraishi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3056&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0505.v1</span></a></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Exploratory study of genetic factors in allergic diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/05/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">SNP-chip</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(Infinium Asian Screening Array)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">564 individuals who participated in the genomic analysis study of the adult cohort study</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Emiko Noguchi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3078&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0508.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000790</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of the pathogenesis of ocular diseases and exploration of therapeutic strategies using disease-specific iPS cells</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/04</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">1 congenital aniridia</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kohji Nishida</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3159&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0512.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000818</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Identification and functional analysis of risk polymorphisms in autoimmune diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/07/30</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq, ATAC-seq, scCITE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000/X Plus)</span></p>\r\n<p><span style=\"font-size: small;\">10x Genomics</span></p>\r\n<p><span style=\"font-size: small;\">(Chromium)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">3 healthy donors</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kazuyoshi Ishigaki</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3195&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0514.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000814</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Analysis of skeletal muscle messenger RNA expression to elucidate pathophysiology of neuromuscular diseases</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/09/22</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(RNA-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">11 myotonic dystrophy type 1 patients</span></p>\r\n<p><span style=\"font-size: small;\">9 control patients</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Masanori P Takahashi</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3110&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0517.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000809</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Evaluation of novel therapies using primary cultured gynecological cancer cells and search for predictors of efficacy</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/17</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Endometrial cancer: 30 cases</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Kosei Hasegawa</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3187&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0521.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000827</span></p>\r\n<p><span style=\"font-size: small;\">E-GEAD-1121</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Elucidation of Molecular Mechanisms of Cancer Immunity</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/29</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, scBCR-seq, scTCR-seq, CITE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq 6000)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">uterine cancer: 10 cases</span></p>\r\n<p><span style=\"font-size: small;\">hereditary breast and ovarian cancer syndrome: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Hideki Ueno</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Unrestricted-access</span></p>\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3122&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0522.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000720</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Immune regulation by cotrolling regulatory T cell-specific epigenome</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/06/26</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(scRNA-seq, TCR-seq, CITE-seq)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">（NovaSeq 6000）</span></p>\r\n<p><span style=\"font-size: small;\">MGI</span></p>\r\n<p><span style=\"font-size: small;\">（DNBSEQ-G400）</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">2 esophagogastric junction cancer</span></p>\r\n<p><span style=\"font-size: small;\">3 Ggastric cancer</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takuro Saito</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n<tr><th>\r\n<p><a href=\"index.php?Itemid=3171&amp;lang=en\" target=\"_blank\"><span style=\"font-size: small;\">hum0527.v1</span></a></p>\r\n<p><span style=\"font-size: small;\">JGAS000823</span></p>\r\n</th>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Genetic mutation profiling of lymphomas arising in the uterine cervix and vagina</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">v1:2025/08/05</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">NGS</span></p>\r\n<p><span style=\"font-size: small;\">(Exome)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Illumina</span></p>\r\n<p><span style=\"font-size: small;\">(NovaSeq X Plus)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Follicle center lymphoma of the lower female genital tract: 1 case</span></p>\r\n<p><span style=\"font-size: small;\">(Japanese)</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Takumi Kitaoka</span></p>\r\n</td>\r\n<td class=\"”highlight”\">\r\n<p><span style=\"font-size: small;\">Controlled-access</span></p>\r\n<p><span style=\"font-size: small;\">(Type I)</span></p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p><span style=\"font-size: small;\"># You can search the data in the DDBJ Sequence Read Archive (DRA), the European Sequence Read Archive (ERA), and the Sequence Read Archive (SRA) through the <a href=\"https://ddbj.nig.ac.jp/search\" target=\"_blank\" rel=\"noopener\">DDBJ Search</a> site. </span></p>\r\n<p><span style=\"font-size: small;\">* The study including processed data by JGA (e.g. alignment results [CRAM], variant call results per sample [gVCF], variant call results per dataset [aggregated VCF] processed in a certain workflow) <a href=\"index.php?option=com_content&amp;view=article&amp;id=2281&amp;Itemid=2290&amp;lang=en\" target=\"_blank\">Learn more</a></span></p>", "publish_up": "2015-03-30"}, {"lang": "ja", "path": "off-premise-server", "title": "機関外サーバ", "fulltext": "", "modified": "2025-01-29", "introtext": "<p><span style=\"font-family: helvetica; font-size: 15pt;\"><strong>所属機関外利用可能サーバ（機関外サーバ）の導入について</strong></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　情報・システム研究機構 データサイエンス共同利用基盤施設（ROIS-DS）ライフサイエンス統合データベースセンター（DBCLS）では、収集・蓄積された多量かつ多様なデータの活用には、データ利用者の全責任の下で自由にデータを利用できる環境を作ることが望ましいと考えています。一方で、個人情報保護法等において新たに規定された要配慮個人情報に該当する臨床情報や個人識別符号に該当するゲノムデータ等を適切に保護することも必要ですが、現状、国際標準となるようなセキュリティ規格はありません。このような状況の中で、研究参加者の個人情報を保護しつつ、生命科学・医学研究において産出されたデータの利活用を目指すにあたり、徐々にデータ解析・保管可能なサーバや計算機環境を拡大していく仕組みが必要であると考えています。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　そこで第一段階として、これまでデータ利用者の所属機関が管理するサーバのみにおいてデータの解析や保管を可能にしていましたが、それに加え、段階的に利用者が所属する機関以外の組織が管理する『機関外サーバ』でのデータ利用を可能にすることとしました。個人情報等を適切に保護するという観点から、『機関外サーバ』は、ヒト試料由来データや臨床情報等の機微な個人情報を解析する環境が整っており、かつNBDCヒトデータ取り扱いセキュリティガイドラインやNBDCヒトデータグループ共有データ取扱いセキュリティガイドラインの遵守を含む、運用に関する覚書をROIS</span><span style=\"font-family: helvetica; font-size: 11pt;\">と締結した機関が所有する計算機環境内にあり、ハイレベル【Type II】セキュリティにおいて必要な対策が実施されているサーバ、としています。</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　現時点では、下記機関外サーバ※への利用申請が可能です。各機関外サーバ運用機関サイトにおいてデータ利用者が確認すべきセキュリティ管理状況や利用規約が公開されていますので、データ利用者自らそれらをご確認ください。ヒトデータベースやヒトデータグループ共有データベースに収録されているデータの利用の際に機関外サーバの利用を予定されている場合は、上記セキュリティ管理状況に関して確認した書類を添付の上、データ利用申請頂きますようお願いいたします。なお、機関外サーバを利用する際は、別途、それぞれの機関外サーバへの利用申請等の手続きが必要です。</span></p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">※『機関外サーバ』を提供する機関</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　・国立遺伝学研究所</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　　　（URL：<a href=\"https://sc.ddbj.nig.ac.jp/guides/using_personal_genome_division/\" target=\"_blank\" rel=\"noopener noreferrer\">https://sc.ddbj.nig.ac.jp/guides/using_personal_genome_division/</a>）</span></p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　・東北メディカル・メガバンク機構</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　　　（URL：<a href=\"https://sc.megabank.tohoku.ac.jp/ph3-doc/application/form.html#id21\" target=\"_blank\" rel=\"noopener noreferrer\">https://sc.megabank.tohoku.ac.jp/ph3-doc/application/form.html#id21</a>）</span></p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　・一般社団法人柏の葉オーミクスゲート（KOG）</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　　　（URL：<a href=\"https://www.kog.or.jp/server.html\" target=\"_blank\" rel=\"noopener noreferrer\">https://www.kog.or.jp/server.html</a>）</span></p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　・東京大学医科学研究所ヒトゲノム解析センター（HGC）</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　　　（URL：<a href=\"https://gc.hgc.jp/nbdc/\" target=\"_blank\" rel=\"noopener noreferrer\">https://gc.hgc.jp/nbdc/</a>）</span></p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">『機関外サーバ』に関する問い合わせは<a href=\"contact-us\" target=\"_blank\" rel=\"noopener noreferrer\">こちら</a>。</span></p>", "publish_up": "2018-08-31"}, {"lang": "en", "path": "off-premise-server", "title": "Off-premise Server", "fulltext": "", "modified": "2024-03-31", "introtext": "<h3><strong><span style=\"color: #000000;\"> Available server outside of affiliated organization (“Off-premise-server”)</span></strong></h3>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">&nbsp; A server that is not owned by data users’ affiliated organization and that is available to the data users to store and/or process controlled-access data, which “off-premise-server” has a computing environment for analyzing human data. The computing environment is owned by an organization that has concluded with ROIS a memorandum concerning operation including compliance with the NBDC Security Guidelines for Human Data (for Database Center Operation Managers and “Off-Premise-Server” Operation Managers). In addition, measures necessary for high level (Type II) security are being implemented in the “off-premise-server.”</span></p>\r\n<p>&nbsp;</p>\r\n<p><strong><span style=\"font-family: helvetica; font-size: 11pt;\">Off-premise-server Providers:</span></strong></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">-&nbsp; &nbsp;National Institute of Genetics (contact e-mail address: sc-helpdesk[at]nig.ac.jp)　</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">-&nbsp; &nbsp;Tohoku Medical Megabank Organization (contact e-mail address: support[at]sc.megabank.tohoku.ac.jp)</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">-&nbsp; &nbsp;Kashiwa-no-ha Omics Gate (contact e-mail address: info[at]kog.or.jp)</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">-&nbsp; &nbsp;Human Genome Center, the Institute of Medical Science, the University of Tokyo (contact e-mail address: support[at]hgc.jp）</span></p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">* Please replace [at] with @</span></p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">For information on the Off-premise-servers:&nbsp;</span><a href=\"/en/contact-us\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 11pt;\">https://humandbs.dbcls.jp/en/contact-us</span></a></p>", "publish_up": "2018-08-31"}, {"lang": "ja", "path": "privacy-policy", "title": "プライバシーポリシー", "fulltext": "", "modified": "2025-03-19", "introtext": "<h1 style=\"text-align: center;\">NBDCヒトデータベースおよびNBDCグループ共有データベース</h1>\r\n<h1 style=\"text-align: center;\">プライバシーポリシー</h1>\r\n<ol>\r\n<li style=\"text-align: left;\">基本的考え方\r\n<p>大学共同利用機関法人 情報・システム研究機構（以下、「ROIS」といいます。）は、ROIS内の組織であるデータサイエンス共同利用基盤施設 ライフサイエンス統合データベースセンター（以下、「DBCLS」といいます。）が「NBDCヒトデータベース」および「NBDCグループ共有データベース」（両データベースを総称して、以下、「本データベース」といいます。）の運営を通じて取得した個人情報を、本ポリシーに基づき利用目的の範囲内で適切に取り扱います。</p>\r\n<p>本データベースの利用（本データベースに提供され公開されているヒトに関するデータ（以下、「ヒトデータ」といいます。）の利用および本データベースへのヒトデータの提供の双方を含みます。以下同じです。）を希望される皆様（以下、「ご本人」といいます。）は、本ポリシーを最後までご確認ください。ご本人が、本ポリシーに記載されたDBCLSによる個人情報の利用を希望しない場合は、本データベースへの各種申請が受理されず、次の①～②のとおり本データベースの利用が制限されることをご承知おきください。なお、「NBDCヒトデータベース」を通じて共有される非制限公開データ（アクセスに制限を設けることなく、利用することが可能な公開データ）は利用申請が必要ありませんので、個人情報を提供しなくてもご利用いただけます。</p>\r\n<ul style=\"list-style: none;\">\r\n<li style=\"text-align: left;\">\r\n<p>① 「NBDCヒトデータベース」の制限公開データ、および、「NBDCグループ共有データベース」を通じて共有されるデータの利用にあたっては、データ利用者や利用目的などを明らかにしたうえで、利用申請ならびにヒトデータ審査委員会の審査による承認が必要となるため、個人情報をご提供いただけない場合は、当該データをご利用いただけません。</p>\r\n</li>\r\n<li style=\"text-align: left;\">\r\n<p>② 本データベースに対して、ヒトデータを提供いただく際には、データ提供申請ならびにヒトデータ審査委員会の審査による承認が必要となるため、個人情報を提供いただけない場合は、ヒトデータを提供いただくことはできません。その結果、アクセッション番号を取得いただくこともできません。</p>\r\n<p>&nbsp;</p>\r\n</li>\r\n</ul>\r\n</li>\r\n<li style=\"text-align: left;\">個人情報の定義\r\n<p>本ポリシーにおいて「個人情報」とは、生存する個人に関する情報であって、次の①～③のいずれかに該当するものをいいます。</p>\r\n<ul style=\"list-style: none;\">\r\n<li style=\"text-align: left;\">\r\n<p>① 当該情報に含まれる氏名、住所、生年月日、性別、職業、電話番号、電子メールアドレス等により特定の個人を識別することができるもの</p>\r\n<p>② その情報のみでは特定の個人を識別できないが、他の情報と容易に照合することができ、この照合により特定の個人を識別できることとなる情報</p>\r\n<p>③ 個人情報の保護に関する法律により定義される「個人識別符号」が含まれるもの</p>\r\n<p>&nbsp;</p>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>収集する個人情報の範囲と利用目的\r\n<p>本データベースでは、本データベースの利用を希望される方の各種申請の受理、ならびに本データベースに関するお問い合わせを受けた際に取得した以下の個人情報を適法かつ適正な手段で収集し、収集した情報を以下の目的およびその目的に付随する目的の達成に必要な範囲内で、適法かつ適正な手段により閲覧・利用します。なお、法令により認められる事由がある場合を除き、ご本人の同意がない限り、この範囲を超えて個人情報を利用することはありません。</p>\r\n</li>\r\n</ol>\r\n<table border=\"1\" style=\"border-collapse: collapse; border: initial solid initial;\" cellpadding=\"0\" cellspacing=\"0\">\r\n<tbody>\r\n<tr>\r\n<td colspan=\"2\" style=\"width: 453px; padding-right: 4px; padding-left: 4px; vertical-align: top; border: 1px solid;\">\r\n<p style=\"text-align: center;\">収集する個人情報</p>\r\n</td>\r\n<td style=\"padding-right: 4px; padding-left: 4px; width: 416px; border: 1px solid; vertical-align: top;\">\r\n<p style=\"text-align: center;\">利用目的</p>\r\n</td>\r\n</tr>\r\n<tr style=\"height: 32px;\">\r\n<td rowspan=\"3\" style=\"width: 152px; padding-right: 4px; padding-left: 4px; height: 32px; border: 1px solid; vertical-align: top;\">\r\n<p>各種申請時に提供いただいた情報</p>\r\n</td>\r\n<td style=\"width: 332px; padding-right: 4px; padding-left: 4px; height: 32px; border: 1px solid; vertical-align: top;\">\r\n<p>研究代表者および所属する機関の長、申請者、研究分担者に関して提供いただいた次の情報。</p>\r\n<p>・氏名</p>\r\n<p>・所属機関名</p>\r\n<p>・部署名</p>\r\n<p>・職名</p>\r\n<p>・住所</p>\r\n<p>・電子メールアドレス</p>\r\n<p>・電話番号</p>\r\n<p>・（受託者がいる場合）受託機関名・部署目・担当者氏名・職名</p>\r\n</td>\r\n<td style=\"padding-right: 4px; padding-left: 4px; height: 32px; width: 416px; border: 1px solid; vertical-align: top;\">\r\n<p>(1) ヒトデータの提供および利用申請の審査関係業務のため。</p>\r\n<p>(2) ヒトデータの提供および利用の申請内容に関するDBCLSからの必要事項の確認や対応依頼の連絡のため。</p>\r\n<p>(3) 各種申請、本データベースの利用に関する問い合わせへの対応や重要事項を通知するため。</p>\r\n<p>(4) 本データベース利用者の利便性向上および円滑なサービスの提供のため。</p>\r\n<p>(5) 本データベースの運営に係るアンケート等の連絡のため。</p>\r\n</td>\r\n</tr>\r\n<tr style=\"height: 34px;\">\r\n<td style=\"width: 312px; padding-right: 4px; padding-left: 4px; height: 34px; border: 1px solid; vertical-align: top;\">\r\n<p>研究代表者の氏名、所属機関名、部署名</p>\r\n</td>\r\n<td style=\"padding-right: 4px; padding-left: 4px; height: 34px; width: 416px; border: 1px solid; vertical-align: top;\">\r\n<p>データ提供者／データ利用者情報の公開のため。</p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<table border=\"1\" style=\"border-collapse: collapse; border: initial solid initial;\" cellpadding=\"0\" cellspacing=\"0\">\r\n<tbody>\r\n<tr>\r\n<td style=\"width: 455px; padding-right: 4px; padding-left: 4px; vertical-align: top; border: 1px solid;\">\r\n<p style=\"text-align: center;\">収集する個人情報</p>\r\n</td>\r\n<td style=\"padding-right: 4px; padding-left: 4px; width: 455px; border: 1px solid; vertical-align: top;\">\r\n<p style=\"text-align: center;\">利用目的</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td style=\"width: 455px; padding-right: 4px; padding-left: 4px; border: 1px solid; vertical-align: top;\">\r\n<p>本データベースのお問い合わせフォームより提供いただいた次の情報。</p>\r\n<p>・氏名</p>\r\n<p>・電子メールアドレス</p>\r\n<p>・所属機関名</p>\r\n</td>\r\n<td style=\"padding-right: 4px; padding-left: 4px; width: 455px; border: 1px solid; vertical-align: top;\">\r\n<p>お問い合わせへの回答、利便性向上、および必要な対応のため。</p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p>&nbsp;</p>\r\n<ol start=\"4\">\r\n<li>第三者提供\r\n<p>DBCLSは、次の①～⑤のいずれかに該当する場合を除き、個人情報を第三者に提供はいたしません。なお、統計データなど個人を識別することができない状態に加工した上で、開示・提供することがあります。</p>\r\n<ul style=\"list-style: none;\">\r\n<li>① あらかじめご本人の同意を得た場合。</li>\r\n<li>② 人の生命、身体または財産の保護のために必要がある場合であって、ご本人の同意を得ることが困難な場合。</li>\r\n<li>③ 公衆衛生の向上または児童の健全な育成の推進のために特に必要がある場合であって、ご本人の同意を得ることが困難な場合。</li>\r\n<li>④ 国の機関もしくは地方公共団体またはその委託を受けた者が法令の定める事務を遂行することに対して協力する必要がある場合であって、ご本人の同意を得ることにより当該事務の遂行に支障を及ぼすおそれがある場合。</li>\r\n<li>⑤ 法令に基づく開示要請があった場合、あるいは研究不正や不正アクセス・脅迫等の違法行為に関する調査への協力依頼があった場合。</li>\r\n<li>&nbsp;</li>\r\n</ul>\r\n</li>\r\n<li>共同利用\r\n<p>各種申請の受理によって収集した情報は、本データベースの特殊性ならびにその運営上の必要性により、ROIS内国立遺伝学研究所（以下、「NIG」といいます。）が管理する日本国内のサーバーにも記録され、NIG生命情報・DDBJセンター（以下、「DDBJセンター」といいます。）のプライバシーポリシー（<a href=\"https://www.ddbj.nig.ac.jp/policies.html#privacy\" target=\"_blank\" rel=\"noopener\">https://www.ddbj.nig.ac.jp/policies.html#privacy</a>）に基づき管理されます。DDBJセンターでは、本データベース利用者の利便性向上および円滑なサービスの提供を目的として必要な場合に限り、DBCLSを経由せずDDBJセンターから直接連絡を入れさせていただくことがあります。また、個人を識別することができない状態に加工した利用者に関する情報やウェブサイトへのアクセス統計をDDBJセンターと共同利用することがあります。</p>\r\n<p>また、DBCLSは国立研究開発法人日本医療研究開発機構（以下、「AMED」といいます。）と、AMEDゲノム制限共有データベース（以下、「AGD」といいます。）の運営にあたり、AGDに関連する各種申請時に提供いただいた全ての個人情報を共同利用いたします。</p>\r\n<p>&nbsp;</p>\r\n</li>\r\n<li>安全管理措置に関する事項\r\n<p>取得し取り扱う個人情報については、その紛失・漏洩防止、滅失・棄損防止、悪用防止、改竄防止および破壊防止のため、必要かつ適切な措置を以下のとおり講じます。</p>\r\n<ul style=\"list-style: none;\">\r\n<li>① DBCLSは、全役職員に対する教育啓蒙活動を実施するほか、個人情報を取扱う部門ごとに責任者を置き、個人情報の適切な管理に努めます。</li>\r\n<li>② DBCLSは、個人情報への不正なアクセスを防止するため、ウェブサイト等についてセキュリティの維持に努めます。</li>\r\n<li>③ DBCLSは、個人情報へのアクセス権限を当該情報にアクセスする必要のある従業員や委託先に限定して付与します。それらの者は、秘密保持義務条項を含む雇用契約又は委託契約を締結し、個人情報について適切な取扱いおよび保護を行わせるように努力し、漏洩、第三者への無断提供、前記3.に記載の利用目的の範囲外での利用の防止を図ります。</li>\r\n<li>&nbsp;</li>\r\n</ul>\r\n</li>\r\n<li>個人情報の開示、訂正・追加・削除、利用停止、第三者提供の停止等\r\n<p>DBCLSが保有する個人情報について、開示、訂正・追加・削除、利用停止・消去または第三者提供の停止等にかかるご本人からの請求があった場合には、DBCLSは、個人情報漏洩防止、正確性、安全性の確保の観点から、法令に特別な手続きが定められている場合を除き、遅滞なく必要な調査を行い、当該請求がご本人によるものであることが確認できた場合に限り、法令に従い、当該請求に誠実に対応いたします。なお、当該請求が法令に定める要件を充たさない場合、調査結果に基づき請求内容が不当と認められた場合、または、法令等により請求を拒絶することが正当と認められる事由がある場合には、DBCLSは請求に応じることができません。</p>\r\n<p>また、開示等の求めに対してDBCLS宛の通信費、交通費および本人確認の際に準備いただく資料等に対して発生する費用等につきましてはご負担ください。手続きの詳細はROISが定める「情報公開・管理について」（<a href=\"https://www.rois.ac.jp/open/01.html\" target=\"_blank\" rel=\"noopener\">https://www.rois.ac.jp/open/01.html</a>）をご参照ください。</p>\r\n<p>&nbsp;</p>\r\n</li>\r\n<li>アクセスログの取得およびアクセス解析ツール等の利用について\r\n<p>ウェブサイトを利用される方の情報をコンピューターやアプリケーションソフト上で記録管理する技術を、「クッキー（Cookie）」といいます。本データベースのウェブサイトは、ご利用になる皆様（以下「利用者」といいます。）に一層便利にご利用いただけるよう、クッキーを使用しています。また、本データベースのウェブサイトでは、利用者のウェブサイトの訪問状況を把握するためにGoogle 社のサービスであるGoogleアナリティクスを利用しています。</p>\r\n<p>本データベースのウェブサイトでGoogleアナリティクスを利用しますと、DBCLSが発行するクッキーをもとにして、Google 社が本データベースのウェブサイトの訪問履歴を収集、記録、分析します。DBCLSは、Google 社からその分析結果を受け取り、利用者のウェブサイトの訪問状況を把握します。Googleアナリティクスにより収集、記録、分析された利用者の情報には、特定の個人を識別する情報は一切含まれません。また、それらの情報は、Google社により同社のプライバシーポリシーに基づいて管理されます。</p>\r\n<p>利用者は、ウェブブラウザのアドオン設定でGoogleアナリティクスを無効にすることにより、DBCLSのGoogleアナリティクス利用によるご自身の情報の収集を停止することも可能です。Googleアナリティクスの無効設定は、Google社によるオプトアウトアドオンのダウンロードページで「Googleアナリティクスオプトアウトアドオン」をダウンロードおよびインストールし、ウェブブラウザのアドオン設定を変更することで実施することができます。なお、利用者がGoogleアナリティクスを無効設定した場合、当該利用者が訪問する本サイト以外のウェブサイトでもGoogleアナリティクスは無効になります。また、当該利用者がウェブブラウザのアドオンを再設定することにより、再度Googleアナリティクスを有効にすることも可能です。Googleアナリティクスの利用規約に関する説明についてはGoogleアナリティクスのサイトを、Google社のプライバシーポリシーに関する説明については同社のサイトをご覧ください。</p>\r\n<p>＜Googleアナリティクス利用規約＞</p>\r\n<p><a href=\"https://marketingplatform.google.com/about/analytics/terms/jp/\" target=\"_blank\" rel=\"noopener\">https://marketingplatform.google.com/about/analytics/terms/jp/</a></p>\r\n<p>＜Googleのサービスを使用するサイトやアプリから収集した情報の Google による使用＞</p>\r\n<p><a href=\"https://policies.google.com/technologies/partner-sites\" target=\"_blank\" rel=\"noopener\">https://policies.google.com/technologies/partner-sites</a></p>\r\n<p>＜Googleアナリティクスオプトアウトアドオン＞</p>\r\n<p><a href=\"https://tools.google.com/dlpage/gaoptout\" target=\"_blank\" rel=\"noopener\">https://tools.google.com/dlpage/gaoptout</a></p>\r\n<p>&nbsp;</p>\r\n</li>\r\n<li>適用範囲\r\n<p>本ポリシーは、ROISが運営・管理する本データベースのサービスにおいて取得される個人情報に対して適用します。本ポリシーに規定されていない内容についてはROISの個人情報の保護に関する規程等（<a href=\"https://www.rois.ac.jp/open/01.html\" target=\"_blank\" rel=\"noopener\">https://www.rois.ac.jp/open/01.html</a>）およびDBCLSのサイトポリシー（<a href=\"https://dbcls.rois.ac.jp/policy.html\" target=\"_blank\" rel=\"noopener\">https://dbcls.rois.ac.jp/policy.html</a>）が適用され、万一、本ポリシーとROISの個人情報の保護に関する規程等およびDBCLSのサイトポリシーとの間で規程の内容が矛盾する場合には、本ポリシーの内容が優先されます。</p>\r\n<p>&nbsp;</p>\r\n</li>\r\n<li>個人情報の保存期間\r\n<p>DBCLSでは、適用される法令を遵守し、本データベースを運営する期間中個人情報を保管します。</p>\r\n<p>&nbsp;</p>\r\n</li>\r\n<li>その他\r\n<p>DBCLSでは、本ポリシーを改定することがあります。改定する場合は、事前に本データベースのウェブサイト（<a href=\"https://humandbs.dbcls.jp/\" target=\"_blank\" rel=\"noopener\">https://humandbs.dbcls.jp/</a>）でお知らせします。</p>\r\n<p>&nbsp;</p>\r\n</li>\r\n<li>お問い合わせ先\r\n<p>〒277-0871　千葉県柏市若柴１７８－４－４</p>\r\n<p>大学共同利用機関法人 情報・システム研究機構 データサイエンス共同利用基盤施設 ライフサイエンス統合データベースセンター</p>\r\n<p>お問い合わせフォーム：<a href=\"https://humandbs.dbcls.jp/contact-us\" target=\"_blank\" rel=\"noopener\">https://humandbs.dbcls.jp/contact-us</a></p>\r\n<p>&nbsp;</p>\r\n</li>\r\n<li>個人情報取扱事業者に関する情報\r\n<p>ROISの代表者（機構長）の氏名は、以下のウェブサイトに記載のとおりです。</p>\r\n<p><a href=\"https://www.rois.ac.jp/about/staff.html\" target=\"_blank\" rel=\"noopener\">https://www.rois.ac.jp/about/staff.html</a></p>\r\n</li>\r\n</ol>\r\n<p style=\"text-align: right;\">制定：2025年3月19日</p>", "publish_up": "2013-03-15"}, {"lang": "en", "path": "privacy-policy", "title": "Privacy policy", "fulltext": "", "modified": "2025-03-19", "introtext": "<h1 style=\"text-align: center;\">NBDC Human Database and NBDC Group Sharing Database</h1>\r\n<h1 style=\"text-align: center;\">Privacy Policy</h1>\r\n<ol>\r\n<li style=\"text-align: left;\">Basic concept\r\n<p>The Research Organization of Information and Systems (hereinafter referred to as \"ROIS\") will handle personal information obtained through the operations of the NBDC Human Database and the NBDC Group Sharing Database (hereinafter collectively referred to as \"the Databases\") by the Database Center for Life Science (hereinafter referred to as \"DBCLS\") within the Joint Support-Center for Data Science Research (hereinafter referred to as \"DS\"), an organization within ROIS, appropriately within the scope of the purposes of use in accordance with this policy.</p>\r\n<p>If you wish to use the Databases (including both the use of publicly available data on humans provided in the Databases (hereinafter referred to as \"Human Data\"), and the submission of Human Data to the Databases; the same shall apply hereinafter), please read this policy through to the end. If you do not wish DBCLS to use your personal information as described in this policy, please be aware that your applications to DBCLS may not be accepted, and that the use of the Databases will be restricted as described below in (i) to (ii). Please note that unrestricted-access data shared through the NBDC Human Database (public data available for use without any access restrictions) can be used without an application for data use, and you can use it without providing personal information.</p>\r\n<ul style=\"list-style: none;\">\r\n<li>(i) The use of controlled-access data from the NBDC Human Database and data shared through the NBDC Group Sharing Database requires an application for data use, along with approval from the Human Data Review Board, after specifying the user of the data and purpose of use, etc. Therefore, if you cannot provide personal information, you will not be able to use these data.</li>\r\n<li>(ii) When providing Human Data to the Databases, an application for data submission and approval by the Human Data Review Board are required. Therefore, if personal information cannot be provided, Human Data cannot be accepted. As a result, an accession number cannot be issued.</li>\r\n<li>&nbsp;</li>\r\n</ul>\r\n</li>\r\n<li style=\"text-align: left;\">Definition of personal information\r\n<p>In this policy, \"personal information\" means information about a living individual that falls under any of the following items (i) through (iii).</p>\r\n<ul style=\"list-style: none;\">\r\n<li>(i) Information that can identify a specific individual by name, address, date of birth, gender, occupation, telephone number, e-mail address, etc., contained therein</li>\r\n<li>(ii) Information that, by itself, cannot identify a specific individual, but can be easily cross-checked with other information to identify a specific individual</li>\r\n<li>(iii) Information that contains an \"individual identification code\" as defined by Japanese law concerning the protection of personal information (Act on the Protection of Personal Information).</li>\r\n<li>&nbsp;</li>\r\n</ul>\r\n</li>\r\n<li>Scope and purpose of use of personal information collected\r\n<p>The Databases collect the following personal information obtained upon receipt of applications from persons who wish to use the Databases, or upon receiving inquiries about the Databases by legal and appropriate means, and access and use the collected information by legal and appropriate means to the extent necessary to achieve the following purposes and purposes incidental to those purposes. Except where permitted by the law, personal information will not be used beyond this scope without the consent of the individual concerned.</p>\r\n</li>\r\n</ol>\r\n<p>&nbsp;</p>\r\n<table border=\"1\" style=\"border-collapse: collapse; border: initial solid initial;\" cellpadding=\"0\" cellspacing=\"0\">\r\n<tbody>\r\n<tr>\r\n<td colspan=\"2\" style=\"width: 453px; padding-right: 4px; padding-left: 4px; vertical-align: top; border: 1px solid;\">\r\n<p style=\"text-align: center;\">Personal information collected</p>\r\n</td>\r\n<td style=\"padding-right: 4px; padding-left: 4px; width: 416px; border: 1px solid; vertical-align: top;\">\r\n<p style=\"text-align: center;\">Purpose of use</p>\r\n</td>\r\n</tr>\r\n<tr style=\"height: 32px;\">\r\n<td rowspan=\"3\" style=\"width: 152px; padding-right: 4px; padding-left: 4px; height: 32px; border: 1px solid; vertical-align: top;\">\r\n<p>Information submitted at the time of applications</p>\r\n</td>\r\n<td style=\"width: 332px; padding-right: 4px; padding-left: 4px; height: 32px; border: 1px solid; vertical-align: top;\">\r\n<p>The following information provided regarding the Principal Investigator, the head of his/her institution, the applicant, and the research contributor.</p>\r\n<p>- Name</p>\r\n<p>- Name of organization</p>\r\n<p>- Name of department</p>\r\n<p>- Position</p>\r\n<p>- Address</p>\r\n<p>- E-mail address</p>\r\n<p>- Phone number</p>\r\n<p>- (If there is an entrustee) Name of the entrusted organization, department, name, and position of the person in charge</p>\r\n</td>\r\n<td style=\"padding-right: 4px; padding-left: 4px; height: 32px; width: 416px; border: 1px solid; vertical-align: top;\">\r\n<p>(1) For operations related to the review of applications for the submission and use of Human Data.</p>\r\n<p>(2) To confirm necessary matters and communicate request for responses from DBCLS regarding application details for the submission and use of Human Data.</p>\r\n<p>(3) To respond to applications and inquiries regarding the use of the Databases and to notify of important matters.</p>\r\n<p>(4) To improve the convenience of users of the Databases, and to provide a smooth service.</p>\r\n<p>(5) To communicate about surveys and other matters related to the operations of the Databases.</p>\r\n</td>\r\n</tr>\r\n<tr style=\"height: 34px;\">\r\n<td style=\"width: 312px; padding-right: 4px; padding-left: 4px; height: 34px; border: 1px solid; vertical-align: top;\">\r\n<p>Name of Principal Investigator, name of institution to which he/she belongs, and department</p>\r\n</td>\r\n<td style=\"padding-right: 4px; padding-left: 4px; height: 34px; width: 416px; border: 1px solid; vertical-align: top;\">\r\n<p>To disclose data submitter / data user information.</p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<table border=\"1\" style=\"border-collapse: collapse; border: initial solid initial;\" cellpadding=\"0\" cellspacing=\"0\">\r\n<tbody>\r\n<tr>\r\n<td style=\"width: 455px; padding-right: 4px; padding-left: 4px; vertical-align: top; border: 1px solid;\">\r\n<p style=\"text-align: center;\">Personal information collected</p>\r\n</td>\r\n<td style=\"padding-right: 4px; padding-left: 4px; width: 455px; border: 1px solid; vertical-align: top;\">\r\n<p style=\"text-align: center;\">Purpose of use</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td style=\"width: 455px; padding-right: 4px; padding-left: 4px; border: 1px solid; vertical-align: top;\">\r\n<p>The following information provided through the inquiry form for the Databases:</p>\r\n<p>- Name</p>\r\n<p>- E-mail address</p>\r\n<p>- Name of organization to which he/she belongs</p>\r\n</td>\r\n<td style=\"padding-right: 4px; padding-left: 4px; width: 455px; border: 1px solid; vertical-align: top;\">\r\n<p>To respond to inquiries, improve convenience and take necessary actions.</p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p>&nbsp;</p>\r\n<ol start=\"4\">\r\n<li>Provision to third parties\r\n<p>DBCLS will not provide personal information to third parties except in the following cases (i) through (v). Please note that statistical data and other information may be disclosed or provided after being processed into a format that does not allow individuals to be identified.</p>\r\n<ul style=\"list-style: none;\">\r\n<li>(i) When the prior consent of the person in question has been obtained.</li>\r\n<li>(ii) When it is necessary for the protection of the life, body, or property of an individual, and it is difficult to obtain the consent of the person in question.</li>\r\n<li>(iii) When it is particularly necessary for improving public health or promoting the sound development of children, and it is difficult to obtain the consent of the person in question.</li>\r\n<li>(iv) When it is necessary to cooperate with a national agency, a local authority, or an individual or entity entrusted by either a national agency or a local authority to execute affairs prescribed by law, and obtaining the consent of the person is likely to impede the execution of such affairs.</li>\r\n<li>(v) When there is a request for disclosure based on laws and regulations, or when there is a request for cooperation with investigations related to research misconduct or illegal activities such as unauthorized access or threats.</li>\r\n<li>&nbsp;</li>\r\n</ul>\r\n</li>\r\n<li>Joint use\r\n<p>Due to the special characteristics of the Databases and the necessity of its operation, information collected through the acceptance of applications will be recorded on servers in Japan managed by the National Institute of Genetics (hereinafter referred to as \"NIG\") within ROIS, and will be managed in accordance with the privacy policies of the NIG Bioinformation and DDBJ Center (hereinafter referred to as \"DDBJ Center\") (<a href=\"https://www.ddbj.nig.ac.jp/policies-e.html#privacy\" target=\"_blank\" rel=\"noopener\">https://www.ddbj.nig.ac.jp/policies-e.html#privacy</a>). For the purpose of improving the convenience of users of the Databases and providing smooth services, the DDBJ Center may contact you directly without going through the DBCLS only when it is required. In addition, information about users that have been processed so that individuals cannot be identified, and website access statistics may be jointly used with the DDBJ Center.</p>\r\n<p>DBCLS and the Japan Agency for Medical Research and Development (hereinafter referred to as \"AMED\") will jointly use all personal information for the operation of the AMED Genome group sharing Database (hereinafter referred to as \"AGD\"), which is provided at the time of applications related to AGD.</p>\r\n<p>&nbsp;</p>\r\n</li>\r\n<li>Matters concerning security control measures\r\n<p>In order to prevent the loss, leakage, impairment, damage, misuse, falsification or destruction of personal information that DBCLS obtains and handles, the following necessary and appropriate measures will be taken.</p>\r\n<ul style=\"list-style: none;\">\r\n<li>(i) DBCLS will conduct educational activities for all officers and employees, appoint a person in charge of each department that handles personal information, and strive to manage personal information appropriately.</li>\r\n<li>(ii) DBCLS will maintain the security of its website to prevent unauthorized access to personal information.</li>\r\n<li>(iii) DBCLS will grant limited access to personal information only to employees and outsourcing contractors who need such access. DBCLS will enter into employment contracts and outsourcing agreements with its employees and contractors, respectively, that include confidentiality clauses, and will make every effort to ensure that the employees and the contractors handle and protect personal information appropriately, and to prevent leakage, unauthorized provision to third parties, and use outside the scope of the purposes of use described in Section 3. above.</li>\r\n<li>&nbsp;</li>\r\n</ul>\r\n</li>\r\n<li>Disclosure, correction, addition, deletion, suspension of use, and suspension of provision to third parties of personal information\r\n<p>When DBCLS receives a request from an individual regarding disclosure, correction, addition, deletion, suspension of use, removal, or suspension of provision to a third party of his/her personal information held by DBCLS, DBCLS will, from the perspective of preventing leakage of personal information and ensuring accuracy and security, conduct a necessary investigation without delay unless special procedures are required by law, and DBCLS will respond to the request in good faith in accordance with the law only when it is confirmed that the request is made by the person in question. DBCLS will not be able to respond to the request if the request does not meet the requirements stipulated by law, if the contents of the request are deemed unreasonable based on the results of the investigation, or if there are justifiable reasons to reject the request based on laws and regulations.</p>\r\n<p>Please be aware that costs associated with requests for disclosure, including communication fees, transportation expenses, and expenses incurred in preparing necessary identification documents, will be the responsibility of the requester. For details on the procedure, please refer to \"Information disclosure and management\" as specified by ROIS (<a href=\"https://www.rois.ac.jp/en/open/01.html\" target=\"_blank\" rel=\"noopener\">https://www.rois.ac.jp/en/open/01.html</a>).</p>\r\n<p>&nbsp;</p>\r\n</li>\r\n<li>Acquisition of access logs and use of access analysis tools\r\n<p>A technology that records and manages information about website users on computers and application software is called a \"cookie.\" The websites of the Databases use cookies to make it more convenient for those who use the websites (hereinafter referred to as \"users\"). And the Databases' websites use Google Analytics, a service provided by Google, Inc. to understand the status of users’ visits to the websites.</p>\r\n<p>When Google Analytics is used on the websites of the Databases, Google collects, records, and analyzes the information about visits to the websites of the Databases based on cookies issued by DBCLS. DBCLS receives the results of this analysis from Google in order to understand how users use the websites. The information collected, recorded, and analyzed by Google Analytics will not include any personally identifiable information, and such information will be managed by Google Inc. in accordance with its privacy policy.</p>\r\n<p>Users may also opt out of having their information collected through DBCLS’s use of Google Analytics by disabling Google Analytics in their web browser's add-on settings. Google Analytics can be disabled by downloading and installing the \"Google Analytics Opt-Out Add-on\" from the Google Opt-Out Add-on Download page and changing the add-on settings on their web browser. If users disable Google Analytics, Google Analytics will also be disabled on websites other than this site that the users visit. Also, it is possible for the users to re-enable Google Analytics by reconfiguring the add-ons on their web browser. For an explanation of Google Analytics Terms of Use, please refer to the Google Analytics website, and for an explanation of Google's privacy policy, please refer to Google's website.</p>\r\n<p>Google Analytics Terms of Service:<br /><a href=\"https://marketingplatform.google.com/about/analytics/terms/us/\" target=\"_blank\" rel=\"noopener\"> https://marketingplatform.google.com/about/analytics/terms/us/ </a></p>\r\n<p>Google's use of information collected from sites and applications that use Google services:<br /><a href=\"https://policies.google.com/technologies/partner-sites?hl=en\" target=\"_blank\" rel=\"noopener\">https://policies.google.com/technologies/partner-sites</a></p>\r\n<p>Google Analytics Opt-Out Add-On:<br /><a href=\"https://tools.google.com/dlpage/gaoptout?hl=en\" target=\"_blank\" rel=\"noopener\"> https://tools.google.com/dlpage/gaoptout </a></p>\r\n<p>&nbsp;</p>\r\n</li>\r\n<li>Scope of application\r\n<p>This policy applies to personal information obtained through the services of the Databases operated and managed by ROIS. The ROIS's regulations and policies regarding the protection of personal information (<a href=\"https://www.rois.ac.jp/open/01.html\" target=\"_blank\" rel=\"noopener\">https://www.rois.ac.jp/open/01.html</a>*) and the policies disclosed by DBCLS (<a href=\"https://dbcls.rois.ac.jp/policy-en.html\" target=\"_blank\" rel=\"noopener\">https://dbcls.rois.ac.jp/policy-en.html</a>) will apply to any information that is not covered by this policy, and in the event of any inconsistency between this policy and the ROIS's regulations and policies regarding the protection of personal information or the DBCLS policy, the terms of this policy shall prevail.</p>\r\n<p><span style=\"font-size: 8pt;\">&nbsp;* This URL links to the Japanese website. The ROIS's regulations and policies regarding the protection of personal information are only available in Japanese on the Japanese website.</span></p>\r\n<p>&nbsp;</p>\r\n</li>\r\n<li>Retention period of personal information\r\n<p>DBCLS retains personal information in compliance with applicable laws and regulations for the duration of the operation of the Databases.</p>\r\n<p>&nbsp;</p>\r\n</li>\r\n<li>Other\r\n<p>DBCLS may revise this policy from time to time. Any revisions will be announced on the website of the Databases（<a href=\"https://humandbs.dbcls.jp/en/\" target=\"_blank\" rel=\"noopener\">https://humandbs.dbcls.jp/en/</a>）in advance.</p>\r\n<p>&nbsp;</p>\r\n</li>\r\n<li>Contact information\r\n<p>Database Center for Life Science (DBCLS), Joint Support-Center for Data Science Research (DS), Research Organization of Information and Systems (ROIS)</p>\r\n<p>178-4-4 Wakashiba, Kashiwa, Chiba 277-0871, JAPAN</p>\r\n<p><a href=\"https://humandbs.dbcls.jp/en/contact-us\" target=\"_blank\" rel=\"noopener\">https://humandbs.dbcls.jp/en/contact-us</a></p>\r\n<p>&nbsp;</p>\r\n</li>\r\n<li>Information on business operators handling personal information\r\n<p>The name, address and representative of ROIS (President) can be found on the following website:</p>\r\n<p><a href=\"https://www.rois.ac.jp/en/about/staff.html\" target=\"_blank\" rel=\"noopener\">https://www.rois.ac.jp/en/about/staff.html</a></p>\r\n</li>\r\n</ol>\r\n<p style=\"text-align: right;\">Date: March 19, 2025</p>", "publish_up": "2013-03-15"}, {"lang": "ja", "path": "publications", "title": "成果発表（日本語）", "fulltext": "", "modified": "2025-09-12", "introtext": "<h1><span style=\"text-decoration: underline; font-family: helvetica; font-size: 15pt;\"><strong>NBDCヒトデータベースに登録されている制限公開データを使用した研究成果</strong></span></h1>\r\n<table class=\"table-style style-greystripes\" style=\"width: 90%;\">\r\n<thead>\r\n<tr><th align=\"center\"><span style=\"font-family: helvetica; font-size: 11pt;\">研究代表者</span></th><th align=\"center\"><span style=\"font-family: helvetica; font-size: 11pt;\">論文タイトル</span></th><th align=\"center\"><span style=\"font-family: helvetica; font-size: 11pt;\">ジャーナル</span></th><th align=\"center\"><span style=\"font-family: helvetica; font-size: 11pt;\">公開日</span></th><th align=\"center\"><span style=\"font-family: helvetica; font-size: 11pt;\">利用データ</span></th></tr>\r\n</thead>\r\n<tbody>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Tianzhong Yang</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Multiancestry Transcriptome-Wide Association Study Identifies Candidate Genes Associated with Hepatoblastoma</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1158/1055-9965.EPI-24-1553\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cancer Epidemiology Biomarkers &amp; Prevention<br />(doi: 10.1158/1055-9965.EPI-24-1553)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2025.8.1</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0233-v1\" target=\"_blank\">JGAD000334</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">角田 達彦</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic Target</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1158/2767-9764.CRC-25-0024\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cancer Research Commun<br />(doi: 10.1158/2767-9764.CRC-25-0024)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2025.6.25</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0067-v1\" target=\"_blank\">JGAD000076</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">白石 航也</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung Adenocarcinoma</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jtho.2025.06.005\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Thoracic Oncology<br />(doi: 10.1016/j.jtho.2025.06.005)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2025.6.12</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"> <a href=\"/hum0066-v1\" target=\"_blank\">JGAD000060</a>、<br /> <a href=\"/hum0053-latest\" target=\"_blank\">JGAD000062</a>、<br /><a href=\"/hum0067-v1\" target=\"_blank\">JGAD000076</a>、<br /> <a href=\"/hum0133-v1\" target=\"_blank\">JGAD000086</a>、<br /> <a href=\"/hum0058-v1\" target=\"_blank\">JGAD000091</a>、<br /> <a href=\"/hum0095-v1\" target=\"_blank\">JGAD000092</a>、<br /> <a href=\"/hum0094-latest\" target=\"_blank\">JGAD000095</a>、<br /> <a href=\"/hum0059-v1\" target=\"_blank\">JGAD000109</a>、<br /> <a href=\"/hum0094-latest\" target=\"_blank\">JGAD000110</a>、<br /> <a href=\"/hum0094-latest\" target=\"_blank\">JGAD000111</a>、<br /><a href=\"/hum0085-latest\" target=\"_blank\">JGAD000116</a>、<br /> <a href=\"/hum0094-latest\" target=\"_blank\">JGAD000122</a>、<br /> <a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<br /> <a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /> <a href=\"/hum0158-latest\" target=\"_blank\">JGAD000228</a>、<br /> <a href=\"/hum0158-latest\" target=\"_blank\">JGAD000229</a>、<br /> <a href=\"/hum0160-latest\" target=\"_blank\">JGAD000233</a>、<br /> <a href=\"/hum0140-v1\" target=\"_blank\">JGAD000236</a>、<br /> <a href=\"/hum0176-v1\" target=\"_blank\">JGAD000250</a>、<br /> <a href=\"/hum0120-latest\" target=\"_blank\">JGAD000311</a>、<br /> <a href=\"/hum0120-latest\" target=\"_blank\">JGAD000312</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">河野 隆志</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung Adenocarcinoma</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jtho.2025.06.005\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Thoracic Oncology<br />(doi: 10.1016/j.jtho.2025.06.005)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2025.6.12</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0060-v1\" target=\"_blank\">JGAD000075</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000209</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">白石 航也</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Impact of germline variants on breast and ovarian cancer risk in Japanese women: an original cohort study and meta-analysis</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.ebiom.2025.105758\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">eBioMedicine<br />(doi: 10.1016/j.ebiom.2025.105758)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2025.5.21</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"> <a href=\"/hum0066-v1\" target=\"_blank\">JGAD000060</a>、<br /> <a href=\"/hum0053-latest\" target=\"_blank\">JGAD000062</a>、<br /><a href=\"/hum0067-v1\" target=\"_blank\">JGAD000076</a>、<br /> <a href=\"/hum0133-v1\" target=\"_blank\">JGAD000086</a>、<br /> <a href=\"/hum0058-v1\" target=\"_blank\">JGAD000091</a>、<br /> <a href=\"/hum0095-v1\" target=\"_blank\">JGAD000092</a>、<br /> <a href=\"/hum0094-latest\" target=\"_blank\">JGAD000095</a>、<br /> <a href=\"/hum0059-v1\" target=\"_blank\">JGAD000109</a>、<br /> <a href=\"/hum0094-latest\" target=\"_blank\">JGAD000110</a>、<br /> <a href=\"/hum0094-latest\" target=\"_blank\">JGAD000111</a>、<br /><a href=\"/hum0085-latest\" target=\"_blank\">JGAD000116</a>、<br /> <a href=\"/hum0094-latest\" target=\"_blank\">JGAD000122</a>、<br /> <a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<br /> <a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /> <a href=\"/hum0158-latest\" target=\"_blank\">JGAD000228</a>、<br /> <a href=\"/hum0158-latest\" target=\"_blank\">JGAD000229</a>、<br /> <a href=\"/hum0160-latest\" target=\"_blank\">JGAD000233</a>、<br /> <a href=\"/hum0140-v1\" target=\"_blank\">JGAD000236</a>、<br /> <a href=\"/hum0176-v1\" target=\"_blank\">JGAD000250</a>、<br /> <a href=\"/hum0120-latest\" target=\"_blank\">JGAD000311</a>、<br /> <a href=\"/hum0120-latest\" target=\"_blank\">JGAD000312</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">岡田 随象</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Dissecting cross-population polygenic heterogeneity across respiratory and cardiometabolic diseases</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-025-58149-y\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi: 10.1038/s41467-025-58149-y)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2025.4.28</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0028-latest\" target=\"_blank\">JGAD000018</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000101</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000102</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000144- <br />JGAD000201</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">平川 晃弘</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Self-Organized Prediction-Classification-Superposition of Longitudinal Cognitive Decline in Alzheimer's Disease: An Application to Novel Clinical Research Methodology</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1109/JBHI.2025.3546020\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">IEEE Journal of Biomedical and Health Informatics<br />(doi: 10.1109/JBHI.2025.3546020)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2025.2.26</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0043-v1\" target=\"_blank\">JGAD000051</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yongxin LI</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Human microbiome-derived peptide affects the development of experimental autoimmune encephalomyelitis via molecular mimicry</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.ebiom.2024.105516\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">eBioMedicine<br />(doi: 10.1016/j.ebiom.2024.105516)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.12.24</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0197-latest\" target=\"_blank\">JGAD000363</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">野口 恵美子</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">A genome-wide meta-analysis reveals shared and population-specific variants for allergic sensitization</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jaci.2024.11.033\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Allergy and Clinical Immunology<br />(doi:10.1016/j.jaci.2024.11.033)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.12.5</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0028-latest\" target=\"_blank\">JGAD000018</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">河野 隆志</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Polygenic Risk Score and Lung Adenocarcinoma Risk Among Never-Smokers by EGFR Mutation Status: A Brief Report</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jtho.2024.11.019\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Thoracic Oncology<br />(doi: 10.1016/j.jtho.2024.11.019)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.11.22</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0060-v1\" target=\"_blank\">JGAD000075</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000209</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">二宮 利治</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Common protein-altering variant in GFAP is associated with white matter lesions in the older Japanese population</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41525-024-00431-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">npj Genomic Medicine<br />(doi:10.1038/s41525-024-00431-x)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.11.13</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">岡田 随象</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genetic legacy of ancient hunter-gatherer Jomon in Japanese populations</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-024-54052-0\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi: 10.1038/s41467-024-54052-0)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.11.12</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0028-latest\" target=\"_blank\">JGAD000018</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000101</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000102</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000144-<br />JGAD000201</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">中杤 昌弘</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Copy number variations in RNF216 and postsynaptic membrane–associated genes are associated with bipolar disorder: a case-control study in the Japanese population</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1111/pcn.13752\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Psychiatry Clinical Neurosciences<br />(doi:10.1111/pcn.13752)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.10.15</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0021-latest\" target=\"_blank\">JGAD000379</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">岡田 随象</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Inconsistent embryo selection across polygenic score methods</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41562-024-02019-y\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">nature human behaviour<br />(doi: 10.1038/s41562-024-02019-y)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.10.14</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0028-latest\" target=\"_blank\">JGAD000018</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000101</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000102</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000144-<br />JGAD000201</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Charles G. Mullighan</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1158/2159-8290.CD-23-1452\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cancer Discovery<br />(doi:10.1158/2159-8290.CD-23-1452)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.10.4</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0096-latest\" target=\"_blank\">JGAD000090</a>、<br /><a href=\"/hum0096-latest\" target=\"_blank\">JGAD000207</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">岡田 随象</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Machine learning reveals heterogeneous associations between environmental factors and cardiometabolic diseases across polygenic risk scores</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s43856-024-00596-7\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">communications medicine<br />(doi: 10.1038/s43856-024-00596-7)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.9.20</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0028-latest\" target=\"_blank\">JGAD000018</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000101</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000102</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000144-<br />JGAD000201</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">岡田 随象</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Large-scale cross-trait genetic analysis highlights shared genetic backgrounds of autoimmune diseases</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1080/25785826.2024.2394258\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Immunological Medicine<br />(doi: 10.1080/25785826.2024.2394258)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.8.22</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0028-latest\" target=\"_blank\">JGAD000018</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000101</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000102</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000144-<br />JGAD000201</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Charles G. Mullighan</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">The genomic basis of childhood T-lineage acute lymphoblastic leukaemia</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41586-024-07807-0\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature<br />(doi:10.1038/s41586-024-07807-0)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.8.14</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0096-latest\" target=\"_blank\">JGAD000090</a>、<br /><a href=\"/hum0096-latest\" target=\"_blank\">JGAD000207</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">金子 猛</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">HLA-DQA1*01:03 and DQB1*06:01 are risk factors for severe COVID-19 pneumonia</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1111/tan.15609\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">HLA<br />(doi: 10.1111/tan.15609)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.7.23</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0028-latest\" target=\"_blank\">JGAD000018</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">岡田 随象</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Common and rare genetic variants predisposing females to unexplained recurrent pregnancy loss</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-024-49993-5\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi:10.1038/s41467-024-49993-5)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.7.17</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0012-v1\" target=\"_blank\">JGAD000012</a>、<br /><a href=\"/hum0028-latest\" target=\"_blank\">JGAD000018</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000101</a>、<a href=\"/hum0014-latest\" target=\"_blank\">JGAD000102</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000144-JGAD000201</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">上辻 茂男</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genome-Wide Association Study with Three Control Cohorts of Japanese Patients with Esotropia and Exotropia of Comitant Strabismus and Idiopathic Superior Oblique Muscle Palsy</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.3390/ijms25136986\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Molecular Sciences<br />(doi:10.3390/ijms25136986)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.6.26</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<a href=\"/hum0311-latest\" target=\"_blank\">JGAD000529</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">寺尾 知可史</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">RNF213 Variants, Vasospastic Angina, and Risk of Fatal Myocardial Infarction</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1001/jamacardio.2024.1483\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JAMA Cardiology<br />(doi:10.1001/jamacardio.2024.1483)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.6.18</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000144-JGAD000201</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000836</a>、<br /><a href=\"/hum0311-latest\" target=\"_blank\">JGAD000529</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Charles G. Mullighan</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Conserved epigenetic hallmarks of T cell aging during immunity and malignancy</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s43587-024-00649-5\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Aging<br />(doi:10.1038/s43587-024-00649-5)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.6.12</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0096-latest\" target=\"_blank\">JGAD000090</a>、<br /><a href=\"/hum0096-latest\" target=\"_blank\">JGAD000207</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">岡田 随象</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Body mass index stratification optimizes polygenic prediction of type 2 diabetes in cross-biobank analyses</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41588-024-01782-y\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Genetics<br />(doi:10.1038/s41588-024-01782-y)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.6.11</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0012-v1\" target=\"_blank\">JGAD000012</a>、<br /><a href=\"/hum0028-latest\" target=\"_blank\">JGAD000018</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000101</a>、<a href=\"/hum0014-latest\" target=\"_blank\">JGAD000102</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000144-JGAD000201</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">寺尾 知可史</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">A genome-wide association study identifies a locus associated with knee extension strength in older Japanese individuals</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s42003-024-06108-6\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Communications Biology<br />(doi:10.1038/s42003-024-06108-6)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.5.20</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000144-JGAD000201</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000836</a>、<br /><a href=\"/hum0311-latest\" target=\"_blank\">JGAD000529</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Martin Hofmann-Apitius</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Semantic Harmonization of Alzheimer’s Disease Datasets Using AD-Mapper</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.3233/JAD-240116\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">The Journal of Prevention of Alzheimer's Disease<br />(doi:10.3233/JAD-240116)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.5.15</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0043-v1\" target=\"_blank\">JGAD000051</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">井狩 彌彦</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Improved Correlation of 18F-Flortaucipir PET SUVRs and Clinical Stages in the Alzheimer Disease Continuum with the MUBADA/PERSI-Based Analysis</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.2967/jnmt.123.267113\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Nuclear Medicine Technology<br />(doi:10.2967/jnmt.123.267113)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.4.16</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0235-v1\" target=\"_blank\">JGAD000378</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">岡田 随象</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genetic drivers of heterogeneity in type 2 diabetes pathophysiology</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41586-024-07019-6\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature<br />(doi:10.1038/s41586-024-07019-6)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.3.14</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0012-v1\" target=\"_blank\">JGAD000012</a>、<br /><a href=\"/hum0028-latest\" target=\"_blank\">JGAD000018</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000101</a>、<a href=\"/hum0014-latest\" target=\"_blank\">JGAD000102</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000144-JGAD000201</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">寺尾 知可史</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-023-44541-z\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi:10.1038/s41467-023-44541-z)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.1.31</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000144-JGAD000201</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000836</a>、<br /><a href=\"/hum0311-latest\" target=\"_blank\">JGAD000529</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Eric Westman</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">A deep learning model for brain age prediction using minimally preprocessed T1w images as input</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.3389/fnagi.2023.1303036\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Frontiers in Aging Neuroscience<br />(doi:10.3389/fnagi.2023.1303036)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.1.8</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\">JGAD000051</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Martin Hofmann-Apitius</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Data-Driven Thresholding Statistically Biases ATN Profiling across Cohort Datasets</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.14283/jpad.2023.100\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">The Journal of Prevention of Alzheimer's Disease<br />(doi:10.14283/jpad.2023.100)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.1</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0043-v1\" target=\"_blank\">JGAD000051</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">福永 航也</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Differential Effects of HLA-B∗15:11 and HLA-A∗31:01 on Carbamazepine-Induced Cutaneous Adverse Reactions</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jid.2023.09.282\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Investigative Dermatology<br />(doi:10.1016/j.jid.2023.09.282)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.10.30</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0028-latest\" target=\"_blank\">JGAD000018</a>、 <a href=\"/hum0114-latest\" target=\"_blank\">JGAD000425</a>、<br /><a href=\"/hum0311-latest\" target=\"_blank\">JGAD000529</a>、<a href=\"/hum0311-latest\" target=\"_blank\">JGAD000660</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">河野 隆志</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome-wide association and whole genome sequencing analyses</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1002/cac2.12498\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cancer Communication<br />(doi:10.1002/cac2.12498)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.10.26</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">白石 航也</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome-wide association and whole genome sequencing analyses</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1002/cac2.12498\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cancer Communication<br />(doi:10.1002/cac2.12498)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt;\">2023.10.26</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt;\"><a href=\"/hum0066-v1\" target=\"_blank\">JGAD000060</a>、<a href=\"/hum0053-latest\" target=\"_blank\">JGAD000062</a>、<br /><a href=\"/hum0067-v1\" target=\"_blank\">JGAD000076</a>、<a href=\"/hum0133-v1\" target=\"_blank\">JGAD000086</a>、<br /><a href=\"/hum0058-v1\" target=\"_blank\">JGAD000091</a>、<a href=\"/hum0095-v1\" target=\"_blank\">JGAD000092</a>、<br /><a href=\"/hum0094-latest\" target=\"_blank\">JGAD000095</a>、<a href=\"/hum0059-v1\" target=\"_blank\">JGAD000109</a>、<br /><a href=\"/hum0094-latest\" target=\"_blank\">JGAD000110</a>、<a href=\"/hum0094-latest\" target=\"_blank\">JGAD000111</a>、<br /><a href=\"/hum0085-latest\" target=\"_blank\">JGAD000116</a>、<br /><a href=\"/hum0094-latest\" target=\"_blank\">JGAD000122</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0158-latest\" target=\"_blank\">JGAD000228</a>、<a href=\"/hum0158-latest\" target=\"_blank\">JGAD000229</a>、<br /><a href=\"/hum0160-latest\" target=\"_blank\">JGAD000233</a>、<a href=\"/hum0140-v1\" target=\"_blank\">JGAD000236</a>、<br /><a href=\"/hum0176-v1\" target=\"_blank\">JGAD000250</a>、<a href=\"/hum0120-latest\" target=\"_blank\">JGAD000311</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">河野 隆志</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Contribution of an Asian-prevalent HLA haplotype to the risk of HBV-related hepatocellular carcinoma</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41598-023-40000-3\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Scientific Reports<br />(doi:10.1038/s41598-023-40000-3)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.8.9</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"/hum0028-latest\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000018</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">河野 隆志</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Contribution of an Asian-prevalent HLA haplotype to the risk of HBV-related hepatocellular carcinoma</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41598-023-40000-3\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Scientific Reports<br />(doi:10.1038/s41598-023-40000-3)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.8.9</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">河野 隆志</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Contribution of an Asian-prevalent HLA haplotype to the risk of HBV-related hepatocellular carcinoma</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41598-023-40000-3\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Scientific Reports<br />(doi: 10.1038/s41598-023-40000-3)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.8.9</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0159-latest\" target=\"_blank\">JGAD000235</a>、<br /> <a href=\"/hum0187-latest\" target=\"_blank\">JGAD000277</a>、<br /> <a href=\"/hum0216-latest\" target=\"_blank\">JGAD000302</a>、<br /> <a href=\"/hum0227-v1\" target=\"_blank\">JGAD000320</a>、<br /> <a href=\"/hum0227-v1\" target=\"_blank\">JGAD000321</a>, <br /> <a href=\"/hum0216-latest\" target=\"_blank\">JGAD000327</a>, <br /> <a href=\"/hum0187-latest\" target=\"_blank\">JGAD000328</a>、<br /> <a href=\"/hum0187-latest\" target=\"_blank\">JGAD000329</a>、<br /> <a href=\"/hum0187-latest\" target=\"_blank\">JGAD000330</a>、<br /> <a href=\"/hum0236-v1\" target=\"_blank\">JGAD000345</a>、<br /> <a href=\"/hum0216-latest\" target=\"_blank\">JGAD000385</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">白石 航也</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Contribution of an Asian-prevalent HLA haplotype to the risk of HBV-related hepatocellular carcinoma</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41598-023-40000-3\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Scientific Reports<br />(doi:10.1038/s41598-023-40000-3)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.8.9</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt;\"><a href=\"/hum0066-v1\" target=\"_blank\">JGAD000060</a>、<a href=\"/hum0053-latest\" target=\"_blank\">JGAD000062</a>、<br /><a href=\"/hum0067-v1\" target=\"_blank\">JGAD000076</a>、<a href=\"/hum0133-v1\" target=\"_blank\">JGAD000086</a>、<br /><a href=\"/hum0058-v1\" target=\"_blank\">JGAD000091</a>、<a href=\"/hum0095-v1\" target=\"_blank\">JGAD000092</a>、<br /><a href=\"/hum0094-latest\" target=\"_blank\">JGAD000095</a>、<a href=\"/hum0059-v1\" target=\"_blank\">JGAD000109</a>、<br /><a href=\"/hum0094-latest\" target=\"_blank\">JGAD000110</a>、<a href=\"/hum0094-latest\" target=\"_blank\">JGAD000111</a>、<br /><a href=\"/hum0085-latest\" target=\"_blank\">JGAD000116</a>、<br /><a href=\"/hum0094-latest\" target=\"_blank\">JGAD000122</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0158-latest\" target=\"_blank\">JGAD000228</a>、<a href=\"/hum0158-latest\" target=\"_blank\">JGAD000229</a>、<br /><a href=\"/hum0160-latest\" target=\"_blank\">JGAD000233</a>、<a href=\"/hum0140-v1\" target=\"_blank\">JGAD000236</a>、<br /><a href=\"/hum0176-v1\" target=\"_blank\">JGAD000250</a>、<a href=\"/hum0120-latest\" target=\"_blank\">JGAD000311</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">枡田 大生</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41598-023-38893-1\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Scientific Reports<br />(doi: 10.1038/s41598-023-38893-1)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.8.3</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Danny Chi Yeu Leung</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Single-cell analysis reveals transcriptomic and epigenomic impacts on the maternal-fetal interface following SARS-CoV-2 infection</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41556-023-01169-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Cell Biology<br />(doi:10.1038/s41556-023-01169-x)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.7.3</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0086-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000073</a>、<a href=\"/hum0086-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000115</a>、<br /><a href=\"index.php?option=com_content&amp;view=article&amp;id=565&amp;Itemid=840&amp;lang=ja\" target=\"_blank\">JGAD000121</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">岡田 随象</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Pan-cancer and cross-population genome-wide association studies dissect shared genetic backgrounds underlying carcinogenesis</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-023-39136-7\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi: 10.1038/s41467-023-39136-7)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.6.20</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000101</a>、<a href=\"/hum0014-latest\" target=\"_blank\">JGAD000102</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000144-JGAD000201</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a>、<a href=\"/hum0028-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000018</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Ming-an Sun</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Endogenous retrovirus-derived enhancers confer the transcriptional regulation of human trophoblast syncytialization</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1093/nar/gkad109\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nucleic Acids Research<br />(doi:10.1093/nar/gkad109)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.6.9</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0086-latest\" target=\"_blank\">JGAD000073</a>、<br /><a href=\"/hum0086-latest\" target=\"_blank\">JGAD000115</a>、<a href=\"/hum0112-v1\" target=\"_blank\">JGAD000121</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">河野 隆志</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-023-38196-z\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi:10.1038/s41467-023-38196-z)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.5.26</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">岡田 随象</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Reconstruction of the personal information from human genome reads in gut metagenome sequencing data</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41564-023-01381-3\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Microbiology<br />(doi:10.1038/s41564-023-01381-3)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.5.15</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0311-latest\" target=\"_blank\">JGAD000529</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">岡田 随象</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">A genome-wide association study for allergen component sensitizations identifies allergen component-specific and allergen protein group-specific associations</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jacig.2023.100086\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">The Journal of Allergy and Clinical Immunology: Global<br />(doi:10.1016/j.jacig.2023.100086)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.5</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">野口 恵美子</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">A genome-wide association study for allergen component sensitizations identifies allergen component-specific and allergen protein group-specific associations</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jacig.2023.100086\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">The Journal of Allergy and Clinical Immunology: Global<br />(doi:10.1016/j.jacig.2023.100086)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.5</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Ansuman Satpathy</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.ccell.2023.03.009\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cancer Cell<br />(doi:10.1016/j.ccell.2023.03.009)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.4.10</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0320-v1\" target=\"_blank\">JGAD000597</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Ming-an Sun</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Regulation of endogenous retrovirus–derived regulatory elements by GATA2/3 and MSX2 in human trophoblast stem cells</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1101/gr.277150.122\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genome Research<br />(doi:10.1101/gr.277150.122)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.2.17</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0086-latest\" target=\"_blank\">JGAD000073</a>、<br /><a href=\"/hum0086-latest\" target=\"_blank\">JGAD000115</a>、<a href=\"/hum0112-v1\" target=\"_blank\">JGAD000121</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Martin Hofmann-Apitius</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Forecasting individual progression trajectories in Alzheimer’s disease</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-022-35712-5\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi:10.1038/s41467-022-35712-5)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.2.10</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Ulf Leser</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.3390/cancers15030936\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cancers<br />(doi:10.3390/cancers15030936)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.2.1</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0201-latest\" target=\"_blank\">JGAD000336</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">上辻 茂男</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genetic Backgrounds Associated With Stent Thrombosis: A Pilot Study From a Percutaneous Coronary Intervention Registry</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jacadv.2022.100172\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JACC: Advances<br />(doi:10.1016/j.jacadv.2022.100172)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.1.27</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000145</a>、<a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000146</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000149</a>、<a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000151</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000155</a>、<a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000156</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000158</a>、<a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000159</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000163</a>、<a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000165</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000166</a>、<a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000167</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000170</a>、<a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000172</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000173</a>、<a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000174</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000175</a>、<a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000182</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000187</a>、<a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000188</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000189</a>、<a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000192</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000193</a>、<a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000194</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000195</a>、<a href=\"/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000196</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000200</a>、<a href=\"/hum0014-latest\" target=\"_blank\">JGAD000201</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"> Christian Wachinger</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Identification of causal effects of neuroanatomy on cognitive decline requires modeling unobserved confounders</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1002/alz.12825\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer's &amp; Dementia<br />(doi:10.1002/alz.12825)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.11.23</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Eric Westman</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer’s disease</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-022-32202-6\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi:10.1038/s41467-022-32202-6)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.8.5</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">万代 昌紀</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1136/jitc-2022-004831\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal for ImmunoTherapy of Cancer<br />(doi:10.1136/jitc-2022-004831)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.7.22</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=189&amp;Itemid=425&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000022</a>、<a href=\"index.php?option=com_content&amp;view=article&amp;id=621&amp;Itemid=885&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000075</a>、<br /><a href=\"index.php?option=com_content&amp;view=article&amp;id=444&amp;Itemid=723&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000076</a>、<a href=\"index.php?option=com_content&amp;view=article&amp;id=643&amp;Itemid=910&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000091</a>、<br /><a href=\"index.php?option=com_content&amp;view=article&amp;id=647&amp;Itemid=914&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000086</a>、<a href=\"/hum0094-latest\" target=\"_blank\">JGAD000095</a>、<br /><a href=\"index.php?option=com_content&amp;view=article&amp;id=636&amp;Itemid=906&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000109</a>、<a href=\"/hum0094-latest\" target=\"_blank\">JGAD000110</a>、<br /><a href=\"/hum0094-latest\" target=\"_blank\">JGAD000111</a>、<a href=\"/hum0094-latest\" target=\"_blank\">JGAD000122</a>、<br /><a href=\"/hum0127-latest\" target=\"_blank\">JGAD000141</a>、<a href=\"index.php?option=com_content&amp;view=article&amp;id=971&amp;Itemid=1181&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000250</a>、<br /><a href=\"index.php?option=com_content&amp;view=article&amp;id=967&amp;Itemid=1177&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000254</a>、<a href=\"/hum0127-latest\" target=\"_blank\">JGAD000380</a></span></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">平川 晃弘</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Estimating the longitudinal trajectory of cognitive function measurement using short-term data with different disease stages: Application in Alzheimer's disease</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1002/sim.9504\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Statics in Medicine<br />(doi:10.1002/sim.9504)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.6.24</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">堀田 紀久子</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1186/s12876-022-02360-4\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">BMC Gastroenterology<br />(doi:10.1186/s12876-022-02360-4)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.6.2</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0055-v1\" target=\"_blank\">JGAD000059</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">岡田 随象</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41588-022-01058-3\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Genetics<br />(doi:10.1038/s41588-022-01058-3)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.5.12</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=220&amp;Itemid=486&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000012</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Martin Hofmann-Apitius</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer’s disease</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1186/s13195-022-01001-y\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer's Research &amp; Therapy<br />(doi:10.1186/s13195-022-01001-y)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.4.20</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">李 元中</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">A high-generalizability machine learning framework for predicting the progression of Alzheimer’s disease using limited data</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41746-022-00577-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">npj Digital Medicine<br />(doi:10.1038/s41746-022-00577-x)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.4.12</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Jonghwan Kim</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Induction of human trophoblast stem-like cells from primed pluripotent stem cells</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1073/pnas.2115709119\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cell Biology<br />(doi:10.1073/pnas.2115709119)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.3.26</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=358&amp;Itemid=650&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000038</a>、<a href=\"/hum0086-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000073</a>、<br /><a href=\"/hum0086-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000115</a>、<a href=\"index.php?option=com_content&amp;view=article&amp;id=565&amp;Itemid=840&amp;lang=ja\" target=\"_blank\">JGAD000121</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">寶珍 輝尚</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Extraction of Genes and Transcripts Associated with Liver Cancer Using Machine Learning</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.52731/ijscai.v6.i1.628\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">International Journal of Smart Computing and Artificial Intelligence<br />(doi:10.52731/ijscai.v6.i1.628)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.3.11</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=643&amp;Itemid=910&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000091</a>、<a href=\"/hum0158-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000228</a>、<br /><a href=\"/hum0158-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000229</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">岡田 随象</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Decoding the diversity of killer immunoglobulin-like receptors by deep sequencing and a high-resolution imputation method</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.xgen.2022.100101\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cell Genomics<br />(doi:10.1016/j.xgen.2022.100101)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.3.9</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Charles G. Mullighan</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1158/2159-8290.cd-21-0145\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cancer Discovery<br />(doi:10.1158/2159-8290.cd-21-0145)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.11.1</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"/hum0096-latest\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000090</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">岡田 随象</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">A cross-population atlas of genetic associations for 220 human phenotypes</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41588-021-00931-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Genetics<br />(doi:10.1038/s41588-021-00931-x)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.9.30</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0028-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000018</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">莚田 泰誠</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genome-wide association study reveals an association between the HLA-DPB1∗02:01:02 allele and wheat-dependent exercise-induced anaphylaxis</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.ajhg.2021.06.017\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">American Journal of Human Genetics<br />(doi:10.1016/j.ajhg.2021.06.017)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.7.9</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"/hum0028-latest\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000018</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Charles de Bock</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-021-24442-9\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi:10.1038/s41467-021-24442-9)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.7.6</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"/hum0096-latest\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000090</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Martin Hofmann-Apitius</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Unraveling the heterogeneity in Alzheimer's disease progression across multiple cohorts and the implications for data-driven disease modeling</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1002/alz.12387\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer’s &amp; Dementia<br />(doi:10.1002/alz.12387)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.6.9</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">佐々木 雅之</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Improved Accuracy of Amyloid PET Quantification with Adaptive Template–Based Anatomic Standardization</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.2967/jnmt.120.261701\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Nuclear Medicine Technology<br />(doi:10.2967/jnmt.120.261701)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.4.5</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Eric Westman</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Stage vs. Subtype Hypothesis in Alzheimer's Disease: A Multi-Cohort and Longitudinal Bayesian Clustering Study</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.2139/ssrn.3797614\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">LANCET<br />(doi:10.2139/ssrn.3797614)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.3.4</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">岡田 随象</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Clinical use of current polygenic risk scores may exacerbate health disparities</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41588-019-0379-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Genetics<br />(doi:10.1038/s41588-019-0379-x)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.1.28</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000101</a>、<a href=\"/hum0014-latest\" target=\"_blank\">JGAD000102</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">河合 洋介</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genome-wide SNP data of Izumo and Makurazaki populations support inner-dual structure model for origin of Yamato people</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s10038-020-00898-3\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Human Genetics<br />(doi:10.1038/s10038-020-00898-3)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.1.25</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000144-JGAD000201</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Martin Hofmann-Apitius</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Evaluating the Alzheimer's disease data landscape</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1002/trc2.12102\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer's &amp; Dementia<br />(doi:10.1002/trc2.12102)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.12.16</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/hum0043-v1\" target=\"_blank\">JGAD000051</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Brock Christensen</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Altered immune phenotype and DNA methylation in panic disorder</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://dx.doi.org/10.1186/s13148-020-00972-9\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Clinical Epigenetics<br />(doi:10.1186/s13148-020-00972-9)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.11.18</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=498&amp;Itemid=779&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000120</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">深見 忠典</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Longitudinal analysis of brain structure using existence probability</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://dx.doi.org/10.1002/brb3.1869\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Brain and Behavior<br />(doi:10.1002/brb3.1869)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.10.9</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">佐々木 雅之</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Development and evaluation of an automated quantification tool for amyloid PET images</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1186/s40658-020-00329-4\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">EJNMMI Physics<br />(doi:10.1186/s40658-020-00329-4)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.9.29</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">佐々木 雅之</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Feasibility study of a PET-only amyloid quantification method: a comparison with visual interpretation</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1007/s12149-020-01486-3\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Annals of Nuclear Medicine<br />(doi:10.1007/s12149-020-01486-3)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.6.13</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">山口 修平</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Prediction of conversion to Alzheimer’s disease using deep survival analysis of MRI images</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1093/braincomms/fcaa057\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Brain Communications<br />(doi:10.1093/braincomms/fcaa057)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.5.27</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">岡田 随象</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Trans-biobank analysis with 676,000 individuals elucidates the association of polygenic risk scores of complex traits with human lifespan</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41591-020-0785-8\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Medicine<br />(doi:10.1038/s41591-020-0785-8)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.3.23</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=220&amp;Itemid=486&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000012</a>、<a href=\"/hum0014-latest\" target=\"_blank\">JGAD000124</a>、<br /><a href=\"/hum0014-latest\" target=\"_blank\">JGAD000144-JGAD000201</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">鈴木 一詩</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1002/trc2.12007\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer’s &amp; Dementia<br />(doi:10.1002/trc2.12007)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.3.20</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">青島 健</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.trci.2019.06.004\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer’s &amp; Dementia<br />(doi:10.1016/j.trci.2019.06.004)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.3.20</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">加藤 隆司</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1007/s12149-019-01420-2\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Annals of Nuclear Medicine<br />(doi:10.1007/s12149-019-01420-2)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2019.11.20</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">菊池 正史</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Current Landscape of Late-Phase Clinical Trials for Alzheimer’s Disease: Comparing Regional Variation Between Subjects in Japan and North America</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1007/s40290-019-00306-y\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Pharmaceutical Medicine<br />(doi:10.1007/s40290-019-00306-y)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2019.11.2</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">千田 道雄</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Voxel-based statistical analysis and quantification of amyloid PET in the Japanese Alzheimer’s disease neuroimaging initiative (J-ADNI) multi-center study</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://dx.doi.org/10.1186/s13550-019-0561-2\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">EJNMMI Research<br />(doi:10.1186/s13550-019-0561-2)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2019.9.18</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Robert Bradley</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.devcel.2019.06.011\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Developmental Cell<br />(doi:10.1016/j.devcel.2019.06.011)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2019.7.18</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=310&amp;Itemid=596&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000047</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Christina Curtis</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Quantitative evidence for early metastatic seeding in colorectal cancer</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41588-019-0423-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Genetics<br />(doi:10.1038/s41588-019-0423-x)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2019.7.17</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=345&amp;Itemid=1345&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000060</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Ana M. Aransay</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">A Comprehensive Study of Vesicular and Non-Vesicular miRNAs from a Volume of Cerebrospinal Fluid Compatible with Clinical Practice</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.7150/thno.31502\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Theranostics<br />(doi:10.7150/thno.31502)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2019.6.19</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"/hum0069-v1\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000064</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">鈴木 一詩</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Effects of sex, educational background, and chronic kidney disease grading on longitudinal cognitive and functional decline in patients in the Japanese Alzheimer's Disease Neuroimaging Initiative study</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.trci.2018.06.008\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer’s &amp; Dementia<br />(doi:10.1016/j.trci.2018.06.008)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2018.7.12</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">野口 恵美子</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">HLA-DQ and RBFOX1 as susceptibility genes for an outbreak of hydrolyzed wheat allergy</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jaci.2019.06.034\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">MECHANISMS OF ALLERGY/IMMUNOLOGY<br />(doi:10.1016/j.jaci.2019.06.034)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2018.7.10</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=220&amp;Itemid=486&amp;lang=ja\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000012</a>、<a href=\"/hum0028-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000018</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">松田 博史</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">The association between “Brain-Age Score” (BAS) and traditional neuropsychological screening tools in Alzheimer's disease</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1002/brb3.1020\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Brain and Behavior<br />(doi:10.1002/brb3.1020)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2018.6.22</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Michael C Donohue</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jalz.2018.03.009\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer’s &amp; Dementia<br />(doi:10.1016/j.jalz.2018.03.009)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2018.5.9</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Danielle Harvey</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jalz.2018.03.009\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer’s &amp; Dementia<br />(doi:10.1016/j.jalz.2018.03.009)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2018.5.9</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">鈴木 一詩</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jalz.2018.03.009\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer’s &amp; Dementia<br />(doi:10.1016/j.jalz.2018.03.009)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2018.5.9</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">堀江 真史</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1158/1541-7786.MCR-17-0191\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Molecular Cancer Research<br />(doi:10.1158/1541-7786.MCR-17-0191)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2017.10.1</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"/hum0083-latest\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000070</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Michael C Donohue</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cross-validation of optimized composites for preclinical Alzheimer's disease</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.trci.2016.12.001\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer’s &amp; Dementia: Translational Research &amp; Clinical Interventions <br />(doi:10.1016/j.trci.2016.12.001)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2016.12.26</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">石井 賢二</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11C-PiB PET amyloid images of the Japanese Alzheimer’s Disease Neuroimaging Initiative (J-ADNI) multicenter study</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1007/s00259-016-3591-2\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">European Journal of Nuclear Medicine and Molecular Imaging <br />(doi:10.1007/s00259-016-3591-2)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2016.12.13</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">千田 道雄</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11C-PiB PET amyloid images of the Japanese Alzheimer’s Disease Neuroimaging Initiative (J-ADNI) multicenter study</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1007/s00259-016-3591-2\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">European Journal of Nuclear Medicine and Molecular Imaging<br />(doi:10.1007/s00259-016-3591-2)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2016.12.13</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">松田 博史</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Sample Size Estimation for Alzheimer’s Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.3233/JAD-160621\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"> Journal of Alzheimer's Disease<br />(doi:10.3233/JAD-160621)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2016.10.12</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">松田 博史</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Histogram-Based Feature Extraction from Individual Gray Matter Similarity-Matrix for Alzheimer’s Disease Classification</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.3233/JAD-160850\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Alzheimer's Disease<br />(doi:10.3233/JAD-160850)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2016.10.6</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">千田 道雄</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Phantom criteria for qualification of brain FDG and amyloid PET across different cameras</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://dx.doi.org/10.1186%2Fs40658-016-0159-y\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">EJNMMI Physics<br />(doi:10.1186%2Fs40658-016-0159-y)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2016.10.6</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=273&amp;Itemid=559&amp;lang=ja\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n</tbody>\r\n</table>", "publish_up": "2016-12-06"}, {"lang": "en", "path": "publications", "title": "成果発表（英語）", "fulltext": "", "modified": "2025-09-12", "introtext": "<h1><span style=\"text-decoration: underline; font-family: helvetica; font-size: 15pt;\"><strong>Publications which were used controlled-access data registered in the NBDC human database</strong></span></h1>\r\n<table class=\"table-style style-greystripes\" style=\"width: 90%;\">\r\n<thead>\r\n<tr><th align=\"center\"><span style=\"font-family: helvetica; font-size: 11pt;\"> Principal Investigator </span></th><th align=\"center\"><span style=\"font-family: helvetica; font-size: 11pt;\">Title </span></th><th align=\"center\"><span style=\"font-family: helvetica; font-size: 11pt;\">Journal</span></th><th align=\"center\"><span style=\"font-family: helvetica; font-size: 11pt;\">Published</span></th><th align=\"center\"><span style=\"font-family: helvetica; font-size: 11pt;\">Used Dataset ID</span></th></tr>\r\n</thead>\r\n<tbody>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Tianzhong Yang</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Multiancestry Transcriptome-Wide Association Study Identifies Candidate Genes Associated with Hepatoblastoma</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1158/1055-9965.EPI-24-1553\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cancer Epidemiology Biomarkers &amp; Prevention<br />(doi: 10.1158/1055-9965.EPI-24-1553)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2025.8.1</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0233-v1\" target=\"_blank\">JGAD000334</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Tatsuhiko Tsunoda</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic Target</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1158/2767-9764.CRC-25-0024\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cancer Research Commun<br />(doi: 10.1158/2767-9764.CRC-25-0024)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2025.6.25</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0067-v1\" target=\"_blank\">JGAD000076</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Kouya Shiraishi</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung Adenocarcinoma</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jtho.2025.06.005\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Thoracic Oncology<br />(doi: 10.1016/j.jtho.2025.06.005)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2025.6.12</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"> <a href=\"/en/hum0066-v1\" target=\"_blank\">JGAD000060</a>, <br /> <a href=\"/en/hum0053-latest\" target=\"_blank\">JGAD000062</a>, <br /><a href=\"/en/hum0067-v1\" target=\"_blank\">JGAD000076</a>, <br /> <a href=\"/en/hum0133-v1\" target=\"_blank\">JGAD000086</a>, <br /> <a href=\"/en/hum0058-v1\" target=\"_blank\">JGAD000091</a>, <br /> <a href=\"/en/hum0095-v1\" target=\"_blank\">JGAD000092</a>, <br /> <a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000095</a>, <br /> <a href=\"/en/hum0059-v1\" target=\"_blank\">JGAD000109</a>, <br /> <a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000110</a>, <br /> <a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000111</a>, <br /><a href=\"/en/hum0085-latest\" target=\"_blank\">JGAD000116</a>, <br /> <a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000122</a>, <br /> <a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>, <br /> <a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000124</a>, <br /> <a href=\"/en/hum0158-latest\" target=\"_blank\">JGAD000228</a>, <br /> <a href=\"/en/hum0158-latest\" target=\"_blank\">JGAD000229</a>, <br /> <a href=\"/en/hum0160-latest\" target=\"_blank\">JGAD000233</a>, <br /> <a href=\"/en/hum0140-v1\" target=\"_blank\">JGAD000236</a>, <br /> <a href=\"/en/hum0176-v1\" target=\"_blank\">JGAD000250</a>, <br /> <a href=\"/en/hum0120-latest\" target=\"_blank\">JGAD000311</a>, <br /> <a href=\"/en/hum0120-latest\" target=\"_blank\">JGAD000312</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Takashi Kohno</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung Adenocarcinoma</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jtho.2025.06.005\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Thoracic Oncology<br />(doi: 10.1016/j.jtho.2025.06.005)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2025.6.12</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0060-v1\" target=\"_blank\">JGAD000075</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000209</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Kouya Shiraishi</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Impact of germline variants on breast and ovarian cancer risk in Japanese women: an original cohort study and meta-analysis</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.ebiom.2025.105758\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">eBioMedicine<br />(doi: 10.1016/j.ebiom.2025.105758)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2025.5.21</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"> <a href=\"/en/hum0066-v1\" target=\"_blank\">JGAD000060</a>, <br /> <a href=\"/en/hum0053-latest\" target=\"_blank\">JGAD000062</a>, <br /><a href=\"/en/hum0067-v1\" target=\"_blank\">JGAD000076</a>, <br /> <a href=\"/en/hum0133-v1\" target=\"_blank\">JGAD000086</a>, <br /> <a href=\"/en/hum0058-v1\" target=\"_blank\">JGAD000091</a>, <br /> <a href=\"/en/hum0095-v1\" target=\"_blank\">JGAD000092</a>, <br /> <a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000095</a>, <br /> <a href=\"/en/hum0059-v1\" target=\"_blank\">JGAD000109</a>, <br /> <a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000110</a>, <br /> <a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000111</a>, <br /><a href=\"/en/hum0085-latest\" target=\"_blank\">JGAD000116</a>, <br /> <a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000122</a>, <br /> <a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>, <br /> <a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000124</a>, <br /> <a href=\"/en/hum0158-latest\" target=\"_blank\">JGAD000228</a>, <br /> <a href=\"/en/hum0158-latest\" target=\"_blank\">JGAD000229</a>, <br /> <a href=\"/en/hum0160-latest\" target=\"_blank\">JGAD000233</a>, <br /> <a href=\"/en/hum0140-v1\" target=\"_blank\">JGAD000236</a>, <br /> <a href=\"/en/hum0176-v1\" target=\"_blank\">JGAD000250</a>, <br /> <a href=\"/en/hum0120-latest\" target=\"_blank\">JGAD000311</a>, <br /> <a href=\"/en/hum0120-latest\" target=\"_blank\">JGAD000312</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yukinori Okada</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Dissecting cross-population polygenic heterogeneity across respiratory and cardiometabolic diseases</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-025-58149-y\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi: 10.1038/s41467-025-58149-y)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2025.4.28</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0028-latest\" target=\"_blank\">JGAD000018</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000101</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000102</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000124</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000144- <br />JGAD000201</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Akihiro Hirakawa</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Self-Organized Prediction-Classification-Superposition of Longitudinal Cognitive Decline in Alzheimer's Disease: An Application to Novel Clinical Research Methodology</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1109/JBHI.2025.3546020\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">IEEE Journal of Biomedical and Health Informatics<br />(doi: 10.1109/JBHI.2025.3546020)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2025.2.26</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0043-v1\" target=\"_blank\">JGAD000051</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yongxin LI</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Human microbiome-derived peptide affects the development of experimental autoimmune encephalomyelitis via molecular mimicry</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.ebiom.2024.105516\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">eBioMedicine<br />(doi: 10.1016/j.ebiom.2024.105516)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.12.24</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0197-latest\" target=\"_blank\">JGAD000363</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Emiko Noguchi</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">A genome-wide meta-analysis reveals shared and population-specific variants for allergic sensitization</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jaci.2024.11.033\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Allergy and Clinical Immunology<br />(doi:10.1016/j.jaci.2024.11.033)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.12.5</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0028-latest\" target=\"_blank\">JGAD000018</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Takashi Kohno</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Polygenic Risk Score and Lung Adenocarcinoma Risk Among Never-Smokers by EGFR Mutation Status: A Brief Report</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jtho.2024.11.019\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Thoracic Oncology<br />(doi: 10.1016/j.jtho.2024.11.019)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.11.22</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0060-v1\" target=\"_blank\">JGAD000075</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000209</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Toshiharu Ninomiya</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Common protein-altering variant in GFAP is associated with white matter lesions in the older Japanese population</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41525-024-00431-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">npj Genomic Medicine<br />(doi:10.1038/s41525-024-00431-x)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.11.13</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yukinori Okada</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genetic legacy of ancient hunter-gatherer Jomon in Japanese populations</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-024-54052-0\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi: 10.1038/s41467-024-54052-0)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.11.12</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0028-latest\" target=\"_blank\">JGAD000018</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000101</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000102</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000124</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000144- <br />JGAD000201</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Masahiro Nakatochi</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Copy number variations in RNF216 and postsynaptic membrane–associated genes are associated with bipolar disorder: a case-control study in the Japanese population</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1111/pcn.13752\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Psychiatry Clinical Neurosciences<br />(doi:10.1111/pcn.13752)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.10.15</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0021-latest\" target=\"_blank\">JGAD000379</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yukinori Okada</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Inconsistent embryo selection across polygenic score methods</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41562-024-02019-y\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">nature human behaviour<br />(doi: 10.1038/s41562-024-02019-y)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.10.14</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0028-latest\" target=\"_blank\">JGAD000018</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000101</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000102</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000124</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000144- <br />JGAD000201</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Charles G. Mullighan</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1158/2159-8290.CD-23-1452\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cancer Discovery<br />(doi:10.1158/2159-8290.CD-23-1452)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.10.4</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0096-latest\" target=\"_blank\">JGAD000090</a>, <br /><a href=\"/en/hum0096-latest\" target=\"_blank\">JGAD000207</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yukinori Okada</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Machine learning reveals heterogeneous associations between environmental factors and cardiometabolic diseases across polygenic risk scores</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s43856-024-00596-7\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">communications medicine<br />(doi: 10.1038/s43856-024-00596-7)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.9.20</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0028-latest\" target=\"_blank\">JGAD000018</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000101</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000102</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000124</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000144-<br />JGAD000201</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yukinori Okada</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Large-scale cross-trait genetic analysis highlights shared genetic backgrounds of autoimmune diseases</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1080/25785826.2024.2394258\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Immunological Medicine<br />(doi: 10.1080/25785826.2024.2394258)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.8.22</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0028-latest\" target=\"_blank\">JGAD000018</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000101</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000102</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000124</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000144- <br />JGAD000201</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Charles G. Mullighan</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">The genomic basis of childhood T-lineage acute lymphoblastic leukaemia</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41586-024-07807-0\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature<br />(doi:10.1038/s41586-024-07807-0)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.8.14</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0096-latest\" target=\"_blank\">JGAD000090</a>, <br /><a href=\"/en/hum0096-latest\" target=\"_blank\">JGAD000207</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Takeshi Kaneko</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">HLA-DQA1*01:03 and DQB1*06:01 are risk factors for severe COVID-19 pneumonia</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1111/tan.15609\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">HLA<br />(doi: 10.1111/tan.15609)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.7.23</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0028-latest\" target=\"_blank\">JGAD000018</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yukinori Okada</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Common and rare genetic variants predisposing females to unexplained recurrent pregnancy loss</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-024-49993-5\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi:10.1038/s41467-024-49993-5)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.7.17</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0012-v1\" target=\"_blank\">JGAD000012</a>, <br /><a href=\"/en/hum0028-latest\" target=\"_blank\">JGAD000018</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000101</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000102</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000124</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000144-JGAD000201</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Shigeo Kamitsuji</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genome-Wide Association Study with Three Control Cohorts of Japanese Patients with Esotropia and Exotropia of Comitant Strabismus and Idiopathic Superior Oblique Muscle Palsy</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.3390/ijms25136986\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Molecular Sciences<br />(doi:10.3390/ijms25136986)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.6.26</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>, <a href=\"/en/hum0311-latest\" target=\"_blank\">JGAD000529</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Chikashi Terao</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">RNF213 Variants, Vasospastic Angina, and Risk of Fatal Myocardial Infarction</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1001/jamacardio.2024.1483\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JAMA Cardiology<br />(doi:10.1001/jamacardio.2024.1483)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.6.18</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000124</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000144-JGAD000201</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000836</a>, <br /><a href=\"/en/hum0311-latest\" target=\"_blank\">JGAD000529</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Charles G. Mullighan</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Conserved epigenetic hallmarks of T cell aging during immunity and malignancy</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s43587-024-00649-5\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Aging<br />(doi:10.1038/s43587-024-00649-5)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.6.12</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0096-latest\" target=\"_blank\">JGAD000090</a>, <br /><a href=\"/en/hum0096-latest\" target=\"_blank\">JGAD000207</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yukinori Okada</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Body mass index stratification optimizes polygenic prediction of type 2 diabetes in cross-biobank analyses</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41588-024-01782-y\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Genetics<br />(doi:10.1038/s41588-024-01782-y)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.6.11</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0012-v1\" target=\"_blank\">JGAD000012</a>, <br /><a href=\"/en/hum0028-latest\" target=\"_blank\">JGAD000018</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000101</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000102</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000124</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000144-JGAD000201</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Chikashi Terao</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">A genome-wide association study identifies a locus associated with knee extension strength in older Japanese individuals</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s42003-024-06108-6\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Communications Biology<br />(doi:10.1038/s42003-024-06108-6)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.5.20</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000124</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000144-JGAD000201</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000836</a>, <br /><a href=\"/en/hum0311-latest\" target=\"_blank\">JGAD000529</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Martin Hofmann-Apitius</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Semantic Harmonization of Alzheimer’s Disease Datasets Using AD-Mapper</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.3233/JAD-240116\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">The Journal of Prevention of Alzheimer's Disease<br />(doi:10.3233/JAD-240116)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.5.15</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0043-v1\" target=\"_blank\">JGAD000051</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yasuhiko Ikari</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Improved Correlation of 18F-Flortaucipir PET SUVRs and Clinical Stages in the Alzheimer Disease Continuum with the MUBADA/PERSI-Based Analysis</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.2967/jnmt.123.267113\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Nuclear Medicine Technology<br />(doi:10.2967/jnmt.123.267113)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.4.16</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0235-v1\" target=\"_blank\">JGAD000378</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yukinori Okada</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genetic drivers of heterogeneity in type 2 diabetes pathophysiology</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41586-024-07019-6\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature<br />(doi:10.1038/s41586-024-07019-6)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.3.14</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0012-v1\" target=\"_blank\">JGAD000012</a>, <br /><a href=\"/en/hum0028-latest\" target=\"_blank\">JGAD000018</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000101</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000102</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000124</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000144-JGAD000201</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Chikashi Terao</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-023-44541-z\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi:10.1038/s41467-023-44541-z)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.1.31</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000124</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000144-JGAD000201</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000836</a>, <br /><a href=\"/en/hum0311-latest\" target=\"_blank\">JGAD000529</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Eric Westman</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">A deep learning model for brain age prediction using minimally preprocessed T1w images as input</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.3389/fnagi.2023.1303036\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Frontiers in Aging Neuroscience<br />(doi:10.3389/fnagi.2023.1303036)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.1.8</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Martin Hofmann-Apitius</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Data-Driven Thresholding Statistically Biases ATN Profiling across Cohort Datasets</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.14283/jpad.2023.100\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">The Journal of Prevention of Alzheimer's Disease<br />(doi:10.14283/jpad.2023.100)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2024.1</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0043-v1\" target=\"_blank\">JGAD000051</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Koya Fukunaga</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Differential Effects of HLA-B∗15:11 and HLA-A∗31:01 on Carbamazepine-Induced Cutaneous Adverse Reactions</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jid.2023.09.282\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Investigative Dermatology<br />(doi:10.1016/j.jid.2023.09.282)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.10.30</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0028-latest\" target=\"_blank\">JGAD000018</a>, <a href=\"/en/hum0114-latest\" target=\"_blank\">JGAD000425</a>, <br /><a href=\"/en/hum0311-latest\" target=\"_blank\">JGAD000529</a>, <a href=\"/en/hum0311-latest\" target=\"_blank\">JGAD000660</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Takashi Kohno</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome-wide association and whole genome sequencing analyses</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1002/cac2.12498\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cancer Communication<br />(doi:10.1002/cac2.12498)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.10.26</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Kouya Shiraishi</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome-wide association and whole genome sequencing analyses</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1002/cac2.12498\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cancer Communication<br />(doi:10.1002/cac2.12498)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.10.26</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0066-v1\" target=\"_blank\">JGAD000060</a>, <a href=\"/en/hum0053-latest\" target=\"_blank\">JGAD000062</a>, <br /><a href=\"/en/hum0067-v1\" target=\"_blank\">JGAD000076</a>, <a href=\"/en/hum0133-v1\" target=\"_blank\">JGAD000086</a>, <br /><a href=\"/en/hum0058-v1\" target=\"_blank\">JGAD000091</a>, <a href=\"/en/hum0095-v1\" target=\"_blank\">JGAD000092</a>, <br /><a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000095</a>, <a href=\"/en/hum0059-v1\" target=\"_blank\">JGAD000109</a>, <br /><a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000110</a>, <a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000111</a>, <br /><a href=\"/en/hum0085-latest\" target=\"_blank\">JGAD000116</a>, <a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000122</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000124</a>, <br /><a href=\"/en/hum0158-latest\" target=\"_blank\">JGAD000228</a>, <a href=\"/en/hum0158-latest\" target=\"_blank\">JGAD000229</a>, <br /><a href=\"/en/hum0160-latest\" target=\"_blank\">JGAD000233</a>, <a href=\"/en/hum0140-v1\" target=\"_blank\">JGAD000236</a>, <br /><a href=\"/en/hum0176-v1\" target=\"_blank\">JGAD000250</a>, <a href=\"/en/hum0120-latest\" target=\"_blank\">JGAD000311</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Takashi Kohno</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Contribution of an Asian-prevalent HLA haplotype to the risk of HBV-related hepatocellular carcinoma</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41598-023-40000-3\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Scientific Reports<br />(doi:10.1038/s41598-023-40000-3)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.8.9</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"/en/hum0028-latest\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000018</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Takashi Kohno</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Contribution of an Asian-prevalent HLA haplotype to the risk of HBV-related hepatocellular carcinoma</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41598-023-40000-3\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Scientific Reports<br />(doi:10.1038/s41598-023-40000-3)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.8.9</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Takashi Kohno</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Contribution of an Asian-prevalent HLA haplotype to the risk of HBV-related hepatocellular carcinoma</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41598-023-40000-3\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Scientific Reports<br />(doi: 10.1038/s41598-023-40000-3)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.8.9</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"> <a href=\"/en/hum0159-latest\" target=\"_blank\">JGAD000235</a>, <br /> <a href=\"/en/hum0187-latest\" target=\"_blank\">JGAD000277</a>, <br /> <a href=\"/en/hum0216-latest\" target=\"_blank\">JGAD000302</a>, <br /> <a href=\"/en/hum0227-v1\" target=\"_blank\">JGAD000320</a>, <br /> <a href=\"/en/hum0227-v1\" target=\"_blank\">JGAD000321</a>, <br /> <a href=\"/en/hum0216-latest\" target=\"_blank\">JGAD000327</a>, <br /> <a href=\"/en/hum0187-latest\" target=\"_blank\">JGAD000328</a>, <br /> <a href=\"/en/hum0187-latest\" target=\"_blank\">JGAD000329</a>, <br /> <a href=\"/en/hum0187-latest\" target=\"_blank\">JGAD000330</a>, <br /> <a href=\"/en/hum0236-v1\" target=\"_blank\">JGAD000345</a>, <br /> <a href=\"/en/hum0216-latest\" target=\"_blank\">JGAD000385</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Kouya Shiraishi</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Contribution of an Asian-prevalent HLA haplotype to the risk of HBV-related hepatocellular carcinoma</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41598-023-40000-3\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Scientific Reports<br />(doi:10.1038/s41598-023-40000-3)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.8.9</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0066-v1\" target=\"_blank\">JGAD000060</a>, <a href=\"/en/hum0053-latest\" target=\"_blank\">JGAD000062</a>, <br /><a href=\"/en/hum0067-v1\" target=\"_blank\">JGAD000076</a>, <a href=\"/en/hum0133-v1\" target=\"_blank\">JGAD000086</a>, <br /><a href=\"/en/hum0058-v1\" target=\"_blank\">JGAD000091</a>, <a href=\"/en/hum0095-v1\" target=\"_blank\">JGAD000092</a>, <br /><a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000095</a>, <a href=\"/en/hum0059-v1\" target=\"_blank\">JGAD000109</a>, <br /><a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000110</a>, <a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000111</a>, <br /><a href=\"/en/hum0085-latest\" target=\"_blank\">JGAD000116</a>, <a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000122</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000124</a>, <br /><a href=\"/en/hum0158-latest\" target=\"_blank\">JGAD000228</a>, <a href=\"/en/hum0158-latest\" target=\"_blank\">JGAD000229</a>, <br /><a href=\"/en/hum0160-latest\" target=\"_blank\">JGAD000233</a>, <a href=\"/en/hum0140-v1\" target=\"_blank\">JGAD000236</a>, <br /><a href=\"/en/hum0176-v1\" target=\"_blank\">JGAD000250</a>, <a href=\"/en/hum0120-latest\" target=\"_blank\">JGAD000311</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Hiroki Masuda</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41598-023-38893-1\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Scientific Reports<br />(doi: 10.1038/s41598-023-38893-1)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.8.3</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Danny Chi Yeu Leung</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Single-cell analysis reveals transcriptomic and epigenomic impacts on the maternal-fetal interface following SARS-CoV-2 infection</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41556-023-01169-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Cell Biology<br />(doi:10.1038/s41556-023-01169-x)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.7.3</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0086-latest\" target=\"_blank\">JGAD000073</a>, <a href=\"/en/hum0086-latest\" target=\"_blank\">JGAD000115</a>, <br /><a href=\"index.php?option=com_content&amp;view=article&amp;id=637&amp;Itemid=1070&amp;lang=en\" target=\"_blank\">JGAD000121</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yukinori Okada</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Pan-cancer and cross-population genome-wide association studies dissect shared genetic backgrounds underlying carcinogenesis</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-023-39136-7\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi: 10.1038/s41467-023-39136-7)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.6.20</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000101</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000102</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000123</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000124</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000144-JGAD000201</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000220</a>, <a href=\"/en/hum0028-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000018</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Ming-an Sun</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Endogenous retrovirus-derived enhancers confer the transcriptional regulation of human trophoblast syncytialization</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1093/nar/gkad109\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nucleic Acids Research<br />(doi:10.1093/nar/gkad109)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.6.9</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0086-latest\" target=\"_blank\">JGAD000073</a>, <br /><a href=\"/en/hum0086-latest\" target=\"_blank\">JGAD000115</a>, <a href=\"/en/hum0112-v1\" target=\"_blank\">JGAD000121</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Takashi Kohno</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-023-38196-z\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi:10.1038/s41467-023-38196-z)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.5.26</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yukinori Okada</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Reconstruction of the personal information from human genome reads in gut metagenome sequencing data</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41564-023-01381-3\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Microbiology<br />(doi:10.1038/s41564-023-01381-3)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.5.15</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0311-latest\" target=\"_blank\">JGAD000529</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yukinori Okada</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">A genome-wide association study for allergen component sensitizations identifies allergen component-specific and allergen protein group-specific associations</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jacig.2023.100086\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">The Journal of Allergy and Clinical Immunology: Global<br />(doi:10.1016/j.jacig.2023.100086)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.5</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Emiko Noguchi</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">A genome-wide association study for allergen component sensitizations identifies allergen component-specific and allergen protein group-specific associations</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jacig.2023.100086\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">The Journal of Allergy and Clinical Immunology: Global<br />(doi:10.1016/j.jacig.2023.100086)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.5</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Ansuman Satpathy</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.ccell.2023.03.009\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cancer Cell<br />(doi:10.1016/j.ccell.2023.03.009)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.4.10</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0320-v1\" target=\"_blank\">JGAD000597</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Ming-an Sun</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Regulation of endogenous retrovirus–derived regulatory elements by GATA2/3 and MSX2 in human trophoblast stem cells</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1101/gr.277150.122\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genome Research<br />(doi:10.1101/gr.277150.122)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.2.17</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0086-latest\" target=\"_blank\">JGAD000073</a>, <br /><a href=\"/en/hum0086-latest\" target=\"_blank\">JGAD000115</a>, <a href=\"/en/hum0112-v1\" target=\"_blank\">JGAD000121</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Martin Hofmann-Apitius</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Forecasting individual progression trajectories in Alzheimer’s disease</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-022-35712-5\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi:10.1038/s41467-022-35712-5)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.2.10</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Ulf Leser</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.3390/cancers15030936\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cancers<br />(doi:10.3390/cancers15030936)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.2.1</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0201-latest\" target=\"_blank\">JGAD000336</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Shigeo Kamitsuji</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genetic Backgrounds Associated With Stent Thrombosis: A Pilot Study From a Percutaneous Coronary Intervention Registry</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jacadv.2022.100172\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JACC: Advances<br />(doi:10.1016/j.jacadv.2022.100172)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2023.1.27</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000123</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000124</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000145</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000146</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000149</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000151</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000155</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000156</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000158</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000159</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000163</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000165</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000166</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000167</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000170</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000172</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000173</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000174</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000175</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000182</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000187</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000188</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000189</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000192</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000193</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000194</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000195</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000196</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000200</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000201</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Christian Wachinger</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Identification of causal effects of neuroanatomy on cognitive decline requires modeling unobserved confounders</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1002/alz.12825\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer's &amp; Dementia<br />(doi:10.1002/alz.12825)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.11.23</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Eric Westman</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer’s disease</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-022-32202-6\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi:10.1038/s41467-022-32202-6)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.8.5</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Masaki Mandai</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1136/jitc-2022-004831\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal for ImmunoTherapy of Cancer<br />(doi:10.1136/jitc-2022-004831)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.7.22</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0030-v1\" target=\"_blank\">JGAD000022</a>, <a href=\"/en/hum0060-v1\" target=\"_blank\">JGAD000075</a>, <br /><a href=\"/en/hum0067-v1\" target=\"_blank\">JGAD000076</a>, <a href=\"/en/hum0058-v1\" target=\"_blank\">JGAD000091</a>, <br /><a href=\"/en/hum0133-v1\" target=\"_blank\">JGAD000086</a>, <a href=\"/en/hum0094-latest\">JGAD000095</a>, <br /><a href=\"/en/hum0059-v1\" target=\"_blank\">JGAD000109</a>, <a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000110</a>, <br /><a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000111</a>, <a href=\"/en/hum0094-latest\" target=\"_blank\">JGAD000122</a>, <br /><a href=\"/en/hum0127-v2\" target=\"_blank\">JGAD000141</a>, <a href=\"/en/hum0176-v1\" target=\"_blank\">JGAD000250</a>, <br /><a href=\"/en/hum0175-v1\" target=\"_blank\">JGAD000254</a>, <a href=\"/en/hum0127-v2\" target=\"_blank\">JGAD000380</a></span></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Akihiro Hirakawa</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Estimating the longitudinal trajectory of cognitive function measurement using short-term data with different disease stages: Application in Alzheimer's disease</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1002/sim.9504\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Statics in Medicine<br />(doi:10.1002/sim.9504)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.6.24</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Kikuko Hotta</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1186/s12876-022-02360-4\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">BMC Gastroenterology<br />(doi:10.1186/s12876-022-02360-4)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.6.2</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0055-v1\" target=\"_blank\">JGAD000059</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yukinori Okada</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41588-022-01058-3\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Genetics<br />(doi:10.1038/s41588-022-01058-3)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.5.12</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"> <a href=\"index.php?option=com_content&amp;view=article&amp;id=153&amp;Itemid=467&amp;lang=en\" target=\"_blank\">JGAD000012</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Martin Hofmann-Apitius</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer’s disease</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1186/s13195-022-01001-y\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer's Research &amp; Therapy<br />(doi:10.1186/s13195-022-01001-y)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.4.20</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yuanzhong Li</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">A high-generalizability machine learning framework for predicting the progression of Alzheimer’s disease using limited data</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41746-022-00577-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">npj Digital Medicine<br />(doi:10.1038/s41746-022-00577-x)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.4.12</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Jonghwan Kim</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Induction of human trophoblast stem-like cells from primed pluripotent stem cells</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1073/pnas.2115709119\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cell Biology<br />(doi:10.1073/pnas.2115709119)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.3.26</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0040-v1\" target=\"_blank\">JGAD000038</a>, <a href=\"/en/hum0086-latest\" target=\"_blank\">JGAD000073</a>, <br /><a href=\"/en/hum0086-latest\" target=\"_blank\">JGAD000115</a>, <a href=\"en/hum0112-v1\" target=\"_blank\">JGAD000121</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Teruhisa Hochin</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Extraction of Genes and Transcripts Associated with Liver Cancer Using Machine Learning</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.52731/ijscai.v6.i1.628\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">International Journal of Smart Computing and Artificial Intelligence<br />(doi:10.52731/ijscai.v6.i1.628)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.3.11</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0058-v1\" target=\"_blank\">JGAD000091</a>, <a href=\"/en/hum0058-v1\" target=\"_blank\">JGAD000228</a>, <br /><a href=\"/en/hum0058-v1\" target=\"_blank\">JGAD000229</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yukinori Okada</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Decoding the diversity of killer immunoglobulin-like receptors by deep sequencing and a high-resolution imputation method</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.xgen.2022.100101\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cell Genomics<br />(doi:10.1016/j.xgen.2022.100101)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2022.3.9</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000123</a>、<a href=\"/en/hum0014-latest\" target=\"_blank\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Charles G. Mullighan</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1158/2159-8290.cd-21-0145\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cancer Discovery<br />(doi:10.1158/2159-8290.cd-21-0145)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.11.1</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"/en/hum0096-latest\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000090</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yukinori Okada</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">A cross-population atlas of genetic associations for 220 human phenotypes</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41588-021-00931-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Genetics<br />(doi:10.1038/s41588-021-00931-x)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.9.30</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0028-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000018</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Taisei Mushiroda</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genome-wide association study reveals an association between the HLA-DPB1∗02:01:02 allele and wheat-dependent exercise-induced anaphylaxis</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.ajhg.2021.06.017\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">American Journal of Human Genetics<br />(doi:10.1016/j.ajhg.2021.06.017)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.7.9</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"/en/hum0028-latest\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000018</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Charles de Bock</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41467-021-24442-9\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Communications<br />(doi:10.1038/s41467-021-24442-9)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.7.6</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"/en/hum0096-latest\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000090</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Martin Hofmann-Apitius</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Unraveling the heterogeneity in Alzheimer's disease progression across multiple cohorts and the implications for data-driven disease modeling</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1002/alz.12387\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer’s &amp; Dementia<br />(doi:10.1002/alz.12387)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.6.9</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Masayuki Sasaki</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Improved Accuracy of Amyloid PET Quantification with Adaptive Template–Based Anatomic Standardization</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.2967/jnmt.120.261701\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Nuclear Medicine Technology<br />(doi:10.2967/jnmt.120.261701)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.4.5</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Eric Westman</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Stage vs. Subtype Hypothesis in Alzheimer's Disease: A Multi-Cohort and Longitudinal Bayesian Clustering Study</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.2139/ssrn.3797614\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">LANCET<br />(doi:10.2139/ssrn.3797614)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.3.4</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yukinori Okada</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Clinical use of current polygenic risk scores may exacerbate health disparities</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41588-019-0379-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Genetics<br />(doi:10.1038/s41588-019-0379-x)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.1.28</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000101</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000102</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000123</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yosuke Kawai</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Genome-wide SNP data of Izumo and Makurazaki populations support inner-dual structure model for origin of Yamato people</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s10038-020-00898-3\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Human Genetics<br />(doi:10.1038/s10038-020-00898-3)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2021.1.25</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000123</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000124</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000144-JGAD000201</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000220</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Martin Hofmann-Apitius</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Evaluating the Alzheimer's disease data landscape</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1002/trc2.12102\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer's &amp; Dementia<br />(doi:10.1002/trc2.12102)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.12.16</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"/en/hum0043-v1\" target=\"_blank\">JGAD000051</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Brock Christensen</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Altered immune phenotype and DNA methylation in panic disorder</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://dx.doi.org/10.1186/s13148-020-00972-9\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Clinical Epigenetics<br />(doi:10.1186/s13148-020-00972-9)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.11.18</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=478&amp;Itemid=892&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000120</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Tadanori Fukami</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Longitudinal analysis of brain structure using existence probability</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://dx.doi.org/10.1002/brb3.1869\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Brain and Behavior<br />(doi:10.1002/brb3.1869)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.10.9</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Masayuki Sasaki</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Development and evaluation of an automated quantification tool for amyloid PET images</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1186/s40658-020-00329-4\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">EJNMMI Physics<br />(doi:10.1186/s40658-020-00329-4)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.9.29</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Masayuki Sasaki</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Feasibility study of a PET-only amyloid quantification method: a comparison with visual interpretation</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1007/s12149-020-01486-3\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Annals of Nuclear Medicine<br />(doi:10.1007/s12149-020-01486-3)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.6.13</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Shuhei Yamaguchi</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Prediction of conversion to Alzheimer’s disease using deep survival analysis of MRI images</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1093/braincomms/fcaa057\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Brain Communications<br />(doi:10.1093/braincomms/fcaa057)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.5.27</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Yukinori Okada</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Trans-biobank analysis with 676,000 individuals elucidates the association of polygenic risk scores of complex traits with human lifespan</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41591-020-0785-8\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Medicine<br />(doi:10.1038/s41591-020-0785-8)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.3.23</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=153&amp;Itemid=467&amp;lang=en\" target=\"_blank\">JGAD000012</a>, <a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000124</a>, <br /><a href=\"/en/hum0014-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000144-JGAD000201</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Kazushi Suzuki</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1002/trc2.12007\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer’s &amp; Dementia<br />(doi:10.1002/trc2.12007)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.3.20</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Ken Aoshima</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.trci.2019.06.004\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer’s &amp; Dementia<br />(doi:10.1016/j.trci.2019.06.004)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2020.3.20</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Takashi Kato</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1007/s12149-019-01420-2\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Annals of Nuclear Medicine<br />(doi:10.1007/s12149-019-01420-2)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2019.11.20</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Masashi Kikuchi</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Current Landscape of Late-Phase Clinical Trials for Alzheimer’s Disease: Comparing Regional Variation Between Subjects in Japan and North America</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1007/s40290-019-00306-y\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Pharmaceutical Medicine<br />(doi:10.1007/s40290-019-00306-y)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2019.11.2</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Michio Senda</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Voxel-based statistical analysis and quantification of amyloid PET in the Japanese Alzheimer’s disease neuroimaging initiative (J-ADNI) multi-center study</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://dx.doi.org/10.1186/s13550-019-0561-2\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">EJNMMI Research<br />(doi:10.1186/s13550-019-0561-2)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2019.9.18</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Robert Bradley</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.devcel.2019.06.011\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Developmental Cell<br />(doi:10.1016/j.devcel.2019.06.011)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2019.7.18</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=320&amp;Itemid=690&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000047</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Christina Curtis</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Quantitative evidence for early metastatic seeding in colorectal cancer</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1038/s41588-019-0423-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Nature Genetics<br />(doi:10.1038/s41588-019-0423-x)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2019.7.17</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=353&amp;Itemid=743&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000060</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Ana M. Aransay</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">A Comprehensive Study of Vesicular and Non-Vesicular miRNAs from a Volume of Cerebrospinal Fluid Compatible with Clinical Practice</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.7150/thno.31502\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Theranostics<br />(doi:10.7150/thno.31502)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2019.6.19</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"/en/hum0069-v1\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000064</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Kazushi Suzuki</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Effects of sex, educational background, and chronic kidney disease grading on longitudinal cognitive and functional decline in patients in the Japanese Alzheimer's Disease Neuroimaging Initiative study</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.trci.2018.06.008\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer’s &amp; Dementia<br />(doi:10.1016/j.trci.2018.06.008)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2018.7.12</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Emiko Noguchi</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">HLA-DQ and RBFOX1 as susceptibility genes for an outbreak of hydrolyzed wheat allergy</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jaci.2019.06.034\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">MECHANISMS OF ALLERGY/IMMUNOLOGY<br />(doi:10.1016/j.jaci.2019.06.034)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2018.7.10</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"> <a href=\"index.php?option=com_content&amp;view=article&amp;id=153&amp;Itemid=467&amp;lang=en\" target=\"_blank\">JGAD000012</a>, <a href=\"/en/hum0028-latest\" target=\"_blank\" rel=\"noopener noreferrer\">JGAD000018</a></span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Hiroshi Matsuda</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">The association between “Brain-Age Score” (BAS) and traditional neuropsychological screening tools in Alzheimer's disease</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1002/brb3.1020\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Brain and Behavior<br />(doi:10.1002/brb3.1020)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2018.6.22</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Michael C Donohue</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jalz.2018.03.009\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer’s &amp; Dementia<br />(doi:10.1016/j.jalz.2018.03.009)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2018.5.9</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Danielle Harvey</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jalz.2018.03.009\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer’s &amp; Dementia<br />(doi:10.1016/j.jalz.2018.03.009)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2018.5.9</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Kazushi Suzuki</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.jalz.2018.03.009\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer’s &amp; Dementia<br />(doi:10.1016/j.jalz.2018.03.009)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2018.5.9</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Masafumi Horie</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1158/1541-7786.MCR-17-0191\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Molecular Cancer Research<br />(doi:10.1158/1541-7786.MCR-17-0191)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2017.10.1</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"/en/hum0083-latest\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000070</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Michael C Donohue</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Cross-validation of optimized composites for preclinical Alzheimer's disease</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1016/j.trci.2016.12.001\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Alzheimer’s &amp; Dementia: Translational Research &amp; Clinical Interventions <br />(doi:10.1016/j.trci.2016.12.001)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2016.12.26</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Kenji Ishii</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11C-PiB PET amyloid images of the Japanese Alzheimer’s Disease Neuroimaging Initiative (J-ADNI) multicenter study</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1007/s00259-016-3591-2\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">European Journal of Nuclear Medicine and Molecular Imaging <br />(doi:10.1007/s00259-016-3591-2)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2016.12.13</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Michio Senda</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11C-PiB PET amyloid images of the Japanese Alzheimer’s Disease Neuroimaging Initiative (J-ADNI) multicenter study</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.1007/s00259-016-3591-2\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">European Journal of Nuclear Medicine and Molecular Imaging<br />(doi:10.1007/s00259-016-3591-2)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2016.12.13</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Hiroshi Matsuda</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Sample Size Estimation for Alzheimer’s Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.3233/JAD-160621\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\"> Journal of Alzheimer's Disease<br />(doi:10.3233/JAD-160621)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2016.10.12</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Hiroshi Matsuda</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Histogram-Based Feature Extraction from Individual Gray Matter Similarity-Matrix for Alzheimer’s Disease Classification</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://doi.org/10.3233/JAD-160850\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Journal of Alzheimer's Disease<br />(doi:10.3233/JAD-160850)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2016.10.6</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n<tr>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Michio Senda</span></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">Phantom criteria for qualification of brain FDG and amyloid PET across different cameras</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"https://dx.doi.org/10.1186%2Fs40658-016-0159-y\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">EJNMMI Physics<br />(doi:10.1186%2Fs40658-016-0159-y)</span></a></td>\r\n<td style=\"vertical-align: middle;\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">2016.10.6</span></td>\r\n<td style=\"vertical-align: middle;\"><a href=\"index.php?option=com_content&amp;view=article&amp;id=299&amp;Itemid=655&amp;lang=en\" target=\"_blank\"><span style=\"font-family: helvetica; font-size: 10pt; line-height: normal;\">JGAD000051</span></a></td>\r\n</tr>\r\n</tbody>\r\n</table>", "publish_up": "2016-12-06"}, {"lang": "ja", "path": "supported-browsers", "title": "対応ブラウザ", "fulltext": "", "modified": "2024-03-29", "introtext": "<p>NBDCヒトデータベース（humandbs.dbcls.jpドメインのページ）はJoomla CMS 3.xを利用しています。対応ブラウザは<a href=\"https://docs.joomla.org/Joomla_Browser_Support\">Joomla Browser Support</a>をご覧ください。</p>", "publish_up": "2013-01-04"}, {"lang": "en", "path": "supported-browsers", "title": "Supported Browsers", "fulltext": "", "modified": "2024-03-29", "introtext": "<p>The NBDC human database (pages under https://humandbs.dbcls.jp) is powered by Joomla CMS 3.x. See <a href=\"https://docs.joomla.org/Joomla_Browser_Support\">Joomla Browser Support </a>.</p>", "publish_up": "2013-01-04"}, {"lang": "ja", "path": "violation", "title": "ガイドライン違反", "fulltext": "", "modified": "2024-08-18", "introtext": "<p><span style=\"font-family: helvetica; font-size: 15pt;\"><strong>ガイドライン違反について</strong></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　共有ガイドラインの「５－３－３.制限公開データ」において、「データ利用者が、<strong><span style=\"color: #ff0000;\">NBDCヒトデータ共有ガイドライン等に違反</span></strong>してヒトに関するデータを利用した場合、または、データ利用にあたって故意もしくは過失により情報漏洩等が起きた場合には、DBCLSは、データ利用の許可の取り消しや、データ利用者の所属機関の長への当該事実の報告や、<strong><span style=\"color: #ff0000;\">当該事実のウェブサイト等での公表</span></strong>を実施することがある。」と明記しています。</span></p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\"><strong>【データ利用期間中ならびに利用終了時の報告未提出への対応】</strong></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　ヒトデータ審査委員会事務局では、 共有ガイドライン「５－３．データ利用者の責務」における「１０．データ利用者は、データ利用終了時には『NBDCヒトデータベース』から取得したすべてのデータ（中略）をNBDCヒトデータ取扱いセキュリティガイドラインに沿って削除し（中略）、データ利用終了申請によりデータ使用（および破棄）の報告を行うこと（受託者の施設での保管および利用も含む）。」ならびに「５－４．利用の手順」における「６．データ利用者は、1年毎にデータの利用状況を、データ利用報告申請（制限公開データ用）により報告する。」に反して、<strong><span style=\"color: #ff0000;\">データ利用報告申請やデータ利用終了申請が未提出の場合、下記の対応を行います。</span></strong></span></p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　・報告期限後30日ごとに180日後まで最大6回、システムからアラートメールを送信（<strong>180日後のメールは機関の長に同送</strong>）</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　・180日後のメール送信時に、利用を制限（データダウンロードやデータセットの追加等不可）</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　・制限モードに移行したデータ利用者について、当該<strong>データの提供者に情報共有</strong></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　・180日以降も未対応の場合、ヒトデータ審査委員会事務局から直接、督促メールを送信</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">　　・さらに未対応の場合、<strong>機関の長や研究分担者に代行依頼メール</strong>を送信</span></p>\r\n<p>&nbsp;</p>\r\n<p><strong><span style=\"font-family: helvetica; font-size: 11pt;\">なお、今後、必要最小限度の範囲の個人データの公表を行うことがあります。</span></strong></p>", "publish_up": "2013-03-15"}, {"lang": "en", "path": "violation", "title": "Violation", "fulltext": "", "modified": "2024-08-18", "introtext": "<h3><strong><span style=\"color: #000000;\">Act for Violation of the Guidelines</span></strong></h3>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">&nbsp;NBDC Guidelines for Human Data Sharing clearly disclose \"In case the data user used human data <span style=\"color: #ff0000;\"><strong>in violation of the NBDC Human Data Sharing Guidelines</strong></span> etc., or caused information leakage etc. in using data intentionally or with negligence, the DBCLS may take one or more further actions such as rescinding of permission for data use, reporting of the fact to the head of the organization to which the data user belongs, <strong><span style=\"color: #ff0000;\">announcing of the fact on the website</span></strong> etc., and so on.\" in the section 5.3.3.</span></p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\"><strong>[Action to non-submission of reports during and at the end of the data use]</strong></span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">The guidelines also stipulate that</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">- 10. When finished with using data, the data user must delete all data obtained from the NBDC Human Database (..) and all the data that can restore the data in accordance with the NBDC Security Guidelines for Human Data (..), and report on the use (and deletion) of the data, using \"Reporting on the completion of data use\" in the section 5.3.3.</span></p>\r\n<p>- 6. In principle, the data user reports on data use status every year, using \"Reporting on the Use of Controlled-access Data\" in the section 5.4.3</p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">&nbsp;<span style=\"color: #ff0000;\"><strong>If any report is not submitted, the following actions shall be taken by the Human Data Review Board Office.</strong></span></span></p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">&nbsp;&nbsp;-&nbsp; &nbsp;The system will send e-mail alerts every 30 days to 180 days up to 6 times after the end of data use. (<strong>The email after 180 days will be sent also to the head of the organization.</strong>)</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">&nbsp;&nbsp;-&nbsp; &nbsp;Data use shall be restricted not to download data and add set data, etc, in 180 days after the end of data use.</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">&nbsp;&nbsp;-&nbsp; &nbsp;<strong>The fact shall be shared with data submitter</strong> about the data user who has been restricted.</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">&nbsp;&nbsp;-&nbsp; &nbsp;If data user does not respond after 180 days, the secretariat of the Human Data Review Board shall send a reminder email directly.</span></p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">&nbsp;&nbsp;-&nbsp; &nbsp;In case of no response after all, the secretariat of the Human Data Review Board shall send <strong>an email to the head of the organization or the research collaborators</strong>.</span></p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-family: helvetica; font-size: 11pt;\">&nbsp;<strong>In the future, we may release personal data to the minimum extent.</strong></span></p>", "publish_up": "2013-03-15"}]
